Clustering O 0 0.0006482398021034896
of O 0 0.0009089524392038584
missense O 0 0.000922325998544693
mutations O 0 6.477491842815652e-05
in O 0 0.00012127735681133345
the O 0 0.0011596317635849118
ataxia B-Disease 1 1.0
- I-Disease 1 0.9993361830711365
telangiectasia I-Disease 1 0.9985477328300476
gene O 0 2.8584265237441286e-05
in O 0 1.9514194718794897e-05
a O 0 2.4562068574596196e-05
sporadic B-Disease 0 0.0012532270047813654
T I-Disease 1 0.9996249675750732
- I-Disease 0 0.022387756034731865
cell I-Disease 0 0.003513001836836338
leukaemia I-Disease 1 0.9965900182723999
. O 0 0.0004890548880212009

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999972581863403
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.001486032153479755
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9991490840911865
T I-Disease 1 0.999782145023346
) O 0 5.093044364912203e-06
is O 0 1.800755399017362e-06
a O 0 8.081064152065665e-06
recessive B-Disease 0 0.00023585521557834
multi I-Disease 0 0.17678767442703247
- I-Disease 1 0.9705724120140076
system I-Disease 0 0.014227005653083324
disorder I-Disease 1 0.9999988079071045
caused O 0 0.029458923265337944
by O 0 2.9860695576644503e-05
mutations O 0 1.1384900972188916e-05
in O 0 2.44346956606023e-05
the O 0 9.253083408111706e-05
ATM O 0 0.0011403183452785015
gene O 0 2.5631621610955335e-05
at O 0 0.00029736364376731217
11q22 O 0 0.0023139282129704952
- O 0 0.0007381031755357981
q23 O 0 0.0016664584400132298
( O 0 5.913208951824345e-05
ref O 0 0.0026078522205352783
. O 0 2.808690805977676e-05
3 O 0 0.0001321218442171812
) O 0 3.830888817901723e-05
. O 0 8.93172255018726e-05

The O 0 0.0003714654303621501
risk O 0 0.00019309089111629874
of O 0 0.0010577146895229816
cancer B-Disease 1 0.9999971389770508
, O 0 0.00014892267063260078
especially O 0 0.000227789263590239
lymphoid B-Disease 1 0.6081604957580566
neoplasias I-Disease 0 0.05841587856411934
, O 0 1.1577913028304465e-05
is O 0 3.4857030186685733e-06
substantially O 0 6.0392612795112655e-05
elevated O 0 0.0016148376744240522
in O 0 6.984872015891597e-05
A B-Disease 1 0.9999679327011108
- I-Disease 1 0.9997619986534119
T I-Disease 1 0.9999996423721313
patients O 0 5.78686740482226e-05
and O 0 1.173348482552683e-05
has O 0 6.4204950831481256e-06
long O 0 1.5841824279050343e-05
been O 0 4.358587375463685e-06
associated O 0 1.3148156540410127e-05
with O 0 3.8793208659626544e-05
chromosomal O 1 0.9999991655349731
instability O 1 1.0
. O 1 0.5880717039108276

By O 0 8.082546264631674e-05
analysing O 0 0.0011342684738337994
tumour B-Disease 1 0.999998927116394
DNA O 0 0.00033764803083613515
from O 0 5.121723734191619e-05
patients O 0 9.412473445991054e-06
with O 0 4.595299287757371e-06
sporadic B-Disease 0 0.0013596059288829565
T I-Disease 1 0.99893718957901
- I-Disease 0 0.001531908637844026
cell I-Disease 0 0.00025022230693139136
prolymphocytic I-Disease 0 0.3110543191432953
leukaemia I-Disease 1 0.9999465942382812
( O 0 0.0006312328623607755
T B-Disease 1 0.999278724193573
- I-Disease 0 0.009444302879273891
PLL I-Disease 1 0.9930644631385803
) O 0 1.5852147043915465e-05
, O 0 3.538207920428249e-06
a O 0 1.0916311111941468e-05
rare O 0 0.00019775722466874868
clonal B-Disease 0 0.004069695249199867
malignancy I-Disease 0 0.01987120695412159
with O 0 1.3119499271851964e-05
similarities O 0 8.723622886464e-05
to O 0 5.635012348648161e-05
a O 0 0.00015407045430038124
mature B-Disease 0 0.0015198432374745607
T I-Disease 1 0.6564579010009766
- I-Disease 0 0.0021604544017463923
cell I-Disease 0 0.00028007879154756665
leukaemia I-Disease 0 0.0040450566448271275
seen O 0 0.00020339360344223678
in O 0 8.697158773429692e-05
A B-Disease 1 0.9964608550071716
- I-Disease 0 0.09406501799821854
T I-Disease 1 0.9973987340927124
, O 0 8.480315955239348e-06
we O 0 1.442618781766214e-06
demonstrate O 0 7.010988611000357e-06
a O 0 3.226864919270156e-06
high O 0 1.584739948157221e-05
frequency O 0 2.988330152220442e-06
of O 0 5.225441054790281e-05
ATM O 0 0.001726721995510161
mutations O 0 6.0124944866402075e-05
in O 0 0.0004507201083470136
T B-Disease 1 0.9929054975509644
- I-Disease 0 0.01096418872475624
PLL I-Disease 1 0.9883610606193542
. O 0 0.00037110975245013833

In O 0 0.0001658213877817616
marked O 0 0.0005264141364023089
contrast O 0 5.8887977502308786e-05
to O 0 2.9809110856149346e-05
the O 0 0.00018463097512722015
ATM O 0 0.0021920029539614916
mutation O 0 1.2164892723376397e-05
pattern O 0 0.00010054817539639771
in O 0 0.00017507038137409836
A B-Disease 1 0.9993403553962708
- I-Disease 0 0.3307212293148041
T I-Disease 1 0.996292769908905
, O 0 9.396401765116025e-06
the O 0 1.116195198846981e-05
most O 0 2.310019226570148e-06
frequent O 0 2.5551246380928205e-06
nucleotide O 0 4.0529193938709795e-06
changes O 0 3.0546307243639603e-06
in O 0 1.160870488092769e-05
this O 0 1.4673569239675999e-05
leukaemia B-Disease 0 0.01657039485871792
were O 0 0.0001407650561304763
missense O 0 0.0008976972312666476
mutations O 0 0.00034625816624611616
. O 0 0.0003437286941334605

These O 0 7.333444955293089e-05
clustered O 0 0.00013770755322184414
in O 0 1.3217352716310415e-05
the O 0 2.0305240468587726e-05
region O 0 3.4469867387088016e-05
corresponding O 0 1.2570426406455226e-05
to O 0 1.4072120393393561e-05
the O 0 4.514349711826071e-05
kinase O 0 2.8562246370711364e-05
domain O 0 2.1511476006708108e-05
, O 0 2.4141195353877265e-06
which O 0 7.08870913967985e-07
is O 0 1.1641735682133003e-06
highly O 0 1.6432491975137964e-05
conserved O 0 3.44369764206931e-05
in O 0 3.6964316677767783e-05
ATM O 0 0.0016129981959238648
- O 0 0.00012195413728477433
related O 0 1.6141704691108316e-05
proteins O 0 1.0668972208804917e-05
in O 0 3.862421726807952e-05
mouse O 0 2.0048022634000517e-05
, O 0 3.1555287023365963e-06
yeast O 0 1.4032692888577003e-05
and O 0 8.993963092507329e-06
Drosophila O 0 8.843622345011681e-05
. O 0 6.318910891423002e-05

The O 0 0.0004490290302783251
resulting O 0 0.0002666128275450319
amino O 0 0.00010635633225319907
- O 0 0.0002904287539422512
acid O 0 3.060058952542022e-05
substitutions O 0 1.7182443116325885e-05
are O 0 1.1521148053361685e-06
predicted O 0 2.1355986973503605e-05
to O 0 6.530315204145154e-06
interfere O 0 3.893062603310682e-05
with O 0 1.218574743688805e-05
ATP O 0 0.011095079593360424
binding O 0 3.2163119612960145e-05
or O 0 2.9572514904430136e-05
substrate O 0 0.00010460549674462527
recognition O 0 0.00033411415643058717
. O 0 0.0004510686849243939

Two O 0 4.275072933523916e-05
of O 0 0.0002599942381493747
seventeen O 0 0.002263405593112111
mutated O 0 0.001631232094950974
T B-Disease 0 0.10414145141839981
- I-Disease 0 0.0020190177019685507
PLL I-Disease 0 0.01872570626437664
samples O 0 1.4911481230228674e-05
had O 0 1.0580112757452298e-05
a O 0 3.7949105262669036e-06
previously O 0 2.9573782740044408e-05
reported O 0 5.55689912289381e-05
A B-Disease 0 0.23844929039478302
- I-Disease 0 0.11794793605804443
T I-Disease 1 0.9991416931152344
allele O 0 0.00011248040391365066
. O 0 0.0001594762725289911

In O 0 0.00035518844379112124
contrast O 0 0.00011765121598728001
, O 0 1.2795147995348088e-05
no O 0 9.671143743616994e-06
mutations O 0 8.324568625539541e-06
were O 0 1.780135244189296e-05
detected O 0 8.13928636489436e-05
in O 0 6.937772468518233e-06
the O 0 1.849564432632178e-05
p53 O 0 1.1660152267722879e-05
gene O 0 4.932480806019157e-06
, O 0 2.0923530428262893e-06
suggesting O 0 1.238593176822178e-05
that O 0 2.664617568370886e-06
this O 0 2.8122931325924583e-05
tumour B-Disease 1 1.0
suppressor O 0 0.002591091440990567
is O 0 1.2567573321575765e-05
not O 0 1.2037038459311589e-06
frequently O 0 2.1363698579079937e-06
altered O 0 1.601422809471842e-05
in O 0 1.0344314432586543e-05
this O 0 2.85166606772691e-05
leukaemia B-Disease 1 0.9448453187942505
. O 0 0.000607718713581562

Occasional O 0 0.0010128073627129197
missense O 0 0.0011073641944676638
mutations O 0 0.0001193966600112617
in O 0 0.00017196231056004763
ATM O 0 0.002094388473778963
were O 0 3.4221888199681416e-05
also O 0 7.946483492560219e-06
found O 0 7.5262237260176335e-06
in O 0 3.304460187791847e-05
tumour B-Disease 1 0.9999600648880005
DNA O 0 0.00011141676077386364
from O 0 1.4297264897322748e-05
patients O 0 6.3948414208425675e-06
with O 0 6.447136456699809e-06
B B-Disease 0 0.0042293258011341095
- I-Disease 0 0.001000929158180952
cell I-Disease 0 0.00023474493355024606
non I-Disease 0 0.0006102249026298523
- I-Disease 0 0.016463503241539
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9927406907081604
( O 0 0.00015522002649959177
B B-Disease 0 0.0031264203134924173
- I-Disease 0 0.0003750972682610154
NHL I-Disease 0 0.0011624840553849936
) O 0 2.2643457668891642e-06
and O 0 1.7197158967974246e-06
a O 0 1.775598320818972e-05
B B-Disease 0 0.0016813369002193213
- I-Disease 0 0.0005533993826247752
NHL I-Disease 0 0.008309493772685528
cell O 0 0.0006828590994700789
line O 0 0.0005695953732356429
. O 0 9.218541526934132e-05

The O 0 0.0001553359761601314
evidence O 0 5.546401007450186e-05
of O 0 4.900560816167854e-05
a O 0 1.5787498341524042e-05
significant O 0 1.8860448108171113e-05
proportion O 0 2.918217796832323e-05
of O 0 0.00014347927935887128
loss O 0 0.0012597835157066584
- O 0 0.00071602693060413
of O 0 0.00026550531038083136
- O 0 0.0002113260852638632
function O 0 1.7646427295403555e-05
mutations O 0 1.2559258721012156e-05
and O 0 6.142264282971155e-06
a O 0 1.5422994692926295e-05
complete O 0 0.00015599156904499978
absence O 0 0.0004888994735665619
of O 0 0.0003436423430684954
the O 0 0.000231576879741624
normal O 0 9.435826359549537e-05
copy O 0 8.271456317743286e-05
of O 0 0.00017507487791590393
ATM O 0 0.0010107095586135983
in O 0 1.7611271687201224e-05
the O 0 1.455085748602869e-05
majority O 0 4.902887212665519e-06
of O 0 0.0001783336920198053
mutated O 0 0.0019743472803384066
tumours B-Disease 1 0.9999998807907104
establishes O 0 0.001436738995835185
somatic O 0 0.0004231538041494787
inactivation O 0 0.0008654249832034111
of O 0 0.00017777546599972993
this O 0 7.828494744899217e-06
gene O 0 3.6201563489157706e-06
in O 0 6.357967322401237e-06
the O 0 2.636820136103779e-05
pathogenesis O 0 0.06619679182767868
of O 0 0.0005769052659161389
sporadic B-Disease 0 0.1969500333070755
T I-Disease 1 0.9999946355819702
- I-Disease 0 0.03631390258669853
PLL I-Disease 1 0.9910169839859009
and O 0 1.8037109839497134e-05
suggests O 0 2.4892267902032472e-05
that O 0 5.661501745635178e-06
ATM O 0 0.0007493564044125378
acts O 0 8.087650348898023e-05
as O 0 0.00010066972754430026
a O 0 0.0006088434020057321
tumour B-Disease 1 1.0
suppressor O 0 0.21461692452430725
. O 0 0.0005848014843650162

As O 0 0.00022761296713724732
constitutional O 0 0.00024574523558840156
DNA O 0 0.00017633441893849522
was O 0 0.00012196832540212199
not O 0 1.0619530712574488e-06
available O 0 9.070876103578485e-07
, O 0 1.0410535651317332e-06
a O 0 1.1020010788342915e-05
putative O 0 0.0006745963473804295
hereditary O 1 0.9991903901100159
predisposition O 1 0.9999818801879883
to O 1 0.9996556043624878
T B-Disease 1 1.0
- I-Disease 1 0.9980913996696472
PLL I-Disease 1 0.9934961795806885
will O 0 7.889518201409373e-06
require O 0 9.85331212177698e-07
further O 0 6.023497007845435e-06
investigation O 0 3.747371010831557e-05
. O 0 2.4862683858373202e-05
. O 0 5.2656039770226926e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.003410335863009095
kinase O 0 0.0002613066171761602
is O 0 1.409939068253152e-05
involved O 0 4.9180885071109515e-06
in O 0 4.102180355403107e-06
the O 0 1.1433122381276917e-05
modulation O 0 1.8196818928117864e-05
of O 0 2.7752337700803764e-05
the O 0 4.503260788624175e-05
Ca2 O 0 0.0004084597167093307
+ O 0 0.0007315235561691225
homeostasis O 0 0.0024374499917030334
in O 0 0.00031290293554775417
skeletal O 1 0.9999688863754272
muscle O 0 0.020940203219652176
cells O 0 0.001469214679673314
. O 0 0.0005196321872062981

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999432563781738
DM B-Disease 1 1.0
) O 0 0.00023579834669362754
, O 0 9.004535058920737e-06
the O 0 2.3274944396689534e-05
most O 0 4.147367144469172e-05
prevalent O 0 0.4988439083099365
muscular B-Disease 1 0.9999990463256836
disorder I-Disease 1 1.0
in O 0 0.07579096406698227
adults O 0 0.00020754126308020204
, O 0 2.366198896197602e-05
is O 0 1.5865576642681845e-05
caused O 0 0.00015363811689894646
by O 0 2.0092886188649572e-05
( O 0 8.091707422863692e-05
CTG O 0 0.029981829226017
) O 0 1.4513550922856666e-05
n O 0 4.8622823669575155e-05
- O 0 7.542608364019543e-05
repeat O 0 6.552022387040779e-05
expansion O 0 3.381439819349907e-05
in O 0 1.965749561350094e-06
a O 0 9.392533684149384e-07
gene O 0 2.6162609856328345e-07
encoding O 0 4.1094060065915983e-07
a O 0 3.9746278162056115e-06
protein O 0 8.026165232877247e-06
kinase O 0 2.8594351533683948e-05
( O 0 3.614082743297331e-05
DM B-Disease 1 0.9994081258773804
protein O 0 0.00016936534666456282
kinase O 0 7.854312570998445e-05
; O 0 1.8711481970967725e-05
DMPK O 0 0.043941233307123184
) O 0 1.4616447515436448e-05
and O 0 3.12463066620694e-06
involves O 0 9.117900845012628e-06
changes O 0 6.911898253747495e-06
in O 0 6.172842404339463e-05
cytoarchitecture O 0 0.0041095297783613205
and O 0 0.00012033252278342843
ion O 0 0.00495144072920084
homeostasis O 0 0.03180498257279396
. O 0 0.000724424549844116

To O 0 7.076547626638785e-05
obtain O 0 2.03552426683018e-05
clues O 0 0.00012182094360468909
to O 0 8.381077350350097e-06
the O 0 2.1420746634248644e-05
normal O 0 1.4685861970065162e-05
biological O 0 1.663232615101151e-05
role O 0 4.311310112825595e-05
of O 0 0.00020745933579746634
DMPK O 1 0.9991463422775269
in O 0 0.00047072049346752465
cellular O 0 0.001162777654826641
ion O 0 0.0017156824469566345
homeostasis O 0 0.0016908386023715138
, O 0 1.832591624406632e-05
we O 0 2.381015974606271e-06
have O 0 4.780104632118309e-07
compared O 0 6.389989266608609e-06
the O 0 3.3692307624733075e-05
resting O 0 0.0007048719562590122
[ O 0 0.00023015731130726635
Ca2 O 0 0.00040908812661655247
+ O 0 0.00048817950300872326
] O 0 0.00033698315382935107
i O 0 4.2046573071274906e-05
, O 0 2.0133675207034685e-06
the O 0 6.404655323422048e-06
amplitude O 0 2.8169315555715002e-05
and O 0 6.8811632445431314e-06
shape O 0 4.415014700498432e-05
of O 0 0.00024984063929878175
depolarization O 0 0.0010617899242788553
- O 0 0.0009850581409409642
induced O 0 0.0005026113940402865
Ca2 O 0 0.00034354685340076685
+ O 0 0.00039077040855772793
transients O 0 0.0006032069795764983
, O 0 3.3991946111200377e-06
and O 0 9.189116099150851e-07
the O 0 6.870750439702533e-06
content O 0 1.288883595407242e-05
of O 0 0.000212365499464795
ATP O 0 0.027752939611673355
- O 0 0.0014233806869015098
driven O 0 0.00038166847662068903
ion O 0 0.0005826933193020523
pumps O 0 0.000200740629225038
in O 0 0.00011874493065988645
cultured O 0 0.0015493362443521619
skeletal O 0 0.046350788325071335
muscle O 0 0.0014589985366910696
cells O 0 0.00020215970289427787
of O 0 0.0005620026495307684
wild O 0 0.0002839762018993497
- O 0 0.00011316637392155826
type O 0 3.078728332184255e-05
and O 0 2.1364887288655154e-05
DMPK O 1 0.9863483905792236
[ O 0 0.0008508972241543233
- O 0 0.000652541290037334
/ O 0 0.00039781583473086357
- O 0 0.0006106807850301266
] O 0 0.0006103729829192162
knockout O 0 0.005060855764895678
mice O 0 0.0009310533641837537
. O 0 0.00013846781803295016

In O 0 0.0003328551829326898
vitro O 0 0.0003964981297031045
- O 0 0.0006450243527069688
differentiated O 0 0.00059405283536762
DMPK O 1 0.9838371872901917
[ O 0 0.0012458099517971277
- O 0 0.0011460470268502831
/ O 0 0.00046456317068077624
- O 0 0.000514068640768528
] O 0 0.0002681929909158498
myotubes O 0 0.001187992631457746
exhibit O 0 0.00015594399883411825
a O 0 2.2738999177818187e-05
higher O 0 4.77723078802228e-05
resting O 0 0.0007806437788531184
[ O 0 0.00015954120317474008
Ca2 O 0 0.00027145983767695725
+ O 0 0.00040802426519803703
] O 0 0.00030337311909534037
i O 0 4.5520027924794704e-05
than O 0 4.340771738498006e-06
do O 0 6.198591563588707e-06
wild O 0 3.655427644844167e-05
- O 0 8.425909618381411e-05
type O 0 8.284892828669399e-05
myotubes O 0 0.001782484701834619
because O 0 5.581483947025845e-06
of O 0 3.0263132430263795e-05
an O 0 7.563019607914612e-06
altered O 0 4.2048737668665126e-05
open O 0 1.4719515093020163e-05
probability O 0 2.764134023891529e-06
of O 0 8.824837277643383e-05
voltage O 0 0.0005367238190956414
- O 0 0.0004621800035238266
dependent O 0 3.422084409976378e-05
l O 0 6.410143396351486e-05
- O 0 4.4582287955563515e-05
type O 0 9.917287570715416e-06
Ca2 O 0 7.678412657696754e-05
+ O 0 6.531529652420431e-05
and O 0 1.3749266145168804e-05
Na O 0 0.004569931887090206
+ O 0 0.00021164810459595174
channels O 0 9.603287617210299e-05
. O 0 4.765746052726172e-05

The O 0 0.0005391616723500192
mutant O 0 0.0008216316346079111
myotubes O 0 0.003534584306180477
exhibit O 0 0.00033945965697057545
smaller O 0 2.3329341274802573e-05
and O 0 9.245432920579333e-06
slower O 0 4.848516618949361e-05
Ca2 O 0 8.626092312624678e-05
+ O 0 4.23921701440122e-05
responses O 0 2.7015501018468058e-06
upon O 0 2.582080014690291e-05
triggering O 0 0.00014327120152302086
by O 0 1.1988019650743809e-05
acetylcholine O 0 0.0003880607255268842
or O 0 4.339482620707713e-05
high O 0 0.0004365080676507205
external O 0 0.00015591098053846508
K O 0 0.0010424882639199495
+ O 0 0.00047200015978887677
. O 0 7.463554356945679e-05

In O 0 0.0002487899619154632
addition O 0 4.567718497128226e-05
, O 0 7.880960765760392e-06
we O 0 1.567400090607407e-06
observed O 0 1.51793653913046e-06
that O 0 2.1522498627746245e-07
these O 0 8.051302415879036e-07
Ca2 O 0 0.0001418310566805303
+ O 0 0.0004853512509725988
transients O 0 0.001127901254221797
partially O 0 0.00018465334142092615
result O 0 6.115343694546027e-06
from O 0 4.883745532424655e-06
an O 0 1.673792439760291e-06
influx O 0 4.2481977288844064e-05
of O 0 7.131584425223991e-05
extracellular O 0 0.00012550853716675192
Ca2 O 0 0.00020548459724523127
+ O 0 5.958083420409821e-05
through O 0 7.635111614945345e-06
the O 0 2.8601281883311458e-05
l O 0 9.229809074895456e-05
- O 0 5.368295751395635e-05
type O 0 1.5690626241848804e-05
Ca2 O 0 0.00013697940448764712
+ O 0 0.0001681301073404029
channel O 0 0.0002988025080412626
. O 0 6.708322325721383e-05

Neither O 0 0.0002605943300295621
the O 0 5.303440411807969e-05
content O 0 1.1078312127210665e-05
nor O 0 1.0533721251704264e-05
the O 0 5.198142844164977e-06
activity O 0 5.4471070143335965e-06
of O 0 7.890045526437461e-05
Na O 0 0.012936421670019627
+ O 0 0.0003753165656235069
/ O 0 0.00014892891340423375
K O 0 0.0002787008124869317
+ O 0 0.00012473161041270941
ATPase O 0 0.000115389542770572
and O 0 1.407432046107715e-05
sarcoplasmic O 0 0.0004732108791358769
reticulum O 0 0.0002304181834915653
Ca2 O 0 0.00019946268002968282
+ O 0 0.00018962210742756724
- O 0 9.363162098452449e-05
ATPase O 0 2.354825846850872e-05
are O 0 4.4082733552386344e-07
affected O 0 6.4242922235280275e-06
by O 0 1.4681954780826345e-05
DMPK O 1 0.9021701216697693
absence O 0 0.0016704995650798082
. O 0 0.00034234250779263675

In O 0 0.00018249149434268475
conclusion O 0 7.59843533160165e-05
, O 0 8.367907867068425e-06
our O 0 5.164936737855896e-06
data O 0 4.300736236473313e-06
suggest O 0 5.749373940489022e-06
that O 0 4.506151981331641e-06
DMPK O 0 0.018030665814876556
is O 0 1.2216863069625106e-05
involved O 0 1.0657440725481138e-05
in O 0 1.9433222405496053e-05
modulating O 0 0.00018391288176644593
the O 0 1.961477755685337e-05
initial O 0 7.86323562351754e-06
events O 0 2.717939241847489e-05
of O 0 0.00013814364501740783
excitation O 0 0.0008632914396002889
- O 0 0.0015446858014911413
contraction O 0 0.0010587999131530523
coupling O 0 0.0004064942477270961
in O 0 0.0003642756200861186
skeletal O 1 0.9995033740997314
muscle O 0 0.002867875387892127
. O 0 0.0003531072288751602
. O 0 0.0002129094791598618

Constitutional O 0 0.01461868453770876
RB1 O 1 0.9999701976776123
- O 0 0.00264055747538805
gene O 0 2.6983605494024232e-05
mutations O 0 1.8367260054219514e-05
in O 0 1.867589890025556e-05
patients O 0 2.733720793912653e-05
with O 0 1.1827225534943864e-05
isolated O 0 0.0005751829594373703
unilateral B-Disease 0 0.00042734743328765035
retinoblastoma I-Disease 1 0.9996354579925537
. O 0 0.00199521379545331

In O 0 0.00020724999194499105
most O 0 2.2502827050630003e-05
patients O 0 2.1502370145753957e-05
with O 0 1.108849210140761e-05
isolated O 0 0.00042911170748993754
unilateral B-Disease 0 0.00025806817575357854
retinoblastoma I-Disease 1 0.9999741315841675
, O 0 0.00034988243714906275
tumor B-Disease 1 0.9996805191040039
development O 0 0.00011086777521995828
is O 0 3.759730361707625e-06
initiated O 0 2.3957160010468215e-05
by O 0 6.606981628465292e-07
somatic O 0 1.1662677025015e-05
inactivation O 0 0.0001845347142079845
of O 0 6.838920671725646e-05
both O 0 7.308643489523092e-06
alleles O 0 3.7817815154994605e-06
of O 0 0.00016889478138182312
the O 0 0.0011204968905076385
RB1 O 1 0.9998325109481812
gene O 0 0.0001361484610242769
. O 0 0.00010065629612654448

However O 0 0.000139419746119529
, O 0 7.414800165861379e-06
some O 0 2.14135934584192e-06
of O 0 4.931351213599555e-05
these O 0 1.888267433969304e-05
patients O 0 6.193415174493566e-05
can O 0 2.1830481273354962e-05
transmit O 0 0.000590484996791929
retinoblastoma B-Disease 0 0.10058947652578354
predisposition O 0 0.005360544193536043
to O 0 0.0002995021059177816
their O 0 0.0001756644924171269
offspring O 0 0.0005251214024610817
. O 0 0.0001676842221058905

To O 0 3.8637921534245834e-05
determine O 0 1.1001026905432809e-05
the O 0 2.654577292560134e-05
frequency O 0 8.519069524481893e-06
and O 0 3.6848880426987307e-06
nature O 0 1.9745346435229294e-05
of O 0 0.00012781280383933336
constitutional O 0 0.0018099998123943806
RB1 O 1 0.9999592304229736
- O 0 0.0008828657446429133
gene O 0 8.205816811823752e-06
mutations O 0 6.7791997935273685e-06
in O 0 1.713129495328758e-05
patients O 0 2.219278394477442e-05
with O 0 1.4778842341911513e-05
isolated O 0 0.00044210258056409657
unilateral B-Disease 0 0.0001895998721010983
retinoblastoma I-Disease 0 0.1186305359005928
, O 0 2.8318745535216294e-05
we O 0 4.1347361730004195e-06
analyzed O 0 1.1043407539546024e-05
DNA O 0 3.196961188223213e-05
from O 0 5.946169767412357e-05
peripheral O 0 0.004435788374394178
blood O 0 0.0010293175000697374
and O 0 0.00023573380894958973
from O 0 0.0023213177919387817
tumor B-Disease 1 0.9999998807907104
tissue O 0 0.4506642818450928
. O 0 0.000702062388882041

The O 0 9.304986451752484e-05
analysis O 0 1.633244210097473e-05
of O 0 0.0005936492816545069
tumors B-Disease 1 0.9999990463256836
from O 0 0.0004026189853902906
54 O 0 0.0003003464953508228
( O 0 1.5246278962877113e-05
71 O 0 7.667700265301391e-05
% O 0 1.0273364750901237e-05
) O 0 3.4982913348358124e-06
of O 0 6.105489592300728e-05
76 O 0 0.0004296140978112817
informative O 0 0.00013312595547176898
patients O 0 4.376942160888575e-05
showed O 0 0.00013436799054034054
loss O 0 0.00035369122633710504
of O 0 0.0005503288120962679
constitutional O 0 0.002942164894193411
heterozygosity O 1 0.9998770952224731
( O 0 0.004934254102408886
LOH O 1 1.0
) O 0 0.00020844516984652728
at O 0 0.001145599060691893
intragenic O 0 0.012193743139505386
loci O 0 0.0016884320648387074
. O 0 0.0003762113628908992

Three O 0 9.893267269944772e-05
of O 0 0.0005747377290390432
13 O 0 0.0017409141873940825
uninformative O 0 0.017728649079799652
patients O 0 0.00024468451738357544
had O 0 0.0003077190194744617
constitutional O 0 0.000768967904150486
deletions O 0 0.002193029271438718
. O 0 0.00044411991257220507

For O 0 4.4700849684886634e-05
39 O 0 5.848592263646424e-05
randomly O 0 7.66692483011866e-06
selected O 0 0.0004298582789488137
tumors B-Disease 1 1.0
, O 0 0.0002841268142219633
SSCP O 1 0.9999821186065674
, O 0 0.0003332536725793034
hetero O 0 0.008069613948464394
- O 0 0.000509567791596055
duplex O 0 0.00027833066997118294
analysis O 0 5.521542334463447e-06
, O 0 5.043405508331489e-06
sequencing O 0 1.4310442566056736e-05
, O 0 2.8555070912261726e-06
and O 0 1.3043471653872984e-06
Southern O 0 1.9014896679436788e-05
blot O 0 3.160175037919544e-05
analysis O 0 4.7022544436003955e-07
were O 0 2.060598262687563e-06
used O 0 2.5035828912223224e-06
to O 0 6.080092134652659e-06
identify O 0 5.306794264470227e-05
mutations O 0 0.00011298392928438261
. O 0 0.00020033125474583358

Mutations O 0 6.562083581229672e-05
were O 0 5.5047523346729577e-05
detected O 0 0.00010037114407168701
in O 0 2.2082793293520808e-05
21 O 0 7.737347186775878e-05
( O 0 5.475565558299422e-06
91 O 0 5.773010343546048e-05
% O 0 7.695021849940531e-06
) O 0 6.7527244027587585e-06
of O 0 0.00023072176554705948
23 O 1 0.7443618774414062
tumors B-Disease 1 1.0
with O 0 0.00558649143204093
LOH O 1 1.0
. O 0 0.0019005527719855309

In O 0 0.00021927493799012154
6 O 0 0.0002109423658112064
( O 0 1.0745544386736583e-05
38 O 0 2.1603043933282606e-05
% O 0 6.419416877179174e-06
) O 0 6.993325314397225e-06
of O 0 0.0002770455612335354
16 O 1 0.9151455760002136
tumors B-Disease 1 1.0
without O 0 0.003123682923614979
LOH O 1 0.9999998807907104
, O 0 2.810346632031724e-05
one O 0 6.022773504810175e-06
mutation O 0 4.258173703419743e-06
was O 0 0.00012399743718560785
detected O 0 8.642510510981083e-05
, O 0 4.197745965939248e-06
and O 0 2.282161858602194e-06
in O 0 1.850524131441489e-05
9 O 0 0.0001376215514028445
( O 0 6.480572210421087e-06
56 O 0 2.0000701624667272e-05
% O 0 5.576924195338506e-06
) O 0 7.4361441875225864e-06
of O 0 0.000163117321790196
the O 0 0.004962061531841755
tumors B-Disease 1 1.0
without O 0 0.002329355338588357
LOH O 1 1.0
, O 0 3.131264747935347e-05
both O 0 7.647018719580956e-06
mutations O 0 2.0910325474687852e-05
were O 0 4.062121661263518e-05
found O 0 7.06527498550713e-05
. O 0 0.00012321585381869227

Thus O 0 0.0002795193868223578
, O 0 4.622550477506593e-06
a O 0 2.891542862926144e-06
total O 0 4.371921932033729e-06
of O 0 4.572886973619461e-05
45 O 0 3.126476440229453e-05
mutations O 0 6.972529263293836e-06
were O 0 2.4335909984074533e-05
identified O 0 4.216196612105705e-05
in O 0 0.00013862951891496778
tumors B-Disease 1 0.9999994039535522
of O 0 0.0029021736700087786
36 O 0 0.0025505339726805687
patients O 0 0.0007444083457812667
. O 0 0.00043934109271503985

Thirty O 0 0.0033002083655446768
- O 0 0.0002568144118413329
nine O 0 2.1223184376140125e-05
of O 0 2.1722657038480975e-05
the O 0 4.076207915204577e-05
mutations O 0 1.711662844172679e-05
- O 0 4.47388447355479e-05
including O 0 3.4506833799241576e-06
34 O 0 2.765453427855391e-05
small O 0 9.31608065002365e-06
mutations O 0 9.506454262009356e-06
, O 0 5.109828634886071e-06
2 O 0 7.159166125347838e-05
large O 0 6.986810331000015e-05
structural O 0 0.004307421389967203
alterations O 0 0.003451574593782425
, O 0 6.553902494488284e-05
and O 0 2.9386741516645998e-05
hypermethylation O 0 0.013668760657310486
in O 0 0.0005543509614653885
3 O 0 0.00412508100271225
tumors O 1 1.0
- O 0 0.000669897417537868
were O 0 2.3077725927578285e-05
not O 0 2.4423620743618812e-06
detected O 0 2.2756441467208788e-05
in O 0 3.898093382304069e-06
the O 0 1.1952882232435513e-05
corresponding O 0 7.400309550575912e-05
peripheral O 0 0.0053110793232917786
blood O 0 0.0015928425127640367
DNA O 0 0.002700342796742916
. O 0 0.0003618272894527763

In O 0 0.000430302694439888
6 O 0 0.00046877205022610724
( O 0 1.9784514734055847e-05
17 O 0 0.000100030614703428
% O 0 9.882562153507024e-06
) O 0 5.338379651220748e-06
of O 0 6.103078703745268e-05
the O 0 0.00021791603649035096
36 O 0 0.0002432446926832199
patients O 0 3.743077832041308e-05
, O 0 5.967783181404229e-06
a O 0 1.3574705917562824e-05
mutation O 0 1.100293593481183e-05
was O 0 0.0001724327157717198
detected O 0 5.86238456889987e-05
in O 0 6.252827915886883e-06
constitutional O 0 3.6500216083368286e-05
DNA O 0 5.105660966364667e-05
, O 0 3.593032261051121e-06
and O 0 2.2968279154156335e-06
1 O 0 4.834835999645293e-05
of O 0 5.52966957911849e-05
these O 0 9.657319424150046e-06
mutations O 0 1.2379980034893379e-05
is O 0 4.795807853952283e-06
known O 0 1.1700030881911516e-05
to O 0 7.901143362687435e-06
be O 0 4.100247679161839e-06
associated O 0 8.01108490122715e-06
with O 0 7.778797225910239e-06
reduced O 0 0.00041921966476365924
expressivity O 0 0.013754644431173801
. O 0 0.000539326632861048

The O 0 0.00016167385911103338
presence O 0 3.463147731963545e-05
of O 0 7.288032793439925e-05
a O 0 3.888936771545559e-05
constitutional O 0 8.283455099444836e-05
mutation O 0 8.94323420652654e-06
was O 0 8.67906492203474e-05
not O 0 1.053156438501901e-06
associated O 0 2.0621318981284276e-06
with O 0 6.899028903717408e-07
an O 0 4.1201287785952445e-06
early O 0 0.00018580238975118846
age O 0 0.0004805337521247566
at O 0 0.001170574571006
treatment O 0 0.0012468392960727215
. O 0 0.0005181510932743549

In O 0 0.0003306154103484005
1 O 0 0.000932548486161977
patient O 0 0.00022980406356509775
, O 0 3.661767550511286e-05
somatic O 0 0.0005108861951157451
mosaicism O 0 0.41687843203544617
was O 0 0.0006018435815349221
demonstrated O 0 7.32167754904367e-05
by O 0 1.3012980843996047e-06
molecular O 0 3.415725359445787e-06
analysis O 0 7.464198574780312e-07
of O 0 2.3953960408107378e-05
DNA O 0 9.517619764665142e-05
and O 0 1.5166231605689973e-05
RNA O 0 0.0005586367333307862
from O 0 0.00012684331159107387
peripheral O 0 0.011461214162409306
blood O 0 0.0037080366164445877
. O 0 0.0008961299317888916

In O 0 0.0005697626038454473
2 O 0 0.0008495309739373624
patients O 0 5.5196494940901175e-05
without O 0 1.1332159374433104e-05
a O 0 3.281842509750277e-05
detectable O 0 0.0007488217670470476
mutation O 0 1.2824464647565037e-05
in O 0 6.455575203290209e-05
peripheral O 0 0.1570037603378296
blood O 0 0.002989701461046934
, O 0 0.00021166366059333086
mosaicism O 1 0.9751484394073486
was O 0 0.0007800177554599941
suggested O 0 3.04283184959786e-05
because O 0 1.5218327007460175e-06
1 O 0 1.7238178770639934e-05
of O 0 1.6586600395385176e-05
the O 0 0.00011829457071144134
patients O 0 0.00023227385827340186
showed O 0 0.011878380551934242
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.00023156670795287937
the O 0 0.0001345812197541818
other O 0 7.634674147993792e-06
later O 0 0.00010217867384199053
developed O 0 0.00015700527001172304
bilateral B-Disease 0 0.007619454059749842
retinoblastoma I-Disease 1 0.9920851588249207
. O 0 0.0007127162534743547

In O 0 0.00022869848180562258
conclusion O 0 7.411863043671474e-05
, O 0 7.0452247200591955e-06
our O 0 3.1954480164131382e-06
results O 0 2.2754377368983114e-06
emphasize O 0 2.0715810023830272e-05
that O 0 1.6256730077657267e-06
the O 0 2.2693680875818245e-05
manifestation O 0 0.0010755909606814384
and O 0 4.9981928896158934e-05
transmissibility O 0 0.009308896027505398
of O 0 0.0007470513228327036
retinoblastoma B-Disease 0 0.012274564243853092
depend O 0 8.718798926565796e-05
on O 0 6.97640425642021e-05
the O 0 4.8764311941340566e-05
nature O 0 2.9040815206826665e-05
of O 0 3.764283246709965e-05
the O 0 3.839575583697297e-05
first O 0 2.323194348718971e-05
mutation O 0 2.7455125746200792e-06
, O 0 1.1547206213435857e-06
its O 0 9.522319714960759e-07
time O 0 2.707554813241586e-06
in O 0 5.455612154037226e-06
development O 0 2.0526220396277495e-05
, O 0 2.549706096033333e-06
and O 0 1.4037790379006765e-06
the O 0 1.0228677638224326e-05
number O 0 5.16451291332487e-06
and O 0 4.0360173443332314e-06
types O 0 9.6999256129493e-06
of O 0 0.00016035258886404335
cells O 0 3.5948232834925875e-05
that O 0 1.973744019778678e-06
are O 0 5.106512617203407e-07
affected O 0 9.340295946458355e-06
. O 0 1.0254520930175204e-05
. O 0 4.355880810180679e-05

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999873638153076
the I-Disease 1 0.8849952220916748
fifth I-Disease 0 0.0022162641398608685
component I-Disease 0 0.0002199709851993248
of I-Disease 0 0.00016958609921857715
complement I-Disease 0 0.0002895001962315291
in O 0 0.0002848015574272722
man O 0 0.0008514280780218542
. O 0 0.00011014406481990591

I O 0 0.2848491966724396
. O 0 0.000756249763071537

Clinical O 0 0.00231648376211524
, O 0 0.0002863294503185898
immunochemical O 0 0.022678039968013763
, O 0 5.4661784815834835e-05
and O 0 1.4384136193257291e-05
family O 0 3.6624871427193284e-05
studies O 0 7.971115701366216e-05
. O 0 0.0002448011946398765

The O 0 0.00015237016486935318
first O 0 4.3187210394535214e-05
recognized O 0 5.883116682525724e-05
human O 0 7.189811003627256e-05
kindred O 0 0.002659925725311041
with O 0 0.00017289171228185296
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999996423721313
the I-Disease 1 0.9801639914512634
fifth I-Disease 0 0.0025165381375700235
component I-Disease 0 0.00019871325639542192
of I-Disease 0 0.0003164909139741212
complement I-Disease 0 0.00064275530166924
( O 0 0.00048088267794810236
C5 O 1 0.9999589920043945
) O 0 3.8565180147998035e-05
is O 0 1.521316335129086e-05
described O 0 0.00012931453238707036
. O 0 0.00012567633530125022

The O 0 0.0007775515550747514
proband O 0 0.004930713213980198
, O 0 2.257825508422684e-05
a O 0 2.9910681405453943e-05
20 O 0 0.00012262043310329318
- O 0 0.00016033713473007083
year O 0 4.268742122803815e-05
- O 0 0.00010248457692796364
old O 0 0.00011313486902508885
black O 0 3.6760917282663286e-05
female O 0 3.2285181077895686e-05
with O 0 0.00013678973482456058
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 1.0
age O 1 0.9999576807022095
11 O 0 0.004814778920263052
, O 0 5.063486605649814e-05
lacked O 0 0.0012900290312245488
serum O 0 0.008257227949798107
hemolytic O 1 0.9999997615814209
complement O 0 0.0003042786265723407
activity O 0 9.059136209543794e-05
, O 0 8.596331099397503e-06
even O 0 7.337786882999353e-06
during O 0 0.0002665845968294889
remission O 0 0.001987193478271365
. O 0 0.00030309014255180955

C5 O 1 0.9999979734420776
was O 0 0.02833026461303234
undetectable O 0 0.008158772252500057
in O 0 6.791827763663605e-05
her O 0 2.209450576629024e-05
serum O 0 0.00011413075844757259
by O 0 2.750570502030314e-06
both O 0 9.352541383123025e-06
immunodiffusion O 0 0.009508993476629257
and O 0 0.00020003787358291447
hemolytic O 1 1.0
assays O 0 0.001540477736853063
. O 0 0.0011809652205556631

Other O 0 1.493093168392079e-05
complement O 0 2.948558540083468e-05
components O 0 6.542793562402949e-05
were O 0 3.461665619397536e-05
normal O 0 2.5706060114316642e-05
during O 0 0.0001608725287951529
remission O 0 0.0006642687367275357
of O 0 0.0013908141991123557
lupus O 1 0.9999994039535522
, O 0 0.00023835118918213993
but O 0 9.194136509904638e-05
C1 O 1 0.9999942779541016
, O 0 0.0006122691556811333
C4 O 1 0.9999970197677612
, O 0 0.00031808079802431166
C2 O 1 0.9826704859733582
, O 0 6.871018558740616e-05
and O 0 9.082663746085018e-05
C3 O 1 0.9999779462814331
levels O 0 0.0021877859253436327
fell O 0 0.2850176692008972
during O 0 0.0031770742498338223
exacerbations O 0 0.08842325955629349
. O 0 0.0006469078944064677

A O 0 0.003618539310991764
younger O 0 0.001079510198906064
half O 0 0.00016228716413024813
- O 0 0.0003094167623203248
sister O 0 7.094169995980337e-05
, O 0 3.0201665595086524e-06
who O 0 4.868571522820275e-06
had O 0 7.130428275559098e-05
no O 0 0.0001271253131562844
underlying O 1 0.9999898672103882
disease O 1 0.9999998807907104
, O 0 7.277961412910372e-05
was O 0 0.0003107893862761557
also O 0 5.306163984641898e-06
found O 0 2.4464995931339217e-06
to O 0 7.777506652928423e-06
lack O 0 0.00046398781705647707
immunochemically O 1 0.9995909333229065
detectable O 1 0.9974403381347656
C5 O 1 0.999996542930603
. O 0 0.001037828391417861

By O 0 0.0010432065464556217
hemolytic O 1 0.9999995231628418
assay O 0 0.0007713179220445454
, O 0 7.126975106075406e-05
she O 0 1.6815660274005495e-05
exhibited O 0 0.00015101399912964553
1 O 0 0.0002524944138713181
- O 0 0.00011069030006183311
2 O 0 2.757981746981386e-05
% O 0 2.7890296223631594e-06
of O 0 3.468991781119257e-05
the O 0 0.00018387009913567454
normal O 0 0.00048478826647624373
serum O 0 0.0028244880959391594
C5 O 1 0.9026669859886169
level O 0 0.00023970240727066994
and O 0 1.0253915206703823e-05
normal O 0 2.278328247484751e-05
concentrations O 0 4.595716018229723e-05
of O 0 3.3346157579217106e-05
other O 0 7.382836429314921e-06
complement O 0 8.028573938645422e-05
components O 0 0.00044528927537612617
. O 0 0.00030865424196235836

C5 O 1 0.9996259212493896
levels O 0 0.0006590298726223409
of O 0 0.0002767694240901619
other O 0 1.1474468010419514e-05
family O 0 1.0565290722297505e-05
members O 0 2.434357838865253e-06
were O 0 7.863010978326201e-06
either O 0 8.235089808295015e-06
normal O 0 2.6438450731802732e-05
or O 0 6.07648598816013e-06
approximately O 0 7.379816815955564e-05
half O 0 0.00012332799087744206
- O 0 0.00019228672317694873
normal O 0 2.2152313249534927e-05
, O 0 2.4681226022948977e-06
consistent O 0 1.0286031283612829e-05
with O 0 4.523094048636267e-06
autosomal O 0 0.0006474521942436695
codominant O 0 0.019781356677412987
inheritance O 0 0.00021587529045064002
of O 0 0.0002813985920511186
the O 0 0.0002779225760605186
gene O 0 0.00031169000430963933
determining O 1 0.9965431094169617
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.017366500571370125

Normal O 0 0.008771095424890518
hemolytic O 1 0.9999995231628418
titers O 0 0.0109488470479846
were O 0 0.0001284391910303384
restored O 0 0.0004121065139770508
to O 0 4.914966211799765e-06
both O 0 9.82936307991622e-06
homozygous O 0 0.0006274711340665817
C5 B-Disease 1 1.0
- I-Disease 1 0.9999661445617676
deficient I-Disease 1 1.0
( O 0 0.0010601949179545045
C5D B-Disease 1 1.0
) O 0 0.0001556045754114166
sera O 0 0.0012775672366842628
by O 0 4.162264303886332e-06
addition O 0 5.39787697562133e-06
of O 0 0.0001573699264554307
highly O 0 0.0016243383288383484
purified O 0 0.00646355701610446
human O 0 0.001416276558302343
C5 O 1 0.9999767541885376
. O 0 0.0007483209483325481

In O 0 0.00043882144382223487
specific O 0 0.0002833409234881401
C5 O 1 0.9999971389770508
titrations O 0 0.016061384230852127
, O 0 5.2845389291178435e-05
however O 0 2.1292862584232353e-05
, O 0 3.465613190201111e-06
it O 0 1.3112241958879167e-06
was O 0 6.021939043421298e-05
noted O 0 9.530437637295108e-06
that O 0 5.677802619175054e-07
when O 0 1.335818865300098e-06
limited O 0 1.6587662230449496e-06
amounts O 0 1.77919864654541e-05
of O 0 0.00043071177788078785
C5 O 1 0.9990893602371216
were O 0 0.00023602148576173931
assayed O 0 0.00018395604274701327
in O 0 7.552611350547522e-06
the O 0 8.739858458284289e-06
presence O 0 8.191984306904487e-06
of O 0 5.7456047215964645e-05
low O 0 0.00028808688512071967
dilutions O 0 0.0011973686050623655
of O 0 0.0003580607590265572
either O 0 0.0009010375943034887
C5D B-Disease 1 1.0
serum O 0 0.006202042102813721
, O 0 5.9414709539851174e-05
curving O 0 0.00030920380959287286
rather O 0 6.621067768719513e-06
than O 0 3.93274149246281e-06
linear O 0 6.393405055860057e-05
dose O 0 0.00037403995520435274
- O 0 0.00020154111552983522
response O 0 4.895972324447939e-06
plots O 0 3.774794822675176e-05
were O 0 1.1645815902738832e-05
consistently O 0 1.386113217449747e-05
obtained O 0 1.1896408977918327e-05
, O 0 2.8284689506108407e-06
suggesting O 0 1.5249973330355715e-05
some O 0 4.640121005650144e-06
inhibitory O 0 0.00021467250189743936
effect O 0 0.00026852250448428094
. O 0 0.00015901922597549856

Further O 0 9.397422400070354e-05
studies O 0 1.959505425475072e-05
suggested O 0 1.3230367585492786e-05
that O 0 2.4504527118551778e-06
low O 0 8.305665687657893e-05
dilutions O 0 0.0015123391058295965
of O 0 0.0008007665746845305
C5D B-Disease 1 0.9999996423721313
serum O 0 0.0013282892759889364
contain O 0 0.00011121168790850788
a O 0 1.9253569917054847e-05
factor O 0 1.7931357433553785e-05
( O 0 6.072743872209685e-06
or O 0 5.102840532344999e-06
factors O 0 1.9622953914222308e-05
) O 0 1.1952153727179393e-05
interfering O 0 3.531530819600448e-05
at O 0 6.251555169001222e-05
some O 0 3.0591379527322715e-06
step O 0 6.242624658625573e-05
in O 0 2.4770812160568312e-05
the O 0 0.00015707909187767655
hemolytic O 1 0.9999785423278809
assay O 0 0.0005128172924742103
of O 0 0.009634443558752537
C5 O 1 0.9999982118606567
, O 0 4.8283305659424514e-05
rather O 0 4.671895112551283e-06
than O 0 1.481970798522525e-06
a O 0 2.1024297893745825e-05
true O 0 0.00039504480082541704
C5 O 1 0.9998928308486938
inhibitor O 0 0.0007479331688955426
or O 0 0.00011838044156320393
inactivator O 0 0.00969608873128891
. O 0 0.0002902079140767455

Of O 0 0.0008999585406854749
clinical O 0 0.0004968072171323001
interest O 0 0.00011300182086415589
are O 0 4.546434411167866e-06
( O 0 7.655848094145767e-06
a O 0 9.417357432539575e-06
) O 0 1.8703188970903284e-06
the O 0 4.04354204874835e-06
documentation O 0 5.168670031707734e-05
of O 0 0.0012201801873743534
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9996883869171143
vasculitis B-Disease 1 1.0
, O 1 0.93556147813797
and O 1 0.9940789937973022
arthritis B-Disease 1 1.0
in O 1 0.5690116882324219
an O 0 0.00013327454507816583
individual O 0 9.525318455416709e-05
lacking O 0 0.005480194464325905
C5 O 1 0.9999905824661255
( O 0 3.577020834200084e-05
and O 0 3.9969854697119445e-06
its O 0 9.066845450433902e-06
biologic O 0 0.0006346069858409464
functions O 0 1.936575245053973e-05
) O 0 9.370878615300171e-06
, O 0 7.899742740846705e-06
and O 0 6.302108886302449e-06
( O 0 1.0810690582729876e-05
b O 0 3.615879177232273e-05
) O 0 2.2144863578432705e-06
a O 0 4.413983333506621e-06
remarkable O 0 0.00010146860586246476
propensity O 0 0.0006393409566953778
to O 0 0.0005257691955193877
bacterial B-Disease 1 1.0
infections I-Disease 1 0.9999996423721313
in O 0 0.0003996425948571414
the O 0 0.00041906224214471877
proband O 0 0.0038816563319414854
, O 0 8.163247002812568e-06
even O 0 3.2585535336693283e-06
during O 0 7.144831033656374e-05
periods O 0 0.00012748062727041543
of O 0 0.00023561337729915977
low O 0 0.0007789023802615702
- O 0 0.0003582610806915909
dose O 0 4.7923982492648065e-05
or O 0 5.001686076866463e-06
alternate O 0 2.9044913389952853e-05
- O 0 0.00023964594583958387
day O 0 0.00021357779041863978
corticosteroid O 0 0.03226868063211441
therapy O 0 0.003663026262074709
. O 0 0.00042976951226592064

Other O 0 1.6095591490739025e-05
observations O 0 1.8276785340276547e-05
indicate O 0 3.826996544376016e-05
that O 0 3.661871915028314e-06
the O 0 0.0001267526240553707
C5D B-Disease 1 0.9999529123306274
state O 0 1.660524503677152e-05
is O 0 3.8440703065134585e-06
compatible O 0 1.2871982107753865e-05
with O 0 2.0458012386370683e-06
normal O 0 4.6837587433401495e-05
coagulation O 0 0.0007307132473215461
function O 0 4.17564733652398e-05
and O 0 1.2547681762953289e-05
the O 0 5.234333366388455e-05
capacity O 0 0.0001925988181028515
to O 0 3.330763865960762e-05
mount O 0 0.0031784591265022755
a O 0 0.0003511244722176343
neutrophilic O 1 0.9932581186294556
leukocytosis O 1 0.9890327453613281
during O 1 0.9938772320747375
pyogenic B-Disease 1 0.9999797344207764
infection I-Disease 0 0.37510794401168823
. O 0 0.0001164913410320878
. O 0 0.00012913696991745383

Susceptibility O 1 0.8506697416305542
to O 1 0.997666597366333
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9964225888252258
twins O 0 0.001043897122144699
: O 0 3.5766361179412343e-06
the O 0 3.113004140686826e-06
role O 0 7.827523404557724e-06
of O 0 4.0255483327200636e-05
genes O 0 4.208283280604519e-05
, O 0 5.416649946710095e-05
HLA O 0 0.09872860461473465
, O 0 3.0125724151730537e-05
and O 0 9.1590800366248e-06
the O 0 8.747313404455781e-05
environment O 0 0.00017944889259524643
. O 0 9.928196959663182e-05

OBJECTIVE O 0 0.0017876267665997148
To O 0 2.2817941498942673e-05
determine O 0 1.0862621820706408e-05
the O 0 1.223190065502422e-05
relative O 0 2.567769115557894e-05
effects O 0 6.076863792259246e-05
of O 0 0.00011064598947996274
genetic O 0 0.0001631926279515028
and O 0 2.0781344574061222e-05
environmental O 0 2.8283608116908e-05
factors O 0 8.422325663559604e-06
in O 0 2.7693014999385923e-05
susceptibility O 0 0.001101994188502431
to O 1 0.7668009996414185
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9980040192604065
AS B-Disease 1 1.0
) O 0 0.00024099716392811388
. O 0 0.00012195576709927991

METHODS O 0 0.0016786482883617282
Twins O 0 0.00045656433212570846
with O 0 9.694598702481017e-06
AS B-Disease 0 0.036642011255025864
were O 0 2.4495686375303194e-05
identified O 0 5.903636520088185e-06
from O 0 4.2879996726696845e-06
the O 0 1.615876863070298e-05
Royal O 0 0.00046265582204796374
National O 0 0.0034854027908295393
Hospital O 1 0.9999920129776001
for O 0 0.0863080620765686
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9893268346786499
. O 0 0.001643683877773583

Clinical O 0 0.0007598762167617679
and O 0 5.736997627536766e-05
radiographic O 0 0.000995611771941185
examinations O 0 0.0004185495781712234
were O 0 7.938390626804903e-05
performed O 0 9.835961827775463e-05
to O 0 2.5141505830106325e-05
establish O 0 0.00026491464814171195
diagnoses O 0 0.0030285317916423082
, O 0 0.00014443851250689477
and O 0 0.0001861998316599056
disease O 1 1.0
severity O 1 0.9980633854866028
was O 0 0.004986252170056105
assessed O 0 9.521895117359236e-05
using O 0 6.146823125163792e-06
a O 0 9.042623787536286e-06
combination O 0 7.897150680946652e-06
of O 0 5.8914709370583296e-05
validated O 0 0.00016773285460658371
scoring O 0 9.725144627736881e-05
systems O 0 0.0007588865701109171
. O 0 0.0001638766989344731

HLA O 1 0.5011334419250488
typing O 0 0.0009292954346165061
for O 0 0.00018397918029222637
HLA O 1 0.9563454389572144
- O 0 0.0018215037416666746
B27 O 0 0.0015232015866786242
, O 0 3.8588797906413674e-05
HLA O 0 0.011405186727643013
- O 0 0.00038890494033694267
B60 O 0 0.0006717840442433953
, O 0 1.0695294804463629e-05
and O 0 4.809411257156171e-05
HLA O 1 0.9983899593353271
- O 0 0.0040826862677931786
DR1 O 1 0.9344381093978882
was O 0 0.00023121325648389757
performed O 0 4.4586879084818065e-05
by O 0 3.264369752287166e-06
polymerase O 0 8.979802805697545e-05
chain O 0 2.5825971533777192e-05
reaction O 0 2.0186355413898127e-06
with O 0 1.8028791828328394e-06
sequence O 0 2.986211438837927e-05
- O 0 7.468637340934947e-05
specific O 0 1.61318337177363e-06
primers O 0 8.860683010425419e-05
, O 0 9.210390089720022e-06
and O 0 1.2365608199615963e-05
zygosity O 0 0.0020100886467844248
was O 0 0.0003022786695510149
assessed O 0 6.708046566927806e-05
using O 0 2.6114497813978232e-05
microsatellite O 0 0.003096888307482004
markers O 0 0.006112786941230297
. O 0 0.0009100595489144325

Genetic O 0 0.0003330885083414614
and O 0 2.9162538339733146e-05
environmental O 0 3.0447941753664054e-05
variance O 0 5.009094365959754e-06
components O 0 4.893504592473619e-05
were O 0 2.2832917238702066e-05
assessed O 0 3.524525891407393e-05
with O 0 4.131783498451114e-06
the O 0 6.092635521781631e-05
program O 0 5.488848910317756e-05
Mx O 0 0.0009181069326587021
, O 0 1.812581672311353e-06
using O 0 5.825022526551038e-07
data O 0 3.2162683964997996e-06
from O 0 2.8733945782732917e-06
this O 0 6.661246061412385e-07
and O 0 9.116606065617816e-07
previous O 0 3.6173123589833267e-06
studies O 0 3.956607088184683e-06
of O 0 9.399751434102654e-05
twins O 0 0.0002711564302444458
with O 0 2.9795610316796228e-05
AS B-Disease 1 0.9998680353164673
. O 0 0.0005513367941603065

RESULTS O 0 0.00033968419302254915
Six O 0 6.357401434797794e-05
of O 0 0.0002612595562823117
8 O 0 0.0014476630603894591
monozygotic O 0 0.005540151614695787
( O 0 0.0006667232373729348
MZ O 1 0.9956854581832886
) O 0 0.00016790565859992057
twin O 0 0.0007171203033067286
pairs O 0 4.9911624955711886e-05
were O 0 0.00011209453077754006
disease O 1 0.9300011992454529
concordant O 0 0.0026719102170318365
, O 0 1.4807113075221423e-05
compared O 0 1.2966926078661345e-05
with O 0 3.85182738682488e-06
4 O 0 8.917271043173969e-05
of O 0 0.00018178726895712316
15 O 0 0.00031419526203535497
B27 O 0 0.001059396774508059
- O 0 0.00011363308294676244
positive O 0 9.092085747397505e-06
dizygotic O 0 0.00236122845672071
( O 0 0.000206768570933491
DZ O 0 0.46319374442100525
) O 0 7.620902033522725e-05
twin O 0 0.0004341675085015595
pairs O 0 1.4600260328734294e-05
( O 0 8.319886546814814e-06
27 O 0 0.00014186717453412712
% O 0 1.24330344988266e-05
) O 0 4.420542609295808e-06
and O 0 4.914478267892264e-06
4 O 0 8.642279863124713e-05
of O 0 0.00038038031198084354
32 O 0 0.002167927334085107
DZ O 1 0.996990442276001
twin O 0 0.002145141828805208
pairs O 0 3.858375202980824e-05
overall O 0 5.395630796556361e-05
( O 0 1.828820677474141e-05
12 O 0 6.748713349225e-05
. O 0 7.334008842008188e-06
5 O 0 4.0389491914538667e-05
% O 0 1.667541619099211e-05
) O 0 4.829882527701557e-05
. O 0 0.00015418360999319702

Nonsignificant O 0 0.01791713386774063
increases O 0 4.205747973173857e-05
in O 0 1.1170002835569903e-05
similarity O 0 1.8522969185141847e-05
with O 0 3.795222028202261e-06
regard O 0 4.176675065536983e-05
to O 0 3.205955363227986e-05
age O 0 0.000603992841206491
at O 1 0.5944160223007202
disease O 1 0.9999998807907104
onset O 1 0.9999849796295166
and O 0 6.523897172883153e-05
all O 0 1.1242246728215832e-05
of O 0 0.00025911774719133973
the O 0 0.0020565406884998083
disease O 1 0.9999666213989258
severity O 0 0.0007475369493477046
scores O 0 7.457484753103927e-05
assessed O 0 3.160566484439187e-05
were O 0 1.3360251614358276e-05
noted O 0 2.2401080059353262e-05
in O 0 0.00013446962111629546
disease O 1 0.9999891519546509
- O 0 0.008201738819479942
concordant O 0 0.02553536184132099
MZ O 1 0.9994027614593506
twins O 0 0.00057568697957322
compared O 0 6.430065695894882e-05
with O 0 8.237813744926825e-05
concordant O 0 0.36633580923080444
DZ O 1 0.9999994039535522
twins O 0 0.016156639903783798
. O 0 0.0007541957893408835

HLA O 1 0.9998177886009216
- O 0 0.0066034141927957535
B27 O 0 0.0019489419646561146
and O 0 1.7107720850617625e-05
B60 O 0 0.00033303481177426875
were O 0 9.24816595215816e-06
associated O 0 5.145266641193302e-06
with O 0 3.2254097277473193e-06
the O 0 0.00025809669750742614
disease O 1 0.9999781847000122
in O 0 0.00038661499274894595
probands O 0 0.06040653586387634
, O 0 1.3439966096484568e-05
and O 0 1.7743899434208288e-06
the O 0 1.4009587175678462e-05
rate O 0 1.68910719366977e-05
of O 0 5.9147427236894146e-05
disease O 0 0.310250461101532
concordance O 0 0.00019118907221127301
was O 0 0.00015901800361461937
significantly O 0 2.5412691684323363e-05
increased O 0 3.9164548070402816e-05
among O 0 0.00010701412247726694
DZ O 1 0.9744600057601929
twin O 0 0.00085688557010144
pairs O 0 9.55125597101869e-06
in O 0 8.429011359112337e-06
which O 0 3.843637387035415e-06
the O 0 6.32533774478361e-05
co O 0 0.00039170519448816776
- O 0 0.00017419834330212325
twin O 0 7.418850145768374e-05
was O 0 3.304901474621147e-05
positive O 0 1.1497833156681736e-06
for O 0 2.2379376787284855e-06
both O 0 1.673761653364636e-05
B27 O 0 0.0028555586468428373
and O 0 0.0002473278727848083
DR1 O 1 0.9996422529220581
. O 0 0.0005008993903174996

Additive O 0 0.00011833913595182821
genetic O 0 8.473682100884616e-05
effects O 0 0.0001798356679501012
were O 0 4.7042824007803574e-05
estimated O 0 2.2840800738777034e-05
to O 0 4.281372184777865e-06
contribute O 0 1.805669307941571e-05
97 O 0 8.271331171272323e-05
% O 0 5.252649316389579e-06
of O 0 2.2074076696299016e-05
the O 0 3.4596323530422524e-05
population O 0 4.835048457607627e-06
variance O 0 8.4648499978357e-06
. O 0 8.20524655864574e-05

CONCLUSION O 0 0.003670081263408065
Susceptibility O 0 0.0014237093273550272
to O 0 0.00012286973651498556
AS B-Disease 1 0.8356176614761353
is O 0 8.998338671517558e-06
largely O 0 1.6156689525814727e-05
genetically O 0 2.9279608497745357e-06
determined O 0 5.860377314093057e-06
, O 0 1.735140358505305e-06
and O 0 9.168527981273655e-07
the O 0 2.0741923435707577e-05
environmental O 0 5.429304655990563e-05
trigger O 0 4.973497198079713e-05
for O 0 1.0160448255192023e-05
the O 0 0.0002151893131667748
disease O 1 0.9997649788856506
is O 0 6.804442818975076e-05
probably O 0 0.0003386919270269573
ubiquitous O 0 0.000803305534645915
. O 0 8.415863703703508e-05

HLA O 1 0.9991648197174072
- O 0 0.0044296374544501305
B27 O 0 0.0009419619455002248
accounts O 0 4.404077117214911e-06
for O 0 1.2420059647411108e-06
a O 0 5.335819423635257e-06
minority O 0 5.094579591968795e-06
of O 0 1.0714201380324084e-05
the O 0 2.3307171431952156e-05
overall O 0 3.0219815016607754e-05
genetic O 0 7.357611320912838e-05
susceptibility O 0 0.00035554548958316445
to O 0 0.0003479522711131722
AS B-Disease 1 0.9999948740005493
. O 0 0.00041089122532866895

Cell O 0 0.002644156338647008
cycle O 0 0.0005093939253129065
- O 0 0.00026666265330277383
dependent O 0 3.929751255782321e-05
colocalization O 0 0.001434932230040431
of O 0 0.00048760653589852154
BARD1 O 1 0.9987611770629883
and O 0 6.44012980046682e-05
BRCA1 O 0 0.0001521275844424963
proteins O 0 4.954467840434518e-06
in O 0 7.81958533480065e-06
discrete O 0 3.265016493969597e-05
nuclear O 0 0.0010417306330054998
domains O 0 0.0008904676651582122
. O 0 0.00037307062302716076

Germ O 1 0.9999904632568359
- O 0 0.001890495652332902
line O 0 0.00017866762937046587
mutations O 0 7.0795745159557555e-06
of O 0 3.134064172627404e-05
the O 0 0.00013447809033095837
BRCA1 O 0 0.0006446129409596324
gene O 0 2.5271698177675717e-05
predispose O 0 0.0002685936924535781
women O 0 5.371000497689238e-06
to O 0 6.95273502060445e-06
early O 0 0.00026698113651946187
- O 0 0.0021251896396279335
onset O 1 0.9999978542327881
breast B-Disease 1 0.9999997615814209
and I-Disease 1 0.9998379945755005
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.0005758856423199177
compromising O 0 0.0010583623079583049
the O 0 8.859441004460678e-05
genes O 0 1.558207077323459e-05
presumptive O 0 0.0007913867593742907
function O 0 2.7596835934673436e-05
as O 0 5.368946222006343e-05
a O 0 0.0002079655387206003
tumor B-Disease 1 0.9997045397758484
suppressor O 0 0.01378235686570406
. O 0 0.000442644814029336

Although O 0 5.7578799896873534e-05
the O 0 5.3614505304722115e-05
biochemical O 0 0.0003237424825783819
properties O 0 0.0007092336309142411
of O 0 0.002962211612612009
BRCA1 O 0 0.004246250260621309
polypeptides O 0 0.0002532118814997375
are O 0 2.3674804197071353e-06
not O 0 2.4440253127977485e-06
understood O 0 4.4029478885931894e-05
, O 0 4.517210072663147e-06
their O 0 3.191756832165993e-06
expression O 0 1.6157197023858316e-05
pattern O 0 0.0001847960229497403
and O 0 4.4160846300655976e-05
subcellular O 0 0.0006149763939902186
localization O 0 0.0005237280274741352
suggest O 0 2.0322213458712213e-05
a O 0 1.090842215489829e-05
role O 0 3.5763485357165337e-05
in O 0 5.3717882110504434e-05
cell O 0 0.00037409848300740123
- O 0 0.0004807149525731802
cycle O 0 0.00020398595370352268
regulation O 0 0.00012618389155250043
. O 0 5.0331615057075396e-05

When O 0 0.0009643537341617048
resting O 0 0.005143177229911089
cells O 0 9.36916476348415e-05
are O 0 4.266291398380417e-06
induced O 0 0.00019663452985696495
to O 0 5.039188908995129e-05
proliferate O 0 0.00043340257252566516
, O 0 5.447797775559593e-06
the O 0 1.3176560969441198e-05
steady O 0 0.00012706508277915418
- O 0 2.3360289560514502e-05
state O 0 1.7703501953292289e-06
levels O 0 1.1126201570732519e-05
of O 0 1.7158929040306248e-05
BRCA1 O 0 9.475654223933816e-05
increase O 0 5.959718237136258e-06
in O 0 2.231528196716681e-05
late O 0 0.000887831614818424
G1 O 0 0.00789731740951538
and O 0 4.53953680334962e-06
reach O 0 6.587561529158847e-06
a O 0 2.7129415229865117e-06
maximum O 0 1.4145018212730065e-05
during O 0 0.0004870744014624506
S O 0 0.0053742993623018265
phase O 0 0.002863955218344927
. O 0 0.0003004710888490081

Moreover O 0 0.0005800737999379635
, O 0 2.607953138067387e-05
in O 0 4.041696593048982e-05
S O 0 0.002937334356829524
phase O 0 0.002181246178224683
cells O 0 0.0001154839774244465
, O 0 1.2050420991727151e-05
BRCA1 O 0 0.00010826563084265217
polypeptides O 0 1.6971953300526366e-05
are O 0 1.780094976311375e-06
hyperphosphorylated O 0 0.000569820636883378
and O 0 8.052369594224729e-06
accumulate O 0 4.673639705288224e-05
into O 0 1.3322768609214108e-05
discrete O 0 5.416096973931417e-05
subnuclear O 0 0.004833084996789694
foci O 0 0.004090602044016123
termed O 0 0.0015937142306938767
" O 0 0.0013238214887678623
BRCA1 O 0 0.0032850259449332952
nuclear O 0 0.006735014263540506
dots O 0 0.003522958140820265
. O 0 0.00026664361939765513

" O 0 0.0032018276397138834
BRCA1 O 0 0.002888075541704893
associates O 0 0.0005808425485156476
in O 0 7.450100383721292e-05
vivo O 0 0.00016976149345282465
with O 0 5.3865223890170455e-06
a O 0 3.1691379263065755e-05
structurally O 0 0.0006509082741104066
related O 0 0.0001330972445430234
protein O 0 0.00030057624098844826
termed O 0 0.005225273780524731
BARD1 O 1 0.9999855756759644
. O 0 0.0008243316551670432

Here O 0 0.00029106938745826483
we O 0 5.720883109461283e-06
show O 0 5.636633886751952e-06
that O 0 6.362003546200867e-07
the O 0 1.021921980282059e-05
steady O 0 0.00010549704893492162
- O 0 2.0381834474392235e-05
state O 0 1.744889232213609e-06
levels O 0 3.5222987207816914e-05
of O 0 0.00010868051322177052
BARD1 O 1 0.9383652210235596
, O 0 1.2592237908393145e-05
unlike O 0 8.729603905521799e-06
those O 0 4.23521078118938e-06
of O 0 0.00011985338642261922
BRCA1 O 0 0.0008976694662123919
, O 0 1.236949992744485e-05
remain O 0 1.5416320820804685e-05
relatively O 0 2.8333474801911507e-06
constant O 0 1.082258404494496e-05
during O 0 0.00037554456503130496
cell O 0 0.0006786789163015783
cycle O 0 0.0008529298938810825
progression O 0 0.02905639074742794
. O 0 0.0004940389771945775

However O 0 0.0003155322337988764
, O 0 5.854429036844522e-05
immunostaining O 0 0.00393763417378068
revealed O 0 0.0005852573667652905
that O 0 3.620851202867925e-05
BARD1 O 1 0.988021969795227
resides O 0 0.0006501884199678898
within O 0 6.590416160179302e-05
BRCA1 O 0 0.0007793846889398992
nuclear O 0 0.0010603575501590967
dots O 0 0.00027036131359636784
during O 0 0.00021679836208932102
S O 0 0.0007814394193701446
phase O 0 0.00023256639542523772
of O 0 0.00011485448339954019
the O 0 0.0001871779968496412
cell O 0 0.00020303321070969105
cycle O 0 5.0249556807102636e-05
, O 0 1.851598881330574e-06
but O 0 3.9722448264001287e-07
not O 0 3.8679621638948447e-07
during O 0 5.0954615289811045e-05
the O 0 8.872199396137148e-05
G1 O 0 0.021233825013041496
phase O 0 0.0017875349149107933
. O 0 0.00022030052787158638

Nevertheless O 0 0.004190069157630205
, O 0 0.000258661835687235
BARD1 O 0 0.49497681856155396
polypeptides O 0 0.00012372530181892216
are O 0 1.288792077502876e-06
found O 0 2.3118527678889222e-06
exclusively O 0 6.498884431493934e-06
in O 0 5.399987912824145e-06
the O 0 1.1777541658375412e-05
nuclear O 0 7.606358849443495e-05
fractions O 0 1.2402621905494016e-05
of O 0 3.714027479873039e-05
both O 0 2.251536352559924e-05
G1 O 0 0.023581093177199364
- O 0 0.00023986677115317434
and O 0 1.5022154002508614e-05
S O 0 0.001618176931515336
- O 0 0.00021182961063459516
phase O 0 0.0007397488225251436
cells O 0 0.00010419871978228912
. O 0 5.303966099745594e-05

Therefore O 0 0.00034806743497028947
, O 0 5.038886229158379e-05
progression O 0 0.0016346229240298271
to O 0 0.0001136240825871937
S O 0 0.0028976178728044033
phase O 0 0.00038238317938521504
is O 0 6.566768206539564e-06
accompanied O 0 1.6148742361110635e-05
by O 0 8.627462761978677e-07
the O 0 3.782034127652878e-06
aggregation O 0 1.2632291145564523e-05
of O 0 0.00019702434656210244
nuclear O 0 0.005824673920869827
BARD1 O 1 0.8863085508346558
polypeptides O 0 0.00012400995183270425
into O 0 6.743695121258497e-05
BRCA1 O 0 0.0011700039030984044
nuclear O 0 0.00443377997726202
dots O 0 0.0019460651092231274
. O 0 0.00019566704577300698

This O 0 0.00010489867418073118
cell O 0 0.0004908714327029884
cycle O 0 0.00018487848865333945
- O 0 0.00014859202201478183
dependent O 0 1.6497406249982305e-05
colocalization O 0 0.000930892420001328
of O 0 0.00044027878902852535
BARD1 O 1 0.9994865655899048
and O 0 9.56139265326783e-05
BRCA1 O 0 0.00031272045453079045
indicates O 0 2.8660422685788944e-05
a O 0 4.3595227907644585e-06
role O 0 1.2178475117252674e-05
for O 0 1.5960895325406455e-05
BARD1 O 1 0.9937864542007446
in O 0 0.00020330441475380212
BRCA1 O 0 0.002153176348656416
- O 0 0.0014859669608995318
mediated O 0 0.004952100105583668
tumor B-Disease 1 0.9999804496765137
suppression O 1 0.9993436932563782
. O 0 0.0008111050701700151

Ethnic O 0 0.0003094748535659164
differences O 0 0.00034048742963932455
in O 0 0.0001531634625280276
the O 0 0.0005810055299662054
HFE O 0 0.4432438015937805
codon O 0 0.00031017608125694096
282 O 0 0.0008563150768168271
( O 0 0.00042858795495703816
Cys O 1 0.9974766373634338
/ O 0 0.007583109196275473
Tyr O 0 0.012329019606113434
) O 0 5.28637356183026e-05
polymorphism O 0 8.722823986317962e-05
. O 0 0.00016202896949835122

Recent O 0 1.4482636288448703e-05
studies O 0 1.9122560388495913e-06
have O 0 2.3674502358517202e-07
shown O 0 7.452770660165697e-06
that O 0 4.356038698460907e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999963045120239
HH B-Disease 1 1.0
) O 0 0.0001346387289231643
is O 0 6.2764443100604694e-06
likely O 0 4.53469965577824e-06
to O 0 4.009752956335433e-06
be O 0 6.0509087234095205e-06
caused O 0 6.631394353462383e-05
by O 0 5.8727641771838535e-06
homozygosity O 0 0.0006611631833948195
for O 0 1.0426143489894457e-05
a O 0 5.559342753258534e-05
Cys282Tyr O 0 0.0035599437542259693
mutation O 0 1.3224160284153186e-05
in O 0 1.9672645066748373e-05
the O 0 0.00011842649837490171
HFE O 0 0.04356565326452255
gene O 0 5.172999226488173e-05
located O 0 0.0002654863055795431
4 O 0 0.00025893596466630697
. O 0 0.00013161836250219494

5 O 0 0.001900966977700591
Mb O 0 0.013583676889538765
telomeric O 0 0.006612416822463274
to O 0 0.000732328393496573
HLA O 1 0.9983838796615601
- O 0 0.0028506938833743334
A O 0 0.0019600638188421726
. O 0 0.00018976953288074583

Population O 0 1.869881816674024e-05
studies O 0 4.109000656171702e-06
of O 0 2.060030419670511e-05
this O 0 4.075252036273014e-06
polymorphism O 0 7.394674867100548e-06
are O 0 9.435817105440947e-07
facilitated O 0 4.527343844529241e-05
by O 0 2.767716296148137e-06
the O 0 1.0264482625643723e-05
fact O 0 5.746490387537051e-06
that O 0 1.3286810371937463e-06
the O 0 4.882792563876137e-05
Cys282Tyr O 0 0.00405014818534255
mutation O 0 1.800170684873592e-05
creates O 0 7.31497784727253e-05
a O 0 6.156601011753082e-05
Rsal O 0 0.006485349964350462
restriction O 0 8.954475197242573e-05
site O 0 0.0006099521997384727
. O 0 0.00012792118650395423

We O 0 4.5822856918675825e-05
have O 0 2.480974671925651e-06
studied O 0 3.697947249747813e-05
the O 0 3.980571636930108e-05
codon O 0 6.055644917069003e-05
282 O 0 0.00036105889012105763
( O 0 0.0003062063187826425
Cys O 1 0.9934887886047363
/ O 0 0.005993164610117674
Tyr O 0 0.004513364750891924
) O 0 9.78365005721571e-06
polymorphism O 0 4.800250735570444e-06
in O 0 3.614016122810426e-06
different O 0 4.5620950572811125e-07
ethnic O 0 2.1750249288743362e-05
groups O 0 7.553504474344663e-06
. O 0 0.00011144800373585895

In O 0 0.00011504806752782315
agreement O 0 4.015759986941703e-05
with O 0 7.877924872445874e-06
previous O 0 9.012693772092462e-05
observations O 0 0.00013405253412202
the O 0 0.0002936689124908298
Tyr O 0 0.002658127574250102
allele O 0 1.0943621418846305e-05
appeared O 0 3.028334140253719e-05
to O 0 6.773803306714399e-06
be O 0 9.755735845828895e-06
rare O 0 4.954883479513228e-05
or O 0 3.481937892502174e-05
absent O 0 0.00035109903546981514
in O 0 7.555573392892256e-05
Asiatic O 0 0.0011612970847636461
( O 0 1.383731887472095e-05
Indian O 0 1.7021142411977053e-05
, O 0 6.629515610256931e-06
Chinese O 0 0.0001264855673070997
) O 0 7.2413936322845984e-06
populations O 0 1.0054610356746707e-05
. O 0 3.501360333757475e-05

The O 0 0.0002118821139447391
highest O 0 0.0003498014120850712
allele O 0 1.032375712384237e-05
frequency O 0 1.1659240044537e-05
( O 0 8.134136805892922e-06
7 O 0 5.7720637414604425e-05
. O 0 4.439287749846699e-06
5 O 0 1.6935557141550817e-05
% O 0 6.031826615071623e-06
) O 0 6.443116490117973e-06
was O 0 0.00015948995132930577
found O 0 2.2763169909012504e-05
in O 0 4.8447411245433614e-05
Swedes O 0 0.0014855921035632491
. O 0 0.0002478061069268733

Saamis O 0 0.018259849399328232
( O 0 7.727009506197646e-05
2 O 0 0.00013443808711599559
% O 0 2.418865915387869e-05
) O 0 1.8208134861197323e-05
and O 0 1.9746927137020975e-05
Mordvinians O 0 0.003459870582446456
( O 0 1.6856700312928297e-05
1 O 0 7.806374924257398e-05
. O 0 4.137359155720333e-06
8 O 0 1.773334042809438e-05
% O 0 2.9636444196512457e-06
) O 0 3.7606771456921706e-06
had O 0 2.2174401237862185e-05
significantly O 0 2.8242639018571936e-05
lower O 0 5.215189958107658e-05
frequencies O 0 8.433908078586683e-06
of O 0 8.559329580748454e-05
the O 0 0.0003866927290800959
Tyr O 0 0.006220236420631409
allele O 0 5.2541821787599474e-05
. O 0 0.00010215343354502693

Comparisons O 0 0.00011054780770791695
with O 0 7.304915470740525e-06
allele O 0 4.76509376312606e-06
frequencies O 0 5.958286237728316e-06
based O 0 2.659857045728131e-06
on O 0 3.3573058317415416e-05
prevalence O 0 0.0002714192378334701
estimates O 0 1.8793924027704634e-05
of O 0 0.00021698258933611214
HH B-Disease 1 0.9999680519104004
showed O 0 0.0002811044396366924
some O 0 1.1601874575717375e-05
disagreements O 0 0.0003031794331036508
with O 0 8.856991371430922e-06
the O 0 0.00014423331595025957
RFLP O 0 0.0010815426940098405
data O 0 4.561649984680116e-05
, O 0 1.0435423064336646e-05
particularly O 0 2.53428934229305e-05
in O 0 7.632276538060978e-05
Finns O 0 0.004062708932906389
. O 0 0.00025193270994350314

The O 0 0.0006546273943968117
newly O 0 0.0044033098965883255
described O 0 0.001900105969980359
HFE O 1 0.9927204847335815
marker O 0 0.001799351186491549
provides O 0 2.045194742095191e-05
a O 0 1.2720418453682214e-05
new O 0 4.163816356594907e-06
approach O 0 2.5212175387423486e-06
to O 0 3.792272991631762e-06
the O 0 1.7597656551515684e-05
screening O 0 2.4761364329606295e-05
of O 0 0.0003174312587361783
HH B-Disease 1 0.9997357726097107
as O 0 7.327251660171896e-05
well O 0 6.771090738766361e-06
as O 0 3.548179392964812e-06
studies O 0 1.5951163732097484e-06
of O 0 1.2554635759443045e-05
the O 0 3.493942131171934e-05
relationship O 0 3.4138865885324776e-05
between O 0 0.0002623133477754891
the O 0 0.0008623118628747761
HFE O 1 0.9999134540557861
Tyr O 0 0.0068700374104082584
allele O 0 1.2753507689922117e-05
and O 0 4.900012754660565e-06
different O 0 1.0333902537240647e-05
disorders O 1 1.0
including O 1 0.9999656677246094
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999772310256958
dominant I-Disease 1 0.9999997615814209
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
associated O 0 0.00048319046618416905
with O 0 3.317773007438518e-05
a O 0 8.549508493160829e-05
missense O 0 0.0001270991488127038
mutation O 0 9.184540431306232e-06
encoding O 0 6.961518374737352e-05
Gly23 O 0 0.007094386033713818
- O 0 0.0005065917503088713
- O 0 0.0001671201316639781
> O 0 4.891951539320871e-05
Val O 0 0.0005577506381087005
in O 0 7.715420360909775e-05
neurophysin O 0 0.06684946268796921
II O 1 1.0
. O 0 0.00151687057223171

Autosomal B-Disease 1 0.9984476566314697
dominant I-Disease 1 0.9999923706054688
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.2026943415403366
ADNDI B-Disease 1 1.0
) O 0 4.018625259050168e-05
is O 0 7.926449143269565e-06
an O 0 2.605767804197967e-05
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 0 0.0013903446961194277
progressive O 1 0.9999964237213135
degeneration O 1 1.0
of O 1 0.9999909400939941
the O 1 0.9998784065246582
magnocellular O 1 0.9998574256896973
neurons O 0 0.0016342182643711567
of O 0 0.0008435268537141383
the O 0 0.0010734933894127607
hypothalamus O 0 0.002211460145190358
leading O 0 0.00014451581228058785
to O 0 1.2087391041859519e-05
decreased O 0 5.7378241763217375e-05
ability O 0 4.950514721713262e-06
to O 0 6.442446647270117e-06
produce O 0 8.252150109910872e-06
the O 0 8.815710316412151e-05
hormone O 0 0.00032344323699362576
arginine O 0 0.0002599218860268593
vasopressin O 0 0.0013267556205391884
( O 0 0.00021047024347353727
AVP O 0 0.08360271900892258
) O 0 7.140457455534488e-05
. O 0 9.087152284337208e-05

Affected O 0 0.000176368368556723
individuals O 0 5.860298642801354e-06
are O 0 2.7420114747656044e-06
not O 0 8.406806045968551e-06
symptomatic O 0 0.0034547641407698393
at O 0 0.0012947465293109417
birth O 0 0.00036735041067004204
, O 0 7.57822363084415e-06
but O 0 1.4857264432066586e-06
usually O 0 5.990980298520299e-06
develop O 0 0.00033064218587242067
diabetes B-Disease 1 0.9999849796295166
insipidus I-Disease 1 0.9934093952178955
at O 0 0.006926996633410454
1 O 0 0.0014476052019745111
- O 0 0.0011629890650510788
6 O 0 0.0005935151712037623
yr O 0 0.00755138136446476
of O 0 0.0005703825736418366
age O 0 0.0023088743910193443
. O 0 0.0004992451868019998

The O 0 8.903590787667781e-05
genetic O 0 5.2791088819503784e-05
locus O 0 7.264649320859462e-05
of O 0 0.0002529520133975893
the O 0 0.0007746170740574598
disease O 1 0.9995627999305725
is O 0 4.032356810057536e-05
the O 0 0.00023755145957693458
AVP O 1 0.9538651704788208
- O 0 0.001210824935697019
neurophysin O 0 0.00838162750005722
II O 1 1.0
( O 0 0.00046075761201791465
NPII O 1 0.9940798878669739
) O 0 1.3749855497735552e-05
gene O 0 5.9460930970089976e-06
, O 0 4.192041615169728e-06
and O 0 3.84109080187045e-06
mutations O 0 1.0958461643895134e-05
that O 0 1.594858622411266e-05
cause O 0 0.0005844557308591902
ADNDI B-Disease 1 0.9996330738067627
have O 0 4.880048891209299e-06
been O 0 4.294367045076797e-06
found O 0 7.108720865289797e-07
in O 0 9.962190006262972e-07
both O 0 4.529153159182897e-07
the O 0 7.720735084149055e-06
signal O 0 6.970944377826527e-05
peptide O 0 3.438929343246855e-05
of O 0 6.473180837929249e-05
the O 0 0.0002528013428673148
prepro O 0 0.04541974514722824
- O 0 0.006781357806175947
AVP O 1 0.9745699763298035
- O 0 0.0019231432816013694
NPII O 1 0.749472975730896
precursor O 0 0.0007076746551319957
and O 0 2.466628939146176e-05
within O 0 9.831103670876473e-05
NPII O 1 0.9988895058631897
itself O 0 0.0011943340068683028
. O 0 0.00016842807235661894

An O 0 0.00013136908819433302
affected O 0 0.0001459432824049145
girl O 0 0.00019030658586416394
who O 0 4.812939096154878e-06
presented O 0 6.460501754190773e-05
at O 0 0.00022373227693606168
9 O 0 0.00012842645810451359
months O 0 5.1047456508968025e-05
of O 0 0.00011810025171143934
age O 0 0.0004006036324426532
and O 0 2.6642705051926896e-05
her O 0 2.665068495844025e-05
similarly O 0 2.55186951108044e-05
affected O 0 5.520828563021496e-05
younger O 0 0.0004751216038130224
brother O 0 0.0005794899188913405
and O 0 2.2398900910047814e-05
father O 0 0.00014364096568897367
were O 0 1.741684172884561e-05
all O 0 3.8557896004931536e-06
found O 0 1.8046855529973982e-06
to O 0 2.7912597033719067e-06
have O 0 1.0591140835458646e-06
a O 0 6.816781933594029e-06
novel O 0 3.0121358577162027e-05
missense O 0 6.551541446242481e-05
mutation O 0 8.373647688131314e-06
( O 0 1.7660586308920756e-05
G1758 O 0 0.0012933551333844662
- O 0 0.00034182044328190386
- O 0 0.00018243597878608853
> O 0 9.42211554502137e-05
T O 0 0.00024730523000471294
) O 0 6.348208785311726e-07
encoding O 0 1.3639646567753516e-06
the O 0 1.775460987119004e-05
amino O 0 9.077582944883034e-06
acid O 0 2.837264764821157e-05
substitution O 0 5.24361603311263e-05
Gly23 O 0 0.00996442511677742
- O 0 0.0007673161453567445
- O 0 0.0002981678699143231
> O 0 0.00017665886844042689
Val O 0 0.0018144629430025816
within O 0 0.0002517727843951434
NPII O 1 0.9983305335044861
. O 0 0.0004123829712625593

The O 0 0.00024077622219920158
mutation O 0 1.5453808373422362e-05
was O 0 7.708212797297165e-05
confirmed O 0 1.0209167157881893e-05
by O 0 2.1050163923064247e-06
restriction O 0 8.588849595980719e-06
endonuclease O 0 6.038172432454303e-05
analysis O 0 1.1786665709223598e-05
. O 0 5.9423990023788065e-05

A O 0 0.019303176552057266
T1 O 1 0.9997362494468689
- O 0 0.0007412617560476065
weighted O 0 4.25104663008824e-05
magnetic O 0 5.080696428194642e-05
resonance O 0 5.0240174459759146e-05
imaging O 0 0.00010670476331142709
of O 0 0.00048659523599781096
the O 0 0.0032977736555039883
fathers O 0 0.024083800613880157
pituitary O 1 0.9999984502792358
gland O 1 0.9942996501922607
demonstrates O 0 0.001470274175517261
an O 0 0.0002576057449914515
attenuated O 0 0.06796922534704208
posterior O 1 0.6668315529823303
pituitary O 1 0.9999997615814209
bright O 1 0.9803755879402161
spot O 0 0.008495785295963287
. O 0 0.0005452088080346584

This O 0 5.900838732486591e-05
mutation O 0 1.6042688002926297e-05
may O 0 2.487596430000849e-05
be O 0 3.0832427455607103e-06
valuable O 0 1.8721799278864637e-05
for O 0 3.3241408345929813e-06
developing O 0 1.7219219444086775e-05
models O 0 7.216341600724263e-06
of O 0 0.000213921201066114
dominantly B-Disease 1 0.9998985528945923
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.00022528893896378577
as O 0 2.6379470000392757e-05
the O 0 2.638445221236907e-05
early O 0 2.70537657343084e-05
age O 0 4.779080700245686e-05
of O 0 0.00013268896145746112
onset O 1 0.9999978542327881
of O 1 0.9976896047592163
symptoms O 1 0.9999923706054688
suggests O 0 0.00021366353030316532
that O 0 4.292254288884578e-06
this O 0 2.9111438379914034e-06
mutation O 0 2.7430733098299243e-06
may O 0 1.0995950106007513e-05
be O 0 3.008865633091773e-06
particularly O 0 4.722099220089149e-06
deleterious O 0 0.0001429745025234297
to O 0 4.241036731400527e-05
the O 0 0.0004650713817682117
magnocellular O 0 0.05490964278578758
neuron O 0 0.0017916151555255055
. O 0 7.204917346825823e-05
. O 0 0.00012875384709332138

Frequent O 0 0.00014143387670628726
inactivation O 0 0.00428274879232049
of O 0 0.21915972232818604
PTEN O 1 1.0
/ O 1 0.5720341801643372
MMAC1 O 1 0.9999908208847046
in O 0 0.00022173496836330742
primary O 1 0.9951525926589966
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04434807598590851

Sporadic B-Disease 1 0.999998927116394
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.006773121189326048
the O 0 0.0005939865950495005
most O 0 5.767507536802441e-05
common O 0 6.0434842453105375e-05
male B-Disease 0 0.0003299202071502805
cancer I-Disease 0 0.001908075180836022
in O 0 8.447961590718478e-05
the O 0 0.00011952481145272031
Western O 0 0.00015379949763882905
world O 0 4.7774537961231545e-05
, O 0 1.370024051539076e-06
yet O 0 1.419126647306257e-06
many O 0 3.3640776564425323e-07
of O 0 6.225801371328998e-06
the O 0 1.9815934138023295e-05
major O 0 8.854499901644886e-05
genetic O 0 3.559231117833406e-05
events O 0 2.7593576305662282e-05
involved O 0 1.5315881682909094e-05
in O 0 2.139453499694355e-05
the O 0 5.402643364504911e-05
progression O 0 0.001078388886526227
of O 0 9.618400508770719e-05
this O 0 1.9625442291726358e-05
often O 0 4.9594971642363816e-05
fatal O 1 0.9983112812042236
cancer B-Disease 1 0.9527810215950012
remain O 0 0.00034935527946799994
to O 0 3.396118336240761e-05
be O 0 5.7609882787801325e-05
elucidated O 0 0.007453669793903828
. O 0 0.0002124460879713297

Numerous O 0 0.0011682442855089903
cytogenetic O 0 0.007939602248370647
and O 0 0.00017451854364480823
allelotype O 0 0.006800293922424316
studies O 0 2.0678526198025793e-05
have O 0 3.609448867791798e-06
reported O 0 9.854028576228302e-06
frequent O 0 6.84691531205317e-06
loss O 0 0.00014243647456169128
of O 0 0.0006047672941349447
heterozygosity O 1 0.9943865537643433
on O 0 0.0054281167685985565
chromosomal O 0 0.023421669378876686
arm O 0 0.004669371526688337
10q O 0 0.0025855209678411484
in O 0 0.0003304713754914701
sporadic B-Disease 1 0.9999921321868896
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9403665065765381

Deletion O 0 0.0010470090201124549
mapping O 0 0.00026857678312808275
studies O 0 2.7209969630348496e-05
have O 0 5.553666596824769e-06
unambiguously O 0 7.652915519429371e-05
identified O 0 1.1642773642961401e-05
a O 0 8.333767254953273e-06
region O 0 8.280484325950965e-05
of O 0 0.00023618961859028786
chromosome O 0 0.0007492557633668184
10q23 O 0 0.0011251496616750956
to O 0 2.1109099179739133e-05
be O 0 4.379257916298229e-06
the O 0 1.2367753697617445e-05
minimal O 0 5.49879769096151e-05
area O 0 0.0001128054573200643
of O 0 0.0002037264930550009
loss O 0 0.0037069320678710938
. O 0 0.0006827910547144711

A O 0 0.000513796869199723
new O 0 5.037795563112013e-05
tumor B-Disease 0 0.013639644719660282
suppressor O 0 0.0008704850915819407
gene O 0 5.413432518253103e-05
, O 0 8.950121264206246e-05
PTEN O 1 0.9997027516365051
/ O 0 0.004930280614644289
MMAC1 O 1 0.9997135996818542
, O 0 3.163361907354556e-05
was O 0 0.00014054818893782794
isolated O 0 5.380355651141144e-05
recently O 0 1.54065310198348e-05
at O 0 1.981548120966181e-05
this O 0 1.5102403949640575e-06
region O 0 4.650179835152812e-05
of O 0 0.00011649045336525887
chromosome O 0 0.0004889251431450248
10q23 O 0 0.0014953968347981572
and O 0 7.740449291304685e-06
found O 0 2.7839116683026077e-06
to O 0 2.2236010863707634e-06
be O 0 2.2869637632538797e-06
inactivated O 0 3.846465187962167e-05
by O 0 4.3353915657462494e-07
mutation O 0 1.9970258335888502e-07
in O 0 4.363902917248197e-06
three O 0 0.0001367967779515311
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999790191650391
lines O 0 0.004387666005641222
. O 0 0.0003426555485930294

We O 0 8.796749170869589e-05
screened O 0 0.0006291520548984408
80 O 0 0.0024503935128450394
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 9.386263263877481e-05
microsatellite O 0 0.0006047136848792434
analysis O 0 1.1903875929419883e-05
and O 0 1.3424902135739103e-05
found O 0 2.588951974757947e-05
chromosome O 0 0.00013269302144180983
10q23 O 0 0.00036025739973410964
to O 0 1.1615404218900949e-05
be O 0 6.915629910508869e-06
deleted O 0 5.389891521190293e-05
in O 0 2.0842036974499933e-05
23 O 0 0.00018873105000238866
cases O 0 8.912255725590512e-05
. O 0 0.00022414434351958334

We O 0 5.261347541818395e-05
then O 0 5.53176778339548e-06
proceeded O 0 1.2045022231177427e-05
with O 0 1.8475317631327925e-07
sequence O 0 1.5266704167515854e-06
analysis O 0 8.684835961503268e-07
of O 0 3.23628046317026e-05
the O 0 0.00012906925985589623
entire O 0 0.0022318828850984573
PTEN O 1 0.99860018491745
/ O 0 0.00443392526358366
MMAC1 O 1 0.977266252040863
coding O 0 0.000776820583269
region O 0 0.0003574174188543111
and O 0 1.0744745850388426e-05
tested O 0 1.313806751568336e-05
for O 0 2.8796657716156915e-06
homozygous O 0 1.2737074030155782e-05
deletion O 0 3.478369762888178e-05
with O 0 6.803908945585135e-06
new O 0 3.843041122308932e-05
intragenic O 0 0.0034785049501806498
markers O 0 0.0005060772527940571
in O 0 3.7136236642254516e-05
these O 0 5.567576408793684e-06
23 O 0 7.180321699706838e-05
cases O 0 8.391634764848277e-06
with O 0 1.2907409654872026e-05
10q23 O 0 0.002169230254366994
loss O 0 0.0008923574350774288
of O 0 0.0036009722389280796
heterozygosity O 1 0.9996598958969116
. O 0 0.0017407399136573076

The O 0 8.557451656088233e-05
identification O 0 9.077098184206989e-06
of O 0 0.00010289037163602188
the O 0 0.0001634818472666666
second O 0 0.0002090586203848943
mutational O 0 0.001068459008820355
event O 0 0.00011141505819978192
in O 0 1.916785004141275e-05
10 O 0 1.1144265045004431e-05
( O 0 4.0626482586958446e-06
43 O 0 3.1994073651731014e-05
% O 0 4.809071833733469e-05
) O 0 0.00030745420372113585
tumors B-Disease 1 1.0
establishes O 1 0.9328976273536682
PTEN O 1 0.9999966621398926
/ O 0 0.017424333840608597
MMAC1 O 1 0.9992256164550781
as O 0 5.0884100346593186e-05
a O 0 1.8309005099581555e-05
main O 0 8.805049583315849e-05
inactivation O 0 0.0003197173646185547
target O 0 1.1793378689617384e-05
of O 0 7.737538544461131e-05
10q O 0 0.0010312687372788787
loss O 0 0.0002771195431705564
in O 0 0.00020719862368423492
sporadic B-Disease 1 0.999921441078186
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0027379938401281834
. O 0 0.00038724756450392306

Risk O 0 0.0007152896141633391
reversals O 0 0.00041898153722286224
in O 0 1.359247926302487e-05
predictive O 0 1.8527262000134215e-05
testing O 0 4.071872172062285e-05
for O 0 0.0004052674921695143
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0037821787409484386

The O 0 5.151821096660569e-05
first O 0 6.774074790882878e-06
predictive O 0 7.193797500804067e-06
testing O 0 1.2386924026941415e-05
for O 0 0.00013022265920881182
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0005709558608941734
HD B-Disease 1 0.8825455904006958
) O 0 1.1872947652591392e-05
was O 0 3.828810804407112e-05
based O 0 6.773155973860412e-07
on O 0 7.947664926177822e-06
analysis O 0 1.492797764512943e-06
of O 0 4.742655801237561e-05
linked O 0 0.0004318905412219465
polymorphic O 0 0.0001188620735774748
DNA O 0 0.00017333906725980341
markers O 0 0.00016748145571909845
to O 0 1.9856644939864054e-05
estimate O 0 9.984761163650546e-06
the O 0 1.4849564649921376e-05
likelihood O 0 3.2167998142540455e-05
of O 0 8.008356962818652e-05
inheriting O 0 0.0007927151746116579
the O 0 9.919188596541062e-05
mutation O 0 1.396383777318988e-05
for O 0 3.45589651260525e-05
HD B-Disease 1 0.8462778329849243
. O 0 0.0002539713168516755

Limits O 0 5.2546085498761386e-05
to O 0 5.734720161854057e-06
accuracy O 0 7.060506959533086e-06
included O 0 5.20090452482691e-06
recombination O 0 4.231851562508382e-06
between O 0 3.76186435460113e-05
the O 0 2.9877270208089612e-05
DNA O 0 8.737459575058892e-05
markers O 0 0.0002012239274336025
and O 0 8.66139725985704e-06
the O 0 5.3926680266158655e-05
mutation O 0 1.5366089428425767e-05
, O 0 1.5826526578166522e-05
pedigree O 0 0.00022462120978161693
structure O 0 0.00028710660990327597
, O 0 8.927887392928824e-06
and O 0 1.9066219465457834e-06
whether O 0 2.7171827241545543e-06
DNA O 0 1.6700339983799495e-05
samples O 0 2.6052612156490795e-06
were O 0 2.569887101344648e-06
available O 0 1.1297717037450639e-06
from O 0 8.277482265839353e-06
family O 0 1.7634734831517562e-05
members O 0 1.4110447409620974e-05
. O 0 0.00010513029701542109

With O 0 1.1250655916228425e-05
direct O 0 7.382822332147043e-06
tests O 0 2.2471488136943663e-06
for O 0 5.817954843223561e-06
the O 0 0.00010921127977780998
HD B-Disease 0 0.021587589755654335
mutation O 0 1.1542622814886272e-05
, O 0 2.212453637184808e-06
we O 0 9.461670060773031e-07
have O 0 3.499007732443715e-07
assessed O 0 5.861053068656474e-06
the O 0 4.856801297137281e-06
accuracy O 0 2.852221996363369e-06
of O 0 8.210678061004728e-06
results O 0 5.534701358556049e-06
obtained O 0 1.5836476450203918e-05
by O 0 9.915073860611301e-06
linkage O 0 0.00027648458490148187
approaches O 0 5.2295832574600354e-05
when O 0 8.295887710119132e-06
requested O 0 7.337283022934571e-06
to O 0 9.147539458354004e-06
do O 0 2.4657088033563923e-06
so O 0 1.70119199083274e-06
by O 0 8.227045782405185e-07
the O 0 5.631787644233555e-06
test O 0 5.758818133472232e-06
individuals O 0 5.5922678257047664e-06
. O 0 8.588100172346458e-05

For O 0 7.021087367320433e-05
six O 0 4.434559741639532e-05
such O 0 4.804299351235386e-06
individuals O 0 3.512934426908032e-06
, O 0 9.635553396947216e-06
there O 0 1.140920358011499e-05
was O 0 0.00012559712922666222
significant O 0 4.3787076720036566e-05
disparity O 0 0.0006098438170738518
between O 0 0.00018550500681158155
the O 0 0.00012216340110171586
tests O 0 3.105275027337484e-05
. O 0 5.7823548559099436e-05

Three O 0 5.737960964324884e-05
went O 0 9.22967738006264e-05
from O 0 1.4475385796686169e-05
a O 0 3.1731782655697316e-05
decreased O 0 0.0003832256479654461
risk O 0 3.814411684288643e-05
to O 0 7.292873306141701e-06
an O 0 3.3529483971506124e-06
increased O 0 5.794829849037342e-05
risk O 0 8.566588076064363e-05
, O 0 6.24770154900034e-06
while O 0 2.475963810866233e-06
in O 0 5.307666469889227e-06
another O 0 6.222886895557167e-06
three O 0 4.764930508827092e-06
the O 0 3.862244921037927e-05
risk O 0 0.00010127894347533584
was O 0 0.0006556831649504602
decreased O 0 0.0019127612467855215
. O 0 0.00039619524613954127

Knowledge O 0 0.0006822011200711131
of O 0 0.0005187043570913374
the O 0 0.0002324941015103832
potential O 0 0.00012853254156652838
reasons O 0 1.0740165635070298e-05
for O 0 1.6390749806305394e-06
these O 0 9.432353067495569e-07
changes O 0 2.2703418380842777e-06
in O 0 6.285459221544443e-06
results O 0 4.407631422509439e-06
and O 0 4.5188903641246725e-06
impact O 0 2.5079869374167174e-05
of O 0 5.287073508952744e-05
these O 0 2.472172855050303e-05
risk O 0 0.00012293549661990255
reversals O 0 0.0011422345414757729
on O 0 0.0001721664157230407
both O 0 2.8969618142582476e-05
patients O 0 3.093658233410679e-05
and O 0 6.686018423351925e-06
the O 0 3.759501487365924e-05
counseling O 0 2.1027448383392766e-05
team O 0 1.0330571967642754e-05
can O 0 1.3450149936033995e-06
assist O 0 7.016111794655444e-06
in O 0 4.514595730142901e-06
the O 0 1.0334238140785601e-05
development O 0 1.1294536307104863e-05
of O 0 2.509290789021179e-05
strategies O 0 2.1594865756924264e-05
for O 0 4.858432475884911e-06
the O 0 0.00010799928713822737
prevention O 0 0.00041161139961332083
and O 0 8.426848580711521e-06
, O 0 6.261330781853758e-06
where O 0 1.1379278475942556e-05
necessary O 0 1.801713187887799e-05
, O 0 7.98798464529682e-06
management O 0 4.475096648093313e-05
of O 0 0.00011897773947566748
a O 0 0.00014428091526497155
risk O 0 0.00011782814544858411
reversal O 0 0.00015669969434384257
in O 0 1.4112089047557674e-05
any O 0 2.654006266311626e-06
predictive O 0 1.0948569979518652e-05
testing O 0 1.616166628082283e-05
program O 0 4.044148590764962e-05
. O 0 1.1378540875739418e-05
. O 0 2.9167627872084267e-05

A O 0 0.002291708718985319
novel O 0 0.00030848977621644735
common O 0 5.7170193031197414e-05
missense O 0 0.0002763477968983352
mutation O 0 2.0707691874122247e-05
G301C O 0 0.00036281338543631136
in O 0 2.6544354113866575e-05
the O 0 5.812263043480925e-05
N O 0 0.0009651814470998943
- O 0 0.00039774415199644864
acetylgalactosamine O 0 0.001046357792802155
- O 0 0.00016408105148002505
6 O 0 0.00015342685219366103
- O 0 0.0002222781185992062
sulfate O 0 0.0005518805119208992
sulfatase O 0 0.0038875772152096033
gene O 0 5.723369758925401e-05
in O 0 0.00020530539040919393
mucopolysaccharidosis B-Disease 1 0.8769979476928711
IVA I-Disease 1 0.9999853372573853
. O 0 0.0009150416008196771

Mucopolysaccharidosis B-Disease 1 0.9999116659164429
IVA I-Disease 1 1.0
( O 0 0.0056679267436265945
MPS B-Disease 1 0.9999985694885254
IVA I-Disease 1 1.0
) O 0 9.769936878001317e-05
is O 0 8.31381021271227e-06
an O 0 1.1380298928997945e-05
autosomal B-Disease 1 0.9966840147972107
recessive I-Disease 1 0.9999992847442627
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 1.0
by O 0 0.0003171185380779207
a O 0 0.00038757664151489735
genetic B-Disease 1 0.999954342842102
defect I-Disease 1 0.9999979734420776
in O 0 0.0008196754497475922
N O 0 0.005617574322968721
- O 0 0.0008922996348701417
acetylgalactosamine O 0 0.0024598620366305113
- O 0 0.0002699723991099745
6 O 0 0.000263676920440048
- O 0 0.0005168473580852151
sulfate O 0 0.0030224304646253586
sulfatase O 0 0.027354886755347252
( O 0 0.00043249534792266786
GALNS O 1 0.9997547268867493
) O 0 0.0001228032197104767
. O 0 9.41678008530289e-05

In O 0 0.00016997786588035524
previous O 0 7.691780047025532e-05
studies O 0 2.940387093985919e-05
, O 0 5.971768587187398e-06
we O 0 1.2305414429647499e-06
have O 0 3.1123789767661947e-07
found O 0 1.5133833812797093e-06
two O 0 1.2779836424670066e-06
common O 0 5.664925538440002e-06
mutations O 0 2.0595316527760588e-05
in O 0 8.127931505441666e-05
Caucasians O 0 0.00108549022115767
and O 0 3.001068216690328e-05
Japanese O 0 0.0007548324065282941
, O 0 3.151615601382218e-05
respectively O 0 0.00015823390276636928
. O 0 0.00014376208127941936

To O 0 0.00018297674250788987
characterize O 0 0.001064508338458836
the O 0 0.00027678784681484103
mutational O 0 0.0018977923318743706
spectrum O 0 0.00018672893929760903
in O 0 1.3117446542310063e-05
various O 0 5.305308604874881e-06
ethnic O 0 1.4240332347981166e-05
groups O 0 8.509014151059091e-07
, O 0 2.2319377421808895e-06
mutations O 0 2.1381063106673537e-06
in O 0 1.211312337545678e-05
the O 0 6.901341839693487e-05
GALNS O 0 0.021820545196533203
gene O 0 1.2659414096560795e-05
in O 0 2.4597044102847576e-05
Colombian O 0 0.0004288633062969893
MPS B-Disease 1 0.9998836517333984
IVA I-Disease 1 1.0
patients O 0 0.00017610052600502968
were O 0 6.180211494211107e-05
investigated O 0 0.0002583072055131197
, O 0 1.123945003200788e-05
and O 0 4.2098536141566e-06
genetic O 0 2.915413824666757e-05
backgrounds O 0 2.8226268113940023e-05
were O 0 2.9560193070210516e-05
extensively O 0 4.55107401649002e-05
analyzed O 0 9.019034223456401e-06
to O 0 2.684796982066473e-06
identify O 0 6.866577678010799e-06
racial O 0 3.39103426085785e-05
origin O 0 6.373727046593558e-06
, O 0 2.454082277836278e-06
based O 0 8.10442713827797e-07
on O 0 1.7388496416970156e-05
mitochondrial O 0 2.8471826226450503e-05
DNA O 0 9.514424891676754e-05
( O 0 1.6187643268494867e-05
mtDNA O 0 1.9231898477301e-05
) O 0 1.3411823601927608e-05
lineages O 0 0.00016331202641595155
. O 0 0.00013240231783129275

Three O 0 0.00025754928356036544
novel O 0 0.0004339819715823978
missense O 0 0.0007342921453528106
mutations O 0 6.138473690953106e-05
never O 0 9.113411215366796e-05
identified O 0 1.2907076779811177e-05
previously O 0 1.621732735657133e-05
in O 0 8.042599802138284e-06
other O 0 1.5504754173889523e-06
populations O 0 1.981499281100696e-06
and O 0 1.6600131402810803e-06
found O 0 3.194427563357749e-06
in O 0 7.484572961402591e-06
16 O 0 3.087324876105413e-05
out O 0 2.9127434117981466e-06
of O 0 4.113771501579322e-05
19 O 0 0.0006760206306353211
Colombian O 0 0.0009946200298145413
MPS B-Disease 1 0.9973631501197815
IVA I-Disease 1 1.0
unrelated O 0 0.00046119678881950676
alleles O 0 1.65190522238845e-05
account O 0 1.509595585957868e-05
for O 0 3.0239938496379182e-05
84 O 0 0.0012660251231864095
. O 0 0.00043219822691753507

2 O 0 0.0003331138868816197
% O 0 2.3111135305953212e-05
of O 0 0.00011428845027694479
the O 0 9.190103446599096e-05
alleles O 0 9.86252780421637e-06
in O 0 1.1566303328436334e-05
this O 0 4.887034265266266e-06
study O 0 2.6371923013357446e-05
. O 0 6.945372297195718e-05

The O 0 0.001202565268613398
G301C O 0 0.0032052993774414062
and O 0 6.140827463241294e-05
S162F O 0 0.0007975123007781804
mutations O 0 1.8236914911540225e-05
account O 0 1.4049699530005455e-05
for O 0 3.529167588567361e-05
68 O 0 0.0009501748718321323
. O 0 0.0004059234051965177

4 O 0 0.0005427009309642017
% O 0 6.523113552248105e-05
and O 0 9.180293272947893e-05
10 O 0 0.00039720479981042445
. O 0 0.00032328080851584673

5 O 0 0.00026299047749489546
% O 0 2.2522192011820152e-05
of O 0 0.00025480033946223557
mutations O 0 0.00011340445780660957
, O 0 2.8554593882290646e-05
respectively O 0 7.455197192030028e-05
, O 0 7.620024916832335e-06
whereas O 0 1.4208046195562929e-05
the O 0 5.806811896036379e-05
remaining O 0 0.0004284456081222743
F69V O 0 0.06434039771556854
is O 0 8.61265289131552e-06
limited O 0 2.2108420125732664e-06
to O 0 5.7147381085087545e-06
a O 0 1.6108857380459085e-05
single O 0 1.3740719623456243e-05
allele O 0 2.1921461666352116e-05
. O 0 7.016816380200908e-05

The O 0 0.00039409258170053363
skewed O 0 0.0001734164252411574
prevalence O 0 0.0002789935388136655
of O 0 0.0002698553435038775
G301C O 0 0.001800397178158164
in O 0 2.5613342586439103e-05
only O 0 9.229964234691579e-06
Colombian O 0 8.306662493851036e-05
patients O 0 1.4925921277608722e-05
and O 0 6.679925263597397e-06
haplotype O 0 5.501881241798401e-05
analysis O 0 4.514884039963363e-06
by O 0 6.245181793929078e-06
restriction O 0 1.1496099432406481e-05
fragment O 0 4.4853932195110247e-05
length O 0 1.3787684110866394e-05
polymorphisms O 0 2.620810664666351e-05
in O 0 1.3183613191358745e-05
the O 0 7.4607647547964e-05
GALNS O 0 0.04422061890363693
gene O 0 1.2119548046030104e-05
suggest O 0 8.747146239329595e-06
that O 0 2.326312369405059e-06
G301C O 0 0.0002158823044737801
originated O 0 5.8921228628605604e-05
from O 0 1.676259853411466e-05
a O 0 3.077988367294893e-05
common O 0 7.369126979028806e-05
ancestor O 0 0.002124443184584379
. O 0 0.0005812091403640807

Investigation O 0 0.0001221892744069919
of O 0 0.00016517454059794545
the O 0 0.0001142648106906563
genetic O 0 6.487729115178809e-05
background O 0 3.912699321517721e-05
by O 0 6.669905360467965e-06
means O 0 2.007256989600137e-05
of O 0 9.05148554011248e-05
mtDNA O 0 3.380137059139088e-05
lineages O 0 3.3711010473780334e-05
indicate O 0 1.5946654457366094e-05
that O 0 1.2519093388618785e-06
all O 0 3.5286075217300095e-06
our O 0 1.228954533871729e-05
patients O 0 6.568051958311116e-06
are O 0 6.949492785679467e-07
probably O 0 1.7146037862403318e-05
of O 0 6.0579670389415696e-05
native O 0 0.00012589618563652039
American O 0 0.00015595796867273748
descent O 0 0.003093070350587368

Low O 0 0.0004746630147565156
frequency O 0 4.209631879348308e-05
of O 0 0.00026287141372449696
BRCA1 O 0 0.0007330552907660604
germline O 0 0.0003044167533516884
mutations O 0 3.0705191420565825e-06
in O 0 3.340816419949988e-06
45 O 0 2.2247644665185362e-05
German O 1 0.9801540374755859
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0015143033815547824
. O 0 0.0007082056254148483

In O 0 5.890611282666214e-05
this O 0 2.1210144041106105e-06
study O 0 1.4630523992309463e-06
we O 0 6.563409442605916e-07
investigated O 0 1.042607345880242e-05
45 O 0 2.0621435396606103e-05
German O 1 0.9657811522483826
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00014915017527528107
for O 0 6.838457920821384e-05
germline O 0 0.0008747850661166012
mutations O 0 2.002463588723913e-05
in O 0 2.677893098734785e-05
the O 0 8.065037400228903e-05
BRCA1 O 0 0.0004804508644156158
gene O 0 5.340284769772552e-05
. O 0 6.401243444997817e-05

We O 0 5.017529474571347e-05
identified O 0 2.4816637960611843e-05
four O 0 1.2144620086473878e-05
germline O 0 0.0004072563606314361
mutations O 0 1.4287301382864825e-05
in O 0 5.430070450529456e-05
three O 0 0.00014457466022577137
breast B-Disease 1 0.9842405319213867
cancer I-Disease 0 0.08165184408426285
families O 0 9.572475391905755e-06
and O 0 5.866136234544683e-06
in O 0 7.012797141214833e-05
one O 0 0.00039851406472735107
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0002526880707591772
. O 0 1.1750191333703697e-05
among O 0 3.905930043401895e-06
these O 0 1.3054423106950708e-06
were O 0 1.8059829017147422e-05
one O 0 2.042600499407854e-05
frameshift O 0 0.0006884902832098305
mutation O 0 2.3035840058582835e-05
, O 0 1.5132927728700452e-05
one O 0 1.5998446542653255e-05
nonsense O 0 0.0002602278545964509
mutation O 0 1.1165187970618717e-05
, O 0 6.109555215516593e-06
one O 0 5.00759961141739e-06
novel O 0 3.538897362886928e-05
splice O 0 0.00025423034094274044
site O 0 0.00025627337163314223
mutation O 0 9.261105333280284e-06
, O 0 5.2491241149255075e-06
and O 0 5.914946996199433e-06
one O 0 1.9348770365468226e-05
missense O 0 0.0004882553475908935
mutation O 0 7.772592653054744e-05
. O 0 0.0003077392466366291

The O 0 0.0009425724856555462
missense O 0 0.0009604969527572393
mutation O 0 3.268125874456018e-05
was O 0 0.00017017409845720977
also O 0 1.1252350304857828e-05
found O 0 6.437527190428227e-06
in O 0 2.6625180908013135e-05
2 O 0 0.00048593568499200046
. O 0 0.0001317534624831751

8 O 0 0.0002926629676949233
% O 0 1.311727100983262e-05
of O 0 4.936771802022122e-05
the O 0 4.285367685952224e-05
general O 0 2.448671693855431e-05
population O 0 5.613577741314657e-06
, O 0 2.8733343242492992e-06
suggesting O 0 5.277846867102198e-06
that O 0 4.389027310480742e-07
it O 0 5.94281118537765e-07
is O 0 1.8584063354865066e-06
not O 0 5.628737653751159e-06
disease O 0 0.41341686248779297
associated O 0 0.00011819725477835163
. O 0 0.0002449275052640587

The O 0 0.00011361661017872393
average O 0 2.813030732795596e-05
age O 0 0.0001622449344722554
of O 0 0.001056973822414875
disease O 1 1.0
onset O 1 0.9999985694885254
in O 0 0.00039845038554631174
those O 0 2.9576378437923267e-05
families O 0 2.256540574308019e-05
harbouring O 0 0.006617165636271238
causative O 0 0.0009132412378676236
mutations O 0 0.00013521203072741628
was O 0 0.0007955043693073094
between O 0 0.00058422313304618
32 O 0 0.0007354392437264323
. O 0 0.0002555304381530732

3 O 0 0.0010729116620495915
and O 0 0.00012742132821585983
37 O 0 0.0006357394158840179
. O 0 0.0003396948450244963

4 O 0 0.0012595400912687182
years O 0 0.00022358086425811052
, O 0 1.0363728506490588e-05
whereas O 0 2.245198265882209e-05
the O 0 6.472496170317754e-05
family O 0 9.458178101340309e-05
harbouring O 0 0.007078401744365692
the O 0 0.0002272460696985945
missense O 0 0.0004434413567651063
mutation O 0 8.597241503593978e-06
had O 0 2.082115679513663e-05
an O 0 3.133123072984745e-06
average O 0 7.836785698600579e-06
age O 0 6.729254528181627e-05
of O 0 0.0001694687525741756
onset O 1 0.9967246651649475
of O 0 0.010075308382511139
51 O 0 0.006966964807361364
. O 0 0.0008717651362530887

2 O 0 0.0026046959683299065
years O 0 0.0014575396198779345
. O 0 0.00031183738610707223

These O 0 1.636894558032509e-05
findings O 0 1.7371357898809947e-05
show O 0 3.442962042754516e-05
that O 0 5.016604973206995e-06
BRCA1 O 0 0.00022905397054273635
is O 0 1.131120188802015e-05
implicated O 0 0.0001389552344335243
in O 0 1.3893237337470055e-05
a O 0 3.963918970839586e-06
small O 0 9.365342634737317e-07
fraction O 0 1.14397316792747e-05
of O 0 0.0004243242146912962
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00014004531840328127
suggesting O 0 6.222625233931467e-05
the O 0 2.5631426979089156e-05
involvement O 0 2.805524127325043e-05
of O 0 5.854596747667529e-05
another O 0 4.1166716982843354e-05
susceptibility O 0 0.0001235097151948139
gene O 0 5.730676275561564e-05
( O 0 6.003149974276312e-05
s O 0 0.0007896707393229008
) O 0 0.00012088917719665915

Paternal O 0 0.011320572346448898
transmission O 1 0.9999475479125977
of O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 1.0

We O 0 7.273632945725694e-05
report O 0 4.405883373692632e-06
a O 0 2.7988833153358428e-06
rare O 0 5.830246209370671e-06
case O 0 7.706744327151682e-06
of O 0 0.00015184828953351825
paternally O 1 0.9999996423721313
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.005575587507337332
. O 0 0.00041569536551833153

The O 0 0.0007673202198930085
proband O 0 0.004230869933962822
is O 0 1.652811079111416e-05
a O 0 1.6838319425005466e-05
23 O 0 0.00012174534640507773
year O 0 8.303732465719804e-05
old O 0 0.001497125718742609
, O 0 0.000300426094327122
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 0.0021816010121256113
who O 0 0.0010635543148964643
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999489784240723

He O 0 0.00025564859970472753
presented O 0 0.0003512299444992095
with O 0 0.0003202057268936187
respiratory O 1 1.0
and O 0 0.0013977069174870849
feeding O 0 0.0048807463608682156
difficulties O 1 0.9601950645446777
at O 0 0.013942140154540539
birth O 0 0.0034331565257161856
. O 0 0.0003828490152955055

His O 0 0.0013024917570874095
two O 0 0.0003261753881815821
sibs O 1 0.876789391040802
suffer O 0 0.0019335136748850346
from O 0 0.0005096039385534823
childhood O 1 0.9999953508377075
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.0325864814221859

Their O 0 0.0001313279935857281
late O 0 0.0009948877850547433
father O 0 0.00029874834581278265
had O 0 3.164680674672127e-05
the O 0 1.856452399806585e-05
adult O 0 5.864066679350799e-06
type O 0 4.008968244306743e-05
of O 0 0.0008773407898843288
DM B-Disease 1 1.0
, O 0 7.461917994078249e-05
with O 0 1.0200642464042176e-05
onset O 1 0.9942479133605957
around O 0 0.0006053820834495127
30 O 0 0.0003247031709179282
years O 0 0.0003470976953394711
. O 0 0.00013087446859572083

Only O 0 1.7579308405402116e-05
six O 0 1.0919101441686507e-05
other O 0 4.967948825651547e-07
cases O 0 1.8840246411855333e-06
of O 0 7.920002099126577e-05
paternal O 0 0.00252726417966187
transmission O 1 0.9989829659461975
of O 1 0.9999988079071045
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.0015026495093479753
been O 0 0.00015065255865920335
reported O 0 7.414082938339561e-05
recently O 0 0.00013683461293112487
. O 0 7.44740100344643e-05

We O 0 2.8707690944429487e-05
review O 0 4.491230356507003e-06
the O 0 1.585089194122702e-05
sex O 0 1.4117635146249086e-05
related O 0 3.5014472814509645e-05
effects O 0 0.0003012975212186575
on O 0 0.0006799355032853782
transmission O 0 0.01097046211361885
of O 1 0.9994981288909912
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9988954067230225

Decreased O 0 0.006799907889217138
fertility O 0 0.0011990057537332177
of O 0 0.00013204601418692619
males O 0 8.572303158871364e-06
with O 0 8.47327373776352e-06
adult O 0 0.00016372051322832704
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.0005992011283524334
contraction O 0 0.0014815988251939416
of O 0 0.00029213944799266756
the O 0 0.00018458081467542797
repeat O 0 0.00043632020242512226
upon O 0 0.00010491408465895802
male O 0 8.310545672429726e-05
transmission O 0 7.17517250450328e-05
contribute O 0 1.1961891686951276e-05
to O 0 9.063569450518116e-06
the O 0 2.9752451155218296e-05
almost O 0 2.208506703027524e-05
absent O 0 3.6914501833962277e-05
occurrence O 0 2.2634803826804273e-05
of O 0 6.676075281575322e-05
paternal O 0 0.0010533391032367945
transmission O 1 0.8009597659111023
of O 1 0.9999983310699463
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999837875366211

Also O 0 6.566277443198487e-05
the O 0 7.642166019650176e-05
fathers O 0 9.494178084423766e-05
of O 0 8.761588833294809e-05
the O 0 0.0001745217014104128
reported O 0 0.00039699903572909534
congenitally O 0 0.014484679326415062
affected O 0 8.183382306015119e-05
children O 0 2.0135665181442164e-05
showed O 0 8.051760232774541e-05
, O 0 5.502629392140079e-06
on O 0 2.5640276362537406e-05
average O 0 2.1369005480664782e-05
, O 0 2.8218086299602874e-05
shorter O 0 0.0005596186965703964
CTG O 1 0.9860784411430359
repeat O 0 0.001790433656424284
lengths O 0 0.001478905905969441
and O 0 1.8661405192688107e-05
hence O 0 5.850500019732863e-05
less O 0 3.2001215004129335e-05
severe O 0 0.004575121682137251
clinical O 0 0.0009320932440459728
symptoms O 1 0.7825954556465149
than O 0 4.6769702748861164e-05
the O 0 8.095389057416469e-05
mothers O 0 3.224665852030739e-05
of O 0 3.926443969248794e-05
children O 0 6.191136344568804e-05
with O 0 0.000976597424596548
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999979734420776

We O 0 3.167376416968182e-05
conclude O 0 6.153700815048069e-05
that O 0 2.4802650386845926e-06
paternal O 0 0.0002174189721699804
transmission O 0 0.026585863903164864
of O 1 0.999990701675415
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.4259048402309418
rare O 0 0.00042766076512634754
and O 0 2.061477061943151e-05
preferentially O 0 7.86706823419081e-06
occurs O 0 2.6063569293910405e-06
with O 0 1.5416155747516314e-06
onset O 1 0.6825584173202515
of O 0 0.13139526546001434
DM B-Disease 1 1.0
past O 0 0.0011850612936541438
30 O 0 0.0001418344327248633
years O 0 4.6068445954006165e-05
in O 0 1.640931805013679e-05
the O 0 7.532595918746665e-05
father O 0 0.0004150048771407455
. O 0 3.40120677719824e-05
. O 0 7.721337169641629e-05

The O 0 0.0028509709518402815
RB1 O 1 0.9977297186851501
gene O 0 8.530027116648853e-05
mutation O 0 1.6087871699710377e-05
in O 0 1.949914440046996e-05
a O 0 5.586882616626099e-05
child O 0 0.0002463845885358751
with O 0 0.00012572175182867795
ectopic B-Disease 1 0.9963409304618835
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 1 0.8211421966552734

The O 0 0.0032521558459848166
RB1 O 1 0.9973835349082947
gene O 0 9.116886940319091e-05
mutation O 0 1.0025254596257582e-05
was O 0 0.000116460352728609
investigated O 0 8.195127884391695e-05
in O 0 3.111113983322866e-05
a O 0 6.849108467577025e-05
child O 0 0.00033638562308624387
with O 0 0.0001351563259959221
ectopic B-Disease 1 0.8376044631004333
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9993188381195068
using O 0 5.638205402647145e-05
DNA O 0 5.5366828746628016e-05
obtained O 0 1.1030167115677614e-05
from O 0 1.0856905646505766e-05
both O 0 8.09800621937029e-06
the O 0 0.00024101532471831888
pineal B-Disease 1 0.9957314133644104
and I-Disease 0 0.0005052944179624319
retinal I-Disease 1 0.9999996423721313
tumours I-Disease 1 1.0
of O 1 0.9998416900634766
the O 1 0.9697467684745789
patient O 0 0.0023241916205734015
. O 0 0.0004104680265299976

A O 0 0.003341651987284422
nonsense O 0 0.0009294903138652444
mutation O 0 1.6319487258442678e-05
in O 0 6.070244126021862e-05
exon O 0 0.0005595692782662809
17 O 0 0.0002374228643020615
( O 0 2.6855477699427865e-05
codon O 0 3.195955287083052e-05
556 O 0 0.0001530752779217437
) O 0 7.924038072815165e-06
of O 0 6.666761328233406e-05
the O 0 0.0004689930356107652
RB1 O 1 0.9921666383743286
gene O 0 2.64233531197533e-05
was O 0 9.440570283913985e-05
found O 0 2.7420269361755345e-06
to O 0 4.787810667039594e-06
be O 0 4.3281888792989776e-06
present O 0 1.9922312276321463e-05
homozygously O 0 0.001417767722159624
in O 0 2.561761903052684e-05
both O 0 1.5103790246939752e-05
the O 0 0.00018633712898008525
retinal B-Disease 1 0.7755530476570129
and I-Disease 0 0.0005489411414600909
the I-Disease 0 0.26497071981430054
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.0036158293951302767

The O 0 0.00023988186148926616
same O 0 2.338257763767615e-05
mutation O 0 2.0450601368793286e-05
was O 0 0.00014345135423354805
present O 0 6.659276550635695e-05
heterozygously O 0 0.0013179630041122437
in O 0 1.7277068764087744e-05
the O 0 2.3204464014270343e-05
DNA O 0 2.6215004254481755e-05
from O 0 1.1010104572051205e-05
the O 0 1.9635423086583614e-05
constitutional O 0 5.545586463995278e-05
cells O 0 1.3785843293590005e-05
of O 0 4.7036544856382534e-05
the O 0 0.00016676262021064758
patient O 0 5.20784524269402e-05
, O 0 8.208556209865492e-06
proving O 0 0.0003042278694920242
it O 0 2.0154404865024844e-06
to O 0 3.6142916997050634e-06
be O 0 4.549687673716107e-06
of O 0 8.090055780485272e-05
germline O 0 0.0025189633015543222
origin O 0 0.00015519133012276143
. O 0 0.0002600130974315107

The O 0 0.00017493971972726285
initial O 0 4.64422300865408e-05
mutation O 0 1.3353908798308112e-05
was O 0 6.732900510542095e-05
shown O 0 1.3184794624976348e-05
to O 0 6.219932402018458e-06
have O 0 1.7712401358949137e-06
occurred O 0 8.360463107237592e-05
in O 0 9.659548595664091e-06
the O 0 4.207761594443582e-05
paternally O 0 0.0007436798186972737
derived O 0 0.00032263394678011537
RB1 O 1 0.8442684412002563
allele O 0 0.00013929004489909858
. O 0 0.0001868616382125765

The O 0 0.0004410433175507933
mutation O 0 2.005750866374001e-05
is O 0 5.393204446590971e-06
in O 0 5.74065734326723e-06
an O 0 2.011126071010949e-06
area O 0 2.4844388462952338e-05
of O 0 1.862098361016251e-05
the O 0 2.8394520995789208e-05
gene O 0 2.3481288735638373e-06
that O 0 4.929838155476318e-07
encodes O 0 2.4134840259648627e-06
the O 0 8.03071179689141e-06
protein O 0 1.4393192941497546e-05
- O 0 3.685344199766405e-05
binding O 0 5.272051566862501e-06
region O 0 6.769377796445042e-05
known O 0 3.938207373721525e-05
as O 0 2.530473648221232e-05
the O 0 8.938913379097357e-05
pocket O 0 0.0006049284129403532
region O 0 0.00010720798309193924
and O 0 8.682643965585157e-06
has O 0 3.8562752706639e-06
been O 0 1.3614638191938866e-05
detected O 0 3.420547363930382e-05
in O 0 4.2721867430373095e-06
other O 0 1.1321391184537788e-06
cases O 0 6.281749847403262e-06
of O 0 0.0003276574134360999
retinoblastoma B-Disease 1 0.8912019729614258
. O 0 0.00026784033980220556
. O 0 0.0002591577358543873

Low O 0 0.0010929659474641085
levels O 0 0.0001814101415220648
of O 0 0.00022448097297456115
beta O 0 0.00098583591170609
hexosaminidase O 0 0.0021151842083781958
A O 0 0.00018723777611739933
in O 0 1.6041343769757077e-05
healthy O 0 1.4807904335611966e-05
individuals O 0 3.9521276562481944e-07
with O 0 5.9586382121779025e-06
apparent O 1 0.9883412718772888
deficiency O 1 1.0
of O 1 0.9980835914611816
this O 0 0.00034421138116158545
enzyme O 0 0.00028590665897354484
. O 0 0.0002089410409098491

Appreciable O 0 0.006112903356552124
beta O 0 0.002790600061416626
hexosaminidase O 0 0.008558925241231918
A O 0 0.0014581255381926894
( O 0 0.00010174793715123087
hex O 0 0.0015717378119006753
A O 0 0.0004531610757112503
) O 0 6.450088221754413e-06
activity O 0 5.7638230828160886e-06
has O 0 4.383791292639216e-06
been O 0 1.2459108802431729e-05
detected O 0 0.00018778540834318846
in O 0 0.00013852235861122608
cultured O 0 0.003496709745377302
skin O 0 0.006036981008946896
fibroblasts O 0 0.0017720843898132443
and O 0 0.00045745220268145204
melanoma B-Disease 1 1.0
tissue O 1 0.8977689743041992
from O 0 0.0003711252938956022
healthy O 0 0.00010790962551254779
individuals O 0 1.8937773802463198e-06
previously O 0 5.0357546570012346e-05
reported O 0 3.867471241392195e-05
as O 0 5.775994577561505e-05
having O 0 0.0009629902779124677
deficiency B-Disease 1 1.0
of I-Disease 1 0.9531323909759521
hex I-Disease 0 0.10584229230880737
A I-Disease 0 0.001125663286074996
activity O 0 2.597847742435988e-05
indistinguishable O 0 1.9244887880631723e-05
from O 0 1.189234467346978e-06
that O 0 1.42954220905267e-07
of O 0 5.238463018031325e-06
patients O 0 8.116701792459935e-06
with O 0 8.06219395599328e-05
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0019180556992068887
TSD B-Disease 1 0.9999990463256836
) O 0 0.0003634070744737983
. O 0 0.0002643590560182929

Identification O 0 0.0001165909125120379
and O 0 7.338579598581418e-05
quantitation O 0 0.0071997432969510555
of O 0 0.003119605127722025
hex O 0 0.009656093083322048
A O 0 0.001576320151798427
, O 0 1.49758234329056e-05
amounting O 0 0.00011861184611916542
to O 0 3.381942951818928e-05
3 O 0 0.00033269557752646506
. O 0 0.0001270423090318218

5 O 0 0.0006099891616031528
% O 0 0.00018036836991086602
- O 0 0.0012394210789352655
6 O 0 0.0008051229524426162
. O 0 0.0002198703441536054

9 O 0 0.0005380240618251264
% O 0 2.094638693961315e-05
of O 0 0.00010707149340305477
total O 0 0.00021425164595711976
beta O 0 0.0012186442036181688
hexosaminidase O 0 0.0019525616662576795
activity O 0 1.3976708032714669e-05
, O 0 1.2702276990239625e-06
has O 0 4.328285854171554e-07
been O 0 6.934094471944263e-07
obtained O 0 2.613365722936578e-06
by O 0 7.196096703410149e-06
cellulose O 0 0.0017053140327334404
acetate O 0 0.001269731903448701
gel O 0 0.002208003308624029
electrophoresis O 0 0.0007223191787488759
, O 0 0.00012783364218194038
DEAE O 1 0.9970865845680237
- O 0 0.001676528831012547
cellulose O 0 0.0031617681961506605
ion O 0 0.0008471451001241803
- O 0 0.0005277057061903179
exchange O 0 0.000285651593003422
chromatography O 0 0.006346242036670446
, O 0 6.710824527544901e-05
radial O 0 0.0008178611751645803
immunodiffusion O 0 0.02063058875501156
, O 0 0.00012001143477391452
and O 0 7.282877777470276e-05
radioimmunoassay O 0 0.02272692508995533
. O 0 0.00040435040136799216

Previous O 0 0.00024531217059120536
family O 0 3.486060813884251e-05
studies O 0 1.1686224752338603e-05
suggested O 0 1.1325622836011462e-05
that O 0 8.797557029538439e-07
these O 0 7.574861342618533e-07
individuals O 0 1.1036038358724909e-06
may O 0 4.766718848259188e-05
be O 0 2.7281163056613877e-05
compound O 0 0.0002206307544838637
heterozygotes O 0 0.00026336335577070713
for O 0 1.0814495908562094e-05
the O 0 7.958719652378932e-05
common O 0 4.541484304354526e-05
mutant O 0 0.0005956754903309047
TSD B-Disease 1 0.9874293208122253
gene O 0 5.3159466915531084e-05
and O 0 9.98725590761751e-06
a O 0 2.5176825147354975e-05
rare O 0 0.00017102062702178955
( O 0 3.620923598646186e-05
allelic O 0 0.00044029345735907555
) O 0 4.3630476284306496e-05
mutant O 0 0.00020026537822559476
gene O 0 0.000144838762935251
. O 0 0.00018037833797279745

Thus O 0 0.00028121727518737316
, O 0 1.2151640476076864e-05
the O 0 1.9718778276001103e-05
postulated O 0 0.00022265313600655645
rate O 0 1.3242308341432363e-05
mutant O 0 4.4898391934111714e-05
gene O 0 4.797358542418806e-06
appears O 0 7.016031304374337e-06
to O 0 1.45855540267803e-06
code O 0 1.0510984793654643e-06
for O 0 1.0789160569402156e-06
the O 0 2.0121420675422996e-05
expression O 0 9.867297194432467e-06
of O 0 6.507022771984339e-05
low O 0 0.00012670151772908866
amounts O 0 3.3109452488133684e-05
of O 0 0.0003605883102864027
hex O 0 0.004281750414520502
A O 0 0.0016583121614530683
. O 0 0.00017136961105279624

Heterozygotes O 0 0.0028319843113422394
for O 0 4.1238617995986715e-05
the O 0 0.0001343091862509027
rare O 0 0.00014102018030826002
mutant O 0 0.00013967642735224217
may O 0 4.1996401705546305e-05
be O 0 4.5681517804041505e-06
indistinguishable O 0 3.544030914781615e-05
from O 0 1.2959780178789515e-05
heterozygotes O 0 0.000220445916056633
for O 0 1.4993028344179038e-05
the O 0 0.0002138212730642408
common O 0 0.0003748388262465596
TSD B-Disease 1 0.9999362230300903
mutant O 0 0.004127491265535355
. O 0 0.0005242544575594366

However O 0 0.0001250214409083128
, O 0 1.0710973583627492e-05
direct O 0 1.3728328667639289e-05
visualization O 0 0.0006002663285471499
and O 0 7.055862079141662e-05
quantitation O 0 0.008024850860238075
of O 0 0.0026334444992244244
hex O 0 0.006179276388138533
A O 0 0.0004362426698207855
by O 0 4.209419785183854e-06
the O 0 8.595863619120792e-06
methods O 0 1.3288267837197054e-05
described O 0 0.00010212148481514305
may O 0 0.00011545468441909179
prevent O 0 0.0003493682888802141
false O 0 0.0001500348444096744
- O 0 0.00021023077715653926
positive O 0 2.0981495254090987e-05
prenatal O 0 0.000525905576068908
diagnosis O 0 0.0014976098900660872
of O 0 0.0029387802351266146
TSD B-Disease 1 0.9999991655349731
in O 0 0.001589191029779613
fetuses O 0 0.0010117634665220976
having O 0 3.842868682113476e-05
the O 0 4.261558933649212e-05
incomplete O 0 0.00033064532908611
hex B-Disease 0 0.006688939873129129
A I-Disease 0 0.23843348026275635
deficiency I-Disease 1 0.9999997615814209
of O 0 0.003617348149418831
the O 0 0.0008717476739548147
type O 0 0.00018489295325707644
described O 0 0.00011721673217834905
in O 0 2.714227230171673e-05
the O 0 5.3096595365786925e-05
four O 0 3.4113287256332114e-05
healthy O 0 0.00015919671568553895
individuals O 0 4.102332241018303e-05

The O 0 0.0009360339608974755
tumor B-Disease 1 0.9807136654853821
suppressor O 0 0.002824306720867753
gene O 0 0.0001681506255408749
Smad4 O 0 0.021156679838895798
/ O 0 0.001380643923766911
Dpc4 O 0 0.0034679751843214035
is O 0 4.756938778882613e-06
required O 0 2.730493179115001e-06
for O 0 9.53991366259288e-06
gastrulation O 0 0.002814043778926134
and O 0 1.7111815395765007e-05
later O 0 8.85867266333662e-05
for O 0 2.5841638489509933e-05
anterior O 0 0.001188295311294496
development O 0 0.00029027817072346807
of O 0 0.0006326135480776429
the O 0 0.0009421499562449753
mouse O 0 0.00024551362730562687
embryo O 0 0.00012061558663845062
. O 0 4.247820834279992e-05

Mutations O 0 6.927202775841579e-05
in O 0 6.190263229655102e-05
the O 0 0.00038323481567204
SMAD4 O 1 0.9999997615814209
/ O 0 0.1668185442686081
DPC4 O 1 0.9999986886978149
tumor B-Disease 1 0.995134174823761
suppressor O 0 0.0012734101619571447
gene O 0 1.3797497558698524e-05
, O 0 3.280948476458434e-06
a O 0 6.2115977925714105e-06
key O 0 0.00013399757153820246
signal O 0 0.00022822101891506463
transducer O 0 9.120322647504508e-05
in O 0 2.0674346160376444e-05
most O 0 3.379074405529536e-05
TGFbeta O 0 0.008603817783296108
- O 0 0.0005013293121010065
related O 0 0.0001045591343427077
pathways O 0 0.00022427774092648178
, O 0 5.234517630015034e-06
are O 0 3.2001705108086753e-07
involved O 0 2.6390775929030497e-06
in O 0 9.125546966970433e-06
50 O 0 2.44997936533764e-05
% O 0 2.7064730602432974e-05
of O 0 0.004101582337170839
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.006881173234432936

Homozygous O 0 0.0019990878645330667
Smad4 O 0 0.023736752569675446
mutant O 0 0.0029821170028299093
mice O 0 0.0016988111892715096
die O 0 0.001531892572529614
before O 0 0.00010282993753207847
day O 0 0.00011763843212975189
7 O 0 0.00026027773856185377
. O 0 8.762967627262697e-05

5 O 0 0.0009520856547169387
of O 0 0.0016314696986228228
embryogenesis O 0 0.013881285674870014
. O 0 0.0006603744113817811

Mutant O 0 0.00073199812322855
embryos O 0 4.946583430864848e-05
have O 0 1.4858370604997617e-06
reduced O 0 9.300900273956358e-06
size O 0 1.3282072359288577e-05
, O 0 6.61175545246806e-06
fail O 0 5.135232277098112e-05
to O 0 3.5612003557616845e-05
gastrulate O 0 0.0030983062461018562
or O 0 2.781874172796961e-05
express O 0 4.421435733092949e-05
a O 0 9.42750702961348e-05
mesodermal O 0 0.0037659895606338978
marker O 0 0.0015072353417053819
, O 0 3.166388705722056e-05
and O 0 1.3164617485017516e-05
show O 0 0.00019953650189563632
abnormal O 0 0.0015618940815329552
visceral O 0 0.061788856983184814
endoderm O 1 0.9978783130645752
development O 0 0.004049707669764757
. O 0 0.0005478279781527817

Growth B-Disease 1 0.999967098236084
retardation I-Disease 1 0.9999996423721313
of O 0 0.04205649718642235
the O 0 0.17416536808013916
Smad4 O 1 0.9999817609786987
- O 0 0.0028386847116053104
deficient O 0 0.0005178704741410911
embryos O 0 2.0496190700214356e-06
results O 0 6.944425194888026e-07
from O 0 3.759113724299823e-06
reduced O 0 5.355625398806296e-05
cell O 0 0.0002205377968493849
proliferation O 0 0.0004980811499990523
rather O 0 5.329568921297323e-06
than O 0 3.220725375285838e-06
increased O 0 8.727849490242079e-05
apoptosis O 0 0.0017422885866835713
. O 0 0.00021695987379644066

Aggregation O 0 0.0004641723062377423
of O 0 0.0009538688464090228
mutant O 0 0.002520244335755706
Smad4 O 1 0.9480203986167908
ES O 1 0.5755068063735962
cells O 0 5.56750237592496e-05
with O 0 8.254794920503628e-06
wild O 0 0.00012942457397002727
- O 0 0.00014277316222433
type O 0 6.0173755628056824e-05
tetraploid O 0 0.00037179936771281064
morulae O 0 0.0033776634372770786
rescues O 0 0.0009659325587563217
the O 0 0.0002918476820923388
gastrulation B-Disease 1 0.9436702132225037
defect I-Disease 1 0.8867929577827454
. O 0 0.0008415494812652469

These O 0 2.007453986152541e-05
results O 0 1.5037363482406363e-05
indicate O 0 3.9875772927189246e-05
that O 0 8.068581337283831e-06
Smad4 O 0 0.001224776729941368
is O 0 3.6876863305224106e-06
initially O 0 2.096727712341817e-06
required O 0 5.783909386991581e-07
for O 0 1.3104665868013399e-06
the O 0 1.3903616491006687e-05
differentiation O 0 7.32132830307819e-05
of O 0 0.00018768910376820713
the O 0 0.000491801998578012
visceral O 0 0.005873534828424454
endoderm O 0 0.013801871798932552
and O 0 2.859495180018712e-05
that O 0 5.5802597671572585e-06
the O 0 8.873915794538334e-05
gastrulation B-Disease 0 0.015110078267753124
defect I-Disease 0 0.003537173382937908
in O 0 0.00015432496729772538
the O 0 0.0004035725141875446
epiblast O 0 0.022460700944066048
is O 0 3.193987504346296e-05
secondary O 0 0.00019317965779919177
and O 0 2.5103556254180148e-05
non O 0 0.00040365621680393815
- O 0 0.0011369938729330897
cell O 0 0.0002653906703926623
autonomous O 0 0.000254385027801618
. O 0 9.007847256725654e-05

Rescued O 0 0.00863844994455576
embryos O 0 0.00020106011652387679
show O 0 0.0004336413985583931
severe O 0 0.043422531336545944
anterior O 1 0.8837786912918091
truncations O 1 0.9875687956809998
, O 0 0.00025880910106934607
indicating O 0 0.0003868704370688647
a O 0 4.091895971214399e-05
second O 0 4.1482217056909576e-05
important O 0 3.0569208320230246e-05
role O 0 4.520734728430398e-05
for O 0 2.984597631439101e-05
Smad4 O 0 0.05085697025060654
in O 0 0.0004201437986921519
anterior O 0 0.03895946219563484
patterning O 0 0.16039612889289856
during O 1 0.9885486364364624
embryogenesis O 0 0.14134708046913147
. O 0 0.0009566866792738438

Prevalence O 0 0.0060108560137450695
of O 0 0.0023571746423840523
p16 O 0 0.005081810988485813
and O 0 0.00031892952392809093
CDK4 O 1 0.9997325539588928
germline O 0 0.002464492805302143
mutations O 0 6.233862222870812e-05
in O 0 0.0001774157863110304
48 O 0 0.0023109326139092445
melanoma B-Disease 1 0.9999996423721313
- O 0 0.0071400804445147514
prone O 0 0.001227609463967383
families O 0 7.693745828873944e-06
in O 0 3.667191049316898e-05
France O 0 0.00031312525970861316
. O 0 0.0003442266315687448

The O 0 0.00052552146371454
French O 0 0.0014861709205433726
Familial B-Disease 1 0.9999955892562866
Melanoma I-Disease 1 1.0
Study O 0 0.0023243501782417297
Group O 0 0.0002852482721209526
. O 0 0.00024689012207090855

Germline O 0 0.011559238657355309
mutations O 0 0.00023238040739670396
in O 0 0.00015720704686827958
the O 0 0.0002780261856969446
p16 O 0 0.0008063252898864448
and O 0 4.7028563130879775e-05
CDK4 O 1 0.5916147828102112
genes O 0 1.4731533156009391e-05
have O 0 1.1751228612411069e-06
been O 0 2.7469163796922658e-06
reported O 0 3.1858207876211964e-06
in O 0 1.844584517129988e-06
a O 0 6.782730906707002e-06
subset O 0 3.4202865208499134e-05
of O 0 0.0005923064309172332
melanoma B-Disease 1 0.9999991655349731
pedigrees O 0 0.003782482584938407
, O 0 3.264014230808243e-05
but O 0 3.944137006328674e-06
their O 0 2.9385175821516896e-06
prevalence O 0 0.0001482860097894445
is O 0 6.036971626599552e-06
not O 0 2.495878106856253e-06
well O 0 1.0011620361183304e-05
known O 0 0.00011114299559267238
. O 0 0.00013523678353521973

We O 0 5.111896462040022e-05
searched O 0 3.213521995348856e-05
for O 0 2.8131944418419152e-06
such O 0 6.218390353751602e-06
germline O 0 0.0011181734735146165
mutations O 0 2.1959311197861098e-05
in O 0 5.281057383399457e-05
48 O 0 0.00048726017121225595
French O 0 0.010540150105953217
melanoma B-Disease 1 1.0
- O 0 0.01658507250249386
prone O 0 0.0007631496991962194
families O 0 1.5547175280516967e-06
selected O 0 4.7184312279568985e-06
according O 0 8.528512012162537e-07
to O 0 1.5985855270628235e-06
two O 0 1.2226361150169396e-06
major O 0 2.122269870596938e-05
criteria O 0 4.991212790628197e-06
families O 0 8.973057674666052e-07
with O 0 1.2300909020268591e-06
at O 0 7.361934694927186e-05
least O 0 2.0974116523575503e-06
three O 0 3.7244292343530105e-06
affected O 0 7.161672783695394e-06
members O 0 1.971836127268034e-06
( O 0 6.251676950341789e-06
n O 0 5.991659782011993e-05
= O 0 9.402207797393203e-05
20 O 0 8.841539965942502e-05
) O 0 3.4635943393368507e-06
or O 0 1.92764764506137e-06
families O 0 1.4284929648056277e-06
with O 0 1.247349928235053e-06
two O 0 6.7307751123735216e-06
affected O 0 3.4823096939362586e-05
members O 0 5.562731075769989e-06
, O 0 4.122954578633653e-06
one O 0 1.9937558590754634e-06
of O 0 2.9397282560239546e-05
them O 0 7.5851216934097465e-06
affected O 0 1.2930201592098456e-05
before O 0 1.5318448276957497e-05
the O 0 1.2551499821711332e-05
age O 0 3.327024387544952e-05
of O 0 8.700186299392954e-05
50 O 0 6.422748265322298e-05
( O 0 1.0848812053154688e-05
n O 0 7.236032251967117e-05
= O 0 9.214199963025749e-05
28 O 0 0.00015728440484963357
) O 0 7.86000418884214e-06
, O 0 2.9949094368930673e-06
and O 0 1.934915189849562e-06
one O 0 2.01244233721809e-06
additional O 0 1.3582035535364412e-05
minor O 0 0.001205385196954012
criterion O 1 0.9065521359443665
. O 0 0.0009789870819076896

Sixteen O 0 0.002874950645491481
different O 0 3.2711501262383536e-05
p16 O 0 0.0015342208789661527
germline O 0 0.001409738208167255
mutations O 0 4.625853034667671e-05
were O 0 4.8884950956562534e-05
found O 0 1.5153074855334125e-05
in O 0 2.258702261315193e-05
21 O 0 0.00013380820746533573
families O 0 6.586229574168101e-06
, O 0 6.620954081881791e-06
while O 0 9.815369594434742e-06
one O 0 2.4522094463463873e-05
germline O 0 0.0014272191328927875
mutation O 0 5.0601560360519215e-05
, O 0 4.580652239383198e-05
Arg24His O 0 0.004321186803281307
, O 0 1.8675649698707275e-05
was O 0 0.00018754992925096303
detected O 0 0.00011880642705364153
in O 0 1.7810167264542542e-05
the O 0 0.00013172696344554424
CDK4 O 1 0.969592273235321
gene O 0 0.00018610310507938266
. O 0 0.00013269581540953368

The O 0 0.00012483631144277751
frequency O 0 2.5930583433364518e-05
of O 0 0.0001576647482579574
p16 O 0 0.00025919926702044904
gene O 0 9.933341971191112e-06
mutation O 0 1.511839855083963e-06
in O 0 4.269987130101072e-06
our O 0 4.168802661297377e-06
sample O 0 5.502212161445641e-07
( O 0 2.453778051858535e-06
44 O 0 1.9086222891928628e-05
% O 0 1.2428837180777919e-05
) O 0 6.660008693870623e-06
is O 0 3.6087637909076875e-06
among O 0 4.039197847305331e-06
the O 0 1.3515428690880071e-05
highest O 0 8.628355135442689e-05
rates O 0 5.573621820076369e-06
yet O 0 2.817587073877803e-06
reported O 0 5.416590738605009e-06
and O 0 2.6339860141888494e-06
the O 0 7.075724715832621e-05
CDK4 O 0 0.12233848869800568
mutation O 0 1.1153238119732123e-05
is O 0 3.613940180002828e-06
the O 0 8.562187758798245e-06
second O 0 2.6563904611975886e-05
mutation O 0 2.7404898901295383e-06
detected O 0 1.71583396877395e-05
in O 0 2.6866537155001424e-06
this O 0 8.059191713982727e-07
gene O 0 6.796865818614606e-06
worldwide O 0 1.686181167315226e-05
. O 0 8.618282299721614e-05

In O 0 0.000220514863030985
summary O 0 0.0002541498397476971
, O 0 1.4415281839319505e-05
our O 0 6.399929588951636e-06
results O 0 1.6093342765088892e-06
show O 0 7.1752497206034604e-06
frequent O 0 8.222439646488056e-06
involvement O 0 4.814757267013192e-05
of O 0 0.00011570818605832756
the O 0 0.00021916099649388343
p16 O 0 0.0005247268709354103
gene O 0 2.4120110538206063e-05
in O 0 9.494584810454398e-05
familial B-Disease 0 0.2821948230266571
melanoma I-Disease 1 0.999998927116394
and O 0 0.00010717404074966908
confirm O 0 5.533800504053943e-05
the O 0 5.2918203437002376e-05
role O 0 3.694901897688396e-05
of O 0 0.00012216807226650417
the O 0 0.00021768469014205039
CDK4 O 1 0.9715108871459961
gene O 0 2.6315796276321635e-05
as O 0 1.8482594896340743e-05
a O 0 7.49745886423625e-05
melanoma B-Disease 1 0.9999749660491943
- O 0 0.0013453521532937884
predisposing O 0 0.0015368734020739794
gene O 0 3.182980071869679e-05
. O 0 2.7703921659849584e-05
. O 0 6.391917122527957e-05

Progression O 1 0.9145089983940125
of O 0 0.009484780952334404
somatic O 0 0.022247495129704475
CTG O 1 0.9996756315231323
repeat O 0 0.0008901486871764064
length O 0 3.107789598288946e-05
heterogeneity O 0 7.448239193763584e-05
in O 0 1.23748095575138e-05
the O 0 3.6667712265625596e-05
blood O 0 0.00016856352158356458
cells O 0 0.00028766310424543917
of O 1 0.9936311841011047
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9998482465744019
. O 0 0.003300492186099291

The O 0 2.0474722987273708e-05
genetic O 0 1.7477006622357294e-05
basis O 0 8.923872519517317e-05
of O 1 0.9996242523193359
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999041557312012
DM B-Disease 1 1.0
) O 0 0.0001433669967809692
is O 0 8.427998182014562e-06
the O 0 1.559860356792342e-05
expansion O 0 0.00011334607552271336
of O 0 0.00014819922216702253
an O 0 0.00013137009227648377
unstable O 0 0.18465879559516907
CTG O 1 0.9504764676094055
repeat O 0 0.0004147193976677954
in O 0 1.706008151813876e-05
the O 0 2.3525411961600184e-05
34 O 0 4.451915810932405e-05
UTR O 0 0.005410691257566214
of O 0 9.558465535519645e-05
the O 0 0.0002793088788166642
DM B-Disease 1 0.9999125003814697
protein O 0 5.834877447341569e-05
kinase O 0 1.756013989506755e-05
gene O 0 6.159762506285915e-06
on O 0 6.0724152717739344e-05
chromosome O 0 0.0001979522785404697
19 O 0 0.0008070336771197617
. O 0 0.00023587052419316024

One O 0 6.56920819892548e-05
of O 0 7.348397775785998e-05
the O 0 7.8710334491916e-05
principal O 0 0.0001994938647840172
features O 0 1.8418477338855155e-05
of O 0 0.00015741540119051933
the O 0 0.0009317314252257347
DM B-Disease 1 1.0
mutation O 0 4.77092107757926e-05
is O 0 8.954662007454317e-06
an O 0 4.023312612844165e-06
extraordinarily O 0 0.00016880592738743871
high O 0 0.0001535228657303378
level O 0 0.00021960529556963593
of O 0 0.0005151896039023995
somatic O 0 0.0025679105892777443
mosaicism O 1 0.7713292241096497
, O 0 5.5067263019736856e-05
due O 0 0.00016475521260872483
to O 0 2.0747540474985726e-05
an O 0 7.18058981874492e-06
extremely O 0 3.264605766162276e-05
high O 0 6.641646177740768e-05
degree O 0 5.436848005047068e-05
of O 0 0.0001776006247382611
somatic O 0 0.0003349650651216507
instability O 0 0.000873361830599606
both O 0 1.354090818495024e-05
within O 0 1.4118390026851557e-05
and O 0 4.2360466068203095e-06
between O 0 7.959971844684333e-05
different O 0 1.780018283170648e-05
tissues O 0 0.0004669940681196749
. O 0 0.00026290121604688466

This O 0 0.00010322626621928066
instability O 0 0.001827248022891581
appears O 0 7.311240915441886e-05
to O 0 6.123017556092236e-06
be O 0 2.833939106494654e-06
biased O 0 6.892210421938216e-06
towards O 0 1.8550825188867748e-05
further O 0 1.307777529291343e-05
expansion O 0 9.987354133045301e-05
and O 0 3.7329032238631044e-06
continuous O 0 2.9642902518389747e-05
throughout O 0 2.1590807591564953e-05
the O 0 4.1290604713140056e-05
life O 0 3.361996277817525e-05
of O 0 3.267683132435195e-05
an O 0 9.48189972405089e-06
individual O 0 5.3187332014204e-06
, O 0 4.289463959139539e-06
features O 0 4.007252300652908e-06
that O 0 8.561245863347722e-07
could O 0 1.982792127819266e-06
be O 0 7.81250378167897e-07
associated O 0 1.7396089333487907e-06
with O 0 1.0920412023551762e-06
the O 0 6.879278225824237e-05
progressive O 0 0.0006554448045790195
nature O 0 0.00012791533663403243
of O 0 0.0005881710676476359
the O 0 0.026323875412344933
disease O 1 0.9999998807907104
. O 0 0.000702749181073159

Although O 0 5.3050785936648026e-05
increasing O 0 3.3749649446690455e-05
measured O 0 2.3466480342904106e-05
allele O 0 4.108099346922245e-06
size O 0 6.180204763950314e-06
between O 0 8.925795555114746e-05
patients O 0 4.931276271236129e-05
clearly O 0 2.7110612791148014e-05
correlates O 0 2.8882779588457197e-05
with O 0 1.6095076489364146e-06
an O 0 2.86731210508151e-06
increased O 0 3.5427096008788794e-05
severity O 0 0.0009946887148544192
of O 0 0.0009125649812631309
symptoms O 0 0.04794962331652641
and O 0 2.9234659450594336e-05
an O 0 8.931412594392896e-06
earlier O 0 4.3686519347829744e-05
age O 0 0.0001329944934695959
of O 0 0.00032658703275956213
onset O 1 0.999396562576294
, O 0 3.355183798703365e-05
this O 0 4.85771397507051e-06
correlation O 0 1.4356193787534721e-05
is O 0 2.8873710107291117e-06
not O 0 8.394223414143198e-07
precise O 0 5.488112492457731e-06
and O 0 3.924802058463683e-06
measured O 0 2.2087258912506513e-05
allele O 0 3.585235162972822e-06
length O 0 1.0988842404913157e-05
cannot O 0 3.6875740079267416e-06
be O 0 9.440768167223723e-07
used O 0 1.7985001932174782e-06
as O 0 3.86842293664813e-06
an O 0 1.3005859500481165e-06
accurate O 0 2.891904478019569e-05
predictor O 0 0.000670268724206835
of O 0 0.0003062001778744161
age O 0 0.0018200520426034927
of O 0 0.004666181281208992
onset O 1 0.9999998807907104
. O 0 0.004113224800676107

In O 0 6.8733497755602e-05
order O 0 6.8726312747458e-06
to O 0 4.242159320710925e-06
further O 0 5.794001936010318e-06
characterize O 0 4.335697667556815e-05
the O 0 3.120967812719755e-05
dynamics O 0 0.0004973135073669255
of O 0 0.005219274200499058
DM B-Disease 1 1.0
CTG O 1 0.9999978542327881
repeat O 0 0.004897096194326878
somatic O 0 0.0009968270314857364
instability O 0 0.0013435576111078262
, O 0 1.2936244274897035e-05
we O 0 2.320184194104513e-06
have O 0 7.945747597659647e-07
studied O 0 3.8110589230200276e-05
repeat O 0 8.916191291064024e-05
length O 0 4.686130068876082e-06
changes O 0 7.052108799143753e-07
over O 0 2.8798854145861696e-06
time O 0 7.008675765973749e-06
in O 0 5.5886303016450256e-05
111 O 1 0.9962857961654663
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0017854287289083004
with O 0 5.136187610332854e-05
varying O 0 0.00015251421427819878
clinical O 0 0.0029460517689585686
severity O 1 0.9985221028327942
and O 0 0.001399242551997304
CTG O 1 0.9936961531639099
repeat O 0 0.0004898534389212728
size O 0 8.647827598906588e-06
over O 0 5.878322099306388e-06
time O 0 3.831011781585403e-06
intervals O 0 3.932148956664605e-06
of O 0 2.3562321075587533e-05
1 O 0 0.0002951844362542033
- O 0 0.00036773079773411155
7 O 0 0.0002050409239018336
years O 0 0.00021467986516654491
. O 0 0.00010493819718249142

We O 0 5.286484520183876e-05
have O 0 1.4514121176034678e-06
found O 0 1.8491143691790057e-06
a O 0 2.909927843575133e-06
direct O 0 8.10318215371808e-06
progression O 0 0.0007331475499086082
of O 0 0.00014137117250356823
the O 0 8.206068741856143e-05
size O 0 1.2336009604041465e-05
heterogeneity O 0 2.280799890286289e-05
over O 0 9.173065336653963e-06
time O 0 4.677066954172915e-06
related O 0 7.604213806189364e-06
to O 0 1.4213711438060272e-05
initial O 0 0.00019576630438677967
CTG O 0 0.08393591642379761
repeat O 0 0.0005891512264497578
size O 0 2.0177167243673466e-05
and O 0 5.187673195905518e-06
the O 0 1.944369614648167e-05
time O 0 1.3334843970369548e-05
interval O 0 2.6917343348031864e-05
and O 0 4.894235189567553e-06
always O 0 4.871093551628292e-06
biased O 0 8.427034117630683e-06
towards O 0 4.611925396602601e-05
further O 0 6.49259309284389e-05
expansion O 0 0.0010242796270176768
. O 0 0.0001935744221555069

Attempts O 0 0.00016587942081969231
to O 0 1.7858348655863665e-05
mathematically O 0 3.14993885695003e-05
model O 0 5.246461569186067e-06
the O 0 1.1878893019456882e-05
dynamics O 0 0.00010778920113807544
have O 0 3.7013605833635665e-06
proved O 0 0.00018837006064131856
only O 0 3.9579012991453055e-06
partially O 0 6.435182149289176e-05
successful O 0 1.4028947589395102e-05
suggesting O 0 6.459629730670713e-06
that O 0 2.0788233712210058e-07
individual O 0 1.235712971947578e-07
specific O 0 8.471541832477669e-07
genetic O 0 6.400260463124141e-05
and O 0 5.602611054200679e-05
/ O 0 0.0004690513596870005
or O 0 3.3234853617614135e-05
environmental O 0 0.00011935841757804155
factors O 0 2.7642985514830798e-05
also O 0 7.116044798749499e-06
play O 0 1.2653174962906633e-05
a O 0 6.560514975717524e-06
role O 0 4.712122608907521e-05
in O 0 9.825969027588144e-05
somatic O 0 0.0012674133758991957
mosaicism O 1 0.91877281665802
. O 0 0.0003101222973782569
. O 0 0.00022136676125228405

Aspartylglucosaminuria B-Disease 1 0.9999605417251587
among O 0 0.00017289930838160217
Palestinian O 0 0.00047190210898406804
Arabs O 0 0.00169114931486547
. O 0 0.00036481363349594176

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.7635558247566223
AGU B-Disease 1 1.0
) O 0 4.621787593350746e-05
is O 0 3.286704668425955e-06
a O 0 1.0118085810972843e-05
rare O 0 0.00023605904425494373
disorder B-Disease 1 1.0
of I-Disease 1 0.9999974966049194
glycoprotein I-Disease 1 0.9999997615814209
metabolism I-Disease 1 0.9870906472206116
caused O 0 0.004234849475324154
by O 0 2.433405097690411e-05
the O 0 0.00021929772628936917
deficiency B-Disease 1 0.9999812841415405
of I-Disease 0 0.0006506788195110857
the I-Disease 0 0.0007618777453899384
lysosomal I-Disease 1 0.9893933534622192
enzyme I-Disease 0 0.00030833366326987743
aspartylglucosaminidase I-Disease 0 0.016231978312134743
( O 0 0.0004000146291218698
AGA O 1 0.9956440925598145
) O 0 0.0001413540740031749
. O 0 0.00010627400479279459

AGU B-Disease 1 1.0
is O 0 0.00019332041847519577
inherited O 1 0.8941585421562195
as O 0 0.00010877849126700312
an O 0 5.4234566050581634e-05
autosomal O 1 0.8781619071960449
recessive O 1 0.9842945337295532
trait O 1 0.9654083847999573
and O 0 0.00038102699909359217
occurs O 0 6.915005360497162e-05
with O 0 8.684970453032292e-06
a O 0 5.488084570970386e-05
high O 0 0.00021799020760226995
frequency O 0 1.5086155144672375e-05
in O 0 2.28763328777859e-05
Finland O 0 7.609958265675232e-05
because O 0 2.53825464824331e-06
of O 0 2.6533674827078357e-05
a O 0 8.435500058112666e-05
founder O 0 0.0014871334424242377
effect O 0 0.000193158644833602
. O 0 0.00011800648644566536

While O 0 0.00012715211778413504
very O 0 1.4618760360463057e-05
few O 0 3.911774547304958e-05
patients O 0 4.6812983782729134e-05
with O 0 6.427600601455197e-05
AGU B-Disease 1 1.0
have O 0 1.5131412510527298e-05
been O 0 1.1035027455363888e-05
reported O 0 9.747979675012175e-06
from O 0 1.1659351912385318e-05
non O 0 0.00012530657113529742
- O 0 0.00016064580995589495
Finnish O 0 0.0005425015697255731
origin O 0 1.56309633894125e-05
, O 0 1.0525245670578443e-05
we O 0 1.2072414392605424e-05
diagnosed O 0 0.04597212374210358
the O 0 0.00022162566892802715
disorder O 1 0.999993085861206
in O 0 0.001039183815009892
8 O 0 0.001620626775547862
patients O 0 7.375003769993782e-05
originating O 0 0.00014117168029770255
from O 0 7.053533772705123e-05
3 O 0 0.00013297090481501073
unrelated O 0 5.06334617966786e-05
families O 0 2.176371026507695e-06
, O 0 1.1458273547759745e-06
all O 0 7.996009685484751e-07
Palestinian O 0 2.8640914024435915e-05
Arabs O 0 8.499498653691262e-05
from O 0 1.2986924048163928e-05
the O 0 4.900019121123478e-05
region O 0 0.00017685724014881998
of O 0 0.0003234105824958533
Jerusalem O 0 0.01256189588457346
. O 0 0.0006267682765610516

The O 0 0.00017970299813896418
clinical O 0 0.0009413671214133501
diagnosis O 1 0.9996036887168884
of O 1 0.9999988079071045
AGU B-Disease 1 1.0
is O 0 0.0005002882098779082
often O 0 2.159838732040953e-05
difficult O 0 2.5509596525807865e-05
, O 0 2.592417786217993e-06
in O 0 3.4711601983872242e-06
particular O 0 3.930307684640866e-06
early O 0 2.968627268273849e-05
in O 0 6.607954219362e-06
the O 0 1.2403638720570598e-05
course O 0 2.8459853638196364e-05
of O 0 5.1760984206339344e-05
the O 0 0.0004447492538020015
disease O 1 0.9999179840087891
, O 0 1.5902067389106378e-05
and O 0 4.3218365135544445e-06
most O 0 3.388275217730552e-06
of O 0 6.0657705034827814e-05
the O 0 0.00011299340985715389
patients O 0 3.1849533115746453e-05
are O 0 6.632715667365119e-06
diagnosed O 0 0.0067397719249129295
after O 0 0.00020565258455462754
the O 0 8.557427645428106e-05
age O 0 0.00015638758486602455
of O 0 0.00034227140713483095
5 O 0 0.0005982689326629043
years O 0 0.0007816136931069195
. O 0 0.0001590211904840544

However O 0 0.00030735836480744183
, O 0 3.359313996043056e-05
since O 0 8.425033593084663e-05
these O 0 1.4407214621314779e-05
patients O 0 4.864745642407797e-05
excrete O 0 0.001322012161836028
early O 0 0.00012776002404280007
large O 0 2.9384304070845246e-05
amounts O 0 1.2777356459992006e-05
of O 0 0.00018628347606863827
aspartylglucosamine O 0 0.004360421560704708
in O 0 0.00010671392374206334
urine O 0 6.831307837273926e-05
, O 0 6.144355666037882e-06
biochemical O 0 3.881785232806578e-05
screening O 0 1.562263241794426e-05
is O 0 7.461567747668596e-06
easy O 0 1.380416961183073e-05
by O 0 7.12778773959144e-06
urine O 0 0.00017627370834816247
chromatography O 0 0.010583991184830666
. O 0 0.00021603961067739874
. O 0 0.00021410219778772444

Detection O 0 0.0004726529587060213
of O 0 0.00021937405108474195
heterozygous O 0 1.9860923202941194e-05
carriers O 0 1.2662903827731498e-05
of O 0 8.224909834098071e-05
the O 0 0.001746272318996489
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999829530715942
telangiectasia I-Disease 1 0.9999933242797852
( O 0 0.00033508456544950604
ATM O 0 0.0022537948098033667
) O 0 6.59231318422826e-06
gene O 0 4.42150803792174e-06
by O 0 8.04400315246312e-06
G2 O 0 0.021168552339076996
phase O 0 0.0014023080002516508
chromosomal O 0 0.0029730855021625757
radiosensitivity O 0 0.082382932305336
of O 0 0.009525777772068977
peripheral O 1 0.9999997615814209
blood O 1 0.9999617338180542
lymphocytes O 0 0.25737589597702026
. O 0 0.0006636175676248968

In O 0 0.0019945825915783644
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999909400939941
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.0008813663152977824
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999322891235352
T I-Disease 1 0.9999983310699463
) O 0 2.700579170777928e-05
patients O 0 1.2752790098602418e-05
, O 0 3.32652552970103e-06
mutations O 0 2.7075134312326554e-06
in O 0 9.69210213952465e-06
a O 0 1.0435692274768371e-05
single O 0 6.145568477222696e-06
gene O 0 8.572581464250106e-06
, O 0 9.247071830031928e-06
ATM O 0 0.0005949886981397867
, O 0 3.1465917800233e-06
result O 0 2.9748634915449657e-06
in O 0 1.8277622075402178e-05
an O 0 0.00011989739869022742
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 1 0.9990246295928955
embraces O 0 0.004176851827651262
a O 0 4.7561345127178356e-05
variety O 0 1.1943219760723878e-05
of O 0 0.00014438427751883864
clinical O 0 0.0005619145813398063
features O 0 0.00022283894941210747
and O 0 6.055552512407303e-05
manifests O 0 0.0005727484822273254
extreme O 0 0.001540608238428831
radiosensitivity O 0 0.14112448692321777
and O 0 3.5846285754814744e-05
a O 0 5.184200199437328e-05
strong O 0 3.744423884199932e-05
pre O 0 0.0012509383959695697
- O 0 0.0007647444144822657
disposition O 0 0.0009772880002856255
to O 0 0.0005105235613882542
malignancy B-Disease 1 0.9995917677879333
. O 0 0.0004983320832252502

Heterozygotes O 0 0.002637005876749754
for O 0 4.590705793816596e-05
the O 0 0.00022416465799324214
ATM O 0 0.002099779201671481
gene O 0 9.236506230081432e-06
have O 0 7.116731808309851e-07
no O 0 1.1610579804255394e-06
clinical O 0 1.2074280675733462e-05
expression O 0 1.500150938227307e-05
of O 0 0.00039757430204190314
A B-Disease 1 0.9999990463256836
- I-Disease 1 0.9994707703590393
T I-Disease 1 0.9999029636383057
but O 0 1.0801280950545333e-05
may O 0 5.3351741371443495e-05
be O 0 5.390066871768795e-05
cancer B-Disease 0 0.003132459707558155
prone O 0 0.0006981149781495333
with O 0 8.088959475571755e-06
a O 0 4.213375723338686e-05
moderate O 0 8.629070362076163e-05
increase O 0 1.824103674152866e-05
in O 0 4.537181303021498e-05
in O 0 6.995604053372517e-05
vitro O 0 0.00035235038376413286
radiosensitivity O 0 0.00867485348135233
. O 0 0.00030566263012588024

We O 0 0.00015338268713094294
performed O 0 0.00029064869158901274
a O 0 8.668329246575013e-05
blind O 0 0.0007081071380525827
chromosomal O 0 0.00022926481324248016
analysis O 0 2.7414247597334906e-05
on O 0 0.0008185206679627299
G2 O 1 0.9951714873313904
- O 0 0.00019918482576031238
phase O 0 0.0001730466028675437
lymphocytes O 0 4.3086100049549714e-05
from O 0 1.1905238352483138e-05
7 O 0 0.00012786703882738948
unrelated O 0 0.00018506120250094682
A B-Disease 1 0.996473491191864
- I-Disease 1 0.9382804036140442
T I-Disease 1 0.999990701675415
patients O 0 5.141170913702808e-05
, O 0 7.164924227254232e-06
13 O 0 6.236597982933745e-05
obligate O 0 0.0001051037252182141
A B-Disease 1 0.9999617338180542
- I-Disease 1 0.9985048770904541
T I-Disease 1 0.9999867677688599
heterozygotes O 0 0.0011243732878938317
( O 0 1.4360987734107766e-05
parents O 0 2.4335176931344904e-06
of O 0 2.9637700208695605e-05
the O 0 0.00011439345689723268
patients O 0 6.303107511484995e-05
) O 0 9.724952178657986e-06
, O 0 4.611353688233066e-06
and O 0 4.402686954563251e-06
14 O 0 6.98278090567328e-05
normal O 0 1.8686961993807927e-05
controls O 0 8.203391189454123e-06
following O 0 2.722419230849482e-05
X O 0 0.0008928379393182695
- O 0 0.0001226864114869386
irradiation O 0 2.5665889552328736e-05
with O 0 3.341667024869821e-06
1 O 0 0.00014718202874064445
Gy O 0 0.0017076957738026977
in O 0 3.1927370400808286e-06
order O 0 1.4493898561340757e-06
to O 0 1.147478656093881e-06
evaluate O 0 7.582879334222525e-06
this O 0 2.488068957973155e-06
cytogenetic O 0 0.0001602634583832696
method O 0 6.235374257812509e-06
as O 0 5.658505870087538e-06
a O 0 5.355410849006148e-06
tool O 0 2.288471114297863e-05
for O 0 5.178055289434269e-06
detection O 0 0.00011605294275796041
of O 0 0.0007667865720577538
ATM O 0 0.018390407785773277
carriers O 0 0.0004047421971336007
. O 0 0.00017288775416091084

Both O 0 0.0004367973597254604
A B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999949932098389
T I-Disease 1 0.9999998807907104
homozygotes O 0 0.003314698114991188
and O 0 2.216651409980841e-05
heterozygotes O 0 0.00017019000370055437
showed O 0 2.7585732823354192e-05
significantly O 0 1.0335518709325697e-05
increased O 0 9.048661922861356e-06
levels O 0 6.231817678781226e-05
of O 0 0.00032419964554719627
radiation O 1 0.9998043179512024
- O 0 0.0037837023846805096
induced O 0 0.002180212875828147
chromatid O 0 0.006748645566403866
damage O 0 0.00043329596519470215
relative O 0 8.847713615978137e-05
to O 0 1.3234732250566594e-05
that O 0 3.1863157801126363e-06
of O 0 7.277802069438621e-05
normal O 0 0.000201101167476736
controls O 0 0.00025940939667634666
. O 0 0.0001867022510850802

These O 0 6.928608399903169e-06
results O 0 4.50211427960312e-06
show O 0 9.020066499942914e-06
that O 0 1.2396853890095372e-06
the O 0 5.626404890790582e-05
G2 O 0 0.3902294635772705
- O 0 0.0002990116481669247
phase O 0 0.000536914449185133
chromosomal O 0 0.001009842730127275
radiosensitivity O 0 0.00293465587310493
assay O 0 1.949432771652937e-05
can O 0 7.210468879748078e-07
be O 0 6.263226168812253e-07
used O 0 1.303071599068062e-06
for O 0 9.360681474390731e-07
the O 0 1.057319332176121e-05
detection O 0 6.467257480835542e-05
of O 0 0.0003718195657711476
A B-Disease 1 0.9999860525131226
- I-Disease 1 0.9993329644203186
T I-Disease 1 0.9999853372573853
heterozygotes O 0 0.006144177168607712
. O 0 0.0003868921776302159

In O 0 0.00011071574408560991
combination O 0 2.3397924451273866e-05
with O 0 6.352270247589331e-06
molecular O 0 6.557992310263216e-05
genetic O 0 8.964223525254056e-05
analyses O 0 4.4124721171101555e-05
, O 0 7.166291652538348e-06
this O 0 1.3016617685934762e-06
test O 0 2.323816033822368e-06
may O 0 4.795281711267307e-06
be O 0 9.493159041085164e-07
of O 0 4.362958407000406e-06
value O 0 8.06280422693817e-06
in O 0 8.298696229758207e-06
studies O 0 6.6657212300924584e-06
of O 0 7.583443220937625e-05
familial B-Disease 0 0.0019908896647393703
and I-Disease 0 0.0003898122813552618
sporadic I-Disease 0 0.36999550461769104
cancers I-Disease 1 0.999849796295166
aimed O 0 0.001225586049258709
at O 0 0.00041420021443627775
determination O 0 6.415042298613116e-05
of O 0 6.920638406882063e-05
the O 0 3.873398236464709e-05
potential O 0 3.4260192478541285e-05
involvement O 0 8.026798604987562e-05
of O 0 0.00026949765742756426
ATM O 0 0.0059600574895739555
mutations O 0 9.566508379066363e-05
in O 0 0.00021374829520937055
tumor B-Disease 1 0.9991705417633057
risk O 0 0.00026137864915654063
or O 0 3.1970343115972355e-05
development O 0 0.00012635078746825457
. O 0 3.781907798838802e-05
. O 0 5.33046004420612e-05

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 0.9999946355819702
: O 0 0.00010729102359618992
identification O 0 2.7428370231064036e-05
and O 0 1.7705709979054518e-05
detection O 0 0.00023597983818035573
of O 0 0.000780927250161767
founder O 0 0.02089669182896614
- O 0 0.00045268185203894973
effect O 0 2.203087933594361e-05
mutations O 0 6.505649707833072e-06
in O 0 5.410349331214093e-06
the O 0 2.7420941478339955e-05
ATM O 0 0.00044016086030751467
gene O 0 4.32176238973625e-06
in O 0 7.961623850860633e-06
ethnic O 0 3.537911834428087e-05
populations O 0 2.3295639039133675e-05
. O 0 4.686756801675074e-05

To O 0 4.4252912630327046e-05
facilitate O 0 5.171411612536758e-05
the O 0 3.0763625545660034e-05
evaluation O 0 2.3141506972024217e-05
of O 0 0.00042692472925409675
ATM O 0 0.007959035225212574
heterozygotes O 0 0.0004933135933242738
for O 0 2.7941365260630846e-05
susceptibility O 0 0.0003996751911472529
to O 0 7.261518476298079e-05
other O 0 5.243271152721718e-05
diseases O 1 0.9999748468399048
, O 0 9.804741239349823e-06
such O 0 5.940776645729784e-06
as O 0 0.0008748522959649563
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999905824661255
, O 0 4.551239180727862e-05
we O 0 9.035072253027465e-06
have O 0 1.2104195548090502e-06
attempted O 0 3.1020696042105556e-05
to O 0 8.684838576300535e-06
define O 0 2.447275437589269e-05
the O 0 3.264157203375362e-05
most O 0 5.865834282303695e-06
common O 0 4.683958650275599e-06
mutations O 0 2.4437738375127083e-06
and O 0 1.140520225817454e-06
their O 0 1.3050726010988e-06
frequencies O 0 1.3330876754480414e-05
in O 0 9.896645497065037e-05
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9983466863632202
telangiectasia I-Disease 1 0.9999840259552002
( O 0 0.00028000216116197407
A B-Disease 1 0.9999814033508301
- I-Disease 1 0.7450074553489685
T I-Disease 1 0.999340832233429
) O 0 2.0835379473282956e-05
homozygotes O 0 0.0002476917870808393
from O 0 1.5073084796313196e-05
10 O 0 2.2995540348347276e-05
ethnic O 0 4.104097024537623e-05
populations O 0 5.4858344810782e-05
. O 0 8.366748079424724e-05

Both O 0 4.277356856619008e-05
genomic O 0 7.07482686266303e-05
mutations O 0 4.1543575207469985e-05
and O 0 9.600303201295901e-06
their O 0 5.3425355872605e-06
effects O 0 0.00015696842456236482
on O 0 0.0001662881695665419
cDNA O 0 0.0002004300185944885
were O 0 3.867257328238338e-05
characterized O 0 0.000248376396484673
. O 0 0.00019373965915292501

Protein O 0 0.0011095288209617138
- O 0 0.0004638063255697489
truncation O 0 0.00020863405370619148
testing O 0 1.1041259313060436e-05
of O 0 4.098143836017698e-05
the O 0 4.8218469601124525e-05
entire O 0 0.00023673883697483689
ATM O 0 0.000587957794778049
cDNA O 0 9.493490506429225e-05
detected O 0 4.925739631289616e-05
92 O 0 7.867040403652936e-05
( O 0 6.895655587868532e-06
66 O 0 6.147976091597229e-05
% O 0 1.8877562979469076e-05
) O 0 1.5256082406267524e-05
truncating O 0 0.00024863111320883036
mutations O 0 1.3931992725702003e-05
in O 0 1.8456597899785265e-05
140 O 0 5.325526581145823e-05
mutant O 0 7.765569171169773e-05
alleles O 0 3.1339925044449046e-05
screened O 0 0.000573490047827363
. O 0 0.00011278082092758268

The O 0 0.0007497185142710805
haplotyping O 0 0.006593150552362204
of O 0 0.0004954065079800785
patients O 0 7.371995161520317e-05
with O 0 8.42275949253235e-06
identical O 0 4.37892485933844e-05
mutations O 0 2.741186835919507e-05
indicates O 0 5.121176582179032e-05
that O 0 1.1372054586900049e-06
almost O 0 4.469043688004604e-06
all O 0 7.810857027834572e-07
of O 0 1.4770669622521382e-05
these O 0 2.6517545848037116e-06
represent O 0 1.2911619705846533e-05
common O 0 1.0783600373542868e-05
ancestry O 0 2.089385816361755e-05
and O 0 9.920438060362358e-06
that O 0 2.5130364065262256e-06
very O 0 5.599777068709955e-06
few O 0 3.868806379614398e-05
spontaneously O 0 0.0002945867308881134
recurring O 0 0.0013054549926891923
ATM O 0 0.013856843113899231
mutations O 0 0.00015044141036923975
exist O 0 0.0003815982781816274
. O 0 0.00028021447360515594

Assays O 0 6.936906720511615e-05
requiring O 0 1.3339447832549922e-05
minimal O 0 4.104652543901466e-05
amounts O 0 1.3193674931244459e-05
of O 0 5.8736321079777554e-05
genomic O 0 5.6395660067209974e-05
DNA O 0 8.861866081133485e-05
were O 0 1.574681118654553e-05
designed O 0 1.826472725952044e-05
to O 0 2.871608558052685e-06
allow O 0 2.9009061108808964e-06
rapid O 0 6.5656888182275e-05
screening O 0 4.5967935875523835e-06
for O 0 3.7653567233064678e-06
common O 0 8.934692232287489e-06
ethnic O 0 0.0001448680559406057
mutations O 0 0.0003545551735442132
. O 0 0.00042893397039733827

These O 0 6.211118306964636e-05
rapid O 0 0.0006451476365327835
assays O 0 6.207238766364753e-05
detected O 0 0.00014256038411986083
mutations O 0 6.089899216021877e-06
in O 0 9.483401299803518e-06
76 O 0 7.963039388414472e-05
% O 0 1.0592448234092444e-05
of O 0 0.00017905101412907243
Costa O 0 0.0004914133460260928
Rican O 0 0.00046780292177572846
patients O 0 5.583560050581582e-05
( O 0 1.584824531164486e-05
3 O 0 8.009762677829713e-05
) O 0 5.281708581605926e-06
, O 0 1.476391503274499e-06
50 O 0 4.372493094706442e-06
% O 0 2.0368090645206394e-06
of O 0 4.344356420915574e-05
Norwegian O 0 0.0005533373914659023
patients O 0 6.324252171907574e-05
( O 0 1.6533409507246688e-05
1 O 0 0.00014548101171385497
) O 0 6.905072496010689e-06
, O 0 2.7929529551329324e-06
25 O 0 1.5591018382110633e-05
% O 0 5.712830443371786e-06
of O 0 0.0001334954722551629
Polish O 1 0.9915508031845093
patients O 0 0.0004186062724329531
( O 0 7.278267003130168e-05
4 O 0 0.00022975190950091928
) O 0 1.050918763212394e-05
, O 0 3.4121603675885126e-06
and O 0 2.529188577682362e-06
14 O 0 2.7571191822062247e-05
% O 0 3.803446816164069e-06
of O 0 0.00010072975419461727
Italian O 0 0.001024165889248252
patients O 0 0.00024627349921502173
( O 0 5.8468966017244384e-05
1 O 0 0.0003845678875222802
) O 0 2.16559292312013e-05
, O 0 5.080106802779483e-06
as O 0 6.275977284531109e-06
well O 0 2.378301815042505e-06
as O 0 9.01211296877591e-06
in O 0 1.6634563507977873e-05
patients O 0 2.9983506465214305e-05
of O 0 0.0005932290805503726
Amish O 0 0.002884951652958989
/ O 0 0.0010753152891993523
Mennonite O 0 0.0008744534570723772
and O 0 2.986453728226479e-05
Irish O 0 0.00031489276443608105
English O 0 0.0002454932837281376
backgrounds O 0 0.0002973174268845469
. O 0 0.00035778083838522434

Additional O 0 5.891578257433139e-05
mutations O 0 3.762083360925317e-05
were O 0 4.051618088851683e-05
observed O 0 3.4052569390041754e-05
in O 0 2.6326240913476795e-05
Japanese O 0 0.0003613694861996919
, O 0 1.9948700355598703e-05
Utah O 0 0.0005474055069498718
Mormon O 0 0.00013589346781373024
, O 0 3.1827958082430996e-06
and O 0 2.2806866581959184e-06
African O 0 5.622338721877895e-05
American O 0 7.473980804206803e-05
patients O 0 0.00013022241182625294
. O 0 0.0002133697853423655

These O 0 6.93817628416582e-06
assays O 0 3.6468861708272016e-06
should O 0 9.642222948968993e-07
facilitate O 0 4.425026418175548e-06
screening O 0 5.732609224651242e-06
for O 0 1.5570305549772456e-05
A B-Disease 1 0.9976418018341064
- I-Disease 0 0.1659122109413147
T I-Disease 1 0.9963538646697998
heterozygotes O 0 0.00020287802908569574
in O 0 7.623499186593108e-06
the O 0 1.4259573617891874e-05
populations O 0 3.952375664084684e-06
studied O 0 5.48040188732557e-05
. O 0 1.308274113398511e-05
. O 0 3.8617254176642746e-05

The O 0 0.0007821813924238086
von B-Disease 1 0.997704803943634
Hippel I-Disease 1 0.9999748468399048
- I-Disease 1 0.9962888956069946
Lindau I-Disease 1 0.9999895095825195
tumor I-Disease 1 0.9635993242263794
suppressor O 0 0.0007356138085015118
gene O 0 5.6783178479236085e-06
is O 0 9.025719691635459e-07
required O 0 1.4990622503319173e-06
for O 0 9.508122275292408e-06
cell O 0 6.915057747391984e-05
cycle O 0 4.1799336031544954e-05
exit O 0 0.00011034000635845587
upon O 0 9.565113577991724e-05
serum O 0 0.0006342206033878028
withdrawal O 0 0.00043737920350395143
. O 0 0.00022626796271651983

The O 0 0.0001879330084193498
inactivation O 0 0.0011678810697048903
of O 0 0.0003230916045140475
the O 0 0.0003906178171746433
von B-Disease 1 0.9978339076042175
Hippel I-Disease 1 0.999935507774353
- I-Disease 1 0.8506984114646912
Lindau I-Disease 1 0.9999796152114868
( I-Disease 0 0.0004750498628709465
VHL I-Disease 1 0.9999774694442749
) I-Disease 0 0.00021756703790742904
tumor I-Disease 1 0.9879671931266785
suppressor O 0 0.0025315796956419945
gene O 0 7.409205863950774e-05
predisposes O 0 0.0005305970553308725
affected O 0 1.2054512808390427e-05
individuals O 0 7.919979907455854e-07
to O 0 7.024078513495624e-06
the O 0 0.0001546105631859973
human O 1 0.9960107803344727
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.00010154594201594591
is O 0 1.4004432159708813e-05
associated O 0 5.597336894425098e-06
with O 0 4.7816233745834325e-06
sporadic B-Disease 1 0.9971869587898254
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.999997615814209
RCC B-Disease 1 1.0
) O 0 0.0005127456970512867
and O 0 0.00022516718308907002
brain B-Disease 1 0.9999880790710449
hemangioblastomas I-Disease 1 0.9999743700027466
. O 0 0.0005791102885268629

VHL O 1 0.9991353154182434
- O 0 0.0016763547901064157
negative O 0 4.8544203309575096e-05
786 O 0 0.0031138802878558636
- O 0 0.0007161780958995223
0 O 0 0.000227260374231264
RCC B-Disease 1 0.9999679327011108
cells O 0 6.504819612018764e-05
are O 0 4.717247520602541e-06
tumorigenic O 0 0.002139188116416335
in O 0 0.00011326828825986013
nude O 0 0.001999390311539173
mice O 0 0.00010255868983222172
which O 0 4.918529612041311e-06
is O 0 5.152047833689721e-06
suppressed O 0 0.00015953437832649797
by O 0 2.6094037366419798e-06
the O 0 2.627747926453594e-05
reintroduction O 0 0.0008113068179227412
of O 0 0.0012268832651898265
VHL B-Disease 1 0.999974250793457
. O 0 0.0011203399626538157

Remarkably O 0 0.0038425454404205084
, O 0 2.0445258996915072e-05
this O 0 3.2507875857845647e-06
occurs O 0 6.860489975224482e-06
without O 0 4.809369329450419e-06
affecting O 0 2.227609365945682e-05
the O 0 3.4035492717521265e-05
growth O 0 4.490691571845673e-05
rate O 0 2.0819230485358275e-05
and O 0 1.1903523954970296e-05
cell O 0 6.808817852288485e-05
cycle O 0 3.90380373573862e-05
profile O 0 1.0782983736135066e-05
of O 0 4.450981577974744e-05
these O 0 1.335701654170407e-05
cells O 0 1.2858928130299319e-05
in O 0 1.5900248399702832e-05
culture O 0 0.00012903171591460705
. O 0 5.044834324507974e-05

The O 0 0.000742412346880883
786 O 0 0.005470693111419678
- O 0 0.0005223201587796211
0 O 0 4.630611147149466e-05
cell O 0 0.00014402759552467614
line O 0 0.00011689872189890593
, O 0 5.605242677120259e-06
like O 0 5.990591489535291e-06
many O 0 2.1332496544346213e-05
cancer B-Disease 0 0.18346954882144928
cells O 0 8.255200373241678e-05
, O 0 8.206739948946051e-06
fails O 0 2.5772140361368656e-05
to O 0 7.002262009336846e-06
exit O 0 0.00011116482346551493
the O 0 6.839951674919575e-05
cell O 0 0.0001367756340187043
cycle O 0 4.142197212786414e-05
upon O 0 4.9760405090637505e-05
serum O 0 0.000492969062179327
withdrawal O 0 0.0003894287801813334
. O 0 0.0002754016895778477

Here O 0 0.0004896484315395355
, O 0 1.1945999176532496e-05
it O 0 9.334579544884036e-07
is O 0 4.953165557708417e-07
shown O 0 1.7279554640481365e-06
that O 0 4.83002509099606e-07
reintroduction O 0 3.658479545265436e-05
of O 0 2.1962243408779614e-05
the O 0 8.48506751935929e-05
wild O 0 0.00014856824418529868
- O 0 0.0002488599857315421
type O 0 0.00013873199350200593
VHL B-Disease 0 0.06317657977342606
gene O 0 1.9354658434167504e-05
restores O 0 6.0285696235951036e-05
the O 0 1.1135054592159577e-05
ability O 0 1.2008594239887316e-05
of O 0 0.00037583839730359614
VHL O 1 0.9999988079071045
- O 0 0.004155063536018133
negative O 0 0.0005490125040523708
RCC B-Disease 1 1.0
cancer I-Disease 0 0.21517516672611237
cells O 0 4.0549770346842706e-05
to O 0 1.026599966280628e-05
exit O 0 0.00010553518950473517
the O 0 0.00010523330274736509
cell O 0 0.0001231449277838692
cycle O 0 7.805592758813873e-05
and O 0 2.0421524823177606e-05
enter O 0 0.00026577679091133177
G0 O 1 0.7518402338027954
/ O 0 0.0014664053451269865
quiescence O 0 0.0025135870091617107
in O 0 0.00017356184253003448
low O 0 0.0012228486593812704
serum O 0 0.002136064460501075
. O 0 0.0001630179613130167

Both O 0 0.0008763110963627696
VHL O 1 0.9998749494552612
- O 0 0.0010695185046643019
positive O 0 1.7485275748185813e-05
and O 0 6.72670139465481e-05
VHL O 1 0.999906063079834
- O 0 0.0015775123611092567
negative O 0 0.00017903224215842783
RCC B-Disease 1 0.9998461008071899
cells O 0 5.679428068106063e-05
exit O 0 0.0001356466964352876
the O 0 0.00010897482570726424
cell O 0 0.00012667299597524107
cycle O 0 2.598635728645604e-05
by O 0 5.846131443831837e-06
contact O 0 4.7388897655764595e-05
inhibition O 0 0.0002949984627775848
. O 0 0.00046721601393073797

The O 0 0.0008074835641309619
cyclin O 0 0.004439253825694323
- O 0 0.000442267773905769
dependent O 0 3.385156742297113e-05
kinase O 0 6.132752605481073e-05
inhibitor O 0 0.0002485206932760775
, O 0 2.5933673896361142e-05
p27 O 0 0.0011854723561555147
, O 0 1.8400569388177246e-05
accumulates O 0 0.00015843108121771365
upon O 0 5.187647184357047e-05
serum O 0 0.00029548179008997977
withdrawal O 0 7.58973037591204e-05
, O 0 3.801437969741528e-06
only O 0 8.727146223463933e-07
in O 0 3.0157975743350107e-06
the O 0 1.3973082786833402e-05
presence O 0 5.488650276674889e-05
of O 0 0.0007012014393694699
VHL B-Disease 1 0.9989567995071411
, O 0 2.4795914214337245e-05
as O 0 8.023777809285093e-06
a O 0 3.0294495445559733e-06
result O 0 3.1733973173686536e-06
of O 0 2.6636102120392025e-05
the O 0 3.726263821590692e-05
stabilization O 0 0.00022289740445557982
of O 0 0.00028178413049317896
the O 0 0.00041881122160702944
protein O 0 0.00028407940408214927
. O 0 0.00013979020877741277

We O 0 6.004076931276359e-05
propose O 0 1.7093860151362605e-05
that O 0 1.72606814885512e-06
the O 0 1.8301725503988564e-05
loss O 0 0.0002054796932497993
of O 0 0.00038616813253611326
wild O 0 0.0005264750216156244
- O 0 0.0007145851268433034
type O 0 0.0003199554921593517
VHL B-Disease 0 0.022800985723733902
gene O 0 7.014787570369663e-06
results O 0 1.6584465356572764e-06
in O 0 2.093327111651888e-06
a O 0 3.2114078294398496e-06
specific O 0 4.1862886064336635e-06
cellular O 0 0.0005138423293828964
defect O 0 0.004302001092582941
in O 0 0.00042528091580606997
serum O 0 0.0021480873692780733
- O 0 0.00030121105373837054
dependent O 0 1.2942759894940536e-05
growth O 0 1.4435063349083066e-05
control O 0 1.0833593478309922e-05
, O 0 1.4960257885832107e-06
which O 0 2.108401758960099e-06
may O 0 2.6152782083954662e-05
initiate O 0 0.00023305298236664385
tumor B-Disease 1 0.9957013726234436
formation O 0 0.010533199645578861
. O 0 0.0008683987543918192

This O 0 4.6096742153167725e-05
is O 0 1.6704130757716484e-05
corrected O 0 8.115771925076842e-05
by O 0 1.793716137399315e-06
the O 0 1.171184158010874e-05
reintroduction O 0 0.00013536281767301261
of O 0 0.00013609108282253146
wild O 0 0.0004998320364393294
- O 0 0.0009246414410881698
type O 0 0.0013276864774525166
VHL B-Disease 1 0.9999983310699463
, O 0 0.0003545328218024224
implicating O 1 0.9894193410873413
VHL B-Disease 1 0.9998488426208496
as O 0 8.992879884317517e-05
the O 0 5.0672060751821846e-05
first O 0 0.00010475861927261576
tumor B-Disease 0 0.006222059018909931
suppressor O 0 0.0005446961149573326
involved O 0 3.019717405550182e-05
in O 0 1.7332768038613722e-05
the O 0 4.562606773106381e-05
regulation O 0 4.376127981231548e-05
of O 0 0.00012145649816375226
cell O 0 0.00029300415189936757
cycle O 0 9.489923832006752e-05
exit O 0 0.00013472144200932235
, O 0 3.6787926092074485e-06
which O 0 1.7510486713945284e-06
is O 0 1.0303918998033623e-06
consistent O 0 2.583549758128356e-06
with O 0 4.980515768693294e-07
its O 0 4.759916009788867e-06
gatekeeper O 0 0.00024421882699243724
function O 0 9.112719453696627e-06
in O 0 4.5691387640545145e-05
the O 0 0.00046568273683078587
kidney O 1 0.9999855756759644
. O 0 0.00019016131409443915
. O 0 0.00022998226631898433

Piebaldism B-Disease 1 1.0
with O 0 0.005557211581617594
deafness B-Disease 1 1.0
: O 0 0.0005121422000229359
molecular O 0 7.312398520298302e-05
evidence O 0 6.272736209211871e-05
for O 0 1.5024920685391407e-05
an O 0 4.290601282264106e-05
expanded O 0 0.06595782190561295
syndrome O 1 1.0
. O 0 0.0015500386944040656

In O 0 0.00021401155390776694
a O 0 0.0001091049998649396
South O 0 0.00039464898873120546
African O 0 0.00012167976819910109
girl O 0 0.0001016032911138609
of O 0 6.610785203520209e-05
Xhosa O 0 0.008910357020795345
stock O 0 0.00028481485787779093
with O 0 1.140677704825066e-05
severe O 1 0.9997730851173401
piebaldism B-Disease 1 0.9999998807907104
and O 0 0.24368876218795776
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.9999836683273315
identified O 0 0.0005641980678774416
a O 0 5.261618935037404e-05
novel O 0 7.599376112921163e-05
missense O 0 0.00012357000377960503
substitution O 0 2.1194262444623746e-05
at O 0 0.00012601522030308843
a O 0 1.6391330063925125e-05
highly O 0 5.290089393383823e-05
conserved O 0 7.926499529276043e-05
residue O 0 7.153004844440147e-05
in O 0 6.385822416632436e-06
the O 0 1.6686601156834513e-05
intracellular O 0 4.179259849479422e-05
kinase O 0 1.9435150534263812e-05
domain O 0 2.441028664179612e-05
of O 0 0.0001337688008788973
the O 0 0.0006369881448335946
KIT O 0 0.03177312761545181
proto O 0 0.011819367296993732
- O 0 0.0015284707769751549
oncogene O 0 0.0034559566993266344
, O 0 4.833283310290426e-05
R796G O 0 0.0021190927363932133
. O 0 0.00016308543854393065

Though O 0 0.0008627589559182525
auditory B-Disease 0 0.03637099638581276
anomalies I-Disease 0 0.026781460270285606
have O 0 2.5327793991891667e-05
been O 0 2.502859388187062e-05
observed O 0 2.0424329704837874e-05
in O 0 3.0191185942385346e-05
mice O 0 7.278974953806028e-05
with O 0 8.049144526012242e-06
dominant O 0 0.0007704624440521002
white O 0 0.0004683158185798675
spotting O 0 0.004253031685948372
( O 0 0.0003509725211188197
W O 0 0.15081347525119781
) O 0 2.3659235012019053e-05
due O 0 0.00012829377374146134
to O 0 0.00013271390344016254
KIT O 0 0.49093127250671387
mutations O 0 0.00036007232847623527
, O 0 0.00025945890229195356
deafness B-Disease 1 1.0
is O 0 0.0002232051338069141
not O 0 1.2147550478402991e-05
typical O 0 3.676638880278915e-05
in O 0 4.695972893387079e-05
human O 0 0.0001075670006684959
piebaldism B-Disease 0 0.013420228846371174
. O 0 0.0002799183421302587

Thus O 0 0.0002853054029401392
, O 0 1.403090118401451e-05
the O 0 2.1935993572697043e-05
occurrence O 0 0.00020004741963930428
of O 0 0.22168850898742676
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.9597209692001343
this O 0 0.00017661170568317175
patient O 0 8.193471876438707e-05
extends O 0 3.247992572141811e-05
considerably O 0 2.9564449505414814e-05
the O 0 7.556861874036258e-06
phenotypic O 0 4.4344116759020835e-05
range O 0 7.855803414713591e-05
of O 0 0.00032592329080216587
piebaldism B-Disease 0 0.007802233565598726
due O 0 0.0005617903079837561
to O 0 0.00012624480586964637
KIT O 0 0.004525554832071066
gene O 0 3.0397257432923652e-05
mutation O 0 5.3396879593492486e-06
in O 0 2.4482045773766004e-05
humans O 0 5.5669712310191244e-05
and O 0 6.2473736761603504e-06
tightens O 0 3.7996422179276124e-05
the O 0 5.366689492802834e-06
clinical O 0 1.9936185708502308e-05
similarity O 0 8.322155917994678e-05
between O 0 0.0007704734453000128
piebaldism B-Disease 0 0.012302136048674583
and O 0 1.3583148756879382e-05
the O 0 8.604672984802164e-06
various O 0 5.998149390507024e-06
forms O 0 0.00010789985390147194
of O 1 0.9996631145477295
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0033923275768756866
. O 0 0.0007297504926100373

Cycloheximide O 0 0.02986917458474636
facilitates O 0 0.00026722688926383853
the O 0 4.472664659260772e-05
identification O 0 1.5702451491961256e-05
of O 0 0.00014820050273556262
aberrant O 0 0.0004781913012266159
transcripts O 0 0.000670683104544878
resulting O 0 8.772790897637606e-05
from O 0 4.2745265091070905e-05
a O 0 3.08613853121642e-05
novel O 0 8.150175563059747e-05
splice O 0 0.0007224747678264976
- O 0 0.0003208297130186111
site O 0 0.0001334345288341865
mutation O 0 5.917164344282355e-06
in O 0 3.16684199788142e-05
COL17A1 O 1 0.661612868309021
in O 0 2.1999552700435743e-05
a O 0 1.3712756299355533e-05
patient O 0 1.3815667443850543e-05
with O 0 9.34375111683039e-06
generalized O 1 0.9962164759635925
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.021559858694672585

Patients O 0 0.0002502793213352561
with O 0 5.74355544813443e-05
generalized O 1 0.9999984502792358
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
often O 0 0.00019310136849526316
show O 0 0.00017176011169794947
decreased O 0 0.0003280681266915053
expression O 0 4.8226836952380836e-05
of O 0 0.00035821201163344085
type O 0 0.0056989858858287334
XVII O 1 1.0
collagen O 0 0.2739843428134918
, O 0 2.943838080682326e-05
a O 0 3.315602953080088e-05
transmembrane O 0 0.0003929165832232684
hemidesmosomal O 0 0.0010105521650984883
protein O 0 2.081639104289934e-05
encoded O 0 1.6385096387239173e-05
by O 0 2.3737678930046968e-05
COL17A1 O 1 0.9310992956161499
. O 0 0.0003028374048881233

This O 0 3.06077090499457e-05
report O 0 8.487281775160227e-06
documents O 0 3.0737232009414583e-05
a O 0 2.2738002371625043e-05
novel O 0 9.278388461098075e-05
splice O 0 0.0008209945517592132
- O 0 0.0002761220675893128
site O 0 0.00015607132809236646
mutation O 0 9.215556929120794e-06
in O 0 4.890943819191307e-05
COL17A1 O 0 0.1730375736951828
in O 0 2.558312007749919e-05
a O 0 2.105987732647918e-05
patient O 0 2.3093951313057914e-05
with O 0 1.2314252671785653e-05
generalized O 1 0.998494029045105
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.0007718424894846976
and O 0 3.620367715484463e-05
applies O 0 1.1831375559268054e-05
a O 0 1.1468985576357227e-05
new O 0 4.723441179521615e-06
methodology O 0 4.797504971065791e-06
to O 0 4.86674252897501e-06
define O 0 3.605590245570056e-05
and O 0 1.0572961400612257e-05
characterize O 0 0.00018838763935491443
the O 0 6.12696458119899e-05
resulting O 0 0.0001048002959578298
mRNA O 0 0.00017110248154494911
splice O 0 0.000356505683157593
variants O 0 0.00013194807979743928
. O 0 0.000127634615637362

Mutational O 0 0.0040074922144412994
analysis O 0 3.473219112493098e-05
of O 0 0.0007255402742885053
COL17A1 O 1 0.9969660639762878
identified O 0 7.288881170097739e-05
a O 0 6.020372165949084e-05
maternally O 0 0.0007476074970327318
inherited O 0 0.03712401166558266
G O 0 0.011122416704893112
- O 0 0.001100498135201633
to O 0 0.0001304381585214287
- O 0 0.0009200466447509825
T O 0 0.0018731635063886642
transversion O 0 0.0009157013846561313
at O 0 9.625144593883306e-05
the O 0 2.3504780983785167e-05
- O 0 4.02634686906822e-05
1 O 0 2.6340754629927687e-05
position O 0 2.1055257093394175e-05
of O 0 9.400020644534379e-05
exon O 0 0.0007786080823279917
32 O 0 0.0003332193591631949
. O 0 0.00015562595217488706

This O 0 4.021331915282644e-05
acceptor O 0 2.2303962396108545e-05
splice O 0 0.00092858518473804
- O 0 0.0003512125404085964
site O 0 9.559404861647636e-05
mutation O 0 2.1960131562082097e-06
led O 0 1.8150405594496988e-05
to O 0 1.1578729754546657e-05
the O 0 5.488571696332656e-05
formation O 0 0.0004058917402289808
of O 0 0.00037584558594971895
aberrant O 0 0.0005228257505223155
transcripts O 0 0.0005580459837801754
present O 0 0.00010730402573244646
at O 0 0.0005925627774558961
extremely O 0 0.0001179874743684195
low O 0 0.00027647457318380475
levels O 0 0.00041961268289014697
. O 0 0.00010113254393218085

Based O 0 4.250037090969272e-05
on O 0 8.093559881672263e-05
our O 0 8.901098226488102e-06
recent O 0 3.435814505792223e-06
finding O 0 5.757989129051566e-06
that O 0 2.076478494927869e-06
cycloheximide O 0 0.0015292648458853364
stabilized O 0 0.0011747903190553188
mutant O 0 0.00046347640454769135
COL17A1 O 1 0.5788354277610779
transcripts O 0 0.000735982321202755
in O 0 5.364590833778493e-05
keratinocytes O 0 0.00022145247203297913
homozygous O 0 1.7316939192824066e-05
for O 0 8.62096840137383e-06
a O 0 6.648476846748963e-05
frameshift O 0 0.0008450323366560042
mutation O 0 1.2225439604662824e-05
, O 0 5.358685939427232e-06
the O 0 2.384235631325282e-05
effects O 0 0.0001281338627450168
of O 0 0.0002384921390330419
the O 0 0.00027865698211826384
splice O 0 0.0014355212915688753
- O 0 0.00019802441238425672
site O 0 4.536203414318152e-05
mutation O 0 8.33215665352327e-07
on O 0 1.31344968394842e-05
splicing O 0 3.2990003091981634e-05
of O 0 0.00013189122546464205
COL17A1 O 0 0.05217583477497101
transcripts O 0 0.00037117869942449033
were O 0 1.0350383490731474e-05
determined O 0 5.4740407904319e-06
using O 0 1.803842337722017e-06
reverse O 0 3.9768532587913796e-05
transcriptase O 0 7.204463327070698e-05
polymerase O 0 7.682938303332776e-05
chain O 0 9.545883585815318e-06
reaction O 0 1.5121397609618725e-06
of O 0 1.7409434803994372e-05
total O 0 4.5769880671286955e-05
RNA O 0 0.0002851925673894584
from O 0 2.812513048411347e-05
keratinocytes O 0 0.0001037727270158939
incubated O 0 8.977414108812809e-05
for O 0 4.889598130830564e-06
2 O 0 0.0001841056946432218
. O 0 9.4807350251358e-05

5 O 0 0.0006811596686020494
h O 0 0.0003715539933182299
in O 0 3.4194355976069346e-05
the O 0 3.227717388654128e-05
presence O 0 1.6936008250922896e-05
or O 0 7.000071946094977e-06
absence O 0 0.0001224141160491854
of O 0 0.00028628905420191586
10 O 0 0.0003181760257575661
microg O 0 0.008570683188736439
cycloheximide O 0 0.006219889502972364
per O 0 0.00011509787873364985
ml O 0 0.0019636941142380238
. O 0 0.00019697625248227268

Using O 0 4.890943819191307e-05
this O 0 1.0434965588501655e-05
approach O 0 1.6680538465152495e-05
, O 0 4.98245253766072e-06
an O 0 7.159487267927034e-06
abnormally O 0 0.0004302887537050992
spliced O 0 0.0005261728074401617
transcript O 0 0.00046027955249883235
was O 0 0.00014321737398859113
identified O 0 7.3875276029866654e-06
that O 0 7.103461712176795e-07
contains O 0 2.328882828805945e-06
an O 0 1.5077606576596736e-06
extra O 0 5.199233328312403e-06
264 O 0 4.47393576905597e-05
bases O 0 3.7609392165904865e-05
upstream O 0 0.00014070748875383288
from O 0 2.9413014999590814e-05
exon O 0 0.0001395056606270373
32 O 0 2.7628224415821023e-05
, O 0 4.523447842075257e-06
resulting O 0 1.9674916984513402e-05
in O 0 3.3272845030296594e-05
a O 0 8.720702317077667e-05
premature O 0 0.0008008779841475189
termination O 0 0.0005349551793187857
codon O 0 0.00038489981670863926
27 O 0 0.0008494099602103233
bp O 0 0.000709764426574111
downstream O 0 0.0003506222565192729
from O 0 2.3895920094219036e-05
the O 0 0.0001274308015126735
cryptic O 0 0.001035802997648716
splice O 0 0.0012397008249536157
site O 0 0.0015110787935554981
. O 0 0.00021006926544941962

Three O 0 4.864768561674282e-05
other O 0 8.025950592127629e-06
splice O 0 0.0002255016879644245
variants O 0 3.323589771753177e-05
, O 0 4.664122570829932e-06
including O 0 2.484038304828573e-06
one O 0 3.385945774425636e-06
derived O 0 8.162328413163777e-06
from O 0 1.7200083675561473e-05
the O 0 4.317946877563372e-05
skipping O 0 0.00014155246026348323
of O 0 0.00010718069097492844
exon O 0 0.0004592295445036143
32 O 0 5.355554094421677e-05
, O 0 4.4995044845563825e-06
were O 0 1.1128281585115474e-05
also O 0 1.4295766050054226e-05
identified O 0 5.869914821232669e-05
. O 0 7.205452857306227e-05

These O 0 1.7981872588279657e-05
results O 0 1.3145021512173116e-05
indicate O 0 3.548095628502779e-05
the O 0 4.0981245547300205e-05
usefulness O 0 0.00019714610243681818
of O 0 0.00018035272660199553
cycloheximide O 0 0.014301435090601444
treatment O 0 0.00014688327792100608
in O 0 4.7895562602207065e-05
evaluating O 0 5.229064845480025e-05
the O 0 6.919819861650467e-05
abnormal O 0 7.606917642988265e-05
processing O 0 8.946314483182505e-05
of O 0 0.00017422490054741502
mRNA O 0 0.00011892714246641845
due O 0 7.668739272048697e-05
to O 0 1.5539777450612746e-05
splice O 0 0.00039819692028686404
- O 0 0.00017719229799695313
site O 0 9.629073610994965e-05
mutations O 0 1.0814495908562094e-05
, O 0 7.820480277587194e-06
because O 0 1.0080187166749965e-05
( O 0 2.9244807592476718e-05
i O 0 0.00010847447993000969
) O 0 1.308309037995059e-05
aberrant O 0 6.445327016990632e-05
splicing O 0 7.331682718358934e-05
often O 0 6.370609753503231e-06
generates O 0 1.3000803846807685e-05
a O 0 2.411348577879835e-05
premature O 0 0.00029975632787682116
termination O 0 0.00023310541291721165
codon O 0 9.433839295525104e-05
, O 0 1.467677611799445e-05
( O 0 1.642279494262766e-05
ii O 1 0.9507890343666077
) O 0 3.4305961889913306e-05
transcripts O 0 0.0003956887230742723
with O 0 2.7663185392157175e-05
premature O 0 0.0008193494286388159
termination O 0 0.0006028716452419758
codons O 0 0.00023779257026035339
can O 0 6.766507340216776e-06
occur O 0 1.832020097936038e-05
at O 0 0.000287224625935778
low O 0 0.0001941763039212674
or O 0 3.9312431908911094e-05
undetectable O 0 0.0015258900821208954
levels O 0 8.991001959657297e-05
due O 0 9.014171519083902e-05
to O 0 2.254400351375807e-05
nonsense O 0 0.00020011133165098727
- O 0 7.828425441402942e-05
mediated O 0 7.09943487890996e-05
mRNA O 0 0.0001029103877954185
decay O 0 0.00031078438041731715
, O 0 5.306968432705617e-06
and O 0 3.6816913961956743e-06
( O 0 1.6592959582339972e-05
iii O 0 0.009476354345679283
) O 0 1.6534449969185516e-05
the O 0 3.5616794775705785e-05
levels O 0 3.482538886601105e-05
of O 0 1.9619192244135775e-05
these O 0 1.7886887917484273e-06
transcripts O 0 4.7893412556732073e-05
can O 0 6.133854526524374e-07
be O 0 6.73629642733431e-07
increased O 0 4.2632814256649e-06
by O 0 9.077920367417391e-06
cycloheximide O 0 0.004425267688930035
. O 0 0.00013846134243067354

A O 0 0.001970624551177025
deletion O 0 0.001025267643854022
mutation O 0 7.15168789611198e-05
in O 0 0.0001831568661145866
COL17A1 O 0 0.46835991740226746
in O 0 4.881307904724963e-05
five O 0 1.2566207260533702e-05
Austrian O 0 9.814170334720984e-05
families O 0 3.277828000136651e-06
with O 0 8.087671631074045e-06
generalized O 1 0.9995631575584412
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
represents O 0 0.004138625226914883
propagation O 0 0.0010086048860102892
of O 0 0.0008222112082876265
an O 0 9.248071728507057e-05
ancestral O 0 0.004568617790937424
allele O 0 0.00013500408385880291
. O 0 0.00014584531891159713

Patients O 0 0.0005501467967405915
with O 0 8.455166971543804e-05
generalized O 1 0.9999969005584717
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.0004901305073872209
a O 0 8.83091488503851e-05
usually O 0 1.791460636013653e-05
nonlethal O 0 0.0003180371131747961
form O 0 0.00010015240695793182
of O 0 0.27732059359550476
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999091625213623
, O 0 0.0001109657168854028
have O 0 9.260027582058683e-06
generalized O 0 0.0004580482200253755
blistering B-Disease 1 0.501947820186615
, O 0 0.058964233845472336
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.014645448885858059
patchy B-Disease 1 0.9999997615814209
alopecia I-Disease 1 1.0
, O 0 0.01626408100128174
and O 1 0.5060933232307434
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9981852173805237

Skin B-Disease 1 0.999836802482605
fragility I-Disease 1 0.9993903636932373
in O 0 0.000678389857057482
most O 0 4.389507375890389e-05
cases O 0 1.518788394605508e-05
is O 0 6.705302439513616e-06
due O 0 3.724007910932414e-05
to O 0 7.455955710611306e-06
mutations O 0 2.612222260722774e-06
in O 0 1.8668688426259905e-06
the O 0 6.920228315721033e-06
gene O 0 1.5969459354892024e-06
encoding O 0 1.145808619185118e-05
type O 0 0.0004549712175503373
XVII O 1 1.0
collagen O 1 0.999270498752594
( O 0 0.0015309754526242614
COL17A1 O 1 0.9999935626983643
) O 0 0.00022938790789339691
. O 0 0.00011210392403881997

Recently O 0 0.0005790258874185383
, O 0 7.651666237507015e-06
we O 0 2.335747240067576e-06
reported O 0 3.2797252060845494e-06
five O 0 1.9331778275955003e-06
Austrian O 0 6.680775550194085e-05
families O 0 2.9273271593410755e-06
with O 0 1.3704207049158867e-05
generalized O 1 0.9988629817962646
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
who O 0 0.0005621092859655619
share O 0 5.0073431339114904e-05
the O 0 0.00011214145342819393
same O 0 0.00010080950596602634
COL17A1 O 1 0.9997574687004089
mutation O 0 0.00011869443551404402
. O 0 0.00013203870912548155

Affected O 0 0.0002333566953893751
individuals O 0 6.47774186290917e-06
in O 0 2.6746291041490622e-05
three O 0 5.160175987839466e-06
families O 0 1.3593624998975429e-06
are O 0 4.91754519771348e-07
homozygous O 0 7.393673513433896e-06
for O 0 1.5069893379404675e-05
4003delTC O 0 0.0016792084788903594
, O 0 1.578506089572329e-05
whereas O 0 1.3977587514091283e-05
those O 0 4.657659246731782e-06
in O 0 1.5090903616510332e-05
two O 0 6.654847311438061e-06
others O 0 9.212885743181687e-06
are O 0 3.72747103938309e-06
compound O 0 0.000687529391143471
heterozygotes O 0 0.003913514781743288
. O 0 0.0004348660877440125

To O 0 9.25502463360317e-05
determine O 0 3.166820897604339e-05
if O 0 7.245849246828584e-06
the O 0 1.9553426682250574e-05
occurrence O 0 4.6338354877661914e-05
of O 0 0.00021480722352862358
4003delTC O 0 0.00198010029271245
in O 0 6.151576963020489e-05
these O 0 1.0134193871635944e-05
unrelated O 0 8.736293239053339e-05
families O 0 1.0308440323569812e-05
signifies O 0 0.0003683463728521019
propagation O 0 9.183568181470037e-05
of O 0 0.00012506602797657251
an O 0 3.73107468476519e-05
ancestral O 0 0.0014239813899621367
allele O 0 2.7792093533207662e-05
or O 0 4.16262264479883e-05
a O 0 0.00015114365669433028
mutational O 0 0.0043737273663282394
hot O 0 0.0010329029755666852
spot O 0 0.00020547930034808815
, O 0 5.311190761858597e-06
haplotypes O 0 4.596321014105342e-05
were O 0 7.736036423011683e-06
determined O 0 8.649114533909597e-06
for O 0 4.613152668753173e-06
polymorphisms O 0 3.625806493801065e-05
both O 0 1.117782449000515e-05
within O 0 6.373570795403793e-05
and O 0 9.949463856173679e-05
flanking O 1 0.9802875518798828
COL17A1 O 1 0.9999996423721313
. O 0 0.0009938646107912064

Five O 0 0.0006882799789309502
intragenic O 0 0.007074553053826094
polymorphisms O 0 0.00029819118208251894
were O 0 2.5650278985267505e-05
chosen O 0 1.1642418030533008e-05
based O 0 3.2801474389998475e-06
on O 0 5.949692058493383e-05
their O 0 3.680044028442353e-05
informativeness O 0 0.009766658768057823
. O 0 0.0003200821520294994

One O 0 7.843474304536358e-05
of O 0 9.996061999117956e-05
these O 0 9.421912182006054e-06
, O 0 4.435017672221875e-06
not O 0 8.84621101704397e-07
previously O 0 1.5824036381673068e-05
reported O 0 1.2923446774948388e-05
, O 0 4.783370059158187e-06
was O 0 0.0003405166498851031
2988 O 0 0.002861980115994811
A O 0 0.0005616765120066702
or O 0 3.196156467311084e-05
C O 0 0.0003012443776242435
that O 0 2.932429197244346e-06
introduces O 0 6.619540272367885e-06
a O 0 2.082203309328179e-06
new O 0 1.4868292055325583e-06
restriction O 0 4.26428186983685e-06
site O 0 4.220919799990952e-05
for O 0 7.117741915863007e-06
Eco0109 O 0 0.003004168625921011
I O 0 0.0043077594600617886
. O 0 0.00014791940338909626

All O 0 5.584794416790828e-05
the O 0 0.00010067232506116852
4003delTC O 0 0.0007281912257894874
alleles O 0 9.685569239081815e-06
showed O 0 3.948285666410811e-05
the O 0 3.120238761766814e-05
same O 0 8.65310721565038e-06
haplotype O 0 7.950345752760768e-05
for O 0 7.255661785166012e-06
these O 0 1.1299212019366678e-05
five O 0 5.2956980653107166e-05
polymorphic O 0 0.00039654099964536726
markers O 0 0.004261594265699387
. O 0 0.0006019781576469541

Fourteen O 0 0.002098672091960907
microsatellite O 0 0.002074233256280422
polymorphisms O 0 0.00021702151570934802
were O 0 2.1786887373309582e-05
selected O 0 7.083160198817495e-06
based O 0 2.500442633390776e-06
on O 0 2.9241517040645704e-05
their O 0 1.240588699147338e-05
high O 0 0.0004116989148315042
heterozygosity O 0 0.0017742349300533533
and O 0 1.1465835996204987e-05
their O 0 5.3307480811781716e-06
location O 0 7.573593757115304e-05
within O 0 5.346266334527172e-05
10q23 O 0 0.0025665247812867165
- O 0 0.000992960762232542
q25 O 0 0.003577534342184663
near O 0 0.006532502360641956
COL17A1 O 1 0.9987762570381165
. O 0 0.0005232521798461676

Three O 0 3.481104431557469e-05
families O 0 1.0044873306469526e-05
shared O 0 0.0001080417277989909
microsatellite O 0 0.0035152812488377094
polymorphisms O 0 0.001119755208492279
covering O 0 0.001796761411242187
at O 0 0.001391255296766758
most O 0 0.00010591646423563361
19 O 0 0.0009763666312210262
cM O 0 0.001136808772571385
, O 0 1.5281069863704033e-05
whereas O 0 1.3564301298174541e-05
the O 0 2.744676203292329e-05
others O 0 6.964142812648788e-06
shared O 0 1.0477734576852527e-05
smaller O 0 8.842357601679396e-06
regions O 0 1.569326013850514e-05
consistent O 0 3.35931072186213e-05
with O 0 8.690522008691914e-06
cross O 0 0.00024717653286643326
- O 0 0.00013370630040299147
over O 0 1.4637203094025608e-05
events O 0 2.251186378998682e-05
during O 0 0.00010168518201680854
passage O 0 4.14381647715345e-05
of O 0 1.5463936506421305e-05
this O 0 2.701897983570234e-06
mutation O 0 2.131522251147544e-06
through O 0 2.932694769697264e-06
several O 0 1.3519825188268442e-05
generations O 0 0.00034028946538455784
. O 0 0.00012500450247898698

These O 0 2.6818854166776873e-05
results O 0 1.81645700649824e-05
indicate O 0 5.626715937978588e-05
that O 0 7.48976390241296e-06
4003delTC O 0 0.0007703173905611038
occurs O 0 1.722283377603162e-05
on O 0 2.545477036619559e-05
a O 0 1.6350895748473704e-05
single O 0 9.992867489927448e-06
ancestral O 0 0.0003082607581745833
allele O 0 2.6776224331115372e-05
. O 0 2.7224141376791522e-05
. O 0 7.54045759094879e-05

The O 0 0.00118457549251616
haptoglobin O 0 0.011935923248529434
- O 0 0.0006136461161077023
gene O 0 1.492966475780122e-05
deletion O 0 7.902093057055026e-05
responsible O 0 6.890189979458228e-05
for O 0 8.572806837037206e-05
anhaptoglobinemia B-Disease 0 0.3781345784664154
. O 0 0.0005149951903149486

We O 0 6.684038089588284e-05
have O 0 4.0790623643260915e-06
found O 0 2.6199213607469574e-06
an O 0 3.608684437494958e-06
allelic O 0 0.00020002052769996226
deletion O 0 0.0003080072347074747
of O 0 0.0005851786700077355
the O 0 0.0015017313417047262
haptoglobin O 0 0.018467722460627556
( O 0 0.00012201951176393777
Hp O 0 0.00021884155285079032
) O 0 6.54489213047782e-06
gene O 0 2.9549969440267887e-06
from O 0 6.9053949118824676e-06
an O 0 3.331913603688008e-06
individual O 0 5.144722308614291e-06
with O 0 2.3971399059519172e-05
anhaptoglobinemia B-Disease 0 0.24977511167526245
. O 0 0.0005262249615043402

The O 0 0.0007382874609902501
Hp O 0 0.0008079712279140949
gene O 0 2.522883369238116e-05
cluster O 0 0.00012524814519565552
consists O 0 3.823359656962566e-05
of O 0 0.00010466047388035804
coding O 0 0.0003374232619535178
regions O 0 7.485150854336098e-05
of O 0 0.00022878832533024251
the O 0 0.00030731031438335776
alpha O 0 0.00034938010503537953
chain O 0 2.7330430384608917e-05
and O 0 4.265575171302771e-06
beta O 0 5.2629933634307235e-05
chain O 0 1.1628681932052132e-05
of O 0 2.8072157874703407e-05
the O 0 8.215707202907652e-05
haptoglobin O 0 0.0015376931987702847
gene O 0 2.5877745429170318e-05
( O 0 1.382068785460433e-05
Hp O 0 8.945514127844945e-05
) O 0 3.3093533602368552e-06
and O 0 1.8718105820880737e-06
of O 0 4.914694727631286e-05
the O 0 0.0001818583405110985
alpha O 0 0.0004510588478296995
chain O 0 4.470097701414488e-05
and O 0 5.188306658965303e-06
beta O 0 8.506941958330572e-05
chain O 0 1.2307384167797863e-05
of O 0 2.1894360543228686e-05
the O 0 7.689389167353511e-05
haptoglobin O 0 0.002359219593927264
- O 0 0.0001349913509329781
related O 0 2.103799670294393e-05
gene O 0 2.078899706248194e-05
( O 0 3.578808536985889e-05
Hpr O 0 0.0020049887243658304
) O 0 1.4925706636859104e-05
, O 0 7.937894224596675e-06
in O 0 3.222154555260204e-05
tandem O 0 0.0004511946754064411
from O 0 5.939442780800164e-05
the O 0 0.000170394909218885
5 O 0 0.00031530761043541133
side O 0 0.00032933783950284123
. O 0 0.00014882910181768239

Southern O 0 0.0014394136378541589
blot O 0 0.0007643232238478959
and O 0 1.9520113710314035e-05
PCR O 0 3.701807509060018e-05
analyses O 0 4.337651716923574e-06
have O 0 7.212222499219934e-07
indicated O 0 4.033270215586526e-06
that O 0 5.052737037658517e-07
the O 0 3.717502522704308e-06
individual O 0 7.988372203726612e-07
with O 0 3.1625784231437137e-06
anhaptoglobinemia B-Disease 0 0.00218102615326643
was O 0 0.00020799966296181083
homozygous O 0 8.577119842811953e-06
for O 0 1.8646660464582965e-06
the O 0 1.4039079360372853e-05
gene O 0 5.835269803355914e-06
deletion O 0 2.482568015693687e-05
and O 0 4.229459136695368e-06
that O 0 1.154305550699064e-06
the O 0 1.2519030860858038e-05
gene O 0 5.238772246229928e-06
deletion O 0 2.944371590274386e-05
was O 0 7.329403888434172e-05
included O 0 7.599979198857909e-06
at O 0 6.017771374899894e-05
least O 0 3.0832720767648425e-06
from O 0 7.339998319366714e-06
the O 0 4.3489988456713036e-05
promoter O 0 0.0010434003779664636
region O 0 0.00028586521511897445
of O 0 0.0004005709779448807
Hp O 0 0.0005838274373672903
to O 0 7.633383211214095e-05
Hpr O 0 0.001959514571353793
alpha O 0 7.712425576755777e-05
but O 0 8.478039603687648e-07
not O 0 2.780581951355998e-07
to O 0 4.770058694703039e-06
Hpr O 0 0.0009379909024573863
beta O 0 0.000552671670448035
( O 0 6.837433465989307e-05
Hpdel O 0 0.00737519608810544
) O 0 7.928450213512406e-05
. O 0 0.00010872922575799748

In O 0 0.00018657217151485384
addition O 0 4.267097756383009e-05
, O 0 1.3079646123514976e-05
we O 0 3.582511226341012e-06
found O 0 1.7186239347211085e-06
seven O 0 4.723198344436241e-06
individuals O 0 5.723818503611255e-07
with O 0 9.205332389683463e-06
hypohaptoglobinemia B-Disease 0 0.0031403673347085714
in O 0 6.380334525601938e-05
three O 0 1.3359933291212656e-05
families O 0 3.408368002055795e-06
, O 0 3.0921589768695412e-06
and O 0 2.3528834844910307e-06
the O 0 3.47472341672983e-05
genotypes O 0 0.00016388640506193042
of O 0 0.00012139212776673958
six O 0 6.341318658087403e-05
of O 0 0.00011766804527724162
the O 0 7.795083365635946e-05
seven O 0 2.9585913580376655e-05
individuals O 0 9.660069508754532e-07
were O 0 8.80741481523728e-06
found O 0 4.273238118912559e-06
to O 0 9.360089279653039e-06
be O 0 3.533555718604475e-05
Hp2 O 0 0.0594106987118721
/ O 0 0.0031839499715715647
Hpdel O 0 0.11268952488899231
. O 0 0.0004687264154199511

The O 0 0.0010036047315225005
phenotypes O 0 0.0009277353528887033
and O 0 4.872916906606406e-05
genotypes O 0 0.0005008564330637455
in O 0 5.514482472790405e-05
one O 0 1.0174352610192727e-05
of O 0 2.4974706320790574e-05
these O 0 2.3983316168596502e-06
three O 0 3.730187700057286e-06
families O 0 1.7364166069455678e-06
showed O 0 1.889908526209183e-05
the O 0 2.3373035219265148e-05
father O 0 9.423984010936692e-05
to O 0 5.688757028110558e-06
be O 0 1.460310068068793e-05
hypohaptoglobinemic B-Disease 0 0.0017565949819982052
( O 0 6.529231177410111e-05
Hp2 O 0 0.0055102095939219
) O 0 2.9410095521598123e-05
and O 0 3.981053669122048e-05
Hp2 O 0 0.15768733620643616
/ O 0 0.0030249988194555044
Hpdel O 0 0.016536369919776917
, O 0 3.046478559554089e-05
the O 0 3.830530840787105e-05
mother O 0 2.8780605134670623e-05
to O 0 6.170987035147846e-06
be O 0 1.2401841559039894e-05
Hp2 O 0 0.002526349388062954
- O 0 0.0001810341200325638
1 O 0 0.00010445549560245126
and O 0 3.6834535421803594e-05
Hp1 O 0 0.010010303929448128
/ O 0 0.0010475575691089034
Hp2 O 0 0.005821960512548685
, O 0 9.964213859348092e-06
one O 0 2.3069280814524973e-06
of O 0 1.571428765601013e-05
the O 0 2.24696341319941e-05
two O 0 2.912393256337964e-06
children O 0 1.4687562952531152e-06
to O 0 2.883953129639849e-06
be O 0 1.0720068530645221e-05
hypohaptoglobinemic B-Disease 0 0.0012933475663885474
( O 0 3.7827659980393946e-05
Hp2 O 0 0.004698149394243956
) O 0 3.3272717701038346e-05
and O 0 3.9522707083960995e-05
Hp2 O 0 0.14548279345035553
/ O 0 0.00366259110160172
Hpdel O 0 0.027563191950321198
, O 0 3.076034045079723e-05
and O 0 5.243130544840824e-06
the O 0 2.1412903151940554e-05
other O 0 3.6541869121720083e-06
child O 0 2.1919182472629473e-05
to O 0 8.084331966529135e-06
be O 0 1.681392859609332e-05
Hp1 O 0 0.00350253120996058
and O 0 4.141936733503826e-05
Hp1 O 1 0.9307734966278076
/ O 0 0.0026759349275380373
Hpdel O 0 0.016117757186293602
, O 0 1.639636502659414e-05
showing O 0 8.464176789857447e-05
an O 0 2.2578018615604378e-05
anomalous O 0 0.0011913247872143984
inheritance O 0 0.000835660204757005
of O 0 0.003669918980449438
Hp O 0 0.00411659199744463
phenotypes O 0 0.0005496033700183034
in O 0 7.429838296957314e-05
the O 0 0.00013058526383247226
child O 0 0.00013070707791484892
with O 0 4.036904647364281e-05
Hp1 O 1 0.6459959745407104
. O 0 0.0005382387316785753

The O 0 0.001830513123422861
Hp2 O 1 0.9857902526855469
/ O 0 0.0031647724099457264
Hpdel O 0 0.006994750816375017
individuals O 0 1.0832249245140702e-05
had O 0 0.00010643342830007896
an O 0 1.3838361155649181e-05
extremely O 0 4.8855126806301996e-05
low O 0 6.047750139259733e-05
level O 0 0.00013122960808686912
of O 0 0.00016542656521778554
Hp O 0 0.0001817810261854902
( O 0 1.0084340829052962e-05
mean O 0 3.1940846383804455e-05
+ O 0 0.00010265164019074291
/ O 0 0.00011069484025938436
- O 0 0.00014840766380075365
SD O 0 0.002030528150498867
= O 0 4.0737129893386737e-05
0 O 0 8.461968718620483e-06
. O 0 5.443554528028471e-06
049 O 0 0.0002876803628169
+ O 0 5.8921454183291644e-05
/ O 0 7.917827315395698e-05
- O 0 7.791358802933246e-05
0 O 0 1.0456930795044173e-05
. O 0 8.76991543918848e-06
043 O 0 0.0012227321276441216
mg O 0 0.0008356410544365644
/ O 0 0.0004073369491379708
ml O 0 0.0003803835716098547
; O 0 6.353409389703302e-06
n O 0 4.873748912359588e-05
= O 0 6.833711813669652e-05
6 O 0 0.00011240354069741443
) O 0 3.3804867598519195e-06
, O 0 1.339026653113251e-06
compared O 0 2.66360643763619e-06
with O 0 1.5975339238138986e-06
the O 0 3.149906115140766e-05
level O 0 0.00013990688603371382
( O 0 4.595404334395425e-06
1 O 0 2.261866393382661e-05
. O 0 2.1070006823720178e-06
64 O 0 1.786710345186293e-05
+ O 0 5.4829579312354326e-05
/ O 0 7.214762445073575e-05
- O 0 5.478112507262267e-05
1 O 0 5.7296871091239154e-05
. O 0 7.94277002569288e-06
07 O 0 0.0006251137237995863
mg O 0 0.0008050307515077293
/ O 0 0.00022075574088376015
ml O 0 0.0001355642161797732
) O 0 1.8416614011584898e-06
obtained O 0 8.18006355984835e-06
from O 0 3.1329793273471296e-05
52 O 0 0.00021484940953087062
healthy O 0 0.000152748660184443
volunteers O 0 4.899934720015153e-05
having O 0 6.898486753925681e-05
phenotype O 0 0.00015777770022395998
Hp2 O 0 0.010201714001595974
, O 0 3.5820252378471196e-05
whereas O 0 3.414759339648299e-05
the O 0 0.0001061437651515007
serum O 0 0.0007874731090851128
Hp O 0 0.00011822814121842384
level O 0 6.90200031385757e-05
of O 0 3.839729106402956e-05
an O 0 3.67309917237435e-06
individual O 0 2.3413892904500244e-06
with O 0 1.0721306352934334e-05
Hp1 O 0 0.12048231065273285
/ O 0 0.0014539625262841582
Hpdel O 0 0.012205999344587326
was O 0 0.001234860741533339
0 O 0 0.00015400817210320383
. O 0 0.00010445429506944492

50 O 0 0.0011311662383377552
mg O 0 0.006112109869718552
/ O 0 0.002135728020220995
ml O 0 0.0010581747628748417
, O 0 1.300717758567771e-05
which O 0 3.6045228171133203e-06
was O 0 5.511098061106168e-05
approximately O 0 9.862546903605107e-06
half O 0 3.1630820558348205e-06
the O 0 4.477096354094101e-06
level O 0 3.238879799027927e-05
of O 0 6.327401933958754e-05
Hp O 0 0.000126116065075621
in O 0 3.119857865385711e-05
control O 0 0.00020141740969847888
sera O 0 0.0014558405382558703
from O 0 2.1357962395995855e-05
the O 0 7.376903522526845e-05
Hp1 O 0 0.0022959276102483273
phenotype O 0 1.777044963091612e-05
( O 0 6.72337182550109e-06
1 O 0 3.312379340059124e-05
. O 0 3.5866953567165183e-06
26 O 0 5.3925243264529854e-05
+ O 0 6.984911306062713e-05
/ O 0 3.631089930422604e-05
- O 0 3.192601434420794e-05
0 O 0 4.6056093196966685e-06
. O 0 2.4304054022650234e-06
33 O 0 4.661803905037232e-05
mg O 0 0.0004924141685478389
/ O 0 0.00023419008357450366
ml O 0 0.00016951544967014343
; O 0 4.205447567073861e-06
n O 0 3.2497333450010046e-05
= O 0 8.206240454455838e-05
9 O 0 9.449188655707985e-05
) O 0 3.0996466193755623e-06
, O 0 8.271116485047969e-07
showing O 0 1.376876298309071e-05
a O 0 2.5387982532265596e-05
gene O 0 5.900962059968151e-05
- O 0 0.00024844103609211743
dosage O 0 0.0001205215448862873
effect O 0 0.00011742235074052587
. O 0 0.0001233597577083856

The O 0 0.00017291480617132038
other O 0 1.4909404853824526e-05
allele O 0 1.1754203114833217e-05
( O 0 3.552350972313434e-05
Hp2 O 0 0.003442843444645405
) O 0 6.9283178163459525e-06
of O 0 2.488555219315458e-05
individuals O 0 7.31139698473271e-06
with O 0 7.153680053306744e-05
Hp2 O 1 0.9997732043266296
/ O 0 0.006331488955765963
Hpdel O 0 0.01940743997693062
was O 0 0.0004457772593013942
found O 0 3.601619027904235e-06
to O 0 3.458992523519555e-06
have O 0 9.10918402041716e-07
, O 0 1.3066404562778189e-06
in O 0 5.24906909049605e-06
all O 0 5.533540388569236e-06
exons O 0 0.000301949999993667
, O 0 9.446835065318737e-06
no O 0 5.893578872928629e-06
mutation O 0 1.8742006204774952e-06
, O 0 1.4126425185168046e-06
by O 0 1.5968684010658762e-06
DNA O 0 7.697091496083885e-05
sequencing O 0 0.00014096613449510187
. O 0 8.938853716244921e-05

On O 0 0.00033624356728978455
the O 0 2.6007977794506587e-05
basis O 0 8.445827916148119e-06
of O 0 3.4910412068711594e-05
the O 0 3.1311094062402844e-05
present O 0 1.699358836049214e-05
study O 0 4.787632860825397e-06
, O 0 1.8870310896090814e-06
the O 0 6.262011083890684e-06
mechanism O 0 3.002198900503572e-05
of O 0 8.67046182975173e-05
anhaptoglobinemia B-Disease 0 0.0031940448097884655
and O 0 1.226165932166623e-05
the O 0 3.451278462307528e-05
mechanism O 0 0.00011025986896129325
of O 0 0.000158081908011809
anomalous O 0 0.0022401870228350163
inheritance O 0 0.0009778757812455297
of O 0 0.0016125037800520658
Hp O 0 0.001851490931585431
phenotypes O 0 0.0003830778878182173
were O 0 7.814879791112617e-05
well O 0 5.538567347684875e-05
explained O 0 0.0001974271726794541
. O 0 0.00011396274203434587

However O 0 0.00011510644253576174
, O 0 7.455151717294939e-06
the O 0 1.9998107745777816e-05
mechanism O 0 8.833046013023704e-05
of O 0 0.0002826914715114981
hypohaptoglobinemia B-Disease 0 0.49420252442359924
remains O 0 0.007181394845247269
unknown O 0 0.0017397874034941196

ATM O 0 0.01267695240676403
mutations O 0 9.544794011162594e-05
and O 0 2.409091393928975e-05
phenotypes O 0 0.0004656167875509709
in O 0 0.0012716114288195968
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
telangiectasia I-Disease 1 0.9999860525131226
families O 0 5.606069680652581e-05
in O 0 4.4222790165804327e-05
the O 0 4.5277152821654454e-05
British O 0 3.988961907452904e-05
Isles O 0 0.0001449535775464028
: O 0 6.686298547720071e-06
expression O 0 7.289688710443443e-06
of O 0 0.00010552049934631214
mutant O 0 0.00040076658478938043
ATM O 0 0.0012767913285642862
and O 0 3.765751898754388e-06
the O 0 1.0791006388899405e-05
risk O 0 1.879078808997292e-05
of O 0 0.0003923293261323124
leukemia B-Disease 1 1.0
, O 1 0.9971945285797119
lymphoma B-Disease 1 1.0
, O 1 0.8051390647888184
and O 1 0.8862193822860718
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.007241599261760712

We O 0 3.418190317461267e-05
report O 0 3.406704308872577e-06
the O 0 6.197143193276133e-06
spectrum O 0 3.7770707422168925e-05
of O 0 0.0002492311177775264
59 O 0 0.0011652917601168156
ATM O 0 0.0036776037886738777
mutations O 0 4.5809010771336034e-05
observed O 0 0.00010210804612142965
in O 0 0.0003049439692404121
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9996583461761475
telangiectasia I-Disease 1 0.9999959468841553
( O 0 0.0005482111591845751
A B-Disease 1 0.9999986886978149
- I-Disease 1 0.9996563196182251
T I-Disease 1 0.9999955892562866
) O 0 1.966277886822354e-05
patients O 0 7.870836270740256e-06
in O 0 1.544342012493871e-05
the O 0 5.994591992930509e-05
British O 0 0.00015072166570462286
Isles O 0 0.001207691733725369
. O 0 0.00025190773885697126

Of O 0 0.0026345779187977314
51 O 0 0.0029395711608231068
ATM O 0 0.008639920502901077
mutations O 0 9.192750439979136e-05
identified O 0 3.9458762330468744e-05
in O 0 2.6132536731893197e-05
families O 0 5.841567144670989e-06
native O 0 1.1765552699216641e-05
to O 0 7.55023484089179e-06
the O 0 3.154005389660597e-05
British O 0 4.6841967559885234e-05
Isles O 0 0.00014370985445566475
, O 0 9.998853784054518e-06
11 O 0 5.444620182970539e-05
were O 0 5.360423165257089e-05
founder O 0 0.0007328087231144309
mutations O 0 1.81592349690618e-05
, O 0 6.2725548559683375e-06
and O 0 6.777945600333624e-06
2 O 0 7.060916686896235e-05
of O 0 9.006437903735787e-05
these O 0 1.524299386801431e-05
11 O 0 0.0001424163783667609
conferred O 0 0.0003290955792181194
a O 0 2.7399166356190108e-05
milder O 0 4.1549516026861966e-05
clinical O 0 3.8518170185852796e-05
phenotype O 0 8.950137271312997e-06
with O 0 1.7561109189045965e-06
respect O 0 1.9417551811784506e-05
to O 0 7.091153383953497e-05
both O 0 0.0008268222445622087
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9995937943458557
cellular O 1 0.9980008006095886
features O 0 0.0012616567546501756
. O 0 0.0005664846394211054

We O 0 5.0569287850521505e-05
report O 0 7.785833986417856e-06
, O 0 1.5386281120299827e-06
in O 0 4.277103016647743e-06
two O 0 7.439577530021779e-06
A B-Disease 0 0.08825354278087616
- I-Disease 0 0.0037885510828346014
T I-Disease 1 0.6214531064033508
families O 0 5.449106993182795e-06
, O 0 3.169601313857129e-06
an O 0 5.710477580578299e-06
ATM O 0 0.001069169258698821
mutation O 0 1.5379211617982946e-05
( O 0 3.293763074907474e-05
7271T O 0 0.0013550652656704187
- O 0 0.00042050203774124384
- O 0 0.00017349566041957587
> O 0 0.00011287980305496603
G O 0 0.0003422684676479548
) O 0 3.913633918273263e-06
that O 0 6.635453360104293e-07
may O 0 6.461565135396086e-06
be O 0 1.3558562841353705e-06
associated O 0 1.434004730072047e-06
with O 0 3.539476836067479e-07
an O 0 1.850172793638194e-06
increased O 0 4.6736353397136554e-05
risk O 0 0.00018984609050676227
of O 0 0.0029405246023088694
breast B-Disease 1 0.9999985694885254
cancer I-Disease 1 0.999384880065918
in O 0 0.00021453213412314653
both O 0 7.522660598624498e-05
homozygotes O 0 0.00217488338239491
and O 0 3.8381949707400054e-05
heterozygotes O 0 0.0005855136550962925
( O 0 2.917316487582866e-05
relative O 0 0.00012259191134944558
risk O 0 0.00011172029189765453
12 O 0 7.164193812059239e-05
. O 0 7.527042271249229e-06
7 O 0 5.1017184887314215e-05
; O 0 4.730740329250693e-06
P O 0 0.0010409163078293204
= O 0 0.000198253765120171
. O 0 3.4324351872783154e-05
0025 O 0 0.0027070604264736176
) O 0 4.314415946282679e-06
, O 0 1.1270801678620046e-06
although O 0 7.653955549358216e-07
there O 0 8.0690978165876e-07
is O 0 8.514485330124444e-07
a O 0 3.1126094199862564e-06
less O 0 2.132230656570755e-05
severe O 0 0.2573646306991577
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9998880624771118
T I-Disease 1 0.9995211362838745
phenotype O 0 2.4074697648757137e-05
in O 0 4.153433565079467e-06
terms O 0 3.2062512218544725e-06
of O 0 1.4775149793422315e-05
the O 0 2.6288355002179742e-05
degree O 0 0.0002700884942896664
of O 0 0.047373466193675995
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9968873858451843

This O 0 5.174173566047102e-05
mutation O 0 2.6254083422827534e-05
( O 0 3.4594606404425576e-05
7271T O 0 0.001844861195422709
- O 0 0.0005399372312240303
- O 0 0.00022148860443849117
> O 0 0.00011581503349589184
G O 0 0.00024730569566600025
) O 0 2.2624981284025125e-06
also O 0 8.745676041144179e-07
allows O 0 3.6612922826861904e-07
expression O 0 2.087364464387065e-06
of O 0 2.452941407682374e-05
full O 0 5.753104414907284e-05
- O 0 0.00010718406701926142
length O 0 1.717487430141773e-05
ATM O 0 0.0003492066462058574
protein O 0 1.0315096915292088e-05
at O 0 3.650268990895711e-05
a O 0 5.622165645036148e-06
level O 0 3.206909605069086e-05
comparable O 0 2.333287920919247e-05
with O 0 1.3976981563246227e-06
that O 0 1.145244027611625e-06
in O 0 1.8403588910587132e-05
unaffected O 0 0.00018816035299096256
individuals O 0 8.52200264489511e-06
. O 0 0.0001524771359981969

In O 0 0.00011935704242205247
addition O 0 1.514478208264336e-05
, O 0 3.4404245070618344e-06
we O 0 7.38436085612193e-07
have O 0 3.180382464051945e-07
studied O 0 3.4035554563160986e-05
18 O 0 0.0002496496890671551
A B-Disease 1 0.9994238615036011
- I-Disease 1 0.993604838848114
T I-Disease 1 0.9999920129776001
patients O 0 4.5345601392909884e-05
, O 0 4.600315151037648e-06
in O 0 6.122205832070904e-06
15 O 0 1.4057995940675028e-05
families O 0 1.0252458650938934e-06
, O 0 1.4762663340661675e-06
who O 0 7.060682037263177e-06
developed O 0 0.002410714980214834
leukemia B-Disease 1 1.0
, O 1 0.9562255144119263
lymphoma B-Disease 1 1.0
, O 1 0.9177094101905823
preleukemic O 1 1.0
T O 1 0.9999998807907104
- O 1 0.8024938702583313
cell O 0 0.0011061802506446838
proliferation O 0 0.14142157137393951
, O 0 5.23351009178441e-05
or O 0 0.001802373444661498
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.005881026852875948
mostly O 0 0.00043967607780359685
in O 0 0.0004307832568883896
childhood O 1 0.7288579344749451
. O 0 0.0007422839989885688

A O 0 0.0017393104499205947
wide O 0 0.00037605754914693534
variety O 0 5.496391167980619e-05
of O 0 0.000638810743112117
ATM O 0 0.010076436214148998
mutation O 0 1.8532120520831086e-05
types O 0 1.7749549442669377e-05
, O 0 7.947362973936833e-06
including O 0 9.973968190024607e-06
missense O 0 0.0003730769967660308
mutations O 0 7.564411498606205e-05
and O 0 7.691736391279846e-05
in O 0 0.0003836597315967083
- O 0 0.001198561629280448
frame O 0 0.0004970241570845246
deletions O 0 6.536040018545464e-05
, O 0 5.129617875354597e-06
were O 0 1.3477111679094378e-05
seen O 0 6.649669376201928e-05
in O 0 2.7218275135965087e-05
these O 0 1.8359520254307427e-05
patients O 0 0.00012637682084459811
. O 0 0.00021765916608273983

We O 0 2.599915023893118e-05
also O 0 1.6131095890159486e-06
show O 0 2.7490127649798524e-06
that O 0 4.4329570414447517e-07
25 O 0 5.450120625027921e-06
% O 0 1.072445115823939e-06
of O 0 2.8472721169237047e-05
all O 0 4.6381595893763006e-05
A B-Disease 1 0.9999890327453613
- I-Disease 1 0.9984849095344543
T I-Disease 1 0.9999864101409912
patients O 0 3.402180300327018e-05
carried O 0 4.085322143509984e-05
in O 0 6.420629506465048e-05
- O 0 0.0005265116924419999
frame O 0 0.00033800603705458343
deletions O 0 0.0001693616359261796
or O 0 4.178829840384424e-05
missense O 0 0.00038946629501879215
mutations O 0 3.3541473385412246e-05
, O 0 8.03101920610061e-06
many O 0 3.6873379940516315e-06
of O 0 2.9177337637520395e-05
which O 0 7.77577133703744e-06
were O 0 9.843996849667747e-06
also O 0 2.421724275336601e-06
associated O 0 1.5556978496533702e-06
with O 0 8.482074917992577e-07
expression O 0 1.2032002814521547e-05
of O 0 0.00016148804570548236
mutant O 0 0.0008542083669453859
ATM O 0 0.00904663372784853
protein O 0 0.0002513281360734254
. O 0 0.00010083738743560389

The O 0 0.0004187447775620967
DMPK O 1 0.9917043447494507
gene O 0 6.399101403076202e-05
of O 0 0.00047975548659451306
severely O 1 0.9999997615814209
affected O 1 0.999997615814209
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.99956876039505
is O 0 0.0011742772767320275
hypermethylated O 1 0.5302071571350098
proximal O 0 0.005076669156551361
to O 0 8.802229422144592e-05
the O 0 9.959050657926127e-05
largely O 0 9.733150363899767e-05
expanded O 0 0.0003082957409787923
CTG O 0 0.3137912452220917
repeat O 0 0.0018702122615650296
. O 0 0.0001642806746531278

Using O 0 0.00018723992980085313
methylation O 0 0.00036478613037616014
- O 0 0.0008968119509518147
sensitive O 0 0.0002117659751093015
restriction O 0 1.978919499379117e-05
enzymes O 0 6.6618194978218526e-06
, O 0 2.205779082942172e-06
we O 0 2.151446778952959e-06
characterized O 0 7.2506536525906995e-06
the O 0 1.7166621546493843e-05
methylation O 0 1.1571796676435042e-05
pattern O 0 7.631592598045245e-05
on O 0 6.363586726365611e-05
the O 0 4.001114939455874e-05
5 O 0 4.769219594891183e-05
side O 0 2.7059002604801208e-05
of O 0 0.00011586453183554113
the O 0 0.0005729899276047945
CTG O 0 0.37457287311553955
repeat O 0 0.00031617211061529815
in O 0 1.8862481738324277e-05
the O 0 6.772257620468736e-05
DMPK O 0 0.01900920458137989
gene O 0 1.2012786100967787e-05
of O 0 4.240672569721937e-05
normal O 0 2.704396320041269e-05
individuals O 0 1.0753649348771432e-06
and O 0 3.9207279769470915e-06
of O 0 0.00011164817988174036
patients O 0 0.0002581419830676168
affected O 0 0.0011567753972485662
with O 1 0.501153290271759
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.0008566512842662632
showing O 0 0.0008408328285440803
expansions O 0 0.0014291810803115368
of O 0 0.0004322886816225946
the O 0 0.0004320911248214543
repetitive O 0 0.0010264297015964985
sequence O 0 0.00018848251784220338
. O 0 0.00016610337479505688

The O 0 0.0001904803211800754
gene O 0 1.7918107914738357e-05
segment O 0 2.8598280550795607e-05
analyzed O 0 7.488278242817614e-06
corresponds O 0 4.99112229590537e-06
to O 0 4.077700850757537e-06
the O 0 2.769282946246676e-05
genomic O 0 0.00014872894098516554
SacI O 0 0.014488102868199348
- O 0 0.0004688517947215587
HindIII O 0 0.0011905289720743895
fragment O 0 5.849562512594275e-05
carrying O 0 3.854308306472376e-05
exons O 0 0.0002573784440755844
11 O 0 0.00039144131005741656
- O 0 0.000539590953849256
15 O 0 0.0002083940926240757
. O 0 0.00011519935651449487

There O 0 7.254596857819706e-05
is O 0 8.746812454774044e-06
constitutive O 0 7.869074761401862e-05
methylation O 0 3.7860208976780996e-05
in O 0 0.00011432126484578475
intron O 0 0.001986750168725848
12 O 0 0.00020529092580545694
at O 0 0.00010030064004240558
restriction O 0 7.767825991322752e-06
sites O 0 1.788810914149508e-05
of O 0 0.00015872229414526373
SacII O 0 0.010455056093633175
and O 0 0.00010655945516191423
HhaI O 0 0.0068420828320086
, O 0 1.9024091670871712e-05
localized O 0 0.00010565824049990624
1 O 0 0.00014821406512055546
, O 0 8.640013220428955e-06
159 O 0 3.6527137126540765e-05
- O 0 5.8698253269540146e-05
1 O 0 5.004965350963175e-05
, O 0 6.3072138800635e-06
232 O 0 3.58342585968785e-05
bp O 0 0.0001326362107647583
upstream O 0 0.00017151085194200277
of O 0 6.477862916653976e-05
the O 0 0.0005369896534830332
CTG O 1 0.9383389949798584
repeat O 0 0.0005367225385271013
, O 0 1.183039421448484e-05
whereas O 0 1.064074422174599e-05
most O 0 6.023933565302286e-06
, O 0 2.85979945147119e-06
if O 0 1.0456325298946467e-06
not O 0 3.2947593808785314e-07
all O 0 9.287481930186914e-07
, O 0 1.511413074695156e-06
of O 0 9.751792276802007e-06
the O 0 1.510419406258734e-05
other O 0 1.8422182392896502e-06
sites O 0 2.277884959767107e-05
of O 0 0.0001781216124072671
SacII O 0 0.015277653001248837
, O 0 7.769449439365417e-05
HhaI O 0 0.004822997841984034
, O 0 2.4514145479770377e-05
and O 0 2.0571291315718554e-05
HpaII O 0 0.002449125749990344
in O 0 1.936772787303198e-05
this O 0 3.726525619640597e-06
region O 0 7.936014299048111e-05
are O 0 3.314046580271679e-06
unmethylated O 0 0.0007238006801344454
, O 0 7.430756340909284e-06
in O 0 1.3586673958343454e-05
normal O 0 2.0562190911732614e-05
individuals O 0 8.774213142714871e-07
and O 0 4.492125299293548e-06
most O 0 8.022399924811907e-06
of O 0 0.00012815999798476696
the O 0 0.00045122025767341256
patients O 0 0.0002573109813965857
. O 0 0.00024193232820834965

In O 0 9.747390140546486e-05
a O 0 1.8759796148515306e-05
number O 0 1.532449823571369e-05
of O 0 0.00016945775132626295
young O 0 0.00047668576007708907
and O 0 6.263011891860515e-05
severely O 0 0.003184880595654249
affected O 0 7.898220064816996e-05
patients O 0 5.562567093875259e-05
, O 0 8.816658009891398e-06
however O 0 9.724756637297105e-06
, O 0 3.2088910302263685e-06
complete O 0 2.3478211005567573e-05
methylation O 0 1.6561847587581724e-05
of O 0 5.313200017553754e-05
these O 0 9.06237619346939e-06
restriction O 0 1.0648266652424354e-05
sites O 0 1.677596810623072e-05
was O 0 4.870593693340197e-05
found O 0 2.18420177588996e-06
in O 0 4.442074441612931e-06
the O 0 2.7974474505754188e-05
mutated O 0 4.963608807884157e-05
allele O 0 2.0142846551607363e-05
. O 0 0.00010592627222649753

In O 0 0.00015671060828026384
most O 0 1.6403371773776598e-05
of O 0 6.12926742178388e-05
these O 0 1.7270134776481427e-05
patients O 0 2.4990717065520585e-05
, O 0 4.838905169890495e-06
the O 0 1.6989748473861255e-05
onset O 0 0.005666851997375488
of O 0 0.0005336989415809512
the O 1 0.6054195761680603
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9950395226478577

Preliminary O 0 0.00019625411368906498
in O 0 0.00040708560845814645
vivo O 0 0.003303979290649295
footprinting O 0 0.006435312330722809
data O 0 2.3303415218833834e-05
gave O 0 1.458285260014236e-05
evidence O 0 2.23471834033262e-05
for O 0 1.0586692951619625e-05
protein O 0 3.7891382817178965e-05
- O 0 0.00016826434875838459
DNA O 0 3.091196049354039e-05
contact O 0 4.270870704203844e-06
in O 0 9.178919754049275e-06
normal O 0 1.1600747711781878e-05
genes O 0 4.826696113013895e-06
at O 0 7.160600216593593e-05
an O 0 1.299257291975664e-05
Sp1 O 0 0.0022664139978587627
consensus O 0 7.235196972033009e-05
binding O 0 1.2490099834394641e-05
site O 0 0.0001494656753493473
upstream O 0 0.0001921157236211002
of O 0 7.904481753939763e-05
the O 0 0.0005325411329977214
CTG O 0 0.29265153408050537
repeat O 0 0.00039786362322047353
and O 0 4.288842319510877e-06
for O 0 1.568789457451203e-06
a O 0 5.876876002730569e-06
significant O 0 1.733230601530522e-05
reduction O 0 3.666285192593932e-05
of O 0 6.290293094934896e-05
this O 0 7.767381248413585e-06
interaction O 0 1.8096186977345496e-05
in O 0 1.4388388990482781e-05
cells O 0 3.5476989523886004e-06
with O 0 8.099250408122316e-07
a O 0 2.72460856649559e-05
hypermethylated O 0 0.007550348527729511
DMPK O 1 0.9901350140571594
gene O 0 5.8888315834337845e-05
. O 0 1.9897966922144406e-05
. O 0 5.6376084103249013e-05

The O 0 0.0030575317796319723
hemochromatosis B-Disease 1 1.0
gene O 0 0.00014884103438816965
product O 0 4.356786666903645e-05
complexes O 0 0.0002653487026691437
with O 0 1.5738134607090615e-05
the O 0 0.00019641322433017194
transferrin O 0 0.0024714521132409573
receptor O 0 7.528501737397164e-05
and O 0 1.263221838598838e-05
lowers O 0 5.991802390781231e-05
its O 0 2.4727121399337193e-06
affinity O 0 5.698715995094972e-06
for O 0 8.625574082543608e-06
ligand O 0 9.892003436107188e-05
binding O 0 4.014484511571936e-05
. O 0 0.00012057740241289139

We O 0 9.278282232116908e-05
recently O 0 6.311299512162805e-05
reported O 0 9.818542821449228e-06
the O 0 1.0359617590438575e-05
positional O 0 0.00011340089986333624
cloning O 0 3.3604221243876964e-05
of O 0 1.0158210898225661e-05
a O 0 5.8781429288501386e-06
candidate O 0 7.812041985744145e-06
gene O 0 1.4134553566691466e-05
for O 0 7.884555088821799e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 1.0
HFE O 1 1.0
. O 0 0.0038022687658667564

The O 0 0.00016274712106678635
gene O 0 1.3948158994026016e-05
product O 0 5.933246029599104e-06
, O 0 2.7145097192260437e-06
a O 0 4.630316198017681e-06
member O 0 5.164385129319271e-06
of O 0 2.6308518499718048e-05
the O 0 8.467576117254794e-05
major O 0 0.001084464485757053
histocompatibility O 1 0.999995231628418
complex O 1 0.8517638444900513
class O 0 0.001027380581945181
I O 0 0.004380842670798302
- O 0 0.0002203416806878522
like O 0 6.434544502553763e-06
family O 0 7.957616617204621e-06
, O 0 1.8426222823109129e-06
was O 0 4.270151111995801e-05
found O 0 3.0760118079342647e-06
to O 0 3.293824420325109e-06
have O 0 1.5537941635557218e-06
a O 0 9.26856228034012e-06
mutation O 0 8.132826224027667e-06
, O 0 2.42223177338019e-05
Cys O 0 0.018222037702798843
- O 0 0.0005851312889717519
282 O 0 0.0005022830446250737
- O 0 0.0004814467974938452
- O 0 0.0002971471403725445
> O 0 0.0002156453119823709
Tyr O 0 0.0017715514404699206
( O 0 2.4055765607045032e-05
C282Y O 0 0.0004931177827529609
) O 0 4.76669401905383e-06
, O 0 1.2894805649921182e-06
in O 0 3.7765089473396074e-06
85 O 0 2.1900668798480183e-05
% O 0 1.34908195832395e-05
of O 0 0.0003092244442086667
patient O 0 0.0006979982135817409
chromosomes O 0 0.0005782248335890472
. O 0 0.0003052772954106331

This O 0 5.858902295585722e-05
mutation O 0 1.4563047443516552e-05
eliminates O 0 6.386036693584174e-05
the O 0 2.6149038603762165e-05
ability O 0 2.130913344444707e-05
of O 0 0.00023776263697072864
HFE O 0 0.05121415853500366
to O 0 4.303353853174485e-05
associate O 0 5.38908461749088e-05
with O 0 7.869394721637946e-06
beta2 O 0 0.009543745778501034
- O 0 0.0009586844244040549
microglobulin O 0 0.0027136916760355234
( O 0 4.484281816985458e-05
beta2m O 0 0.0024914462119340897
) O 0 2.5741854187799618e-05
and O 0 2.3773043722030707e-05
prevents O 0 0.00014784156519453973
cell O 0 0.0008705253712832928
- O 0 0.0006808970938436687
surface O 0 0.0004602764965966344
expression O 0 0.00016242045967373997
. O 0 0.0001688458287389949

A O 0 0.0015478228451684117
second O 0 0.00012293396866880357
mutation O 0 3.255739102314692e-06
that O 0 6.747535508111469e-07
has O 0 1.5030818758532405e-06
no O 0 2.0051165847689845e-06
effect O 0 1.6373114704038016e-05
on O 0 0.00016041527851484716
beta2m O 0 0.005042674019932747
association O 0 8.164442260749638e-05
, O 0 4.9571706767892465e-05
H63D O 1 0.9608032703399658
, O 0 2.0612822481780313e-05
was O 0 0.00010120016668224707
found O 0 5.7003030633495655e-06
in O 0 6.23451796855079e-06
eight O 0 9.410283382749185e-06
out O 0 2.048794385700603e-06
of O 0 2.4910721549531445e-05
nine O 0 0.0001033992666634731
patients O 0 1.64616994879907e-05
heterozygous O 0 3.5675234357768204e-06
for O 0 4.670505404646974e-06
the O 0 0.00011940735566895455
C282Y O 0 0.002286298433318734
mutant O 0 0.0007005691877566278
. O 0 0.0002242644695797935

In O 0 0.00010954462049994618
this O 0 6.9898114816169254e-06
report O 0 8.339698069903534e-06
, O 0 1.8621070694280206e-06
we O 0 1.3324662404556875e-06
demonstrate O 0 3.174970333930105e-05
in O 0 4.6574798034271225e-05
cultured O 0 0.0003108285600319505
293 O 0 0.0007696222164668143
cells O 0 0.00033963608439080417
overexpressing O 0 0.007278244476765394
wild O 0 0.00023580393462907523
- O 0 0.00013848431990481913
type O 0 2.864058842533268e-05
or O 0 1.8360606190981343e-05
mutant O 0 0.00026228782371617854
HFE O 0 0.019035061821341515
proteins O 0 1.2234829227963928e-05
that O 0 1.7521997506264597e-06
both O 0 2.615867060740129e-06
the O 0 4.237758184899576e-05
wild O 0 9.131487604463473e-05
- O 0 0.00011052113404730335
type O 0 7.25870777387172e-05
and O 0 0.00010578344517853111
H63D O 1 0.9998160004615784
HFE O 1 0.6496351957321167
proteins O 0 3.041073796339333e-05
form O 0 2.4411683625658043e-05
stable O 0 0.00024822723935358226
complexes O 0 8.574646926717833e-05
with O 0 5.442542715172749e-06
the O 0 0.00013695941015612334
transferrin O 0 0.0028767785988748074
receptor O 0 0.0001827648957259953
( O 0 0.00012117584992665797
TfR O 0 0.012221918441355228
) O 0 7.222245039884001e-05
. O 0 8.296166197396815e-05

The O 0 0.0010640145046636462
C282Y O 0 0.002922483952715993
mutation O 0 3.347526217112318e-05
nearly O 0 5.555738971452229e-05
completely O 0 0.00015965399506967515
prevents O 0 1.6054198567871936e-05
the O 0 2.001090979319997e-05
association O 0 1.5868679838604294e-05
of O 0 6.155626761028543e-05
the O 0 0.00016244075959548354
mutant O 0 0.0004632809432223439
HFE O 0 0.03904731571674347
protein O 0 5.3459407354239374e-05
with O 0 1.0836464753083419e-05
the O 0 0.0002799508802127093
TfR O 0 0.19851091504096985
. O 0 0.00023513089399784803

Studies O 0 0.00013707125617656857
on O 0 0.0004967331187799573
cell O 0 0.00047866234672255814
- O 0 0.00013067632971797138
associated O 0 1.1814497156592552e-05
transferrin O 0 0.00035562232369557023
at O 0 8.4792758570984e-05
37 O 0 2.1331825337256305e-05
degrees O 0 2.6516627258388326e-05
C O 0 0.00024010725610423833
suggest O 0 1.0824174751178361e-05
that O 0 1.4185583268044866e-06
the O 0 5.583458914770745e-05
overexpressed O 0 0.0019759349524974823
wild O 0 0.00011407842976041138
- O 0 0.00013553811004385352
type O 0 0.0001198241370730102
HFE O 0 0.024311622604727745
protein O 0 4.137412543059327e-05
decreases O 0 2.0594925445038825e-05
the O 0 1.928433084685821e-05
affinity O 0 1.332650390395429e-05
of O 0 8.365551184397191e-05
the O 0 0.0002660085156094283
TfR O 0 0.009329770691692829
for O 0 0.0001363958726869896
transferrin O 0 0.008995607495307922
. O 0 0.00023522281844634563

The O 0 0.003169318428263068
overexpressed O 0 0.029673177748918533
H63D O 1 0.972655177116394
protein O 0 8.369117858819664e-05
does O 0 2.816952928696992e-06
not O 0 7.855656463107152e-07
have O 0 5.328972179086122e-07
this O 0 5.927127517679764e-07
effect O 0 1.0937809747701976e-05
, O 0 2.863773033823236e-06
providing O 0 3.7659028748748824e-06
the O 0 6.425627816497581e-06
first O 0 4.790738330484601e-06
direct O 0 1.5764577483423636e-06
evidence O 0 9.944735211320221e-06
for O 0 3.0684877856401727e-06
a O 0 1.1608393833739683e-05
functional O 0 5.173315366846509e-05
consequence O 0 0.0001577115326654166
of O 0 0.00037793684168718755
the O 0 0.001102733425796032
H63D O 1 0.999964714050293
mutation O 0 9.100038005271927e-05
. O 0 8.548480400349945e-05

Addition O 0 0.00012638549378607422
of O 0 0.001180313527584076
soluble O 0 0.006407520268112421
wild O 0 0.000598398910369724
- O 0 0.0008139155106619
type O 0 0.000844139140099287
HFE O 1 0.9999984502792358
/ O 0 0.007252577692270279
beta2m O 0 0.025364095345139503
heterodimers O 0 0.004933828487992287
to O 0 0.0001902657822938636
cultured O 0 0.0005903358105570078
cells O 0 3.4763466828735545e-05
also O 0 4.9263035180047154e-06
decreased O 0 8.092409552773461e-05
the O 0 3.102608025074005e-05
apparent O 0 0.00015122105833142996
affinity O 0 2.694164140848443e-05
of O 0 0.00016717033577151597
the O 0 0.00029917762731201947
TfR O 0 0.0037046188954263926
for O 0 1.3444684554997366e-05
its O 0 1.306496142206015e-05
ligand O 0 7.17433140380308e-05
under O 0 0.00014385930262506008
steady O 0 0.0006914644036442041
- O 0 0.00010407726949779317
state O 0 5.167774361325428e-06
conditions O 0 2.2280257326201536e-05
, O 0 2.67254267782846e-06
both O 0 2.398381866441923e-06
in O 0 2.139786010957323e-05
293 O 0 0.00023421106743626297
cells O 0 3.263282269472256e-05
and O 0 1.3892110473534558e-05
in O 0 0.00019326439360156655
HeLa O 0 0.029987188056111336
cells O 0 0.00024258623307105154
. O 0 7.603276753798127e-05

Furthermore O 0 0.0003420668945182115
, O 0 1.9301129213999957e-05
at O 0 0.00011156933032907546
4 O 0 7.260043639689684e-05
degrees O 0 5.256678196019493e-05
C O 0 0.00032550535979680717
, O 0 4.253972747392254e-06
the O 0 1.6477908502565697e-05
added O 0 4.939079735777341e-05
soluble O 0 0.00021411688067018986
complex O 0 0.000543696922250092
of O 0 0.0011108096223324537
HFE O 1 0.999998927116394
/ O 0 0.007299318909645081
beta2m O 0 0.007677088025957346
inhibited O 0 0.00011554478987818584
binding O 0 6.3932070588634815e-06
of O 0 0.00010347501665819436
transferrin O 0 0.0035359517205506563
to O 0 0.00032179406844079494
HeLa O 0 0.02963290922343731
cell O 0 0.00042276008753106
TfR O 0 0.002069735201075673
in O 0 1.8983930203830823e-05
a O 0 3.440946602495387e-05
concentration O 0 0.0034572407603263855
- O 0 0.0006006365292705595
dependent O 0 3.341600313433446e-05
manner O 0 5.272065391181968e-05
. O 0 6.571676931343973e-05

Scatchard O 0 0.001908258767798543
plots O 0 9.441236761631444e-05
of O 0 9.31263857637532e-05
these O 0 7.071477284625871e-06
data O 0 8.993397386802826e-06
indicate O 0 1.100430017686449e-05
that O 0 2.393008116996498e-06
the O 0 2.9282618925208226e-05
added O 0 5.889010935788974e-05
heterodimer O 0 0.0002911895571742207
substantially O 0 6.702459359075874e-05
reduced O 0 1.0540453331486788e-05
the O 0 1.604440330993384e-05
affinity O 0 2.3722812329651788e-05
of O 0 0.00042471836786717176
TfR O 0 0.021729597821831703
for O 0 0.00025846436619758606
transferrin O 0 0.01312374696135521
. O 0 0.00028839134029112756

These O 0 5.427775704447413e-06
results O 0 2.6588045329845045e-06
establish O 0 1.234795490745455e-05
a O 0 9.782605047803372e-06
molecular O 0 6.749833119101822e-05
link O 0 0.0008232742547988892
between O 0 0.001784897642210126
HFE O 1 0.9983265995979309
and O 0 3.347986057633534e-05
a O 0 1.6422480257460847e-05
key O 0 0.00010620876855682582
protein O 0 1.6584797776886262e-05
involved O 0 1.2629882803594228e-05
in O 0 0.00014958286192268133
iron O 1 0.9986811280250549
transport O 0 0.0003745797148440033
, O 0 2.378905082878191e-05
the O 0 0.00011606954649323598
TfR O 0 0.014331634156405926
, O 0 2.56067232839996e-05
and O 0 7.2672678470553365e-06
raise O 0 2.312198375875596e-05
the O 0 1.6173524272744544e-05
possibility O 0 2.2028316379874013e-05
that O 0 1.3603792012872873e-06
alterations O 0 5.74725927435793e-05
in O 0 8.36386334412964e-06
this O 0 3.123269152638386e-06
regulatory O 0 5.322743527358398e-05
mechanism O 0 0.00013966324331704527
may O 0 3.4519140172051266e-05
play O 0 1.1718846508301795e-05
a O 0 3.222476379960426e-06
role O 0 4.094722498848569e-06
in O 0 4.831139904126758e-06
the O 0 3.9524857129435986e-05
pathogenesis O 1 0.9999940395355225
of O 1 0.9985849857330322
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999982118606567
. O 0 0.0026341232005506754

Genomic O 0 0.00017549273616168648
organization O 0 2.0741923435707577e-05
of O 0 0.00018166146764997393
the O 0 0.0010663707507774234
UBE3A O 1 0.9999973773956299
/ O 0 0.011682489886879921
E6 O 1 0.9970423579216003
- O 0 0.0018757078796625137
AP O 0 0.0007100363727658987
gene O 0 5.294866696203826e-06
and O 0 3.017350991285639e-06
related O 0 7.320582517422736e-05
pseudogenes O 0 0.0018587160157039762
. O 0 0.00034752965439110994

The O 0 0.001329190214164555
UBE3A O 0 0.039517831057310104
gene O 0 3.714031117851846e-05
encodes O 0 2.9519795134547167e-05
the O 0 8.312725549330935e-05
E6 O 0 0.03886670246720314
- O 0 0.0012088369112461805
AP O 0 0.0013620432000607252
ubiquitin O 0 0.00034966637031175196
- O 0 0.00012844186858274043
protein O 0 1.4598785128328018e-05
ligase O 0 7.234645454445854e-05
and O 0 4.764398454426555e-06
has O 0 2.232427505077794e-06
recently O 0 5.404913281381596e-06
been O 0 1.326360347775335e-06
shown O 0 1.3729459169553593e-06
to O 0 8.61756234371569e-07
be O 0 1.3545975434681168e-06
mutated O 0 5.844634142704308e-05
in O 0 0.0009516901336610317
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9989155530929565
who O 0 0.0005587522755376995
lack O 0 0.0051333243027329445
15q11 O 0 0.024966472759842873
- O 0 0.002098187804222107
q13 O 0 0.0007888091495260596
deletions O 0 0.00011165265459567308
or O 0 2.8331549401627854e-05
chromosome O 0 0.0005030077882111073
15 O 0 0.0009433131199330091
paternal O 0 0.009358767420053482
uniparental B-Disease 1 0.9999798536300659
disomy I-Disease 1 0.9996786117553711
. O 0 0.0020029444713145494

Previous O 0 0.002379664918407798
UBE3A O 0 0.06626182049512863
cDNA O 0 0.00012678984785452485
analysis O 0 2.7300138754071668e-06
has O 0 1.7286309912378783e-06
shown O 0 1.8091070614900673e-06
a O 0 4.168771283730166e-06
coding O 0 4.706095569417812e-05
region O 0 0.00011012126924470067
of O 0 0.00016323712770827115
approximately O 0 0.000386338826501742
2 O 0 0.0009966695215553045
. O 0 0.00022742380679119378

6 O 0 0.0022569794673472643
kb O 0 0.0032327226363122463
and O 0 2.845795279426966e-05
a O 0 6.54421019135043e-05
3 O 0 0.00025331618962809443
- O 0 0.0003789130423683673
untranslated O 0 0.0035618082620203495
region O 0 0.0005761818611063063
( O 0 6.0846112319268286e-05
UTR O 0 0.018590442836284637
) O 0 1.939830144692678e-05
of O 0 0.00016207314911298454
< O 0 0.0010143077233806252
50 O 0 0.00013678843970410526
bp O 0 0.0002016076323343441
, O 0 3.380357838977943e-06
whereas O 0 2.6848224479181226e-06
Northern O 0 5.060644525656244e-06
analysis O 0 4.060801472860476e-07
has O 0 1.0305600426363526e-06
indicated O 0 4.530061687546549e-06
mRNA O 0 8.760027412790805e-06
sizes O 0 1.5978325791365933e-06
of O 0 1.6914204024942592e-05
5 O 0 0.00012148638779763132
- O 0 0.0002695377334021032
8 O 0 0.0001859415351646021
kb O 0 0.003290334017947316
. O 0 0.00019938757759518921

We O 0 1.5212147445708979e-05
have O 0 3.7042278222543246e-07
analyzed O 0 3.130775212412118e-06
additional O 0 2.6044513106171507e-06
cDNA O 0 8.964932203525677e-05
clones O 0 0.0001086741904146038
and O 0 1.4692969898533192e-06
provide O 0 1.0256546829623403e-06
evidence O 0 6.884149570396403e-06
for O 0 1.6985884485620772e-06
an O 0 2.0249676708772313e-06
additional O 0 9.000748832477257e-06
0 O 0 8.958317630458623e-05
. O 0 0.0001243541919393465

5 O 0 0.0006918549770489335
kb O 0 0.0023965483997017145
of O 0 0.0010438691824674606
5 O 0 0.0010601201793178916
- O 0 0.0010831609833985567
UTR O 0 0.011727488599717617
and O 0 8.789340427028947e-06
> O 0 2.448330633342266e-05
2 O 0 3.9642516640014946e-05
kb O 0 0.0004462083161342889
of O 0 0.0002873854245990515
3 O 0 0.0012342773843556643
- O 0 0.0029799402691423893
UTR O 0 0.46181607246398926
. O 0 0.00024630752159282565

We O 0 2.024699824687559e-05
have O 0 6.424798471016402e-07
established O 0 1.2307983524806332e-05
the O 0 6.853474587842356e-06
genomic O 0 1.5909166904748417e-05
organization O 0 9.274433978134766e-06
of O 0 0.00018762703984975815
UBE3A O 0 0.04430883750319481
and O 0 6.664170541625936e-06
the O 0 7.630962500115857e-06
sequence O 0 8.4681851149071e-06
of O 0 0.0002061956620309502
intron O 0 0.008089428767561913
- O 0 0.0020391654688864946
exon O 0 0.0005252465489320457
borders O 0 4.4665946916211396e-05
. O 0 5.3331703384174034e-05

We O 0 5.498467362485826e-05
have O 0 2.389653673162684e-06
also O 0 1.6667645468260162e-06
mapped O 0 1.5822557543287985e-05
two O 0 2.4968612706288695e-06
highly O 0 3.163250221405178e-05
homologous O 0 2.750629573711194e-05
processed O 0 7.43827476981096e-05
pseudogenes O 0 0.0005004854174330831
, O 0 6.647868576692417e-05
UBE3AP1 O 1 0.9291295409202576
and O 0 0.00011640449520200491
UBE3AP2 O 1 0.989652693271637
, O 0 1.1738913599401712e-05
to O 0 1.0189947715844028e-05
chromosomes O 0 6.690336249448592e-06
2 O 0 2.989704989886377e-05
and O 0 5.138151664141333e-06
21 O 0 9.357049566460773e-05
, O 0 9.732318176247645e-06
respectively O 0 3.075060521950945e-05
, O 0 3.609228315326618e-06
and O 0 1.5599944163113832e-06
determined O 0 5.406862328527495e-06
their O 0 2.5617905521357898e-06
genomic O 0 4.953163443133235e-05
organization O 0 3.203394589945674e-05
. O 0 6.974356074351817e-05

These O 0 2.0378063709358685e-05
results O 0 1.0624519745761063e-05
will O 0 3.1191286780085647e-06
form O 0 2.0462364318518667e-06
the O 0 4.576973424263997e-06
basis O 0 1.5468481251446065e-06
for O 0 1.2943287401867565e-06
studies O 0 4.167300176050048e-06
of O 0 5.606171180261299e-05
mutation O 0 2.7520041840034537e-05
and O 0 3.852948429994285e-05
imprinting O 0 0.0014113903744146228
of O 0 0.005844649393111467
UBE3A O 1 0.9999942779541016
. O 0 0.0014734307769685984

Mutation O 0 0.00013068914995528758
spectrum O 0 0.0004113972245249897
and O 0 5.859735028934665e-05
genotype O 0 0.0003075060958508402
- O 0 0.0001876672904472798
phenotype O 0 3.6842379813606385e-06
analyses O 0 5.845434770890279e-06
in O 0 3.47713939845562e-05
Cowden B-Disease 1 0.9999992847442627
disease I-Disease 1 0.9999986886978149
and O 0 0.00019260581757407635
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.00014266047219280154
two O 0 0.00013326971384231
hamartoma B-Disease 1 0.9999998807907104
syndromes I-Disease 1 0.9999998807907104
with O 0 0.059096209704875946
germline O 1 0.9999997615814209
PTEN O 1 1.0
mutation O 0 0.0012144696665927768
. O 0 0.0006094042328186333

The O 0 0.0031512007117271423
tumour B-Disease 1 1.0
suppressor O 1 0.8577756881713867
gene O 0 0.0006163790822029114
PTEN O 0 0.02432897314429283
, O 0 1.1080024705734104e-05
which O 0 2.846724328264827e-06
maps O 0 2.203835902037099e-05
to O 0 6.0356109315762296e-05
10q23 O 0 0.004043101333081722
. O 0 0.0002567172341514379

3 O 0 0.0002503996074665338
and O 0 8.96234269021079e-06
encodes O 0 7.0848896029929165e-06
a O 0 1.0395700883236714e-05
403 O 0 1.60587460413808e-05
amino O 0 6.517696874652756e-06
acid O 0 1.3148582183930557e-05
dual O 0 3.7356108805397525e-05
specificity O 0 0.0001270985376322642
phosphatase O 0 0.0017151646316051483
( O 0 7.218395330710337e-05
protein O 0 0.00012295613123569638
tyrosine O 0 0.0001641655690036714
phosphatase O 0 0.0007784795016050339
; O 0 1.8684913811739534e-05
PTPase O 0 0.0025960637722164392
) O 0 1.0437453966005705e-05
, O 0 2.682600779735367e-06
was O 0 4.4421609345590696e-05
shown O 0 1.2793708265235182e-05
recently O 0 1.9410517779760994e-05
to O 0 4.3770701267931145e-06
play O 0 6.479298917838605e-06
a O 0 3.422164809308015e-06
broad O 0 1.4165239917929284e-05
role O 0 3.857893170788884e-05
in O 0 0.00010953156015602872
human O 0 0.0002963069418910891
malignancy B-Disease 1 0.9999204874038696
. O 0 0.00038575162761844695

Somatic O 0 0.03617793321609497
PTEN O 1 0.9891583919525146
deletions O 0 0.0012632868019863963
and O 0 3.86919746233616e-05
mutations O 0 2.6699450245359913e-05
were O 0 3.03425458696438e-05
observed O 0 2.1148433006601408e-05
in O 0 3.1244671845342964e-05
sporadic B-Disease 0 0.0009494042606092989
breast I-Disease 1 0.9668393135070801
, I-Disease 0 0.00011523449211381376
brain I-Disease 1 0.9998724460601807
, I-Disease 0 0.0002379043580731377
prostate I-Disease 1 1.0
and I-Disease 1 0.9999903440475464
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999908208847046
lines O 0 0.0006863408489152789
and O 0 1.609685023140628e-05
in O 0 1.659193185332697e-05
several O 0 2.2644131604465656e-05
primary O 0 0.000525266514159739
tumours B-Disease 1 0.9999998807907104
such O 0 7.447769894497469e-05
as O 1 0.9856101870536804
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9999988079071045

In O 0 0.0002711957204155624
addition O 0 0.00013544793182518333
, O 0 9.632665023673326e-05
PTEN O 0 0.04873939976096153
was O 0 0.00029702900792472064
identified O 0 1.2117236110498197e-05
as O 0 4.100232217751909e-06
the O 0 7.599023319926346e-06
susceptibility O 0 2.8355823815218173e-05
gene O 0 3.233676352465409e-06
for O 0 4.598779923981056e-06
two O 0 8.394478936679661e-05
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.004888677038252354
CD B-Disease 1 0.999733030796051
; O 0 0.0001840669137891382
MIM O 1 0.9839761257171631
158350 O 0 0.00178741745185107
) O 0 9.130630132858641e-06
and O 0 1.542396603326779e-05
Bannayan B-Disease 0 0.04799565672874451
- I-Disease 0 0.00351894274353981
Zonana I-Disease 1 0.9466013312339783
( I-Disease 0 0.00021271283912938088
BZS I-Disease 1 0.8743842244148254
) I-Disease 0 5.168324787518941e-05
or I-Disease 0 4.687127875513397e-05
Ruvalcaba I-Disease 0 0.009940466843545437
- I-Disease 0 0.001062539522536099
Riley I-Disease 0 0.0010902335634455085
- I-Disease 0 0.0016135097248479724
Smith I-Disease 0 0.005658529698848724
syndrome I-Disease 1 1.0
( O 0 0.0035699440632015467
MIM O 1 0.9999963045120239
153480 O 0 0.06858082115650177
) O 0 0.00024397634842898697
. O 0 0.0002166357298847288

Constitutive O 0 0.0029346810188144445
DNA O 0 0.0007430624682456255
from O 0 0.0001982847461476922
37 O 0 0.0003519322781357914
CD B-Disease 0 0.0021406440064311028
families O 0 1.2611815691343509e-05
and O 0 1.120869637816213e-05
seven O 0 7.816938159521669e-05
BZS B-Disease 0 0.06760647892951965
families O 0 1.0513628694752697e-05
was O 0 6.656978803221136e-05
screened O 0 6.245918484637514e-05
for O 0 4.042363434564322e-05
germline O 0 0.011168294586241245
PTEN O 1 0.9971278309822083
mutations O 0 0.000613953045103699
. O 0 0.0005883717676624656

PTEN O 0 0.073483407497406
mutations O 0 7.469948468497023e-05
were O 0 4.818224988412112e-05
identified O 0 1.3410854080575518e-05
in O 0 1.185907512990525e-05
30 O 0 4.512404484557919e-05
of O 0 0.00011708401871146634
37 O 0 0.00012479502765927464
( O 0 2.231323924206663e-05
81 O 0 0.00014446138811763376
% O 0 2.8058855605195276e-05
) O 0 3.323079363326542e-05
CD B-Disease 0 0.0010655715595930815
families O 0 3.793810265051434e-06
, O 0 3.7781587707286235e-06
including O 0 7.827673471183516e-06
missense O 0 0.0002625082270242274
and O 0 4.7560257371515036e-05
nonsense O 0 0.0006445941398851573
point O 0 0.0005621965974569321
mutations O 0 6.68355351081118e-05
, O 0 2.1316896891221404e-05
deletions O 0 0.0001604027347639203
, O 0 2.7834134016302414e-05
insertions O 0 0.000143749886774458
, O 0 1.253107166121481e-05
a O 0 3.48461871908512e-05
deletion O 0 0.0005432359175756574
/ O 0 0.0008466971339657903
insertion O 0 0.0002843837137334049
and O 0 7.977321365615353e-05
splice O 0 0.0012717951321974397
site O 0 0.0011037655640393496
mutations O 0 0.00019057952158618718
. O 0 0.00022347898629959673

These O 0 4.8924877773970366e-05
mutations O 0 3.0974577384768054e-05
were O 0 2.6626628823578358e-05
scattered O 0 3.635303437476978e-05
over O 0 2.409720946161542e-05
the O 0 3.4381129808025435e-05
entire O 0 0.00014032790204510093
length O 0 4.056810576003045e-05
of O 0 0.0002527774777263403
PTEN O 0 0.03885921463370323
, O 0 1.2829357729060575e-05
with O 0 1.2356344996078406e-06
the O 0 1.0846350050996989e-05
exception O 0 1.1249347153352574e-05
of O 0 3.313725028419867e-05
the O 0 5.05540992890019e-05
first O 0 3.566679515643045e-05
, O 0 6.004256192682078e-06
fourth O 0 4.35393703810405e-05
and O 0 3.1600216061633546e-06
last O 0 7.403316703857854e-05
exons O 0 0.0007999734953045845
. O 0 0.00015904591418802738

A O 0 0.00851939432322979
hot O 0 0.0026267000939697027
spot O 0 0.0006001017754897475
for O 0 8.728964894544333e-05
PTEN O 0 0.016384178772568703
mutation O 0 2.59356529568322e-05
in O 0 5.191264790482819e-05
CD B-Disease 0 0.002255978062748909
was O 0 0.00021592840494122356
identified O 0 1.4348460354085546e-05
in O 0 1.47230221045902e-05
exon O 0 7.398234447464347e-05
5 O 0 9.741520443640184e-06
that O 0 4.281851602172537e-07
contains O 0 3.187747324773227e-06
the O 0 4.068448834004812e-05
PTPase O 0 0.005352163687348366
core O 0 0.0006652348092757165
motif O 0 7.438402099069208e-05
, O 0 1.8133995354219223e-06
with O 0 5.615680152004643e-07
13 O 0 2.884162859118078e-05
of O 0 0.00010002622730098665
30 O 0 0.0001880552590591833
( O 0 1.049468573910417e-05
43 O 0 4.4309577788226306e-05
% O 0 1.6350286387023516e-05
) O 0 1.6950874851318076e-05
CD B-Disease 0 0.0008576709660701454
mutations O 0 7.494279543607263e-06
identified O 0 9.033642527356278e-06
in O 0 1.4708568414789625e-05
this O 0 1.4178376659401692e-05
exon O 0 0.000678824435453862
. O 0 7.888676191214472e-05

Seven O 0 0.0002577222476247698
of O 0 0.0003715984639711678
30 O 0 0.00025844070478342474
( O 0 2.9891318263253197e-05
23 O 0 0.0001404329959768802
% O 0 1.1828939932456706e-05
) O 0 4.76350351164001e-06
were O 0 1.1207755051145796e-05
within O 0 1.755190169205889e-05
the O 0 7.660647679585963e-05
core O 0 0.0011039853561669588
motif O 0 0.0002821177477017045
, O 0 7.67444544180762e-06
the O 0 9.137738743447699e-06
majority O 0 2.302644361407147e-06
( O 0 5.763179615314584e-06
five O 0 7.782760803820565e-06
of O 0 4.66749734187033e-05
seven O 0 6.094489071983844e-05
) O 0 3.30626494360331e-06
of O 0 2.1079084035591222e-05
which O 0 8.022522706596646e-06
were O 0 4.183331475360319e-05
missense O 0 0.0002283028297824785
mutations O 0 7.630238542333245e-05
, O 0 3.567543171811849e-05
possibly O 0 0.00015355991490650922
pointing O 0 0.00010827058576978743
to O 0 5.4598594942945056e-06
the O 0 1.1519431609485764e-05
functional O 0 1.9426737708272412e-05
significance O 0 7.989783625816926e-05
of O 0 9.06635177670978e-05
this O 0 1.93923096958315e-05
region O 0 0.0005449643940664828
. O 0 0.00010606463911244646

Germline O 0 0.18291601538658142
PTEN O 0 0.12992073595523834
mutations O 0 6.617855979129672e-05
were O 0 4.352313408162445e-05
identified O 0 1.494057596573839e-05
in O 0 6.899740583321545e-06
four O 0 3.4523227441241033e-06
of O 0 4.426300074555911e-05
seven O 0 5.218364822212607e-05
( O 0 1.115101531468099e-05
57 O 0 7.918899791548029e-05
% O 0 3.785963053815067e-05
) O 0 9.000326099339873e-05
BZS B-Disease 1 0.5232728123664856
families O 0 5.240156315267086e-05
studied O 0 0.0012181951897218823
. O 0 0.00037312647327780724

Interestingly O 0 0.0022229424212127924
, O 0 3.337676389492117e-05
none O 0 2.660178142832592e-05
of O 0 3.23673702951055e-05
these O 0 1.0098372513311915e-05
mutations O 0 3.454835314187221e-05
was O 0 0.000325463101034984
observed O 0 2.265797957079485e-05
in O 0 2.0997109459131025e-05
the O 0 0.00013804699119646102
PTPase O 0 0.03566225990653038
core O 0 0.006115105468779802
motif O 0 0.0021414358634501696
. O 0 0.00020847101404797286

It O 0 3.999474938609637e-05
is O 0 7.810365787008777e-06
also O 0 3.962962637160672e-06
worthy O 0 4.509229984250851e-05
of O 0 4.504545358940959e-05
note O 0 1.6848953237058595e-05
that O 0 1.363941237286781e-06
a O 0 1.0411040420876816e-05
single O 0 9.41374855756294e-06
nonsense O 0 0.0001160943356808275
point O 0 0.00012503002653829753
mutation O 0 1.0317812666471582e-05
, O 0 1.317340684181545e-05
R233X O 0 0.0003713956684805453
, O 0 6.830265647295164e-06
was O 0 6.127198139438406e-05
observed O 0 7.833878953533713e-06
in O 0 6.489960469480138e-06
the O 0 3.432703670114279e-05
germline O 0 0.0002910130424425006
DNA O 0 6.0183625464560464e-05
from O 0 2.2035837901057675e-05
two O 0 1.4333500075736083e-05
unrelated O 0 0.00012354538193903863
CD B-Disease 0 0.0019014158751815557
families O 0 1.609883111086674e-05
and O 0 3.0033472285140306e-05
one O 0 0.00010434140131110325
BZS B-Disease 1 0.9989792108535767
family O 0 0.00041931000305339694
. O 0 0.00022902796627022326

Genotype O 0 0.002821674570441246
- O 0 0.0008309420081786811
phenotype O 0 2.019476050918456e-05
studies O 0 4.812654879060574e-06
were O 0 6.733510417689104e-06
not O 0 1.0280685955876834e-06
performed O 0 2.6494182748137973e-05
on O 0 2.1205180019023828e-05
this O 0 1.2586779121193103e-06
small O 0 2.4191413103835657e-06
group O 0 3.838435986835975e-06
of O 0 0.00032474807812832296
BZS B-Disease 1 0.9996974468231201
families O 0 0.00011662894394248724
. O 0 0.00016843578487168998

However O 0 0.00031474808929488063
, O 0 3.919825394405052e-05
genotype O 0 0.000144271703902632
- O 0 0.00014283633208833635
phenotype O 0 1.1236931641178671e-05
analysis O 0 4.321754204283934e-06
inthe O 0 0.0007482778164558113
group O 0 1.3024530744587537e-05
of O 0 0.00028734817169606686
CD B-Disease 0 0.00892068725079298
families O 0 1.4267408914747648e-05
revealed O 0 0.00012478252756409347
two O 0 1.7935706182470312e-06
possible O 0 4.411534064274747e-06
associations O 0 3.7159854855417507e-06
worthy O 0 0.00011842265666928142
of O 0 0.00013958921772427857
follow O 0 4.167912993580103e-05
- O 0 0.00010964211105601862
up O 0 1.424459696863778e-05
in O 0 6.665492946922313e-06
independent O 0 3.721472012330196e-06
analyses O 0 3.660908623714931e-05
. O 0 7.851421105442569e-05

The O 0 0.0002703368663787842
first O 0 0.00012807387975044549
was O 0 0.00026951770996674895
an O 0 1.0757684322015848e-05
association O 0 2.221353497589007e-05
noted O 0 1.8221371647086926e-05
in O 0 5.677397439285414e-06
the O 0 1.3991802916279994e-05
group O 0 2.3007060008239932e-06
of O 0 4.527257624431513e-05
CD B-Disease 0 0.0022549647837877274
families O 0 1.233261082234094e-05
with O 0 6.20806822553277e-05
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.002634228440001607

A O 0 0.0006357838865369558
correlation O 0 4.7476336476393044e-05
was O 0 0.00018552463734522462
observed O 0 8.720176992937922e-06
between O 0 3.453603130765259e-05
the O 0 5.6973072787513956e-05
presence O 0 8.932301716413349e-05
/ O 0 0.0002053316420642659
absence O 0 0.0001597761147422716
of O 0 0.00036450091283768415
a O 0 0.0005202241591177881
PTEN O 0 0.2140161097049713
mutation O 0 1.6349928046111017e-05
and O 0 3.524531621224014e-06
the O 0 1.298994629905792e-05
type O 0 4.269369310350157e-05
of O 0 0.0003098944143857807
breast O 1 0.8759968280792236
involvement O 0 0.003717112587764859
( O 0 0.0002699528413359076
unaffected O 0 0.0013398290611803532
versus O 0 0.003833424998447299
benign O 1 0.9956821203231812
versus O 1 0.9943745136260986
malignant O 1 1.0
) O 0 0.0013221425469964743
. O 0 0.000830369011964649

Specifically O 0 7.531388837378472e-05
and O 0 1.0522656339162495e-05
more O 0 3.253889190091286e-06
directly O 0 1.5784067727508955e-05
, O 0 3.4716169921011897e-06
an O 0 3.808782594205695e-06
association O 0 2.4792036128928885e-05
was O 0 0.00021580634347628802
also O 0 4.17085084336577e-06
observed O 0 7.486336471629329e-06
between O 0 1.4787301552132703e-05
the O 0 1.212359347846359e-05
presence O 0 8.26399445941206e-06
of O 0 4.380056998343207e-05
a O 0 0.00018374915816821158
PTEN O 1 0.9991907477378845
mutation O 0 0.00012172062270110473
and O 0 0.00038019323255866766
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.036412570625543594

Secondly O 0 0.0031283230055123568
, O 0 2.8218732040841132e-05
there O 0 1.300215535593452e-05
appeared O 0 5.766105095972307e-05
to O 0 5.947193130850792e-06
be O 0 6.030428721714998e-06
an O 0 4.196597274130909e-06
interdependent O 0 0.0004729991196654737
association O 0 4.081716178916395e-05
between O 0 0.00024423186550848186
mutations O 0 6.323192064883187e-05
upstream O 0 0.000506209151353687
and O 0 7.445638402714394e-06
within O 0 1.563091791467741e-05
the O 0 8.792841254035011e-05
PTPase O 0 0.014482616446912289
core O 0 0.003143529174849391
motif O 0 0.00036549658398143947
, O 0 9.972255611501168e-06
the O 0 3.40643928211648e-05
core O 0 0.00038843342917971313
motif O 0 6.631925498368219e-05
containing O 0 9.130718353844713e-06
the O 0 1.0012508937506936e-05
majority O 0 2.4703549570403993e-06
of O 0 5.365486504160799e-05
missense O 0 0.0004970051813870668
mutations O 0 5.12079568579793e-05
, O 0 1.5171409359027166e-05
and O 0 5.65550089959288e-06
the O 0 2.498294816177804e-05
involvement O 0 5.179693107493222e-05
of O 0 7.175693463068455e-05
all O 0 2.368700188526418e-05
major O 0 0.0015144266653805971
organ O 1 0.9999918937683105
systems O 1 0.610637903213501
( O 0 0.00011096888920292258
central O 0 0.0019816718995571136
nervous O 0 0.0010533209424465895
system O 0 0.0004951235605403781
, O 0 0.0001872286811703816
thyroid O 1 1.0
, O 1 0.9108654260635376
breast O 1 1.0
, O 0 0.12996341288089752
skin O 1 0.9999995231628418
and O 1 0.9985388517379761
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 0.06753209978342056
. O 0 0.0014155766693875194

However O 0 0.0002523038419894874
, O 0 1.1725095646397676e-05
these O 0 2.2387466742657125e-06
observations O 0 1.0116918019775767e-05
would O 0 3.5309303711983375e-06
need O 0 2.9245616133266594e-06
to O 0 4.17292358179111e-06
be O 0 2.568025138316443e-06
confirmed O 0 3.872032266372116e-06
by O 0 5.708832304662792e-07
studying O 0 7.415945674438262e-06
a O 0 2.9929335596534656e-06
larger O 0 6.3614606915507466e-06
number O 0 5.003289061278338e-06
of O 0 0.00017387540719937533
CD B-Disease 0 0.008028261363506317
families O 0 6.369100447045639e-05
. O 0 0.00018244677630718797

Molecular O 0 0.05907316505908966
defects O 1 0.9998425245285034
leading O 0 0.0005935375229455531
to O 0 3.5074426705250517e-05
human O 0 6.189430132508278e-05
complement B-Disease 0 0.0010003757197409868
component I-Disease 1 0.9999994039535522
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0006251431768760085
an O 0 4.522317249211483e-05
African O 0 0.0002205994096584618
- O 0 0.00014150213974062353
American O 0 2.487506571924314e-05
family O 0 4.153506233706139e-05
. O 0 6.859233690192923e-05

Complement B-Disease 0 0.0031072604469954967
component I-Disease 1 0.9999994039535522
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.013327592983841896
C6D B-Disease 1 0.9999963045120239
) O 0 9.679403592599556e-05
was O 0 0.0005685883807018399
diagnosed O 0 0.0029055560007691383
in O 0 5.496789526659995e-05
a O 0 4.534897379926406e-05
16 O 0 0.00014845436089672148
- O 0 0.0001090789883164689
year O 0 2.40702665905701e-05
- O 0 5.9530517319217324e-05
old O 0 7.216104859253392e-05
African O 0 2.507733370293863e-05
- O 0 3.0183759008650668e-05
American O 0 4.457495833776193e-06
male O 0 2.6659556169761345e-05
with O 0 4.728308704216033e-05
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.00285366945900023

The O 0 0.000718972587492317
patients O 0 0.00011943423305638134
father O 0 0.0001537729549454525
and O 0 1.4761712918698322e-05
two O 0 1.7896709323395044e-05
brothers O 0 0.0006274516927078366
also O 0 7.04260528436862e-05
had O 0 0.0004508756974246353
C6D B-Disease 1 0.9995852112770081
, O 0 1.832002635637764e-05
but O 0 1.0234767842121073e-06
gave O 0 4.404997071105754e-06
no O 0 3.7236052321532043e-06
history O 0 0.00010303430462954566
of O 0 0.0009052149252966046
meningitis B-Disease 1 0.9999778270721436
or O 0 0.00020350769045762718
other O 0 0.00024196576850954443
neisserial B-Disease 1 0.9999942779541016
infection I-Disease 1 0.9972637891769409
. O 0 0.000610159826464951

By O 0 3.222280429326929e-05
using O 0 1.5347139196819626e-05
exon O 0 0.00014156474207993597
- O 0 1.9491242710500956e-05
specific O 0 4.3165459828742314e-07
polymerase O 0 4.817140870727599e-05
chain O 0 2.6791985874297097e-05
reaction O 0 8.404673280892894e-06
( O 0 2.1206838937359862e-05
PCR O 0 0.000138286646688357
) O 0 2.9059872758807614e-05
/ O 0 0.0001585867430549115
single O 0 3.94844391848892e-05
- O 0 0.00031317066168412566
strand O 0 6.10541901551187e-05
conformation O 0 1.0047499017673545e-05
polymorphism O 0 3.30388229485834e-06
as O 0 4.506005552684655e-06
a O 0 2.0114428025408415e-06
screening O 0 2.9911102501500864e-06
step O 0 1.8300119336345233e-05
and O 0 2.0673694507422624e-06
nucleotide O 0 5.836895070387982e-06
sequencing O 0 9.690919796412345e-06
of O 0 3.6099492717767134e-05
target O 0 2.02276623895159e-05
exons O 0 0.00015635075396858156
, O 0 4.77554840472294e-06
we O 0 1.2599160754689365e-06
determined O 0 2.705918404899421e-06
that O 0 7.675013193875202e-07
the O 0 1.6896290617296472e-05
proband O 0 0.0009629746782593429
was O 0 8.932326454669237e-05
a O 0 1.1095029549323954e-05
compound O 0 7.72674466134049e-05
heterozygote O 0 0.00014919726527296007
for O 0 1.4629444194724783e-05
two O 0 5.067606980446726e-05
C6 O 1 0.9998874664306641
gene O 0 0.0001021750649670139
mutations O 0 0.00012942790635861456
. O 0 0.00020708583178929985

The O 0 0.00030258455080911517
first O 0 9.263191896025091e-05
, O 0 1.318424165219767e-05
1195delC O 0 0.00046815734822303057
located O 0 0.00015062023885548115
in O 0 4.657901808968745e-05
exon O 0 0.00028079503681510687
7 O 0 0.00013464040239341557
, O 0 5.643905751639977e-06
is O 0 2.0511656657618005e-06
a O 0 4.2109977584914304e-06
novel O 0 1.7608097550692037e-05
mutation O 0 2.3295160644920543e-06
, O 0 1.3668346809936338e-06
while O 0 1.3017946685067727e-06
the O 0 1.0940595529973507e-05
second O 0 3.943559204344638e-05
, O 0 1.3400063835433684e-05
1936delG O 0 0.000424551370088011
in O 0 5.5191128922160715e-05
exon O 0 0.00032864033710211515
12 O 0 5.6262975704157725e-05
, O 0 3.963393737649312e-06
has O 0 1.867376226982742e-06
been O 0 3.0353664897120325e-06
described O 0 9.146396223513875e-06
before O 0 3.418239066377282e-05
to O 0 2.795141153910663e-05
cause O 0 0.00041189201874658465
C6D B-Disease 1 0.8530964255332947
in O 0 3.64156294381246e-05
an O 0 7.315805760299554e-06
unrelated O 0 0.00011212541721761227
African O 0 0.00011339635238982737
- O 0 0.00017959269462153316
American O 0 1.75582154042786e-05
individual O 0 8.03702641860582e-06
. O 0 6.161157944006845e-05

Both O 0 7.20471070962958e-05
mutations O 0 3.491863390081562e-05
result O 0 9.199958731187508e-05
in O 0 0.00022705571609549224
premature O 0 0.0016822696197777987
termination O 0 0.001404841779731214
codons O 0 0.0015492663951590657
and O 0 0.0005107757169753313
C6 O 1 0.9992399215698242
null O 0 0.0007440860499627888
alleles O 0 0.00011288464884273708
. O 0 0.00021458246919792145

Allele O 0 0.00013885163934901357
- O 0 8.576282561989501e-05
specific O 0 1.5990277688615606e-06
PCR O 0 2.1545720301219262e-05
indicated O 0 8.195470400096383e-06
that O 0 7.266743864420278e-07
the O 0 8.873884326021653e-06
probands O 0 0.0006377878016792238
two O 0 9.36860033107223e-06
brothers O 0 0.00024110863159876317
also O 0 2.3258591681951657e-05
inherited O 0 0.012757373042404652
the O 0 0.0006367826135829091
1195delC O 0 0.003178625600412488
mutation O 0 1.6607478755759075e-05
from O 0 2.838526233972516e-05
their O 0 9.20436650631018e-06
heterozygous O 0 1.8592467313283123e-05
mother O 0 3.3801276003941894e-05
and O 0 3.5290988762426423e-06
the O 0 4.6010140067664906e-05
1936delG O 0 0.00060087296878919
mutation O 0 5.019112904847134e-06
from O 0 1.7495514839538373e-05
their O 0 1.4982794709794689e-05
homozygous O 0 0.00013476511230692267
father O 0 0.0005481240805238485
. O 0 5.4012729378882796e-05
. O 0 0.00011292793351458386

PAX6 O 1 0.9821369051933289
mutations O 0 0.0006919650477357209
reviewed O 0 0.0009006233885884285
. O 0 0.00029734460986219347

Mutations O 0 0.00046919938176870346
in O 0 0.0004064147942699492
PAX6 O 0 0.13610996305942535
are O 0 1.0397178812127095e-05
responsible O 0 4.262567017576657e-05
for O 0 5.7238714362028986e-05
human O 0 0.00037392962258309126
aniridia B-Disease 1 0.9999983310699463
and O 0 3.129643664578907e-05
have O 0 4.658130364987301e-06
also O 0 3.5852488053933484e-06
been O 0 6.267352546274196e-06
found O 0 1.942632707141456e-06
in O 0 7.674503649468534e-06
patients O 0 1.7750158804119565e-05
with O 0 2.4457074687234126e-05
Peters B-Disease 1 0.9999997615814209
anomaly I-Disease 1 1.0
, O 0 0.001080693444237113
with O 1 0.9999618530273438
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999995231628418
with O 1 0.9999500513076782
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.0019292671931907535
and O 0 6.887522613396868e-05
with O 0 0.000297453225357458
isolated B-Disease 1 0.9999997615814209
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.32851845026016235

No O 0 8.53780802572146e-05
locus O 0 7.024831575108692e-05
other O 0 5.2992463679402135e-06
than O 0 9.282264727517031e-06
chromosome O 0 0.0001792867697076872
11p13 O 0 0.0007886731764301658
has O 0 1.6254161891993135e-05
been O 0 4.2178293369943276e-05
implicated O 0 0.0009155971347354352
in O 0 0.0005275362054817379
aniridia B-Disease 1 0.9999985694885254
, O 0 0.00013829140516463667
and O 0 8.407497080042958e-05
PAX6 O 1 0.9372438788414001
is O 0 3.6519995774142444e-05
clearly O 0 3.777924212045036e-05
the O 0 3.4184085961896926e-05
major O 0 0.00012016740947728977
, O 0 5.116958163853269e-06
if O 0 6.656127311543969e-07
not O 0 1.894738801411222e-07
only O 0 5.739166795137862e-07
, O 0 2.6145351057493826e-06
gene O 0 7.244723292387789e-06
responsible O 0 7.28461382095702e-05
. O 0 0.00019094219896942377

Twenty O 0 0.0023360939230769873
- O 0 0.00023229712678585202
eight O 0 1.9376224372535944e-05
percent O 0 1.3154025509720668e-05
of O 0 6.027828567312099e-05
identified O 0 0.0001305571204284206
PAX6 O 0 0.016299817711114883
mutations O 0 6.375151860993356e-05
are O 0 1.4457851648330688e-05
C O 0 0.002653794828802347
- O 0 0.0013238838873803616
T O 0 0.0009018643177114427
changes O 0 8.15011571830837e-06
at O 0 0.00019729466293938458
CpG O 0 0.0009502512984909117
dinucleotides O 0 0.0017789884004741907
, O 0 1.0739428944361862e-05
20 O 0 1.9127932318951935e-05
% O 0 3.1547135677101323e-06
are O 0 2.3067523216013797e-06
splicing O 0 6.74590773996897e-05
errors O 0 0.0003020579752046615
, O 0 1.6809439330245368e-05
and O 0 2.7426285669207573e-06
more O 0 1.2715511275018798e-06
than O 0 1.853234834925388e-06
30 O 0 2.1112520698807202e-05
% O 0 6.118902092566714e-06
are O 0 1.7045504137058742e-06
deletion O 0 0.00012797511590179056
or O 0 4.287100091460161e-05
insertion O 0 0.0005097955581732094
events O 0 0.0007743883179500699
. O 0 0.00033603020710870624

There O 0 0.000141435899422504
is O 0 1.9609075025073253e-05
a O 0 3.7782592698931694e-05
noticeably O 0 0.0006176672759465873
elevated O 0 0.0035524230916053057
level O 0 0.00027232433785684407
of O 0 0.00018969914526678622
mutation O 0 9.779770152817946e-06
in O 0 1.2915856132167391e-05
the O 0 2.5717732569319196e-05
paired O 0 1.3017539458815008e-05
domain O 0 6.716719326504972e-06
compared O 0 7.273078153957613e-06
with O 0 2.084076868413831e-06
the O 0 3.836270479951054e-05
rest O 0 6.673351163044572e-05
of O 0 7.58858586777933e-05
the O 0 0.00019131215231027454
gene O 0 0.00010816275607794523
. O 0 0.00010026191012002528

Increased O 0 0.0002274851722177118
mutation O 0 1.2245463040017057e-05
in O 0 1.7355527234030887e-05
the O 0 5.306617094902322e-05
homeodomain O 0 0.0007412935374304652
is O 0 3.448798224781058e-06
accounted O 0 7.808794180164114e-06
for O 0 1.6108497220557183e-06
by O 0 4.855926363234175e-06
the O 0 0.00011617562267929316
hypermutable O 0 0.00797304604202509
CpG O 0 0.0026018682401627302
dinucleotide O 0 0.001996232895180583
in O 0 0.00016584464174229652
codon O 0 0.00014677867875434458
240 O 0 0.00016712873184587806
. O 0 8.20430796011351e-05

Very O 0 2.5043969799298793e-05
nearly O 0 2.2941394490771927e-05
all O 0 3.966759322793223e-06
mutations O 0 1.0044854207080789e-05
appear O 0 4.3532683775993064e-05
to O 0 4.2505518649704754e-05
cause O 0 0.0003136660670861602
loss O 0 0.0003816460957750678
of O 0 0.00025931422715075314
function O 0 7.681576244067401e-05
of O 0 0.00031716993544250727
the O 0 0.00018467237532604486
mutant O 0 0.0001367255754303187
allele O 0 4.857566182181472e-06
, O 0 1.728904749143112e-06
and O 0 7.568268642899056e-07
more O 0 2.6119479912267707e-07
than O 0 9.238701181857323e-07
80 O 0 1.541086567158345e-05
% O 0 4.883847850578604e-06
of O 0 0.0001625451841391623
exonic O 0 0.0056318617425858974
substitutions O 0 0.0001681339490460232
result O 0 8.087665628409013e-05
in O 0 0.00017903085972648114
nonsense O 0 0.0015460462309420109
codons O 0 0.001794294686987996
. O 0 0.0003813678922597319

In O 0 0.0001693908852757886
a O 0 4.728326894110069e-05
gene O 0 6.381122602761025e-06
with O 0 2.030136329267407e-06
such O 0 7.605373866681475e-06
extraordinarily O 0 0.0005050608888268471
high O 0 0.00015616540622431785
sequence O 0 1.098991106118774e-05
conservation O 0 9.6217972895829e-06
throughout O 0 5.471618806041079e-06
evolution O 0 2.4800619939924218e-05
, O 0 2.271422317789984e-06
there O 0 4.919233106193133e-06
are O 0 3.266767862442066e-06
presumed O 0 0.0009887240594252944
undiscovered O 0 0.03865550458431244
missense O 0 0.0011131702922284603
mutations O 0 9.191356366500258e-05
, O 0 2.053628304565791e-05
these O 0 4.961655122315278e-06
are O 0 1.8052207906293916e-06
hypothesized O 0 9.514988050796092e-05
to O 0 8.84109249454923e-06
exist O 0 2.9866159820812754e-05
in O 0 2.2104957679403014e-05
as O 0 5.577790943789296e-05
- O 0 0.0001382014888804406
yet O 0 1.8819213437382132e-05
unidentified O 0 8.045788126764819e-05
phenotypes O 0 5.527392204385251e-05
. O 0 2.782508272503037e-05
. O 0 9.075373964151368e-05

Genetic O 0 0.0010127099230885506
heterogeneity O 0 0.0012164829531684518
and O 0 7.141193054849282e-05
penetrance O 0 0.0006538192974403501
analysis O 0 8.301593879878055e-06
of O 0 0.00013813179975841194
the O 0 0.00030844920547679067
BRCA1 O 0 0.0004721711447928101
and O 0 1.8259102944284678e-05
BRCA2 O 0 0.00029094924684613943
genes O 0 2.7988060537609272e-05
in O 0 0.0002172513195546344
breast B-Disease 1 0.998910665512085
cancer I-Disease 1 0.9988207221031189
families O 0 0.0001282214798266068
. O 0 0.00031546427635475993

The O 0 0.21692684292793274
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999295473098755
Consortium O 0 0.0019851254764944315
. O 0 0.00025100292987190187

The O 0 9.26834181882441e-05
contribution O 0 4.5074331865180284e-05
of O 0 0.0001677801919868216
BRCA1 O 0 0.0006449100328609347
and O 0 2.5026063667610288e-05
BRCA2 O 0 0.0009504315676167607
to O 0 0.0003949828096665442
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9958683252334595
assessed O 0 0.00024111942911986262
by O 0 1.6312205843860283e-05
linkage O 0 0.00016087973199319094
and O 0 5.7087299865088426e-06
mutation O 0 1.096679284273705e-06
analysis O 0 1.1610645742621273e-06
in O 0 9.7129041023436e-06
237 O 0 4.364546111901291e-05
families O 0 2.30208434004453e-06
, O 0 7.674171911276062e-07
each O 0 1.2801849891275197e-07
with O 0 5.44898000498506e-07
at O 0 5.78027029405348e-05
least O 0 2.5743170226633083e-06
four O 0 2.5132521841442212e-06
cases O 0 1.0336977538827341e-05
of O 0 0.0007643863209523261
breast B-Disease 1 0.9999977350234985
cancer I-Disease 1 0.9971924424171448
, O 0 1.70008515851805e-05
collected O 0 1.0199425560131203e-05
by O 0 5.4156612350197975e-06
the O 0 0.0004000813642051071
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9995114803314209
Consortium O 0 0.0013223453424870968
. O 0 0.00015892447845544666

Families O 0 3.605095116654411e-05
were O 0 2.8313452276051976e-05
included O 0 1.857479765021708e-05
without O 0 9.182859685097355e-06
regard O 0 2.0012415916426107e-05
to O 0 9.80946424533613e-06
the O 0 2.9882399758207612e-05
occurrence O 0 0.00013757091073784977
of O 0 0.002134684007614851
ovarian B-Disease 1 1.0
or I-Disease 0 0.0023025847040116787
other I-Disease 0 0.00114755192771554
cancers I-Disease 1 0.999998927116394
. O 0 0.001787120709195733

Overall O 0 0.0009657646878622472
, O 0 0.00014849059516564012
disease O 1 0.9998125433921814
was O 0 0.003042020369321108
linked O 0 0.0007611060864292085
to O 0 6.337993545457721e-05
BRCA1 O 0 0.00022638191876467317
in O 0 1.0246193596685771e-05
an O 0 1.8620289665705059e-06
estimated O 0 2.2818290744908154e-05
52 O 0 1.7704123820294626e-05
% O 0 3.575278697098838e-06
of O 0 5.70970842090901e-05
families O 0 1.7947128071682528e-05
, O 0 9.696059350972064e-06
to O 0 2.656833930814173e-05
BRCA2 O 0 0.0002718734904192388
in O 0 3.2645868486724794e-05
32 O 0 4.0164908568840474e-05
% O 0 7.783205546729732e-06
of O 0 8.060425170697272e-05
families O 0 1.577877083036583e-05
, O 0 8.685335160407703e-06
and O 0 2.5011725028889487e-06
to O 0 6.655799097643467e-06
neither O 0 1.783868901839014e-05
gene O 0 2.435851001791889e-06
in O 0 6.423569629987469e-06
16 O 0 3.4052180126309395e-05
% O 0 4.227265890222043e-06
( O 0 3.971252226619981e-06
95 O 0 2.6262046958436258e-05
% O 0 7.056858066789573e-06
confidence O 0 0.0002046670560957864
interval O 0 0.0002066786983050406
[ O 0 0.001623243559151888
CI O 1 0.9285501837730408
] O 0 0.000279587839031592
6 O 0 0.00010010656114900485
% O 0 1.1972391803283244e-05
- O 0 8.200068987207487e-05
28 O 0 9.985658107325435e-05
% O 0 1.2532900655060075e-05
) O 0 7.362952146650059e-06
, O 0 3.5148782444593962e-06
suggesting O 0 3.088090306846425e-05
other O 0 8.203805919038132e-06
predisposition O 0 0.0016808649525046349
genes O 0 0.0004139526863582432
. O 0 0.00042701445636339486

The O 0 0.00017522084817755967
majority O 0 1.2349486496532336e-05
( O 0 1.034437445923686e-05
81 O 0 7.862345955800265e-05
% O 0 8.01217720436398e-06
) O 0 2.818027724060812e-06
of O 0 7.963996176840737e-05
the O 0 0.0017939797835424542
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.8834885344840586e-05
were O 0 4.8705009248806164e-05
due O 0 0.00021526443015318364
to O 0 7.528616697527468e-05
BRCA1 O 0 0.00032234768150374293
, O 0 5.667757250193972e-06
with O 0 1.6523937347301398e-06
most O 0 7.914779416751117e-06
others O 0 9.744959243107587e-06
( O 0 8.261315088020638e-06
14 O 0 7.532955351052806e-05
% O 0 1.3405177014647052e-05
) O 0 1.666479693085421e-05
due O 0 0.00029556461959145963
to O 0 0.0003829524794127792
BRCA2 O 0 0.004710542503744364
. O 0 0.0005209980299696326

Conversely O 0 0.0005507029127329588
, O 0 6.041682809154736e-06
the O 0 6.314628535619704e-06
majority O 0 1.2789016636816086e-06
of O 0 1.633861211303156e-05
families O 0 7.389690836134832e-06
with O 0 8.075594450929202e-06
male B-Disease 0 0.00022259306570049375
and I-Disease 0 8.871335739968345e-05
female I-Disease 0 0.002501153852790594
breast I-Disease 1 0.9999270439147949
cancer I-Disease 1 0.9993368983268738
were O 0 0.00024896275135688484
due O 0 0.000661392929032445
to O 0 0.0001553334586787969
BRCA2 O 0 0.0007306710467673838
( O 0 3.161250788252801e-05
76 O 0 0.0003013834066223353
% O 0 6.569334072992206e-05
) O 0 6.894922262290493e-05
. O 0 0.00015164053183980286

The O 0 0.00028863150510005653
largest O 0 0.0003117779560852796
proportion O 0 5.3116596973268315e-05
( O 0 1.1807660484919325e-05
67 O 0 6.192989530973136e-05
% O 0 9.495961421635002e-06
) O 0 6.016597126290435e-06
of O 0 3.6327630368759856e-05
families O 0 6.187228336784756e-06
due O 0 0.00012853671796619892
to O 0 1.0815465429914184e-05
other O 0 3.4659667562664254e-06
genes O 0 5.794366643385729e-06
was O 0 7.389547681668773e-05
found O 0 2.0391335056046955e-06
in O 0 3.3360120141878724e-06
families O 0 8.674488753968035e-07
with O 0 9.805495437831269e-07
four O 0 5.2179302656440996e-06
or O 0 5.403666364145465e-06
five O 0 1.0674670193111524e-05
cases O 0 1.4645833289250731e-05
of O 0 0.0008580793510191143
female O 0 0.300872802734375
breast B-Disease 1 0.9999983310699463
cancer I-Disease 1 0.9999822378158569
only O 0 0.0003094353014603257
. O 0 0.00024382516858167946

These O 0 2.2656899091089144e-05
estimates O 0 1.3153925465303473e-05
were O 0 9.263667379855178e-06
not O 0 1.3979354207549477e-06
substantially O 0 3.973320053773932e-05
affected O 0 5.3399326134240255e-06
either O 0 2.2492972675536294e-06
by O 0 1.3571267345469096e-06
changing O 0 8.384859029320069e-06
the O 0 1.4432311218115501e-05
assumed O 0 0.00016302791482303292
penetrance O 0 0.0008227825746871531
model O 0 9.411935025127605e-06
for O 0 1.574019006511662e-05
BRCA1 O 0 0.0003705511335283518
or O 0 1.090879686671542e-05
by O 0 5.3219805522530805e-06
including O 0 1.3456525266519748e-05
or O 0 4.184572389931418e-05
excluding O 0 0.0003254851617384702
BRCA1 O 0 0.00108715845271945
mutation O 0 2.0349167243693955e-05
data O 0 0.00010472157737240195
. O 0 0.00013654876966029406

Among O 0 8.92152456799522e-05
those O 0 1.1225191883568186e-05
families O 0 7.1012113949109334e-06
with O 0 2.9298291337909177e-05
disease O 1 0.9999887943267822
due O 0 0.01538886409252882
to O 0 0.00041609187610447407
BRCA1 O 0 0.0007631243206560612
that O 0 6.256198048504302e-06
were O 0 1.3021662198298145e-05
tested O 0 1.2450463145796675e-05
by O 0 1.1323076023472822e-06
one O 0 1.2861744380643358e-06
of O 0 1.5644965969840996e-05
the O 0 2.4014210794121027e-05
standard O 0 1.986139795917552e-05
screening O 0 7.986887794686481e-06
methods O 0 5.305075774231227e-06
, O 0 3.013974492205307e-06
mutations O 0 3.924787051801104e-06
were O 0 1.834866634453647e-05
detected O 0 5.169616633793339e-05
in O 0 7.603589892823948e-06
the O 0 1.3341815247258637e-05
coding O 0 4.031918433611281e-05
sequence O 0 1.5488569260924123e-05
or O 0 5.610912012343761e-06
splice O 0 4.6970344556029886e-05
sites O 0 1.2844170669268351e-05
in O 0 3.575299160729628e-06
an O 0 1.5558670156679e-06
estimated O 0 1.8350207028561272e-05
63 O 0 3.8818001485196874e-05
% O 0 6.464917532866821e-06
( O 0 9.683362804935314e-06
95 O 0 9.674253669800237e-05
% O 0 6.356152152875438e-05
CI O 0 0.20777559280395508
51 O 0 0.00030347987194545567
% O 0 5.6401036999886855e-05
- O 0 0.0003499908489175141
77 O 0 0.00022113115119282156
% O 0 5.66954659007024e-05
) O 0 6.77216739859432e-05
. O 0 0.00015721769887022674

The O 0 0.0002231991820735857
estimated O 0 8.863353286869824e-05
sensitivity O 0 7.561167876701802e-05
was O 0 0.00014671137614641339
identical O 0 2.038211960098124e-06
for O 0 1.1432666724431328e-06
direct O 0 6.983808361837873e-06
sequencing O 0 1.8025759345619008e-05
and O 0 3.63390927304863e-06
other O 0 3.4044114727294073e-06
techniques O 0 0.00014338080654852092
. O 0 0.0001672301150392741

The O 0 0.00047729365178383887
penetrance O 0 0.0036036388482898474
of O 0 0.0009114583372138441
BRCA2 O 0 0.0016511949943378568
was O 0 0.00033915365929715335
estimated O 0 2.815078551066108e-05
by O 0 3.5470088732836302e-06
maximizing O 0 7.463270594598725e-05
the O 0 7.873667345847934e-05
LOD O 0 0.03736279904842377
score O 0 0.0001171581752714701
in O 0 9.843730367720127e-05
BRCA2 O 0 0.0011087148450314999
- O 0 0.00015878149133641273
mutation O 0 3.0484902708849404e-06
families O 0 1.0167863138121902e-06
, O 0 1.1894285307789687e-06
over O 0 7.028501386230346e-06
all O 0 3.5082607610092964e-06
possible O 0 3.271942478022538e-05
penetrance O 0 0.0012003376614302397
functions O 0 0.00013846028014086187
. O 0 0.0002890384930651635

The O 0 4.538886059890501e-05
estimated O 0 2.7007028620573692e-05
cumulative O 0 0.00011872908362420276
risk O 0 7.47799567761831e-05
of O 0 0.0006478806608356535
breast B-Disease 1 0.9960970282554626
cancer I-Disease 0 0.14072352647781372
reached O 0 0.0006604792433790863
28 O 0 0.00022122518566902727
% O 0 9.226848305843305e-06
( O 0 6.809322712797439e-06
95 O 0 8.544306911062449e-05
% O 0 4.795022323378362e-05
CI O 1 0.7038354277610779
9 O 0 0.0003960004250984639
% O 0 2.2523567167809233e-05
- O 0 0.00010680595732992515
44 O 0 2.5974119125748985e-05
% O 0 6.944789220142411e-06
) O 0 3.3773965242289705e-06
by O 0 5.318165221979143e-06
age O 0 0.00013219164975453168
50 O 0 4.882633948000148e-05
years O 0 4.599008752848022e-05
and O 0 5.959241207165178e-06
84 O 0 7.851092232158408e-05
% O 0 1.1742584320018068e-05
( O 0 1.3428000784188043e-05
95 O 0 8.977679681265727e-05
% O 0 5.142004374647513e-05
CI O 0 0.22924305498600006
43 O 0 0.00015768084267619997
% O 0 2.3541637347079813e-05
- O 0 7.753433601465076e-05
95 O 0 3.323802229715511e-05
% O 0 5.017188868805533e-06
) O 0 2.503210225768271e-06
by O 0 3.2479240417160327e-06
age O 0 0.00012548676750157028
70 O 0 0.00013739838323090225
years O 0 0.0004188024322502315
. O 0 0.00017403396486770362

The O 0 0.000347215827787295
corresponding O 1 0.8807913064956665
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9932740926742554
were O 0 0.0005677557201124728
0 O 0 0.00023997084645088762
. O 0 0.0001845076185418293

4 O 0 0.0004220654955133796
% O 0 1.9944647647207603e-05
( O 0 1.924176831380464e-05
95 O 0 0.0001273684756597504
% O 0 5.366279583540745e-05
CI O 0 0.027898814529180527
0 O 0 3.060157905565575e-05
% O 0 1.4090948752709664e-05
- O 0 5.35636099812109e-05
1 O 0 3.279167867731303e-05
% O 0 3.5550383472582325e-06
) O 0 1.3284657143231016e-06
by O 0 1.3622617416331195e-06
age O 0 3.846043182420544e-05
50 O 0 2.5459892640355974e-05
years O 0 5.183097528060898e-05
and O 0 5.056553163740318e-06
27 O 0 7.205933798104525e-05
% O 0 9.90890202956507e-06
( O 0 1.4464609193964861e-05
95 O 0 0.00010671932250261307
% O 0 4.104448817088269e-05
CI O 0 0.027737516909837723
0 O 0 3.454212492215447e-05
% O 0 1.6394393242080696e-05
- O 0 6.770036270609125e-05
47 O 0 2.458672497596126e-05
% O 0 6.295567345659947e-06
) O 0 3.377924713277025e-06
by O 0 2.6383604563307017e-06
age O 0 0.0001514649484306574
70 O 0 0.00019565696129575372
years O 0 0.0003627508122008294
. O 0 0.000171364052221179

The O 0 0.0004351700481493026
lifetime O 0 0.0010746036423370242
risk O 0 0.0008079034159891307
of O 0 0.02060154266655445
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999701976776123
appears O 0 0.00019918559701181948
similar O 0 4.7170451580313966e-06
to O 0 1.2131019502703566e-05
the O 0 6.63480386720039e-05
risk O 0 0.00010454158473294228
in O 0 5.67823663004674e-05
BRCA1 O 0 0.0006585583905689418
carriers O 0 2.5964063752326183e-05
, O 0 3.5869657040166203e-06
but O 0 1.107907337427605e-06
there O 0 2.1090452264616033e-06
was O 0 3.3720691135386005e-05
some O 0 1.7971834722629865e-06
suggestion O 0 1.6188925656024367e-05
of O 0 4.067215559189208e-05
a O 0 5.499206599779427e-05
lower O 0 0.00032121874392032623
risk O 0 8.446003630524501e-05
in O 0 5.498121026903391e-05
BRCA2 O 0 0.0006072827382013202
carriers O 0 3.0270866773207672e-05
< O 0 0.00016332541417796165
50 O 0 2.831907113431953e-05
years O 0 4.328278373577632e-05
of O 0 0.00013858340389560908
age O 0 0.0013906314270570874
. O 0 0.00040404716855846345

Eye B-Disease 1 0.999799907207489
movement I-Disease 0 0.0025831612292677164
abnormalities I-Disease 0 0.01879781298339367
correlate O 0 0.00018131260003428906
with O 0 2.2852738766232505e-05
genotype O 0 0.00014049083983991295
in O 0 0.00017558679974172264
autosomal O 1 0.9959034323692322
dominant O 1 0.9999935626983643
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 0.0032890350557863712

We O 0 0.0002911473857238889
compared O 0 0.000571624783333391
horizontal O 0 0.004613490309566259
eye O 0 0.01667061261832714
movements O 0 0.0009531012619845569
( O 0 0.00025607136194594204
visually O 0 0.0013849996030330658
guided O 0 0.0015789865283295512
saccades O 0 0.016065075993537903
, O 0 0.00010169585584662855
antisaccades O 0 0.004021755885332823
, O 0 2.3006596165942028e-05
and O 0 1.2477503332775086e-05
smooth O 0 0.00022323302982840687
pursuit O 0 0.00046431325608864427
) O 0 7.3283326855744235e-06
in O 0 1.1979221198998857e-05
control O 0 4.940577855450101e-05
subjects O 0 0.00015443579468410462
( O 0 1.964935836440418e-05
n O 0 0.00010014438157668337
= O 0 0.00011468157026683912
14 O 0 0.00010487957479199395
) O 0 9.400972885487135e-06
and O 0 4.650664322980447e-06
patients O 0 5.580945980909746e-06
with O 0 2.485540790075902e-06
three O 0 6.212889275047928e-06
forms O 0 3.9797669160179794e-05
of O 0 0.0021873617079108953
autosomal O 1 0.9998472929000854
dominant O 1 0.9999973773956299
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999903440475464
I I-Disease 1 0.9999992847442627
spinocerebellar B-Disease 1 0.9999949932098389
ataxias I-Disease 0 0.056512121111154556
1 I-Disease 0 0.00042789013241417706
and I-Disease 0 1.4017338799021672e-05
2 I-Disease 0 0.0001582803815836087
( O 0 4.160550452070311e-05
SCA1 B-Disease 0 0.02814570814371109
, O 0 8.237022484536283e-06
n O 0 2.8365075195324607e-05
= O 0 3.4173655876656994e-05
11 O 0 7.041275239316747e-05
; O 0 5.343972588889301e-06
SCA2 B-Disease 0 0.008215134963393211
, O 0 8.178457392205019e-06
n O 0 2.1188887330936268e-05
= O 0 3.058839138248004e-05
10 O 0 1.6730069546611048e-05
) O 0 7.1562244556844234e-06
and O 0 2.3048276489134878e-05
SCA3 B-Disease 1 0.9999998807907104
/ O 0 0.0027880563866347075
Machado B-Disease 0 0.0025289561599493027
- I-Disease 0 0.0009692688472568989
Joseph I-Disease 1 0.8885998129844666
disease I-Disease 1 0.9999964237213135
( O 0 0.00047447870019823313
MJD B-Disease 1 1.0
) O 0 5.7182736782124266e-05
( O 0 1.0819509043358266e-05
n O 0 6.092100738896988e-05
= O 0 0.00012507880455814302
16 O 0 0.0002467404992785305
) O 0 3.614844899857417e-05
. O 0 6.020813816576265e-05

In O 0 0.0015717585338279605
SCA1 B-Disease 1 0.9957190155982971
, O 0 4.1021248762262985e-05
saccade O 0 0.0001640333648538217
amplitude O 0 5.7616038247942924e-05
was O 0 8.398226054850966e-05
significantly O 0 1.780787351890467e-05
increased O 0 1.1215945960429963e-05
, O 0 4.079443442606134e-06
resulting O 0 3.0129027436487377e-05
in O 0 9.802235581446439e-05
hypermetria B-Disease 0 0.010594073683023453
. O 0 0.00024613802088424563

The O 0 0.0006798820686526597
smooth O 0 0.0008290352416224778
pursuit O 0 0.0006483450997620821
gain O 0 0.00037107893149368465
was O 0 0.001206367858685553
decreased O 0 0.0014104739530012012
. O 0 0.00020240659068804234

In O 0 0.002339895348995924
SCA2 B-Disease 1 0.998991072177887
, O 0 7.83020950620994e-05
saccade O 0 0.0003617503389250487
velocity O 0 6.70213921694085e-05
was O 0 0.0005306089296936989
markedly O 0 0.0008334543090313673
decreased O 0 0.001461512059904635
. O 0 0.00018660523346625268

The O 0 0.00015244078531395644
percentage O 0 9.52793488977477e-05
of O 0 0.00013746209151577204
errors O 0 0.0008669642847962677
in O 0 0.00024896557442843914
antisaccades O 0 0.006325875874608755
was O 0 0.00026052253087982535
greatly O 0 5.79331572225783e-05
increased O 0 1.14238800961175e-05
and O 0 3.2451841889269417e-06
was O 0 4.46286539954599e-05
significantly O 0 6.186626706039533e-06
correlated O 0 6.44583906250773e-06
with O 0 1.1950635325774783e-06
age O 0 0.0002585299371276051
at O 0 0.34707656502723694
disease O 1 0.9999998807907104
onset O 1 0.9999998807907104
. O 0 0.0032320283353328705

In O 0 0.00011377597547834739
addition O 0 1.3177001164876856e-05
, O 0 5.272569524095161e-06
a O 0 6.405840395018458e-06
correlation O 0 1.6640118701616302e-05
between O 0 0.00022625677229370922
smooth O 0 0.0007726229378022254
pursuit O 0 0.0004243982257321477
gain O 0 0.00011934088979614899
and O 0 7.291086149052717e-06
the O 0 1.6966530893114395e-05
number O 0 7.70877977629425e-06
of O 0 0.0002444447891321033
trinucleotide O 1 0.9916934370994568
repeats O 0 0.0012392675271257758
was O 0 0.0008300921181216836
found O 0 8.796732436167076e-05
. O 0 8.51103977765888e-05

In O 0 0.004855981562286615
SCA3 B-Disease 1 1.0
, O 0 0.000979976961389184
gaze B-Disease 0 0.01945546455681324
- I-Disease 0 0.003212754614651203
evoked I-Disease 0 0.0034469261299818754
nystagmus I-Disease 0 0.00226380187086761
was O 0 0.0003703308175317943
often O 0 5.185121608519694e-06
present O 0 1.671364407229703e-05
as O 0 3.703664697241038e-05
was O 0 0.0005625737248919904
saccade O 0 0.002076326636597514
hypometria O 0 0.0053778477013111115
and O 0 3.674030813272111e-05
smooth O 0 0.0003796427045017481
pursuit O 0 0.00038932968163862824
gain O 0 0.0004285251197870821
was O 0 0.0011903950944542885
markedly O 0 0.0010654295329004526
decreased O 0 0.001631733844988048
. O 0 0.00022044064826332033

Three O 0 8.649633673485368e-05
major O 0 0.00022137860651127994
criteria O 0 7.76160741224885e-05
, O 0 2.3902548491605558e-05
saccade O 0 0.0004760691663250327
amplitude O 0 0.00017798137560021132
, O 0 1.8432394426781684e-05
saccade O 0 0.00023044474073685706
velocity O 0 3.899052171618678e-05
, O 0 9.062964636541437e-06
and O 0 5.379587491916027e-06
presence O 0 4.086767876287922e-05
of O 0 0.0007160539389587939
gaze B-Disease 0 0.03203439339995384
- I-Disease 0 0.00423402339220047
evoked I-Disease 0 0.0037677790969610214
nystagmus I-Disease 0 0.0015385278966277838
, O 0 1.0421142178529408e-05
permitted O 0 6.63464516037493e-06
the O 0 1.7534168364363723e-05
correct O 0 1.7652502720011398e-05
assignment O 0 1.3549200957641006e-05
of O 0 3.9219903555931523e-05
90 O 0 5.7088043831754476e-05
% O 0 1.160415467893472e-05
of O 0 0.00013832330296281725
the O 0 0.0005008521256968379
SCA1 B-Disease 1 0.9805464148521423
, O 0 8.226580575865228e-06
90 O 0 9.137712368101347e-06
% O 0 2.3405700630974025e-06
of O 0 7.061738142510876e-05
the O 0 0.0005556160467676818
SCA2 B-Disease 1 0.998460054397583
, O 0 1.6381487512262538e-05
and O 0 3.453840463407687e-06
93 O 0 3.6753837775904685e-05
% O 0 5.092811534268549e-06
of O 0 8.109529881039634e-05
the O 0 0.0001892095897346735
patients O 0 8.460844401270151e-05
with O 0 5.198120197746903e-05
SCA3 B-Disease 1 1.0
to O 0 5.238358426140621e-05
their O 0 9.129811587627046e-06
genetically O 0 1.43794723044266e-05
confirmed O 0 9.008263077703305e-06
patient O 0 1.7473555999458767e-05
group O 0 4.4065050133212935e-06
and O 0 6.198414212121861e-06
, O 0 7.265244676091243e-06
therefore O 0 1.1645849554042798e-05
, O 0 6.2862327467883006e-06
may O 0 3.269434455432929e-05
help O 0 5.09530545969028e-05
orient O 0 0.00419408455491066
diagnoses O 0 0.0008144318126142025
of O 0 0.00446922006085515
SCA1 B-Disease 1 1.0
, O 0 0.0005297824391163886
SCA2 B-Disease 1 0.9999712705612183
, O 0 5.5272288591368124e-05
and O 0 5.582345693255775e-05
SCA3 B-Disease 1 1.0
at O 0 0.0003297670918982476
early O 0 4.407635788084008e-05
clinical O 0 3.778248719754629e-05
stages O 0 0.0003749834140762687
of O 0 0.0009174647275358438
the O 0 0.029348857700824738
diseases O 1 1.0
. O 0 0.0003134012222290039
. O 0 0.00024323980323970318

Genetic O 0 4.7958819777704775e-05
basis O 0 1.4705230569234118e-05
and O 0 5.844291990797501e-06
molecular O 0 4.9845129979075864e-05
mechanism O 0 0.0005959004047326744
for O 0 0.0034118222538381815
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999997615814209

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 0.08967214822769165
more O 0 5.4981002904241905e-05
than O 0 1.8847556930268183e-05
300 O 0 5.303612124407664e-05
, O 0 1.198976951855002e-05
000 O 0 0.00021494737302418798
sudden O 0 0.00026519037783145905
deaths O 0 2.900632898672484e-05
each O 0 1.0576454769761767e-06
year O 0 1.4945348993933294e-05
in O 0 1.2985289686184842e-05
the O 0 0.00010069325799122453
USA O 0 0.0007643863209523261
alone O 0 0.00010913766891462728
. O 0 8.906818402465433e-05

In O 0 0.0001295669499086216
approximately O 0 0.00011079569230787456
5 O 0 0.00013742093869950622
- O 0 0.00014679293963126838
12 O 0 2.733976361923851e-05
% O 0 3.7433769648487214e-06
of O 0 3.0246455935412087e-05
these O 0 8.13069345895201e-06
cases O 0 1.883152981463354e-05
, O 0 5.073720330983633e-06
there O 0 5.214398697717115e-06
are O 0 1.1980029057667707e-06
no O 0 2.7063904781243764e-05
demonstrable O 0 0.17788414657115936
cardiac O 1 0.999997615814209
or O 0 0.0035167697351425886
non O 1 0.9999569654464722
- O 1 0.9999916553497314
cardiac O 1 0.9999960660934448
causes O 0 0.00019725441234186292
to O 0 2.9588227334897965e-05
account O 0 4.681109203374945e-06
for O 0 2.621776047817548e-06
the O 0 1.887486178020481e-05
episode O 0 5.410077574197203e-05
, O 0 2.168889523090911e-06
which O 0 5.321425646798161e-07
is O 0 5.347829983293195e-07
therefore O 0 7.685216019126528e-07
classified O 0 2.4713075617910363e-05
as O 0 0.00015147289377637208
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 1.0
IVF B-Disease 1 1.0
) O 0 0.0006028020288795233
. O 0 0.00020465359557420015

A O 0 0.0005642803735099733
distinct O 0 4.0930906834546477e-05
group O 0 3.690851735882461e-05
of O 0 0.0015530303353443742
IVF B-Disease 1 1.0
patients O 0 0.00017088271852117032
has O 0 1.0423448657093104e-05
been O 0 8.110348971968051e-06
found O 0 2.1653613657690585e-06
to O 0 2.0448394479899434e-06
present O 0 1.191853061754955e-05
with O 0 6.707208740408532e-06
a O 0 0.00012239368516020477
characteristic O 0 0.0018184580840170383
electrocardiographic O 1 0.9993181228637695
pattern O 0 0.00919361226260662
. O 0 0.001064332784153521

Because O 0 0.0001579830568516627
of O 0 0.0002282371133333072
the O 0 0.00014910922618582845
small O 0 1.902182339108549e-05
size O 0 9.382325515616685e-06
of O 0 3.4049451642204076e-05
most O 0 1.4702117368869949e-05
pedigrees O 0 0.00015792912745382637
and O 0 7.816058314347174e-06
the O 0 5.046075602876954e-05
high O 0 0.000568972434848547
incidence O 0 0.0007658787653781474
of O 0 0.0006329839234240353
sudden B-Disease 0 0.019764740020036697
death I-Disease 0 0.0013300844002515078
, O 0 7.3894861998269334e-06
however O 0 2.8661911528615747e-06
, O 0 8.701010756340111e-07
molecular O 0 7.455322247551521e-06
genetic O 0 1.933733256009873e-05
studies O 0 3.316488437121734e-05
of O 0 0.0007976935594342649
IVF B-Disease 1 0.9993334412574768
have O 0 7.086653567967005e-06
not O 0 1.43740862768027e-06
yet O 0 4.6640070650028065e-06
been O 0 8.325521775987e-06
done O 0 4.396964141051285e-05
. O 0 4.808888479601592e-05

Because O 0 0.0019341709557920694
IVF B-Disease 1 1.0
causes O 1 0.9999884366989136
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.999991774559021
, O 0 6.49193607387133e-05
we O 0 9.787607268663123e-06
investigated O 0 4.372252442408353e-05
whether O 0 1.7969701730180532e-05
malfunction O 0 0.010248292237520218
of O 0 0.00020451255841180682
ion O 0 0.0004307635535951704
channels O 0 8.7773943960201e-05
could O 0 2.4823975763865747e-05
cause O 0 8.00093766883947e-05
the O 0 7.52250271034427e-05
disorder O 0 0.13036221265792847
by O 0 2.413087713648565e-05
studying O 0 5.678084562532604e-05
mutations O 0 6.823910553066526e-06
in O 0 1.3111768566886894e-05
the O 0 8.184788021026179e-05
cardiac O 0 0.00307304784655571
sodium O 0 0.0002668254019226879
channel O 0 0.0006971143302507699
gene O 0 0.00019948321278207004
SCN5A O 1 0.9183688759803772
. O 0 0.00028969618142582476

We O 0 5.055120709585026e-05
have O 0 2.767742444120813e-06
now O 0 1.16852997962269e-05
identified O 0 6.155587016110076e-06
a O 0 1.3145548109605443e-05
missense O 0 0.00017247746291104704
mutation O 0 1.2204646736790892e-05
, O 0 7.75731405155966e-06
a O 0 3.091308462899178e-05
splice O 0 0.0011272208066657186
- O 0 0.0004623322165571153
donor O 0 2.3795540982973762e-05
mutation O 0 4.242203885951312e-06
, O 0 4.69872293251683e-06
and O 0 3.867869509122102e-06
a O 0 2.376107659074478e-05
frameshift O 0 0.00027097214478999376
mutation O 0 4.031700882478617e-06
in O 0 1.0111304618476424e-05
the O 0 2.158561983378604e-05
coding O 0 0.00013723525626119226
region O 0 0.00025719741825014353
of O 0 0.000511355116032064
SCN5A O 1 0.9909013509750366
in O 0 0.0001239464763784781
three O 0 9.167959069600329e-05
IVF B-Disease 0 0.132868692278862
families O 0 2.4744369511608966e-05
. O 0 6.172248686198145e-05

We O 0 3.797063254751265e-05
show O 0 1.389499993820209e-05
that O 0 1.3092923154545133e-06
sodium O 0 6.258996108954307e-06
channels O 0 5.816379143652739e-06
with O 0 1.1222600733162835e-06
the O 0 4.456872557057068e-05
missense O 0 0.00035242733429186046
mutation O 0 1.78057343873661e-05
recover O 0 0.00044209518819116056
from O 0 3.17371086566709e-05
inactivation O 0 0.0010340632870793343
more O 0 1.5567602531518787e-05
rapidly O 0 0.00015218618500512093
than O 0 1.6886165212781634e-06
normal O 0 8.86274574440904e-06
and O 0 2.564787109804456e-06
that O 0 1.9015448060599738e-06
the O 0 4.789720333064906e-05
frameshift O 0 0.0007035791059024632
mutation O 0 1.1709808859450277e-05
causes O 0 2.9860979338991456e-05
the O 0 3.5844095691572875e-05
sodium O 0 2.6121522751054727e-05
channel O 0 1.621159208298195e-05
to O 0 4.595000973495189e-06
be O 0 4.7490516408288386e-06
non O 0 4.246565731591545e-05
- O 0 0.00017750954430084676
functional O 0 0.00017984733858611435
. O 0 0.0001515468757133931

Our O 0 8.109243208309636e-05
results O 0 5.005933417123742e-06
indicate O 0 8.943891771195922e-06
that O 0 1.5981770502548898e-06
mutations O 0 1.0333676073059905e-05
in O 0 7.029923290247098e-05
cardiac O 0 0.008834444917738438
ion O 0 0.0012601359048858285
- O 0 0.00046129070688039064
channel O 0 5.338502523954958e-05
genes O 0 1.2244704521435779e-06
contribute O 0 2.629147275001742e-06
to O 0 1.8616134411786334e-06
the O 0 1.1239952982577961e-05
risk O 0 1.921634975587949e-05
of O 0 0.00013387265789788216
developing O 0 0.0012026105541735888
IVF B-Disease 1 0.9993293285369873
. O 0 0.00011093915964011103
. O 0 0.00011047772568417713

Molecular O 0 0.000933867588173598
heterogeneity O 0 0.0020274461712688208
in O 0 0.0009487197967246175
mucopolysaccharidosis B-Disease 1 0.8949489593505859
IVA I-Disease 1 0.9992986917495728
in O 0 0.00015446305042132735
Australia O 0 1.2712002899206709e-05
and O 0 3.0216272079996997e-06
Northern O 0 2.0369086996652186e-05
Ireland O 0 3.5053126339334995e-05
: O 0 4.358799742476549e-06
nine O 0 1.3540855434257537e-05
novel O 0 2.580853833933361e-05
mutations O 0 1.044600776367588e-05
including O 0 3.964017014368437e-05
T312S O 0 0.001791868475265801
, O 0 2.34454964811448e-05
a O 0 1.7978425603359938e-05
common O 0 1.538066499051638e-05
allele O 0 1.2131597941333894e-05
that O 0 3.6614667351386743e-06
confers O 0 0.00017232721438631415
a O 0 8.411466114921495e-05
mild O 0 0.0005568178603425622
phenotype O 0 0.0005358997732400894
. O 0 0.0003510833194013685

Mucopolysaccharidosis B-Disease 1 0.9999107122421265
IVA I-Disease 1 1.0
( O 0 0.00775831937789917
MPS B-Disease 1 0.9999991655349731
IVA I-Disease 1 1.0
) O 0 0.00010510934953344986
is O 0 1.0434776413603686e-05
an O 0 1.385411451337859e-05
autosomal B-Disease 1 0.9991770386695862
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 1.0
by O 0 0.00016859325114637613
a O 0 0.000223382274270989
genetic B-Disease 1 0.999941349029541
defect I-Disease 1 0.9999990463256836
in O 0 0.0008520451956428587
N O 0 0.005831552669405937
- O 0 0.0006944609340280294
acetylgalactosamine O 0 0.0020402739755809307
- O 0 0.00023474740737583488
6 O 0 0.00031827675411477685
- O 0 0.0006408929475583136
sulfate O 0 0.0033464799635112286
sulfatase O 0 0.04844745248556137
( O 0 0.0007617103983648121
GALNS O 1 0.9998487234115601
) O 0 0.00021365477005019784
. O 0 0.00016203144332394004

Previous O 0 0.00011309592809993774
studies O 0 1.7294858480454423e-05
of O 0 0.00014199169527273625
patients O 0 3.755240686587058e-05
from O 0 4.27924569521565e-05
a O 0 3.822663347818889e-05
British O 0 5.92893993598409e-05
- O 0 9.670058352639899e-05
Irish O 0 4.269247074262239e-05
population O 0 1.104939201468369e-06
showed O 0 1.1110636478406377e-05
that O 0 1.3103466471875436e-06
the O 0 2.2293501388048753e-05
I113F O 0 0.00044524300028569996
mutation O 0 3.158846993756015e-06
is O 0 1.6226387060669367e-06
the O 0 3.6118176467425656e-06
most O 0 2.719702479225816e-06
common O 0 2.629172513479716e-06
single O 0 5.1063061619061045e-06
mutation O 0 1.0569270671112463e-05
among O 0 9.815293014980853e-05
MPS B-Disease 1 0.9999915361404419
IVA I-Disease 1 1.0
patients O 0 0.0014680161839351058
and O 0 6.368395406752825e-05
produces O 0 4.906939284410328e-05
a O 0 7.908289990155026e-05
severe O 0 0.2981458306312561
clinical O 0 0.0012537211878225207
phenotype O 0 0.000999260344542563
. O 0 0.00042013381607830524

We O 0 7.090868894010782e-05
studied O 0 0.00011721382179530337
mutations O 0 1.228530345542822e-05
in O 0 1.8371219994151033e-05
the O 0 9.023752500070259e-05
GALNS O 0 0.011661982163786888
gene O 0 4.2692990973591805e-06
from O 0 5.259717454464408e-06
23 O 0 6.945683708181605e-05
additional O 0 3.344462675158866e-05
MPS B-Disease 1 0.9925096035003662
IVA I-Disease 1 1.0
patients O 0 0.0004348481015767902
( O 0 3.6427642044145614e-05
15 O 0 6.17997648078017e-05
from O 0 1.4948114767321385e-05
Australia O 0 4.235796041029971e-06
, O 0 1.429198960067879e-06
8 O 0 9.311070243711583e-06
from O 0 5.980733931210125e-06
Northern O 0 4.725938197225332e-05
Ireland O 0 3.707601354108192e-05
) O 0 3.572674586393987e-06
, O 0 7.000298865023069e-07
with O 0 3.879621317537385e-07
various O 0 8.411240742134396e-06
clinical O 0 0.00069392379373312
phenotypes O 0 0.0038561730179935694
( O 0 0.00041546561988070607
severe O 0 0.3831932544708252
, O 0 0.00011691510735545307
16 O 0 0.00017933975323103368
cases O 0 1.8275270122103393e-05
; O 0 9.425011739949696e-06
intermediate O 0 0.00029360424377955496
, O 0 1.4727573216077872e-05
4 O 0 4.926618203171529e-05
cases O 0 1.3160124581190757e-05
; O 0 4.903373792330967e-06
mild O 0 0.00010799125448102131
, O 0 2.536610554670915e-05
3 O 0 0.0001265035243704915
cases O 0 6.568081153091043e-05
) O 0 7.25194186088629e-05
. O 0 9.384311852045357e-05

We O 0 7.658216054551303e-05
found O 0 7.469997854059329e-06
two O 0 2.3653115022170823e-06
common O 0 5.975522981316317e-06
mutations O 0 6.153884896775708e-06
that O 0 1.8660928162717028e-06
together O 0 6.081181709305383e-06
accounted O 0 2.0994226360926405e-05
for O 0 5.634043645841302e-06
32 O 0 2.514543848519679e-05
% O 0 5.4611091400147416e-06
of O 0 7.402857590932399e-05
the O 0 0.00015811112825758755
44 O 0 0.00011933872883673757
unrelated O 0 9.510198287898675e-05
alleles O 0 7.461745553882793e-06
in O 0 3.0485596653306857e-05
these O 0 1.8552947949501686e-05
patients O 0 0.0001728244824334979
. O 0 0.0002019044477492571

One O 0 0.0001028130718623288
is O 0 1.6329731806763448e-05
the O 0 7.087420817697421e-05
T312S O 0 0.0009815875673666596
mutation O 0 8.89681359694805e-06
, O 0 3.844730144919595e-06
a O 0 1.0479173397470731e-05
novel O 0 5.110873462399468e-05
mutation O 0 3.3493754472146975e-06
found O 0 3.7329496080928948e-06
exclusively O 0 1.567735853313934e-05
in O 0 2.6475845515960827e-05
milder O 0 0.00022593037283513695
patients O 0 0.00017429835861548781
. O 0 0.0002111717767547816

The O 0 0.00027732254238799214
other O 0 9.036140909302048e-06
is O 0 4.262423772161128e-06
the O 0 1.2947476534463931e-05
previously O 0 4.061017534695566e-05
described O 0 6.501930329250172e-05
I113F O 0 0.0004897353355772793
that O 0 2.715504024308757e-06
produces O 0 1.0244883924315218e-05
a O 0 6.205268437042832e-05
severe O 0 0.014667713083326817
phenotype O 0 0.0009892677189782262
. O 0 0.0004932409501634538

The O 0 0.000908658083062619
I113F O 0 0.0016473617870360613
and O 0 2.3189510102383792e-05
T312S O 0 0.00025920398184098303
mutations O 0 6.5791737142717466e-06
accounted O 0 2.5969189664465375e-05
for O 0 8.134198651532643e-06
8 O 0 7.387744699371979e-05
( O 0 6.8012232077308e-06
18 O 0 4.703914964920841e-05
% O 0 7.527257366746198e-06
) O 0 5.481667813000968e-06
and O 0 9.621851859265007e-06
6 O 0 0.00011239378363825381
( O 0 8.536773748346604e-06
14 O 0 3.845537139568478e-05
% O 0 6.184998255776009e-06
) O 0 3.660252332338132e-06
of O 0 5.693027196684852e-05
44 O 0 0.00011366048420313746
unrelated O 0 0.00017618147830944508
alleles O 0 3.075330096180551e-05
, O 0 5.5212392908288166e-05
respectively O 0 0.00034866886562667787
. O 0 0.0002878494269680232

The O 0 0.0004314075340516865
relatively O 0 0.00013820886670146137
high O 0 0.0006684535183012486
residual O 0 0.006211536005139351
GALNS O 1 0.9996838569641113
activity O 0 0.00013783590111415833
seen O 0 0.0001517611526651308
when O 0 5.451393917610403e-06
the O 0 7.930750143714249e-06
T312S O 0 0.0001669573539402336
mutant O 0 3.4439308365108445e-05
cDNA O 0 9.831010538619012e-05
is O 0 1.3747167940891813e-05
overexpressed O 0 0.0004324153997004032
in O 0 2.0841560399276204e-05
mutant O 0 0.00021193809516262263
cells O 0 1.6598025467828847e-05
provides O 0 2.0949187273799907e-06
an O 0 1.2042194157402264e-06
explanation O 0 5.0088651732949074e-06
for O 0 3.5734378798224498e-06
the O 0 0.00011969315528403968
mild O 0 0.0002708419633563608
phenotype O 0 7.469200500054285e-05
in O 0 3.402712172828615e-05
patients O 0 1.0896882486122195e-05
with O 0 2.663873146957485e-06
this O 0 9.461775334784761e-06
mutation O 0 2.8789112548111007e-05
. O 0 0.00011772011202992871

The O 0 0.00013319858408067375
distribution O 0 2.034392673522234e-05
and O 0 6.533960004162509e-06
relative O 0 1.82579351530876e-05
frequencies O 0 1.0538141395954881e-05
of O 0 7.346212078118697e-05
the O 0 0.0001344986230833456
I113F O 0 0.0015043498715385795
and O 0 2.240697904198896e-05
T312S O 0 0.000367050088243559
mutations O 0 7.567218290205346e-06
in O 0 1.0854669199034106e-05
Australia O 0 4.412594535097014e-06
corresponded O 0 1.7658379874774255e-05
to O 0 5.314717327564722e-06
those O 0 4.01412216888275e-06
observed O 0 1.774323573044967e-05
in O 0 1.8902564988820814e-05
Northern O 0 5.6754754041321576e-05
Ireland O 0 3.323916098452173e-05
and O 0 3.4320094073336804e-06
are O 0 5.119136972098204e-07
unique O 0 3.533567905833479e-06
to O 0 5.154072368895868e-06
these O 0 2.755511559371371e-06
two O 0 3.0779426651861286e-06
populations O 0 3.913700766133843e-06
, O 0 1.6232206689892337e-06
suggesting O 0 5.6193998716480564e-06
that O 0 5.245143483989523e-07
both O 0 2.0657139430113602e-06
mutations O 0 6.387418125086697e-06
were O 0 1.7830712749855593e-05
probably O 0 2.4797191144898534e-05
introduced O 0 2.681856585695641e-06
to O 0 2.0386630694702035e-06
Australia O 0 2.025678440986667e-06
by O 0 1.4847589682176476e-06
Irish O 0 6.673987809335813e-05
migrants O 0 2.6190415155724622e-05
during O 0 0.00014167399785947055
the O 0 7.878662290750071e-05
19th O 0 0.0012030223151668906
century O 0 0.0015810063341632485
. O 0 0.00021784268028568476

Haplotype O 0 0.0005342205986380577
analysis O 0 1.217097360495245e-05
using O 0 2.3919810701045208e-05
6 O 0 0.00044005614472553134
RFLPs O 0 0.0018716421909630299
provides O 0 3.3599712878640275e-06
additional O 0 1.9848125702992547e-06
data O 0 8.105886990961153e-06
that O 0 1.9656069980555912e-06
the O 0 2.9463266400853172e-05
I113F O 0 0.0003896820708177984
mutation O 0 5.258283181319712e-06
originated O 0 2.3925744244479574e-05
from O 0 9.028353815665469e-06
a O 0 1.6668007447151467e-05
common O 0 2.9655853722942993e-05
ancestor O 0 0.0009780918480828404
. O 0 0.0004027965187560767

The O 0 0.00017374646267853677
other O 0 9.016178410092834e-06
9 O 0 0.0001257699477719143
novel O 0 3.778108293772675e-05
mutations O 0 1.0033346370619256e-05
identified O 0 5.400399913924048e-06
in O 0 8.414810508838855e-06
these O 0 3.6137264487479115e-06
23 O 0 0.00012841334682889283
patients O 0 1.1683349839586299e-05
were O 0 1.0224776815448422e-05
each O 0 5.595023822024814e-07
limited O 0 2.0571112600009656e-06
to O 0 1.108904143620748e-05
a O 0 2.6133382561965846e-05
single O 0 1.520811565569602e-05
family O 0 4.084137617610395e-05
. O 0 7.573825132567436e-05

These O 0 1.4108672075963113e-05
data O 0 6.711033620376838e-06
provide O 0 1.8064728237732197e-06
further O 0 7.212021955638193e-06
evidence O 0 1.7013486285577528e-05
for O 0 6.214809673110722e-06
extensive O 0 0.0002174054825445637
allelic O 0 0.001019845250993967
heterogeneity O 0 0.0015020573046058416
in O 0 0.000667129410430789
MPS B-Disease 1 0.9962301850318909
IVA I-Disease 1 0.9999998807907104
in O 0 0.0003366371674928814
British O 0 0.0002462986158207059
- O 0 0.0006021125009283423
Irish O 0 0.0002636532881297171
patients O 0 1.773716212483123e-05
and O 0 3.0817668630334083e-06
provide O 0 2.971642516058637e-06
evidence O 0 1.4701768122904468e-05
for O 0 6.989358098508092e-06
their O 0 6.839743036834989e-06
transmission O 0 6.437182310037315e-05
to O 0 6.682028015347896e-06
Australia O 0 3.2718032798584318e-06
by O 0 1.3098007229928044e-06
British O 0 2.3635961042600684e-05
- O 0 0.00012939926818944514
Irish O 0 0.0001977564679691568
migrants O 0 5.7375887990929186e-05
. O 0 1.7811713405535556e-05
. O 0 4.683959923568182e-05

Identification O 0 9.54464849201031e-05
of O 0 0.0007377968868240714
constitutional O 0 0.007468705996870995
WT1 O 1 0.9999728202819824
mutations O 0 0.00018817975069396198
, O 0 1.793101546354592e-05
in O 0 2.138637501047924e-05
patients O 0 2.8588736313395202e-05
with O 0 1.8930637452285737e-05
isolated O 1 0.9724336266517639
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.0003547650994732976
and O 0 9.484015208727214e-06
analysis O 0 3.1587446756020654e-06
of O 0 0.00022081592760514468
genotype O 0 0.0008615008555352688
/ O 0 0.0006401155842468143
phenotype O 0 3.422139707254246e-05
correlations O 0 4.669545160140842e-05
by O 0 3.875005404552212e-06
use O 0 2.838109821823309e-06
of O 0 6.878792919451371e-05
a O 0 6.165824743220583e-05
computerized O 0 0.00038319805753417313
mutation O 0 1.7676273273536935e-05
database O 0 5.2710904128616676e-05
. O 0 0.00010334070975659415

Constitutional O 0 0.0002780312206596136
mutations O 0 4.50245788670145e-05
of O 0 0.00023833867453504354
the O 0 0.0006098574376665056
WT1 O 0 0.038297638297080994
gene O 0 1.6673413483658805e-05
, O 0 3.3517080737510696e-06
encoding O 0 1.1703825293807313e-05
a O 0 0.00010571103484835476
zinc O 0 0.05359308421611786
- O 0 0.0007298384443856776
finger O 0 0.00018372606427874416
transcription O 0 0.0001466665999032557
factor O 0 2.2176791389938444e-05
involved O 0 3.029761319339741e-05
in O 0 0.00022989764693193138
renal O 1 1.0
and O 0 0.03289512172341347
gonadal O 1 1.0
development O 0 0.003455414203926921
, O 0 2.7927271730732173e-05
are O 0 8.731567504582927e-07
found O 0 9.612144822312985e-07
in O 0 3.187565198459197e-06
most O 0 1.438343815607368e-06
patients O 0 5.035216872784076e-06
with O 0 1.260517819900997e-05
Denys B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.05227300524711609
DDS B-Disease 1 1.0
) O 0 0.00011296389129711315
, O 0 2.7833124477183446e-05
or O 0 0.00012199669436085969
diffuse B-Disease 1 0.9999960660934448
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9998917579650879
DMS B-Disease 1 1.0
) O 0 7.399730384349823e-05
associated O 0 1.7659120203461498e-05
with O 0 1.5169065591180697e-05
pseudohermaphroditism B-Disease 1 0.9999998807907104
and O 0 0.00018780546088237315
/ O 0 0.0034916286822408438
or O 0 0.0010501407086849213
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 0.002442830242216587
WT B-Disease 1 0.9999995231628418
) O 0 0.00019614635675679892
. O 0 0.00012961811444256455

Most O 0 0.00014120532432571054
mutations O 0 0.00017877975187730044
in O 0 0.000769029138609767
DDS B-Disease 1 1.0
patients O 0 0.0012323157861828804
lie O 0 0.0022472634445875883
in O 0 0.000150040999869816
exon O 0 0.0004466430691536516
8 O 0 0.00013762654270976782
or O 0 1.7660433513810858e-05
exon O 0 0.00023207618505693972
9 O 0 0.00012756722571793944
, O 0 1.3011172086407896e-05
encoding O 0 0.0001647490862524137
zinc O 0 0.03104383870959282
finger O 0 0.0043298364616930485
2 O 0 0.001366341020911932
or O 0 0.0005470218602567911
zinc O 0 0.2845175564289093
finger O 0 0.001400109613314271
3 O 0 0.00016196964133996516
, O 0 1.0047489013231825e-05
respectively O 0 1.9542874724720605e-05
, O 0 2.633584244904341e-06
with O 0 2.1378841665864456e-06
a O 0 4.2192779801553115e-05
hot O 0 0.0005277389427646995
spot O 0 0.00025136314798146486
( O 0 2.0143153960816562e-05
R394W O 0 0.00043791887583211064
) O 0 7.3121432251355145e-06
in O 0 3.610875501180999e-05
exon O 0 0.000527343712747097
9 O 0 0.0006102155894041061
. O 0 0.00012959710147697479

We O 0 2.3198801500257105e-05
analyzed O 0 1.588377563166432e-05
a O 0 3.3763401461328613e-06
series O 0 4.803570845979266e-06
of O 0 4.5209679228719324e-05
24 O 0 0.00019821633759420365
patients O 0 2.6427334887557663e-05
, O 0 6.543456493091071e-06
10 O 0 1.4072765225137118e-05
with O 0 1.2396614692988805e-05
isolated B-Disease 0 0.002862687921151519
DMS I-Disease 1 0.9999998807907104
( O 0 0.001074555329978466
IDMS B-Disease 1 0.9999088048934937
) O 0 3.174601079081185e-05
, O 0 4.400831585371634e-06
10 O 0 1.5114092093426734e-05
with O 0 1.2367695489956532e-05
DDS B-Disease 1 0.9999990463256836
, O 0 1.898414848255925e-05
and O 0 3.956943146476988e-06
4 O 0 9.619648335501552e-05
with O 0 6.505905912490562e-05
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 0 0.3710326850414276
/ O 1 0.9999333620071411
or O 1 0.6146814227104187
WT B-Disease 1 1.0
. O 0 0.0018610478146001697

We O 0 0.0001543807447887957
report O 0 5.317823161021806e-05
WT1 O 0 0.009329295717179775
heterozygous O 0 1.6676720406394452e-05
mutations O 0 6.0202237364137545e-06
in O 0 2.67846007773187e-05
16 O 0 0.00018285222176928073
patients O 0 3.867179839289747e-05
, O 0 8.92899333848618e-06
4 O 0 5.894561763852835e-05
of O 0 9.253841562895104e-05
whom O 0 0.00016632179904263467
presented O 0 0.0006011680234223604
with O 0 0.00032606502645649016
IDMS B-Disease 1 0.9999996423721313
. O 0 0.0015417777467519045

One O 0 0.0002406252024229616
male O 0 0.00010718630801420659
and O 0 2.020899592025671e-05
two O 0 3.7443060136865824e-05
female O 0 0.001222072052769363
IDMS B-Disease 1 0.9999997615814209
patients O 0 0.0006297754007391632
with O 0 0.00038294022670015693
WT1 O 1 0.9999998807907104
mutations O 0 0.0030677581671625376
underwent O 1 0.9999804496765137
normal O 0 0.021456515416502953
puberty O 1 0.9721355438232422
. O 0 0.0004673534131143242

Two O 0 8.111083297990263e-05
mutations O 0 7.024884689599276e-05
associated O 0 6.0722763009835035e-05
with O 0 6.640594801865518e-05
IDMS B-Disease 1 0.9999406337738037
are O 0 3.998015017714351e-06
different O 0 7.386904030681762e-07
from O 0 9.165220944851171e-06
those O 0 7.2426510087097995e-06
described O 0 9.587678505340591e-05
in O 0 0.0003161646018270403
DDS B-Disease 1 1.0
patients O 0 0.0009140308829955757
. O 0 0.0003767412854358554

No O 0 0.0013273387448862195
WT1 O 0 0.4711824357509613
mutations O 0 0.00011732732673408464
were O 0 5.4829579312354326e-05
detected O 0 9.448512719245628e-05
in O 0 1.0674589248083066e-05
the O 0 2.2103484297986142e-05
six O 0 4.664863081416115e-05
other O 0 5.6541812227806076e-05
IDMS B-Disease 1 0.9999996423721313
patients O 0 0.00017168594058603048
, O 0 2.522775139368605e-05
suggesting O 0 5.307361061568372e-05
genetic O 0 7.498924969695508e-05
heterogeneity O 0 0.0006720676901750267
of O 0 0.0014790523564442992
this O 0 0.0007631133194081485
disease O 1 0.9999997615814209
. O 0 0.000953936018049717

We O 0 6.115569703979418e-05
analyzed O 0 0.0001599649986019358
genotype O 0 0.00037103259819559753
/ O 0 0.0005986836622469127
phenotype O 0 5.722255809814669e-05
correlations O 0 0.0001205826920340769
, O 0 6.3272273109760135e-06
on O 0 1.346537010249449e-05
the O 0 5.627884092973545e-06
basis O 0 2.040273557213368e-06
of O 0 1.5079825971042737e-05
the O 0 3.12753145408351e-05
constitution O 0 1.8130094758816995e-05
of O 0 6.638961349381134e-05
a O 0 0.00015098923176992685
WT1 O 0 0.01671692728996277
mutation O 0 7.231435574794887e-06
database O 0 1.1161866495967843e-05
of O 0 0.00019716884708032012
84 O 0 0.004332961980253458
germ O 1 0.9999971389770508
- O 0 0.0023523217532783747
line O 0 0.00021168302919249982
mutations O 0 5.351244908524677e-06
, O 0 1.4595432276109932e-06
to O 0 1.8319761920793098e-06
compare O 0 6.034905254637124e-06
the O 0 8.372569936909713e-06
distribution O 0 3.879808900819626e-06
and O 0 2.65924586528854e-06
type O 0 3.0272371077444404e-05
of O 0 0.00023699854500591755
mutations O 0 4.749304935103282e-05
, O 0 5.4570641623286065e-06
according O 0 1.7087007790905773e-06
to O 0 3.2843545341165736e-06
the O 0 2.502109964552801e-05
different O 0 6.72396163281519e-06
symptoms O 0 0.0056101055815815926
. O 0 0.0009423635783605278

This O 0 3.919077425962314e-05
demonstrated O 0 0.0002246666408609599
( O 0 1.7838809071690775e-05
1 O 0 7.146172720240429e-05
) O 0 3.984761860920116e-06
the O 0 8.941468877310399e-06
association O 0 6.3316579144157e-06
between O 0 3.634838867583312e-05
mutations O 0 1.0456930795044173e-05
in O 0 3.4040782338706776e-05
exons O 0 0.0001715419493848458
8 O 0 8.695599535712972e-05
and O 0 1.6500396668561734e-05
9 O 0 0.00033656947198323905
and O 0 7.879061013227329e-05
DMS B-Disease 1 0.9973405003547668
; O 0 1.77606416400522e-05
( O 0 1.3118297829350922e-05
2 O 0 0.00012451151269488037
) O 0 8.810539839032572e-06
among O 0 1.330971372226486e-05
patients O 0 3.6263634683564305e-05
with O 0 7.323619502130896e-05
DMS B-Disease 1 0.9999737739562988
, O 0 4.420681216288358e-05
a O 0 1.8444174202159047e-05
higher O 0 1.827964479161892e-05
frequency O 0 7.232655661937315e-06
of O 0 5.173759564058855e-05
exon O 0 0.00018478826677892357
8 O 0 4.90459096909035e-05
mutations O 0 6.3618736021453515e-06
among O 0 9.366545782540925e-06
46 O 0 0.0001032380823744461
, O 0 5.5743763368809596e-05
XY O 0 0.035978127270936966
patients O 0 5.466355651151389e-05
with O 0 1.1549350347195286e-05
female O 0 0.0001303625467699021
phenotype O 0 2.2305537640932016e-05
than O 0 6.810043487348594e-06
among O 0 1.853927824413404e-05
46 O 0 0.00015682824596296996
, O 0 5.9688656619982794e-05
XY O 0 0.4017293155193329
patients O 0 6.791490886826068e-05
with O 0 1.1324412298563402e-05
sexual O 0 0.00021560110326390713
ambiguity O 0 0.0018859878182411194
or O 0 0.000272357341600582
male O 0 0.00031791161745786667
phenotype O 0 8.474676724290475e-05
; O 0 6.568703156517586e-06
and O 0 1.0940761967503931e-05
( O 0 1.5028072994027752e-05
3 O 0 5.017849980504252e-05
) O 0 1.6938276985456469e-06
statistically O 0 9.379572247780743e-07
significant O 0 3.025906607945217e-06
evidence O 0 1.3173344996175729e-05
that O 0 1.5143853033805499e-06
mutations O 0 3.7632103158102836e-06
in O 0 2.0367728211567737e-05
exons O 0 0.00019233915372751653
8 O 0 7.692983490414917e-05
and O 0 7.403381914627971e-06
9 O 0 9.85443766694516e-05
preferentially O 0 1.0714958989410661e-05
affect O 0 7.818481208232697e-06
amino O 0 5.279779998090817e-06
acids O 0 1.2829879096898367e-06
with O 0 4.3468094190757256e-07
different O 0 4.923523420075071e-07
functions O 0 1.4177133380144369e-05
. O 0 2.7986057830275968e-05
. O 0 6.762170960428193e-05

The O 0 0.0013252462958917022
185delAG O 0 0.007929148152470589
BRCA1 O 0 0.0011599527206271887
mutation O 0 1.3900394151278306e-05
originated O 0 3.692316386150196e-05
before O 0 1.9619212253019214e-05
the O 0 9.263542779081035e-06
dispersion O 0 3.140314220217988e-05
of O 0 8.864375558914617e-05
Jews O 0 0.0006283858674578369
in O 0 5.7201825256925076e-05
the O 0 5.185337067814544e-05
diaspora O 0 6.092588591855019e-05
and O 0 3.7135055208636913e-06
is O 0 2.400674929958768e-06
not O 0 6.375669272529194e-07
limited O 0 3.6897233712807065e-06
to O 0 3.5652068618219346e-05
Ashkenazim O 0 0.008155457675457
. O 0 0.0004685803141910583

The O 0 0.0007547918357886374
185delAG O 0 0.002848193049430847
mutation O 0 2.986769686685875e-05
in O 0 8.134817471727729e-05
BRCA1 O 0 0.0007151032332330942
is O 0 1.894439810712356e-05
detected O 0 4.7540532250422984e-05
in O 0 5.335539299267111e-06
Ashkenazi O 0 2.2062924472265877e-05
Jews O 0 4.194724533590488e-05
both O 0 6.199584277055692e-06
in O 0 4.910178540740162e-05
familial B-Disease 1 0.9997484087944031
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.001584863057360053
in O 0 9.050140215549618e-05
the O 0 5.055188012192957e-05
general O 0 2.9077617000439204e-05
population O 0 1.5216603060252964e-05
. O 0 6.155684968689457e-05

All O 0 5.013573536416516e-05
tested O 0 8.753647125558928e-05
Ashkenazi O 0 0.0001274222886422649
mutation O 0 9.723968105390668e-06
carriers O 0 7.695315616729204e-06
share O 0 3.35352433467051e-06
the O 0 2.040859908447601e-05
same O 0 8.016083484108094e-06
allelic O 0 0.00014751781418453902
pattern O 0 0.0001672849612077698
at O 0 0.00036311810254119337
the O 0 0.00017165482859127223
BRCA1 O 0 0.0007525645778514445
locus O 0 0.00022068059479352087
. O 0 0.0001248350163223222

Our O 0 0.00023543104180134833
previous O 0 4.5943583245389163e-05
study O 0 8.378457096114289e-06
showed O 0 2.4866572857717983e-05
that O 0 1.6316669189109234e-06
this O 0 1.7471039654992637e-06
Ashkenazi O 0 6.697116623399779e-05
mutation O 0 8.519833500031382e-06
also O 0 5.885389782633865e-06
occurs O 0 4.893815457762685e-06
in O 0 8.461588549835142e-06
Iraqi O 0 8.985970634967089e-05
Jews O 0 0.00012886438344139606
with O 0 6.170063443278195e-06
a O 0 2.096673233609181e-05
similar O 0 1.7696935174171813e-05
allelic O 0 0.0016169046284630895
pattern O 0 0.0032761371694505215
. O 0 0.0007455286104232073

We O 0 3.155801823595539e-05
extended O 0 1.7709375242702663e-05
our O 0 4.742950750369346e-06
analysis O 0 5.790659542981302e-07
to O 0 3.6164226457913173e-06
other O 0 5.126394626131514e-06
non O 0 8.247442747233436e-05
- O 0 0.00014454213669523597
Ashkenazi O 0 4.7697019908810034e-05
subsets O 0 3.279605516581796e-05
354 O 0 5.849160879733972e-05
of O 0 6.536414730362594e-05
Moroccan O 0 0.00023843685630708933
origin O 0 2.5056391677935608e-05
, O 0 2.070488699246198e-05
200 O 0 5.800280632684007e-05
Yemenites O 0 0.0022613380569964647
and O 0 1.01236555565265e-05
150 O 0 4.906190588371828e-05
Iranian O 0 0.00024952093372121453
Jews O 0 0.0005719349137507379
. O 0 0.0001774076808942482

Heteroduplex O 0 0.00746924988925457
analysis O 0 1.6610503735137172e-05
complemented O 0 5.730665725423023e-05
by O 0 1.6671095863785013e-06
direct O 0 3.4015101846307516e-06
DNA O 0 5.416830754256807e-05
sequencing O 0 5.5450364015996456e-05
of O 0 0.00019203661940991879
abnormally O 0 0.001049455488100648
migrating O 0 8.9262131950818e-05
bands O 0 0.0001216638702317141
were O 0 3.802038554567844e-05
employed O 0 0.00019824733317364007
. O 0 0.00017198314890265465

Four O 0 0.00010556618508417159
of O 0 0.00016327030607499182
Moroccan O 0 0.00028980031493119895
origin O 0 1.4104904039413668e-05
( O 0 1.0815630048455205e-05
1 O 0 4.726379847852513e-05
. O 0 3.877678409480723e-06
1 O 0 2.8767601179424673e-05
% O 0 8.647861250210553e-06
) O 0 4.74935995953274e-06
and O 0 4.406622792885173e-06
none O 0 4.549000004772097e-05
of O 0 0.00017507420852780342
the O 0 0.0005172566743567586
Yemenites O 0 0.011116854846477509
or O 0 4.1378229070687667e-05
Iranians O 0 0.00020686518109869212
was O 0 0.00018258531054016203
a O 0 1.1374081623216625e-05
carrier O 0 1.8508719222154468e-05
of O 0 3.671663216664456e-05
the O 0 0.00017454850603826344
185delAG O 0 0.003942469600588083
mutation O 0 7.317950803553686e-05
. O 0 0.0001319908769801259

BRCA1 O 0 0.0066678887233138084
allelic O 0 0.0011284009087830782
patterns O 0 7.745820767013356e-05
were O 0 1.7716942238621414e-05
determined O 0 7.833901690901257e-06
for O 0 2.579972488092608e-06
four O 0 5.390983005781891e-06
of O 0 1.9511253412929364e-05
these O 0 3.134922280878527e-06
individuals O 0 5.797566586807079e-07
and O 0 2.1835996903973864e-06
for O 0 3.877016297337832e-06
12 O 0 3.0859944672556594e-05
additional O 0 6.83083817420993e-06
non O 0 0.00018104138143826276
- O 0 0.0001262012228835374
Ashkenazi O 0 5.655318818753585e-05
185delAG O 0 0.00017726124497130513
mutation O 0 1.1365874570401502e-06
carriers O 0 1.165637740996317e-06
who O 0 4.511862698564073e-06
had O 0 0.00032538280356675386
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9855831861495972

Six O 0 0.0009559303289279342
non O 0 0.0014943149872124195
- O 0 0.0004830175021197647
Ashkenazi O 0 0.00010612029291223735
individuals O 0 1.8977548279508483e-06
shared O 0 2.2441878172685392e-05
the O 0 7.11481916368939e-05
common O 0 4.327023634687066e-05
Ashkenazi O 0 0.0004954558680765331
haplotype O 0 0.0007358101429417729
, O 0 3.0628063541371375e-05
four O 0 1.9243308997829445e-05
had O 0 3.7600537325488403e-05
a O 0 2.3736523871775717e-05
closely O 0 3.951408143620938e-05
related O 0 8.561745926272124e-05
pattern O 0 0.00037533443537540734
, O 0 2.0881829186691903e-05
and O 0 8.506543053954374e-06
the O 0 5.001854515285231e-05
rest O 0 8.531817002221942e-05
( O 0 8.284084287879523e-06
n O 0 5.769235212937929e-05
= O 0 0.0001379313471261412
6 O 0 0.0001288284984184429
) O 0 5.9229228099866305e-06
displayed O 0 6.556265725521371e-05
a O 0 3.266860585426912e-05
distinct O 0 0.0001032101281452924
BRCA1 O 0 0.002662582090124488
allelic O 0 0.002826921408995986
pattern O 0 0.0029664018657058477
. O 0 0.0007400434697046876

We O 0 4.906312460661866e-05
conclude O 0 9.11638344405219e-05
that O 0 2.2650606297247577e-06
the O 0 5.640953895635903e-05
185delAG O 0 0.0034550579730421305
BRCA1 O 0 0.00042260935879312456
mutation O 0 7.463197562174173e-06
occurs O 0 4.252277449268149e-06
in O 0 5.00759961141739e-06
some O 0 4.698597422247985e-06
non O 0 0.00015385817096102983
- O 0 0.00013356002455111593
Ashkenazi O 0 3.518733137752861e-05
populations O 0 1.553173319734924e-06
at O 0 1.9668856111820787e-05
rates O 0 2.5894503323797835e-06
comparable O 0 5.344737019186141e-06
with O 0 1.3017325954933767e-06
that O 0 3.971945261582732e-06
of O 0 0.00030452184728346765
Ashkenazim O 0 0.021399661898612976
. O 0 0.0007728036143817008

The O 0 0.00010797312279464677
majority O 0 6.683952506136848e-06
of O 0 9.949093509931117e-05
Jewish O 0 0.00040649116272106767
185delAG O 0 0.0026830467395484447
mutation O 0 2.695078910619486e-05
carriers O 0 1.1176886800967623e-05
have O 0 1.2589276821017847e-06
a O 0 8.627713214082178e-06
common O 0 1.8879003619076684e-05
allelic O 0 0.0006856948602944613
pattern O 0 0.0005547304754145443
, O 0 2.6981417249771766e-05
supporting O 0 8.815138426143676e-05
the O 0 0.0002554032835178077
founder O 0 0.002272309036925435
effect O 0 8.823886309983209e-05
notion O 0 8.315745071740821e-05
, O 0 5.492772743309615e-06
but O 0 1.3606828588308417e-06
dating O 0 5.184555993764661e-05
the O 0 1.1673370863718446e-05
mutations O 0 2.283844878547825e-06
origin O 0 1.3848944035999011e-06
to O 0 3.6068267945665866e-06
an O 0 1.6920631651373697e-06
earlier O 0 2.1008405383327045e-05
date O 0 4.5637036237167194e-05
than O 0 2.76912078334135e-06
currently O 0 6.906205271661747e-06
estimated O 0 7.932716107461601e-05
. O 0 0.00011392449960112572

However O 0 0.0001294113608309999
, O 0 1.1639775038929656e-05
the O 0 1.0502445547899697e-05
different O 0 9.937670029103174e-07
allelic O 0 0.00015183670620899647
pattern O 0 0.0001929329737322405
at O 0 0.00030361878452822566
the O 0 0.00011962434655288234
BRCA1 O 0 0.0003775671939365566
locus O 0 6.217203190317377e-05
even O 0 5.385988515627105e-06
in O 0 2.5629537958593573e-06
some O 0 1.4544882560585393e-06
Jewish O 0 2.771583604044281e-05
mutation O 0 6.6586435423232615e-06
carriers O 0 1.0223489880445413e-05
, O 0 2.7979972401226405e-06
might O 0 4.019715106551303e-06
suggest O 0 3.2704774639569223e-06
that O 0 6.902359359628463e-07
the O 0 1.890613384603057e-05
mutation O 0 4.518123205343727e-06
arose O 0 8.233934931922704e-05
independently O 0 2.166307604056783e-05
. O 0 1.197615983983269e-05
. O 0 3.916597052011639e-05

Crystal O 0 0.017245862632989883
structure O 0 0.0013305468019098043
of O 0 0.002950997557491064
the O 1 0.9679989218711853
hemochromatosis B-Disease 1 1.0
protein O 1 0.8369263410568237
HFE O 1 0.9999297857284546
and O 0 5.994363164063543e-05
characterization O 0 7.08760999259539e-05
of O 0 9.40090831136331e-05
its O 0 2.1524361727642827e-05
interaction O 0 1.4538430150423665e-05
with O 0 1.1616101801337209e-05
transferrin O 0 0.0025923573412001133
receptor O 0 0.00023221209994517267
. O 0 0.00012143288040533662

HFE O 1 0.9738736748695374
is O 0 0.00017527648014947772
an O 0 5.483177665155381e-05
MHC O 0 0.014755929820239544
- O 0 0.0005087737808935344
related O 0 2.996492912643589e-05
protein O 0 6.172906068968587e-06
that O 0 5.49357139334461e-07
is O 0 4.6809165610284253e-07
mutated O 0 1.7388824744557496e-06
in O 0 2.0708030206151307e-06
the O 0 6.627575203310698e-05
iron B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999998807907104

HFE O 0 0.25322216749191284
binds O 0 0.000316864054184407
to O 0 7.94652514741756e-05
transferrin O 0 0.002492963569238782
receptor O 0 0.00015762554539833218
( O 0 5.5091742979129776e-05
TfR O 0 0.003622321877628565
) O 0 8.840957889333367e-06
and O 0 2.637585566844791e-06
reduces O 0 6.704599400109146e-06
its O 0 3.818435288849287e-06
affinity O 0 1.8521803212934174e-05
for O 0 4.2402643884997815e-05
iron O 1 0.9966514706611633
- O 0 0.0014653680846095085
loaded O 0 0.0002542666916269809
transferrin O 0 0.0023510551545768976
, O 0 8.826242992654443e-05
implicating O 1 0.7947949171066284
HFE O 1 0.9999988079071045
in O 0 0.007762731984257698
iron O 1 1.0
metabolism O 0 0.2340935319662094
. O 0 0.0005403210525400937

The O 0 0.001218833844177425
2 O 0 0.0015257465420290828
. O 0 0.0002293201396241784

6 O 0 0.004783076234161854
A O 0 0.006531283259391785
crystal O 1 0.8445448279380798
structure O 0 0.01816282980144024
of O 0 0.010907995514571667
HFE O 1 0.9999772310256958
reveals O 0 0.0005025761784054339
the O 0 2.6372425054432824e-05
locations O 0 2.4201857740990818e-05
of O 0 0.0008039027452468872
hemochromatosis B-Disease 1 1.0
mutations O 0 0.0009446925250813365
and O 0 0.00022787507623434067
a O 0 0.0003519156889524311
patch O 1 0.9899367094039917
of O 0 0.0021033207885921
histidines O 0 0.09222196042537689
that O 0 1.1692479347402696e-05
could O 0 5.7408487919019535e-06
be O 0 1.4328140878205886e-06
involved O 0 4.2562778617138974e-06
in O 0 2.744807170529384e-05
pH O 0 0.0013671499909833074
- O 0 0.0003174521552864462
dependent O 0 3.080020542256534e-05
interactions O 0 2.7510046493262053e-05
. O 0 7.372290565399453e-05

We O 0 3.6883680877508596e-05
also O 0 6.390915586962365e-06
demonstrate O 0 3.7531073758145794e-05
that O 0 1.7872556782094762e-05
soluble O 0 0.002382945502176881
TfR O 0 0.053020961582660675
and O 0 0.0002661800244823098
HFE O 1 0.9861564636230469
bind O 0 0.0004828094388358295
tightly O 0 0.00016696180682629347
at O 0 5.732343561248854e-05
the O 0 2.2365409677149728e-05
basic O 0 8.106057066470385e-05
pH O 0 0.00043606889084912837
of O 0 0.00025796235422603786
the O 0 0.0007017686730250716
cell O 0 0.0005126461619511247
surface O 0 0.0003107064694631845
, O 0 1.0011965059675276e-05
but O 0 1.644643020881631e-06
not O 0 2.2383624127542134e-06
at O 0 7.866125088185072e-05
the O 0 0.00010213609493803233
acidic O 0 0.0004372743715066463
pH O 0 0.001126980292610824
of O 0 0.002165538491681218
intracellular O 0 0.006959390826523304
vesicles O 0 0.024775905534625053
. O 0 0.0013503797817975283

TfR O 1 0.9788193106651306
HFE O 1 0.8678394556045532
stoichiometry O 0 0.0015735330525785685
( O 0 8.094038639683276e-05
2 O 0 0.00018290626758243889
1 O 0 0.00012066345516359434
) O 0 8.026670002436731e-06
differs O 0 1.692499608907383e-05
from O 0 2.787381708913017e-05
TfR O 0 0.004632171243429184
transferrin O 0 0.0012667110422626138
stoichiometry O 0 0.00018286930571775883
( O 0 2.5358171114930883e-05
2 O 0 0.000149091036291793
2 O 0 0.000162824711878784
) O 0 1.0847301382455043e-05
, O 0 2.6934212655760348e-06
implying O 0 2.083832077914849e-05
a O 0 3.0466881071333773e-06
different O 0 4.682081851115072e-07
mode O 0 1.8809631001204252e-05
of O 0 5.025689097237773e-05
binding O 0 1.363403680443298e-05
for O 0 0.00010745116014732048
HFE O 1 0.9972656965255737
and O 0 0.00017363831284455955
transferrin O 0 0.0028739417903125286
to O 0 0.00014506654406432062
TfR O 0 0.012908521108329296
, O 0 1.3174338164390065e-05
consistent O 0 1.1830134099000134e-05
with O 0 1.9604101453296607e-06
our O 0 2.761094583547674e-05
demonstration O 0 0.00028601541998796165
that O 0 3.601047501433641e-05
HFE O 1 0.9561664462089539
, O 0 8.315856393892318e-05
transferrin O 0 0.0027474232483655214
, O 0 3.0209992473828606e-05
and O 0 2.8277459932724014e-05
TfR O 0 0.005147494375705719
form O 0 5.724248330807313e-05
a O 0 0.00016788803623057902
ternary O 0 0.005789351649582386
complex O 0 0.150483638048172
. O 0 0.0007886893581598997

Identification O 0 5.457215229398571e-05
of O 0 0.00019347682246007025
three O 0 3.5795048461295664e-05
novel O 0 0.00014803680824115872
mutations O 0 7.592532710987143e-06
and O 0 3.6931169233866967e-06
a O 0 1.1489763892313931e-05
high O 0 7.620494579896331e-05
frequency O 0 7.358796210610308e-06
of O 0 4.7152952902251855e-05
the O 0 9.944740304490551e-05
Arg778Leu O 0 0.0012692689197137952
mutation O 0 2.622100964799756e-06
in O 0 1.0927414223260712e-05
Korean O 0 0.0022346514742821455
patients O 0 2.7195492293685675e-05
with O 0 3.142137938993983e-05
Wilson B-Disease 1 0.9984365105628967
disease I-Disease 1 0.9999997615814209
. O 0 0.0008598865242674947

Four O 0 0.0003630146384239197
mutations O 0 0.00025199903757311404
- O 0 0.0008444110862910748
- O 0 0.0005541769205592573
R778L O 0 0.0008224258781410754
, O 0 1.1730565347534139e-05
A874V O 0 0.00034311661147512496
, O 0 9.134306310443208e-06
L1083F O 0 0.00024849342298693955
, O 0 7.229587026813533e-06
and O 0 8.048084964684676e-06
2304delC O 0 0.0010033826110884547
- O 0 0.00027586129726842046
- O 0 9.483129542786628e-05
in O 0 1.8864137018681504e-05
the O 0 9.531896648695692e-05
copper O 0 0.0056449053809046745
- O 0 8.742760110180825e-05
transporting O 0 4.9886410124599934e-05
enzyme O 0 1.1523265129653737e-05
, O 0 1.7253836631425656e-05
P O 0 0.0012454647803679109
- O 0 0.00018199086480308324
type O 0 9.892947127809748e-05
ATPase O 0 0.0004118602373637259
( O 0 9.086667705560103e-05
ATP7B O 0 0.09129709005355835
) O 0 9.103468983084895e-06
, O 0 1.0074354577227496e-06
were O 0 2.8153845050837845e-06
identified O 0 2.9866607746953378e-06
in O 0 1.547004285384901e-05
Korean O 0 0.009149818681180477
Patients O 0 3.8878057239344344e-05
with O 0 3.696628846228123e-05
Wilson B-Disease 1 0.9998655319213867
disease I-Disease 1 1.0
. O 0 0.0015233148587867618

Arg778Leu O 0 0.1294839084148407
, O 0 6.114660209277645e-05
the O 0 3.840889985440299e-05
most O 0 4.25872622145107e-06
frequently O 0 9.197600775223691e-06
reported O 0 8.170396540663205e-06
mutation O 0 1.1272769597781007e-06
of O 0 2.3420181605615653e-05
this O 0 8.785644240560941e-06
enzyme O 0 2.140522701665759e-05
, O 0 8.995310054160655e-06
was O 0 7.287837797775865e-05
found O 0 4.064221684529912e-06
in O 0 6.2127114688337315e-06
six O 0 1.3177792425267398e-05
of O 0 7.39197275834158e-05
eight O 0 0.0001733883109409362
unrelated O 0 0.00023814835003577173
patients O 0 3.9149239455582574e-05
studied O 0 0.000248575845034793
, O 0 8.572925253247377e-06
an O 0 3.010823320437339e-06
allele O 0 2.908457645389717e-06
frequency O 0 1.3203153685026336e-05
of O 0 0.00034326984314247966
37 O 0 0.0008584227762185037
. O 0 0.0002615878183860332

5 O 0 0.0004498000780586153
% O 0 4.937501944368705e-05
, O 0 1.2074683581886347e-05
which O 0 3.291290340712294e-06
is O 0 4.115773208468454e-06
considerably O 0 2.4268512788694352e-05
higher O 0 6.570727236976381e-06
than O 0 1.0564197054918623e-06
those O 0 2.392330543443677e-06
in O 0 1.2712330317299347e-05
other O 0 6.478953309851931e-06
Asian O 0 0.00015865132445469499
populations O 0 1.1360672942828387e-05
. O 0 2.7144187697558664e-05

The O 0 0.00021132123947609216
novel O 0 6.25306274741888e-05
single O 0 1.1338548574713059e-05
nucleotide O 0 3.133104837615974e-05
deletion O 0 0.00016427348600700498
, O 0 2.3807890102034435e-05
2304delC O 0 0.0010420636972412467
, O 0 2.006202339543961e-05
was O 0 0.00017397689225617796
found O 0 6.799653874622891e-06
in O 0 2.0272213077987544e-05
one O 0 1.608248749107588e-05
patient O 0 9.126002987613901e-05
. O 0 0.0001178822130896151

Since O 0 0.00022483014618046582
a O 0 1.3344538274395745e-05
mutation O 0 3.5399662010604516e-06
at O 0 7.059765630401671e-05
cDNA O 0 0.00015761246322654188
nucleotide O 0 0.0001260811841348186
2302 O 0 0.004964065738022327
( O 0 1.9256893210695125e-05
2302insC O 0 0.0006502826581709087
) O 0 8.09063385531772e-06
had O 0 1.2858166883233935e-05
been O 0 9.151727681455668e-06
previously O 0 2.410886372672394e-05
described O 0 1.8782244296744466e-05
, O 0 1.6363933355023619e-06
this O 0 7.380347710750357e-07
region O 0 3.40777805831749e-05
of O 0 7.094575266819447e-05
the O 0 0.0002854128833860159
ATP7B O 1 0.9995482563972473
gene O 0 4.690677815233357e-05
may O 0 3.129291508230381e-05
be O 0 3.423973794269841e-06
susceptible O 0 1.5890302165644243e-05
to O 0 6.313568974292139e-06
gene O 0 5.873934424016625e-05
rearrangements O 0 0.03552761673927307
causing O 1 0.9999068975448608
Wilson B-Disease 1 0.9999922513961792
disease I-Disease 1 0.9999998807907104
. O 0 0.001198053709231317

Disruption O 0 0.0037607962731271982
of O 0 0.0005861256504431367
splicing O 0 0.00026496718055568635
regulated O 0 3.7239300581859425e-05
by O 0 4.028092462249333e-06
a O 0 3.1112536817090586e-05
CUG O 0 0.11364816874265671
- O 0 0.00019112107111141086
binding O 0 7.867848580644932e-06
protein O 0 0.00016569967556279153
in O 0 0.002017070073634386
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.01055960264056921

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999557733535767
DM B-Disease 1 1.0
) O 0 0.0005144895403645933
is O 0 4.4208918552612886e-05
caused O 0 0.0001783158368198201
by O 0 1.2275711014808621e-05
a O 0 8.483675628667697e-05
CTG O 0 0.022908689454197884
expansion O 0 0.0001723357563605532
in O 0 1.0602595466480125e-05
the O 0 1.1792152690759394e-05
3 O 0 3.184285378665663e-05
untranslated O 0 0.0009753578924573958
region O 0 7.268876652233303e-05
of O 0 0.00012423946463968605
the O 0 0.0010678224498406053
DM B-Disease 1 1.0
gene O 0 0.0005495182704180479
. O 0 0.00018358227680437267

One O 0 3.7449415685841814e-05
model O 0 3.54674193658866e-05
of O 0 0.0010482999496161938
DM B-Disease 1 1.0
pathogenesis O 1 0.9999998807907104
suggests O 0 0.0003847961488645524
that O 0 8.351046744792257e-06
RNAs O 0 9.167048847302794e-05
from O 0 7.059402378217783e-06
the O 0 8.52314133226173e-06
expanded O 0 9.067797691386659e-06
allele O 0 8.763317396187631e-07
create O 0 3.453149020060664e-06
a O 0 9.371700798510574e-06
gain O 0 8.577745757065713e-05
- O 0 0.00015429581981152296
of O 0 0.00012155776494182646
- O 0 0.00015835736121516675
function O 0 7.612608442286728e-06
mutation O 0 1.749698299136071e-06
by O 0 1.1942386208829703e-06
the O 0 8.095203156699426e-06
inappropriate O 0 1.8055763575830497e-05
binding O 0 2.337861815249198e-06
of O 0 3.450137228355743e-05
proteins O 0 5.975836302241078e-06
to O 0 2.0129213226027787e-05
the O 0 0.00019366246124263853
CUG O 1 0.9976001381874084
repeats O 0 0.0013083532685413957
. O 0 0.00016765817417763174

Data O 0 0.0001156857906607911
presented O 0 0.00013910264533478767
here O 0 3.44823238265235e-05
indicate O 0 1.1402742529753596e-05
that O 0 8.108122528938111e-07
the O 0 1.0530788131291047e-05
conserved O 0 0.00011739055480575189
heterogeneous O 0 0.0009403653093613684
nuclear O 0 0.005148004740476608
ribonucleoprotein O 0 0.037647899240255356
, O 0 7.548890425823629e-05
CUG O 0 0.027269700542092323
- O 0 0.0001657069515204057
binding O 0 4.876764251093846e-06
protein O 0 2.6235113182337955e-05
( O 0 4.2649295210139826e-05
CUG O 1 0.7018312215805054
- O 0 0.0006938612787052989
BP O 0 0.0012160103069618344
) O 0 3.0025623800611356e-06
, O 0 1.9307826732983813e-06
may O 0 1.5151369552768301e-05
mediate O 0 0.0001492614537710324
the O 0 0.00023819714260753244
trans O 0 0.000838353531435132
- O 0 0.00016782594320829958
dominant O 0 5.528235487872735e-05
effect O 0 1.1045166502299253e-05
of O 0 4.497197369346395e-05
the O 0 0.0001294696266995743
RNA O 0 0.0012154370779171586
. O 0 6.052354001440108e-05

CUG O 1 0.9999724626541138
- O 0 0.012095684185624123
BP O 0 0.005201967898756266
was O 0 0.00015550386160612106
found O 0 2.8724905405397294e-06
to O 0 3.0425826480495743e-06
bind O 0 4.3131449274369515e-06
to O 0 3.889048002747586e-06
the O 0 4.842666749027558e-05
human O 0 0.00020914673223160207
cardiac O 1 0.9999977350234985
troponin O 1 0.9999972581863403
T O 1 0.9993969202041626
( O 0 0.00015420861018355936
cTNT O 0 0.003329996718093753
) O 0 1.1589268979150802e-05
pre O 0 0.0005527317989617586
- O 0 0.0002654539712239057
messenger O 0 8.244745549745858e-05
RNA O 0 6.506396312033758e-05
and O 0 2.7039654924010392e-06
regulate O 0 4.003363756055478e-06
its O 0 3.5033863241551444e-06
alternative O 0 1.4544420082529541e-05
splicing O 0 8.051614713622257e-05
. O 0 7.673069194424897e-05

Splicing O 0 0.00035910989390686154
of O 0 0.0005158759886398911
cTNT O 0 0.013930285349488258
was O 0 0.0019670696929097176
disrupted O 0 0.004024056252092123
in O 0 0.0005437820800580084
DM B-Disease 1 1.0
striated O 1 0.9931081533432007
muscle O 0 0.0014064782299101353
and O 0 6.628459959756583e-05
in O 0 7.29193925508298e-05
normal O 0 5.1522434660000727e-05
cells O 0 5.353204869606998e-06
expressing O 0 7.0347509790735785e-06
transcripts O 0 7.977260247571394e-05
that O 0 3.5348994060768746e-06
contain O 0 0.0002891060139518231
CUG O 1 0.9810282588005066
repeats O 0 0.0013397312723100185
. O 0 0.0001839574397308752

Altered O 0 0.0003380470734555274
expression O 0 2.6075376808876172e-05
of O 0 9.027212217915803e-05
genes O 0 3.4369884815532714e-05
regulated O 0 6.579709588550031e-05
posttranscriptionally O 0 0.0008513456559740007
by O 0 3.205093162250705e-05
CUG O 1 0.9996762275695801
- O 0 0.001038638991303742
BP O 0 0.0007248264155350626
therefore O 0 4.902373348159017e-06
may O 0 5.890084139537066e-06
contribute O 0 1.2500157026806846e-05
to O 0 0.00011860709491884336
DM B-Disease 1 1.0
pathogenesis O 1 0.9999997615814209
. O 0 0.00028131462750025094
. O 0 0.00016247297753579915

Identification O 0 0.00010164591367356479
of O 0 0.0004056762845721096
a O 0 0.00019838535808958113
novel O 0 0.0003061143506783992
nonsense O 0 0.00044506523408927023
mutation O 0 6.177723662403878e-06
and O 0 4.63997002952965e-06
a O 0 1.4248617844714317e-05
missense O 0 6.0269834648352116e-05
substitution O 0 1.5972376786521636e-05
in O 0 3.89436972909607e-05
the O 0 0.00013780513836536556
vasopressin O 0 0.0008161592995747924
- O 0 0.0005181755404919386
neurophysin O 0 0.002658163895830512
II O 1 0.9999938011169434
gene O 0 1.2484014405345079e-05
in O 0 5.372634859668324e-06
two O 0 1.5492723832721822e-06
Spanish O 0 1.9368208086234517e-05
kindreds O 0 0.0001480317150708288
with O 0 1.1529365110618528e-05
familial B-Disease 1 0.9999819993972778
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.4010913074016571

Familial B-Disease 1 0.9999986886978149
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9997757077217102
FNDI B-Disease 1 1.0
) O 0 3.4162247175117955e-05
is O 0 2.350624981772853e-06
an O 0 2.7311493795423303e-06
autosomal B-Disease 1 0.9024465680122375
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
caused O 1 1.0
by O 0 0.0933903232216835
deficiency O 1 1.0
in O 0 0.0028895449358969927
the O 0 0.004648561589419842
antidiuretic O 0 0.04562118276953697
hormone O 0 0.0027239241171628237
arginine O 0 0.0010344756301492453
vasopressin O 0 0.001754544209688902
( O 0 6.877061241539195e-05
AVP O 0 0.005457496736198664
) O 0 3.034445853700163e-06
encoded O 0 2.3431541649188148e-06
by O 0 2.223215233243536e-06
the O 0 7.352224929491058e-05
AVP O 0 0.030520552769303322
- O 0 0.0010191595647484064
neurophysin O 0 0.008658270351588726
II O 1 1.0
( O 0 0.0009663131204433739
AVP O 1 0.9909411072731018
- O 0 0.0019725554157048464
NPII O 0 0.029472723603248596
) O 0 1.0164169907511678e-05
gene O 0 6.361904070217861e-06
on O 0 9.198028419632465e-05
chromosome O 0 0.0007751627126708627
20p13 O 0 0.004993577487766743
. O 0 0.00029432590235956013

In O 0 0.00011612269008764997
this O 0 6.287071755650686e-06
study O 0 6.945955192350084e-06
, O 0 2.245867790406919e-06
we O 0 9.902552164930967e-07
analyzed O 0 2.7356904865882825e-06
two O 0 7.558560355391819e-07
families O 0 2.196335572079988e-06
with O 0 1.3347682397579774e-05
FNDI B-Disease 1 0.9999964237213135
using O 0 7.788692892063409e-05
direct O 0 6.254250183701515e-05
automated O 0 0.0009060009615495801
fluorescent O 0 0.00017111946363002062
, O 0 1.2496820090746041e-05
solid O 0 0.00011526988964760676
phase O 0 0.0006393830408342183
, O 0 1.8710179574554786e-05
single O 0 5.419365606940119e-06
- O 0 2.463909004291054e-05
stranded O 0 1.4912291590007953e-05
DNA O 0 3.3156366043840535e-06
sequencing O 0 2.87366310658399e-06
of O 0 4.0401664591627195e-05
PCR O 0 0.00039325508987531066
- O 0 0.0010015462758019567
amplified O 0 0.002200461458414793
AVP O 0 0.046678654849529266
- O 0 0.0016344409668818116
NPII O 0 0.033067408949136734
DNA O 0 0.00044845810043625534
. O 0 0.00010391601972514763

In O 0 0.00014190802176017314
one O 0 1.1283986168564297e-05
of O 0 4.5011871407041326e-05
the O 0 4.698087286669761e-05
families O 0 8.312003046739846e-06
, O 0 5.183362191019114e-06
affected O 0 5.485893780132756e-06
individuals O 0 9.157097906609124e-07
presented O 0 5.610588050330989e-05
a O 0 4.230042395647615e-05
novel O 0 0.00012754435010720044
nonsense O 0 0.0002098900731652975
mutation O 0 5.794554454041645e-06
in O 0 2.2769054339732975e-05
exon O 0 0.00010547240526648238
3 O 0 2.1795907741761766e-05
of O 0 2.3639748178538866e-05
the O 0 2.6781739506986924e-05
gene O 0 4.931483545078663e-06
, O 0 1.0967211210299865e-06
consisting O 0 2.615971652630833e-06
in O 0 6.5049794102378655e-06
a O 0 2.1169940737308934e-05
G O 0 0.000430625572334975
to O 0 5.333668741513975e-05
T O 0 0.0026722813490778208
transition O 0 0.0006365872686728835
at O 0 0.0006329126772470772
nucleotide O 0 0.0003137121384497732
2101 O 0 0.005139767192304134
, O 0 9.87745625025127e-06
which O 0 3.6225874282536097e-06
produces O 0 2.2732037905370817e-06
a O 0 6.027255039953161e-06
stop O 0 2.1027766706538387e-05
signal O 0 6.472007953561842e-05
in O 0 2.281393790326547e-05
codon O 0 2.711883462325204e-05
82 O 0 0.0001936070912051946
( O 0 0.0001082357921404764
Glu O 0 0.01267344318330288
) O 0 3.143421054119244e-05
of O 0 0.0006442867452278733
NPII O 1 0.999962568283081
. O 0 0.0010312824742868543

The O 0 0.0014123683795332909
premature O 0 0.0017850291915237904
termination O 0 0.0002812001039274037
eliminates O 0 0.00012636753672268242
part O 0 5.042809061706066e-05
of O 0 0.0001528710563434288
the O 0 0.00031015477725304663
C O 0 0.0014390985015779734
- O 0 0.00018008361803367734
terminal O 0 0.0002894855279009789
domain O 0 7.213826756924391e-05
of O 0 0.00033157598227262497
NPII O 1 0.9916126728057861
, O 0 1.5535242710029706e-05
including O 0 4.798420377483126e-06
a O 0 2.50761386269005e-05
cysteine O 0 4.503093441599049e-05
residue O 0 0.00012654272723011672
in O 0 1.754838740453124e-05
position O 0 2.1838684915564954e-05
85 O 0 4.777248977916315e-05
, O 0 3.8626426430710126e-06
which O 0 1.1693755368469283e-06
could O 0 1.8033108517556684e-06
be O 0 1.580359253239294e-06
involved O 0 4.151591838308377e-06
in O 0 1.2581698683789e-05
the O 0 5.812318704556674e-05
correct O 0 0.00018724794790614396
folding O 0 0.0017672813264653087
of O 0 0.0007296625408343971
the O 0 0.0022319164127111435
prohormone O 1 0.9949648976325989
. O 0 0.0009186718380078673

In O 0 0.00014868812286294997
the O 0 7.805845962138847e-05
second O 0 5.0409911636961624e-05
family O 0 9.638144547352567e-06
, O 0 2.632966470628162e-06
a O 0 8.548007826902904e-06
G279A O 0 0.00030203984351828694
substitution O 0 2.608905742818024e-05
at O 0 0.00016471499111503363
position O 0 5.289362889016047e-05
- O 0 4.4339762098388746e-05
1 O 0 2.2570075088879094e-05
of O 0 2.615298035379965e-05
the O 0 5.011030953028239e-05
signal O 0 0.00028107682010158896
peptide O 0 0.00015130083193071187
was O 0 9.029330249177292e-05
observed O 0 5.260886155156186e-06
in O 0 2.3084380700311158e-06
all O 0 1.6326848708558828e-06
affected O 0 1.3302074876264669e-05
individuals O 0 6.258918801904656e-06
. O 0 0.00011737846944015473

This O 0 7.163960981415585e-05
missense O 0 0.0006668624118901789
mutation O 0 2.2781499865232036e-05
, O 0 1.5457375411642715e-05
which O 0 2.316762947884854e-05
replaces O 0 0.0011709153186529875
Ala O 0 0.00374281476251781
with O 0 4.304843605495989e-05
Thr O 0 0.4419096112251282
, O 0 2.144302379747387e-05
is O 0 6.591715646209195e-06
frequent O 0 2.2276115487329662e-05
among O 0 0.00018379157700110227
FNDI B-Disease 1 1.0
patients O 0 0.00026554608484730124
and O 0 2.0434306861716323e-05
is O 0 1.54672688950086e-05
thought O 0 8.259173227997962e-06
to O 0 3.1647534797230037e-06
reduce O 0 8.37930383568164e-06
the O 0 2.5165349143208005e-05
efficiency O 0 2.5460281904088333e-05
of O 0 5.3251405915943906e-05
cleavage O 0 0.0004569428856484592
by O 0 3.0125953344395384e-05
signal O 0 0.0012064138427376747
peptidases O 0 0.004830175545066595
. O 0 7.192532939370722e-05
. O 0 8.632643584860489e-05

Genetic O 0 0.00042256969027221203
heterogeneity O 0 0.001265349448658526
of O 0 0.013187428005039692
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 9.449270146433264e-05
due O 0 0.0006185258971527219
to O 0 0.00015819650434423238
TWIST O 0 0.00800749659538269
and O 0 0.00015003813314251602
FGFR O 1 0.9999240636825562
mutations O 0 0.0004888451076112688
. O 0 0.0003853506059385836

Thirty O 0 0.011614745482802391
- O 0 0.0011471222387626767
two O 0 1.5358706150436774e-05
unrelated O 0 5.954685912001878e-05
patients O 0 5.312052053341176e-06
with O 0 1.3825941778122797e-06
features O 0 2.7539366783457808e-05
of O 0 0.002776609268039465
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.249627818353474e-05
a O 0 3.887876300723292e-05
common O 0 7.116013875929639e-05
autosomal B-Disease 0 0.03299492970108986
dominant I-Disease 1 0.9997876286506653
condition I-Disease 1 0.9999997615814209
of O 1 1.0
craniosynostosis B-Disease 1 1.0
and O 1 1.0
limb B-Disease 1 1.0
anomalies I-Disease 1 1.0
, O 0 0.00013802475586999208
were O 0 2.985340506711509e-05
screened O 0 4.164385245530866e-05
for O 0 6.877745363453869e-06
mutations O 0 1.5174332474998664e-05
in O 0 7.768397335894406e-05
TWIST O 0 0.0030287448316812515
, O 0 7.72824787418358e-05
FGFR2 O 1 0.9947876930236816
, O 0 6.29525602562353e-05
and O 0 8.238363807322457e-05
FGFR3 O 1 0.9999396800994873
. O 0 0.0006628837436437607

Nine O 0 0.000768192287068814
novel O 0 0.0001878412876976654
and O 0 1.3722333278565202e-05
three O 0 2.0913495973218232e-05
recurrent O 0 0.0017674502450972795
TWIST O 0 0.004988578148186207
mutations O 0 4.5313739974517375e-05
were O 0 4.4276806875132024e-05
found O 0 1.3821215361531358e-05
in O 0 2.3633167074876837e-05
12 O 0 0.00012299927766434848
families O 0 2.2222964616958052e-05
. O 0 9.333709749625996e-05

Seven O 0 0.00010741293954197317
families O 0 5.293059075484052e-06
were O 0 9.172365025733598e-06
found O 0 5.057763701188378e-06
to O 0 4.04310594603885e-06
have O 0 4.183782039035577e-06
the O 0 0.00014386820839717984
FGFR3 O 1 0.9981563687324524
P250R O 0 0.002752125496044755
mutation O 0 1.2072990102751646e-05
, O 0 5.8791406445379835e-06
and O 0 3.0123885608190903e-06
one O 0 3.0868377507431433e-06
individual O 0 1.753945070959162e-06
was O 0 6.74929324304685e-05
found O 0 2.0329473500169115e-06
to O 0 3.543215598256211e-06
have O 0 2.5321426164737204e-06
an O 0 1.69506820384413e-05
FGFR2 O 1 0.9775803089141846
VV269 O 0 0.005422096233814955
- O 0 0.0004989341250620782
270 O 0 0.0001192987838294357
deletion O 0 0.0005372159066610038
. O 0 0.0001793944975361228

To O 0 8.931806951295584e-05
date O 0 0.00029056501807644963
, O 0 1.0181312973145396e-05
our O 0 7.787006325088441e-06
detection O 0 2.8779728381778114e-05
rate O 0 1.8008027836913243e-05
for O 0 1.676592364674434e-05
TWIST O 0 0.0020814312156289816
or O 0 0.0001102859532693401
FGFR O 0 0.10488055646419525
mutations O 0 2.5876559448079206e-05
is O 0 6.400686743290862e-06
68 O 0 2.5502322387183085e-05
% O 0 4.337113750807475e-06
in O 0 1.6471090930281207e-05
our O 0 0.00012374052312225103
Saethre B-Disease 1 0.9999842643737793
- I-Disease 1 0.9999130964279175
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0006872873054817319
, O 0 3.9338236092589796e-05
including O 0 2.036667865468189e-05
our O 0 7.779814040986821e-05
five O 0 3.98261436203029e-05
patients O 0 2.0339892216725275e-05
elsewhere O 0 2.2195663405000232e-05
reported O 0 1.8701226508710533e-05
with O 0 1.0593488696031272e-05
TWIST O 0 0.00453171506524086
mutations O 0 0.00022726644237991422
. O 0 0.00028113042935729027

More O 0 1.7728911188896745e-05
than O 0 3.5832044886774383e-06
35 O 0 2.3328895622398704e-05
different O 0 2.197712319684797e-06
TWIST O 0 0.0006378857651725411
mutations O 0 1.2662529115914367e-05
are O 0 2.145308371837018e-06
now O 0 1.1967687896685675e-05
known O 0 1.697991683613509e-05
in O 0 1.2179497389297467e-05
the O 0 4.2680745536927134e-05
literature O 0 9.421630966244265e-05
. O 0 8.884982526069507e-05

The O 0 0.0005731438286602497
most O 0 3.552293492248282e-05
common O 0 1.4977723367337603e-05
phenotypic O 0 0.0002615097910165787
features O 0 0.00010885206575039774
, O 0 1.0253045729768928e-05
present O 0 1.544707265566103e-05
in O 0 1.3583641703007743e-05
more O 0 1.244168288394576e-06
than O 0 9.23928212159808e-07
a O 0 5.554244580707746e-06
third O 0 1.7382759324391373e-05
of O 0 4.573175101540983e-05
our O 0 2.7627671443042345e-05
patients O 0 1.2011365470243618e-05
with O 0 1.016292935673846e-05
TWIST O 0 0.002601626794785261
mutations O 0 6.29034184385091e-05
, O 0 2.2024198187864386e-05
are O 0 8.477461051370483e-06
coronal B-Disease 0 0.011122558265924454
synostosis I-Disease 1 0.6987881064414978
, O 0 0.00020499361562542617
brachycephaly B-Disease 0 0.1485353410243988
, O 0 0.00015856378013268113
low B-Disease 0 0.0029306698124855757
frontal I-Disease 1 0.999995231628418
hairline I-Disease 1 1.0
, O 0 0.006574992090463638
facial B-Disease 1 0.9999998807907104
asymmetry I-Disease 1 1.0
, O 0 0.3926367461681366
ptosis B-Disease 1 0.9999994039535522
, O 0 0.000584015273489058
hypertelorism B-Disease 1 0.999011754989624
, O 0 0.0001422296481905505
broad B-Disease 0 0.0020373216830193996
great I-Disease 1 0.9999912977218628
toes I-Disease 1 0.9979472756385803
, O 0 7.664017175557092e-05
and O 0 7.446080417139456e-05
clinodactyly B-Disease 0 0.1583859622478485
. O 0 0.0003964497009292245

Significant O 0 0.0021645845845341682
intra O 0 0.03434237837791443
- O 0 0.0017763491487130523
and O 0 3.5085835406789556e-05
interfamilial O 0 0.0012703156098723412
phenotypic O 0 0.00029389074188657105
variability O 0 0.0003929596277885139
is O 0 1.2163640349172056e-05
present O 0 1.736546073516365e-05
for O 0 5.983923074381892e-06
either O 0 2.907534144469537e-05
TWIST O 0 0.0011817552149295807
mutations O 0 4.959289435646497e-05
or O 0 0.0001094240287784487
FGFR O 1 0.9997779726982117
mutations O 0 0.0004261079302523285
. O 0 0.0002709210093598813

The O 0 0.0002592741511762142
overlap O 0 5.25544019183144e-05
in O 0 2.183431206503883e-05
clinical O 0 6.209121784195304e-05
features O 0 4.035972960991785e-05
and O 0 1.144693396781804e-05
the O 0 5.49928518012166e-05
presence O 0 3.217947232769802e-05
, O 0 2.3704803879809333e-06
in O 0 2.8597883101610932e-06
the O 0 6.666839908575639e-06
same O 0 2.0826580566790653e-06
genes O 0 3.3938567867153324e-06
, O 0 1.7802206002670573e-06
of O 0 1.4326050404633861e-05
mutations O 0 3.585919102988555e-06
for O 0 4.1906264414137695e-06
more O 0 2.0866898466920247e-06
than O 0 3.085463276875089e-06
one O 0 1.3119185496179853e-05
craniosynostotic B-Disease 0 0.002090449444949627
condition I-Disease 0 0.00030894484370946884
- O 0 9.277512435801327e-05
such O 0 3.3260118925682036e-06
as O 0 7.10891981725581e-05
Saethre B-Disease 0 0.41732874512672424
- I-Disease 0 0.0007112205494195223
Chotzen I-Disease 0 0.00278863706625998
, I-Disease 0 2.473078347975388e-05
Crouzon I-Disease 0 0.0031050785910338163
, I-Disease 0 2.8253036362002604e-05
and I-Disease 0 9.654716996010393e-05
Pfeiffer I-Disease 1 0.9999977350234985
syndromes I-Disease 1 0.9999914169311523
- O 0 0.00213022343814373
support O 0 4.5967859477968886e-05
the O 0 0.0001399813627358526
hypothesis O 0 5.2793402574025095e-05
that O 0 5.302330009726575e-06
TWIST O 0 0.0005893719498999417
and O 0 1.4238947187550366e-05
FGFRs O 0 0.0011903096456080675
are O 0 1.1114599374195677e-06
components O 0 7.629819265275728e-06
of O 0 3.72513422917109e-05
the O 0 3.849889253615402e-05
same O 0 5.609809704765212e-06
molecular O 0 1.9699680706253275e-05
pathway O 0 3.1172643502941355e-05
involved O 0 8.199558578780852e-06
in O 0 8.220824383897707e-06
the O 0 3.274839400546625e-05
modulation O 0 0.0005323419463820755
of O 0 0.006752852816134691
craniofacial O 1 1.0
and O 1 0.6166480779647827
limb O 1 0.9999973773956299
development O 0 0.0010594780324026942
in O 0 0.0002497677633073181
humans O 0 9.594446601113304e-05
. O 0 1.7586951798875816e-05
. O 0 3.455049591138959e-05

Mutation O 0 6.8528011070156936e-06
analysis O 0 4.499247097555781e-06
of O 0 0.0003905699704773724
UBE3A O 1 1.0
in O 1 0.999996542930603
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999938011169434
. O 0 0.0051399036310613155

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9975090026855469
AS B-Disease 1 1.0
) O 0 6.540710455738008e-05
is O 0 1.1702820302161854e-05
caused O 0 8.582213922636583e-05
by O 0 1.1919234566448722e-05
chromosome O 0 0.00038501614471897483
15q11 O 0 0.003508994821459055
- O 0 0.0008886711439117789
q13 O 0 0.000789097452070564
deletions O 0 5.7212408137274906e-05
of O 0 7.751171506242827e-05
maternal O 0 0.00020177263650111854
origin O 0 2.383560422458686e-05
, O 0 1.0479852790012956e-05
by O 0 1.0117197234649211e-05
paternal O 0 0.0016323879826813936
uniparental B-Disease 1 0.9999901056289673
disomy I-Disease 1 0.9999674558639526
( O 0 0.005001985467970371
UPD B-Disease 1 0.9999994039535522
) O 0 0.00013539937208406627
15 O 0 0.00017190445214509964
, O 0 1.8927747078123502e-05
by O 0 3.7251869798637927e-05
imprinting O 0 0.014460419304668903
defects O 1 0.9999438524246216
, O 0 8.095204248093069e-05
and O 0 1.4475178431894165e-05
by O 0 9.294711162510794e-06
mutations O 0 2.290309566888027e-05
in O 0 7.695829117437825e-05
the O 0 0.0005935904919169843
UBE3A O 1 0.9871254563331604
gene O 0 0.00024317884526681155
. O 0 0.00014236275455914438

UBE3A O 0 0.13764308393001556
encodes O 0 0.0003048742073588073
a O 0 0.00011596665717661381
ubiquitin O 0 0.0005831175367347896
- O 0 0.00029549526516348124
protein O 0 2.759836206678301e-05
ligase O 0 9.883310121949762e-05
and O 0 1.1768874173867516e-05
shows O 0 0.00015522654575761408
brain O 0 0.004072689916938543
- O 0 0.0006124436622485518
specific O 0 1.734771649353206e-05
imprinting O 0 0.0012391152558848262
. O 0 0.0002849297598004341

Here O 0 0.00034103807411156595
we O 0 1.8669667042559013e-05
describe O 0 0.00017922968254424632
UBE3A O 0 0.06167539581656456
coding O 0 0.0010743685998022556
- O 0 0.0006930705276317894
region O 0 0.00012867848272435367
mutations O 0 8.670719580550212e-06
detected O 0 3.391910286154598e-05
by O 0 5.521716502698837e-06
SSCP O 0 0.004275408107787371
analysis O 0 5.158861767995404e-06
in O 0 2.0262703401385807e-05
13 O 0 0.00016138814680743963
AS B-Disease 0 0.2124466747045517
individuals O 0 9.137093911704142e-06
or O 0 3.566257510101423e-05
families O 0 4.6127875975798815e-05
. O 0 0.00020024704281240702

Two O 0 5.289878026815131e-05
identical O 0 6.0918915551155806e-05
de O 0 0.0010945763206109405
novo O 0 0.0011556354584172368
5 O 0 0.0006804449949413538
- O 0 0.0007969202124513686
bp O 0 0.000346658838680014
duplications O 0 0.0004967433051206172
in O 0 5.7455770729575306e-05
exon O 0 0.0002949455811176449
16 O 0 0.00013809149095322937
were O 0 4.895269012195058e-05
found O 0 6.778679380659014e-05
. O 0 0.00014879676746204495

Among O 0 0.00010379628656664863
the O 0 3.38527315761894e-05
other O 0 2.246647454740014e-06
11 O 0 3.879491123370826e-05
unique O 0 1.3222394954937045e-05
mutations O 0 1.7766891687642783e-05
, O 0 1.0247873433399945e-05
8 O 0 7.094290776876733e-05
were O 0 2.2071129933465272e-05
small O 0 1.2416185199981555e-05
deletions O 0 5.6669417972443625e-05
or O 0 2.9917586289229803e-05
insertions O 0 0.0003345393924973905
predicted O 0 0.0003577431198209524
to O 0 8.510796033078805e-05
cause O 0 0.0006972867995500565
frameshifts O 0 0.007307201158255339
, O 0 3.20421349897515e-05
1 O 0 8.22757720015943e-05
was O 0 0.00011044117127312347
a O 0 7.91153433965519e-06
mutation O 0 1.70108171460015e-06
to O 0 4.802192052011378e-06
a O 0 2.4080853108898737e-05
stop O 0 6.0418817156460136e-05
codon O 0 2.340336868655868e-05
, O 0 4.806325250683585e-06
1 O 0 6.0527345340233296e-05
was O 0 0.0001510500005679205
a O 0 2.81930151686538e-05
missense O 0 0.00012831993808504194
mutation O 0 5.454103757074336e-06
, O 0 6.274528914218536e-06
and O 0 5.8520890888758e-06
1 O 0 0.00012243945093359798
was O 0 0.00041101680835708976
predicted O 0 0.00013687416503671557
to O 0 2.7838643291033804e-05
cause O 0 0.00012058856373187155
insertion O 0 9.193873120239004e-05
of O 0 0.00032980352989397943
an O 0 0.00014883109543006867
isoleucine O 0 0.0033372987527400255
in O 0 7.205508154584095e-05
the O 0 0.00014523055870085955
hect O 0 0.002083456376567483
domain O 0 5.8241363149136305e-05
of O 0 0.0001457300822949037
the O 0 0.0004471278516575694
UBE3A O 0 0.15175680816173553
protein O 0 5.0660943088587373e-05
, O 0 2.911621322709834e-06
which O 0 5.699687903870654e-07
functions O 0 2.513194658604334e-06
in O 0 4.6744735300308093e-05
E2 O 0 0.008687772788107395
binding O 0 2.3485512429033406e-05
and O 0 3.0155159038258716e-05
ubiquitin O 0 0.0004187449812889099
transfer O 0 0.0005077292444184422
. O 0 0.00031538729672320187

Eight O 0 0.00015854548837523907
of O 0 9.932959801517427e-05
the O 0 4.8388443246949464e-05
cases O 0 1.372035694657825e-05
were O 0 5.776115722255781e-05
familial O 0 0.0006468406645581126
, O 0 5.4882417316548526e-05
and O 0 2.195453635067679e-05
five O 0 4.169431849732064e-05
were O 0 7.039516640361398e-05
sporadic O 0 0.0008869728771969676
. O 0 0.0002995480317622423

In O 0 0.00032668732455931604
two O 0 3.5236484109191224e-05
familial O 0 0.0011745654046535492
cases O 0 0.00021999153250362724
and O 0 9.167066309601068e-05
one O 0 5.74989098822698e-05
sporadic O 0 0.00041384794167242944
case O 0 0.0001025516539812088
, O 0 3.33781645167619e-05
mosaicism O 0 0.00822367426007986
for O 0 0.00020926522847730666
UBE3A O 1 0.9981860518455505
mutations O 0 0.00012295131455175579
was O 0 0.00044279865687713027
detected O 0 8.606094343122095e-05
in O 0 8.692353731021285e-06
the O 0 2.5998157070716843e-05
mother O 0 1.7432079403079115e-05
of O 0 3.219251811970025e-05
three O 0 5.152543235453777e-05
AS B-Disease 1 0.9994557499885559
sons O 0 0.0022848164662718773
, O 0 1.1829525647044647e-05
in O 0 1.63285785674816e-05
the O 0 5.484944995259866e-05
maternal O 0 0.00017932915943674743
grandfather O 0 0.0003645924443844706
of O 0 0.00012493085523601621
two O 0 3.8407877582358196e-05
AS B-Disease 1 0.9984278678894043
first O 0 0.00019275776867289096
cousins O 0 0.00010298380948370323
, O 0 4.472748059924925e-06
and O 0 2.64283289652667e-06
in O 0 1.7544840375194326e-05
the O 0 9.486485942034051e-05
mother O 0 6.334477075142786e-05
of O 0 7.294512761291116e-05
an O 0 9.264896652894095e-05
AS B-Disease 1 0.9999985694885254
daughter O 0 0.005257434211671352
. O 0 0.00032813288271427155

The O 0 0.0001431483105989173
frequencies O 0 1.786454777175095e-05
with O 0 2.2628648821410025e-06
which O 0 2.8604974886548007e-06
we O 0 2.427509798508254e-06
detected O 0 1.875437556009274e-05
mutations O 0 2.682362946870853e-06
were O 0 1.1460829227871727e-05
5 O 0 3.386199750821106e-05
( O 0 4.686988177127205e-06
14 O 0 3.118700624327175e-05
% O 0 4.704210823547328e-06
) O 0 3.085054459006642e-06
of O 0 5.751601202064194e-05
35 O 0 6.651432340731844e-05
in O 0 2.9868211640859954e-05
sporadic O 0 8.67231356096454e-05
cases O 0 1.2120414794480894e-05
and O 0 1.1840281331387814e-05
8 O 0 7.727569754933938e-05
( O 0 7.40347377359285e-06
80 O 0 2.6457089916220866e-05
% O 0 5.792410775029566e-06
) O 0 2.6160466859437292e-06
of O 0 4.9929425586014986e-05
10 O 0 6.565274816239253e-05
in O 0 4.519864160101861e-05
familial O 0 0.0005671772523783147
cases O 0 0.00024585702340118587
. O 0 0.00013039262557867914
. O 0 0.00018972918041981757

The O 0 0.005212193354964256
hemochromatosis B-Disease 1 1.0
845 O 1 0.8513146042823792
G O 0 0.04248370975255966
- O 0 0.0015553722623735666
- O 0 0.00019456866721156985
> O 0 2.995766953972634e-05
A O 0 5.3469702834263444e-05
and O 0 2.838245109160198e-06
187 O 0 1.0041080713563133e-05
C O 0 0.00015018656267784536
- O 0 8.553576481062919e-05
- O 0 5.503959982888773e-05
> O 0 5.065737059339881e-05
G O 0 0.00022263595019467175
mutations O 0 1.4112547432887368e-05
: O 0 8.588439413870219e-06
prevalence O 0 0.0001776731078280136
in O 0 6.869373464724049e-05
non O 0 0.00038078177021816373
- O 0 0.0007843875209800899
Caucasian O 0 0.0007426292286254466
populations O 0 2.6787130991579033e-05
. O 0 5.1168131903978065e-05

Hemochromatosis B-Disease 1 0.9999998807907104
, O 0 0.00027352917823009193
the O 0 0.0050915624015033245
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999998807907104
, O 0 0.0002161001757485792
leads O 0 0.0002775894245132804
, O 0 2.284367656102404e-05
if O 0 2.6614316084305756e-05
untreated O 1 0.9872956871986389
, O 0 2.407635111012496e-05
to O 0 0.0001395492727169767
progressive O 1 0.9999911785125732
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.0019503532676026225
premature B-Disease 0 0.09950137883424759
death I-Disease 0 0.4395008981227875
. O 0 0.00041532187606208026

The O 0 0.005882975645363331
hemochromatosis B-Disease 1 1.0
gene O 0 0.002764270640909672
, O 0 0.0003678775392472744
HFE O 1 0.9995856881141663
, O 0 3.6938097764505073e-05
recently O 0 2.2421729227062315e-05
has O 0 2.1724811176682124e-06
been O 0 2.8536449008242926e-06
identified O 0 9.045151273312513e-06
, O 0 2.699819333429332e-06
and O 0 1.6735018562030746e-06
characterization O 0 2.3779844923410565e-05
of O 0 5.607753337244503e-05
this O 0 6.3044412854651455e-06
gene O 0 5.744846930610947e-06
has O 0 1.4460845250141574e-06
shown O 0 1.8839815538740368e-06
that O 0 2.535341536713531e-07
it O 0 1.5578967804685817e-07
contains O 0 3.9990726463656756e-07
two O 0 1.7589741219126154e-07
mutations O 0 3.262777852341969e-07
that O 0 2.418190092612349e-07
result O 0 3.6056985663890373e-06
in O 0 1.419020009052474e-05
amino O 0 1.0878794455493335e-05
acid O 0 2.2319623894873075e-05
substitutions O 0 5.78963736188598e-05
- O 0 0.0001314754772465676
cDNA O 0 6.81903911754489e-05
nucleotides O 0 2.7565143682295457e-05
845 O 0 0.0003849375934805721
G O 0 0.000617369485553354
- O 0 0.0002455124631524086
- O 0 9.751834295457229e-05
> O 0 3.831955837085843e-05
A O 0 0.0001764016633387655
( O 0 1.0346801900595892e-05
C282Y O 0 0.00022655508655589074
) O 0 3.174284074702882e-06
and O 0 1.9980614069936564e-06
187 O 0 1.6237027011811733e-05
C O 0 0.0002794759639073163
- O 0 0.00012549286475405097
- O 0 8.90712472028099e-05
> O 0 0.00011294234718661755
G O 0 0.0008924794965423644
( O 0 0.00010846661461982876
H63D O 1 0.9670946598052979
) O 0 0.00011771607387345284
. O 0 0.00011859488586196676

Although O 0 0.0030020654667168856
hemochromatosis B-Disease 1 1.0
is O 0 0.0003457179118413478
common O 0 8.861004607751966e-05
in O 0 0.00017451787425670773
Caucasians O 0 0.0017878677463158965
, O 0 2.441887954773847e-05
affecting O 0 8.050117321545258e-05
> O 0 0.0001224886073032394
= O 0 9.745122224558145e-05
1 O 0 0.00014341966016218066
/ O 0 7.682440627831966e-05
300 O 0 1.9388609871384688e-05
individuals O 0 1.0146242175324005e-06
of O 0 7.194899080786854e-05
northern O 0 8.16005194792524e-05
European O 0 2.2118450942798518e-05
origin O 0 9.722300092107616e-06
, O 0 4.188924776826752e-06
it O 0 8.772606747697864e-07
has O 0 4.89670128445141e-07
not O 0 2.2618715433964098e-07
been O 0 1.7440243027522229e-06
recognized O 0 4.355782948550768e-06
in O 0 5.289698492561001e-06
other O 0 3.129587184957927e-06
populations O 0 1.6220248653553426e-05
. O 0 3.711974204634316e-05

The O 0 0.00011477095540612936
present O 0 4.468196493689902e-05
study O 0 1.157780297944555e-05
used O 0 2.5260469556087628e-05
PCR O 0 0.00014393888704944402
and O 0 1.6725649402360432e-05
restriction O 0 2.7440533813205548e-05
- O 0 5.026110738981515e-05
enzyme O 0 2.888461722250213e-06
digestion O 0 1.5412908396683633e-05
to O 0 2.206789076808491e-06
analyze O 0 8.33047761261696e-06
the O 0 7.935956091387197e-06
frequency O 0 2.2462875222117873e-06
of O 0 2.5278832254116423e-05
the O 0 9.546769433654845e-05
845 O 0 0.0013228899333626032
G O 0 0.0010165636194869876
- O 0 0.00020664164912886918
- O 0 6.915882840985432e-05
> O 0 2.7042699002777226e-05
A O 0 6.845132156740874e-05
and O 0 3.5572256820159964e-06
187 O 0 1.89919719559839e-05
C O 0 0.00024331379972863942
- O 0 0.0001010832711472176
- O 0 6.311637116596103e-05
> O 0 5.80793057451956e-05
G O 0 0.000229751254664734
mutations O 0 1.7230124285561033e-05
in O 0 8.63701498019509e-05
HLA O 0 0.012805976904928684
- O 0 0.00023350759875029325
typed O 0 2.5563220333424397e-05
samples O 0 7.982531315064989e-06
from O 0 1.9265966329840012e-05
non O 0 0.0002937117242254317
- O 0 0.0003755978832487017
Caucasian O 0 0.0002591384982224554
populations O 0 3.100427193203359e-06
, O 0 2.110658897436224e-06
comprising O 0 1.2982888620172162e-05
Australian O 0 4.1775991121539846e-05
Aboriginal O 0 0.00015756227367091924
, O 0 1.5579335013171658e-05
Chinese O 0 0.00019012251868844032
, O 0 1.4480011486739386e-05
and O 0 2.210211277997587e-05
Pacific O 0 0.0009819705737754703
Islanders O 0 0.0012178939068689942
. O 0 0.00020043192489538342

Results O 0 3.835260577034205e-05
showed O 0 6.247062265174463e-05
that O 0 2.7810403935291106e-06
the O 0 5.978652916382998e-05
845 O 0 0.0019480648916214705
G O 0 0.0027383205015212297
- O 0 0.0007710477220825851
- O 0 0.00021012757497373968
> O 0 7.388490485027432e-05
A O 0 7.842996274121106e-05
mutation O 0 2.5133001599897398e-06
was O 0 3.7118326872587204e-05
present O 0 7.742900379525963e-06
in O 0 8.84758719621459e-06
these O 0 3.7167867503740126e-06
populations O 0 4.275822448107647e-06
( O 0 2.2380229438567767e-06
allele O 0 1.0382119626228814e-06
frequency O 0 2.4966207092802506e-06
0 O 0 4.191401785647031e-06
. O 0 2.285903974552639e-06
32 O 0 1.359508496534545e-05
% O 0 5.877739567949902e-06
) O 0 8.3275226643309e-06
, O 0 8.74677971296478e-06
and O 0 8.287007403851021e-06
, O 0 1.7663196558714844e-05
furthermore O 0 5.7930727052735165e-05
, O 0 9.432907972950488e-06
it O 0 3.4412582863296848e-06
was O 0 7.54926513764076e-05
always O 0 3.6807855394727085e-06
seen O 0 9.734787454362959e-06
in O 0 2.837901547536603e-06
conjunction O 0 3.202441439498216e-05
with O 0 2.8533990189316683e-05
HLA O 1 0.9992376565933228
haplotypes O 0 0.0011946656741201878
common O 0 8.840376540319994e-05
in O 0 0.00015781019465066493
Caucasians O 0 0.0012311952887102962
, O 0 1.800555401132442e-05
suggesting O 0 3.895937334164046e-05
that O 0 1.0388655027782079e-05
845 O 0 0.0016586357960477471
G O 0 0.003207542235031724
- O 0 0.0007419674075208604
- O 0 0.00027923303423449397
> O 0 7.759186701150611e-05
A O 0 0.00010589345765765756
may O 0 1.4748655303264968e-05
have O 0 8.053360147641797e-07
been O 0 2.467306103426381e-06
introduced O 0 2.1371972707129316e-06
into O 0 1.0489524129297934e-06
these O 0 1.827901314754854e-07
populations O 0 8.117042398225749e-07
by O 0 1.611716470506508e-06
Caucasian O 0 0.00033474035444669425
admixture O 0 0.001540374825708568
. O 0 0.0006691727903671563

187 O 0 0.0006778970710001886
C O 0 0.002066181041300297
- O 0 0.0005865736166015267
- O 0 0.00021080362785141915
> O 0 0.00011081492266384885
G O 0 0.0003470517403911799
was O 0 9.800459520192817e-05
present O 0 1.4474599083769135e-05
at O 0 4.4778793380828574e-05
an O 0 1.8129793488697032e-06
allele O 0 1.2267614692973439e-06
frequency O 0 8.048959898587782e-06
of O 0 0.0002237907174276188
2 O 0 0.0009504297631792724
. O 0 0.0003338705573696643

68 O 0 0.0007086897967383265
% O 0 4.789200102095492e-05
in O 0 4.2016989027615637e-05
the O 0 3.8825255614938214e-05
two O 0 3.0844103093841113e-06
populations O 0 2.378970748395659e-06
analyzed O 0 1.7036734789144248e-05
( O 0 5.411386155174114e-06
Australian O 0 3.260684752603993e-05
Aboriginal O 0 9.218558989232406e-05
and O 0 1.6690881238901056e-05
Chinese O 0 0.0005486314184963703
) O 0 5.1026767323492095e-05
. O 0 7.24134806660004e-05

In O 0 0.00017064758867491037
the O 0 6.644041422987357e-05
Australian O 0 5.126474206917919e-05
Aboriginal O 0 7.568409637315199e-05
samples O 0 9.284965017286595e-06
, O 0 3.885318619722966e-06
187 O 0 1.4995073797763325e-05
C O 0 0.00037358776899054646
- O 0 0.00019626646826509386
- O 0 8.676317520439625e-05
> O 0 8.187253843061626e-05
G O 0 0.0002328348346054554
was O 0 5.5878310377011076e-05
found O 0 1.024012703965127e-06
to O 0 1.2062228051945567e-06
be O 0 1.778905357241456e-06
associated O 0 5.075723947811639e-06
with O 0 1.8874070519814268e-05
HLA O 1 0.9998863935470581
haplotypes O 0 0.0021289365831762552
common O 0 0.00022282473219092935
in O 0 0.0003817261604126543
Caucasians O 0 0.002854089019820094
, O 0 2.4924172976170667e-05
suggesting O 0 2.6800085834111087e-05
that O 0 1.1767389196393196e-06
it O 0 1.1884443438248127e-06
was O 0 2.297066203027498e-05
introduced O 0 2.807970531648607e-06
by O 0 8.724899771550554e-07
recent O 0 8.304206858156249e-06
admixture O 0 0.000298863451462239
. O 0 0.0002183936012443155

In O 0 0.0002029246388701722
the O 0 8.900687680579722e-05
Chinese O 0 0.00012044388859067112
samples O 0 4.714000624517212e-06
analyzed O 0 1.3625652172777336e-05
, O 0 2.7198245788895292e-06
187 O 0 1.3564999790105503e-05
C O 0 0.0002796115877572447
- O 0 0.00015759577217977494
- O 0 0.00011691131658153608
> O 0 0.00012368577881716192
G O 0 0.00039790800656192005
was O 0 0.00011578611156437546
present O 0 2.953987495857291e-05
in O 0 1.712054836389143e-05
association O 0 9.24399500945583e-06
with O 0 2.528040567995049e-06
a O 0 1.6357476852135733e-05
wide O 0 5.1508675824152306e-05
variety O 0 2.2480564439320005e-05
of O 0 0.0010792820248752832
HLA O 1 0.999992847442627
haplotypes O 0 0.0013718799455091357
, O 0 1.1510776857903693e-05
showing O 0 2.1667932742275298e-05
this O 0 1.8155503767047776e-06
mutation O 0 7.663888368369953e-07
to O 0 3.6873379940516315e-06
be O 0 3.103426706729806e-06
widespread O 0 3.4297583624720573e-05
and O 0 8.94482946023345e-06
likely O 0 1.592607623024378e-05
to O 0 1.5616018572472967e-05
predate O 0 0.000548194395378232
the O 0 1.1723239367711358e-05
more O 0 7.438147235916404e-07
genetically O 0 4.6271197788883e-06
restricted O 0 6.592941645067185e-06
845 O 0 0.0005295468145050108
G O 0 0.00175448227673769
- O 0 0.0007689272752031684
- O 0 0.0002850454766303301
> O 0 9.907050844049081e-05
A O 0 0.0002513175713829696
mutation O 0 2.075644806609489e-05
. O 0 4.3615167669486254e-05

Genotype O 0 0.002541396301239729
- O 0 0.0006405870663002133
phenotype O 0 3.414065940887667e-05
correlations O 0 0.00013903329090680927
in O 0 0.0002939868427347392
attenuated B-Disease 1 0.930274486541748
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
. O 0 0.0034845173358917236

Germ O 1 0.9999856948852539
- O 0 0.0023677723947912455
line O 0 0.00019313949451316148
mutations O 0 5.761065040132962e-06
of O 0 7.529722643084824e-05
the O 0 0.000462168303783983
tumor B-Disease 1 0.9991323351860046
suppressor O 0 0.0040377480909228325
APC O 0 0.0008715022122487426
are O 0 2.5182857825711835e-06
implicated O 0 0.00019820424495264888
in O 0 0.00024394980573561043
attenuated B-Disease 1 0.989046037197113
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.997886598110199
AAPC B-Disease 1 1.0
) O 0 5.660654278472066e-05
, O 0 2.3420727757184068e-06
a O 0 2.5030335564224515e-06
variant O 0 3.586591628845781e-05
of O 0 0.0008704769425094128
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.999992847442627
FAP B-Disease 1 0.9999998807907104
) O 0 0.00048409102600999177
. O 0 0.00023859264911152422

AAPC B-Disease 1 0.9999991655349731
is O 0 2.579530337243341e-05
recognized O 0 1.0725304491643328e-05
by O 0 1.1641003538898076e-06
the O 0 5.845061423315201e-06
occurrence O 0 2.5210052626789548e-05
of O 0 0.0001726857735775411
< O 0 0.006762447766959667
100 O 0 0.0018058030400425196
colonic B-Disease 1 0.9995143413543701
adenomas I-Disease 0 0.09612562507390976
and O 0 9.3786393335904e-06
a O 0 1.2006738870695699e-05
later O 0 0.0001021866628434509
onset O 1 0.9999706745147705
of O 1 0.9999983310699463
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0017149654449895024
age O 0 0.0014718965394422412
> O 0 0.0003161959466524422
40 O 0 0.00010071169526781887
years O 0 0.00014227521023713052
) O 0 3.2648793421685696e-05
. O 0 5.504206274054013e-05

The O 0 0.000229423341806978
aim O 0 0.00013228319585323334
of O 0 3.656693661469035e-05
this O 0 3.697977035699296e-06
study O 0 3.340443527122261e-06
was O 0 3.3679811167530715e-05
to O 0 5.121322828927077e-06
assess O 0 8.859010995365679e-05
genotype O 0 0.00018668979464564472
- O 0 0.00030014722142368555
phenotype O 0 4.0895396523410454e-05
correlations O 0 0.0003407900803722441
in O 0 0.0005674046697095037
AAPC B-Disease 1 0.9999995231628418
families O 0 0.0001239476550836116
. O 0 0.000223579365410842

By O 0 9.567392407916486e-05
protein O 0 0.00011127713514724746
- O 0 0.0001362892653560266
truncation O 0 0.00015018886188045144
test O 0 2.1116691641509533e-05
( O 0 2.658199991856236e-05
PTT O 0 0.0004245965101290494
) O 0 2.029781853707391e-06
assay O 0 3.017028802787536e-06
, O 0 1.2783822285200586e-06
the O 0 5.0581065806909464e-06
entire O 0 4.305545735405758e-05
coding O 0 0.0001119539447245188
region O 0 0.00014122390712145716
of O 0 0.00016669298929627985
the O 0 0.00028834049589931965
APC B-Disease 0 0.0018767659785225987
gene O 0 1.694651109573897e-05
was O 0 7.082165393512696e-05
screened O 0 2.045145993179176e-05
in O 0 2.920971382991411e-06
affected O 0 3.2658272175467573e-06
individuals O 0 1.8433501054460066e-06
from O 0 0.00015265635738614947
11 O 0 0.13279153406620026
AAPC B-Disease 1 1.0
kindreds O 0 0.008792105130851269
, O 0 2.460891664668452e-05
and O 0 3.755093530344311e-06
their O 0 3.012538172697532e-06
phenotypic O 0 0.00010295691026840359
differences O 0 0.00024374102940782905
were O 0 0.0003331684856675565
examined O 0 0.0014752784045413136
. O 0 0.0002979928394779563

Five O 0 0.00045374484034255147
novel O 0 0.0013128813588991761
germ O 1 0.9995680451393127
- O 0 0.002587132388725877
line O 0 0.0009105955250561237
APC B-Disease 0 0.00076905736932531
mutations O 0 1.0787015526148025e-05
were O 0 2.1496176486834884e-05
identified O 0 3.9409536839229986e-05
in O 0 5.971513382974081e-05
seven O 0 0.00030601455364376307
kindreds O 0 0.007349502295255661
. O 0 0.0003900172596331686

Mutations O 0 0.0002498744579497725
were O 0 0.00010834421846084297
located O 0 0.00013449450489133596
in O 0 7.927673323138151e-06
three O 0 2.40160443354398e-06
different O 0 2.785021990803216e-07
regions O 0 5.780943411082262e-06
of O 0 4.530289879767224e-05
the O 0 0.00024577268050052226
APC B-Disease 0 0.0009734361083246768
gene O 0 1.2749202142003924e-05
( O 0 4.586192972055869e-06
1 O 0 3.860411015921272e-05
) O 0 2.106733518303372e-06
at O 0 1.9058339603361674e-05
the O 0 1.5600418919348158e-05
5 O 0 1.8840637494577095e-05
end O 0 7.942737283883616e-05
spanning O 0 0.00035243923775851727
exons O 0 0.00018024424207396805
4 O 0 8.394126780331135e-05
and O 0 8.508125574735459e-06
5 O 0 5.040241376264021e-05
, O 0 1.02995081761037e-05
( O 0 5.397640052251518e-06
2 O 0 3.653612657217309e-05
) O 0 3.879372343362775e-06
within O 0 1.6751235307310708e-05
exon O 0 0.00013524864334613085
9 O 0 9.398049587616697e-05
, O 0 6.163282705529127e-06
and O 0 3.1958015824784525e-06
( O 0 5.863037586095743e-06
3 O 0 4.37612397945486e-05
) O 0 3.908441613020841e-06
at O 0 4.7129222366493195e-05
the O 0 2.2424208509619348e-05
3 O 0 4.78916808788199e-05
distal O 0 0.0005555265233851969
end O 0 0.00037166752736084163
of O 0 0.00025908215320669115
the O 0 0.0003600912168622017
gene O 0 0.0001427245733793825
. O 0 0.00011097545211669058

Variability O 0 0.0008061074186116457
in O 0 3.645360266091302e-05
the O 0 3.250972804380581e-05
number O 0 5.005318598705344e-05
of O 1 0.8089179992675781
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9985170960426331
most O 0 7.568106957478449e-05
apparent O 0 0.00018918202840723097
in O 0 1.2573135791171808e-05
individuals O 0 1.039617814058147e-06
with O 0 3.785952912949142e-06
mutations O 0 1.5676236216677353e-05
in O 0 5.6620043324073777e-05
region O 0 0.0003641548100858927
1 O 0 0.0004489785060286522
, O 0 2.4735216356930323e-05
and O 0 3.2249732612399384e-05
upper O 1 0.8181434273719788
- O 1 0.9596766233444214
gastrointestinal O 1 0.996653139591217
manifestations O 0 0.056382935494184494
were O 0 0.0005351511645130813
more O 0 4.2937943362630904e-05
severe O 0 0.002386986743658781
in O 0 0.00017133237270172685
them O 0 5.29950630152598e-05
. O 0 0.0001755740522639826

In O 0 8.908780728233978e-05
individuals O 0 2.8790013857360464e-06
with O 0 4.120828180020908e-06
mutations O 0 2.054764627246186e-05
in O 0 3.4000717278104275e-05
either O 0 3.054531407542527e-05
region O 0 0.0001936802000273019
2 O 0 0.00012573564890772104
or O 0 1.8413244106341153e-05
region O 0 0.00021073028619866818
3 O 0 6.076307545299642e-05
, O 0 4.410836027091136e-06
the O 0 4.636679477698635e-06
average O 0 3.82109419660992e-06
number O 0 5.584135124081513e-06
of O 0 0.0003095846332143992
adenomas B-Disease 0 0.10600349307060242
tended O 0 0.00019863217312376946
to O 0 3.356598244863562e-05
be O 0 1.5397072274936363e-05
lower O 0 2.991427572851535e-05
than O 0 1.0400970040791435e-06
those O 0 1.0682579159038141e-06
in O 0 2.312443712071399e-06
individuals O 0 2.5567038619556115e-07
with O 0 1.675210342000355e-06
mutations O 0 1.2064242582709994e-05
in O 0 3.899818329955451e-05
region O 0 0.0002564104797784239
1 O 0 0.00012967386282980442
, O 0 4.833969342143973e-06
although O 0 3.2378422929468798e-06
age O 0 7.142950198613107e-05
at O 0 0.0002699489996302873
diagnosis O 0 0.0007682179566472769
was O 0 0.0006456966511905193
similar O 0 4.2314142774557695e-05
. O 0 0.0002770862483885139

In O 0 0.0010709587950259447
all O 0 0.0008534066728316247
AAPC B-Disease 1 0.9999998807907104
kindreds O 0 0.0055664945393800735
, O 0 1.4177727280184627e-05
a O 0 1.3253539691504557e-05
predominance O 0 0.0009788237512111664
of O 0 0.0014422812964767218
right O 0 0.11834840476512909
- O 1 0.9999998807907104
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 1.0
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 0 0.00970413163304329
was O 0 0.0035734330303967
observed O 0 0.0001609937462490052
. O 0 0.00015054586401674896

No O 0 0.003243054961785674
desmoid B-Disease 1 0.9999818801879883
tumors I-Disease 1 1.0
were O 0 0.0005723845679312944
found O 0 6.364630826283246e-05
in O 0 6.301124085439369e-05
these O 0 6.214915629243478e-05
kindreds O 0 0.005241622682660818
. O 0 0.0003252438036724925

Our O 0 0.00011854693002533168
data O 0 2.2555122995981947e-05
suggest O 0 1.8212893337477e-05
that O 0 4.512904069997603e-06
, O 0 1.4594386811950244e-05
in O 0 0.00015951400564517826
AAPC B-Disease 1 0.999996542930603
families O 0 1.504992997070076e-05
, O 0 2.5576891857781447e-06
the O 0 5.788699581898982e-06
location O 0 1.8943728719023056e-05
of O 0 5.363695527194068e-05
the O 0 0.00036973675014451146
APC B-Disease 0 0.008213083259761333
mutation O 0 4.5897158997831866e-05
may O 0 0.00014687977090943605
partially O 0 0.00037424860056489706
predict O 0 1.9421664546825923e-05
specific O 0 1.593927322574018e-06
phenotypic O 0 0.00021124309569131583
expression O 0 0.00042448684689588845
. O 0 0.0005146886687725782

This O 0 2.4620039766887203e-05
should O 0 7.275340067280922e-06
help O 0 6.088795544201275e-06
in O 0 3.6112805901211686e-06
the O 0 9.41536472964799e-06
design O 0 1.3002291780139785e-05
of O 0 3.2490141165908426e-05
tailored O 0 4.990905654267408e-05
clinical O 0 0.00023568706819787621
- O 0 0.0007306804764084518
management O 0 0.00015181124035734683
protocols O 0 0.0001713026431389153
in O 0 1.4572328836948145e-05
this O 0 3.205508164683124e-06
subset O 0 2.9694227123400196e-05
of O 0 0.000398931180825457
FAP B-Disease 1 0.9987654685974121
patients O 0 0.00037601060466840863
. O 0 8.785197860561311e-05
. O 0 0.0001563722180435434

Wilms B-Disease 1 0.9999992847442627
' I-Disease 0 0.05606972426176071
tumor I-Disease 0 0.2762148976325989
1 O 0 0.0008020465611480176
and O 0 8.775268361205235e-05
Dax O 1 0.992324709892273
- O 0 0.0002856325590983033
1 O 0 6.145443330751732e-05
modulate O 0 5.993128434056416e-05
the O 0 1.996765422518365e-05
orphan O 0 0.00021920136350672692
nuclear O 0 0.0003925380588043481
receptor O 0 0.00018696072220336646
SF O 0 0.018497804179787636
- O 0 9.702135866973549e-05
1 O 0 3.2530446333112195e-05
in O 0 1.2304333722568117e-05
sex O 0 1.6522628357051872e-05
- O 0 2.284750917169731e-05
specific O 0 2.028914877882926e-06
gene O 0 1.62215183081571e-05
expression O 0 5.949981641606428e-05
. O 0 0.00012688443530350924

Products O 0 0.00013100831711199135
of O 0 0.0004940598737448454
steroidogenic O 0 0.010402844287455082
factor O 0 0.00020082523406017572
1 O 0 0.0003643871168605983
( O 0 8.703132334630936e-05
SF O 0 0.04780437797307968
- O 0 0.00016163977852556854
1 O 0 4.7635923692723736e-05
) O 0 6.038313131284667e-06
and O 0 1.7081605619750917e-05
Wilms B-Disease 1 0.9999881982803345
tumor I-Disease 1 0.9982125759124756
1 O 0 0.0013615399366244674
( O 0 0.00017197724082507193
WT1 O 0 0.020000241696834564
) O 0 7.051873126329156e-06
genes O 0 1.3998378562973812e-06
are O 0 2.2362023344157933e-07
essential O 0 6.686540928058093e-06
for O 0 7.77618697611615e-06
mammalian O 0 0.00012592764687724411
gonadogenesis O 0 0.0014339711051434278
prior O 0 0.00011102393182227388
to O 0 2.8434840714908205e-05
sexual O 0 0.0001421252527507022
differentiation O 0 0.0019677700474858284
. O 0 0.000849642266985029

In O 0 0.00025081582134589553
males O 0 4.8966558097163215e-05
, O 0 0.00013201075489632785
SF O 1 0.9985558390617371
- O 0 0.00046810333151370287
1 O 0 5.5464486649725586e-05
participates O 0 1.024435641738819e-05
in O 0 5.795820015919162e-06
sexual O 0 1.0070060852740426e-05
development O 0 2.1191715859458782e-05
by O 0 3.536861868269625e-06
regulating O 0 1.6718791812309064e-05
expression O 0 3.262539848947199e-06
of O 0 5.0995393394259736e-05
the O 0 0.0002681712794583291
polypeptide O 0 0.0047332970425486565
hormone O 0 0.0018499399302527308
Mullerian O 0 0.1357133984565735
inhibiting O 0 0.0016189418965950608
substance O 0 0.0020422700326889753
( O 0 0.000758808571845293
MIS O 1 0.9994580149650574
) O 0 0.00018189128604717553
. O 0 0.00016394031990785152

Here O 0 0.0003340266121085733
, O 0 7.292233476619003e-06
we O 0 1.7982653162107454e-06
show O 0 9.77902345766779e-06
that O 0 1.1298221579636447e-05
WT1 O 1 0.9247104525566101
- O 0 0.0031098229810595512
KTS O 0 0.11620592325925827
isoforms O 0 2.2537489712703973e-05
associate O 0 6.19841375737451e-05
and O 0 9.783295354282018e-06
synergize O 0 0.0024061850272119045
with O 0 8.083918510237709e-05
SF O 1 0.9997745156288147
- O 0 0.0005587367922998965
1 O 0 0.00010087528789881617
to O 0 3.234935138607398e-05
promote O 0 0.0007727406919002533
MIS O 1 0.987506628036499
expression O 0 0.00020584148296620697
. O 0 0.00011947707389481366

In O 0 0.00022266992891673
contrast O 0 0.0002767491096165031
, O 0 0.00013928406406193972
WT1 O 1 0.947996973991394
missense O 0 0.0006597375031560659
mutations O 0 2.871825927286409e-05
, O 0 8.428030923823826e-06
associated O 0 5.873923328181263e-06
with O 0 6.062628472136566e-06
male B-Disease 0 0.00028674089116975665
pseudohermaphroditism I-Disease 1 0.9999992847442627
in O 0 0.0009697250789031386
Denys B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999986886978149
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 8.25113311293535e-05
fail O 0 0.00015995264402590692
to O 0 4.928624912281521e-05
synergize O 0 0.005458816885948181
with O 0 0.00016393203986808658
SF O 1 0.9999980926513672
- O 0 0.002168136416003108
1 O 0 0.00043199703213758767
. O 0 8.46330585773103e-05

Additionally O 0 0.0002001451066462323
, O 0 1.2978728591406252e-05
the O 0 6.462979217758402e-05
X O 0 0.0025961229111999273
- O 0 0.0007497146143577993
linked O 0 0.00034189780126325786
, O 0 1.0388744158262853e-05
candidate O 0 1.0492153705854435e-05
dosage O 0 0.00019113892631139606
- O 0 0.00019983503443654627
sensitive O 0 0.00014241664030123502
sex O 0 2.9981276384205557e-05
- O 0 5.200802843319252e-05
reversal O 0 7.563763210782781e-05
gene O 0 1.9864333808072843e-05
, O 0 1.4364507478603628e-05
Dax O 0 0.0350567027926445
- O 0 0.00032094414927996695
1 O 0 9.682367090135813e-05
, O 0 8.549149242753629e-06
antagonizes O 0 0.0003645865945145488
synergy O 0 0.0006706658168695867
between O 0 0.00116358429659158
SF O 1 0.9999266862869263
- O 0 0.0010497096227481961
1 O 0 0.00021039642160758376
and O 0 5.696720472769812e-05
WT1 O 0 0.031174087896943092
, O 0 6.855963874841109e-06
most O 0 3.2569223549216986e-06
likely O 0 3.3997166610788554e-06
through O 0 9.464503705203242e-07
a O 0 1.050525270329672e-06
direct O 0 1.384170786877803e-06
interaction O 0 1.0541036317590624e-05
with O 0 3.184819797752425e-05
SF O 1 0.9999490976333618
- O 0 0.00147195253521204
1 O 0 0.00041264150058850646
. O 0 0.0001045272292685695

We O 0 9.977092850022018e-05
propose O 0 6.60651276120916e-05
that O 0 1.9239896573708393e-05
WT1 O 0 0.050052348524332047
and O 0 0.00014484387065749615
Dax O 1 0.9977337121963501
- O 0 0.0006523028714582324
1 O 0 0.00013609445886686444
functionally O 0 0.00011320392513880506
oppose O 0 3.859762728097849e-06
each O 0 2.6942433350996e-07
other O 0 9.397695066581946e-07
in O 0 2.6905847335001454e-05
testis O 0 0.0016279906267300248
development O 0 4.717427509604022e-05
by O 0 1.356419761577854e-05
modulating O 0 0.001554973190650344
SF O 1 0.9998179078102112
- O 0 0.0006449004868045449
1 O 0 0.0001913971791509539
- O 0 0.0001628467725822702
mediated O 0 0.0002491553022991866
transactivation O 0 0.0020536205265671015
. O 0 4.2167997889919207e-05
. O 0 5.2635150495916605e-05

A O 0 0.0011784171219915152
mouse O 0 5.413194958237e-05
model O 0 6.320075044641271e-06
for O 0 5.5382879509124905e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999810457229614
- O 1 0.9996546506881714
centre O 0 0.009676455520093441
mutations O 0 0.0001405179064022377
. O 0 0.00018600374460220337

Imprinting O 0 0.0021842706482857466
in O 0 0.0001933115563588217
the O 0 0.0002658442244865
15q11 O 0 0.004070522263646126
- O 0 0.0004883791552856565
q13 O 0 0.00033874259679578245
region O 0 5.4926076700212434e-05
involves O 0 1.7501757611171342e-05
an O 0 1.4548861145158298e-05
imprinting O 0 0.0010030870325863361
centre O 0 0.002858610125258565
( O 0 0.0002080821868730709
IC O 0 0.01672838255763054
) O 0 2.3156275346991606e-05
, O 0 3.195320232407539e-06
mapping O 0 1.2080960914317984e-05
in O 0 7.150194505811669e-06
part O 0 1.1655994057946373e-05
to O 0 6.867435786261922e-06
the O 0 4.520364382187836e-05
promoter O 0 0.0006745237042196095
and O 0 9.808388313103933e-06
first O 0 6.207854312378913e-05
exon O 0 0.0007196299848146737
of O 0 0.0006091420073062181
SNRPN O 1 0.9999713897705078
. O 0 0.0008233852568082511

Deletion O 0 0.0009239214705303311
of O 0 0.0010720468126237392
this O 0 0.00022004272614140064
IC O 0 0.11464498192071915
abolishes O 0 0.001277316128835082
local O 0 5.003609840059653e-05
paternally O 0 0.00017319005564786494
derived O 0 8.084980436251499e-06
gene O 0 2.155615902665886e-06
expression O 0 1.1433287454565288e-06
and O 0 6.412806214939337e-07
results O 0 2.500039499864215e-06
in O 0 6.935900455573574e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999971389770508
PWS B-Disease 1 1.0
) O 0 0.0017847345443442464
. O 0 0.000475479057058692

We O 0 3.3445456210756674e-05
have O 0 1.1754926845242153e-06
created O 0 1.355814492853824e-05
two O 0 2.8190518150950084e-06
deletion O 0 9.491137461736798e-05
mutations O 0 3.0132505344226956e-05
in O 0 8.622196037322283e-05
mice O 0 0.00021474086679518223
to O 0 5.890325701329857e-05
understand O 0 0.0009870750363916159
PWS B-Disease 1 1.0
and O 0 7.663761061849073e-05
the O 0 0.0001100055014831014
mechanism O 0 0.00013875622244086117
of O 0 0.00019975920440629125
this O 0 0.00012871332000941038
IC O 0 0.21855467557907104
. O 0 0.0005050895269960165

Mice O 0 0.010839585214853287
harbouring O 0 0.026984579861164093
an O 0 9.99494586721994e-05
intragenic O 0 0.011974980123341084
deletion O 0 0.001207791268825531
in O 0 0.0003410491335671395
Snrpn O 0 0.023268233984708786
are O 0 1.8234288290841505e-05
phenotypically O 0 0.0006808137986809015
normal O 0 5.261086698737927e-05
, O 0 4.7407529564225115e-06
suggesting O 0 7.939831448311452e-06
that O 0 1.2334128314250847e-06
mutations O 0 1.0025829396909103e-05
of O 0 0.00021522995666600764
SNRPN O 1 0.9975600242614746
are O 0 2.706021405174397e-06
not O 0 8.444341688118584e-07
sufficient O 0 1.7238031432498246e-05
to O 0 6.0053829656681046e-05
induce O 0 0.007001954596489668
PWS B-Disease 1 1.0
. O 0 0.0025063322391361

Mice O 0 0.0003278745571151376
with O 0 4.427085968927713e-06
a O 0 1.244832674274221e-05
larger O 0 1.2703083484666422e-05
deletion O 0 6.696925265714526e-05
involving O 0 7.331053348025307e-05
both O 0 5.797129779239185e-05
Snrpn O 0 0.008827758021652699
and O 0 3.0499260901706293e-05
the O 0 0.000262481247773394
putative O 1 0.9469015002250671
PWS O 1 1.0
- O 0 0.14673645794391632
IC O 0 0.02695336751639843
lack O 0 0.00020527135347947478
expression O 0 2.2880085452925414e-05
of O 0 9.611928544472903e-05
the O 0 0.0001367811200907454
imprinted O 0 0.0007168438169173896
genes O 0 6.857127300463617e-05
Zfp127 O 0 0.0042248498648405075
( O 0 7.06755236024037e-05
mouse O 0 5.228311783866957e-05
homologue O 0 0.00016999634681269526
of O 0 0.00030713254818692803
ZNF127 O 1 0.999901294708252
) O 0 0.00017885681882034987
, O 0 9.514897828921676e-05
Ndn O 0 0.012780130840837955
and O 0 8.992408402264118e-05
Ipw O 0 0.006316076032817364
, O 0 3.366138116689399e-05
and O 0 1.1454306331870612e-05
manifest O 0 0.0004189583705738187
several O 0 4.93359038955532e-05
phenotypes O 0 0.0003706083807628602
common O 0 0.00027001925627700984
to O 0 0.006956135854125023
PWS B-Disease 1 1.0
infants O 1 0.9999552965164185
. O 0 0.0012802118435502052

These O 0 2.6764479116536677e-05
data O 0 2.129442509613e-05
demonstrate O 0 4.1263636376243085e-05
that O 0 1.6954876400632202e-06
both O 0 1.7107714711528388e-06
the O 0 1.3157765351934358e-05
position O 0 1.5411380445584655e-05
of O 0 4.982298196409829e-05
the O 0 0.0001493810414103791
IC O 0 0.006697417236864567
and O 0 1.2895682630187366e-05
its O 0 8.392884410568513e-06
role O 0 2.0177340047666803e-05
in O 0 5.791980129288277e-06
the O 0 7.084091976139462e-06
coordinate O 0 3.333188260512543e-06
expression O 0 3.087326604145346e-06
of O 0 3.122870475635864e-05
genes O 0 1.0810556887008715e-05
is O 0 6.7366954681347124e-06
conserved O 0 7.315159018617123e-05
between O 0 0.00014527652820106596
mouse O 0 8.90500086825341e-05
and O 0 7.000599453022005e-06
human O 0 1.3443710486171767e-05
, O 0 4.499041097005829e-06
and O 0 2.8496688173618168e-06
indicate O 0 1.911575236590579e-05
that O 0 3.6057535908184946e-06
the O 0 4.377810182631947e-05
mouse O 0 2.9224594982224517e-05
is O 0 1.3459183492159355e-06
a O 0 3.082172497670399e-06
suitable O 0 8.715438525541686e-06
model O 0 3.2174589250644203e-06
system O 0 1.3470326848619152e-05
in O 0 3.958701654482866e-06
which O 0 1.0304883062417503e-06
to O 0 2.5907370400091168e-06
investigate O 0 1.0230571206193417e-05
the O 0 1.3230443073553033e-05
molecular O 0 3.991975972894579e-05
mechanisms O 0 0.00011329939297866076
of O 0 0.00022041039483156055
imprinting O 0 0.00048806227277964354
in O 0 3.379627742106095e-05
this O 0 2.8103306703997077e-06
region O 0 2.8384612960508093e-05
of O 0 2.7110043447464705e-05
the O 0 6.098855010350235e-05
genome O 0 8.226455247495323e-05
. O 0 1.3096534530632198e-05
. O 0 3.662560266093351e-05

Mutations O 0 8.697756129549816e-05
of O 0 0.0003342195996083319
the O 0 0.0005545074236579239
ATM O 0 0.003070648293942213
gene O 0 1.905966564663686e-05
detected O 0 2.5625680791563354e-05
in O 0 2.1180523617658764e-05
Japanese O 0 0.010409974493086338
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
telangiectasia I-Disease 1 0.9999998807907104
patients O 0 0.000213616483961232
: O 0 1.7337495592073537e-05
possible O 0 1.7087633750634268e-05
preponderance O 0 0.0006798645481467247
of O 0 0.0001000101983663626
the O 0 8.150719804689288e-05
two O 0 1.8583425116958097e-05
founder O 0 0.0006516077555716038
mutations O 0 4.1301987948827446e-05
4612del165 O 0 0.0014604768948629498
and O 0 5.542456347029656e-05
7883del5 O 0 0.004647348076105118
. O 0 0.00026051606982946396

The O 0 0.0009290639427490532
ATM O 0 0.006878152955323458
( O 0 0.00021568353986367583
A O 1 0.9986592531204224
- O 0 0.1437188982963562
T O 1 0.9877967238426208
, O 0 1.0697252946556546e-05
mutated O 0 1.087761211238103e-05
) O 0 2.092193426506128e-06
gene O 0 2.814640993165085e-06
on O 0 3.972115882788785e-05
human O 0 8.51453878567554e-05
chromosome O 0 0.0005242052138783038
11q22 O 0 0.005445694085210562
. O 0 0.00029703439213335514

3 O 0 0.0004523210518527776
has O 0 1.8206797903985716e-05
recently O 0 2.4553382900194265e-05
been O 0 5.589356533164391e-06
identified O 0 4.0509412428946234e-06
as O 0 2.1917387584835524e-06
the O 0 5.3643971114070155e-06
gene O 0 1.8209954077974544e-06
responsible O 0 2.9232735414552735e-06
for O 0 1.1984989214397501e-06
the O 0 2.07479370146757e-05
human O 0 0.00011827630078187212
recessive B-Disease 1 0.999847412109375
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.002491667866706848
A B-Disease 1 1.0
- I-Disease 1 0.9999711513519287
T I-Disease 1 0.9999926090240479
) O 0 6.474946712842211e-05
. O 0 5.045815487392247e-05

In O 0 6.716406642226502e-05
order O 0 6.5650833676045295e-06
to O 0 3.973350885644322e-06
define O 0 1.861814052972477e-05
the O 0 1.953905484697316e-05
types O 0 4.2547373595880345e-05
of O 0 0.0017581492429599166
disease O 1 1.0
- O 0 0.011386818252503872
causing O 0 0.0009559262543916702
ATM O 0 0.0008672038675285876
mutations O 0 9.296270945924334e-06
in O 0 2.082028368022293e-05
Japanese O 0 0.001068670186214149
A B-Disease 1 0.9999779462814331
- I-Disease 1 0.9979867935180664
T I-Disease 1 0.9999929666519165
patients O 0 2.1110588932060637e-05
as O 0 1.4317500244942494e-05
well O 0 3.7993067962815985e-06
as O 0 4.416990122990683e-06
to O 0 3.4066456464643124e-06
look O 0 4.312178134568967e-06
for O 0 2.694063596209162e-06
possible O 0 4.9496415158500895e-05
mutational O 0 0.002060156548395753
hotspots O 0 0.0009817250538617373
, O 0 1.1035658644686919e-05
reverse O 0 8.85988847585395e-05
- O 0 0.00015997185255400836
transcribed O 0 0.00010278014815412462
RNA O 0 8.822472591418773e-05
derived O 0 5.715032330044778e-06
from O 0 1.0795514754136093e-05
ten O 0 7.011326670181006e-05
patients O 0 1.703169800748583e-05
belonging O 0 2.259643588331528e-05
to O 0 1.4244814337871503e-05
eight O 0 7.227542664622888e-05
unrelated O 0 0.00020876101916655898
Japanese O 0 0.0017587977927178144
A B-Disease 1 0.9997676014900208
- I-Disease 0 0.05846528336405754
T I-Disease 1 0.9456835985183716
families O 0 6.622905857511796e-06
was O 0 6.255215703276917e-05
analyzed O 0 1.2067292118445039e-05
for O 0 2.3426757707056822e-06
mutations O 0 6.6980037445318885e-06
by O 0 4.4723765313392505e-06
the O 0 2.9198046831879765e-05
restriction O 0 1.3450019650917966e-05
endonuclease O 0 0.00011349685519235209
fingerprinting O 0 0.00010389540693722665
method O 0 5.668757512466982e-05
. O 0 0.0001377649314235896

As O 0 0.00016329831851180643
has O 0 8.485565558657981e-06
been O 0 5.108951427246211e-06
reported O 0 5.403851446317276e-06
by O 0 1.199411258312466e-06
others O 0 3.2046737032942474e-06
, O 0 1.4575930435967166e-06
mutations O 0 1.5334761656049523e-06
that O 0 1.3906992535339668e-06
lead O 0 4.523796451394446e-05
to O 0 5.877117291674949e-05
exon O 0 0.0010514043970033526
skipping O 0 0.0004242324212100357
or O 0 4.088198329554871e-05
premature O 0 0.00043131355778314173
protein O 0 4.065602115588263e-05
truncation O 0 0.0004432814021129161
were O 0 8.927344606490806e-05
also O 0 1.3696238056581933e-05
predominant O 0 0.00012172177957836539
in O 0 3.858202398987487e-05
our O 0 5.5850290664238855e-05
mutants O 0 0.0003975151921622455
. O 0 0.00010945461690425873

Six O 0 4.878045365330763e-05
different O 0 1.585878976584354e-06
mutations O 0 5.462348781293258e-06
were O 0 1.351361242996063e-05
identified O 0 1.547689134895336e-05
on O 0 5.266286461846903e-05
12 O 0 4.5010408939560875e-05
of O 0 5.3711424698121846e-05
the O 0 7.67096207709983e-05
16 O 0 0.00014572007057722658
alleles O 0 1.5455709217349067e-05
examined O 0 0.00048522776341997087
. O 0 0.00019706980674527586

Four O 0 0.00013165021664462984
were O 0 4.6224045945564285e-05
deletions O 0 9.605339437257499e-05
involving O 0 9.152060374617577e-05
a O 0 9.171561396215111e-05
loss O 0 0.0005609657964669168
of O 0 0.00046467542415484786
a O 0 0.0001537469943286851
single O 0 4.840778638026677e-05
exon O 0 0.0004409058019518852
exon O 0 0.0002627766807563603
7 O 0 0.00011575211101444438
, O 0 1.0241113159281667e-05
exon O 0 0.00016700990090612322
16 O 0 8.441422687610611e-05
, O 0 1.2696616067842115e-05
exon O 0 0.00014057579392101616
33 O 0 6.103649502620101e-05
or O 0 3.278220538049936e-05
exon O 0 0.0006307139992713928
35 O 0 0.00023629458155483007
. O 0 0.00016113104356918484

The O 0 0.0002964173909276724
others O 0 3.2405605452368036e-05
were O 0 1.922078627103474e-05
minute O 0 3.831678259302862e-05
deletions O 0 0.00012882309965789318
, O 0 1.6388486983487383e-05
4649delA O 0 0.0005250053363852203
in O 0 6.729883170919493e-05
exon O 0 0.000405088096158579
33 O 0 9.853093069978058e-05
and O 0 2.1204372387728654e-05
7883del5 O 0 0.000691459805238992
in O 0 6.857245170976967e-05
exon O 0 0.0007238466641865671
55 O 0 0.0002950606285594404
. O 0 0.00012885023897979409

The O 0 0.00046208527055568993
mutations O 0 0.00014391310105565935
4612del165 O 0 0.001269100815989077
and O 0 2.7874933948623948e-05
7883del5 O 0 0.0006188051193021238
were O 0 1.814318966353312e-05
found O 0 4.69185397378169e-06
in O 0 4.681100563175278e-06
more O 0 5.429237717180513e-07
than O 0 7.562172754660423e-07
two O 0 1.294634785153903e-06
unrelated O 0 1.5755613276269287e-05
families O 0 2.608557906569331e-06
; O 0 1.6471167327836156e-06
44 O 0 1.9309967683511786e-05
% O 0 1.21181610666099e-05
( O 0 2.1084411855554208e-05
7 O 0 0.0001653035869821906
of O 0 0.00022629408340435475
16 O 0 0.00023095947108231485
) O 0 7.1704748734191526e-06
of O 0 2.7971060262643732e-05
the O 0 3.426287366892211e-05
mutant O 0 3.614731031120755e-05
alleles O 0 2.952366003228235e-06
had O 0 1.5604673535563052e-05
one O 0 2.1121693407621933e-06
of O 0 1.2081859495083336e-05
the O 0 3.150596603518352e-05
two O 0 1.0029539225797635e-05
mutations O 0 3.954427666030824e-05
. O 0 0.00011896548676304519

The O 0 0.000949477544054389
4612del165 O 0 0.0022531517315655947
mutations O 0 1.9236025764257647e-05
in O 0 9.3338039732771e-06
three O 0 1.781368723641208e-06
different O 0 1.6647932454816328e-07
families O 0 3.916550781468686e-07
were O 0 2.9720506518060574e-06
all O 0 1.1708607416949235e-06
ascribed O 0 7.014683069428429e-05
to O 0 1.4347037904371973e-05
the O 0 6.344960274873301e-05
same O 0 3.434956670389511e-05
T O 0 0.002453386317938566
- O 0 0.00021841106354258955
- O 0 7.567233114968985e-05
> O 0 1.6235757357208058e-05
A O 0 3.5511482565198094e-05
substitution O 0 6.0750726333935745e-06
at O 0 4.585647184285335e-05
the O 0 1.7371325157000683e-05
splice O 0 0.00012514668924268335
donor O 0 1.4100681255513337e-05
site O 0 0.00012144607171649113
in O 0 3.570756234694272e-05
intron O 0 0.003244417952373624
33 O 0 0.000916084973141551
. O 0 0.00027787830913439393

Microsatellite O 0 0.01576537825167179
genotyping O 0 0.004014434292912483
around O 0 0.0004256753600202501
the O 0 0.00038716726703569293
ATM O 0 0.002466812962666154
locus O 0 0.00014302032650448382
also O 0 6.560433575941715e-06
indicated O 0 8.803232958598528e-06
that O 0 1.1128524874948198e-06
a O 0 7.034335339994868e-06
common O 0 8.925248039304279e-06
haplotype O 0 0.00022384515614248812
was O 0 0.0002348835114389658
shared O 0 1.5255995094776154e-05
by O 0 1.9222795799578307e-06
the O 0 7.13511326466687e-06
mutant O 0 1.130603595811408e-05
alleles O 0 2.0556108211167157e-06
in O 0 7.76455181039637e-06
both O 0 9.143178431259003e-06
mutations O 0 6.947159999981523e-05
. O 0 0.00022337120026350021

This O 0 3.732498225872405e-05
suggests O 0 2.0133091311436146e-05
that O 0 1.0043245310953353e-06
these O 0 1.2934118558405316e-06
two O 0 8.617138519184664e-06
founder O 0 0.0008928872994147241
mutations O 0 3.0866711313137785e-05
may O 0 5.937584865023382e-05
be O 0 9.8408436315367e-06
predominant O 0 5.036555739934556e-05
among O 0 1.2977689038962126e-05
Japanese O 0 0.0003806592430919409
ATM O 0 0.0015294688055291772
mutant O 0 0.00012137500016251579
alleles O 0 5.8620935305953026e-05
. O 0 0.00016540275828447193

W474C O 0 0.011726615950465202
amino O 0 0.0005037637311033905
acid O 0 0.0002512577339075506
substitution O 0 7.861340418457985e-05
affects O 0 5.675107968272641e-05
early O 0 4.210949191474356e-05
processing O 0 2.70400178123964e-05
of O 0 4.8977064579958096e-05
the O 0 6.477207352872938e-05
alpha O 0 6.275733903748915e-05
- O 0 1.1381427611922845e-05
subunit O 0 1.3194455732445931e-06
of O 0 1.687062467681244e-05
beta O 0 0.00023522460833191872
- O 0 0.0002560933353379369
hexosaminidase O 0 0.0012253636959940195
A O 0 0.00013373461843002588
and O 0 5.07925915371743e-06
is O 0 2.8799349820474163e-06
associated O 0 4.853199243370909e-06
with O 0 1.6642752598272637e-05
subacute O 1 0.9995124340057373
G B-Disease 1 0.9983602166175842
( I-Disease 0 0.0013866652734577656
M2 I-Disease 1 0.9999887943267822
) I-Disease 0 0.00023430555302184075
gangliosidosis I-Disease 0 0.01095227524638176
. O 0 0.0002503812429495156

Mutations O 0 0.00017562830180395395
in O 0 0.00010428052337374538
the O 0 0.00029785194783471525
HEXA O 0 0.025878217071294785
gene O 0 9.504986337560695e-06
, O 0 1.2157181572547415e-06
encoding O 0 1.254002881978522e-06
the O 0 1.4394675417861436e-05
alpha O 0 3.745770300156437e-05
- O 0 7.245565939228982e-06
subunit O 0 9.911831284625805e-07
of O 0 1.5439591152244247e-05
beta O 0 0.0001729915093164891
- O 0 0.00014005746925249696
hexosaminidase O 0 0.001100488705560565
A O 0 0.00034978907206095755
( O 0 2.6063866243930534e-05
Hex O 0 0.0010450606932863593
A O 0 0.000405727478209883
) O 0 8.328745934704784e-06
, O 0 2.532722191972425e-06
that O 0 1.3711625115320203e-06
abolish O 0 8.51980148581788e-05
Hex O 0 0.0001852091372711584
A O 0 3.435251710470766e-05
enzyme O 0 2.5497402020846494e-06
activity O 0 2.0860868971794844e-05
cause O 0 0.002551022684201598
Tay B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0006222075899131596
TSD B-Disease 1 0.9999942779541016
) O 0 7.564252882730216e-05
, O 0 1.5781959518790245e-05
the O 0 0.0001000435950118117
fatal O 0 0.027756746858358383
infantile B-Disease 0 0.10079094022512436
form I-Disease 0 0.00022697498206980526
of I-Disease 1 0.6563177108764648
G I-Disease 1 0.9988337159156799
( I-Disease 0 0.0007164030103012919
M2 I-Disease 1 0.9989548921585083
) I-Disease 0 7.543608080595732e-05
gangliosidosis I-Disease 0 0.001902604359202087
, I-Disease 0 1.2861159120802768e-05
Type I-Disease 0 0.00013904082879889756
1 I-Disease 0 0.0009502667817287147
. O 0 0.000254229613346979

Less O 0 0.0011261822655797005
severe O 1 0.9962137341499329
, O 0 0.00038629811024293303
subacute O 1 0.9999181032180786
( O 0 0.0006580206681974232
juvenile O 1 0.9998505115509033
- O 0 0.005677510518580675
onset O 1 0.9999734163284302
) O 0 0.0001388262171531096
and O 0 0.00011700232425937429
chronic O 1 1.0
( O 0 0.0005543255829252303
adult O 0 0.00042189087253063917
- O 0 0.0013116322224959731
onset O 1 0.6695882678031921
) O 0 1.679072556726169e-05
variants O 0 1.3344614671950694e-05
are O 0 8.465863743367663e-07
characterized O 0 1.0120266779267695e-05
by O 0 1.560750433782232e-06
a O 0 9.417420187673997e-06
broad O 0 3.458992432570085e-05
spectrum O 0 0.0001995450584217906
of O 0 0.0004393656272441149
clinical O 0 0.0016512019792571664
manifestations O 1 0.6339564323425293
and O 0 7.144857954699546e-05
are O 0 1.9829585653496906e-06
associated O 0 6.926216883584857e-06
with O 0 4.475657988223247e-06
residual O 0 0.0010789076332002878
levels O 0 0.0008428221917711198
of O 0 0.0008956044912338257
Hex O 0 0.003174979006871581
A O 0 0.0005275268922559917
enzyme O 0 1.3831249816576019e-05
activity O 0 3.44127111020498e-05
. O 0 5.433680780697614e-05

We O 0 3.849544009426609e-05
identified O 0 1.867237369879149e-05
a O 0 6.028541247360408e-05
1422 O 0 0.02318934164941311
G O 0 0.0038785068318247795
- O 0 0.0006053324323147535
- O 0 0.00017175731773022562
> O 0 5.838628931087442e-05
C O 0 0.00022836423886474222
( O 0 1.3137278074282221e-05
amino O 0 1.665049967414234e-05
acid O 0 5.502353815245442e-05
W474C O 0 0.0004884745576418936
) O 0 4.193293079879368e-06
substitution O 0 4.868000360147562e-06
in O 0 8.639535735710524e-06
the O 0 1.3070146451354958e-05
first O 0 8.373017408302985e-06
position O 0 8.835849257593509e-06
of O 0 6.665630644420162e-05
exon O 0 0.0003950459067709744
13 O 0 0.00018519393051974475
of O 0 0.0007478229817934334
HEXA O 1 0.6527466177940369
of O 0 0.0005986716132611036
a O 0 0.00019266862364020199
non O 0 0.000776125758420676
- O 0 0.0005260303732939065
Jewish O 0 0.00016803636390250176
proband O 0 0.005179702304303646
who O 0 5.309583502821624e-05
manifested O 0 0.0004252658982295543
a O 0 7.995399937499315e-05
subacute O 0 0.011339053511619568
variant O 0 0.00046415108954533935
of O 0 0.003434349549934268
G B-Disease 1 0.9958531856536865
( I-Disease 0 0.0009948337683454156
M2 I-Disease 1 0.9999216794967651
) I-Disease 0 0.0002097942488035187
gangliosidosis I-Disease 0 0.005926033016294241
. O 0 0.0002219949383288622

On O 0 0.00047661515418440104
the O 0 0.0001275177055504173
second O 0 0.00021675080643035471
maternally O 0 0.0012460887664929032
inherited O 0 0.008686508052051067
allele O 0 4.454106237972155e-05
, O 0 9.492900971963536e-06
we O 0 2.6260224785801256e-06
identified O 0 4.670826001529349e-06
the O 0 2.8402320822351612e-05
common O 0 0.00022662292758468539
infantile O 1 1.0
disease O 1 1.0
- O 1 0.996529757976532
causing O 0 0.005919026210904121
4 O 0 0.0009298571385443211
- O 0 0.0006417557597160339
bp O 0 0.0001202492494485341
insertion O 0 4.08758241974283e-05
, O 0 2.0577412215061486e-05
+ O 0 0.0007502714870497584
TATC O 1 0.9947454929351807
1278 O 0 0.037511203438043594
, O 0 4.107839777134359e-05
in O 0 7.244227163027972e-05
exon O 0 0.0009065165068022907
11 O 0 0.0005129565834067762
. O 0 0.00018394901417195797

Pulse O 0 0.011966082267463207
- O 0 0.00046087842201814055
chase O 0 6.0909620515303686e-05
analysis O 0 1.876586452453921e-06
using O 0 1.0807195394590963e-05
proband O 0 0.0034392622765153646
fibroblasts O 0 0.00014655000995844603
revealed O 0 0.00016512433649040759
that O 0 2.952185923277284e-06
the O 0 1.850732405728195e-05
W474C O 0 0.0004047966795042157
- O 0 4.921621803077869e-05
containing O 0 1.2900431102025323e-05
alpha O 0 6.276368367252871e-05
- O 0 1.4992914657341316e-05
subunit O 0 3.4981846965820296e-06
precursor O 0 8.834190521156415e-05
was O 0 9.194294398184866e-05
normally O 0 7.615513368364191e-06
synthesized O 0 4.5795510231982917e-05
, O 0 2.360230155318277e-06
but O 0 6.574504709533358e-07
not O 0 8.500376225129003e-07
phosphorylated O 0 2.1085297703393735e-05
or O 0 1.1150844329677057e-05
secreted O 0 2.5067100068554282e-05
, O 0 4.303694367990829e-06
and O 0 4.72368492410169e-06
the O 0 7.175419159466401e-05
mature O 0 0.00037588499253615737
lysosomal O 0 0.004522640258073807
alpha O 0 0.00047129206359386444
- O 0 7.813888805685565e-05
subunit O 0 9.435931133339182e-06
was O 0 6.872077938169241e-05
not O 0 4.1634984881966375e-06
detected O 0 0.00014379237836692482
. O 0 4.90089732920751e-05

When O 0 0.00012228041305206716
the O 0 9.441056317882612e-05
W474C O 0 0.0007885366794653237
- O 0 7.471017306670547e-05
containing O 0 2.7364825655240566e-05
alpha O 0 7.656931120436639e-05
- O 0 2.2148573407321237e-05
subunit O 0 6.013247457303805e-06
was O 0 0.00013373870751820505
transiently O 0 0.0005225492059253156
co O 0 9.174727892968804e-05
- O 0 1.8155391444452107e-05
expressed O 0 2.556323806857108e-06
with O 0 9.989551017497433e-07
the O 0 2.4093533284030855e-05
beta O 0 5.503481952473521e-05
- O 0 1.637245986785274e-05
subunit O 0 1.1017866654583486e-06
to O 0 2.163833869417431e-06
produce O 0 7.750702934572473e-06
Hex O 0 0.0004291703808121383
A O 0 0.00029511493630707264
( O 0 1.972381869563833e-05
alphabeta O 0 0.0015864098677411675
) O 0 1.221257662109565e-05
in O 0 6.444122118409723e-05
COS O 0 0.236373171210289
- O 0 0.0005233340780250728
7 O 0 0.00019307469483464956
cells O 0 1.4863548130961135e-05
, O 0 2.3038501240080222e-06
the O 0 1.743183020153083e-05
mature O 0 4.495267785387114e-05
alpha O 0 5.947898898739368e-05
- O 0 1.5961717508616857e-05
subunit O 0 2.575345888544689e-06
was O 0 3.602620563469827e-05
present O 0 1.1926274055440444e-05
, O 0 1.9739698018383933e-06
but O 0 3.4902694778793375e-07
its O 0 1.4703593933518277e-06
level O 0 4.66635829070583e-05
was O 0 7.762946916045621e-05
much O 0 7.501079835492419e-06
lower O 0 1.776889075699728e-05
than O 0 8.335081815857848e-07
that O 0 5.689841486855585e-07
from O 0 7.96177664597053e-06
normal O 0 3.288427978986874e-05
alpha O 0 0.00011573268420761451
- O 0 4.218151298118755e-05
subunit O 0 6.851481430203421e-06
transfections O 0 0.00025021348847076297
, O 0 1.476025545343873e-06
although O 0 8.210233772842912e-07
higher O 0 3.203063670298434e-06
than O 0 6.234692477846693e-07
in O 0 6.176374427013798e-06
those O 0 5.7621414271125104e-06
cells O 0 1.608868478797376e-05
transfected O 0 0.00013656790542881936
with O 0 1.127374844145379e-06
an O 0 2.7818282433145214e-06
alpha O 0 8.456296200165525e-05
- O 0 3.882481178152375e-05
subunit O 0 6.811186722188722e-06
associated O 0 8.241421710408758e-06
with O 0 2.246106305392459e-05
infantile O 1 0.9999501705169678
TSD B-Disease 1 1.0
. O 0 0.0026912789326161146

Furthermore O 0 0.0004504842509049922
, O 0 1.6551774024264887e-05
the O 0 3.383943112567067e-05
precursor O 0 0.00024328620929736644
level O 0 0.00011769498814828694
of O 0 7.859954348532483e-05
the O 0 0.00011894392810063437
W474C O 0 0.0007731709047220647
alpha O 0 6.995670264586806e-05
- O 0 9.321750439994503e-06
subunit O 0 1.1539092383827665e-06
was O 0 1.0114776159753092e-05
found O 0 8.34529430449038e-07
to O 0 3.064764769078465e-06
accumulate O 0 1.8138811356038786e-05
in O 0 4.009118129033595e-06
comparison O 0 4.9335531002725475e-06
to O 0 8.948396498453803e-06
the O 0 2.7761443561757915e-05
normal O 0 2.8626278435694985e-05
alpha O 0 3.908258076990023e-05
- O 0 1.9119379430776462e-05
subunit O 0 4.017653282062383e-06
precursor O 0 0.0001855230366345495
levels O 0 0.00015277489728759974
. O 0 4.16088369092904e-05

We O 0 3.1793151720194146e-05
conclude O 0 6.691901944577694e-05
that O 0 2.671683887456311e-06
the O 0 6.399552512448281e-05
1422 O 0 0.027910225093364716
G O 0 0.004545028321444988
- O 0 0.001063689705915749
- O 0 0.0002874547499231994
> O 0 7.18366281944327e-05
C O 0 0.00015151247498579323
mutation O 0 1.6816226207083673e-06
is O 0 9.63482420957007e-07
the O 0 4.7474895836785436e-06
cause O 0 3.4757962566800416e-05
of O 0 0.000148509003338404
Hex B-Disease 0 0.007991531863808632
A I-Disease 1 0.8564980030059814
enzyme I-Disease 1 0.9995903372764587
deficiency I-Disease 1 1.0
in O 0 0.0006641164654865861
the O 0 0.0009463951573707163
proband O 0 0.01979725807905197
. O 0 0.00031986404792405665

The O 0 0.0004522391245700419
resulting O 0 0.00038082676474004984
W474C O 0 0.0015087288338690996
substitution O 0 8.319394692080095e-05
clearly O 0 9.719045192468911e-05
interferes O 0 6.177089380798861e-05
with O 0 3.348519612700329e-06
alpha O 0 9.100002353079617e-05
- O 0 2.2991462174104527e-05
subunit O 0 3.0404476092371624e-06
processing O 0 1.0432039744046051e-05
, O 0 1.934101646838826e-06
but O 0 5.486681402544491e-07
because O 0 3.6477797493716935e-07
the O 0 4.483988959691487e-06
base O 0 1.5673114830860868e-05
substitution O 0 2.7233385480940342e-05
falls O 0 0.000799650268163532
at O 0 6.607432442251593e-05
the O 0 1.5330564565374516e-05
first O 0 9.203260560752824e-06
position O 0 2.2670601538266055e-05
of O 0 8.60407599247992e-05
exon O 0 0.0004264191666152328
13 O 0 0.00012240291107445955
, O 0 8.46807142806938e-06
aberrant O 0 4.0760136471362785e-05
splicing O 0 3.085502976318821e-05
may O 0 1.6879172108019702e-05
also O 0 3.4544500522315502e-06
contribute O 0 1.4006355741003063e-05
to O 0 5.389141369960271e-05
Hex B-Disease 0 0.006511228159070015
A I-Disease 0 0.008926372975111008
deficiency I-Disease 1 0.9999598264694214
in O 0 0.00010734934767242521
this O 0 2.9642902518389747e-05
proband O 0 0.004271206445991993
. O 0 4.5207263610791415e-05
. O 0 5.780964784207754e-05

Two O 0 3.629650018410757e-05
frequent O 0 3.993301288574003e-05
missense O 0 0.0002972805523313582
mutations O 0 0.00021732342429459095
in O 0 0.007772177457809448
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.36131346225738525

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0008051179465837777
an O 0 0.0010138332145288587
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9958322644233704
early O 1 1.0
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.9999297857284546

A O 0 0.0009839897975325584
century O 0 0.0002555789251346141
after O 0 1.9163535398547538e-05
its O 0 1.676719307397434e-06
recognition O 0 1.1324391380185261e-05
as O 0 5.305948798195459e-05
a O 0 0.00016121557564474642
syndrome O 1 0.9999996423721313
by O 0 5.9523710660869256e-05
Vaughan O 0 0.0009357209783047438
Pendred O 0 0.004508758895099163
, O 0 6.669835784123279e-06
the O 0 5.368367783376016e-05
disease O 1 0.9995554089546204
gene O 0 7.605916471220553e-05
( O 0 0.00011117838585050777
PDS O 1 0.9956343770027161
) O 0 1.3296315955813043e-05
was O 0 7.919503696030006e-05
mapped O 0 4.001130218966864e-05
to O 0 2.759354902082123e-05
chromosome O 0 0.0006181454518809915
7q22 O 0 0.007279402110725641
- O 0 0.0025620388332754374
q31 O 0 0.003514994168654084
. O 0 0.00014506738807540387

1 O 0 0.0011798222549259663
and O 0 6.9422138039954e-05
, O 0 1.89270795090124e-05
recently O 0 4.4795324356528e-05
, O 0 2.5184058358718175e-06
found O 0 1.061612806552148e-06
to O 0 1.6730326706237975e-06
encode O 0 9.561281331116334e-06
a O 0 3.503230618662201e-05
putative O 0 0.0010521404910832644
sulfate O 0 0.006619260646402836
transporter O 0 0.019672058522701263
. O 0 0.0005873088957741857

We O 0 3.697877036756836e-05
performed O 0 2.7810890969703905e-05
mutation O 0 1.5725626099083456e-06
analysis O 0 4.4861650394523167e-07
of O 0 3.071115497732535e-05
the O 0 0.0001351738756056875
PDS B-Disease 1 0.8604060411453247
gene O 0 1.4699959137942642e-05
in O 0 1.5891637303866446e-05
patients O 0 1.5447927580680698e-05
from O 0 2.6486401111469604e-05
14 O 0 0.00018806853040587157
Pendred B-Disease 0 0.0020522703416645527
families O 0 3.931803803425282e-06
originating O 0 1.5885669199633412e-05
from O 0 9.100066563405562e-06
seven O 0 9.09479149413528e-06
countries O 0 8.321690643242619e-07
and O 0 1.5895310525593231e-06
identified O 0 8.773998160904739e-06
all O 0 9.07322100829333e-06
mutations O 0 8.677194273332134e-05
. O 0 0.00025275215739384294

The O 0 0.0002518565743230283
mutations O 0 5.286977830110118e-05
include O 0 3.946440847357735e-05
three O 0 2.849200609489344e-05
single O 0 1.9037737729377113e-05
base O 0 6.782210402889177e-05
deletions O 0 0.00012998322199564427
, O 0 1.2952341421623714e-05
one O 0 6.460843451350229e-06
splice O 0 0.0002158837451133877
site O 0 0.00016533321468159556
mutation O 0 5.4549250307900365e-06
and O 0 8.719379366084468e-06
10 O 0 7.953379099490121e-05
missense O 0 0.0003157483006361872
mutations O 0 0.0002307303511770442
. O 0 0.00036206954973749816

One O 0 0.00016685485024936497
missense O 0 0.0004665264568757266
mutation O 0 4.161828474025242e-05
( O 0 6.531074905069545e-05
L236P O 0 0.0013329896610230207
) O 0 1.6501388017786667e-05
was O 0 0.00017166268662549555
found O 0 1.0593054867058527e-05
in O 0 8.822613381198607e-06
a O 0 9.66148218140006e-06
homozygous O 0 8.657845683046617e-06
state O 0 5.0058806664310396e-06
in O 0 1.2395798876241315e-05
two O 0 8.934811376093421e-06
consanguineous O 0 0.0007384340860880911
families O 0 9.573489478498232e-06
and O 0 8.324299415107816e-06
in O 0 2.073452742479276e-05
a O 0 2.2263055143412203e-05
heterozygous O 0 4.776359219249571e-06
state O 0 2.4465205115120625e-06
in O 0 2.3994525690795854e-06
five O 0 4.948726200382225e-06
additional O 0 1.1126626304758247e-05
non O 0 0.00045173222315497696
- O 0 0.0010003943461924791
consanguineous O 0 0.0018523546168580651
families O 0 3.25873916153796e-05
. O 0 8.099382102955133e-05

Another O 0 0.00048112659715116024
missense O 0 0.0015086481580510736
mutation O 0 0.00011711415572790429
( O 0 0.0001015073066810146
T416P O 0 0.0017090230248868465
) O 0 2.7719537683879025e-05
was O 0 0.0002307006361661479
found O 0 1.1405439181544352e-05
in O 0 1.0892768841586076e-05
a O 0 1.051225535775302e-05
homozygous O 0 1.1580917089304421e-05
state O 0 6.720122200931655e-06
in O 0 1.1852856914629228e-05
one O 0 5.387200872064568e-06
family O 0 8.714623618288897e-06
and O 0 2.532437292757095e-06
in O 0 9.18910518521443e-06
a O 0 1.1636935596470721e-05
heterozygous O 0 2.2244410047278507e-06
state O 0 2.4925814159360016e-06
in O 0 5.758538009104086e-06
four O 0 8.659695595270023e-06
families O 0 1.1949645340791903e-05
. O 0 9.793620847631246e-05

Pendred B-Disease 0 0.3941190242767334
patients O 0 0.0002561275032348931
in O 0 8.832877210807055e-05
three O 0 8.479664393234998e-05
non O 0 0.0005240478785708547
- O 0 0.00045076911919750273
consanguineous O 0 0.0006184978410601616
families O 0 2.5579820430721156e-06
were O 0 5.284192411636468e-06
shown O 0 6.358804057526868e-06
to O 0 6.401956397894537e-06
be O 0 1.8327067664358765e-05
compound O 0 0.0002028540475293994
heterozygotes O 0 0.0004027554241474718
for O 0 4.4374111894285306e-05
L236P O 0 0.003124835202470422
and O 0 0.00011516991071403027
T416P O 0 0.006483518984168768
. O 0 0.00033911486389115453

In O 0 0.00010508809646125883
total O 0 6.210400897543877e-05
, O 0 1.775144482962787e-05
one O 0 4.192377218714682e-06
or O 0 2.0508527995843906e-06
both O 0 2.0329550807218766e-06
of O 0 3.072082108701579e-05
these O 0 8.314302249345928e-06
mutations O 0 1.3694330846192315e-05
were O 0 1.6701724234735593e-05
found O 0 3.658329205791233e-06
in O 0 6.936846602911828e-06
nine O 0 2.045969267783221e-05
of O 0 4.8201094614341855e-05
the O 0 7.347052451223135e-05
14 O 0 9.945803321897984e-05
families O 0 6.702911377942655e-06
analyzed O 0 0.00010525277320994064
. O 0 9.168282122118399e-05

The O 0 6.960509199416265e-05
identification O 0 9.498352483205963e-06
of O 0 6.904541805852205e-05
two O 0 2.9452085072989576e-05
frequent O 0 0.00010738847049651667
PDS B-Disease 1 0.9662373661994934
mutations O 0 1.630356018722523e-05
will O 0 1.9973601865785895e-06
facilitate O 0 1.0167368600377813e-05
the O 0 1.2848446203861386e-05
molecular O 0 5.4379732318921015e-05
diagnosis O 0 0.0026441612280905247
of O 1 0.9999592304229736
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9872022271156311

Insertional O 0 0.016108127310872078
mutation O 0 5.183458051760681e-05
by O 0 2.0016350390505977e-05
transposable O 0 0.0027213296853005886
element O 0 0.0005113250808790326
, O 0 0.0001429967232979834
L1 O 0 0.017967242747545242
, O 0 1.918368616316002e-05
in O 0 2.152662091248203e-05
the O 0 0.00017439262592233717
DMD B-Disease 1 0.9999207258224487
gene O 0 1.420159878762206e-05
results O 0 6.638100785494316e-06
in O 0 3.9737675251672044e-05
X B-Disease 0 0.41046231985092163
- I-Disease 1 0.9206541776657104
linked I-Disease 1 0.9985381364822388
dilated I-Disease 1 0.9999254941940308
cardiomyopathy I-Disease 1 1.0
. O 0 0.006520608440041542

X B-Disease 1 0.9989925026893616
- I-Disease 1 0.9996316432952881
linked I-Disease 1 0.9999722242355347
dilated I-Disease 1 0.9999973773956299
cardiomyopathy I-Disease 1 1.0
( O 0 0.1923786848783493
XLDCM B-Disease 1 0.9999998807907104
) O 0 4.9932139518205076e-05
is O 0 4.276222171029076e-06
a O 0 6.91500963512226e-06
clinical O 0 3.8559224776690826e-05
phenotype O 0 3.083843694184907e-05
of O 0 0.0003323142300359905
dystrophinopathy B-Disease 1 0.8772574067115784
which O 0 2.02233022719156e-05
is O 0 7.516740879509598e-06
characterized O 0 2.405556006124243e-05
by O 0 1.198856898554368e-05
preferential O 0 0.0005203746841289103
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9637446403503418
without O 0 0.00016652140766382217
any O 0 2.6499739760765806e-05
overt O 0 0.0003218244237359613
clinical O 0 0.0012858412228524685
signs O 1 0.9991673231124878
of O 1 0.9999997615814209
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9999936819076538

To O 0 7.191401527961716e-05
date O 0 0.00010283916344633326
, O 0 2.733950623223791e-06
several O 0 1.0995214552167454e-06
mutations O 0 7.813159754732624e-06
in O 0 6.309169111773372e-05
the O 0 0.25561031699180603
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9841610789299011
, O 0 0.004573477897793055
DMD O 1 1.0
, O 0 4.0334416553378105e-05
have O 0 1.4825616290181642e-06
been O 0 3.3635299132583896e-06
identified O 0 3.489241862553172e-06
in O 0 7.363780241576023e-06
patients O 0 1.4080282198847272e-05
with O 0 2.8445254429243505e-05
XLDCM B-Disease 1 0.999998927116394
, O 0 4.505275501287542e-05
but O 0 3.3612661809456768e-06
a O 0 5.8342288866697345e-06
pathogenic O 0 1.6510421119164675e-05
correlation O 0 6.8992271735623945e-06
of O 0 3.258403739891946e-05
these O 0 1.1841896593978163e-05
cardiospecific O 0 0.002157416893169284
mutations O 0 5.0444923545001075e-05
in O 0 0.0002422510733595118
DMD O 1 0.9999994039535522
with O 0 8.042820263653994e-05
the O 0 0.0008989708730950952
XLDCM B-Disease 1 0.9999009370803833
phenotype O 0 7.116570486687124e-05
has O 0 9.158188731817063e-06
remained O 0 0.00014856172492727637
to O 0 7.468594503734494e-06
be O 0 2.1311654563760385e-05
elucidated O 0 0.0052129593677818775
. O 0 0.00019747193437069654

We O 0 5.747675822931342e-05
report O 0 6.1165796978457365e-06
here O 0 5.230904662312241e-06
the O 0 5.047673766966909e-06
identification O 0 2.4092066723824246e-06
of O 0 3.692305472213775e-05
a O 0 3.54618787241634e-05
unique O 0 6.688846042379737e-05
de O 0 0.00134522735606879
novo O 0 0.00157751829829067
L1 O 0 0.009599093347787857
insertion O 0 0.00024644986842758954
in O 0 5.173463068786077e-05
the O 0 8.384662942262366e-05
muscle O 0 0.0001483059604652226
exon O 0 0.0003227157285436988
1 O 0 0.0002447900187689811
in O 0 0.00020689221855718642
DMD O 1 0.9999890327453613
in O 0 0.00018282432574778795
three O 0 9.834498632699251e-05
XLDCM B-Disease 1 0.9988070726394653
patients O 0 4.439722033566795e-05
from O 0 2.3560905901831575e-05
two O 0 1.2614390470844228e-05
unrelated O 0 0.00014462016406469047
Japanese O 0 0.0005328947445377707
families O 0 2.3809479898773134e-05
. O 0 8.668237569509074e-05

The O 0 0.0003162797656841576
insertion O 0 0.00035196414683014154
was O 0 0.00045566802145913243
a O 0 4.357566649559885e-05
5 O 0 9.517547732684761e-05
- O 0 7.16203503543511e-05
truncated O 0 4.387937588035129e-05
form O 0 5.037873052060604e-06
of O 0 0.0001136403443524614
human O 0 0.00021688912238460034
L1 O 0 0.017795220017433167
inversely O 0 0.0002775330503936857
integrated O 0 0.00011696707224473357
in O 0 1.8847520550480112e-05
the O 0 4.56496600236278e-05
5 O 0 9.213083831127733e-05
- O 0 8.776406320976093e-05
untranslated O 0 0.0007290765643119812
region O 0 8.452893234789371e-05
in O 0 1.9037537640542723e-05
the O 0 6.978907185839489e-05
muscle O 0 0.000157158327056095
exon O 0 0.0002682615304365754
1 O 0 6.398527330020443e-05
, O 0 2.385356992817833e-06
which O 0 8.06716627721471e-07
affected O 0 2.2208607788343215e-06
the O 0 6.626241884077899e-06
transcription O 0 5.296773451846093e-05
or O 0 6.237633897399064e-06
the O 0 3.7249032175168395e-05
stability O 0 0.0003525017818901688
of O 0 0.00014477275544777513
the O 0 0.00023795403831172734
muscle O 0 0.00013752946688327938
form O 0 3.0358378353412263e-05
of O 0 0.0005061428528279066
dystrophin O 0 0.0029354707803577185
transcripts O 0 0.0005718942848034203
but O 0 2.1166215447010472e-06
not O 0 2.6057256263811723e-07
that O 0 1.7929056639331975e-07
of O 0 2.4093624233501032e-05
the O 0 0.0004547535500023514
brain O 1 0.9967504739761353
or O 0 0.0009009976056404412
Purkinje O 1 0.988031268119812
cell O 0 0.0009909789077937603
form O 0 7.103267853381112e-05
, O 0 2.119949749612715e-05
probably O 0 5.4419411753769964e-05
due O 0 3.737947918125428e-05
to O 0 5.5017271733959205e-06
its O 0 3.5351893075130647e-06
unique O 0 3.817058768618153e-06
site O 0 5.8608977269614115e-05
of O 0 6.294853665167466e-05
integration O 0 0.0006213092710822821
. O 0 0.0003261156671214849

We O 0 6.015585677232593e-05
speculate O 0 4.303673995309509e-05
that O 0 5.426624056781293e-07
this O 0 4.782635301125993e-07
insertion O 0 1.6102761946967803e-05
of O 0 4.879260086454451e-05
an O 0 3.697644206113182e-05
L1 O 0 0.013701806776225567
sequence O 0 0.00018145875947084278
in O 0 0.000605814391747117
DMD O 1 0.9999920129776001
is O 0 2.935817428806331e-05
responsible O 0 1.4930960787751246e-05
for O 0 2.439014679112006e-06
some O 0 2.1594798909063684e-06
of O 0 2.124027378158644e-05
the O 0 1.8484077372704633e-05
population O 0 2.2326573798636673e-06
of O 0 2.6467840143595822e-05
Japanese O 0 0.00043281770194880664
patients O 0 3.066614590352401e-05
with O 0 3.902939715771936e-05
XLDCM B-Disease 1 0.9999963045120239
. O 0 0.000161450618179515
. O 0 0.00011163434101035818

Severe O 0 0.18893681466579437
early O 0 0.02013544924557209
- O 1 0.9996689558029175
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999675750732422
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999998807907104
red O 1 1.0
hair O 1 0.9990307092666626
pigmentation O 1 0.9960803389549255
caused O 1 0.9878026843070984
by O 0 0.0004265539173502475
POMC O 1 0.9999080896377563
mutations O 0 0.0001475634053349495
in O 0 0.00018155740690417588
humans O 0 0.00019395482377149165
. O 0 9.850210335571319e-05

Sequential O 0 0.0005201009334996343
cleavage O 0 0.0006204170058481395
of O 0 0.0003051897219847888
the O 0 0.00023143956786952913
precursor O 0 0.0006381666171364486
protein O 0 4.559762237477116e-05
pre O 0 0.0006810158374719322
- O 0 0.00043106626253575087
pro O 0 0.0007937226328067482
- O 0 0.0004020068154204637
opiomelanocortin O 0 0.002656894037500024
( O 0 8.694158168509603e-05
POMC O 0 0.02661200799047947
) O 0 8.795796929916833e-06
generates O 0 5.660843271471094e-06
the O 0 3.411533543840051e-05
melanocortin O 0 0.004538901150226593
peptides O 0 0.00014440450468100607
adrenocorticotrophin O 0 0.005705052986741066
( O 0 0.00021677810582332313
ACTH O 0 0.013598180375993252
) O 0 4.845577495871112e-05
, O 0 4.9684676923789084e-05
melanocyte O 0 0.010232951492071152
- O 0 0.002320613246411085
stimulating O 0 0.0018329875310882926
hormones O 0 0.00038635116652585566
( O 0 4.2555078834993765e-05
MSH O 0 0.038602542132139206
) O 0 1.2995274119020905e-05
alpha O 0 4.979457298759371e-05
, O 0 2.417280256850063e-06
beta O 0 2.0059957023477182e-05
and O 0 2.86941281046893e-06
gamma O 0 1.3778378161077853e-05
as O 0 3.761739208130166e-06
well O 0 1.0888776387218968e-06
as O 0 3.0845192213746486e-06
the O 0 1.304029137827456e-05
opioid O 0 0.00016821848112158477
- O 0 0.00011699584138114005
receptor O 0 1.6253603462246247e-05
ligand O 0 0.00014590528735425323
beta O 0 0.001148827257566154
- O 0 0.0012209441047161818
endorphin O 0 0.003197482554242015
. O 0 5.641244206344709e-05

While O 0 7.008251122897491e-05
a O 0 2.204783959314227e-05
few O 0 1.0035050763690379e-05
cases O 0 7.94106654211646e-06
of O 0 0.0007382986950688064
isolated O 1 0.9994024038314819
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
have O 0 3.942317925975658e-05
been O 0 8.601238369010389e-05
reported O 0 0.00012735329801216722
( O 0 0.00016048643738031387
OMIM O 1 0.9559850096702576
201400 O 0 0.0075493380427360535
) O 0 4.609050301951356e-05
, O 0 1.6341820810339414e-05
an O 0 5.407725620898418e-05
inherited O 1 1.0
POMC O 1 1.0
defect O 1 0.9999895095825195
has O 0 7.434700091835111e-05
not O 0 5.690601483365754e-06
been O 0 1.1096224625362083e-05
described O 0 2.360854523431044e-05
so O 0 9.191104254568927e-06
far O 0 2.678582677617669e-05
. O 0 4.4002783397445455e-05

Recent O 0 0.00010795213165692985
studies O 0 3.098296656389721e-05
in O 0 3.727251896634698e-05
animal O 0 2.3486854843213223e-05
models O 0 5.687433258572128e-06
elucidated O 0 0.00042260816553607583
a O 0 1.4244108569982927e-05
central O 0 6.121578917372972e-05
role O 0 3.5532222682377324e-05
of O 0 0.00028361499425955117
alpha O 0 0.0029170229099690914
- O 0 0.0017404648242518306
MSH O 0 0.025345453992486
in O 0 1.4621382433688268e-05
the O 0 1.4675921192974783e-05
regulation O 0 8.854239240463357e-06
of O 0 1.3885939551983029e-05
food O 0 9.429993042431306e-06
intake O 0 6.311352990451269e-06
by O 0 4.918712761536881e-07
activation O 0 1.2203902770124841e-05
of O 0 0.00011400263610994443
the O 0 0.0003969600657001138
brain O 0 0.008016284555196762
melanocortin O 0 0.046240516006946564
- O 0 0.00040151833673007786
4 O 0 0.00011073960195062682
- O 0 8.496613008901477e-05
receptor O 0 3.7161142245167866e-05
( O 0 4.0453214751323685e-05
MC4 O 0 0.03969142958521843
- O 0 0.00037326503661461174
R O 0 0.0003097260487265885
; O 0 3.6313804230303504e-06
refs O 0 0.00022660844842903316
3 O 0 4.998860458726995e-05
- O 0 3.844261300400831e-05
5 O 0 1.053217511071125e-05
) O 0 7.841277920306311e-07
and O 0 7.710528393545246e-07
the O 0 9.556377335684374e-06
linkage O 0 0.0001296891859965399
of O 0 0.00014026141434442252
human O 0 0.000370343477698043
obesity B-Disease 1 0.9998801946640015
to O 0 0.00010290370846632868
chromosome O 0 7.029830157989636e-05
2 O 0 8.403897663811222e-05
in O 0 1.7909549569594674e-05
close O 0 4.854504004470073e-05
proximity O 0 5.146586045157164e-05
to O 0 1.7211012163897976e-05
the O 0 0.00014140043640509248
POMC O 0 0.042797889560461044
locus O 0 0.00012866524048149586
, O 0 5.078086815046845e-06
led O 0 1.834593786043115e-05
to O 0 4.660903414333006e-06
the O 0 1.2580798284034245e-05
proposal O 0 3.589723974073422e-06
of O 0 1.2533211702248082e-05
an O 0 9.284256520913914e-06
association O 0 5.082649295218289e-05
of O 0 0.000689381267875433
POMC O 1 0.999993085861206
with O 0 0.00021827223827131093
human O 0 0.002202322008088231
obesity B-Disease 1 1.0
. O 0 0.0009276836644858122

The O 0 0.00011958557297475636
dual O 0 7.051825377857313e-05
role O 0 0.00010191602632403374
of O 0 0.000855805235914886
alpha O 0 0.0077607533894479275
- O 0 0.004472338128834963
MSH O 1 0.9338428974151611
in O 0 9.038995631271973e-05
regulating O 0 0.000547537172678858
food O 0 0.00012683955719694495
intake O 0 0.0003638537891674787
and O 0 8.354127930942923e-05
influencing O 0 0.0027543078176677227
hair O 0 0.0030582977924495935
pigmentation O 0 0.0036839270032942295
predicts O 0 0.0004277584084775299
that O 0 3.2208174616243923e-06
the O 0 2.126824801962357e-05
phenotype O 0 1.589391104062088e-05
associated O 0 4.7101361815293785e-06
with O 0 5.594593858404551e-06
a O 0 0.00016993963799905032
defect O 0 0.40659084916114807
in O 0 0.0007526471163146198
POMC O 1 0.999855637550354
function O 0 5.798146958113648e-05
would O 0 2.157726339646615e-05
include O 0 8.038042869884521e-05
obesity B-Disease 1 1.0
, O 0 9.482632594881579e-05
alteration O 0 0.0029119872488081455
in O 0 0.0011443442199379206
pigmentation O 1 0.9999551773071289
and O 1 0.9961821436882019
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.00530337356030941

The O 0 0.00020441685046534985
observation O 0 0.0002583540044724941
of O 0 0.000288831302896142
these O 0 5.0716782425297424e-05
symptoms O 0 0.0012119688326492906
in O 0 8.845048432704061e-05
two O 0 2.773603773675859e-05
probands O 0 0.0012168966932222247
prompted O 0 3.499657759675756e-05
us O 0 4.465664915187517e-06
to O 0 1.3155354281479958e-06
search O 0 3.32699505634082e-06
for O 0 2.0315751498856116e-06
mutations O 0 8.24981998448493e-06
within O 0 2.497909008525312e-05
their O 0 4.924899258185178e-05
POMC O 1 0.9831529259681702
genes O 0 0.00017017213394865394
. O 0 0.00019233163038734347

Patient O 0 0.0007237930549308658
1 O 0 0.0004907921538688242
was O 0 0.0004300634318497032
found O 0 7.800163075444289e-06
to O 0 7.62094032324967e-06
be O 0 5.884828624402871e-06
a O 0 1.4984480912971776e-05
compound O 0 0.00011464089766377583
heterozygote O 0 0.00014091374760027975
for O 0 3.33619027514942e-06
two O 0 3.8009884519851767e-06
mutations O 0 1.1521375199663453e-05
in O 0 4.187554441159591e-05
exon O 0 0.00027577902073971927
3 O 0 9.973211126634851e-05
( O 0 3.2657826523063704e-05
G7013T O 0 0.0011464526178315282
, O 0 2.2962845832807943e-05
C7133delta O 0 0.0017176910769194365
) O 0 6.759039024473168e-06
which O 0 1.3779159644400352e-06
interfere O 0 3.60714648195426e-06
with O 0 4.910600068797066e-07
appropriate O 0 4.319314939493779e-06
synthesis O 0 5.690433317795396e-05
of O 0 0.0008647181675769389
ACTH O 0 0.05710684135556221
and O 0 0.00026010535657405853
alpha O 0 0.0029177966061979532
- O 0 0.003084514755755663
MSH O 1 0.9672737121582031
. O 0 0.00016372956451959908

Patient O 0 0.0007672584033571184
2 O 0 0.00038139239768497646
was O 0 0.00032934918999671936
homozygous O 0 7.71486884332262e-06
for O 0 2.1885387013753643e-06
a O 0 8.65915080794366e-06
mutation O 0 2.647559995239135e-06
in O 0 2.154099456674885e-05
exon O 0 0.00019665309810079634
2 O 0 0.00013117580965626985
( O 0 3.34919968736358e-05
C3804A O 0 0.0005918135866522789
) O 0 1.4884741176501848e-05
which O 0 2.9052722311462276e-05
abolishes O 0 0.005816809833049774
POMC O 1 0.9952404499053955
translation O 0 0.0013579877559095621
. O 0 0.0003798251855187118

These O 0 3.0949831852922216e-05
findings O 0 2.1930096409050748e-05
represent O 0 1.0268525329593103e-05
the O 0 1.5013891243143007e-05
first O 0 7.705546522629447e-06
examples O 0 1.2740888450935017e-05
of O 0 7.017974712653086e-05
a O 0 0.00015212221478577703
genetic B-Disease 1 0.9999608993530273
defect I-Disease 1 0.9999997615814209
within O 0 0.0005406367708928883
the O 0 0.0012086171191185713
POMC O 1 0.998181939125061
gene O 0 1.3892891729483381e-05
and O 0 2.87039279101009e-06
define O 0 1.3828216651745606e-05
a O 0 2.27210512093734e-05
new O 0 0.00013850652612745762
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 1 0.9566943645477295
in O 0 0.0005324723897501826
early O 0 0.04925539344549179
- O 1 0.9882591962814331
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.999618649482727
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999986886978149
red O 1 0.9999996423721313
hair O 1 0.9885514974594116
pigmentation O 1 0.7283239364624023
. O 0 0.0002524381270632148
. O 0 0.0001833267160691321

A O 0 0.0008856073254719377
European O 0 5.3971951274434105e-05
multicenter O 0 0.0010356204584240913
study O 0 5.332102591637522e-05
of O 0 0.003381374990567565
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
: O 0 0.0003126092778984457
classification O 0 0.00023701526515651494
of O 0 0.0004771501407958567
105 O 0 0.0006221155053935945
mutations O 0 2.1909318093094043e-05
and O 0 2.9684642868232913e-06
a O 0 5.2757231969735585e-06
general O 0 1.1818926395790186e-05
system O 0 2.922473504440859e-05
for O 0 6.971910806896631e-06
genotype O 0 4.2326737457187846e-05
- O 0 5.178236824576743e-05
based O 0 2.013467337746988e-06
prediction O 0 4.4811604311689734e-05
of O 0 0.0002848542353603989
metabolic O 1 0.947605550289154
phenotype O 0 0.0007329795625992119
. O 0 0.00045480337576009333

Phenylketonuria B-Disease 1 0.9999874830245972
( O 0 0.0076311915181577206
PKU B-Disease 1 0.9999983310699463
) O 0 0.000182630232302472
and O 0 6.183217192301527e-05
mild B-Disease 0 0.19282478094100952
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9800398349761963
MHP B-Disease 1 1.0
) O 0 6.545284122694284e-05
are O 0 8.960369086707942e-06
allelic B-Disease 0 0.0065051657147705555
disorders I-Disease 1 1.0
caused O 1 0.9318627715110779
by O 0 4.3259096855763346e-05
mutations O 0 1.216507916979026e-05
in O 0 7.132323844416533e-06
the O 0 1.2448266716091894e-05
gene O 0 2.3975812837306876e-06
encoding O 0 2.3446033083018847e-05
phenylalanine O 0 0.0008524110307916999
hydroxylase O 0 0.005566906649619341
( O 0 0.0017137553077191114
PAH O 1 1.0
) O 0 0.0005240875179879367
. O 0 0.00018192773859482259

Previous O 0 0.00019747325859498233
studies O 0 1.8827255189535208e-05
have O 0 1.7735271740093594e-06
suggested O 0 3.627302930908627e-06
that O 0 5.723491085518617e-07
the O 0 4.911142696073512e-06
highly O 0 1.3532309822039679e-05
variable O 0 8.917683771869633e-06
metabolic O 0 0.004834775812923908
phenotypes O 0 0.004174764268100262
of O 1 0.9999994039535522
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9821338057518005
with O 1 0.6539026498794556
PAH O 1 1.0
genotypes O 1 0.976237416267395
. O 0 0.0008744347142055631

We O 0 3.875478796544485e-05
identified O 0 8.769095984462183e-06
both O 0 5.393698302214034e-06
causative O 0 0.0004955423064529896
mutations O 0 7.888134132372215e-05
in O 0 0.00020254365517757833
686 O 0 0.0038156898226588964
patients O 0 0.00011170270590810105
from O 0 6.193633453221992e-05
seven O 0 8.432267350144684e-05
European O 0 4.723459642264061e-05
centers O 0 0.00018696534971240908
. O 0 9.217504702974111e-05

On O 0 0.00032848844421096146
the O 0 2.7040377972298302e-05
basis O 0 9.189246156893205e-06
of O 0 2.297379614901729e-05
the O 0 1.5257100130838808e-05
phenotypic O 0 7.054732122924179e-05
characteristics O 0 8.65783731569536e-05
of O 0 0.0005625021294690669
297 O 0 0.0019947809632867575
functionally O 0 0.003597811795771122
hemizygous O 0 0.01702406443655491
patients O 0 7.43325290386565e-05
, O 0 6.738680895068683e-06
105 O 0 3.317260416224599e-05
of O 0 4.131040986976586e-05
the O 0 7.156941865105182e-05
mutations O 0 8.530685590812936e-06
were O 0 9.30407622945495e-06
assigned O 0 1.0656241101969499e-05
to O 0 7.993075087142643e-06
one O 0 3.795471457124222e-06
of O 0 2.592919918242842e-05
four O 0 9.4737479230389e-06
arbitrary O 0 6.077738362364471e-06
phenotype O 0 2.975432107632514e-05
categories O 0 0.0001653507206356153
. O 0 0.00026268576039001346

We O 0 4.183566852589138e-05
proposed O 0 3.031697815458756e-05
and O 0 7.95509731688071e-06
tested O 0 2.2834179617348127e-05
a O 0 5.678567049471894e-06
simple O 0 3.1987044621928362e-06
model O 0 2.2865472146804677e-06
for O 0 1.188828491649474e-06
correlation O 0 1.064646949089365e-05
between O 0 0.00013455789303407073
genotype O 0 8.647457434562966e-05
and O 0 1.0586006283119787e-05
phenotypic O 0 0.00023433817841578275
outcome O 0 0.0005691101541742682
. O 0 0.00041273748502135277

The O 0 0.00034785084426403046
observed O 0 7.956148328958079e-05
phenotype O 0 3.142560672131367e-05
matched O 0 3.809874760918319e-05
the O 0 3.330167237436399e-05
predicted O 0 9.858912380877882e-05
phenotype O 0 1.263853300770279e-05
in O 0 1.394172250002157e-05
79 O 0 6.847234908491373e-05
% O 0 9.16496901481878e-06
of O 0 0.00010001038754126057
the O 0 0.0002069480688078329
cases O 0 3.820673009613529e-05
, O 0 1.1613077731453814e-05
and O 0 3.3910616821231088e-06
in O 0 6.400119218596956e-06
only O 0 3.848537744488567e-06
5 O 0 2.214825690316502e-05
of O 0 3.979914617957547e-05
184 O 0 0.0002287558454554528
patients O 0 4.4516014895634726e-05
was O 0 0.00022044254001230001
the O 0 3.718365769600496e-05
observed O 0 1.4377032130141743e-05
phenotype O 0 4.696097221312812e-06
more O 0 4.694663573445723e-07
than O 0 9.014347597258165e-07
one O 0 1.62807941705978e-06
category O 0 3.359016773174517e-06
away O 0 7.352567081397865e-06
from O 0 3.846996605716413e-06
that O 0 2.529656512706424e-06
expected O 0 7.358467701124027e-05
. O 0 0.00010265066521242261

Among O 0 0.0001218776305904612
the O 0 4.9859914724947885e-05
seven O 0 3.5285516787553206e-05
contributing O 0 4.9615551688475534e-05
centers O 0 2.7900412533199415e-05
, O 0 2.46336321652052e-06
the O 0 6.347952421492664e-06
proportion O 0 1.0491552529856563e-05
of O 0 7.2232294769492e-05
patients O 0 3.2884527172427624e-05
for O 0 1.1840360457426868e-05
whom O 0 6.471502274507657e-05
the O 0 8.348378469236195e-05
observed O 0 4.930993964080699e-05
phenotype O 0 1.3829640920448583e-05
did O 0 6.3906477407726925e-06
not O 0 7.521348948102968e-07
match O 0 1.0240957635687664e-05
the O 0 1.2553007763926871e-05
predicted O 0 3.347915844642557e-05
phenotype O 0 8.763628102315124e-06
was O 0 7.130271114874631e-05
4 O 0 3.2355645089410245e-05
% O 0 1.1010714842996094e-05
- O 0 0.00011156389518873766
23 O 0 0.00012597735621966422
% O 0 2.3563265131087974e-05
( O 0 6.075345663703047e-05
P O 0 0.003299510572105646
< O 0 0.001599166658706963
. O 0 7.195427315309644e-05
0001 O 0 0.0076117669232189655
) O 0 1.3237913663033396e-05
, O 0 2.992060217366088e-06
suggesting O 0 9.137259439739864e-06
that O 0 7.518272582274221e-07
differences O 0 7.237610134325223e-06
in O 0 5.043386408942752e-06
methods O 0 3.215231799913454e-06
used O 0 9.192401194013655e-06
for O 0 1.5137360605876893e-05
mutation O 0 2.5067147362278774e-05
detection O 0 0.0001838462776504457
or O 0 4.4957181671634316e-05
phenotype O 0 5.5450891522923484e-05
classification O 0 8.692889241501689e-05
may O 0 4.123256803723052e-05
account O 0 4.0816539694787934e-06
for O 0 1.963920567504829e-06
a O 0 4.1483981476631016e-06
considerable O 0 3.575001755962148e-05
proportion O 0 4.456685564946383e-05
of O 0 0.00024923300952650607
genotype O 0 0.0008534355438314378
- O 0 0.0017412056913599372
phenotype O 0 0.0001740973675623536
inconsistencies O 0 0.0017408063868060708
. O 0 0.0003603602817747742

Our O 0 5.6067485274979845e-05
data O 0 1.4291403203969821e-05
indicate O 0 2.031064468610566e-05
that O 0 8.754424015933182e-06
the O 0 0.0009440373396500945
PAH O 1 1.0
- O 0 0.0017906252760440111
mutation O 0 8.570079444325529e-06
genotype O 0 1.1610829460551031e-05
is O 0 1.5388363863166887e-06
the O 0 5.745098860643338e-06
main O 0 4.788880323758349e-05
determinant O 0 0.00028429264784790576
of O 0 0.0003299922391306609
metabolic O 0 0.297971248626709
phenotype O 0 8.596809493610635e-05
in O 0 3.753357668756507e-05
most O 0 2.4674147425685078e-05
patients O 0 0.000259625434409827
with O 1 0.586214542388916
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.45826783776283264

In O 0 0.0001058950656442903
the O 0 4.939098653267138e-05
present O 0 3.6206405638949946e-05
study O 0 7.516812729591038e-06
, O 0 1.488568614149699e-06
the O 0 5.559702458413085e-06
classification O 0 3.882059172610752e-05
of O 0 0.0005777559708803892
105 O 0 0.015903495252132416
PAH O 1 1.0
mutations O 0 0.00020476113422773778
may O 0 4.660020931623876e-05
allow O 0 3.7565766888292274e-06
the O 0 1.1453815204731654e-05
prediction O 0 2.2384487238014117e-05
of O 0 1.1956735761486925e-05
the O 0 2.3563870854559354e-05
biochemical O 0 0.00012074655387550592
phenotype O 0 2.8833461328758858e-05
in O 0 3.201451909262687e-05
> O 0 0.0001339758455287665
10 O 0 2.8328928237897344e-05
, O 0 4.972687747795135e-06
000 O 0 0.0001003677025437355
genotypes O 0 0.00017867104907054454
, O 0 6.0128459153929725e-06
which O 0 3.0779719963902608e-06
may O 0 1.0864476280403323e-05
be O 0 1.21803100228135e-06
useful O 0 1.3999059547131765e-06
for O 0 1.0463307944519329e-06
the O 0 2.404642873443663e-05
management O 0 9.886430052574724e-05
of O 0 0.0005835292977280915
hyperphenylalaninemia B-Disease 1 0.9999995231628418
in O 0 0.0015849341871216893
newborns O 0 0.002771153813228011
. O 0 0.0002085147425532341

Somatic O 0 0.002514272229745984
instability O 0 0.00730799650773406
of O 0 0.002519911155104637
the O 0 0.0031254293862730265
CTG O 1 0.9994078874588013
repeat O 0 0.0005990049103274941
in O 0 4.430991975823417e-05
mice O 0 0.00010474593727849424
transgenic O 0 6.950984243303537e-05
for O 0 8.224259545386303e-06
the O 0 0.0024590594694018364
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9093580842018127
is O 0 0.00013109378051012754
age O 0 0.00019641174003481865
dependent O 0 1.599392999196425e-05
but O 0 1.5778261968080187e-06
not O 0 4.3631152379930427e-07
correlated O 0 2.336014404136222e-06
to O 0 1.7829306671046652e-06
the O 0 8.397703822993208e-06
relative O 0 5.219812737777829e-05
intertissue O 0 0.0015545482747256756
transcription O 0 0.0008443538681603968
levels O 0 0.0007034224690869451
and O 0 0.00014308061508927494
proliferative O 1 0.9990266561508179
capacities O 0 0.012963219545781612
. O 0 0.0008354134042747319

A O 0 0.007582198362797499
( O 0 0.0006813723011873662
CTG O 1 0.6151636838912964
) O 0 5.4449006711365655e-05
nexpansion O 0 0.0009719172958284616
in O 0 1.825340950745158e-05
the O 0 4.4040098146069795e-05
3 O 0 0.00010636951628839597
- O 0 0.00018404392176307738
untranslated O 0 0.0022625077981501818
region O 0 0.00045644771307706833
( O 0 7.162362453527749e-05
UTR O 0 0.013034726493060589
) O 0 6.290514193096897e-06
of O 0 2.6294472263543867e-05
the O 0 9.971176041290164e-05
DM O 1 0.999896764755249
protein O 0 5.4061478294897825e-05
kinase O 0 1.9978435375378467e-05
gene O 0 1.3241120541351847e-05
( O 0 2.5086663299589418e-05
DMPK O 0 0.014694745652377605
) O 0 3.771178853639867e-06
is O 0 1.6269867728624376e-06
responsible O 0 1.2978827726328745e-05
for O 0 7.772058597765863e-05
causing O 1 0.9999998807907104
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999688863754272
DM B-Disease 1 1.0
) O 0 0.0010081984801217914
. O 0 0.00031459267484024167

Major O 0 0.010786418803036213
instability O 0 0.06895748525857925
, O 0 3.361242852406576e-05
with O 0 3.900354386132676e-06
very O 0 8.1296620919602e-06
large O 0 1.966337913472671e-05
expansions O 0 0.00028546134126372635
between O 0 0.00018130880198441446
generations O 0 0.00013309877249412239
and O 0 6.486216989287641e-06
high O 0 9.752978075994179e-05
levels O 0 9.49716632021591e-05
of O 0 0.0002321924112038687
somatic O 0 0.0015599516918882728
mosaicism O 0 0.04584764316678047
, O 0 3.740647662198171e-05
is O 0 8.041748515097424e-06
observed O 0 2.232198676210828e-05
in O 0 5.147214324097149e-05
patients O 0 0.00012937189603690058
. O 0 0.0002210398524766788

There O 0 0.00010811984975589439
is O 0 8.497437193000223e-06
a O 0 6.01049532633624e-06
good O 0 2.962740154544008e-06
correlation O 0 3.863659458147595e-06
between O 0 4.7043722588568926e-05
repeat O 0 0.00022764879395253956
size O 0 2.0390154531924054e-05
( O 0 4.029956016893266e-06
at O 0 2.633975054777693e-05
least O 0 2.134133865183685e-06
in O 0 1.6738285921746865e-05
leucocytes O 0 0.0021972081158310175
) O 0 1.1502153029141482e-05
, O 0 3.1892800507193897e-06
clinical O 0 4.816819273401052e-05
severity O 0 0.0011048291344195604
and O 0 8.277611777884886e-05
age O 0 0.0009959766175597906
of O 0 0.0044416384771466255
onset O 1 0.9999998807907104
. O 0 0.0033196068834513426

The O 0 0.0019456484587863088
trinucleotide O 1 0.9997320771217346
repeat O 0 0.0032095417845994234
instability O 0 0.004208168480545282
mechanisms O 0 0.0002854256599675864
involved O 0 0.0001384759962093085
in O 0 0.0003677122003864497
DM B-Disease 1 1.0
and O 0 4.0113958675647154e-05
other O 0 1.4674102203571238e-05
human O 0 0.0003102772170677781
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 9.60260076681152e-05
unknown O 0 0.0008535193046554923
. O 0 0.0001859229087131098

We O 0 6.841895810794085e-05
studied O 0 0.00017468200530856848
somatic O 0 0.0003409265773370862
instability O 0 0.0014278655871748924
by O 0 2.8754762752214447e-05
measuring O 0 0.002564772730693221
the O 0 0.0006979859317652881
CTG O 1 0.578715443611145
repeat O 0 0.0005022544064559042
length O 0 2.5461837140028365e-05
at O 0 4.781916504725814e-05
several O 0 4.858603915636195e-06
ages O 0 4.355809869593941e-05
in O 0 1.0069081326946616e-05
various O 0 2.825945193762891e-05
tissues O 0 0.00015285942936316133
of O 0 0.0003634268359746784
transgenic O 0 0.0017697546863928437
mice O 0 0.00011601555161178112
carrying O 0 2.932162897195667e-05
a O 0 4.1729719669092447e-05
( O 0 8.454763883491978e-05
CTG O 0 0.47810718417167664
) O 0 5.8967998484149575e-05
55expansion O 0 0.002031771233305335
surrounded O 0 0.0003414339735172689
by O 0 4.816253749595489e-06
45 O 0 1.850788976298645e-05
kb O 0 0.0007462656940333545
of O 0 0.00015970620734151453
the O 0 0.0003637630434241146
human O 0 0.0007141092792153358
DM B-Disease 1 1.0
region O 0 0.0013055413728579879
, O 0 1.2140787475800607e-05
using O 0 8.531947059964295e-06
small O 0 3.0704417440574616e-05
- O 0 0.00020833390590269119
pool O 0 0.00026052576140500605
PCR O 0 0.00015928418724797666
. O 0 6.351098272716627e-05

These O 0 0.00015966188220772892
mice O 0 0.00011316217569401488
have O 0 1.7023020291162538e-06
been O 0 3.57313797394454e-06
shown O 0 9.54413553699851e-06
to O 0 8.920371328713372e-06
reproduce O 0 2.9463155442499556e-05
the O 0 1.9634073396446183e-05
intergenerational O 0 0.0001927169505506754
and O 0 1.6204852727241814e-05
somatic O 0 0.0001363164046779275
instability O 0 0.0013871716801077127
of O 0 0.0007600315730087459
the O 0 0.0007716744439676404
55 O 0 0.0011751697165891528
CTG O 1 0.9437752962112427
repeat O 0 0.0005719531327486038
suggesting O 0 4.532990715233609e-05
that O 0 1.0241709560432355e-06
surrounding O 0 3.886548802256584e-05
sequences O 0 3.5734105949813966e-06
and O 0 2.5281419766542967e-06
the O 0 2.2693639039061964e-05
chromatin O 0 0.0002133254165528342
environment O 0 9.024670362123288e-06
are O 0 4.0875178797250555e-07
involved O 0 5.410751782619627e-06
in O 0 5.964939919067547e-05
instability O 0 0.015881994739174843
mechanisms O 0 0.00222983630374074
. O 0 0.00033014328801073134

As O 0 0.00014494764036498964
observed O 0 2.3352713469648734e-05
in O 0 7.945952347654384e-06
some O 0 2.7908974971069256e-06
of O 0 4.658168472815305e-05
the O 0 0.00017585135356057435
tissues O 0 0.0005254826392047107
of O 0 0.003993410617113113
DM B-Disease 1 1.0
patients O 0 0.001229962334036827
, O 0 3.585804734029807e-05
there O 0 1.3546306945499964e-05
is O 0 6.626866706938017e-06
a O 0 1.0850301805476192e-05
tendency O 0 2.5100778657360934e-05
for O 0 1.1644838195934426e-05
repeat O 0 0.00040143128717318177
length O 0 4.6694560296600685e-05
and O 0 1.4908537195879035e-05
somatic O 0 0.0001903772063087672
mosaicism O 0 0.004436438903212547
to O 0 2.823881368385628e-05
increase O 0 1.1508768693602178e-05
with O 0 3.2121552067110315e-06
the O 0 4.444415390025824e-05
age O 0 0.00015638892364222556
of O 0 0.00025796311092562973
the O 0 0.000678147713188082
mouse O 0 0.0006248954450711608
. O 0 0.00011158773122588173

Furthermore O 0 0.0010437702294439077
, O 0 2.050790499197319e-05
we O 0 4.218108188069891e-06
observed O 0 6.470715561590623e-06
no O 0 2.93538096229895e-06
correlation O 0 8.970578164735343e-06
between O 0 5.3316703997552395e-05
the O 0 4.793870175490156e-05
somatic O 0 6.29898568149656e-05
mutation O 0 1.129899737861706e-05
rate O 0 4.281600922695361e-05
and O 0 5.154130485607311e-05
tissue O 0 0.0027420055121183395
proliferation O 1 0.9981541037559509
capacity O 0 0.00488612474873662
. O 0 0.0002880816755350679

The O 0 0.0006840751739218831
somatic O 0 0.00035462999949231744
mutation O 0 1.71866067830706e-05
rates O 0 1.3423865311779082e-05
in O 0 6.003070666338317e-06
different O 0 9.840832717600279e-07
tissues O 0 3.54212497768458e-05
were O 0 8.251347026089206e-06
also O 0 2.569076059444342e-06
not O 0 7.589424626530672e-07
correlated O 0 2.94179835691466e-06
to O 0 2.761183168331627e-06
the O 0 2.273492282256484e-05
relative O 0 7.567818101961166e-05
inter O 0 0.00443928362801671
- O 0 0.0007091694278642535
tissue O 0 5.1278573664603755e-05
difference O 0 5.9471708482305985e-06
in O 0 4.1474131649010815e-06
transcriptional O 0 1.3132242202118505e-05
levels O 0 1.4889667909301352e-05
of O 0 7.954664397402667e-06
the O 0 1.0764221769932192e-05
three O 0 3.931035280402284e-06
genes O 0 8.284677278425079e-06
( O 0 2.7151309041073546e-05
DMAHP O 1 0.599138081073761
, O 0 8.02597205620259e-05
DMPK O 0 0.08025749772787094
and O 0 4.0475206333212554e-05
59 O 0 0.00015925228944979608
) O 0 2.480809598637279e-05
surrounding O 0 0.0003271701280027628
the O 0 0.0001269234053324908
repeat O 0 0.0006380285485647619
. O 0 4.964044637745246e-05
. O 0 6.434911483665928e-05

A O 0 0.002102744532749057
novel O 0 0.0003619771741796285
missense O 0 0.00045606560888700187
mutation O 0 2.085342930513434e-05
in O 0 4.3026480852859095e-05
patients O 0 4.127174543100409e-05
from O 0 9.071273234440014e-05
a O 0 0.00025264493888244033
retinoblastoma B-Disease 1 0.8542535901069641
pedigree O 0 0.0007890331908129156
showing O 0 0.00021929916692897677
only O 0 1.7436568668927066e-05
mild O 0 6.6999280534219e-05
expression O 0 1.9879531464539468e-05
of O 0 0.0002280926564708352
the O 0 0.001136917038820684
tumor B-Disease 1 0.9991083741188049
phenotype O 0 0.00042577943531796336
. O 0 0.00022286936291493475

We O 0 4.123822509427555e-05
have O 0 2.9729833386227256e-06
used O 0 1.1007365174009465e-05
single O 0 9.880555808194913e-06
strand O 0 1.5273231838364154e-05
conformation O 0 2.5354556782986037e-06
polymorphism O 0 7.126532182155643e-07
analysis O 0 3.0514931381731003e-07
to O 0 9.571576811140403e-07
study O 0 1.6546646293136291e-06
the O 0 8.323759175254963e-06
27 O 0 7.996605563675985e-05
exons O 0 0.00011678796727210283
of O 0 0.0001202729981741868
the O 0 0.0007525524124503136
RB1 O 1 0.9841324090957642
gene O 0 1.5019274542282801e-05
in O 0 9.233714081346989e-06
individuals O 0 1.828331733122468e-06
from O 0 2.198755828430876e-05
a O 0 3.7908117519691586e-05
family O 0 3.1997249607229605e-05
showing O 0 0.00014958686369936913
mild O 0 0.00018898313282988966
expression O 0 4.754216206492856e-05
of O 0 0.00030194970895536244
the O 0 0.0007453311118297279
retinoblastoma B-Disease 1 0.9942793846130371
phenotype O 0 0.0004998415824957192
. O 0 0.00027612759731709957

In O 0 7.744462345726788e-05
this O 0 3.0740029615117237e-06
family O 0 5.845607574883616e-06
affected O 0 6.440388460760005e-06
individuals O 0 2.4596401999588124e-06
developed O 0 0.0003739740059245378
unilateral B-Disease 0 0.002536491956561804
tumors I-Disease 1 1.0
and O 0 0.00016427879745606333
, O 0 1.1381991498637944e-05
as O 0 9.037588824867271e-06
a O 0 5.333697572496021e-06
result O 0 5.473967576108407e-06
of O 0 8.37722109281458e-05
linkage O 0 0.0006384568987414241
analysis O 0 2.018184204644058e-05
, O 0 2.343315827602055e-05
unaffected O 0 0.00011246860958635807
mutation O 0 7.01084127285867e-06
carriers O 0 6.085179393267026e-06
were O 0 8.281130249088164e-06
also O 0 4.131476543989265e-06
identified O 0 1.5693993191234767e-05
within O 0 2.3903347027953714e-05
the O 0 9.944228804670274e-05
pedigree O 0 0.0012232057051733136
. O 0 0.0001688738411758095

A O 0 0.0014609525678679347
single O 0 6.422086880775169e-05
band O 0 0.00021756766363978386
shift O 0 5.979826892144047e-05
using O 0 1.9216387954656966e-05
SSCP O 0 0.025996021926403046
was O 0 0.0002455838839523494
identified O 0 1.3857814337825403e-05
in O 0 1.640822119952645e-05
exon O 0 0.00012868385238107294
21 O 0 5.888056330149993e-05
which O 0 3.768496753764339e-06
resulted O 0 4.340782470535487e-05
in O 0 1.835808507166803e-05
a O 0 2.1879041014472023e-05
missense O 0 9.710354788694531e-05
mutation O 0 8.277450433524791e-06
converting O 0 0.0001320875744568184
a O 0 0.00022099667694419622
cys O 0 0.058089472353458405
- O 0 0.0017442088574171066
- O 0 0.00042490140185691416
> O 0 0.00012097069702576846
arg O 0 6.956932338653132e-05
at O 0 6.016136103426106e-05
nucleotide O 0 1.152646291302517e-05
position O 0 2.966649117297493e-05
28 O 0 0.00010208897583652288
in O 0 2.997333103849087e-05
the O 0 0.00021409158944152296
exon O 0 0.0012264467077329755
. O 0 0.00010292570368619636

The O 0 0.00042442575795575976
mutation O 0 5.7813729654299095e-05
destroyed O 0 0.0012670180294662714
an O 0 2.961730569950305e-05
NdeI O 0 0.003726357826963067
restriction O 0 8.134957170113921e-05
enzyme O 0 4.5080436393618584e-05
site O 0 0.0006251848535612226
. O 0 0.00012944245827384293

Analysis O 0 1.3075804417894688e-05
of O 0 5.9993501054123044e-05
all O 0 1.1615691619226709e-05
family O 0 1.076082480722107e-05
members O 0 3.142519062748761e-06
demonstrated O 0 2.4738494175835513e-05
that O 0 1.3540537793232943e-06
the O 0 1.6780064470367506e-05
missense O 0 0.00020763507927767932
mutation O 0 2.405230225122068e-05
co O 0 0.00030110395164228976
- O 0 0.00017977567040361464
segregated O 0 6.205350655363873e-05
with O 0 5.184587735129753e-06
patients O 0 0.00010978586215060204
with O 0 0.0005588598432950675
tumors B-Disease 1 1.0
or O 0 0.0021077431738376617
who O 0 0.00013940884673502296
, O 0 1.5278972568921745e-05
as O 0 1.3280426173878368e-05
a O 0 8.149214409058914e-06
result O 0 9.094166671275161e-06
of O 0 4.8640173190506175e-05
linkage O 0 0.00018569240637589246
analysis O 0 4.523749794316245e-06
had O 0 2.9069631636957638e-05
been O 0 8.76534977578558e-06
predicted O 0 1.2904307368444279e-05
to O 0 2.680424813661375e-06
carry O 0 5.503321972355479e-06
the O 0 4.471039937925525e-05
predisposing O 0 0.0015229673590511084
mutation O 0 5.525241795112379e-05
. O 0 0.00015365349827334285

These O 0 2.0736464648507535e-05
observations O 0 4.47624406660907e-05
point O 0 8.189252548618242e-05
to O 0 1.1249518138356507e-05
another O 0 1.0875516636588145e-05
region O 0 7.264801388373598e-05
of O 0 0.00012395592057146132
the O 0 0.0005047620506957173
RB1 O 1 0.9976505637168884
gene O 0 2.1518861103686504e-05
where O 0 1.2958618754055351e-05
mutations O 0 2.334166083528544e-06
only O 0 1.0133236401088652e-06
modify O 0 3.463356506472337e-06
the O 0 4.96519578518928e-06
function O 0 2.690533165150555e-06
of O 0 2.6790630727191456e-05
the O 0 7.2317139711231e-05
gene O 0 1.073715520760743e-05
and O 0 4.277478637959575e-06
raise O 0 8.945580702857114e-06
important O 0 4.4203193283465225e-06
questions O 0 1.7358040622639237e-06
for O 0 9.310983273280726e-07
genetic O 0 2.2588788851862773e-05
counseling O 0 4.296309271012433e-05
in O 0 3.159319021506235e-05
families O 0 6.082306754251476e-06
with O 0 6.404252417269163e-06
these O 0 1.6584923287155107e-05
distinctive O 0 0.0002388204593444243
phenotypes O 0 0.0008882355759851635
. O 0 0.00019177439389750361
. O 0 0.00024876627139747143

Maternal B-Disease 0 0.01358017511665821
disomy I-Disease 1 0.9993069171905518
and O 0 0.005266065243631601
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.008022790774703026
with O 0 0.0002689662796910852
gamete O 0 0.00906537938863039
complementation O 0 0.004879535175859928
in O 0 9.924107871484011e-05
a O 0 2.2876070943311788e-05
case O 0 1.504766260040924e-05
of O 0 8.642856846563518e-05
familial O 0 0.0012594974832609296
translocation O 0 0.004150636959820986
( O 0 9.321506513515487e-05
3 O 0 0.00017509925237391144
; O 0 6.649657734669745e-06
15 O 0 7.287546031875536e-05
) O 0 1.3139332622813527e-05
( O 0 2.031577969319187e-05
p25 O 0 0.0010183569975197315
; O 0 8.822562449495308e-06
q11 O 0 0.000429635401815176
. O 0 1.723032255540602e-05
2 O 0 0.00015776626241859049
) O 0 3.683496106532402e-05
. O 0 7.01710523571819e-05

Maternal B-Disease 0 0.3194406032562256
uniparental I-Disease 1 0.9999922513961792
disomy I-Disease 1 0.9999802112579346
( I-Disease 0 0.004167787730693817
UPD I-Disease 1 0.9999984502792358
) I-Disease 0 4.030431227874942e-05
for I-Disease 0 2.000730273721274e-05
chromosome I-Disease 0 0.00014590026694349945
15 I-Disease 0 6.446581392083317e-05
is O 0 3.82072994398186e-06
responsible O 0 5.067709480499616e-06
for O 0 1.422758373337274e-06
an O 0 1.880940203591308e-06
estimated O 0 1.8407064999337308e-05
30 O 0 1.0972569725709036e-05
% O 0 1.1033976079488639e-06
of O 0 1.099207020160975e-05
cases O 0 1.5991032341844402e-05
of O 0 0.00246490933932364
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999946355819702
PWS B-Disease 1 1.0
) O 0 0.0025463253259658813
. O 0 0.0005596360424533486

We O 0 4.504180105868727e-05
report O 0 5.447792318591382e-06
on O 0 1.1985162018390838e-05
an O 0 1.1092087106590043e-06
unusual O 0 3.7180700473982142e-06
case O 0 1.8890203136834316e-05
of O 0 0.00013830380339641124
maternal B-Disease 0 0.0014663997571915388
disomy I-Disease 0 0.07235818356275558
15 I-Disease 0 0.000734628876671195
in O 0 0.0005417946958914399
PWS B-Disease 1 1.0
that O 0 1.588672967045568e-05
is O 0 3.5073242088401457e-06
most O 0 1.6571596006542677e-06
consistent O 0 5.145487648405833e-06
with O 0 2.4845478492352413e-06
adjacent O 0 0.00035172581556253135
- O 0 0.00020405210671015084
1 O 0 0.00011205209011677653
segregation O 0 0.0004265056049916893
of O 0 5.0818543968489394e-05
a O 0 4.8246529331663623e-05
paternal O 0 0.00034815454273484647
t O 0 0.00019976988551206887
( O 0 1.2792646884918213e-05
3 O 0 6.58433636999689e-05
; O 0 4.734563390229596e-06
15 O 0 6.281003152253106e-05
) O 0 1.5553654520772398e-05
( O 0 2.2802236344432458e-05
p25 O 0 0.0010456170421093702
; O 0 1.010060623229947e-05
q11 O 0 0.0003436179249547422
. O 0 4.560660727292998e-06
2 O 0 1.932935083459597e-05
) O 0 9.25799838569219e-07
with O 0 5.75368972022261e-07
simultaneous O 0 1.4559215742337983e-05
maternal O 0 0.000630396360065788
meiotic O 0 0.01266403216868639
nondisjunction O 0 0.01372972410172224
for O 0 0.00015020662976894528
chromosome O 0 0.0007541317609138787
15 O 0 0.0007842450868338346
. O 0 0.00029536656802520156

The O 0 0.0004329606599640101
patient O 0 0.00013762811431661248
( O 0 4.94155719934497e-05
J O 0 0.0029980107210576534
. O 0 2.7578840672504157e-05
B O 0 0.00028562056832015514
. O 0 2.946091171907028e-06
) O 0 8.877540267349104e-07
, O 0 9.19991009595833e-07
a O 0 6.819292138970923e-06
17 O 0 0.0001440628693671897
- O 0 0.00015584408538416028
year O 0 7.199586980277672e-05
- O 0 0.00021172300330363214
old O 0 0.0004022636858280748
white O 0 8.775887545198202e-05
male O 0 9.654182940721512e-05
with O 0 9.276486525777727e-05
PWS B-Disease 1 1.0
, O 0 0.00017336104065179825
was O 0 0.00028132693842053413
found O 0 5.172039436729392e-06
to O 0 4.440761131263571e-06
have O 0 1.4988563634688035e-06
47 O 0 2.1401756384875625e-05
chromosomes O 0 1.295347829000093e-05
with O 0 2.8639781248784857e-06
a O 0 5.3623913117917255e-05
supernumerary O 0 0.005151126533746719
, O 0 0.00010125703556695953
paternal O 0 0.0010013625724241138
der O 1 0.9756361246109009
( O 0 9.782401320990175e-05
15 O 0 9.914913243846968e-05
) O 0 4.928841008222662e-06
consisting O 0 1.1626552804955281e-05
of O 0 0.00015381300181616098
the O 0 0.00048273353604599833
short O 0 0.00037536578020080924
arm O 0 0.0005051653715781868
and O 0 2.15450218092883e-05
the O 0 0.0002499483525753021
proximal O 1 0.9730100035667419
long O 0 0.0018580210162326694
arm O 0 0.0007380932802334428
of O 0 0.0005934410728514194
chromosome O 0 0.0008491096668876708
15 O 0 0.0004627925518434495
, O 0 5.150484503246844e-05
and O 0 5.805344699183479e-05
distal O 1 0.9995375871658325
chromosome O 1 0.9955527186393738
arm O 1 0.9990884065628052
3p O 1 0.9999414682388306
. O 0 0.002143849851563573

The O 0 0.0013629930326715112
t O 0 0.0004574443446472287
( O 0 2.0972773199900985e-05
3 O 0 5.2145445806672797e-05
; O 0 2.5976644337788457e-06
15 O 0 2.9337770683923736e-05
) O 0 4.198643182462547e-06
was O 0 6.0109407058916986e-05
present O 0 1.1415188964747358e-05
in O 0 1.1307060049148276e-05
the O 0 1.936451553774532e-05
balanced O 0 3.0017893095646286e-06
state O 0 2.6344432626501657e-06
in O 0 6.568252501892857e-06
the O 0 3.808044129982591e-05
patients O 0 4.386243017506786e-05
father O 0 0.0003201703366357833
and O 0 3.082006151089445e-05
a O 0 0.00013938119809608907
sister O 0 0.0008212202810682356
. O 0 0.00015263655222952366

Fluorescent O 0 0.002053934382274747
in O 0 0.00021797502995468676
situ O 0 0.0018156628357246518
hybridization O 0 1.0587388715066481e-05
analysis O 0 3.4527636216807878e-06
demonstrated O 0 7.762591849314049e-05
that O 0 6.5107269620057195e-06
the O 0 0.00020764536748174578
PWS B-Disease 1 1.0
critical O 0 0.0003249233413953334
region O 0 0.0003361000563018024
resided O 0 0.0005870378226973116
on O 0 6.253927858779207e-05
the O 0 3.6202814953867346e-05
derivative O 0 8.539274131180719e-05
chromosome O 0 7.69592443248257e-05
3 O 0 6.589297845494002e-05
and O 0 2.9054137939965585e-06
that O 0 1.4301588180387625e-06
there O 0 5.223267635301454e-06
was O 0 5.848162618349306e-05
no O 0 5.659229373122798e-06
deletion O 0 6.377359386533499e-05
of O 0 0.00030119181610643864
the O 0 0.002150909276679158
PWS B-Disease 1 1.0
region O 0 0.0020552745554596186
on O 0 0.00029695709235966206
the O 0 9.659247734816745e-05
normal O 0 4.2221476178383455e-05
pair O 0 2.1576768631348386e-05
of O 0 8.785147656453773e-05
15s O 0 0.0012641956564038992
present O 0 0.0001461500651203096
in O 0 0.0004366659850347787
J O 1 0.9809826016426086
. O 0 0.0006511707906611264

B O 0 0.04180106893181801
. O 0 0.0007520907092839479

Methylation O 0 6.212563312146813e-05
analysis O 0 1.1266115507169161e-05
at O 0 0.00027916571707464755
exon O 0 0.00018272428133059293
alpha O 0 4.365636414149776e-05
of O 0 1.8390113837085664e-05
the O 0 2.792610030155629e-05
small O 0 1.3892508832213935e-05
nuclear O 0 0.0007614045753143728
ribonucleoprotein O 0 0.003580166259780526
- O 0 9.189033880829811e-05
associated O 0 7.735180588497315e-06
polypeptide O 0 0.00015721964882686734
N O 0 0.001001217169687152
( O 0 6.10696806688793e-05
SNRPN O 1 0.7259666323661804
) O 0 1.5321196769946255e-05
gene O 0 7.399584774248069e-06
showed O 0 3.099638706771657e-05
a O 0 1.9298147890367545e-05
pattern O 0 7.903584628365934e-05
characteristic O 0 4.3830648792209104e-05
of O 0 0.00011847462883451954
only O 0 1.391182559018489e-05
the O 0 5.213033000472933e-05
maternal O 0 0.0002985798055306077
chromosome O 0 0.00012781828991137445
15 O 0 0.00016628880985081196
in O 0 0.00021713141177315265
J O 0 0.2531611919403076
. O 0 0.0003959479508921504

B O 0 0.05389741063117981
. O 0 0.0008309404365718365

Maternal B-Disease 0 0.007548208814114332
disomy I-Disease 0 0.012415321543812752
was O 0 0.0003701829118654132
confirmed O 0 1.735393743729219e-05
by O 0 2.3544075702375267e-06
polymerase O 0 7.591062603751197e-05
chain O 0 1.6766660337452777e-05
reaction O 0 9.910177141136955e-07
analysis O 0 7.236563988044509e-07
of O 0 6.241975643206388e-05
microsatellite O 0 0.0009561936603859067
repeats O 0 0.0001739582949085161
at O 0 0.00014826422557234764
the O 0 5.633937689708546e-05
gamma O 0 0.00014839549839962274
- O 0 0.00011098878894699737
aminobutyric O 0 0.00033146183704957366
acid O 0 1.111934852815466e-05
receptor O 0 8.364963832718786e-06
beta3 O 0 0.00041027163388207555
subunit O 0 2.2852738766232505e-05
( O 0 2.485495679138694e-05
GABRB3 O 0 0.024913087487220764
) O 0 4.134808841627091e-05
locus O 0 0.00021349330199882388
. O 0 0.0001291258813580498

A O 0 0.006787854712456465
niece O 0 0.0047846222296357155
( O 0 6.8018285674043e-05
B O 0 0.0008330115233547986
. O 0 2.0078754459973425e-05
B O 0 0.00018738352810032666
. O 0 2.861351731553441e-06
) O 0 5.642478413392382e-07
with O 0 1.0443728797326912e-06
45 O 0 2.099802986776922e-05
chromosomes O 0 1.0552703315624967e-05
and O 0 3.985696366726188e-06
the O 0 1.811924266803544e-05
derivative O 0 2.889517418225296e-05
3 O 0 4.12966292060446e-05
but O 0 1.9032937643714831e-06
without O 0 3.916583409591112e-06
the O 0 6.830467464169487e-05
der O 0 0.025384200736880302
( O 0 5.3850362746743485e-05
15 O 0 0.00012410400086082518
) O 0 1.4595944776374381e-05
demonstrated O 0 5.907447848585434e-05
a O 0 1.4923245544196106e-05
phenotype O 0 1.2453621820895933e-05
consistent O 0 4.698489647125825e-06
with O 0 6.086242478886561e-07
that O 0 7.434134090544831e-07
reported O 0 5.2626178330683615e-06
for O 0 4.9822338041849434e-06
haploinsufficiency O 0 0.002470513805747032
of O 0 0.0008105842280201614
distal O 0 0.11937083303928375
3 O 0 0.008139724843204021
p O 0 0.004866189323365688
. O 0 0.0003279004886280745

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999994039535522
associated O 0 0.0007819962338544428
with O 0 9.837800462264568e-05
unbalanced O 0 0.002960007172077894
segregation O 0 0.013321117497980595
of O 0 0.002182006137445569
non O 0 0.064325250685215
- O 0 0.007438963279128075
Robertsonian O 0 0.010353615507483482
translocations O 0 0.00012469427019823343
has O 0 4.673169769375818e-06
been O 0 4.743855242850259e-06
reported O 0 4.545619503915077e-06
previously O 0 1.070472444553161e-05
but O 0 9.665100151323713e-07
has O 0 1.269999984288006e-06
not O 0 1.0410753930045757e-06
, O 0 1.2342177342361538e-06
to O 0 2.62593493971508e-06
our O 0 9.031816261995118e-06
knowledge O 0 2.837757347151637e-05
, O 0 3.3128490031231195e-06
been O 0 3.0175929168763105e-06
observed O 0 2.5715812626003753e-06
in O 0 5.4563352023251355e-06
a O 0 1.4701780855830293e-05
case O 0 0.0001063680974766612
of O 0 0.002398950280621648
PWS B-Disease 1 1.0
. O 0 0.003041768679395318

Furthermore O 0 0.0014386147959157825
, O 0 3.424033639021218e-05
our O 0 1.292100569116883e-05
findings O 0 3.641954435806838e-06
are O 0 2.548222823861579e-07
best O 0 1.4482926644632244e-06
interpreted O 0 7.5791776907863095e-06
as O 0 1.0477134310349356e-05
true O 0 6.685447442578152e-05
gamete O 0 0.000625291489996016
complementation O 0 0.0015266896225512028
resulting O 0 0.00037179901846684515
in O 0 0.00040061603067442775
maternal B-Disease 0 0.29048237204551697
UPD I-Disease 1 1.0
15 I-Disease 0 0.012993047945201397
and O 0 0.002777601359412074
PWS B-Disease 1 1.0

Schwartz B-Disease 0 0.035684943199157715
- I-Disease 1 0.8733512759208679
Jampel I-Disease 1 0.999992847442627
syndrome I-Disease 1 0.9999998807907104
type I-Disease 0 0.0009045432670973241
2 I-Disease 0 0.0019800171721726656
and O 0 0.00033321144292131066
Stuve B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999761581420898
Wiedemann I-Disease 1 0.9999959468841553
syndrome I-Disease 1 0.9999998807907104
: O 0 4.7246132453437895e-05
a O 0 2.016529833781533e-05
case O 0 1.9709905245690607e-05
for O 0 8.393363714276347e-06
" O 0 0.00016873284766916186
lumping O 0 0.0007466256502084434
" O 0 0.00046030813246034086
. O 0 0.00013489960110746324

Recent O 0 0.00010529042629059404
studies O 0 2.36827545450069e-05
demonstrated O 0 0.00011623391037574038
the O 0 3.442295565037057e-05
existence O 0 5.626780694001354e-05
of O 0 4.4064167013857514e-05
a O 0 3.7933612475171685e-05
genetically O 0 3.0804905691184103e-05
distinct O 0 6.84839778841706e-06
, O 0 3.5053378724114737e-06
usually O 0 8.302665150949906e-07
lethal O 0 3.145127720927121e-06
form O 0 1.09216625787667e-06
of O 0 3.515522985253483e-05
the O 0 0.00011837118654511869
Schwartz B-Disease 0 0.0023506740108132362
- I-Disease 0 0.01399995107203722
Jampel I-Disease 1 0.9999986886978149
syndrome I-Disease 1 1.0
( O 0 0.002045714296400547
SJS B-Disease 1 1.0
) O 0 9.686309931566939e-05
of O 0 0.0018230231944471598
myotonia B-Disease 1 1.0
and O 0 0.015875302255153656
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.0007962293457239866
which O 0 6.386189488694072e-05
we O 0 4.729679858428426e-05
called O 0 0.00017368716362398118
SJS B-Disease 1 0.9962747097015381
type I-Disease 0 0.0003056873974855989
2 I-Disease 0 0.0006491971435025334
. O 0 0.00015110819367691875

This O 0 0.00026434543542563915
disorder O 1 0.9999991655349731
is O 0 0.00047131406608968973
reminiscent O 0 0.004569060169160366
of O 0 0.0004309031937737018
another O 0 9.550794493407011e-05
rare O 0 0.00015874591190367937
condition O 0 0.00024910614592954516
, O 0 1.1595615433179773e-05
the O 0 9.978538582799956e-05
Stuve B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999978542327881
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0049704196862876415
SWS B-Disease 1 0.9999483823776245
) O 0 2.8041304176440462e-05
, O 0 4.802558578376193e-06
which O 0 1.7608349480724428e-06
comprises O 0 4.076464392710477e-05
campomelia B-Disease 0 0.0016270988853648305
at O 0 0.00030347381834872067
birth O 0 0.00043267972068861127
with O 0 0.00017718721937853843
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9999723434448242
contractures B-Disease 1 1.0
, O 0 0.000595767458435148
and O 0 0.0001190282273455523
early B-Disease 0 0.0017243309412151575
death I-Disease 0 0.018480723723769188
. O 0 0.0002917714591603726

To O 0 3.188701157341711e-05
test O 0 5.176574632059783e-06
for O 0 4.675840045820223e-06
possible O 0 2.6873129172599874e-05
nosologic O 0 0.0011538155376911163
identity O 0 3.781207851716317e-05
between O 0 0.0003161019121762365
these O 0 0.00013478824985213578
disorders O 1 0.9999998807907104
, O 0 0.0001740366278681904
we O 0 1.8736463971436024e-05
reviewed O 0 1.0009282050305046e-05
the O 0 1.05049093690468e-05
literature O 0 6.093838237575255e-06
and O 0 7.062055829010205e-07
obtained O 0 2.8967651815037243e-06
a O 0 7.401179573207628e-06
follow O 0 7.501509116991656e-06
- O 0 2.979225610033609e-05
up O 0 6.564708201040048e-06
of O 0 8.199340300052427e-06
the O 0 9.8946047728532e-06
only O 0 1.9847104795189807e-06
two O 0 3.4419836083543487e-06
surviving O 0 0.0006592120626010001
patients O 0 2.8985366952838376e-05
, O 0 1.0137683602806646e-05
one O 0 9.718656656332314e-06
with O 0 3.351966734044254e-05
SJS B-Disease 1 0.9988293051719666
type I-Disease 0 0.000313052732963115
2 I-Disease 0 0.00035644762101583183
at O 0 0.00023269948724191636
age O 0 8.236197027144954e-05
10 O 0 2.183722608606331e-05
years O 0 3.1519943149760365e-05
and O 0 3.434700829529902e-06
another O 0 1.3486908756021876e-05
with O 0 2.6342513592680916e-05
SWS B-Disease 0 0.366635799407959
at O 0 0.0009245661203749478
age O 0 0.0007819749880582094
7 O 0 0.000617963494732976
years O 0 0.0006129239336587489
. O 0 0.0002661381440702826

Patients O 0 0.0004622568958438933
reported O 0 7.284767343662679e-05
as O 0 2.702588972169906e-05
having O 0 6.704434781568125e-05
either O 0 0.0003449426149018109
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.0035192316863685846
SWS B-Disease 1 0.9965789914131165
presented O 0 0.00021053309319540858
a O 0 2.223048977612052e-05
combination O 0 2.4394043066422455e-05
of O 0 7.033303700154647e-05
a O 0 8.20163986645639e-05
severe O 0 0.02022913098335266
, O 0 4.2086405301233754e-05
prenatal O 0 0.09466244280338287
- O 1 0.999189555644989
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.999991774559021
with O 1 0.9999998807907104
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999932050704956
feeding O 1 0.9969261288642883
difficulties O 1 0.9996742010116577
, O 0 8.60633299453184e-05
tendency O 0 0.0002207984507549554
to O 0 0.0004084324755240232
hyperthermia B-Disease 1 0.999705970287323
, O 0 5.0217371608596295e-05
and O 0 1.9020500985789113e-05
frequent O 0 8.594891551183537e-05
death O 0 0.0007215167279355228
in O 0 0.00017762297648005188
infancy O 0 0.0011401305673643947
) O 0 2.0043803488078993e-06
with O 0 4.5011816496298707e-07
a O 0 7.90821468399372e-06
distinct O 0 4.721365257864818e-05
campomelic B-Disease 1 0.9999812841415405
- I-Disease 1 0.9998754262924194
metaphyseal I-Disease 1 0.9999992847442627
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.7337912321090698

The O 0 0.00012108482769690454
similarity O 0 0.00010390611714683473
of O 0 0.00029275339329615235
the O 0 0.00027265428798273206
clinical O 0 0.00025220957468263805
and O 0 3.5386139643378556e-05
radiographic O 0 0.001158085186034441
findings O 0 0.00010052019206341356
is O 0 1.2190768757136539e-05
so O 0 2.9057462143100565e-06
extensive O 0 2.2308857296593487e-05
that O 0 3.906410711351782e-06
these O 0 2.687174674065318e-05
disorders O 1 0.9999423027038574
appear O 0 0.0006688846042379737
to O 0 6.606423994526267e-05
be O 0 1.9537135813152418e-05
a O 0 2.3559401597594842e-05
single O 0 1.749970397213474e-05
entity O 0 0.00018241754150949419
. O 0 0.00019616057397797704

The O 0 0.0003537365992087871
follow O 0 6.689190195174888e-05
- O 0 0.000122335011838004
up O 0 1.6513493392267264e-05
observation O 0 4.113167233299464e-05
of O 0 2.644384585437365e-05
an O 0 1.0383396329416428e-05
identical O 0 9.300615602114704e-06
and O 0 5.333453373168595e-06
unique O 0 3.129315155092627e-05
pattern O 0 0.0004933723830617964
of O 0 0.06696363538503647
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.0016995586920529604
the O 0 0.00043721141992136836
two O 0 2.9998609534231946e-05
patients O 0 2.6506741050980054e-05
( O 0 1.0902890608122107e-05
one O 0 8.963736036093906e-06
with O 0 2.0148803741903976e-05
SJS B-Disease 1 0.9996945858001709
type I-Disease 0 0.000214004612644203
2 I-Disease 0 0.0002915423538070172
, O 0 1.3508264601114206e-05
one O 0 8.777354196354281e-06
with O 0 2.7890993806067854e-05
SWS B-Disease 1 0.9955086708068848
) O 0 0.00012229569256305695
surviving O 0 0.002924189204350114
beyond O 0 0.0010007922537624836
infancy O 0 0.0012893687235191464
adds O 0 1.2447958397387993e-05
to O 0 2.440885509713553e-06
the O 0 1.3124154065735638e-05
evidence O 0 1.8021462892647833e-05
in O 0 9.978705747926142e-06
favor O 0 7.185932645370485e-06
of O 0 8.2778962678276e-05
identity O 0 0.0002978002594318241
. O 0 0.00030646531376987696

The O 0 0.00044724400504492223
hypothesis O 0 0.0001372085534967482
that O 0 4.3643212848110124e-05
SWS B-Disease 1 0.576310396194458
and O 0 0.00021442865545395762
SJS B-Disease 1 0.9978563189506531
type I-Disease 0 0.0001842982164816931
2 I-Disease 0 0.00010671820200514048
are O 0 7.625503712915815e-07
the O 0 1.0399955499451607e-05
same O 0 2.8599863071576692e-05
disorder O 1 0.9965152740478516
should O 0 3.951581675210036e-05
be O 0 1.2801419870811515e-05
testable O 0 1.973772123164963e-05
by O 0 1.3093273310005316e-06
molecular O 0 1.4092547644395381e-05
methods O 0 1.8326631106901914e-05
. O 0 3.204396853107028e-05
. O 0 5.9100908401887864e-05

A O 0 0.0013532881857827306
mouse O 0 6.881239823997021e-05
model O 0 3.2735042623244226e-06
of O 0 4.511862789513543e-05
severe O 1 0.9999978542327881
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9997498393058777
defects O 1 1.0
in O 0 0.40501752495765686
hemostasis O 1 1.0
and O 1 0.9717110991477966
thrombosis B-Disease 1 1.0
. O 0 0.03349762782454491

von B-Disease 1 0.9917884469032288
Willebrand I-Disease 1 0.9999998807907104
factor I-Disease 0 0.002650737762451172
( I-Disease 0 0.0009300652891397476
vWf I-Disease 1 0.9999839067459106
) I-Disease 1 0.8594713807106018
deficiency I-Disease 1 1.0
causes O 1 0.9999951124191284
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9908146262168884
humans O 0 0.0020953135099262
. O 0 0.0002463091805111617

We O 0 6.10735296504572e-05
generated O 0 1.4844311408523936e-05
a O 0 1.327494373981608e-05
mouse O 0 6.7537939685280435e-06
model O 0 9.822952051763423e-07
for O 0 1.215069005411351e-06
this O 0 5.523501840798417e-06
disease O 0 0.0005157123669050634
by O 0 3.0179580789990723e-06
using O 0 6.360453880915884e-06
gene O 0 1.5461782822967507e-05
targeting O 0 3.48297726304736e-05
. O 0 6.961372127989307e-05

vWf B-Disease 1 0.9669617414474487
- I-Disease 0 0.41353803873062134
deficient I-Disease 0 0.17168119549751282
mice O 0 0.00022012896079104394
appeared O 0 9.61533805821091e-05
normal O 0 2.9931428798590787e-05
at O 0 9.898655844153836e-05
birth O 0 9.275522461393848e-05
; O 0 1.6620311953374767e-06
they O 0 2.062686235149158e-06
were O 0 2.2422027541324496e-05
viable O 0 0.0001697550032986328
and O 0 3.090878090006299e-05
fertile O 0 0.0038077158387750387
. O 0 0.00029694376280531287

Neither O 0 0.0022786816116422415
vWf O 0 0.014243895187973976
nor O 0 0.0009883581660687923
vWf O 0 0.010255621746182442
propolypeptide O 0 0.009790890850126743
( O 0 9.790166950551793e-05
von B-Disease 0 0.04357962682843208
Willebrand I-Disease 1 0.9999923706054688
antigen O 0 0.003035883419215679
II O 1 1.0
) O 0 6.649440911132842e-05
were O 0 4.406148218549788e-05
detectable O 0 0.00026322825578972697
in O 0 3.421258588787168e-05
plasma O 0 0.00022581536904908717
, O 0 2.0122188288951293e-05
platelets O 0 0.00029068972798995674
, O 0 1.4137573089101352e-05
or O 0 2.626510104164481e-05
endothelial O 0 0.00041922726086340845
cells O 0 2.1401103367679752e-05
of O 0 6.103416671976447e-05
the O 0 0.00010502018267288804
homozygous O 0 0.00010877506429096684
mutant O 0 0.0004893325385637581
mice O 0 0.0006244036485441029
. O 0 9.030432556755841e-05

The O 0 0.000647024076897651
mutant O 0 0.0027936019469052553
mice O 0 0.0031086697708815336
exhibited O 0 0.01232383493334055
defects O 1 0.9999040365219116
in O 0 0.0010902176145464182
hemostasis O 0 0.26853859424591064
with O 0 4.439832628122531e-05
a O 0 0.00024265956017188728
highly O 0 0.016498802229762077
prolonged O 1 0.9999974966049194
bleeding O 1 0.9999991655349731
time O 0 0.0007941251969896257
and O 0 0.00012996910663787276
spontaneous O 0 0.0009509414667263627
bleeding O 1 0.964745283126831
events O 0 0.0001376126310788095
in O 0 2.628414767968934e-05
approximately O 0 3.20687577186618e-05
10 O 0 2.6623707526596263e-05
% O 0 1.5043588064145297e-05
of O 0 0.0005888380110263824
neonates O 0 0.014266448095440865
. O 0 0.0006673309835605323

As O 0 0.000174850327312015
in O 0 3.45082808053121e-05
the O 0 0.00010811778338393196
human O 0 0.00024371476320084184
disease O 1 0.9292142391204834
, O 0 1.4178849596646614e-05
the O 0 5.4118168918648735e-05
factor O 0 0.00010049277625512332
VIII O 1 0.6170859932899475
level O 0 0.0003335317596793175
in O 0 3.001709410455078e-05
these O 0 7.737216947134584e-06
mice O 0 4.202760464977473e-05
was O 0 4.175415961071849e-05
reduced O 0 7.753104910079855e-06
strongly O 0 2.88262231151748e-06
as O 0 4.391009042592486e-06
a O 0 3.278687245256151e-06
result O 0 4.758862814924214e-06
of O 0 2.632505857036449e-05
the O 0 4.921199433738366e-05
lack O 0 0.00012456045078579336
of O 0 0.00014774712326470762
protection O 0 0.0002924493164755404
provided O 0 0.00010394921991974115
by O 0 7.193651254056022e-05
vWf O 0 0.008152145892381668
. O 0 0.00030985509511083364

Defective O 1 0.9999780654907227
thrombosis B-Disease 1 0.999998927116394
in O 0 0.002266794675961137
mutant O 0 0.00224708067253232
mice O 0 0.0004249407211318612
was O 0 0.0002658888406585902
also O 0 1.2324004273978062e-05
evident O 0 9.483636677032337e-05
in O 0 7.849861503927968e-06
an O 0 1.7394330598108354e-06
in O 0 1.416021586919669e-05
vivo O 0 0.00014479290985036641
model O 0 4.096307748113759e-05
of O 0 0.0031041190959513187
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.018218277022242546

In O 0 7.595407078042626e-05
this O 0 5.7097913668258116e-06
model O 0 5.2795685405726545e-06
, O 0 3.1936567665979965e-06
the O 0 3.299551099189557e-05
exteriorized O 0 0.0039701517671346664
mesentery O 0 0.003425507340580225
was O 0 0.0011305344523862004
superfused O 0 0.004197332076728344
with O 0 0.0001488912821514532
ferric O 1 0.9999954700469971
chloride O 0 0.04849933460354805
and O 0 0.0002459297247696668
the O 0 0.0006412381771951914
accumulation O 0 0.024090217426419258
of O 0 0.004692021291702986
fluorescently O 0 0.0388508066534996
labeled O 0 0.002010584343224764
platelets O 0 0.0011108631733804941
was O 0 0.00029779798933304846
observed O 0 3.329735409351997e-05
by O 0 1.1332840585964732e-05
intravital O 0 0.0024821304250508547
microscopy O 0 0.0002756294561550021
. O 0 0.00017126963939517736

We O 0 5.651744140777737e-05
conclude O 0 9.080775635084137e-05
that O 0 1.7689764035822009e-06
these O 0 2.96703228741535e-06
mice O 0 5.20537250849884e-05
very O 0 6.414362360374071e-06
closely O 0 4.185182842775248e-05
mimic O 0 0.0015177499735727906
severe O 0 0.12373273819684982
human O 0 0.002444923622533679
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.00044604085269384086
will O 0 3.538610690156929e-05
be O 0 5.556352789426455e-06
very O 0 9.599366421753075e-07
useful O 0 1.2138690408391994e-06
for O 0 6.872827498227707e-07
investigating O 0 1.0036504136223812e-05
the O 0 1.7842738088802435e-05
role O 0 4.5442397095030174e-05
of O 0 0.00020639038120862097
vWf O 0 0.0021016481332480907
in O 0 5.068926839157939e-05
normal O 0 9.656024485593662e-05
physiology O 0 0.00018994530546478927
and O 0 1.2707372661679983e-05
in O 0 9.293884068029001e-05
disease O 1 0.9962957501411438
models O 0 4.663279833039269e-05
. O 0 5.6689732446102425e-05
. O 0 9.485996997682378e-05

Oral O 1 0.9845959544181824
contraceptives O 0 0.013543521985411644
and O 0 1.61699626914924e-05
the O 0 6.023794412612915e-05
risk O 0 0.00012530668755061924
of O 1 0.9706501364707947
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999899864196777

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999879598617554
Study O 0 0.003166714683175087
Group O 0 0.00023260031593963504
. O 0 0.00019855813297908753

BACKGROUND O 0 0.004686491098254919
Women O 0 7.883141370257363e-05
with O 0 6.710189154546242e-06
mutations O 0 2.3158307158155367e-05
in O 0 3.705508788698353e-05
either O 0 3.060645394725725e-05
the O 0 0.00011880744568770751
BRCA1 O 0 0.0003342307754792273
or O 0 1.5248983800120186e-05
the O 0 5.363803211366758e-05
BRCA2 O 0 0.00028525100788101554
gene O 0 2.9222476314316737e-06
have O 0 6.530189011755283e-07
a O 0 3.0160852020344464e-06
high O 0 5.840209632879123e-05
lifetime O 0 8.125528984237462e-05
risk O 0 0.00018706537957768887
of O 1 0.998080849647522
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8759066462516785

Oral O 1 0.9998311996459961
contraceptives O 1 0.9998958110809326
protect O 1 0.7057889103889465
against O 1 0.9999979734420776
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0036862166598439217
general O 0 0.0003714006161317229
, O 0 1.7999234842136502e-05
but O 0 1.6996092426779796e-06
it O 0 6.638123863922374e-07
is O 0 8.081642590695992e-07
not O 0 3.8270465552159294e-07
known O 0 6.989171652094228e-06
whether O 0 1.6120991404022789e-06
they O 0 1.0457961252541281e-06
also O 0 1.8228927274321904e-06
protect O 0 1.7564610971021466e-05
against O 0 3.4548713301774114e-05
hereditary B-Disease 1 0.9991751313209534
forms I-Disease 1 0.9694300293922424
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9994993209838867

METHODS O 0 0.0004303351161070168
We O 0 2.2580023141927086e-05
enrolled O 0 6.820554699515924e-05
207 O 0 9.419851994607598e-05
women O 0 6.581972229469102e-06
with O 0 3.553581336745992e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.5527549386024475
161 O 0 0.001049080747179687
of O 0 0.0010425786022096872
their O 0 0.00011119280679849908
sisters O 0 0.00035309322993271053
as O 0 1.4956286577216815e-05
controls O 0 1.2157725905126426e-05
in O 0 9.546502951707225e-06
a O 0 1.850035368988756e-05
case O 0 3.700769957504235e-05
- O 0 0.00015667757543269545
control O 0 6.65602638036944e-05
study O 0 3.0615243304055184e-05
. O 0 6.416461110347882e-05

All O 0 7.120032387319952e-05
the O 0 0.00010393931006547064
patients O 0 2.3132944988901727e-05
carried O 0 1.7230684534297325e-05
a O 0 8.681277904543094e-06
pathogenic O 0 1.4600149370380677e-05
mutation O 0 1.931821316247806e-06
in O 0 8.606280971434899e-06
either O 0 1.7280546671827324e-05
BRCA1 O 0 0.00027537046116776764
( O 0 1.81762152351439e-05
179 O 0 5.995626997901127e-05
women O 0 1.8490511138224974e-05
) O 0 7.799671948305331e-06
or O 0 2.1547610231209546e-05
BRCA2 O 0 0.001223648083396256
( O 0 0.0001032355212373659
28 O 0 0.0013355908449739218
women O 0 0.0001546199928270653
) O 0 5.609689105767757e-05
. O 0 9.901685552904382e-05

The O 0 0.0004599230014719069
control O 0 0.0003374780935700983
women O 0 1.8927963537862524e-05
were O 0 1.2054306353093125e-05
enrolled O 0 5.516213059308939e-05
regardless O 0 1.649517253099475e-05
of O 0 8.019591041374952e-05
whether O 0 1.4758025827177335e-05
or O 0 6.762004431948299e-06
not O 0 3.4611045975907473e-06
they O 0 2.2019164589437423e-06
had O 0 2.7324305847287178e-05
either O 0 2.3397924451273866e-05
mutation O 0 3.643212403403595e-05
. O 0 0.00010429752728668973

Lifetime O 0 0.0007275836542248726
histories O 0 0.0005042109405621886
of O 0 0.001549190143123269
oral O 1 0.9967986345291138
- O 0 0.008148630149662495
contraceptive O 0 0.00023274739214684814
use O 0 3.0070098091528052e-06
were O 0 6.723711976519553e-06
obtained O 0 9.050353583006654e-06
by O 0 5.1581191655714065e-06
interview O 0 2.7241590942139737e-05
or O 0 2.532413191147498e-06
by O 0 9.884719247565954e-07
written O 0 7.155325079111208e-07
questionnaire O 0 2.5114024992944906e-06
and O 0 1.4749927004231722e-06
were O 0 7.130025096557802e-06
compared O 0 2.6680843802751042e-05
between O 0 0.0005147173651494086
patients O 0 0.00013494567247107625
and O 0 5.7063112762989476e-05
control O 0 0.0005017980583943427
women O 0 4.0216731576947495e-05
, O 0 9.331534783996176e-06
after O 0 4.3045358324889094e-05
adjustment O 0 7.801254832884297e-05
for O 0 6.727335858158767e-06
year O 0 2.570262768131215e-05
of O 0 0.00011085107689723372
birth O 0 0.0004957754863426089
and O 0 7.55725268390961e-05
parity O 0 0.002718739677220583
. O 0 0.00023035446065478027

RESULTS O 0 0.0002365231339354068
The O 0 6.175781163619831e-05
adjusted O 0 7.58874521125108e-05
odds O 0 0.00017104344442486763
ratio O 0 9.096220310311764e-05
for O 0 0.00039574041147716343
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.00017663258768152446
with O 0 1.076006537914509e-05
any O 0 1.0365942216594703e-05
past O 0 1.835444345488213e-05
use O 0 3.771437832256197e-06
of O 0 0.00011268546222709119
oral O 0 0.006716884672641754
contraceptives O 0 0.00954101886600256
was O 0 0.0014389257412403822
0 O 0 0.00012390805932227522
. O 0 8.857168722897768e-05

5 O 0 0.0003467191709205508
( O 0 2.8209475203766488e-05
95 O 0 7.158319203881547e-05
percent O 0 1.883524782897439e-05
confidence O 0 7.311240915441886e-05
interval O 0 4.04363963752985e-05
, O 0 5.763636181654874e-06
0 O 0 2.8097892936784774e-06
. O 0 1.1210897810087772e-06
3 O 0 5.680994036083575e-06
to O 0 5.3956946430844255e-06
0 O 0 8.65325637278147e-06
. O 0 5.026974122301908e-06
8 O 0 5.440011955215596e-05
) O 0 1.6531295841559768e-05
. O 0 4.042405998916365e-05

The O 0 0.00047370907850563526
risk O 0 0.00017086610023397952
decreased O 0 0.00018693917081691325
with O 0 5.994763796479674e-06
increasing O 0 2.4382832634728402e-05
duration O 0 0.00010948393901344389
of O 0 7.562537211924791e-05
use O 0 2.144633799616713e-05
( O 0 2.9287395591381937e-05
P O 0 0.00047818946768529713
for O 0 1.2406313544488512e-05
trend O 0 6.189778650877997e-05
, O 0 3.941470822610427e-06
< O 0 5.359773786040023e-05
0 O 0 8.929215255193412e-06
. O 0 5.910723302804399e-06
001 O 0 0.0003031014057341963
) O 0 2.1599989850074053e-06
; O 0 4.293734718885389e-07
use O 0 1.0852916147996439e-06
for O 0 4.634831384464633e-06
six O 0 1.9748153135878965e-05
or O 0 3.5113937428832287e-06
more O 0 8.691257562531973e-07
years O 0 2.4574301278335042e-05
was O 0 6.727374420734122e-05
associated O 0 2.1180067051318474e-06
with O 0 6.424014031836123e-07
a O 0 7.164856015151599e-06
60 O 0 2.3635780962649733e-05
percent O 0 1.9174651242792606e-05
reduction O 0 9.103699267143384e-05
in O 0 0.0001517151395091787
risk O 0 0.00045196866267360747
. O 0 0.00024025839229580015

Oral O 1 0.9961941242218018
- O 0 0.009378107264637947
contraceptive O 0 0.0003771353221964091
use O 0 1.778475780156441e-05
protected O 0 0.0015176524175330997
against O 1 0.994300365447998
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 7.51529005356133e-05
for O 0 1.5237005754897837e-05
carriers O 0 1.008107210509479e-05
of O 0 6.474847759818658e-05
the O 0 0.00021811662008985877
BRCA1 O 0 0.0006081793108023703
mutation O 0 1.5584357242914848e-05
( O 0 9.168394171865657e-06
odds O 0 0.00013994306209497154
ratio O 0 1.4656425264547579e-05
, O 0 1.909817683554138e-06
0 O 0 2.4912505978136323e-06
. O 0 1.6598928596067708e-06
5 O 0 8.240195711550768e-06
; O 0 4.6141505549712747e-07
95 O 0 1.65508572536055e-05
percent O 0 1.271023393201176e-05
confidence O 0 7.629540050402284e-05
interval O 0 2.5135990654234774e-05
, O 0 4.788527803611942e-06
0 O 0 3.0882101782481186e-06
. O 0 1.1766838952098624e-06
3 O 0 4.0264603740070015e-06
to O 0 2.5274189283663873e-06
0 O 0 4.616224487108411e-06
. O 0 2.6510870156926103e-06
9 O 0 2.639592821651604e-05
) O 0 1.1822394299088046e-06
and O 0 8.338849966094131e-07
for O 0 1.374258545183693e-06
carriers O 0 9.58944292506203e-06
of O 0 4.109791188966483e-05
the O 0 0.00017080387624446303
BRCA2 O 0 0.0006703856051899493
mutation O 0 1.2226022590766661e-05
( O 0 9.604927981854416e-06
odds O 0 0.00013956059410702437
ratio O 0 2.3716658688499592e-05
, O 0 2.5354408990097e-06
0 O 0 2.1458117771544494e-06
. O 0 1.3260568039186182e-06
4 O 0 6.873338861623779e-06
; O 0 3.9353611214210105e-07
95 O 0 1.457104917790275e-05
percent O 0 1.495846936450107e-05
confidence O 0 6.952641706448048e-05
interval O 0 2.263402711832896e-05
, O 0 3.68378482562548e-06
0 O 0 2.245974883408053e-06
. O 0 9.4356647650784e-07
2 O 0 5.247722583590075e-06
to O 0 4.044586603413336e-06
1 O 0 3.343722710269503e-05
. O 0 5.574472652369877e-06
1 O 0 9.318181400885805e-05
) O 0 2.1969868612359278e-05
. O 0 4.669500776799396e-05

CONCLUSIONS O 0 0.005475469399243593
Oral O 1 0.6591130495071411
- O 0 0.004459649324417114
contraceptive O 0 0.00027888422482647
use O 0 6.3094880715652835e-06
may O 0 1.1512775017763488e-05
reduce O 0 1.2915535990032367e-05
the O 0 2.449801831971854e-05
risk O 0 7.913751323940232e-05
of O 0 0.02951655350625515
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0014583852607756853
women O 0 1.7311358533333987e-05
with O 0 1.742527956594131e-06
pathogenic O 0 3.2127256417879835e-05
mutations O 0 9.768490599526558e-06
in O 0 1.3306211258168332e-05
the O 0 0.00010187541192863137
BRCA1 O 0 0.00039463804569095373
or O 0 7.990698213689029e-05
BRCA2 O 0 0.002783705946058035
gene O 0 0.0004861661873292178

A O 0 0.0014206100022420287
Japanese O 0 0.0009690559236332774
family O 0 0.0001034758024616167
with O 0 4.3372856453061104e-05
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.00020335115550551564
a O 0 0.0004256536194588989
codon O 0 0.00020314630819484591
291 O 0 0.00014860987721476704
deletion O 0 0.00016147279529832304
: O 0 1.1500452274049167e-05
a O 0 1.2322970178502146e-05
clinical O 0 0.00010678639955585822
, O 0 4.363189509604126e-05
biochemical O 0 0.0005587554769590497
, O 0 0.00010302644659532234
pathological O 0 0.011311065405607224
, O 0 8.720644109416753e-05
and O 0 2.324646084161941e-05
genetic O 0 0.0002145239559467882
report O 0 0.00011865370470331982
. O 0 0.00016513092850800604

We O 0 3.706074130604975e-05
report O 0 3.027658976861858e-06
a O 0 2.5146139250864508e-06
Japanese O 0 5.13633422087878e-05
family O 0 1.80702318175463e-05
with O 0 5.8164332585874945e-05
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9979068040847778
ALD B-Disease 1 1.0
) O 0 0.00011078915122197941
with O 0 8.752061148697976e-06
a O 0 3.187886250088923e-05
three O 0 1.625811455596704e-05
base O 0 5.358935231924988e-05
pair O 0 3.787443711189553e-05
deletion O 0 0.0001498832571087405
( O 0 7.20586467650719e-05
delGAG O 0 0.003715170780196786
291 O 0 0.0002024139103014022
) O 0 1.132201578002423e-05
in O 0 4.7564750275341794e-05
the O 0 0.0007852483540773392
ALD B-Disease 1 1.0
gene O 0 0.000707316561602056
. O 0 0.00032505253329873085

A O 0 0.0011801026994362473
variety O 0 8.12063371995464e-05
of O 0 0.00031742764986120164
phenotypes O 0 0.0004128166183363646
were O 0 6.224880780791864e-05
observed O 0 3.326072692289017e-05
within O 0 8.176054507202934e-06
this O 0 3.605798383432557e-06
family O 0 4.18248564528767e-05
. O 0 7.239227852551267e-05

While O 0 8.433264883933589e-05
the O 0 0.00022118828201200813
proband O 0 0.008050232194364071
( O 0 7.43645869079046e-05
patient O 0 6.443986785598099e-05
1 O 0 0.00023089913884177804
) O 0 1.7751004634192213e-05
was O 0 0.00013537069025915116
classified O 0 0.00011146756150992587
as O 0 3.0377519578905776e-05
having O 0 2.8418306101229973e-05
a O 0 1.8092441678163595e-05
rare O 0 7.470403943443671e-05
intermediate O 0 0.0003974564897362143
type O 0 9.119531023316085e-05
of O 0 0.0005459433305077255
adult O 0 0.0004691135254688561
cerebral O 1 0.9148226380348206
and O 0 0.0006462088786065578
cerebello O 1 0.9999992847442627
- O 1 0.9992004036903381
brain O 1 0.988808810710907
stem O 0 0.0007294960087165236
forms O 0 4.13450543419458e-05
, O 0 1.583212724654004e-05
his O 0 9.487408533459529e-05
younger O 0 0.0005536650423891842
brother O 0 0.000470472703455016
( O 0 2.2750755306333303e-05
patient O 0 4.820468166144565e-05
2 O 0 0.0001521686208434403
) O 0 1.603308555786498e-05
and O 0 2.105449493683409e-05
nephew O 0 0.0018637743778526783
( O 0 3.671484228107147e-05
patient O 0 3.247264612582512e-05
3 O 0 5.883958874619566e-05
) O 0 7.368093974946532e-06
had O 0 4.0683557017473504e-05
a O 0 0.0003066366189159453
childhood O 1 0.9999728202819824
ALD B-Disease 1 1.0
type O 1 0.8622846007347107
. O 0 0.0018454204546287656

Another O 0 0.0009153747232630849
nephew O 0 0.007443939335644245
( O 0 7.196731166914105e-05
patient O 0 7.441708294209093e-05
4 O 0 0.00012736374628730118
) O 0 6.100373411754845e-06
of O 0 6.1031372752040625e-05
patient O 0 6.877481064293534e-05
1 O 0 0.0002242704649688676
was O 0 0.00021942636521998793
classified O 0 5.8927071222569793e-05
as O 0 1.5870646166149527e-05
having O 0 1.749685179674998e-05
an O 0 1.0927643415925559e-05
adolescent O 0 0.0008926635491661727
form O 0 0.00025040991022251546
. O 0 0.0004872244317084551

The O 0 0.0006681964732706547
tau O 0 0.0018057163106277585
level O 0 0.00020535786461550742
in O 0 4.2810050217667595e-05
the O 0 0.00020629556092899293
cerebrospinal O 0 0.010144737549126148
fluid O 0 0.003906719386577606
( O 0 0.0007440641056746244
CSF O 1 0.9997262358665466
) O 0 4.67344798380509e-05
in O 0 4.174348941887729e-05
patient O 0 2.1770852981717326e-05
1 O 0 6.364430737448856e-05
was O 0 0.00010748497152235359
as O 0 6.548901183123235e-06
high O 0 2.1307345377863385e-05
as O 0 1.5425670198965236e-06
that O 0 2.285399745005634e-07
of O 0 1.0823265256476589e-05
patients O 0 3.2205785828409716e-05
with O 0 0.00018934495165012777
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0009108191006816924
AD B-Disease 0 0.0089450404047966
) O 0 0.00010694975935621187
. O 0 9.794704237719998e-05

His O 0 0.0053245751187205315
brain O 0 0.27654096484184265
magnetic O 0 0.003075286280363798
resonance O 0 0.0012264024699106812
image O 0 0.0011240364983677864
( O 0 0.00012281844101380557
MRI O 0 0.005037609487771988
) O 0 4.651164272218011e-05
showed O 0 0.00019487834651954472
abnormalities B-Disease 0 0.002896399237215519
in I-Disease 0 0.00010209246829617769
the I-Disease 0 0.0004016515740659088
bilateral I-Disease 1 0.9940987825393677
cerebellar I-Disease 1 0.9999998807907104
hemispheres I-Disease 0 0.03470485284924507
and O 0 0.0010361050954088569
brain O 1 0.9999964237213135
stem O 0 0.33165985345840454
, O 0 2.658929952303879e-05
but O 0 1.8129308045899961e-06
not O 0 7.096237482073775e-07
in O 0 7.921257747511845e-06
the O 0 0.0001278009731322527
cerebral O 0 0.01795024611055851
white O 0 0.00026039688964374363
matter O 0 8.996293036034331e-05
, O 0 5.285241059027612e-06
where O 0 5.716482064599404e-06
marked O 0 9.367324673803523e-05
reductions O 0 6.251030572457239e-05
of O 0 0.00023313763085752726
the O 0 0.0007874667062424123
cerebral O 1 0.9921302199363708
blood O 0 0.0033244651276618242
flow O 0 0.0023052042815834284
and O 0 0.00015807029558345675
oxygen O 0 0.0004297009145375341
metabolism O 0 0.00015278448699973524
were O 0 1.9745382815017365e-05
clearly O 0 2.640836282807868e-05
demonstrated O 0 0.00011194156832061708
by O 0 1.4895632375555579e-05
positron O 0 0.0007630839245393872
emission O 0 6.867139745736495e-05
tomography O 0 0.00014526252925861627
( O 0 0.0001699843560345471
PET O 0 0.001646040822379291
) O 0 4.385264401207678e-05
. O 0 8.271157275885344e-05

In O 0 0.00047581782564520836
patients O 0 0.00010657033271854743
2 O 0 0.0003095268039032817
and O 0 2.4108610887196846e-05
3 O 0 8.0745572631713e-05
, O 0 5.6286839935637545e-06
the O 0 1.1279187674517743e-05
autopsy O 0 6.637340993620455e-05
findings O 0 2.328373557247687e-05
showed O 0 0.0002645728818606585
massive O 0 0.042986106127500534
demyelination B-Disease 1 1.0
of I-Disease 1 0.7490196228027344
the I-Disease 1 0.9864872097969055
cerebral I-Disease 1 0.9999566078186035
white I-Disease 0 0.0006085936911404133
matter I-Disease 0 7.63601710787043e-05
with O 0 3.4764441352308495e-06
sparing O 0 4.801877003046684e-05
of O 0 0.00020655497792176902
the O 0 0.0016424295026808977
U O 1 0.9999994039535522
- O 0 0.022048719227313995
fibers O 0 0.0004812848928850144
, O 0 5.852301455888664e-06
compatible O 0 7.597472631459823e-06
with O 0 4.916288389722467e-07
the O 0 1.0020055015047546e-05
findings O 0 2.59356529568322e-05
of O 0 0.0005627779755741358
childhood O 1 0.999998927116394
ALD B-Disease 1 1.0
. O 0 0.007709518074989319

Oleic O 0 0.050221458077430725
and O 0 0.001075783628039062
erucic O 1 0.9021046757698059
acids O 0 0.000559675449039787
( O 0 0.000183229916729033
Lorenzos O 0 0.007806798443198204
Oil O 0 0.0003808839537668973
) O 0 2.900143044826109e-06
were O 0 3.5948453387391055e-06
administered O 0 6.736708655807888e-06
to O 0 9.803928151086438e-06
patients O 0 2.0173569282633252e-05
1 O 0 0.00017907544679474086
and O 0 1.714580866973847e-05
4 O 0 7.126580021576956e-05
, O 0 4.395148152980255e-06
but O 0 9.713353392726276e-07
sufficient O 0 2.1145649952813983e-05
effectiveness O 0 3.0646326194982976e-05
was O 0 7.829238893464208e-05
not O 0 2.7502244392962893e-06
obtained O 0 4.6783265133854e-05
. O 0 7.615800859639421e-05

The O 0 0.00018217769684270024
findings O 0 2.3019412765279412e-05
in O 0 1.1469226592453197e-05
this O 0 2.806618340400746e-06
family O 0 6.064132321625948e-06
suggest O 0 5.029174644732848e-06
that O 0 1.8576337197373505e-06
delGAG291 O 0 0.00015054356481414288
is O 0 3.084401441810769e-06
part O 0 1.4091149751038756e-05
of O 0 8.771385182626545e-05
the O 0 0.00021524226758629084
cause O 0 0.000408366322517395
of O 0 0.0009369967738166451
Japanese O 1 0.9872521162033081
ALD B-Disease 1 1.0
with O 0 8.498168608639389e-05
phenotypic O 0 0.001414908329024911
variations O 0 0.0018248064443469048
. O 0 0.0010260590352118015

Moreover O 0 0.0006855681422166526
, O 0 1.1201707820873708e-05
although O 0 3.377873326826375e-06
the O 0 6.088494046707638e-06
scale O 0 5.594741742243059e-05
of O 0 5.292931018630043e-05
the O 0 5.147852425579913e-05
study O 0 5.637354661303107e-06
is O 0 1.8679694449019735e-06
limited O 0 2.1739938347309362e-06
, O 0 1.2169732599431882e-06
there O 0 1.4396063079402666e-06
is O 0 1.5174329064393532e-06
a O 0 4.294997779652476e-06
possibility O 0 3.753494092961773e-05
that O 0 8.633292964077555e-06
PET O 0 0.0004507025296334177
can O 0 8.291236554214265e-06
detect O 0 0.00033326796256005764
an O 0 5.260931357042864e-05
insidious B-Disease 0 0.009363189339637756
lesion I-Disease 0 0.018727730959653854
which O 0 3.524999920045957e-05
is O 0 1.1371229447831865e-05
undetectable O 0 0.00017022507381625473
by O 0 1.5895220712991431e-06
computed O 0 1.536781928734854e-05
tomogram O 0 0.0031240377575159073
( O 0 0.00011546316818566993
CT O 0 0.010378675535321236
) O 0 2.799556023092009e-05
or O 0 1.992713805520907e-05
MRI O 0 0.0013715258101001382
analysis O 0 1.0426759217807557e-05
, O 0 4.145115781284403e-06
and O 0 1.25968188058323e-06
that O 0 6.044554652362422e-07
the O 0 8.918134881241713e-06
higher O 0 8.935468031268101e-06
level O 0 4.470989006222226e-05
of O 0 6.525441131088883e-05
tau O 0 0.0002574923273641616
reflects O 0 8.058468665694818e-06
the O 0 3.5798163935396587e-06
process O 0 5.045204488851596e-06
of O 0 0.0001950255682459101
neuronal B-Disease 1 0.807909369468689
degeneration I-Disease 1 1.0
in O 1 0.9999943971633911
ALD B-Disease 1 1.0
. O 0 0.006155325565487146

Lorenzos O 0 0.07249948382377625
Oil O 0 0.0008995393291115761
should O 0 3.810948328464292e-06
be O 0 1.0149881290999474e-06
given O 0 1.2781993063981645e-06
in O 0 2.4928713173721917e-06
the O 0 1.1528749382705428e-05
early O 0 5.534460433409549e-05
stage O 0 0.0002833023318089545
. O 0 4.040891144541092e-05
. O 0 6.920546002220362e-05

Nonsense O 0 0.0020186833571642637
mutation O 0 2.3265489289769903e-05
in O 0 6.319321255432442e-05
exon O 0 0.0002712860004976392
4 O 0 7.416756125167012e-05
of O 0 0.00011996179091511294
human O 0 0.00011441832612035796
complement O 0 0.0003945635980926454
C9 O 1 0.9735775589942932
gene O 0 1.719013016554527e-05
is O 0 2.007558123295894e-06
the O 0 7.163216650951654e-06
major O 0 4.31318512710277e-05
cause O 0 3.910468876711093e-05
of O 0 0.00012065401097061113
Japanese O 0 0.009902700781822205
complement B-Disease 0 0.20460526645183563
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.002409577602520585

Deficiency B-Disease 1 1.0
of I-Disease 0 0.019643370062112808
the I-Disease 0 0.003250326029956341
ninth I-Disease 0 0.0033338936045765877
component I-Disease 0 0.0002126653998857364
of I-Disease 0 0.00012189216795377433
human I-Disease 0 8.103096479317173e-05
complement I-Disease 0 0.0004227083409205079
( O 0 0.0002841565874405205
C9 O 1 0.9953688979148865
) O 0 1.6360034351237118e-05
is O 0 2.312853894181899e-06
the O 0 5.368112397263758e-06
most O 0 7.696828106418252e-06
common O 0 6.774544453946874e-05
complement B-Disease 1 0.9999746084213257
deficiency I-Disease 1 1.0
in O 0 0.0029237710405141115
Japan O 0 0.001369771547615528
but O 0 4.794349024450639e-06
is O 0 2.038060529230279e-06
rare O 0 8.486513252137229e-06
in O 0 7.831989023543429e-06
other O 0 3.557945092325099e-06
countries O 0 6.836124157416634e-06
. O 0 6.602179200854152e-05

We O 0 3.459513754933141e-05
studied O 0 3.1269977625925094e-05
the O 0 5.22299887961708e-06
molecular O 0 1.0174314411415253e-05
basis O 0 2.2652166080661118e-05
of O 0 0.002973109483718872
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 0.0005081298877485096
four O 0 0.00017210125224664807
Japanese O 0 0.027071626856923103
C9 B-Disease 1 1.0
- I-Disease 0 0.29479897022247314
deficient I-Disease 0 0.014139153994619846
patients O 0 1.901099858514499e-05
who O 0 1.2726510249194689e-05
had O 0 0.00018663336231838912
suffered O 1 0.9999985694885254
from O 1 0.9994290471076965
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.003994292579591274

Direct O 0 8.759299089433625e-05
sequencing O 0 0.00021544183255173266
of O 0 0.0008122606668621302
amplified O 0 0.0038746213540434837
C9 O 0 0.04668133705854416
cDNA O 0 0.0002700431796256453
and O 0 8.003829861991107e-06
DNA O 0 4.054033706779592e-05
revealed O 0 9.09068767214194e-05
a O 0 2.0431927623576485e-05
nonsense O 0 0.00012106313079129905
substitution O 0 5.1713275752263144e-05
( O 0 8.198457362595946e-05
CGA O 0 0.004220939707010984
- O 0 0.0004167536390013993
- O 0 0.00022428843658417463
> O 0 0.0001551708992337808
TGA O 0 0.0011768646072596312
) O 0 7.3614210123196244e-06
at O 0 4.328236900619231e-05
codon O 0 9.787607268663123e-06
95 O 0 2.5539950001984835e-05
in O 0 1.7242831745534204e-05
exon O 0 9.61365076364018e-05
4 O 0 3.1478612072532997e-05
in O 0 1.4084633221500553e-05
the O 0 5.962459908914752e-05
four O 0 0.0002069705369649455
C9 B-Disease 1 0.9999264478683472
- I-Disease 0 0.00526855094358325
deficient I-Disease 0 0.0034759375266730785
individuals O 0 1.3644169484905433e-05
. O 0 0.00011226523929508403

An O 0 7.98730761744082e-05
allele O 0 3.201213985448703e-05
- O 0 5.5126220104284585e-05
specific O 0 1.4196707525115926e-06
polymerase O 0 0.0003013885871041566
chain O 0 8.475533104501665e-05
reaction O 0 1.356543907604646e-05
system O 0 8.197019633371383e-05
designed O 0 6.740287790307775e-05
to O 0 2.0248677174095064e-05
detect O 0 7.71873164921999e-05
exclusively O 0 8.245274329965468e-06
only O 0 1.1999718481092714e-06
one O 0 1.0318187833036063e-06
of O 0 1.0922205547103658e-05
the O 0 4.478246773942374e-05
normal O 0 2.04413227038458e-05
and O 0 3.715028924489161e-06
mutant O 0 1.7125805243267678e-05
alleles O 0 5.811893515783595e-06
indicated O 0 9.015035175252706e-06
that O 0 5.918192300669034e-07
all O 0 7.779440807098581e-07
the O 0 6.34349225947517e-06
four O 0 3.0451717520918464e-06
patients O 0 6.0068623497500084e-06
were O 0 1.0225303412880749e-05
homozygous O 0 8.552288818464149e-06
for O 0 4.818698471353855e-06
the O 0 4.973857357981615e-05
mutation O 0 7.58703163228347e-06
in O 0 3.587652099668048e-05
exon O 0 0.00017243534966837615
4 O 0 5.2153693104628474e-05
and O 0 4.831278147321427e-06
that O 0 2.1391383597801905e-06
the O 0 2.1932692106929608e-05
parents O 0 3.1123361168283736e-06
of O 0 3.16160949296318e-05
patient O 0 7.08865190972574e-05
2 O 0 0.00021035890677012503
were O 0 8.51570803206414e-05
heterozygous O 0 5.551168214878999e-05
. O 0 8.663766493555158e-05

The O 0 0.0003726817376445979
common O 0 4.1656643588794395e-05
mutation O 0 1.2026506738038734e-05
at O 0 0.00015258709026966244
codon O 0 3.7141231587156653e-05
95 O 0 7.067026308504865e-05
in O 0 3.284998456365429e-05
exon O 0 0.0001503246749052778
4 O 0 3.778129757847637e-05
might O 0 3.0657381557830377e-06
be O 0 4.2722663806671335e-07
responsible O 0 2.1343680600693915e-06
for O 0 2.482200670783641e-06
most O 0 3.3840140531538054e-05
Japanese O 1 0.6667718887329102
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0005285668303258717
. O 0 0.00027773636975325644

BRCA1 O 0 0.0007269847556017339
required O 0 1.4392039702215698e-05
for O 0 3.378326800884679e-05
transcription O 0 0.0038453228771686554
- O 0 0.0014758823672309518
coupled O 0 0.0003347007732372731
repair O 0 0.0018973172409459949
of O 0 0.0006657280027866364
oxidative O 0 0.003328311489894986
DNA O 0 0.004985104314982891
damage O 1 0.545337438583374
. O 0 0.0007762759341858327

The O 0 0.001895102672278881
breast B-Disease 1 0.9999953508377075
and I-Disease 1 0.9991027116775513
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999412298202515
gene O 0 0.0010420820908620954
BRCA1 O 0 0.0013921074569225311
encodes O 0 0.00010435195144964382
a O 0 0.00015294222976081073
zinc O 0 0.011284690350294113
finger O 0 0.0005432234611362219
protein O 0 3.0320448786369525e-05
of O 0 0.00010144519183086231
unknown O 0 0.0002709021791815758
function O 0 0.00010206308797933161
. O 0 0.00014693116827402264

Association O 0 0.0001382869086228311
of O 0 0.00023282950860448182
the O 0 0.00018925579206552356
BRCA1 O 0 0.00014734391879756004
protein O 0 3.964081315643853e-06
with O 0 1.059731403074693e-06
the O 0 3.289625601610169e-05
DNA O 0 0.00017804586968850344
repair O 0 0.0022304749581962824
protein O 0 0.00023745023645460606
Rad51 O 0 0.0021804783027619123
and O 0 6.86096109348e-06
changes O 0 1.8728819668467622e-06
in O 0 3.865033704641974e-06
the O 0 8.390530638280325e-06
phosphorylation O 0 2.4710573143238435e-06
and O 0 4.071782768733101e-06
cellular O 0 3.2023745006881654e-05
localization O 0 9.465793118579313e-05
of O 0 6.089324233471416e-05
the O 0 5.0581969844643027e-05
protein O 0 2.3331300326390192e-05
after O 0 4.603489287546836e-05
exposure O 0 0.00013468085671775043
to O 0 3.709942757268436e-05
DNA O 0 0.0005436232895590365
- O 0 0.0002981297730002552
damaging O 0 0.00017658477008808404
agents O 0 6.1872815422248095e-06
are O 0 4.3512972069947864e-07
consistent O 0 4.363058451417601e-06
with O 0 9.011631618704996e-07
a O 0 6.439277058234438e-06
role O 0 3.3432257623644546e-05
for O 0 2.7507056074682623e-05
BRCA1 O 0 0.00038672739174216986
in O 0 0.00011129039921797812
DNA O 0 0.0006052862736396492
repair O 0 0.015092560090124607
. O 0 0.00036676606396213174

Here O 0 0.0003354481013957411
, O 0 5.883980975340819e-06
it O 0 5.462737249217753e-07
is O 0 6.208928198248032e-07
shown O 0 2.3842835616960656e-06
that O 0 1.359230168418435e-06
mouse O 0 2.620783016027417e-05
embryonic O 0 0.00013616793148685247
stem O 0 0.00030872985371388495
cells O 0 7.038925832603127e-05
deficient B-Disease 0 0.00071112927980721
in I-Disease 0 2.754010165517684e-05
BRCA1 I-Disease 0 0.00026853353483602405
are O 0 2.3749291813146556e-06
defective O 0 0.00017525193106848747
in O 0 1.8927421479020268e-05
the O 0 1.6301710275001824e-05
ability O 0 1.6569937315580319e-06
to O 0 2.223363480879925e-06
carry O 0 1.8268589201397845e-06
out O 0 2.4990456495288527e-06
transcription O 0 0.00021251723228488117
- O 0 0.00020115311781410128
coupled O 0 0.00012204022641526535
repair O 0 0.0007295589311979711
of O 0 0.0003942650218959898
oxidative O 0 0.0016274460358545184
DNA O 0 0.002414960414171219
damage O 0 0.009690916165709496
, O 0 3.636947076302022e-05
and O 0 1.4771318092243746e-05
are O 0 6.973194103920832e-06
hypersensitive O 0 0.001376938191242516
to O 0 0.00037359754787757993
ionizing O 1 0.939539909362793
radiation O 0 0.018457677215337753
and O 0 8.778967458056286e-05
hydrogen O 0 0.00017598569684196264
peroxide O 0 0.0002968642220366746
. O 0 0.00019967695698142052

These O 0 2.4366145225940272e-05
results O 0 2.2666430595563725e-05
suggest O 0 3.8605285226367414e-05
that O 0 1.974244514713064e-05
BRCA1 O 0 0.0006231506704352796
participates O 0 8.532305946573615e-05
, O 0 7.727056072326377e-06
directly O 0 6.5150129557878245e-06
or O 0 5.8030982472701e-06
indirectly O 0 4.513308158493601e-05
, O 0 7.344991445279447e-06
in O 0 2.314439734618645e-05
transcription O 0 0.0006538485758937895
- O 0 0.0005816052434965968
coupled O 0 0.00014942663256078959
repair O 0 0.0010071847354993224
of O 0 0.000515206775162369
oxidative O 0 0.0024421552661806345
DNA O 0 0.0029450589790940285
damage O 0 0.0154196135699749
. O 0 0.00013517205661628395
. O 0 0.00011237170838285238

Truncation O 0 0.0033782157115638256
mutations O 0 0.00010728160850703716
in O 0 6.074858902138658e-05
the O 0 0.00012546450307127088
transactivation O 0 0.002818256849423051
region O 0 0.0004760368901770562
of O 0 0.0005403001559898257
PAX6 O 1 0.9457408785820007
result O 0 0.0001048546691890806
in O 0 0.00010000485781347379
dominant O 0 0.0006273632170632482
- O 0 0.0001895621098810807
negative O 0 1.5577506928821094e-05
mutants O 0 0.0003094252897426486
. O 0 4.368435111246072e-05

PAX6 O 0 0.08840034902095795
is O 0 3.552348061930388e-05
a O 0 9.871147085505072e-06
transcription O 0 4.3524752982193604e-05
factor O 0 7.527429715992184e-06
with O 0 9.280894346375135e-07
two O 0 2.4054299956333125e-06
DNA O 0 6.855970423202962e-05
- O 0 8.35760947666131e-05
binding O 0 7.422200724249706e-06
domains O 0 0.0001241333520738408
( O 0 5.2924260671716183e-05
paired O 0 0.00011488844029372558
box O 0 0.00029985466971993446
and O 0 2.1651612769346684e-05
homeobox O 0 0.0013196320505812764
) O 0 1.0392707736173179e-05
and O 0 4.446448201633757e-06
a O 0 3.316488437121734e-05
proline O 0 0.0006965582142584026
- O 0 0.0004059159255120903
serine O 0 6.327123992377892e-05
- O 0 0.00018420246487949044
threonine O 0 6.793304783059284e-05
( O 0 5.125593816046603e-05
PST O 0 0.08225524425506592
) O 0 3.636586188804358e-05
- O 0 0.000191948187421076
rich O 0 5.031890032114461e-05
transactivation O 0 0.0012868397170677781
domain O 0 0.00037468469236046076
. O 0 0.0001823587663238868

PAX6 O 1 0.9999880790710449
regulates O 0 0.005818171892315149
eye O 0 0.006481464486569166
development O 0 0.0003055959241464734
in O 0 9.092325490200892e-05
animals O 0 2.4496943296981044e-05
ranging O 0 0.00018263407400809228
from O 0 0.00019272668578196317
jellyfish O 0 7.468694093404338e-05
to O 0 1.5763804185553454e-05
Drosophila O 0 5.6107488489942625e-05
to O 0 2.427166145935189e-05
humans O 0 0.00012397543468978256
. O 0 7.096253102645278e-05

Heterozygous O 0 0.00013674149522557855
mutations O 0 5.435603452497162e-05
in O 0 2.9954013371025212e-05
the O 0 0.00011751733836717904
human O 0 0.00012529653031378984
PAX6 O 0 0.09655597805976868
gene O 0 2.65175367530901e-05
result O 0 7.199418632808374e-06
in O 0 4.476178673940012e-06
various O 0 5.164232334209373e-06
phenotypes O 0 5.808296555187553e-05
, O 0 6.215544544829754e-06
including O 0 1.8447482943884097e-05
aniridia B-Disease 1 1.0
, O 0 0.0006939485901966691
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 0.0002836014609783888
autosomal B-Disease 1 0.7085704207420349
dominant I-Disease 1 0.9999428987503052
keratitis I-Disease 1 1.0
, O 0 0.000987824285402894
and O 0 0.0009128706296905875
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9998902082443237

It O 0 3.025438854820095e-05
is O 0 8.043190973694436e-06
believed O 0 2.1447565814014524e-05
that O 0 4.7209195486175304e-07
the O 0 6.4327032305300236e-06
mutated O 0 1.4337846550915856e-05
allele O 0 3.059522896364797e-06
of O 0 8.823027746984735e-05
PAX6 O 0 0.041568025946617126
produces O 0 4.241044734953903e-05
an O 0 1.0868061508517712e-05
inactive O 0 0.00028234589262865484
protein O 0 5.345910176401958e-05
and O 0 3.076999564655125e-05
aniridia B-Disease 1 0.9996210336685181
is O 0 2.4048953491728753e-05
caused O 0 6.056476559024304e-05
due O 0 7.67061865190044e-05
to O 0 3.9121961890487e-05
genetic O 0 0.00041418775799684227
haploinsufficiency O 0 0.03267478570342064
. O 0 0.00036459488910622895

However O 0 0.00015921340673230588
, O 0 9.47696480579907e-06
several O 0 5.592705292656319e-06
truncation O 0 0.00030197130399756134
mutations O 0 1.6029538528528064e-05
have O 0 2.1327973627194297e-06
been O 0 6.661057341261767e-06
found O 0 2.5796871341299266e-06
to O 0 2.267755917273462e-06
occur O 0 5.14294151798822e-06
in O 0 1.2342468835413456e-05
the O 0 7.046871905913576e-05
C O 0 0.000928832043427974
- O 0 0.0002644314372446388
terminal O 0 0.0003975203144364059
half O 0 2.1909276256337762e-05
of O 0 0.00010281523282174021
PAX6 O 0 0.10746248811483383
in O 0 0.00011658334551611915
patients O 0 5.1459730457281694e-05
with O 0 3.074978303629905e-05
Aniridia B-Disease 1 0.9999967813491821
resulting O 0 0.0003206441178917885
in O 0 5.634244007524103e-05
mutant O 0 4.145168713876046e-05
proteins O 0 2.349616352148587e-06
that O 0 8.032956770875899e-07
retain O 0 8.180734766938258e-06
the O 0 2.1204836230026558e-05
DNA O 0 8.171724766725674e-05
- O 0 4.638336758944206e-05
binding O 0 1.828942231441033e-06
domains O 0 1.8392500351183116e-05
but O 0 2.5095971523114713e-06
have O 0 1.8520756839279784e-06
lost O 0 7.767760689603165e-05
most O 0 4.480193183553638e-06
of O 0 4.723522943095304e-05
the O 0 0.00013194078928790987
transactivation O 0 0.004920126870274544
domain O 0 0.0006853946833871305
. O 0 0.0002828003780450672

It O 0 3.3468721085228026e-05
is O 0 6.814948847022606e-06
not O 0 1.0824913942997227e-06
clear O 0 4.71125031253905e-06
whether O 0 3.2830207601364236e-06
such O 0 4.95619769935729e-06
mutants O 0 0.0003197612822987139
really O 0 6.693401519441977e-05
behave O 0 2.349500937270932e-05
as O 0 1.7101359844673425e-05
loss O 0 0.00024855334777384996
- O 0 0.00019610428716987371
of O 0 0.00011612202069954947
- O 0 0.00019329572387505323
function O 0 1.7364334780722857e-05
mutants O 0 5.447185321827419e-05
as O 0 1.1237831131438725e-05
predicted O 0 6.433033559005708e-05
by O 0 1.193247408082243e-05
haploinsufficiency O 0 0.005453493446111679
. O 0 0.0002421889512334019

Contrary O 0 0.00022575898037757725
to O 0 1.4238974472391419e-05
this O 0 4.753900611831341e-06
theory O 0 5.332570071914233e-05
, O 0 4.904585239273729e-06
our O 0 3.6179267226543743e-06
data O 0 4.686791271524271e-06
showed O 0 1.1610265573835932e-05
that O 0 1.4137799553282093e-06
these O 0 1.9617941688920837e-06
mutants O 0 5.166659684618935e-05
are O 0 2.1191178802837385e-06
dominant O 0 0.00011782635556301102
- O 0 0.00010022787319030613
negative O 0 9.873595445242245e-06
in O 0 3.273609036114067e-05
transient O 0 0.00035273321554996073
transfection O 0 0.0006995461881160736
assays O 0 1.917161534947809e-05
when O 0 5.537790457310621e-06
they O 0 5.071622695140832e-07
are O 0 4.813287546312495e-07
coexpressed O 0 0.0003764636057894677
with O 0 1.749536386341788e-05
wild O 0 0.00038445278187282383
- O 0 0.0008536363602615893
type O 0 0.0006897824932821095
PAX6 O 1 0.9974416494369507
. O 0 0.0005088282632641494

We O 0 3.7179117498453707e-05
found O 0 5.083358701085672e-06
that O 0 1.2124853583372897e-06
the O 0 3.114168794127181e-05
dominant O 0 0.00030741136288270354
- O 0 0.00013676639355253428
negative O 0 7.308204203582136e-06
effects O 0 7.444092625519261e-05
result O 0 1.8135282516595908e-05
from O 0 1.4512137568090111e-05
the O 0 2.1729578293161467e-05
enhanced O 0 8.321456698467955e-05
DNA O 0 3.3766838896553963e-05
binding O 0 3.994737198809162e-06
ability O 0 5.311292170517845e-06
of O 0 6.380948616424575e-05
these O 0 3.08210619550664e-05
mutants O 0 0.0008011612226255238
. O 0 0.00012520051677711308

Kinetic O 0 0.0004470888525247574
studies O 0 2.1235413441900164e-05
of O 0 0.00014892990293446928
binding O 0 3.0047223845031112e-05
and O 0 2.0900215531582944e-05
dissociation O 0 7.533472671639174e-05
revealed O 0 0.00011307813110761344
that O 0 1.7945322952073184e-06
various O 0 2.5880108296405524e-06
truncation O 0 0.0002485564327798784
mutants O 0 0.00011317631287965924
have O 0 5.164665708434768e-06
3 O 0 6.172837311169133e-05
- O 0 0.00010169876622967422
5 O 0 5.2892773965140805e-05
- O 0 5.064442666480318e-05
fold O 0 1.016696205624612e-05
higher O 0 3.597630211515934e-06
affinity O 0 1.8364700054007699e-06
to O 0 2.0572092580550816e-06
various O 0 8.030543540371582e-06
DNA O 0 0.00013792897516395897
- O 0 4.195368819637224e-05
binding O 0 1.2681954331128509e-06
sites O 0 7.569917215732858e-06
when O 0 2.3820084606995806e-06
compared O 0 2.4644089080538834e-06
with O 0 1.2629319599000155e-06
the O 0 5.137240077601746e-05
wild O 0 0.0002658797020558268
- O 0 0.0003999216132797301
type O 0 0.0006089148228056729
PAX6 O 1 0.986171305179596
. O 0 0.0007453133002854884

These O 0 1.3862309060641564e-05
results O 0 6.964932708797278e-06
provide O 0 3.869241936627077e-06
a O 0 8.271375008916948e-06
new O 0 6.58826547805802e-06
insight O 0 4.3386840843595564e-05
into O 0 4.509036443778314e-06
the O 0 6.121540536696557e-06
role O 0 1.1596278454817366e-05
of O 0 7.218105747597292e-05
mutant O 0 0.0006069051451049745
PAX6 O 1 0.9941614270210266
in O 0 0.00044987068395130336
causing O 0 0.004652984905987978
aniridia B-Disease 1 0.9999942779541016
. O 0 0.00021890831703785807
. O 0 0.000153938279254362

Reversal O 0 0.004207391757518053
of O 1 0.9242973923683167
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9971103668212891
excellent O 0 0.011470677331089973
neuropsychologic O 0 0.28859925270080566
outcome O 0 0.00022235017968341708
in O 0 8.768760017119348e-05
very B-Disease 0 3.32982417603489e-05
- I-Disease 0 0.00012220699863974005
long I-Disease 0 0.00010249455226585269
- I-Disease 0 0.0001015245434246026
chain I-Disease 0 4.156565046287142e-05
acyl I-Disease 0 5.6961878726724535e-05
- I-Disease 0 0.00011772516882047057
coenzyme I-Disease 0 3.0219498512451537e-05
A I-Disease 0 0.001917135901749134
dehydrogenase I-Disease 0 0.06851494312286377
deficiency I-Disease 1 1.0
. O 0 0.0017931850161403418

Very B-Disease 0 0.00045807138667441905
- I-Disease 0 0.00047021376667544246
long I-Disease 0 0.0001845072692958638
- I-Disease 0 0.00020293373381718993
chain I-Disease 0 3.2429998100269586e-05
acyl I-Disease 0 3.7599784263875335e-05
- I-Disease 0 6.919773295521736e-05
coenzyme I-Disease 0 4.167451152170543e-06
A I-Disease 0 0.00010887209646170959
dehydrogenase I-Disease 0 0.0001765499182511121
( I-Disease 0 0.00015883160813245922
VLCAD I-Disease 1 0.9999995231628418
) I-Disease 0 0.000512508733663708
deficiency I-Disease 1 0.9999483823776245
is O 0 4.693286609835923e-05
a O 0 0.00011134263331769034
disorder O 1 0.9999972581863403
of O 1 0.9999186992645264
fatty O 1 0.9995347261428833
acid O 0 0.0016210859175771475
beta O 0 0.0005829630536027253
oxidation O 0 6.467023195000365e-05
that O 0 7.241863386298064e-06
reportedly O 0 5.5407021136488765e-05
has O 0 4.602263743436197e-06
high O 0 7.417194865411147e-05
rates O 0 1.3802537068841048e-05
of O 0 7.74322179495357e-05
morbidity O 0 0.0013889557449147105
and O 0 7.506702240789309e-05
mortality O 0 0.0014923723647370934
. O 0 0.00022199451632332057

We O 0 2.784469870675821e-05
describe O 0 1.7166654288303107e-05
the O 0 1.3521191249310505e-05
outcome O 0 1.575876922288444e-05
of O 0 3.254416151321493e-05
a O 0 2.7803995180875063e-05
5 O 0 6.771999323973432e-05
- O 0 0.00010600619862088934
year O 0 3.988973185187206e-05
- O 0 0.00011499750689836219
old O 0 0.0001317357673542574
girl O 0 0.00015130775864236057
with O 0 0.00010293423110852018
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0020219003781676292
was O 0 0.001768508111126721
first O 0 5.7433691836195067e-05
seen O 0 7.005089719314128e-05
at O 0 4.448040999704972e-05
5 O 0 1.2112083823012654e-05
months O 0 5.394037998485146e-06
of O 0 3.358212052262388e-05
age O 0 0.00030766884447075427
with O 0 0.00011447464930824935
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999998807907104
encephalopathy B-Disease 1 1.0
, O 0 0.25020352005958557
and O 0 0.0030922661535441875
hypotonia B-Disease 1 0.9996562004089355
. O 0 0.0025465795770287514

Biochemical O 0 0.0010969804134219885
studies O 0 0.000296876416541636
indicated O 1 0.9988862872123718
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9998860359191895
by O 0 8.271708793472499e-05
a O 0 6.301424582488835e-05
stable O 0 0.00019373524992261082
yet O 0 3.0477340260404162e-05
inactive O 0 0.00017006216512527317
enzyme O 0 4.029277988593094e-05
. O 0 9.916690760292113e-05

Molecular O 0 0.0002469014434609562
genetic O 0 7.474736776202917e-05
analysis O 0 1.270519078389043e-05
of O 0 0.000372740178136155
her O 0 0.0004722294688690454
VLCAD O 1 0.9991484880447388
gene O 0 7.311449735425413e-05
revealed O 0 0.000279105530353263
a O 0 9.137758752331138e-05
T1372C O 0 0.0015730852028355002
( O 0 7.93389554019086e-05
F458L O 0 0.0018056485569104552
) O 0 3.441573426243849e-05
missense O 0 0.0001812092523323372
mutation O 0 2.094938281516079e-05
and O 0 3.557786112651229e-05
a O 0 0.0004656696110032499
1668 O 1 0.9996280670166016
ACAG O 1 0.9999979734420776
1669 O 0 0.4096858501434326
splice O 0 0.005354385357350111
site O 0 0.0013524654787033796
mutation O 0 7.197129889391363e-05
. O 0 0.0001331065286649391

After O 0 0.00012688878632616252
initial O 0 3.6069555790163577e-05
treatment O 0 8.469772001262754e-05
with O 0 8.102996071102098e-05
intravenous O 1 0.9630308151245117
glucose O 0 0.06944812834262848
and O 0 0.0006922513712197542
carnitine O 1 0.9005019664764404
, O 0 4.3278323573758826e-05
the O 0 7.009019464021549e-05
patient O 0 3.392654252820648e-05
has O 0 7.158176231314428e-06
thrived O 0 0.0002795393520500511
on O 0 3.038227259821724e-05
a O 0 1.9694007278303616e-05
low O 0 0.00026590152992866933
- O 0 0.0003404393792152405
fat O 0 9.726796270115301e-05
diet O 0 1.3976494301459752e-05
supplemented O 0 1.172156316897599e-05
with O 0 2.8815859423048096e-06
medium O 0 0.0001344588672509417
- O 0 0.00028318242402747273
chain O 0 8.738958422327414e-05
triglyceride O 0 0.0003059346345253289
oil O 0 0.00041122332913801074
and O 0 5.1234041166026145e-05
carnitine O 0 0.003546474501490593
and O 0 3.720678432728164e-05
avoidance O 0 0.0010653453646227717
of O 0 0.0027316745836287737
fasting O 0 0.004134392365813255
. O 0 0.0004594563215505332

Her O 0 0.008628974668681622
ventricular O 1 0.9999955892562866
hypertrophy O 1 0.9996949434280396
resolved O 0 0.00374004733748734
significantly O 0 0.00013086124090477824
over O 0 3.802089486271143e-05
1 O 0 0.00012147943198215216
year O 0 7.293928501894698e-05
, O 0 1.6626796423224732e-05
and O 0 3.460213338257745e-05
cognitively O 0 0.003484119661152363
, O 0 2.571447112131864e-05
she O 0 1.1612457456067204e-05
is O 0 3.5103091704513645e-06
in O 0 6.410753940144787e-06
the O 0 1.8147879018215463e-05
superior O 0 0.00010219397518085316
range O 0 4.061811705469154e-05
for O 0 3.2661875593476e-05
age O 0 0.0010340589797124267
. O 0 0.00032758177258074284

Clinical O 0 0.00039015006041154265
recognition O 0 0.0016078585758805275
of O 1 1.0
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.000713080691639334
important O 0 0.00010748906061053276
because O 0 3.2668676794855855e-06
it O 0 3.1637441111342923e-07
is O 0 3.2560140539317217e-07
one O 0 2.1917647075042623e-07
of O 0 4.584312591759954e-06
the O 0 2.1088775611133315e-05
few O 0 3.420893335714936e-05
directly O 0 0.00018042305600829422
treatable O 1 0.9999994039535522
causes O 0 0.0019532216247171164
of O 1 0.9998339414596558
cardiomyopathy B-Disease 1 1.0
in O 1 0.9981478452682495
children O 0 0.0009976032888516784
. O 0 0.00011027501750504598
. O 0 0.00010980764636769891

Cloning O 0 0.0005191440577618778
of O 0 0.0002070354821626097
a O 0 6.363338616210967e-05
novel O 0 6.875737017253414e-05
member O 0 1.9587654605857097e-05
of O 0 4.198863098281436e-05
the O 0 0.00012925054761581123
low O 0 0.0003010471409652382
- O 0 0.00015705841360613704
density O 0 2.0689096345449798e-05
lipoprotein O 0 0.0004831031255889684
receptor O 0 9.460197179578245e-05
family O 0 0.00011611693480517715
. O 0 8.071940101217479e-05

A O 0 0.0006359238759614527
gene O 0 1.181746119982563e-05
encoding O 0 1.0676055353542324e-05
a O 0 2.5508841645205393e-05
novel O 0 8.861164678819478e-05
transmembrane O 0 0.00027563655748963356
protein O 0 2.036615478573367e-05
was O 0 5.449357922771014e-05
identified O 0 2.966687134176027e-06
by O 0 2.0767031116974977e-07
DNA O 0 1.1793105159085826e-06
sequence O 0 2.5915207402249507e-07
analysis O 0 1.0457747379177817e-07
within O 0 7.035704356894712e-07
the O 0 1.1452962098701391e-05
insulin B-Disease 0 0.000276024715276435
- I-Disease 0 0.0005938083631917834
dependent I-Disease 0 0.00020303495693951845
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.009325796738266945
IDDM B-Disease 1 0.9999994039535522
) O 0 7.844866195227951e-05
locus O 0 0.00034619797952473164
IDDM4 O 1 0.8100129961967468
on O 0 0.0006379766273312271
chromosome O 0 0.0010670155752450228
11q13 O 0 0.00425470806658268
. O 0 0.00025885525974445045

Based O 0 5.014027556171641e-05
on O 0 8.637335849925876e-05
its O 0 3.385240779607557e-05
chromosomal O 0 0.0003569354012142867
position O 0 0.00011398209608159959
, O 0 8.989058187580667e-06
this O 0 2.132534973497968e-06
gene O 0 3.7541631172643974e-06
is O 0 1.4769112794965622e-06
a O 0 2.0694685645139543e-06
candidate O 0 1.4774240071346867e-06
for O 0 1.048556441674009e-06
conferring O 0 0.00013581548410002142
susceptibility O 0 0.000765258795581758
to O 0 0.0008905839640647173
diabetes B-Disease 1 1.0
. O 0 0.0032006436958909035

The O 0 0.0002304285007994622
gene O 0 3.9947561162989587e-05
, O 0 1.3679449693881907e-05
termed O 0 0.00015869371418375522
low O 0 0.000164821365615353
- O 0 8.975745004136115e-05
density O 0 8.356711077794898e-06
lipoprotein O 0 0.00010613050835672766
receptor O 0 1.2254972716618795e-05
related O 0 2.4926121113821864e-05
protein O 0 2.2608161089010537e-05
5 O 0 4.062881271238439e-05
( O 0 2.6564715881249867e-05
LRP5 O 0 0.013247133232653141
) O 0 7.070505944284378e-06
, O 0 1.5199326526271761e-06
encodes O 0 2.04582261176256e-06
a O 0 5.132181740918895e-06
protein O 0 1.8988095689564943e-05
of O 0 0.0002277955791214481
1615 O 0 0.00927452091127634
amino O 0 6.800459959777072e-05
acids O 0 7.492479198845103e-06
that O 0 9.16775832138228e-07
contains O 0 6.261497674131533e-06
conserved O 0 3.0325942134368233e-05
modules O 0 3.0958541174186394e-05
which O 0 1.0879570027100272e-06
are O 0 1.9230739667364105e-07
characteristic O 0 7.333043868129607e-06
of O 0 5.1874889322789386e-05
the O 0 9.76357696345076e-05
low O 0 0.0002910091425292194
- O 0 9.407266770722345e-05
density O 0 3.046382698812522e-05
lipoprotein O 0 0.0014464922714978456
( O 0 0.0002640547463670373
LDL O 0 0.008514928631484509
) O 0 2.4178372768801637e-05
receptor O 0 2.7573636543820612e-05
family O 0 3.6819048546021804e-05
. O 0 4.6137556637404487e-05

These O 0 3.5059078072663397e-05
modules O 0 0.0001468250120524317
include O 0 1.2550542123790365e-05
a O 0 2.251656405860558e-05
putative O 0 0.00015942883328534663
signal O 0 0.00013456428132485598
peptide O 0 3.397871114430018e-05
for O 0 6.3095358200371265e-06
protein O 0 1.334619264525827e-05
export O 0 2.507891258574091e-05
, O 0 3.872254183079349e-06
four O 0 7.922059012344107e-06
epidermal O 0 0.00035226528416387737
growth O 0 4.699341661762446e-05
factor O 0 4.676381649915129e-05
( O 0 4.006957897217944e-05
EGF O 0 0.007665196433663368
) O 0 1.0059137821372133e-05
repeats O 0 2.7371324904379435e-05
with O 0 5.022598543291679e-06
associated O 0 2.8689190003206022e-05
spacer O 0 0.0005155402468517423
domains O 0 0.000216634914977476
, O 0 4.667043685913086e-05
three O 0 7.232106872834265e-05
LDL O 0 0.026776976883411407
- O 0 0.0007901298813521862
receptor O 0 8.30005228635855e-05
( O 0 5.9875364968320355e-05
LDLR O 0 0.04217823967337608
) O 0 1.5877036275924183e-05
repeats O 0 5.899313691770658e-05
, O 0 4.0114164221449755e-06
a O 0 8.134059498843271e-06
single O 0 1.5599405742250383e-05
transmembrane O 0 0.0009826200548559427
spanning O 0 0.003700901987031102
domain O 0 0.0006408658227883279
, O 0 3.559787728590891e-05
and O 0 1.3470904377754778e-05
a O 0 6.163884972920641e-05
cytoplasmic O 0 0.00032075721537694335
domain O 0 0.0005723208887502551
. O 0 0.0003041765303350985

The O 0 9.786759619601071e-05
encoded O 0 1.910955506900791e-05
protein O 0 8.356543730769772e-06
has O 0 1.0646909913702984e-06
a O 0 1.5832767985557439e-06
unique O 0 3.8145333292050054e-06
organization O 0 5.690124453394674e-06
of O 0 0.00014908818411640823
EGF O 1 0.9898968935012817
and O 0 0.00021752929023932666
LDLR O 1 0.9996569156646729
repeats O 0 0.0004899516934528947
; O 0 7.078116141201463e-06
therefore O 0 2.7771347959060222e-05
, O 0 3.756186561076902e-05
LRP5 O 0 0.079966239631176
likely O 0 3.684985495056026e-05
represents O 0 7.3344849624845665e-06
a O 0 4.397928023536224e-06
new O 0 2.525876652725856e-06
category O 0 7.571432888653362e-06
of O 0 5.8916848502121866e-05
the O 0 0.0004971203161403537
LDLR O 1 0.9998674392700195
family O 0 0.0001643753203097731
. O 0 0.00016301237337756902

Both O 0 0.00019513828738126904
human O 0 0.00016982639499474317
and O 0 0.00012142510968260467
mouse O 0 0.0006520668976008892
LRP5 O 1 0.9997929930686951
cDNAs O 0 0.0023314408026635647
have O 0 2.2643869215244194e-06
been O 0 4.928277576254914e-06
isolated O 0 1.4711570656800177e-05
and O 0 1.2602741890077596e-06
the O 0 7.855403055145871e-06
encoded O 0 5.966212938801618e-06
mature O 0 1.277951287192991e-05
proteins O 0 5.751857088398538e-07
are O 0 3.0684245189149806e-07
95 O 0 1.1086905942647718e-05
% O 0 4.356946192274336e-06
identical O 0 1.1492744306451641e-05
, O 0 5.973648057988612e-06
indicating O 0 6.0204863984836265e-05
a O 0 1.7245265553356148e-05
high O 0 8.222274482250214e-05
degree O 0 4.815716602024622e-05
of O 0 0.00016726840112823993
evolutionary O 0 0.00028069951804354787
conservation O 0 7.405745418509468e-05
. O 0 1.7276592188864015e-05
. O 0 3.861051663989201e-05

The O 0 0.0009022510494105518
APC B-Disease 0 0.00424354150891304
variants O 0 0.00011705968790920451
I1307K O 0 0.0007147649885155261
and O 0 1.0080475476570427e-05
E1317Q O 0 0.00020378729095682502
are O 0 1.3959397620055825e-06
associated O 0 6.334187492029741e-05
with O 0 0.015462856739759445
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.010244124568998814
but O 0 1.771839743014425e-05
not O 0 1.625773734303948e-06
always O 0 2.953836201413651e-06
with O 0 3.7610001868415566e-07
a O 0 9.592552487447392e-06
family O 0 2.0517294615274295e-05
history O 0 0.00041192283970303833
. O 0 0.00016681096167303622

Classical O 1 0.6603479981422424
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999815225601196
FAP B-Disease 1 0.9999957084655762
) O 0 6.0270926041994244e-05
is O 0 8.262418305093888e-06
a O 0 2.6535090000834316e-05
high O 0 0.0010207234881818295
- O 0 0.002021937631070614
penetrance O 0 0.01244161743670702
autosomal B-Disease 0 0.1315588504076004
dominant I-Disease 1 0.9996823072433472
disease I-Disease 1 1.0
that O 0 7.725933392066509e-05
predisposes O 0 0.0017411586595699191
to O 0 2.173249959014356e-05
hundreds O 0 4.306038681534119e-05
or O 0 6.627764832956018e-06
thousands O 0 0.0001987295545404777
of O 1 0.9998835325241089
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 0.0013767146738246083
that O 0 1.842866731749382e-05
results O 0 1.2422319741745014e-05
from O 0 2.9161285056034103e-05
truncating O 0 0.00038148133899085224
mutations O 0 1.5435767636517994e-05
in O 0 2.656846663739998e-05
the O 0 0.00019635891658253968
APC B-Disease 0 0.002444163430482149
gene O 0 8.194956899387762e-05
. O 0 0.00011107094178441912

A O 0 0.0011385584948584437
variant O 0 0.0004042779328301549
of O 0 0.001005495898425579
FAP B-Disease 1 0.9985328912734985
is O 0 0.00044978101504966617
attenuated B-Disease 0 0.10919755697250366
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9995883107185364
, O 0 4.572948455461301e-05
which O 0 6.160203156468924e-06
results O 0 1.656194217503071e-05
from O 0 0.00012960933963768184
germ O 1 0.9996366500854492
- O 0 0.0008972871582955122
line O 0 0.00016971728473436087
mutations O 0 3.1284173473977717e-06
in O 0 4.344283752288902e-06
the O 0 1.083718871086603e-05
5 O 0 1.4080590517551173e-05
and O 0 1.7154570741695352e-06
3 O 0 1.1849329894175753e-05
regions O 0 7.302512585738441e-06
of O 0 6.51464652037248e-05
the O 0 0.00044856584281660616
APC B-Disease 0 0.004710466600954533
gene O 0 0.00010771500819828361
. O 0 0.00010143048712052405

Attenuated B-Disease 1 0.9999936819076538
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.0013409090461209416
have O 0 2.3737791707389988e-05
" O 0 0.0001883032382465899
multiple O 0 0.0003623056982178241
" O 1 0.9999828338623047
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.0007016704184934497
typically O 0 3.060415110667236e-05
fewer O 0 1.9215289285057224e-05
than O 0 7.166168416006258e-06
100 O 0 4.982326936442405e-05
) O 0 5.404763669503154e-06
without O 0 5.194346613279777e-06
the O 0 4.443957732291892e-05
florid O 0 0.0017473024781793356
phenotype O 0 4.965762491337955e-05
of O 0 0.0006923516048118472
classical O 0 0.036374855786561966
FAP B-Disease 1 0.9995772242546082
. O 0 0.0008759937481954694

Another O 0 0.0001783308107405901
group O 0 2.2747848561266437e-05
of O 0 0.00015845827874727547
patients O 0 0.00014348543481901288
with O 0 7.229624316096306e-05
multiple O 0 0.0035864433739334345
adenomas B-Disease 1 0.9999990463256836
has O 0 9.015976684167981e-05
no O 0 1.8556984286988154e-05
mutations O 0 4.936471214023186e-06
in O 0 1.75945351656992e-05
the O 0 8.277043525595218e-05
APC B-Disease 0 0.0009031295776367188
gene O 0 1.2081191016477533e-05
, O 0 3.3340145364491036e-06
and O 0 2.155274614779046e-06
their O 0 3.335751216582139e-06
phenotype O 0 1.27512930703233e-05
probably O 0 1.4586148608941585e-05
results O 0 1.4630523992309463e-06
from O 0 3.6161775369691895e-06
variation O 0 1.4713396012666635e-05
at O 0 0.0001310477964580059
a O 0 2.8442920665838756e-05
locus O 0 0.00012741949467454106
, O 0 2.2592406821786426e-05
or O 0 2.0138928448432125e-05
loci O 0 9.732093894854188e-05
, O 0 9.94725814962294e-06
elsewhere O 0 1.53131659317296e-05
in O 0 8.806086952972692e-06
the O 0 3.8721580494893715e-05
genome O 0 0.00014208054926712066
. O 0 5.6025040976237506e-05

Recently O 0 0.0007151387399062514
, O 0 1.0560979717411101e-05
however O 0 5.4775032367615495e-06
, O 0 2.4293717615364585e-06
a O 0 5.204005447012605e-06
missense O 0 0.0001140233944170177
variant O 0 0.00018057934357784688
of O 0 0.001580218318849802
APC B-Disease 0 0.12507495284080505
( O 0 0.0002495827793609351
I1307K O 0 0.0017183844465762377
) O 0 1.1799127605627291e-05
was O 0 5.523798972717486e-05
described O 0 8.412564966420177e-06
that O 0 4.6115684426695225e-07
confers O 0 9.599964869266842e-06
an O 0 9.55942482505634e-07
increased O 0 1.2960200365341734e-05
risk O 0 0.000309905648464337
of O 1 0.9999922513961792
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0025816995184868574
including O 0 0.00025905200163833797
multiple O 0 0.007389130536466837
adenomas B-Disease 1 0.9999996423721313
, O 0 0.00038706950726918876
in O 0 0.0005487098824232817
Ashkenazim O 0 0.47529336810112
. O 0 0.0004920432693324983

We O 0 5.489027171279304e-05
have O 0 3.4558074730739463e-06
studied O 0 4.2587402276694775e-05
a O 0 4.145416369283339e-06
set O 0 6.993465831328649e-06
of O 0 1.3616741853184067e-05
164 O 0 7.424136128975078e-05
patients O 0 2.1032901713624597e-05
with O 0 3.123192072962411e-05
multiple O 1 0.9999957084655762
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9988002777099609
carcinoma I-Disease 1 1.0
and O 0 0.002009473741054535
analyzed O 0 0.0014886941062286496
codons O 0 0.001114852842874825
1263 O 0 0.02520616166293621
- O 0 0.003111579455435276
1377 O 0 0.017469948157668114
( O 0 0.00015529168013017625
exon O 0 0.0008686250657774508
15G O 0 0.0004752466338686645
) O 0 2.546527639424312e-06
of O 0 2.0755775040015578e-05
the O 0 6.352539639919996e-05
APC B-Disease 0 0.0008281336049549282
gene O 0 1.780889397196006e-05
for O 0 3.9509897760581225e-05
germ O 1 0.9999005794525146
- O 0 0.0013783881440758705
line O 0 0.00036310323048383
variants O 0 9.641247015679255e-05
. O 0 0.000136056580231525

Three O 0 0.00014415728219319135
patients O 0 4.6116794692352414e-05
with O 0 7.91314960224554e-06
the O 0 0.00018981783068738878
I1307K O 0 0.000994178932160139
allele O 0 1.1515432561282068e-05
were O 0 2.4048953491728753e-05
detected O 0 5.2803723519900814e-05
, O 0 1.1757550737456768e-06
each O 0 2.18339891944197e-07
of O 0 5.500265979208052e-05
Ashkenazi O 0 0.000871638476382941
descent O 0 0.0017521372064948082
. O 0 0.0006564116338267922

Four O 0 0.00018532607646193355
patients O 0 9.282139944843948e-05
had O 0 0.00024933283566497266
a O 0 0.0005701380432583392
germ O 1 0.999996542930603
- O 0 0.003571323351934552
line O 0 0.0007039878400973976
E1317Q O 0 0.0008346972172148526
missense O 0 0.00021158071467652917
variant O 0 0.00016544171376153827
of O 0 0.000592012656852603
APC O 0 0.002857607090845704
that O 0 1.2277876521693543e-05
was O 0 0.0001235568051924929
not O 0 1.429299800292938e-06
present O 0 1.3238040082796942e-05
in O 0 2.992360714415554e-05
controls O 0 3.2130319596035406e-05
; O 0 2.206069439125713e-06
one O 0 2.500332811905537e-06
of O 0 2.3560367480968125e-05
these O 0 4.458235252968734e-06
individuals O 0 2.2681840619043214e-06
had O 0 4.013072248199023e-05
an O 0 8.444861123280134e-06
unusually O 0 3.9588041545357555e-05
large O 0 9.619007869332563e-06
number O 0 8.806910045677796e-06
of O 0 0.00035315717104822397
metaplastic B-Disease 1 0.7433362007141113
polyps I-Disease 0 0.0046504950150847435
of I-Disease 0 0.0005149770295247436
the I-Disease 0 0.001437881961464882
colorectum I-Disease 1 0.5676965713500977
. O 0 0.00048882479313761

There O 0 7.10463646100834e-05
is O 0 7.630365871591493e-06
increasing O 0 8.342321962118149e-06
evidence O 0 1.0539086360950023e-05
that O 0 2.1929222384642344e-06
there O 0 1.2813879948225804e-05
exist O 0 0.00015442667063325644
germ O 0 0.1562974750995636
- O 0 0.0002623150940053165
line O 0 5.524947846424766e-05
variants O 0 1.0334179023629986e-05
of O 0 4.4484142563305795e-05
the O 0 0.00019137689378112555
APC B-Disease 0 0.0009017353295348585
gene O 0 6.844937161076814e-06
that O 0 8.633618904241303e-07
predispose O 0 5.440291715785861e-05
to O 0 2.753052967818803e-06
the O 0 5.001648332836339e-06
development O 0 1.125898415921256e-05
of O 0 0.0001288366038352251
multiple O 1 0.9999986886978149
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 0.004415279254317284
but O 0 1.759158112690784e-05
without O 0 1.4362753063323908e-05
the O 0 7.334032852668315e-05
florid O 0 0.0028631219174712896
phenotype O 0 7.036423630779609e-05
of O 0 0.0005001696990802884
classical O 0 0.02585701458156109
FAP B-Disease 1 0.9898966550827026
, O 0 2.0265330022084527e-05
and O 0 2.6259649530402385e-06
possibly O 0 1.3265767847769894e-05
with O 0 1.17651336495328e-06
importance O 0 0.000495218439027667
for O 0 0.010782751254737377
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.08980774134397507
in O 0 7.779109728289768e-05
the O 0 3.523184932419099e-05
general O 0 1.4498360542347655e-05
population O 0 3.966063104599016e-06
. O 0 9.624072845326737e-06
. O 0 3.559665856300853e-05

Genomic O 0 9.201108332490548e-05
structure O 0 0.0001188972091767937
of O 0 0.00013041800411883742
the O 0 0.0011829845607280731
human O 1 0.9999922513961792
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999996423721313
CLD B-Disease 1 1.0
) O 0 0.00041068566497415304
gene O 0 0.00019516621250659227
. O 0 0.0001411046541761607

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.00024772598408162594
is O 0 2.914246761065442e-05
caused O 0 6.9565670855809e-05
by O 0 3.3606570468691643e-06
mutations O 0 3.9525903048343025e-06
in O 0 4.121212896279758e-06
a O 0 4.667130269808695e-06
gene O 0 1.8252185327582993e-06
which O 0 1.4362739193529706e-06
encodes O 0 1.0963103704852983e-05
an O 0 3.0629726097686216e-05
intestinal O 1 0.999994158744812
anion O 0 0.03403126820921898
transporter O 1 0.9248354434967041
. O 0 0.0014008978614583611

We O 0 6.777179805794731e-05
report O 0 7.780889973219018e-06
here O 0 5.5341101869998965e-06
the O 0 3.7520369460253278e-06
complete O 0 1.7452241081628017e-05
genomic O 0 2.0906993086100556e-05
organization O 0 5.2822479119640775e-06
of O 0 4.420356344780885e-05
the O 0 0.00017527832824271172
human O 0 0.0003273345355410129
CLD B-Disease 1 0.9719183444976807
gene O 0 4.296038969187066e-05
which O 0 1.0248166290693916e-05
spans O 0 0.0004692421352956444
approximately O 0 0.00018109801749233156
39kb O 0 0.003255412681028247
, O 0 1.4388197996595409e-05
and O 0 5.085666543891421e-06
comprises O 0 8.48401541588828e-05
21 O 0 0.0008104908629320562
exons O 0 0.0021584732457995415
. O 0 0.00024786798167042434

All O 0 0.00022442535555455834
exon O 0 0.0024309055879712105
/ O 0 0.0007064846577122808
intron O 0 0.0008692879346199334
boundaries O 0 9.000046702567488e-06
conform O 0 1.5113370864128228e-05
to O 0 9.592973583494313e-06
the O 0 0.00012050855730194598
GT O 0 0.004854799248278141
/ O 0 0.002121297875419259
AG O 1 0.996093213558197
rule O 0 0.0015031876973807812
. O 0 0.0003294879861641675

An O 0 1.279251227970235e-05
analysis O 0 3.6466983601712855e-06
of O 0 7.586799620185047e-05
the O 0 0.00026337840245105326
putative O 0 0.0014069054741412401
promoter O 0 0.0012520732125267386
region O 0 7.859017932787538e-05
sequence O 0 1.7259975720662624e-05
shows O 0 3.3892465580720454e-05
a O 0 8.823642565403134e-05
putative O 0 0.0029294604901224375
TATA O 1 0.8898668885231018
box O 0 0.0007653623470105231
and O 0 1.1767438081733417e-05
predicts O 0 4.8153498937608674e-05
multiple O 0 9.934004992828704e-06
transcription O 0 0.0002990806242451072
factor O 0 6.323071283986792e-05
binding O 0 1.1690527571772691e-05
sites O 0 0.00012144329230068251
. O 0 8.13069855212234e-05

The O 0 0.00020045677956659347
genomic O 0 0.00017677716095931828
structure O 0 0.00043878573342226446
was O 0 0.0002373323222855106
determined O 0 1.6269344996544532e-05
using O 0 1.6496572925461805e-06
DNA O 0 2.2895430447533727e-05
from O 0 6.028445113770431e-06
several O 0 2.252482772746589e-06
sources O 0 7.100344646460144e-06
including O 0 2.460841415086179e-06
multiple O 0 3.096807631663978e-05
large O 0 0.0005314861191436648
- O 0 0.0016154252225533128
insert O 0 0.00030975701520219445
libaries O 0 0.0006674377946183085
and O 0 3.1642316571378615e-06
genomic O 0 1.37777351483237e-05
DNA O 0 7.981627277331427e-05
from O 0 0.0001318565191468224
Finnish O 1 0.9932317733764648
CLD B-Disease 1 0.9999998807907104
patients O 0 0.0003630338469520211
and O 0 0.00012468118802644312
controls O 0 0.0006591225392185152
. O 0 0.000560800835955888

Exon O 0 0.009053539484739304
- O 0 0.0003668419667519629
specific O 0 6.675467375316657e-06
primers O 0 0.0001008757681120187
developed O 0 2.2926347810425796e-05
in O 0 4.370534043118823e-06
this O 0 6.867755928396946e-07
study O 0 1.3549412187785492e-06
will O 0 1.0684240123737254e-06
facilitate O 0 7.647893653484061e-06
mutation O 0 1.146308250099537e-06
screening O 0 1.979311946342932e-06
studies O 0 3.0855901513859862e-06
of O 0 2.9729366360697895e-05
patients O 0 2.296192542416975e-05
with O 0 1.413002610206604e-05
the O 0 0.0018277950584888458
disease O 1 0.9999998807907104
. O 0 0.0007861542399041355

Genomic O 0 7.329083018703386e-05
sequencing O 0 7.406182703562081e-05
of O 0 0.00030884085572324693
a O 0 0.0006466293125413358
BAC O 1 0.9996575117111206
clone O 0 0.012386309914290905
H O 1 0.9998840093612671
_ O 0 0.00016051244165282696
RG364P16 O 0 0.0005307975807227194
revealed O 0 8.322973008034751e-05
the O 0 1.434701061953092e-05
presence O 0 1.0826465768332127e-05
of O 0 6.0632835811702535e-05
another O 0 3.444337926339358e-05
, O 0 6.508976184704807e-06
highly O 0 1.286157566937618e-05
homologous O 0 1.9251019693911076e-05
gene O 0 5.272358066576999e-06
3 O 0 2.6290259484085254e-05
of O 0 7.103118696250021e-05
the O 0 0.0005246991640888155
CLD B-Disease 1 0.9959651231765747
gene O 0 2.177826718252618e-05
, O 0 2.200757535320008e-06
with O 0 5.630308805848472e-07
a O 0 3.494983275231789e-06
similar O 0 1.9502529085002607e-06
genomic O 0 5.963262083241716e-05
structure O 0 0.00018088366778101772
, O 0 5.688626515620854e-06
recently O 0 7.814844138920307e-06
identified O 0 2.0060574570379686e-06
as O 0 4.059828370372998e-06
the O 0 0.00010612756886985153
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 0.002230615122243762
( O 0 0.000781672541052103
PDS B-Disease 1 0.9998975992202759
) O 0 0.00013057878823019564
. O 0 4.9115929869003594e-05
. O 0 0.0001015953384921886

The O 0 0.0015434963861480355
APCI1307K O 1 0.9997963309288025
allele O 0 0.00020856803166680038
and O 0 0.00012483642785809934
cancer B-Disease 1 0.9473254084587097
risk O 0 0.00021840111003257334
in O 0 5.1002785767195746e-05
a O 0 2.388644134043716e-05
community O 0 8.350871212314814e-06
- O 0 1.6740872524678707e-05
based O 0 4.4692933443002403e-07
study O 0 1.2486328841987415e-06
of O 0 3.248196662752889e-05
Ashkenazi O 0 0.0006387039320543408
Jews O 0 0.002176686655730009
. O 0 0.0006934001576155424

Mutations O 0 0.0003617503389250487
in O 0 0.00025514967273920774
APC O 0 0.0018418121617287397
are O 0 3.3003868793457514e-06
classically O 0 0.000245829374762252
associated O 0 2.186273195547983e-05
with O 0 4.063303640577942e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999998807907104
FAP B-Disease 1 1.0
) O 0 9.533004777040333e-05
, O 0 7.077549526002258e-06
a O 0 1.781042192305904e-05
highly O 0 0.0010016842279583216
penetrant O 1 0.9999997615814209
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9995009899139404
multiple O 1 1.0
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 0 0.0021178829483687878
, O 0 6.19467900833115e-05
without O 0 3.8154666981427e-05
surgical O 0 0.0012335616629570723
intervention O 0 0.00016355171101167798
, O 0 4.8637962208886165e-06
the O 0 5.590038654190721e-06
development O 0 3.660381480585784e-05
of O 1 0.9054586291313171
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9995394945144653
CRC B-Disease 1 0.9999767541885376
) O 0 0.0001632886560400948
. O 0 9.7352392913308e-05

APC B-Disease 0 0.011908713728189468
is O 0 8.342711225850508e-05
a O 0 0.00041332771070301533
tumour O 1 1.0
- O 0 0.009105975739657879
suppressor O 0 0.0009200571803376079
gene O 0 1.3257218597573228e-05
, O 0 4.446185357664945e-06
and O 0 8.42054305394413e-06
somatic O 0 0.00021501498122233897
loss O 0 0.0020272242836654186
occurs O 0 0.0005866219289600849
in O 0 0.0015218100743368268
tumours B-Disease 1 1.0
. O 0 0.0032443860545754433

The O 0 0.0025806818157434464
germline O 0 0.0262137558311224
T O 0 0.015200657770037651
- O 0 0.000322174106258899
to O 0 4.435109440237284e-05
- O 0 0.00013648575986735523
A O 0 0.0001539987715659663
transversion O 0 0.0007386797806248069
responsible O 0 1.8535198250901885e-05
for O 0 9.795115147426259e-06
the O 0 0.00019458311726339161
APC O 0 0.0021936942357569933
I1307K O 0 0.0007091369479894638
allele O 0 4.685874955612235e-06
converts O 0 6.538834441016661e-06
the O 0 2.375899020989891e-05
wild O 0 2.2969721612753347e-05
- O 0 1.0123558240593411e-05
type O 0 1.4823976925981697e-06
sequence O 0 1.4332637192637776e-06
to O 0 4.302984052628744e-06
a O 0 5.4624582844553515e-05
homopolymer O 1 0.9935888051986694
tract O 1 0.999595582485199
( O 0 0.0005149096832610667
A8 O 1 0.9827793836593628
) O 0 2.0616913388948888e-05
that O 0 2.8966271656827303e-06
is O 0 1.3457333807309624e-05
genetically O 0 0.000109545660961885
unstable O 0 0.001679968903772533
and O 0 5.247957960818894e-05
prone O 0 0.0009422936127521098
to O 0 9.771456097951159e-05
somatic O 0 0.0006760450778529048
mutation O 0 0.00016574913752265275
. O 0 0.00024073051463346928

The O 0 0.0006480146548710763
I1307K O 0 0.0017543871654197574
allele O 0 1.418251486029476e-05
was O 0 0.00010397926962468773
found O 0 1.5836598322493955e-05
in O 0 4.1495113691780716e-05
6 O 0 0.0006496111745946109
. O 0 0.00017498778470326215

1 O 0 0.0005189338116906583
% O 0 6.869255594210699e-05
of O 0 0.0005465949652716517
unselected O 0 0.04054301977157593
Ashkenazi O 0 0.001320137525908649
Jews O 0 0.0009729558369144797
and O 0 4.604951391229406e-05
higher O 0 6.4354513597209e-05
proportions O 0 0.00018556461145635694
of O 0 0.0003115120343863964
Ashkenazim O 0 0.004938084166496992
with O 0 4.0463248296873644e-05
family O 0 6.786415906390175e-05
or O 0 2.759536619123537e-05
personal O 0 0.00023967886227183044
histories O 0 0.001661133486777544
of O 1 0.9213002920150757
CRC B-Disease 1 0.9999854564666748
( O 0 0.0005306911189109087
ref O 0 0.007535374723374844
. O 0 2.7356401915312745e-05
2 O 0 0.000122852623462677
) O 0 3.022044984390959e-05
. O 0 6.928258517291397e-05

To O 0 3.751726035261527e-05
evaluate O 0 2.4405373551417142e-05
the O 0 2.413308720861096e-05
role O 0 2.8671463951468468e-05
of O 0 0.0001573594199726358
I1307K O 0 0.001966178650036454
in O 0 0.00013563754328060895
cancer B-Disease 0 0.0031465087085962296
, O 0 2.556548861321062e-05
we O 0 3.0849936592858285e-05
genotyped O 0 0.002408446744084358
5 O 0 0.00018380804976914078
, O 0 3.383639705134556e-05
081 O 0 0.0035510642919689417
Ashkenazi O 0 0.0002641071623656899
volunteers O 0 3.559264951036312e-05
in O 0 1.1220718079130165e-05
a O 0 1.1784441085183062e-05
community O 0 1.0178972843277734e-05
survey O 0 6.910693628014997e-05
. O 0 0.0001353747065877542

Risk O 0 0.000686046842020005
of O 0 0.0028380246367305517
developing O 1 0.9997658133506775
colorectal B-Disease 1 1.0
, I-Disease 0 0.026184149086475372
breast I-Disease 1 0.9979377388954163
and I-Disease 0 8.742477075429633e-05
other I-Disease 0 5.121909634908661e-05
cancers I-Disease 0 0.03658515214920044
were O 0 7.009814726188779e-05
compared O 0 8.836474444251508e-05
between O 0 0.0004979654913768172
genotyped O 0 0.021743880584836006
I1307K O 0 0.0023219771683216095
carriers O 0 4.160630123806186e-05
and O 0 1.0381118045188487e-05
non O 0 0.00013494979066308588
- O 0 0.0001617387606529519
carriers O 0 1.1202840141777415e-05
and O 0 1.4413261624213192e-06
their O 0 1.2833146456614486e-06
first O 0 1.88512585737044e-05
- O 0 7.865757652325556e-05
degree O 0 8.709857502253726e-05
relatives O 0 0.00020931352628394961
. O 0 0.000117723029688932

Sperm O 0 8.964556036517024e-05
DNA O 0 2.2640546376351267e-05
analysis O 0 2.3476341084460728e-06
in O 0 1.5223294212773908e-05
a O 0 0.0001465458481106907
Friedreich B-Disease 1 0.9998793601989746
ataxia I-Disease 1 0.9999825954437256
premutation O 1 0.9998503923416138
carrier O 0 0.0015495650004595518
suggests O 0 0.00014130069757811725
both O 0 3.793885844061151e-05
meiotic O 0 0.0031955877784639597
and O 0 9.059896547114477e-05
mitotic O 0 0.0005889312014915049
expansion O 0 0.0004393448762129992
in O 0 5.116954707773402e-05
the O 0 0.00020116732048336416
FRDA B-Disease 1 0.9866741895675659
gene O 0 0.00016953516751527786
. O 0 0.00011385217658244073

Friedreich B-Disease 1 0.9999995231628418
ataxia I-Disease 1 0.9999988079071045
is O 0 0.001240987447090447
usually O 0 0.00011214723053853959
caused O 0 0.0003032432869076729
by O 0 9.84144389803987e-06
an O 0 6.023451078362996e-06
expansion O 0 0.0002336216130061075
of O 0 0.0003102035843767226
a O 0 0.00040875287959352136
GAA O 0 0.020876189693808556
trinucleotide O 0 0.04298259690403938
repeat O 0 0.0005430048913694918
in O 0 5.009650340070948e-05
intron O 0 0.0009105426725000143
1 O 0 9.576302545610815e-05
of O 0 0.00012141898332629353
the O 0 0.00030529621290042996
FRDA B-Disease 1 0.9992437362670898
gene O 0 9.183787187794223e-05
. O 0 8.06114767328836e-05

Occasionally O 0 0.00039138045394793153
, O 0 1.4438960533880163e-05
a O 0 1.188425267173443e-05
fully O 0 6.838607805548236e-05
expanded O 0 3.035603185708169e-05
allele O 0 3.3698679544613697e-06
has O 0 1.2651740917135612e-06
been O 0 3.961972652177792e-06
found O 0 2.526098342059413e-06
to O 0 5.4795095820736606e-06
arise O 0 3.9988804928725585e-05
from O 0 2.273444624734111e-05
a O 0 4.973971226718277e-05
premutation O 0 0.0024064662866294384
of O 0 0.0003613832523114979
100 O 0 0.00035183620639145374
or O 0 4.974939292878844e-05
less O 0 9.824581502471119e-05
triplet O 0 0.0030956577975302935
repeats O 0 0.0018185245571658015
. O 0 0.0003834683448076248

We O 0 5.0986251153517514e-05
have O 0 2.117533995260601e-06
examined O 0 1.7910915630636737e-05
the O 0 1.4429475413635373e-05
sperm O 0 8.76862759469077e-06
DNA O 0 1.3387571016210131e-05
of O 0 3.4875170968007296e-05
a O 0 9.774159116204828e-05
premutation O 0 0.009922589175403118
carrier O 0 0.00043421308510005474
. O 0 0.00019546845578588545

This O 0 3.778792597586289e-05
mans O 0 0.000491425977088511
leucocyte O 0 0.0021575482096523046
DNA O 0 0.00019502798386383802
showed O 0 9.032843809109181e-05
one O 0 8.15694329503458e-06
normal O 0 8.948105460149236e-06
allele O 0 1.2275642120584962e-06
and O 0 1.4858114809612744e-06
one O 0 1.529462679172866e-06
allele O 0 1.0234444971501944e-06
of O 0 1.870103005785495e-05
approximately O 0 0.00011224586341995746
100 O 0 0.00021989988454151899
repeats O 0 0.000634899246506393
. O 0 0.00015845103189349174

His O 0 0.001204156782478094
sperm O 0 7.89006007835269e-05
showed O 0 2.300231790286489e-05
an O 0 2.0014369965792866e-06
expanded O 0 1.957193308044225e-05
allele O 0 2.553516651460086e-06
in O 0 1.5718303984613158e-05
a O 0 5.1542137953219935e-05
tight O 0 0.00020393540035001934
range O 0 3.5804303479380906e-05
centering O 0 0.00027179261087439954
on O 0 3.978575477958657e-05
a O 0 7.0644741754222196e-06
size O 0 6.883644800836919e-06
of O 0 3.5208075132686645e-05
approximately O 0 0.00014332176942843944
320 O 0 0.0005950182094238698
trinucleotide O 0 0.18640556931495667
repeats O 0 0.0012942434987053275
. O 0 0.00020657939603552222

His O 0 0.002494745422154665
affected O 0 0.0009992859559133649
son O 0 0.0037402960006147623
has O 0 3.344405195093714e-05
repeat O 0 0.0001809933892218396
sizes O 0 3.1622366805095226e-05
of O 0 0.0003743970883078873
1040 O 0 0.0032394747249782085
and O 0 9.277140634367242e-05
540 O 0 0.0016745905159041286
. O 0 0.0003008489147759974

These O 0 1.9147533748764545e-05
data O 0 2.519065856176894e-05
suggest O 0 9.38703215069836e-06
that O 0 2.5455369723204058e-06
expansion O 0 0.00011429771257098764
occurs O 0 5.358067028282676e-06
in O 0 4.11349355999846e-06
two O 0 1.9822664398816414e-06
stages O 0 8.416392665822059e-05
, O 0 4.607304617820773e-06
the O 0 9.948547813110054e-06
first O 0 1.8662651200429536e-05
during O 0 0.00013114153989590704
meiosis O 0 0.00021131237735971808
followed O 0 2.918768768722657e-05
by O 0 4.467262442631181e-06
a O 0 1.71632655110443e-05
second O 0 0.00010304972965968773
mitotic O 0 0.0005906507140025496
expansion O 0 0.0014307445380836725
. O 0 0.00031244117417372763

We O 0 3.2786141673568636e-05
also O 0 3.772430545723182e-06
show O 0 6.548169949383009e-06
that O 0 8.079701387941896e-07
in O 0 2.94923415822268e-06
all O 0 1.852538503044343e-06
informative O 0 1.7771160855772905e-05
carrier O 0 2.7851017875946127e-05
father O 0 6.132131966296583e-05
to O 0 1.8887754777097143e-05
affected O 0 5.8990379329770803e-05
child O 0 7.849490066291764e-05
transmissions O 0 0.00011826366244349629
, O 0 2.5839094632829074e-06
with O 0 6.933360054972582e-07
the O 0 1.8614875443745404e-05
notable O 0 3.505162021610886e-05
exception O 0 1.1602726772252936e-05
of O 0 7.405604992527515e-05
the O 0 0.0002020910760620609
premutation O 0 0.004880378022789955
carrier O 0 9.607712854631245e-05
, O 0 6.508219030365581e-06
the O 0 1.549226180941332e-05
expansion O 0 0.0001546657003927976
size O 0 2.7187765226699412e-05
decreases O 0 7.870087574701756e-05
. O 0 1.995657839870546e-05
. O 0 5.762779983342625e-05

The O 0 0.00048713688738644123
R496H O 0 0.0013840990141034126
mutation O 0 1.1094023648183793e-05
of O 0 0.00013271276839077473
arylsulfatase O 0 0.015886027365922928
A O 0 0.0006063838955014944
does O 0 7.320069016714115e-06
not O 0 1.0352605386287905e-05
cause O 0 0.0023137566167861223
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 0.0034566428512334824

Deficiency B-Disease 1 1.0
of I-Disease 1 0.9945884943008423
arylsulfatase I-Disease 1 0.9999836683273315
A I-Disease 1 0.9709477424621582
( O 0 0.00036273730802349746
ARSA O 1 0.9939775466918945
) O 0 1.2861845789302606e-05
enzyme O 0 1.126506322179921e-05
activity O 0 8.763962250668555e-05
causes O 0 0.0022129809949547052
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 0.152745321393013
MLD B-Disease 1 1.0
) O 0 0.0005330913700163364
. O 0 0.00022974313469603658

A O 0 0.0003896096022799611
number O 0 1.6401148968725465e-05
of O 0 0.0003708685399033129
ARSA O 1 0.9971237778663635
gene O 0 4.5123830204829574e-05
mutations O 0 2.6258714569848962e-05
responsible O 0 9.833899093791842e-05
for O 0 0.00017008585564326495
MLD B-Disease 1 1.0
have O 0 3.882214514305815e-05
been O 0 3.997492240159772e-05
identified O 0 5.4827803978696465e-05
. O 0 8.234515553340316e-05

Recently O 0 0.0008356720791198313
, O 0 1.7050062524504028e-05
the O 0 4.635939694708213e-05
R496H O 0 0.0008363635861314833
mutation O 0 1.2224984857311938e-05
of O 0 0.00029200135031715035
ARSA O 1 0.9917563199996948
was O 0 0.0004202824493404478
proposed O 0 9.575315743859392e-06
to O 0 3.0903195238352055e-06
be O 0 3.3108274237747537e-06
a O 0 1.3742107512371149e-05
cause O 0 0.00016738551494199783
of O 0 0.002364509040489793
MLD B-Disease 1 1.0
( O 0 0.0005726860254071653
Draghia O 0 0.01457441970705986
et O 0 0.0017584421439096332
al O 0 0.0007221079431474209
. O 0 9.868794222711585e-06
, O 0 6.878860403958242e-06
1997 O 0 0.00011826693662442267
) O 0 3.652553277788684e-05
. O 0 9.090627281693742e-05

We O 0 4.396133590489626e-05
have O 0 3.6199558053340297e-06
investigated O 0 8.357800834346563e-05
the O 0 9.339655662188306e-05
R496H O 0 0.0010550463339313865
mutation O 0 4.6598456719948445e-06
and O 0 2.299560946994461e-06
found O 0 1.6877471580301062e-06
this O 0 1.282130597246578e-06
mutation O 0 1.9397225514694583e-06
at O 0 4.489938146434724e-05
a O 0 5.977021373837488e-06
relatively O 0 5.669362963089952e-06
high O 0 1.7409101928933524e-05
frequency O 0 1.5586857671223697e-06
in O 0 1.974022552531096e-06
an O 0 1.1246214626225992e-06
African O 0 5.816778411826817e-06
American O 0 3.4409627005516086e-06
population O 0 9.555360520607792e-07
( O 0 2.3816473913029768e-06
f O 0 1.1060757060477044e-05
= O 0 1.9299657651572488e-05
0 O 0 6.677314104308607e-06
. O 0 4.739550604426768e-06
09 O 0 0.0002048228489002213
, O 0 5.2736604629899375e-06
n O 0 2.644566302478779e-05
= O 0 5.872769543202594e-05
61 O 0 0.00010122390813194215
subjects O 0 0.00034602999221533537
) O 0 7.387293589999899e-05
. O 0 9.172889986075461e-05

The O 0 0.0023081032559275627
ARSA O 1 0.9625446200370789
enzyme O 0 4.21066397393588e-05
activity O 0 3.067641591769643e-05
in O 0 1.3008790119783953e-05
subjects O 0 6.038829087628983e-05
with O 0 5.34326409251662e-06
and O 0 1.2144145330239553e-05
without O 0 2.1810918042319827e-05
the O 0 8.706636435817927e-05
R496H O 0 0.0009459875873290002
mutation O 0 8.058591447479557e-06
was O 0 8.976447134045884e-05
determined O 0 1.4797358744544908e-05
and O 0 2.642719437062624e-06
found O 0 5.3936878430249635e-06
to O 0 6.766520073142601e-06
be O 0 1.8399341570329852e-05
normal O 0 9.224133827956393e-05
. O 0 5.7564524468034506e-05

It O 0 3.238876524847001e-05
is O 0 3.96134555558092e-06
therefore O 0 4.139079919696087e-06
concluded O 0 3.6422086850507185e-05
that O 0 7.974473419380956e-07
the O 0 1.7049282178049907e-05
R496H O 0 0.0005562914302572608
mutation O 0 1.2056812920491211e-05
of O 0 0.0003777315141633153
ARSA O 1 0.9992026686668396
does O 0 2.383310675213579e-05
not O 0 4.206450284982566e-06
negatively O 0 8.847131539369002e-06
influence O 0 1.8255637769470923e-05
the O 0 2.573321216914337e-05
activity O 0 1.6517838957952335e-05
of O 0 0.00022988338605500758
ARSA O 1 0.9567499160766602
and O 0 1.4513743735733442e-05
is O 0 4.647312380257063e-06
not O 0 1.389119120176474e-06
a O 0 2.2380325390258804e-05
cause O 0 0.0005627785576507449
of O 0 0.015144141390919685
MLD B-Disease 1 1.0

Down O 0 0.005121733993291855
- O 0 0.00037856283597648144
regulation O 0 2.2608353901887313e-05
of O 0 7.626047590747476e-05
transmembrane O 0 0.004127804655581713
carbonic O 0 0.014529787935316563
anhydrases O 1 0.6039254665374756
in O 0 0.0031287488527595997
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999969005584717
lines O 0 0.002613604534417391
by O 0 5.1200830057496205e-05
wild O 0 0.0001349714002572
- O 0 0.00015483687457162887
type O 0 8.686971705174074e-05
von B-Disease 1 0.7470189929008484
Hippel I-Disease 1 0.9997150301933289
- I-Disease 0 0.17948541045188904
Lindau I-Disease 1 0.9968553781509399
transgenes O 0 0.018275490030646324
. O 0 0.00040376957622356713

To O 0 0.0001295029796892777
discover O 0 7.565884152427316e-05
genes O 0 7.73858937463956e-06
involved O 0 1.4672591532871593e-05
in O 0 7.697282126173377e-05
von B-Disease 1 0.7944087982177734
Hippel I-Disease 1 0.9994812607765198
- I-Disease 0 0.08576033264398575
Lindau I-Disease 1 0.999647855758667
( O 0 0.0004370383103378117
VHL B-Disease 1 0.9995607733726501
) O 0 7.043182995403185e-05
- O 0 0.00021111623209435493
mediated O 0 0.0003073929692618549
carcinogenesis O 0 0.10800269991159439
, O 0 1.0460301382408943e-05
we O 0 6.5205881583096925e-06
used O 0 0.0002568004420027137
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.9926137924194336
stably O 0 0.24732103943824768
transfected O 0 0.003007075283676386
with O 0 2.604664405225776e-05
wild O 0 0.00030250122654251754
- O 0 0.0007213983917608857
type O 0 0.0007749706855975091
VHL O 1 0.9999872446060181
- O 0 0.0025758773554116488
expressing O 0 0.00043556041782721877
transgenes O 0 0.007172188255935907
. O 0 0.0002596746780909598

Large O 0 0.0008561167633160949
- O 0 0.000433109060395509
scale O 0 0.0001968992582987994
RNA O 0 0.0003244188555981964
differential O 0 4.3455078412080184e-05
display O 0 0.0001448626717319712
technology O 0 6.896170816617087e-05
applied O 0 7.710184036113787e-06
to O 0 5.871072517038556e-06
these O 0 5.802384293929208e-06
cell O 0 2.627798130561132e-05
lines O 0 1.391406749462476e-05
identified O 0 4.439185431692749e-06
several O 0 1.7710053725750186e-06
differentially O 0 4.557545980787836e-05
expressed O 0 6.138950084277894e-06
genes O 0 2.7952446544077247e-06
, O 0 1.5383801610369119e-06
including O 0 1.318314843956614e-06
an O 0 1.7915341231855564e-05
alpha O 0 0.0011743048671633005
carbonic O 0 0.007556736934930086
anhydrase O 0 0.008793119341135025
gene O 0 5.6835451687220484e-05
, O 0 2.7204883735976182e-05
termed O 0 0.0014707811642438173
CA12 O 1 0.99964439868927
. O 0 0.0005377692286856472

The O 0 0.0001927983685163781
deduced O 0 0.00010125258995685726
protein O 0 5.631604835798498e-06
sequence O 0 7.289298991963733e-06
was O 0 4.4279171561356634e-05
classified O 0 2.8189282602397725e-05
as O 0 8.482435077894479e-06
a O 0 1.055580287356861e-05
one O 0 1.5641355275874957e-05
- O 0 0.00029575853841379285
pass O 0 0.0002067594905383885
transmembrane O 0 0.003100137459114194
CA O 0 0.003931052982807159
possessing O 0 0.00021351772011257708
an O 0 3.507128349156119e-05
apparently O 0 0.00025023974012583494
intact O 0 0.0002485009899828583
catalytic O 0 5.1159200666006655e-05
domain O 0 7.162102701840922e-05
in O 0 5.647304715239443e-05
the O 0 0.00021530958474613726
extracellular O 0 0.0023055134806782007
CA O 0 0.39144760370254517
module O 0 0.005089425016194582
. O 0 0.0001814225979615003

Reintroduced O 0 0.0039024408906698227
wild O 0 0.0009138004388660192
- O 0 0.0009732609032653272
type O 0 0.0007401810144074261
VHL B-Disease 1 0.9977796673774719
strongly O 0 7.994790212251246e-05
inhibited O 0 6.471107190009207e-05
the O 0 2.0244064216967672e-05
overexpression O 0 5.139906352269463e-05
of O 0 7.01648896210827e-05
the O 0 0.00011973720393143594
CA12 O 0 0.01571563072502613
gene O 0 3.611965667005279e-06
in O 0 2.0887644041067688e-06
the O 0 1.4703225133416709e-05
parental O 0 0.0001810199610190466
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.991486132144928
. O 0 0.0013886138331145048

Similar O 0 1.3773150385532063e-05
results O 0 7.26458665667451e-06
were O 0 1.2812876775569748e-05
obtained O 0 1.523425817140378e-05
with O 0 3.668625504360534e-05
CA9 O 1 0.9804420471191406
, O 0 2.4528970243409276e-05
encoding O 0 3.553188071236946e-05
another O 0 0.00012239661009516567
transmembrane O 0 0.0026023173704743385
CA O 0 0.0015536574646830559
with O 0 6.007417596265441e-06
an O 0 1.5657175026717596e-05
intact O 0 0.0007018843316473067
catalytic O 0 0.0004300281289033592
domain O 0 0.0006589884869754314
. O 0 0.0003763796412386

Although O 0 2.526808384573087e-05
both O 0 5.9201670410402585e-06
domains O 0 4.9899917939910665e-05
of O 0 0.00033155950950458646
the O 0 0.001143664587289095
VHL B-Disease 1 0.9957382678985596
protein O 0 5.685626820195466e-05
contribute O 0 1.6347339624189772e-05
to O 0 1.5270523363142274e-05
regulation O 0 6.116607983130962e-05
of O 0 0.00027403401327319443
CA12 O 1 0.9986830353736877
expression O 0 0.00011414609616622329
, O 0 8.197775969165377e-06
the O 0 2.6137420718441717e-05
elongin O 0 0.0008886003633961082
binding O 0 5.755315214628354e-06
domain O 0 3.9371861930703744e-05
alone O 0 4.249935591360554e-05
could O 0 1.4699538951390423e-05
effectively O 0 0.00017952968482859433
regulate O 0 0.0003344165743328631
CA9 O 1 0.9975729584693909
expression O 0 0.0003810875059571117
. O 0 0.00022889436513651162

We O 0 0.00014192737580742687
mapped O 0 0.0006519336602650583
CA12 O 1 0.9913860559463501
and O 0 0.00030293589225038886
CA9 O 1 0.9851768016815186
loci O 0 0.0003019684518221766
to O 0 0.00016632019833195955
chromosome O 0 0.0006556828739121556
bands O 0 0.0017666412750259042
15q22 O 0 0.004777899477630854
and O 0 0.00010537921480135992
17q21 O 0 0.005130284000188112
. O 0 0.00025615780032239854

2 O 0 0.0013750636717304587
respectively O 0 0.0005348259001038969
, O 0 3.694648330565542e-05
regions O 0 9.974105341825634e-05
prone O 0 0.0004924113745801151
to O 0 4.241077112965286e-05
amplification O 0 0.00018225326493848115
in O 0 5.089113983558491e-05
some O 0 3.8588572351727635e-05
human O 0 0.0006620010826736689
cancers B-Disease 1 0.9993571639060974
. O 0 0.0009881213773041964

Additional O 0 4.479100971366279e-05
experiments O 0 4.6151992137311026e-05
are O 0 7.451772034983151e-07
needed O 0 4.512499344855314e-06
to O 0 1.661866463109618e-06
define O 0 1.0889756595133804e-05
the O 0 1.819268800318241e-05
role O 0 7.301653386093676e-05
of O 0 0.0006374925142154098
CA O 1 0.60158771276474
IX O 1 0.9998754262924194
and O 0 0.0003693072940222919
CA O 0 0.005659548100084066
XII O 1 0.9985081553459167
enzymes O 0 1.8672853911994025e-05
in O 0 1.3597355064121075e-05
the O 0 2.1874533558730036e-05
regulation O 0 1.4436605852097273e-05
of O 0 3.8830847188364714e-05
pH O 0 0.000328415451804176
in O 0 3.702174581121653e-05
the O 0 7.151619502110407e-05
extracellular O 0 0.00024800747632980347
microenvironment O 0 0.0007193385390564799
and O 0 3.350199676788179e-06
its O 0 3.815042418864323e-06
potential O 0 2.5040195396286435e-05
impact O 0 8.117993274936453e-05
on O 0 0.00044196119415573776
cancer B-Disease 1 0.989646852016449
cell O 0 0.001077802386134863
growth O 0 0.0003843336889985949
. O 0 0.00010836923320312053

A O 0 0.0003423629386816174
gene O 0 4.9721238610800356e-06
encoding O 0 8.178994903573766e-06
a O 0 2.2205995264812373e-05
transmembrane O 0 0.0003685901465360075
protein O 0 1.8836954041034915e-05
is O 0 1.925486913023633e-06
mutated O 0 3.6153603559796466e-06
in O 0 1.0747211263151257e-06
patients O 0 5.6250510169775225e-06
with O 0 2.8731188649544492e-05
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.0031390348449349403
. O 0 0.000451294967206195

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999947547912598
WFS B-Disease 1 1.0
; O 0 0.0014506452716886997
OMIM O 1 0.999996542930603
222300 O 0 0.01279895193874836
) O 0 1.5189564692263957e-05
is O 0 3.9650949474889785e-06
an O 0 1.0436169759486802e-05
autosomal B-Disease 1 0.9999872446060181
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9999582767486572
by O 0 0.003486732952296734
young O 0 0.29428988695144653
- O 0 0.07824988663196564
onset O 1 0.9999988079071045
non O 1 0.7713916301727295
- O 0 0.03359184041619301
immune O 0 0.0013570283772423863
insulin B-Disease 0 0.0007630057516507804
- I-Disease 0 0.001139099826104939
dependent I-Disease 0 0.00023934774799272418
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999974966049194
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.9968109726905823

Linkage O 0 0.0022304081358015537
to O 0 0.00010819729504873976
markers O 0 0.0010775733971968293
on O 0 0.0007079714559949934
chromosome O 0 0.0019402685575187206
4p O 0 0.045609623193740845
was O 0 0.0005801530787721276
confirmed O 0 3.5623623261926696e-05
in O 0 1.5584180800942704e-05
five O 0 2.2442649424192496e-05
families O 0 9.23480729397852e-06
. O 0 7.391063263639808e-05

On O 0 0.00011197102867299691
the O 0 1.4910996469552629e-05
basis O 0 9.77366289589554e-06
of O 0 0.0002562357112765312
meiotic O 1 0.9856941103935242
recombinants O 1 0.9999754428863525
and O 0 0.0017848109127953649
disease O 1 1.0
- O 0 0.003809642978012562
associated O 0 6.392307113856077e-05
haplotypes O 0 0.0003536328731570393
, O 0 2.9861204893677495e-05
the O 0 0.00020291341934353113
WFS B-Disease 1 0.9959197044372559
gene O 0 2.4403210773016326e-05
was O 0 7.994050974957645e-05
localized O 0 4.6936896978877485e-05
to O 0 1.648973011469934e-05
a O 0 0.00017306920199189335
BAC O 1 0.9732921123504639
/ O 0 0.0020891937892884016
P1 O 0 0.02403048612177372
contig O 0 0.0032745711505413055
of O 0 0.00017834252503234893
less O 0 3.379454210516997e-05
than O 0 1.1497732884890866e-05
250 O 0 9.337858500657603e-05
kb O 0 0.003915333189070225
. O 0 0.0002775693137664348

Mutations O 0 0.0001453803270123899
in O 0 3.911543171852827e-05
a O 0 2.4028777261264622e-05
novel O 0 6.450283399317414e-05
gene O 0 2.7690846764016896e-05
( O 0 3.6867080780211836e-05
WFS1 O 0 0.0122587401419878
) O 0 5.443274403660325e-06
encoding O 0 7.4858221523754764e-06
a O 0 2.2008198357070796e-05
putative O 0 0.00037477738806046546
transmembrane O 0 0.00042929843766614795
protein O 0 3.171865682816133e-05
were O 0 1.588970008015167e-05
found O 0 3.3623884974076645e-06
in O 0 3.860212018480524e-06
all O 0 1.960567260539392e-06
affected O 0 7.740463843219914e-06
individuals O 0 1.7071484990083263e-06
in O 0 5.323845107341185e-05
six O 0 0.00037259040982462466
WFS B-Disease 1 0.9995917677879333
families O 0 2.0847881387453526e-05
, O 0 3.0407145459321328e-06
and O 0 1.6777589735283982e-06
these O 0 1.390860916217207e-06
mutations O 0 4.341467047197511e-06
were O 0 7.735047802270856e-06
associated O 0 7.94405787019059e-06
with O 0 6.9694842750323005e-06
the O 0 0.0010964475804939866
disease O 1 1.0
phenotype O 0 0.0012443240266293287
. O 0 0.00043819969869218767

WFS1 O 1 0.9963719844818115
appears O 0 0.00023708149092271924
to O 0 9.823927939578425e-06
function O 0 1.0839772585313767e-05
in O 0 2.14555038837716e-05
survival O 0 0.0002462192496750504
of O 0 0.00022022236953489482
islet O 0 0.002391476184129715
beta O 0 0.0013861755141988397
- O 0 0.0005172559758648276
cells O 0 2.627204048621934e-05
and O 0 8.023639566090424e-06
neurons O 0 0.00012247366248629987
. O 0 2.7767480787588283e-05
. O 0 6.627701804973185e-05

Stable O 0 0.0017471336759626865
interaction O 0 4.090799848199822e-05
between O 0 0.000120756340038497
the O 0 6.141126505099237e-05
products O 0 2.1834977815160528e-05
of O 0 7.689975609537214e-05
the O 0 0.00014404459216166288
BRCA1 O 0 0.0006261008093133569
and O 0 4.534629260888323e-05
BRCA2 O 0 0.002535294508561492
tumor B-Disease 0 0.03013482317328453
suppressor O 0 0.0008562220027670264
genes O 0 1.4000506780575961e-05
in O 0 2.4811051844153553e-05
mitotic O 0 0.00027468163170851767
and O 0 8.27647527330555e-05
meiotic O 0 0.02164960466325283
cells O 0 0.0009585734806023538
. O 0 0.0003560745099093765

BRCA1 O 0 0.009458620101213455
and O 0 0.00020951000624336302
BRCA2 O 0 0.0006241617375053465
account O 0 6.341447715385584e-06
for O 0 3.850487246381817e-06
most O 0 3.2364282560592983e-06
cases O 0 2.990844905070844e-06
of O 0 5.9336791309760883e-05
familial O 0 0.0009171408019028604
, O 0 6.184031371958554e-05
early O 0 0.0009543283376842737
onset O 1 1.0
breast B-Disease 1 0.9999357461929321
and I-Disease 0 0.00034471575054340065
/ I-Disease 1 0.9999794960021973
or I-Disease 1 0.9999700784683228
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00037818928831256926
encode O 0 6.44494648440741e-05
products O 0 1.4933068086975254e-05
that O 0 6.24881124622334e-07
each O 0 2.536492900162557e-07
interact O 0 3.5457371723168762e-06
with O 0 4.694055860454682e-06
hRAD51 O 0 0.0032718658912926912
. O 0 0.00023078403319232166

Results O 0 5.399902875069529e-05
presented O 0 0.0001699122367426753
here O 0 3.399086563149467e-05
show O 0 2.7472375222714618e-05
that O 0 4.169792646280257e-06
BRCA1 O 0 0.00031944073271006346
and O 0 2.990571920236107e-05
BRCA2 O 0 0.0008164828177541494
coexist O 0 0.00014538671530317515
in O 0 1.4249704690882936e-05
a O 0 1.7561111235409044e-05
biochemical O 0 0.00018274169997312129
complex O 0 0.0021197753958404064
and O 0 9.546032379148528e-05
colocalize O 0 0.00699522765353322
in O 0 0.0001669139164732769
subnuclear O 0 0.00830304715782404
foci O 0 0.002409181324765086
in O 0 0.0001330614904873073
somatic O 0 0.0002954606316052377
cells O 0 4.835237268707715e-05
and O 0 4.89477224618895e-06
on O 0 2.1651632778230123e-05
the O 0 1.146784870798001e-05
axial O 0 2.018688610405661e-05
elements O 0 2.511414095351938e-05
of O 0 0.0002016256912611425
developing O 0 0.0007362589822150767
synaptonemal O 0 0.021454747766256332
complexes O 0 0.003016851842403412
. O 0 0.0002715737500693649

Like O 0 0.0010292836232110858
BRCA1 O 0 0.004210926592350006
and O 0 0.0004088126588612795
RAD51 O 1 0.9993866682052612
, O 0 0.00014715689758304507
BRCA2 O 0 0.0011009019799530506
relocates O 0 0.0005525781307369471
to O 0 0.00010497772746020928
PCNA O 0 0.020152302458882332
+ O 0 0.0001751617091940716
replication O 0 5.51849152543582e-05
sites O 0 1.2532385881058872e-05
following O 0 1.2644463822653051e-05
exposure O 0 0.00016817871073726565
of O 0 0.00025770452339202166
S O 0 0.006032904610037804
phase O 0 0.0016380333108827472
cells O 0 6.306570139713585e-05
to O 0 5.1683640776900575e-05
hydroxyurea O 0 0.0068937502801418304
or O 0 0.00039919576374813914
UV O 1 0.5572147369384766
irradiation O 0 0.00141701172105968
. O 0 0.00018433528020977974

Thus O 0 0.0006455397233366966
, O 0 0.00010134116018889472
BRCA1 O 0 0.0006230256403796375
and O 0 4.637239544535987e-05
BRCA2 O 0 0.00045363412937149405
participate O 0 2.9755738069070503e-05
, O 0 6.219991519174073e-06
together O 0 6.1840132730139885e-06
, O 0 1.803386567189591e-06
in O 0 6.226448931556661e-06
a O 0 3.3486470783827826e-05
pathway O 0 0.00023628152848687023
( O 0 2.5962033760151826e-05
s O 0 0.00010359941370552406
) O 0 2.6188422452833038e-06
associated O 0 2.024029299718677e-06
with O 0 1.0673281849449268e-06
the O 0 2.5356139303767122e-05
activation O 0 4.283773887436837e-05
of O 0 0.0003756106016226113
double O 0 0.00022925670782569796
- O 0 0.000821211317088455
strand O 0 0.0001284799654968083
break O 0 0.0001003527722787112
repair O 0 0.0005909556639380753
and O 0 4.235027518006973e-05
/ O 0 0.000266826682491228
or O 0 3.352535713929683e-05
homologous O 0 0.0003159741754643619
recombination O 0 0.000260580942267552
. O 0 0.00021599883621092886

Dysfunction O 1 0.9996944665908813
of O 0 0.019904164597392082
this O 0 0.00034397750278003514
pathway O 0 0.000679194345138967
may O 0 4.717202318715863e-05
be O 0 3.502086656226311e-06
a O 0 2.648815325301257e-06
general O 0 5.2084742492297664e-06
phenomenon O 0 1.6520738427061588e-05
in O 0 2.6338855150243035e-06
the O 0 2.277500243508257e-06
majority O 0 3.2027779184318206e-07
of O 0 6.4006130742200185e-06
cases O 0 6.410741661966313e-06
of O 0 0.0003753822238650173
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9884722828865051
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.01105464156717062
. O 0 0.0005687506636604667

A O 0 0.0021549330558627844
novel O 0 0.0005151421646587551
Arg362Ser O 0 0.0028665426652878523
mutation O 0 6.874361133668572e-06
in O 0 1.0384881534264423e-05
the O 0 4.464788798941299e-05
sterol O 0 0.0002176587440771982
27 O 0 0.0003656236222013831
- O 0 0.0003672545135486871
hydroxylase O 0 0.0002721857454162091
gene O 0 4.1473511373624206e-05
( O 0 5.29427379660774e-05
CYP27 O 0 0.035489365458488464
) O 0 8.587334377807565e-06
: O 0 2.5877911866700742e-06
its O 0 3.622532176450477e-06
effects O 0 6.623304216191173e-05
on O 0 0.00012361786502879113
pre O 0 0.0005808795103803277
- O 0 0.00014495980576612055
mRNA O 0 2.0863415556959808e-05
splicing O 0 1.9274180885986425e-05
and O 0 2.7604564820649102e-06
enzyme O 0 7.063726116030011e-06
activity O 0 4.448202162166126e-05
. O 0 9.488322393735871e-05

A O 0 0.0016833911649882793
novel O 0 0.00017806488904170692
C O 0 0.0003559005563147366
to O 0 2.0138793843216263e-05
A O 0 0.00014163066225592047
mutation O 0 2.1104294773977017e-06
in O 0 4.120718131161993e-06
the O 0 2.0224593754392117e-05
sterol O 0 0.00017563985602464527
27 O 0 0.00030536961276084185
- O 0 0.0003035360132344067
hydroxylase O 0 0.0003197768528480083
gene O 0 3.7649009755114093e-05
( O 0 5.676439468516037e-05
CYP27 O 0 0.037803295999765396
) O 0 1.0316671250620857e-05
was O 0 6.203074008226395e-05
identified O 0 5.311069344315911e-06
by O 0 2.9553830245276913e-06
sequencing O 0 5.1403865654719993e-05
amplified O 0 0.00033529510255903006
CYP27 O 0 0.016025185585021973
gene O 0 1.5386356608360074e-05
products O 0 6.735154784109909e-06
from O 0 7.825090506230481e-06
a O 0 1.0759541510196868e-05
patient O 0 2.2612171960645355e-05
with O 0 3.1831743399379775e-05
cerebrotendinous B-Disease 1 0.9999998807907104
xanthomatosis I-Disease 1 1.0
( O 0 0.004653183743357658
CTX B-Disease 1 0.9999991655349731
) O 0 0.0005054962239228189
. O 0 0.00025015740538947284

The O 0 0.0004129921435378492
mutation O 0 1.8761318642646074e-05
changed O 0 5.7830278819892555e-05
the O 0 6.599169864784926e-05
adrenodoxin O 0 0.001846147933974862
cofactor O 0 0.00012122149928472936
binding O 0 1.2657204933930188e-05
residue O 0 0.00019560233340598643
362Arg O 0 0.0007376355351880193
to O 0 7.043498771963641e-05
362Ser O 0 0.0041762543842196465
( O 0 0.00027620475157164037
CGT O 1 0.9366714954376221
362Arg O 0 0.006184680853039026
to O 0 0.0004491396539378911
AGT O 1 0.9999947547912598
362Ser O 0 0.014872616156935692
) O 0 4.5395961933536455e-05
, O 0 4.476537014852511e-06
and O 0 3.3906089811353013e-06
was O 0 0.00020147179020568728
responsible O 0 0.00011748864926630631
for O 0 0.0002261829940835014
deficiency O 1 1.0
in O 0 0.0008213517721742392
the O 0 0.0007733278325758874
sterol O 0 0.0015351168112829328
27 O 0 0.0012205801904201508
- O 0 0.0005888474988751113
hydroxylase O 0 0.0001951129816006869
activity O 0 1.3296418728714343e-05
, O 0 1.91247863767785e-06
as O 0 1.7214716763191973e-06
confirmed O 0 3.561404355423292e-06
by O 0 8.003516995813698e-07
expression O 0 3.1029887850309024e-06
of O 0 2.849518568837084e-05
mutant O 0 4.195292422082275e-05
cDNA O 0 0.00011320954217808321
into O 0 7.381068280665204e-05
COS O 0 0.017893405631184578
- O 0 0.0004910878487862647
1 O 0 0.00019235769286751747
cells O 0 6.894455873407423e-05
. O 0 3.636315886978991e-05

Quantitative O 0 4.6012944949325174e-05
analysis O 0 5.075095032225363e-06
showed O 0 3.6574747355189174e-05
that O 0 1.3233924391897744e-06
the O 0 1.2131412404414732e-05
expression O 0 7.463005204044748e-06
of O 0 9.22112594707869e-05
CYP27 O 0 0.03171130269765854
gene O 0 1.5381427147076465e-05
mRNA O 0 1.9291303033242002e-05
in O 0 2.6731645448307972e-06
the O 0 8.676080142322462e-06
patient O 0 4.988338332623243e-06
represented O 0 9.42630686040502e-06
52 O 0 0.00025207182625308633
. O 0 0.00013656569353770465

5 O 0 0.0004001650959253311
% O 0 3.1518378818873316e-05
of O 0 0.00021070477669127285
the O 0 0.00044220706331543624
normal O 0 0.000512648664880544
level O 0 0.0019195536151528358
. O 0 0.00029054065817035735

As O 0 0.00010380470484960824
the O 0 5.342240910977125e-05
mutation O 0 8.55936377774924e-06
occurred O 0 0.00012935239647049457
at O 0 5.3426279919222e-05
the O 0 1.6908414181671105e-05
penultimate O 0 0.0002812934690155089
nucleotide O 0 1.5133750821405556e-05
of O 0 8.922646520659328e-05
exon O 0 0.00028887292137369514
6 O 0 0.00015161550254561007
( O 0 1.4370370081451256e-05
- O 0 5.495086224982515e-05
2 O 0 2.96531379717635e-05
position O 0 1.2475265975808725e-05
of O 0 8.612498641014099e-05
exon O 0 0.0003958001616410911
6 O 0 0.00033807253930717707
- O 0 0.00030920407152734697
intron O 0 0.0010245410958305001
6 O 0 0.00019147491548210382
splice O 0 0.00021630199626088142
site O 0 0.00010647688031895086
) O 0 2.0149886950093787e-06
of O 0 1.1761008863686584e-05
the O 0 3.0349867301993072e-05
gene O 0 1.642519055167213e-05
, O 0 5.389636044128565e-06
we O 0 3.7321055970096495e-06
hypothesized O 0 3.373111394466832e-05
that O 0 1.387036832056765e-06
the O 0 2.2658668967778794e-05
mutation O 0 1.0663133252819534e-05
may O 0 5.017735020373948e-05
partially O 0 0.0001821311452658847
affect O 0 9.406085155205801e-06
the O 0 1.533256727270782e-05
normal O 0 1.5448311387444846e-05
splicing O 0 1.985653034353163e-05
efficiency O 0 2.4539265723433346e-05
in O 0 2.0469606170081533e-05
exon O 0 0.00022022027405910194
6 O 0 0.00013432686682790518
and O 0 1.0981812920363154e-05
cause O 0 4.568467556964606e-05
alternative O 0 1.4193583410815336e-05
splicing O 0 4.8413923650514334e-05
elsewhere O 0 2.3474853151128627e-05
, O 0 1.7892552932607941e-06
which O 0 1.0062256023957161e-06
resulted O 0 3.786417801165953e-05
in O 0 2.8988628400838934e-05
decreased O 0 0.00037080643232911825
transcript O 0 0.0005186219932511449
in O 0 3.9086906326701865e-05
the O 0 0.00018385570729151368
patient O 0 0.00024130017845891416
. O 0 0.00011725383956218138

Transfection O 0 0.008402022533118725
of O 0 0.0022794778924435377
constructed O 1 0.8341737389564514
minigenes O 0 0.027441207319498062
, O 0 2.7748948923544958e-05
with O 0 4.1612479435571e-06
or O 0 1.2986267392989248e-05
without O 0 1.4808694686507806e-05
the O 0 5.186549242353067e-05
mutation O 0 1.1449402336438652e-05
, O 0 8.121176506392658e-06
into O 0 7.671430648770183e-05
COS O 0 0.4077499210834503
- O 0 0.0003751334152184427
1 O 0 0.00011009386071236804
cells O 0 4.980637640983332e-06
confirmed O 0 1.8276588207299937e-06
that O 0 4.4979245217291464e-07
the O 0 8.363830602320377e-06
mutant O 0 8.250313840107992e-05
minigene O 0 0.001605390920303762
was O 0 0.0001097088388632983
responsible O 0 1.589275780133903e-05
for O 0 4.33868581239949e-06
a O 0 1.942699782375712e-05
mRNA O 0 3.370995182194747e-05
species O 0 3.267694808073429e-07
alternatively O 0 6.010873676132178e-06
spliced O 0 4.2600848246365786e-05
at O 0 7.817668665666133e-05
an O 0 1.79829712578794e-05
activated O 0 0.00129427679348737
cryptic O 0 0.0015400911215692759
5 O 0 0.00012664558016695082
splice O 0 0.00023070922179613262
site O 0 0.00034325942397117615
88 O 0 0.000202147348318249
bp O 0 0.0002546179748605937
upstream O 0 9.662922821007669e-05
from O 0 5.001490535505582e-06
the O 0 1.5208420336421113e-05
3 O 0 2.9558559617726132e-05
end O 0 0.00011589679343160242
of O 0 0.00024357678194064647
exon O 0 0.0012658509658649564
6 O 0 0.0007724639144726098
. O 0 0.0001204755826620385

Our O 0 7.707639451837167e-05
data O 0 9.972617590392474e-06
suggest O 0 8.063834684435278e-06
that O 0 7.473371965716069e-07
the O 0 1.3030469744990114e-05
C O 0 9.834142838371918e-05
to O 0 9.183104339172132e-06
A O 0 7.979253132361919e-05
mutation O 0 1.240031792804075e-06
at O 0 1.9977978809038177e-05
the O 0 9.21918672247557e-06
penultimate O 0 0.00020930654136464
nucleotide O 0 7.847803317417856e-06
of O 0 4.7230994823621586e-05
exon O 0 0.00024213998403865844
6 O 0 0.00010077760089188814
of O 0 0.00011049331806134433
the O 0 0.0002643104235175997
CYP27 O 1 0.8139135241508484
gene O 0 1.2190060260763858e-05
not O 0 1.9694305137818446e-06
only O 0 6.525291610159911e-06
causes O 0 7.437578460667282e-05
the O 0 0.0003318074159324169
deficiency B-Disease 1 0.9999089241027832
in I-Disease 0 0.00015043423627503216
the I-Disease 0 0.00018323829863220453
sterol I-Disease 0 0.0007277860422618687
27 I-Disease 0 0.0007586526917293668
- I-Disease 0 0.0003947554505430162
hydroxylase I-Disease 0 0.00024386377481278032
activity I-Disease 0 1.9132055967929773e-05
, O 0 4.308630650484702e-06
but O 0 1.2909816859973944e-06
also O 0 5.783611868537264e-06
partially O 0 0.00011686607467709109
leads O 0 1.3287952242535539e-05
to O 0 7.0005057750677224e-06
alternative O 0 6.772408141841879e-06
pre O 0 0.0002051809278782457
- O 0 5.7615325204096735e-05
mRNA O 0 1.1919507414859254e-05
splicing O 0 7.3245246312581e-06
of O 0 1.2002823496004567e-05
the O 0 4.36863956565503e-05
gene O 0 6.32893352303654e-05
. O 0 7.948608981678262e-05

To O 0 0.00020145141752436757
our O 0 9.289188892580569e-05
knowledge O 0 0.00013844601926393807
, O 0 8.092555617622565e-06
this O 0 1.2735633845295524e-06
is O 0 1.4447281273533008e-06
the O 0 3.572844889276894e-06
first O 0 6.211378604348283e-06
report O 0 1.9545223040040582e-06
regarding O 0 1.2939723092131317e-05
effects O 0 9.911906818160787e-05
on O 0 0.00014549696061294526
pre O 0 0.0005526618915610015
- O 0 8.755391172599047e-05
mRNA O 0 1.385496034345124e-05
splicing O 0 5.521616458281642e-06
of O 0 7.805267159710638e-06
a O 0 8.93947344593471e-06
mutation O 0 2.225985781478812e-06
at O 0 7.760393782518804e-05
the O 0 5.396593041950837e-05
- O 0 7.408895180560648e-05
2 O 0 3.3060427085729316e-05
position O 0 1.8085489500663243e-05
of O 0 3.9969279896467924e-05
a O 0 4.856346276937984e-05
5 O 0 0.00016159401275217533
splice O 0 0.001240626792423427
site O 0 0.001206111628562212
. O 0 0.00019315845565870404

ATM O 0 0.029126090928912163
germline O 0 0.004548925906419754
mutations O 0 0.00011857406934723258
in O 0 0.0002659461461007595
classical O 1 0.9962393045425415
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.000351383670931682
in O 0 6.444288737839088e-05
the O 0 8.923735731514171e-05
Dutch O 0 0.00040552220889367163
population O 0 2.8378170100040734e-05
. O 0 9.362306445837021e-05

Germline O 0 0.01014374103397131
mutations O 0 8.988130139186978e-05
in O 0 7.022272620815784e-05
the O 0 0.0001748948561726138
ATM O 0 0.0012415465898811817
gene O 0 2.227238610430504e-06
are O 0 1.1286436318869164e-07
responsible O 0 1.1138409945488092e-06
for O 0 9.877454658635543e-07
the O 0 0.00018738835933618248
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9638534188270569
A B-Disease 1 1.0
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999990463256836
) O 0 6.103672785684466e-05
. O 0 8.364490349777043e-05

In O 0 0.00025873162667267025
our O 0 4.9316524382447824e-05
study O 0 9.984341886593029e-06
, O 0 1.8214747115052887e-06
we O 0 7.79668710038095e-07
have O 0 2.8853568778686167e-07
determined O 0 2.614283403090667e-06
the O 0 1.879394221759867e-05
ATM O 0 0.0004345430643297732
mutation O 0 2.1770729290437885e-06
spectrum O 0 2.8042053600074723e-05
in O 0 2.26124520850135e-05
19 O 0 0.00026028347201645374
classical O 0 0.0013707815669476986
A B-Disease 1 0.9999953508377075
- I-Disease 1 0.9998890161514282
T I-Disease 1 0.999998927116394
patients O 0 4.669068584917113e-05
, O 0 3.1920917535899207e-06
including O 0 2.061105533357477e-06
some O 0 3.418172809688258e-06
immigrant O 0 1.557698669785168e-05
populations O 0 5.218149453867227e-06
, O 0 1.750662931954139e-06
as O 0 4.761504897032864e-06
well O 0 2.662433189470903e-06
as O 0 6.5498311414557975e-06
12 O 0 2.1171919797779992e-05
of O 0 3.775406730710529e-05
Dutch O 0 0.00032558292150497437
ethnic O 0 0.00012612833234015852
origin O 0 8.558928675483912e-05
. O 0 0.00017624329484533519

Both O 0 1.847501698648557e-05
the O 0 2.878799023164902e-05
protein O 0 9.653727829572745e-06
truncation O 0 7.505406392738223e-05
test O 0 3.579348049242981e-05
( O 0 3.105997166130692e-05
PTT O 0 0.0007737601408734918
) O 0 4.00995168092777e-06
and O 0 1.5505493138334714e-06
the O 0 9.787139788386412e-06
restriction O 0 9.782941560843028e-06
endonuclease O 0 0.00011302198254270479
fingerprinting O 0 0.0003267103456892073
( O 0 0.00013834546552971005
REF O 0 0.018451645970344543
) O 0 3.8211601349757984e-06
method O 0 1.573207669025578e-06
were O 0 3.4371973924862687e-06
used O 0 4.0365175664192066e-06
and O 0 2.696963065318414e-06
compared O 0 6.776297595934011e-06
for O 0 4.318598257668782e-06
their O 0 7.6020960477762856e-06
detection O 0 8.723655628273264e-05
efficiency O 0 4.4771448301617056e-05
, O 0 3.135095539619215e-06
identifying O 0 2.203398798883427e-05
76 O 0 6.822454452048987e-05
% O 0 6.4913656387943774e-06
and O 0 5.518678790394915e-06
60 O 0 2.003452755161561e-05
% O 0 5.09206302012899e-06
of O 0 7.78183966758661e-05
the O 0 0.0002160346630262211
mutations O 0 7.456894672941417e-05
, O 0 3.7714842619607225e-05
respectively O 0 0.0004238888213876635
. O 0 0.00021090375958010554

Most O 0 0.0001902996882563457
patients O 0 5.077082823845558e-05
were O 0 3.846461186185479e-05
found O 0 1.4896045286150184e-05
to O 0 1.5724361219326966e-05
be O 0 3.3225060178665444e-05
compound O 0 0.0007885434897616506
heterozygote O 0 0.0022094890009611845
. O 0 0.00026048379368148744

Seventeen O 0 0.0016553158638998866
mutations O 0 4.9846268666442484e-05
were O 0 3.571294291759841e-05
distinct O 0 1.6394285921705887e-05
, O 0 8.426985004916787e-06
of O 0 4.2176205170108005e-05
which O 0 1.625146614969708e-05
10 O 0 2.372195194766391e-05
were O 0 5.3857211241847835e-06
not O 0 1.8181390259996988e-06
reported O 0 1.829997927416116e-05
previously O 0 0.00011225175694562495
. O 0 0.00011448709119576961

Mutations O 0 0.00014282613119576126
are O 0 8.99595397640951e-06
small O 0 2.335944191145245e-05
deletions O 0 0.00016252812929451466
or O 0 5.7010627642739564e-05
point O 0 0.0005576433031819761
mutations O 0 6.758348172297701e-05
frequently O 0 4.054702367284335e-05
affecting O 0 0.00011296669254079461
splice O 0 0.000528642616700381
sites O 0 0.0003499041486065835
. O 0 0.00021514788386411965

Moreover O 0 0.0008368574199266732
, O 0 2.7371062969905324e-05
a O 0 4.214001455693506e-05
16 O 0 0.0005083825089968741
. O 0 0.00018949902732856572

7 O 0 0.0022621082607656717
- O 0 0.0004627766611520201
kb O 0 0.0006989736575633287
genomic O 0 3.838370685116388e-05
deletion O 0 6.95751587045379e-05
of O 0 0.00014154691598378122
the O 0 0.00011047371663153172
3 O 0 8.185420301742852e-05
end O 0 0.00010735794785432518
of O 0 4.279960194253363e-05
the O 0 4.4463278754847124e-05
gene O 0 7.673713298572693e-06
, O 0 1.6594829048699467e-06
most O 0 1.2555801731650718e-06
likely O 0 2.228046014352003e-06
a O 0 1.8609069911690312e-06
result O 0 3.156618731736671e-06
of O 0 2.3644843167858198e-05
recombination O 0 1.3373342881095596e-05
between O 0 0.00012208119733259082
two O 0 2.5994761017500423e-05
LINE O 0 0.0027688881382346153
elements O 0 7.669485785299912e-05
, O 0 3.067603392992169e-05
was O 0 0.00029367368551902473
identified O 0 0.0001280048891203478
. O 0 0.00010686869791243225

The O 0 0.0003478433645796031
most O 0 2.3102409613784403e-05
frequently O 0 1.1423302566981874e-05
found O 0 6.5347508098057006e-06
mutation O 0 2.0233153463777853e-06
, O 0 1.6114920526888454e-06
identified O 0 4.568713848129846e-06
in O 0 5.81020321988035e-06
three O 0 4.478065875446191e-06
unrelated O 0 4.832389095099643e-05
Turkish O 0 0.0006659237551502883
A B-Disease 1 0.9999409914016724
- I-Disease 1 0.9808967113494873
T I-Disease 1 0.9998323917388916
individuals O 0 3.2315924727299716e-06
, O 0 5.324605353962397e-06
was O 0 7.213592471089214e-05
previously O 0 2.1443966033984907e-05
described O 0 6.7931459852843545e-06
to O 0 1.705425233922142e-06
be O 0 1.2649425116251223e-06
a O 0 3.179828809152241e-06
Turkish O 0 0.0001338779111392796
A B-Disease 1 0.9995085000991821
- I-Disease 1 0.9913522005081177
T I-Disease 1 0.9999948740005493
founder O 0 0.0055522858165204525
mutation O 0 7.015766459517181e-05
. O 0 0.0001329557126155123

The O 0 0.00029483172693289816
presence O 0 0.00012865051394328475
of O 0 0.00043169897980988026
a O 0 0.0002793571329675615
founder O 0 0.0020134798251092434
mutation O 0 8.09644643595675e-06
among O 0 5.218612386670429e-06
relatively O 0 2.6195766622549854e-06
small O 0 7.896539955254411e-07
ethnic O 0 3.324629005874158e-06
population O 0 1.3720375591219636e-06
groups O 0 3.527712237882952e-07
in O 0 7.630380423506722e-06
Western O 0 6.184232188388705e-05
Europe O 0 6.757987284800038e-05
could O 0 4.767857262777397e-06
indicate O 0 7.620896667503985e-06
a O 0 8.810245162749197e-06
high O 0 7.173599442467093e-05
carrier O 0 2.3904394765850157e-05
frequency O 0 5.057537237007637e-06
in O 0 9.205525202560239e-06
such O 0 3.4915085507236654e-06
communities O 0 2.815008701873012e-05
. O 0 0.00011924954014830291

In O 0 0.0004044433298986405
patients O 0 7.599934906465933e-05
of O 0 0.0002599915023893118
Dutch O 0 0.0006942819454707205
ethnic O 0 0.0001328644430032
origin O 0 5.2831630455330014e-05
, O 0 1.552626781631261e-05
however O 0 1.0112229574588127e-05
, O 0 3.6128303690929897e-06
no O 0 4.518200967140729e-06
significant O 0 6.610772106796503e-05
founder O 0 0.0010000555776059628
effect O 0 4.1554907511454076e-05
could O 0 4.502629508351674e-06
be O 0 2.3298116502701305e-06
identified O 0 1.2240022442711052e-05
. O 0 3.0052840884309262e-05

The O 0 0.0001903950033010915
observed O 0 5.20691137353424e-05
genetic O 0 4.7804394853301346e-05
heterogeneity O 0 0.00018646546232048422
including O 0 1.617267662368249e-05
the O 0 6.615880556637421e-05
relative O 0 0.00019747007172554731
high O 0 0.00029432057635858655
percentage O 0 7.578115037176758e-05
of O 0 0.00014801224460825324
splice O 0 0.001768162939697504
- O 0 0.0004680292622651905
site O 0 0.00016775076801422983
mutations O 0 1.4328345969261136e-05
had O 0 4.366740176919848e-05
no O 0 1.4648933756689075e-05
reflection O 0 0.00014374879538081586
on O 0 0.00020849209977313876
the O 0 0.00012579945905599743
phenotype O 0 0.00025058852043002844
. O 0 0.00014406534319277853

All O 0 7.209576142486185e-05
patients O 0 0.0001374504208797589
manifested O 0 0.0017653231043368578
classical O 0 0.005693050101399422
A B-Disease 1 0.999997615814209
- I-Disease 1 0.7471160292625427
T I-Disease 1 0.9807401895523071
and O 0 6.145334282336989e-06
increased O 0 2.6774359866976738e-05
cellular O 0 0.00013591523747891188
radioresistant O 0 0.001727322000078857
DNA O 0 0.00031185077386908233
synthesis O 0 0.0005518178804777563
. O 0 0.00021386797016020864

Determination O 0 0.00029994273791089654
of O 0 0.00016861736366990954
the O 0 7.23031407687813e-05
genomic O 0 4.396775329951197e-05
structure O 0 0.00016043502546381205
of O 0 0.00011811624426627532
the O 0 0.00020228253561072052
COL4A4 O 1 0.9990262985229492
gene O 0 9.791192496777512e-06
and O 0 1.0032380259872298e-06
of O 0 1.2803068784705829e-05
novel O 0 7.758668652968481e-05
mutations O 0 8.705382060725242e-05
causing O 0 0.01472898107022047
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999983310699463

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.8758426308631897
a O 0 0.008261734619736671
progressive O 1 0.9999996423721313
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9999539852142334
by O 0 0.11158795654773712
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9979605674743652
abnormalities I-Disease 1 0.9998201727867126
and O 0 7.984961121110246e-05
associated O 0 7.659595576114953e-05
with O 0 2.6516348953009583e-05
mutations O 0 4.7584802814526483e-05
in O 0 7.658960385015234e-05
either O 0 4.1748986404854804e-05
the O 0 0.0002759139460977167
COL4A3 O 1 0.9975305199623108
or O 0 3.119813118246384e-05
the O 0 9.580394544173032e-05
COL4A4 O 0 0.2603292167186737
gene O 0 1.2035813597321976e-05
, O 0 1.0339385880797636e-06
which O 0 4.437978020632727e-07
encode O 0 1.6492639360876638e-06
the O 0 1.966240415640641e-05
alpha3 O 0 0.0010716821998357773
and O 0 2.682759986782912e-05
alpha4 O 0 0.005571052897721529
type O 0 0.004478702787309885
IV O 1 1.0
collagen O 1 0.999998927116394
chains O 0 0.005967279430478811
, O 0 0.00011648023064481094
respectively O 0 0.00036393149639479816
. O 0 0.00024172919802367687

To O 0 9.574549039825797e-05
date O 0 0.0002643366460688412
, O 0 7.211099728010595e-06
mutation O 0 1.3370730584938428e-06
screening O 0 4.616867499862565e-06
in O 0 8.303636604978237e-06
the O 0 1.0868860044865869e-05
two O 0 2.8626782295759767e-06
genes O 0 5.686814802174922e-06
has O 0 2.9486461698979838e-06
been O 0 5.7657580327941105e-06
hampered O 0 8.5634776041843e-05
by O 0 6.555284812748141e-07
the O 0 4.24787140218541e-06
lack O 0 1.578990850248374e-05
of O 0 4.57724163425155e-05
genomic O 0 0.00010173812916036695
structure O 0 0.0006664973916485906
information O 0 9.376618982059881e-05
. O 0 0.00014233139518182725

We O 0 4.745555997942574e-05
report O 0 7.85297652328154e-06
here O 0 6.993065198912518e-06
the O 0 3.94450944440905e-06
complete O 0 2.8697179004666395e-05
characterization O 0 6.159218901302665e-05
of O 0 6.686766573693603e-05
the O 0 8.518282265868038e-05
48 O 0 5.957503890385851e-05
exons O 0 0.00013105978723615408
of O 0 9.15782293304801e-05
the O 0 0.0003060203744098544
COL4A4 O 1 0.9907612204551697
gene O 0 1.8693379388423637e-05
, O 0 2.0632610358006787e-06
a O 0 4.143294063396752e-06
comprehensive O 0 3.977065352955833e-05
gene O 0 1.5069635082909372e-05
screen O 0 8.756727038417011e-05
, O 0 6.0313027461234014e-06
and O 0 8.821240840006794e-07
the O 0 4.2071001189469825e-06
subsequent O 0 2.679548560990952e-05
detection O 0 5.4634689149679616e-05
of O 0 8.88984723133035e-05
10 O 0 5.34915343450848e-05
novel O 0 2.940381455118768e-05
mutations O 0 3.825750809482997e-06
in O 0 5.493694516189862e-06
eight O 0 2.9033504688413814e-05
patients O 0 7.691618520766497e-05
diagnosed O 1 0.9999855756759644
with O 0 0.0002580905274953693
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 1.0

Furthermore O 0 0.0008112990180961788
, O 0 2.0338206013548188e-05
we O 0 5.361369403544813e-06
identified O 0 7.904113772383425e-06
a O 0 9.214976671501063e-06
glycine O 0 3.51449016307015e-05
to O 0 2.3605618480360135e-05
alanine O 0 3.651700171758421e-05
substitution O 0 2.494164800737053e-05
in O 0 5.6800014135660604e-05
the O 0 0.0002785956021398306
collagenous O 0 0.0068683200515806675
domain O 0 0.00012991606490686536
that O 0 8.494780558976345e-06
is O 0 9.337231858808082e-06
apparently O 0 3.3177886507473886e-05
silent O 0 0.00018736797210294753
in O 0 1.0447988643136341e-05
the O 0 1.614275242900476e-05
heterozygous O 0 4.006709787063301e-06
carriers O 0 5.959945610811701e-06
, O 0 3.093545501542394e-06
in O 0 2.7949865398113616e-05
11 O 0 0.00042762511293403804
. O 0 0.00021201508934609592

5 O 0 0.00021502072922885418
% O 0 1.378648721583886e-05
of O 0 9.706079436000437e-05
all O 0 4.479878771235235e-05
control O 0 0.0001495378091931343
individuals O 0 7.8395669333986e-06
, O 0 1.4238186849979684e-05
and O 0 9.763396519701928e-06
in O 0 3.297792500234209e-05
one O 0 1.5510935554630123e-05
control O 0 2.76130795100471e-05
individual O 0 1.1469907121863798e-06
homozygous O 0 5.127372787683271e-06
for O 0 2.2391652692022035e-06
this O 0 2.7489629701449303e-06
glycine O 0 6.129840039648116e-05
substitution O 0 0.00010888963879551739
. O 0 0.00025776002439670265

There O 0 0.00013637168740388006
has O 0 1.4708737580804154e-05
been O 0 1.0042574103863444e-05
no O 0 3.1533147648588056e-06
previous O 0 5.4681549954693764e-06
finding O 0 9.808182767301332e-06
of O 0 2.126561048498843e-05
a O 0 2.638415026012808e-05
glycine O 0 3.4406908525852486e-05
substitution O 0 1.546281600894872e-05
that O 0 2.98664917863789e-06
is O 0 2.729316292970907e-06
not O 0 7.555511274404125e-07
associated O 0 2.0129566564719426e-06
with O 0 1.9191327282896964e-06
any O 0 7.762990207993425e-06
obvious O 0 0.0001557854120619595
phenotype O 0 5.757012331741862e-05
in O 0 4.435185473994352e-05
homozygous O 0 5.298758333083242e-05
individuals O 0 1.979459193535149e-05
. O 0 0.0002193813561461866

Founder O 0 0.24555703997612
BRCA1 O 0 0.0026193037629127502
and O 0 7.10569293005392e-05
BRCA2 O 0 0.0004052707809023559
mutations O 0 1.5094171430973802e-05
in O 0 1.0488382031326182e-05
French O 0 0.00011212743993382901
Canadian O 0 0.0007003853679634631
breast B-Disease 1 0.9999943971633911
and I-Disease 1 0.9987683892250061
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0017012892058119178
. O 0 0.000767592980992049

We O 0 3.167454997310415e-05
have O 0 3.3121539217972895e-06
identified O 0 6.568465778400423e-06
four O 0 4.1490229705232196e-06
mutations O 0 2.792164877973846e-06
in O 0 2.1692389964300673e-06
each O 0 2.6572558908810606e-07
of O 0 5.6004049838520586e-05
the O 0 0.0006391966016963124
breast B-Disease 1 0.9999793767929077
cancer I-Disease 1 0.9999871253967285
- O 0 0.002016320824623108
susceptibility O 0 0.0003766664012800902
genes O 0 4.529425496002659e-05
, O 0 1.9654080460895784e-05
BRCA1 O 0 0.0003069486701861024
and O 0 2.9173857910791412e-05
BRCA2 O 0 0.0003377835964784026
, O 0 3.1960303203959484e-06
in O 0 3.961897164117545e-06
French O 0 6.265125557547435e-05
Canadian O 0 0.00024853440118022263
breast B-Disease 1 0.999970555305481
cancer I-Disease 1 0.9999995231628418
and O 0 0.004735960159450769
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0003190134302712977
from O 0 0.0004846132069360465
Quebec O 0 0.00469712819904089
. O 0 0.000244795810431242

To O 0 0.0001947070995811373
identify O 0 0.0003764514112845063
founder O 0 0.011285768821835518
effects O 0 0.0012589715188369155
, O 0 2.7063286324846558e-05
we O 0 4.22235007135896e-06
examined O 0 2.8757232939824462e-05
independently O 0 6.215046141733183e-06
ascertained O 0 9.002574370242655e-05
French O 0 7.055889000184834e-05
Canadian O 0 0.00023444945691153407
cancer B-Disease 0 0.000884082168340683
families O 0 5.617122496914817e-06
for O 0 3.883370027324418e-06
the O 0 2.4754494006629102e-05
distribution O 0 9.068100553122349e-06
of O 0 6.414001836674288e-05
these O 0 1.5283547327271663e-05
eight O 0 0.00011083732533734292
mutations O 0 6.705846317345276e-05
. O 0 0.0001481075305491686

Mutations O 0 0.00010183569247601554
were O 0 4.476154936128296e-05
found O 0 1.3190001482143998e-05
in O 0 1.8494250980438665e-05
41 O 0 6.104673957452178e-05
of O 0 0.0001419189793523401
97 O 0 0.0009505302296020091
families O 0 5.290392437018454e-05
. O 0 0.00015727480058558285

Six O 0 0.00020214311371091753
of O 0 0.00012771619367413223
eight O 0 8.692250412423164e-05
mutations O 0 2.4657165340613574e-05
were O 0 2.8051683329977095e-05
observed O 0 3.8277848943835124e-05
at O 0 0.0001665137824602425
least O 0 2.098245568049606e-05
twice O 0 0.00012541667092591524
. O 0 7.319918950088322e-05

The O 0 0.0018927960190922022
BRCA1 O 0 0.004171440377831459
C4446T O 0 0.0023102432023733854
mutation O 0 3.146537346765399e-05
was O 0 0.00013704811863135546
the O 0 4.115172123420052e-05
most O 0 7.304413884412497e-06
common O 0 8.106320819933899e-06
mutation O 0 4.673731382354163e-06
found O 0 3.962773917010054e-06
, O 0 1.7215405705428566e-06
followed O 0 5.060330295236781e-06
by O 0 3.063470330744167e-06
the O 0 8.62402084749192e-05
BRCA2 O 0 0.0014977131504565477
8765delAG O 0 0.0036602532491087914
mutation O 0 9.29346788325347e-05
. O 0 0.00014043244300410151

Together O 0 0.0001691907091299072
, O 0 1.3107192899042275e-05
these O 0 2.828209971994511e-06
mutations O 0 1.0136232958757319e-05
were O 0 1.9975863324361853e-05
found O 0 1.075904947356321e-05
in O 0 1.5175141925283242e-05
28 O 0 9.408908954355866e-05
of O 0 6.52937451377511e-05
41 O 0 9.755481005413458e-05
families O 0 3.882370492647169e-06
identified O 0 6.602587291126838e-06
to O 0 5.633592536469223e-06
have O 0 3.325269744891557e-06
a O 0 4.1814644646365196e-05
mutation O 0 4.802898547495715e-05
. O 0 8.33936283015646e-05

The O 0 0.00044205092126503587
odds O 0 0.0007281048456206918
of O 0 0.00014633552927989513
detection O 0 9.642921213526279e-05
of O 0 8.11736608739011e-05
any O 0 1.8500053556635976e-05
of O 0 9.870482608675957e-05
the O 0 7.917163748061284e-05
four O 0 3.389789708307944e-05
BRCA1 O 0 0.0002202232280978933
mutations O 0 2.594930811028462e-05
was O 0 0.0005457666702568531
18 O 0 0.000727630453184247
. O 0 0.00026194320525974035

7x O 0 0.05531027913093567
greater O 0 0.0003165002563036978
if O 0 1.4579306480300147e-05
one O 0 3.396236934349872e-06
or O 0 9.991380238716374e-07
more O 0 2.7309854999657546e-07
cases O 0 1.1514641300891526e-05
of O 0 0.08161570131778717
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.001451978925615549
also O 0 2.8712838684441522e-05
present O 0 4.430527042131871e-05
in O 0 3.6506658943835646e-05
the O 0 0.00011871640890603885
family O 0 8.204715413739905e-05
. O 0 9.650344145484269e-05

The O 0 0.0004543570685200393
odds O 0 0.0004881813656538725
of O 0 0.00012204743688926101
detection O 0 0.0001384386414429173
of O 0 8.283352508442476e-05
any O 0 7.2943757913890295e-06
of O 0 9.319550008513033e-05
the O 0 7.900857599452138e-05
four O 0 3.119358007097617e-05
BRCA2 O 0 0.0002666110231075436
mutations O 0 1.998777406697627e-05
was O 0 0.00034112585126422346
5 O 0 0.0003594226436689496
. O 0 0.00015456427354365587

3x O 0 0.008343585766851902
greater O 0 0.00018533527327235788
if O 0 8.263656127383001e-06
there O 0 4.479996732698055e-06
were O 0 5.277111995383166e-06
at O 0 2.142822449968662e-05
least O 0 1.1611874697337043e-06
five O 0 2.759464223345276e-06
cases O 0 7.4022668741235975e-06
of O 0 0.0005392058519646525
breast B-Disease 1 0.9999855756759644
cancer I-Disease 1 0.9995434880256653
in O 0 0.0002721987257245928
the O 0 0.0003982521593570709
family O 0 0.00012339976092334837
. O 0 0.00011151730723213404

Interestingly O 0 0.0007865693769417703
, O 0 8.025621355045587e-06
the O 0 9.739124834595714e-06
presence O 0 1.597941627551336e-05
of O 0 0.0001891507999971509
a O 0 0.0007438725442625582
breast B-Disease 1 0.9997273087501526
cancer I-Disease 1 0.9941148161888123
case O 0 0.00023339006293099374
< O 0 0.00046217755880206823
36 O 0 4.733759124064818e-05
years O 0 3.154507794533856e-05
of O 0 5.6936023611342534e-05
age O 0 0.00027442927239462733
was O 0 0.00021110213128849864
strongly O 0 4.0577460822532885e-06
predictive O 0 9.024566679727286e-06
of O 0 3.6149689549347386e-05
the O 0 3.6997327697463334e-05
presence O 0 8.450452696706634e-06
of O 0 1.667796095716767e-05
any O 0 2.942819719464751e-06
of O 0 2.4593289708718657e-05
the O 0 4.1443741793045774e-05
eight O 0 3.799414116656408e-05
mutations O 0 2.2636573703493923e-05
screened O 0 0.0002483183634467423
. O 0 0.00010221112461294979

Carriers O 0 0.00015125120989978313
of O 0 0.00011007025022991002
the O 0 8.687551598995924e-05
same O 0 1.8770624592434615e-05
mutation O 0 3.6706339869851945e-06
, O 0 2.3078084723238135e-06
from O 0 3.333919266879093e-06
different O 0 4.254254974966898e-07
families O 0 1.013010887618293e-06
, O 0 2.7418493573350133e-06
shared O 0 1.0741528058133554e-05
similar O 0 1.4071973055251874e-05
haplotypes O 0 0.0004976150812581182
, O 0 1.6553667592233978e-05
indicating O 0 5.596565824816935e-05
that O 0 1.3528598401535419e-06
the O 0 1.0982284948113374e-05
mutant O 0 2.301735003129579e-05
alleles O 0 2.7441881229606224e-06
were O 0 6.407612545444863e-06
likely O 0 5.3298790589906275e-06
to O 0 3.0847161269775825e-06
be O 0 1.7044691276169033e-06
identical O 0 2.0996410512452712e-06
by O 0 1.2292816791159566e-06
descent O 0 1.5299327060347423e-05
for O 0 5.200066425459227e-06
a O 0 2.388603206782136e-05
mutation O 0 3.69244412468106e-06
in O 0 1.3035491065238602e-05
the O 0 8.200912998290733e-05
founder O 0 0.0007866919622756541
population O 0 9.779788342711981e-06
. O 0 6.051534728612751e-05

The O 0 0.00010008117533288896
identification O 0 2.2311176508083008e-05
of O 0 0.0003234361647628248
common O 0 0.0005265733925625682
BRCA1 O 0 0.00452268123626709
and O 0 0.00013694177323486656
BRCA2 O 0 0.0009412738727405667
mutations O 0 1.8000815543928184e-05
will O 0 6.717206360917771e-06
facilitate O 0 2.8318529075477272e-05
carrier O 0 7.774133337079547e-06
detection O 0 7.226988145703217e-06
in O 0 2.204517613790813e-06
French O 0 3.176545214955695e-05
Canadian O 0 0.0001921509247040376
breast B-Disease 1 0.9998668432235718
cancer I-Disease 1 0.9999964237213135
and O 0 0.0016923967050388455
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0022948330733925104
. O 0 0.0008288701064884663

Are O 0 8.367234840989113e-05
Dp71 O 0 0.021786877885460854
and O 0 0.00016073881124611944
Dp140 O 0 0.010123595595359802
brain O 0 0.0034040987957268953
dystrophin O 0 0.0010186299914494157
isoforms O 0 1.2838905604439788e-05
related O 0 1.755695848260075e-05
to O 0 2.2361124138114974e-05
cognitive B-Disease 1 0.8047722578048706
impairment I-Disease 1 1.0
in O 1 1.0
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999902248382568

Molecular O 0 0.00045885451254434884
study O 0 2.8956468668184243e-05
and O 0 1.0881970410991926e-05
neuropsychological O 0 7.3148803494405e-05
analysis O 0 2.6014452032541158e-06
were O 0 1.0973260032187682e-05
performed O 0 1.4531804481521249e-05
concurrently O 0 1.2403828804963268e-05
on O 0 2.3979240722837858e-05
49 O 0 6.961810868233442e-05
patients O 0 9.190699347527698e-05
with O 0 0.030703315511345863
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DMD B-Disease 1 1.0
) O 0 0.00018945944611914456
in O 0 3.0502520530717447e-05
order O 0 7.967830242705531e-06
to O 0 5.862931629962986e-06
find O 0 5.518257694347994e-06
a O 0 3.7246636566123925e-06
molecular O 0 8.60816908243578e-06
explanation O 0 2.9822376745869406e-06
for O 0 3.40816018251644e-06
the O 0 6.611207209061831e-05
cognitive B-Disease 0 0.0020764926448464394
impairment I-Disease 1 0.9930877089500427
observed O 0 0.0008932941127568483
in O 0 0.0005577357369475067
most O 0 0.0007473481819033623
DMD B-Disease 1 1.0
patients O 0 0.0019327005138620734
. O 0 0.0005055227666161954

Complete O 0 0.00014227886276785284
analysis O 0 6.739304808434099e-06
of O 0 8.332979632541537e-05
the O 0 0.00011476712097646669
dystrophin O 0 0.0013520624488592148
gene O 0 3.180485873599537e-05
was O 0 0.0001321974559687078
performed O 0 4.385469219414517e-05
to O 0 7.297986940102419e-06
define O 0 2.7684720407705754e-05
the O 0 4.428499232744798e-05
localization O 0 0.0005811830633319914
of O 0 0.00020783551735803485
deletions O 0 0.0004500920185819268
and O 0 4.3314248614478856e-05
duplications O 0 0.0005751887219958007
in O 0 3.6231413105269894e-05
relation O 0 4.661616912926547e-05
to O 0 1.7104330254369415e-05
the O 0 0.00011139157868456095
different O 0 7.310815271921456e-05
DMD B-Disease 1 1.0
promoters O 0 0.279401957988739
. O 0 0.0005932183121331036

Qualitative O 0 7.13160407030955e-05
analysis O 0 1.166517995443428e-05
of O 0 0.00025240128161385655
the O 0 0.0006000174907967448
Dp71 O 0 0.018227258697152138
transcript O 0 0.0006893680547364056
and O 0 6.601113909709966e-06
testing O 0 2.485538288965472e-06
for O 0 9.092814821087813e-07
the O 0 6.814357675466454e-06
specific O 0 9.894782806441071e-07
first O 0 2.7150350433657877e-05
exon O 0 0.00011326700041536242
of O 0 4.741982411360368e-05
Dp140 O 0 0.0005161611479707062
were O 0 2.0467889044084586e-05
also O 0 5.299392796587199e-06
carried O 0 2.469616083544679e-05
out O 0 1.577910006744787e-05
. O 0 5.462760600494221e-05

Neuropsychological O 0 0.0013376142596825957
analysis O 0 1.676985812082421e-05
assessed O 0 8.35039172670804e-05
verbal O 0 0.00013516523176804185
and O 0 0.00011781467765104026
visuospatial O 0 0.019916316494345665
intelligence O 0 0.0002300250343978405
, O 0 1.91658764379099e-05
verbal O 0 0.0001655136584304273
memory O 1 0.9999474287033081
, O 0 0.0001583555422257632
and O 0 4.4225067540537566e-05
reading O 0 0.0007835168507881463
skills O 0 0.0023091579787433147
. O 0 0.0004080079379491508

Comparison O 0 0.0002490258775651455
of O 0 0.0003728887240868062
molecular O 0 0.00033383845584467053
and O 0 5.1568145863711834e-05
psychometric O 0 0.0006856938707642257
findings O 0 7.456781168002635e-05
demonstrated O 0 0.000271943979896605
that O 0 1.3031886737735476e-05
deletions O 0 9.307649452239275e-05
and O 0 1.5478868590435013e-05
duplications O 0 0.000412075431086123
that O 0 6.326545644697035e-06
were O 0 2.9983219064888544e-05
localized O 0 0.0001477139157941565
in O 0 3.386445314390585e-05
the O 0 7.504232053179294e-05
distal O 0 0.000877316459082067
part O 0 0.0001299247524002567
of O 0 0.00023914103803690523
the O 0 0.00019363513274583966
gene O 0 1.7522466805530712e-05
seemed O 0 2.0407818738021888e-05
to O 0 9.944772045855643e-07
be O 0 8.196988119379967e-07
preferentially O 0 3.97860276279971e-06
associated O 0 3.4352085549471667e-06
with O 0 7.430770438077161e-06
cognitive B-Disease 0 0.1548561155796051
impairment I-Disease 1 0.9999997615814209
. O 1 0.9197928309440613

Two O 0 9.722993127070367e-05
altered O 0 0.00035719070001505315
Dp71 O 0 0.004327570088207722
transcripts O 0 0.00048615483683533967
and O 0 1.0594731975288596e-05
two O 0 4.404127594170859e-06
deleted O 0 9.378568938700482e-05
Dp140 O 0 0.0002323957160115242
DNA O 0 1.5281055311788805e-05
sequences O 0 4.122141035622917e-06
were O 0 7.13075269231922e-06
found O 0 2.508795660105534e-06
in O 0 6.1409523368638474e-06
four O 0 1.0971963092742953e-05
patients O 0 4.123315738979727e-05
with O 0 0.00011773336154874414
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9999947547912598

These O 0 1.9913002688554116e-05
findings O 0 7.212199761852389e-06
suggest O 0 3.1511442557530245e-06
that O 0 4.2198519167868653e-07
some O 0 4.447260835149791e-07
sequences O 0 3.3706844533298863e-06
located O 0 3.4640692319953814e-05
in O 0 7.374174401775235e-06
the O 0 3.200493665644899e-05
distal O 0 0.0004868699761573225
part O 0 0.00010742072481662035
of O 0 0.00019896066805813462
the O 0 0.00015131452528294176
gene O 0 2.126208164554555e-05
and O 0 5.915178007853683e-06
, O 0 3.4572976801428013e-06
in O 0 7.127665867301403e-06
particular O 0 8.668007467349526e-06
, O 0 8.748464097152464e-06
some O 0 1.496877030149335e-05
DMD B-Disease 1 0.999674916267395
isoforms O 0 2.5229892344214022e-05
expressed O 0 1.1425318007241003e-05
in O 0 1.8474276657798328e-05
the O 0 9.523029439151287e-05
brain O 0 0.0009161762427538633
may O 0 3.854076931020245e-05
be O 0 2.1280125110934023e-06
related O 0 3.748560629901476e-06
to O 0 5.647976649925113e-06
the O 0 2.6518955564824864e-05
cognitive B-Disease 0 0.0012092371471226215
impairment I-Disease 1 0.999455988407135
associated O 0 0.0032076353672891855
with O 0 0.0018085642950609326
DMD B-Disease 1 1.0
. O 0 0.0010436460142955184
. O 0 0.0004252539074514061

I1307K O 0 0.03766782581806183
APC O 0 0.010500866919755936
and O 0 7.796792488079518e-05
hMLH1 O 0 0.0017680840101093054
mutations O 0 3.8767764635849744e-05
in O 0 3.367393946973607e-05
a O 0 5.824758773087524e-05
non O 0 0.0001916440814966336
- O 0 6.308760202955455e-05
Jewish O 0 7.982059287314769e-06
family O 0 2.8585368454514537e-06
with O 0 2.711428351176437e-06
hereditary B-Disease 1 0.9999990463256836
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999657869338989

We O 0 3.7491219700314105e-05
describe O 0 1.970434095710516e-05
a O 0 6.007182946632383e-06
French O 0 6.340526306303218e-05
Canadian O 0 0.0001318517461186275
hereditary B-Disease 1 0.9999927282333374
non I-Disease 1 0.9999992847442627
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999998807907104
HNPCC B-Disease 1 1.0
) O 0 0.0006752476328983903
kindred O 0 0.0020319924224168062
which O 0 2.0600502466550097e-05
carries O 0 3.673322862596251e-05
a O 0 1.68634214787744e-05
novel O 0 7.6867057941854e-05
truncating O 0 0.0006699353689327836
mutation O 0 2.1212179490248673e-05
in O 0 7.882330100983381e-05
hMLH1 O 0 0.005810867063701153
. O 0 0.00028585511608980596

Interestingly O 0 0.0016068576369434595
, O 0 3.9046477468218654e-05
the O 0 0.00016698060790076852
I1307K O 0 0.0034690448082983494
APC O 0 0.0022086817771196365
polymorphism O 0 2.9354618163779378e-05
, O 0 4.206714947940782e-06
associated O 0 1.590265014783654e-06
with O 0 4.626660370377067e-07
an O 0 1.6139974832185544e-06
increased O 0 3.686785566969775e-05
risk O 0 0.000247166637564078
of O 1 0.999977707862854
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0003665888507384807
is O 0 1.4977766113588586e-05
also O 0 2.9108468879712746e-06
present O 0 6.9878524300293066e-06
in O 0 9.799104191188235e-06
this O 0 5.2619452617364004e-06
family O 0 3.88742373615969e-05
. O 0 8.530516061000526e-05

The O 0 0.001342579023912549
I1307K O 0 0.0020496996585279703
polymorphism O 0 6.026828123140149e-05
has O 0 7.718166671111248e-06
previously O 0 1.1423204341554083e-05
only O 0 1.013982000586111e-06
been O 0 3.0022274586372077e-06
identified O 0 3.3661742691037944e-06
in O 0 4.152886958763702e-06
individuals O 0 1.4059091881790664e-06
of O 0 0.00017592799849808216
self O 0 0.000887931848410517
- O 0 0.0009115217835642397
reported O 0 4.568284566630609e-05
Ashkenazi O 0 0.00014371451106853783
Jewish O 0 0.00011566472676349804
origins O 0 0.0009018346900120378
. O 0 0.0002874769561458379

In O 0 0.00020585897436831146
addition O 0 3.595461021177471e-05
, O 0 8.712845556146931e-06
in O 0 9.242488886229694e-06
this O 0 2.384606432315195e-06
family O 0 1.1403884855099022e-05
, O 0 3.307602355562267e-06
there O 0 4.342046850069892e-06
appears O 0 1.4130484487395734e-05
to O 0 3.7732290820713388e-06
be O 0 4.325052486819914e-06
no O 0 5.143720954947639e-06
relationship O 0 2.1755389752797782e-05
between O 0 9.309531742474064e-05
the O 0 0.00020152113575022668
I1307K O 0 0.0007272522780112922
polymorphism O 0 2.177002352254931e-05
and O 0 3.432343191889231e-06
the O 0 1.2614979823410977e-05
presence O 0 1.9647110093501396e-05
or O 0 1.1849172551592346e-05
absence O 0 0.00024264382955152541
of O 0 0.0020501220133155584
cancer B-Disease 1 0.9999910593032837
. O 0 0.0002836463681887835
. O 0 0.00023077809601090848

Identification O 0 0.00012120774772483855
of O 0 0.0003286933060735464
a O 0 0.00011337083560647443
novel O 0 7.638464740011841e-05
mutation O 0 5.956229870207608e-06
of O 0 5.3234445658745244e-05
the O 0 0.0003148903779219836
CPO O 0 0.005450580734759569
gene O 0 1.0213646419288125e-05
in O 0 1.1148144039907493e-05
a O 0 2.2079422706156038e-05
Japanese O 0 0.0009145988151431084
hereditary B-Disease 1 0.9997726082801819
coproporphyria I-Disease 1 0.9997813105583191
family O 0 0.0008267679368145764
. O 0 0.00033974050893448293

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 1 0.9705613255500793
HCP B-Disease 1 1.0
) O 0 6.61147860228084e-05
is O 0 7.5059888331452385e-06
an O 0 1.0933273188129533e-05
autosomal B-Disease 1 0.9993782043457031
dominant I-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
characterized O 0 0.002553106751292944
by O 0 5.7507961173541844e-05
a O 0 0.0005771660362370312
deficiency B-Disease 1 1.0
of I-Disease 1 0.9998693466186523
coproporphyrinogen I-Disease 1 0.9999992847442627
oxidase I-Disease 0 0.0014067045412957668
( O 0 0.00023992054047994316
CPO O 0 0.012380331754684448
) O 0 2.1255107640172355e-05
caused O 0 6.506973295472562e-05
by O 0 3.6741853364219423e-06
a O 0 8.930577678256668e-06
mutation O 0 2.244358483949327e-06
in O 0 1.0258649126626551e-05
the O 0 0.00013181279064156115
CPO O 0 0.007225166540592909
gene O 0 7.814037962816656e-05
. O 0 8.77714337548241e-05

Only O 0 5.3776209824718535e-05
11 O 0 0.0001609191531315446
mutations O 0 1.0008184290200006e-05
of O 0 4.789442027686164e-05
the O 0 6.570512050529942e-05
gene O 0 4.528320914687356e-06
have O 0 1.1480959756227094e-06
been O 0 7.1025729084794875e-06
reported O 0 2.8143267627456225e-05
in O 0 0.00022338100825436413
HCP B-Disease 1 0.9999994039535522
patients O 0 0.0009391587227582932
. O 0 0.00043827254557982087

We O 0 5.678962043020874e-05
report O 0 7.3013288783840835e-06
another O 0 9.253406460629776e-06
mutation O 0 2.950609541585436e-06
in O 0 1.0999086043739226e-05
a O 0 3.694140832521953e-05
Japanese O 0 0.0008947183378040791
family O 0 0.00010684160952223465
. O 0 9.982079791370779e-05

Polymerase O 0 0.00499599939212203
chain O 0 0.0008088983013294637
reaction O 0 0.00015085021732375026
- O 0 0.0005771115538664162
single O 0 1.6170917660929263e-05
strand O 0 2.3608567062183283e-05
conformational O 0 4.739948508358793e-06
polymorphism O 0 3.0550475003110478e-06
and O 0 1.1730223832273623e-06
direct O 0 1.231534611179086e-06
sequence O 0 7.386189281533007e-06
analyses O 0 7.420685960823903e-06
demonstrated O 0 4.001862907898612e-05
a O 0 2.8187132556922734e-05
C O 0 0.0003461092128418386
to O 0 3.651410952443257e-05
T O 0 0.0005120509304106236
substitution O 0 1.0640155778673943e-05
in O 0 2.0912737454636954e-05
exon O 0 6.877376290503889e-05
1 O 0 3.5379187465878204e-05
of O 0 3.844290768029168e-05
the O 0 8.670643728692085e-05
CPO O 0 0.0019475623266771436
gene O 0 6.146225132397376e-06
at O 0 5.683610652340576e-05
nucleotide O 0 1.1973213986493647e-05
position O 0 1.660527595959138e-05
85 O 0 3.780053884838708e-05
, O 0 4.698005795944482e-06
which O 0 5.73475244891597e-06
lies O 0 0.0001475990138715133
in O 0 1.2802323908545077e-05
the O 0 3.493235999485478e-05
putative O 0 0.000283388770185411
presequence O 0 0.0007588587468490005
for O 0 7.799032573529985e-06
targeting O 0 1.5973504559951834e-05
to O 0 6.387566099874675e-05
mitochondria O 0 0.0003409990749787539
. O 0 0.00010305287287337705

This O 0 2.1721165467170067e-05
mutation O 0 5.346755642676726e-06
changes O 0 4.369679572846508e-06
the O 0 1.8006756363320164e-05
codon O 0 1.2210200111439917e-05
for O 0 4.255141448084032e-06
glutamine O 0 1.1445996278780513e-05
to O 0 7.226133675430901e-06
a O 0 1.958617940545082e-05
termination O 0 7.763954636175185e-05
codon O 0 5.503303691511974e-05
at O 0 0.00040151033317670226
amino O 0 4.3233030737610534e-05
acid O 0 9.369217877974734e-05
position O 0 0.0002487970923539251
29 O 0 0.0011358509073033929
. O 0 0.00021936086704954505

MaeI O 0 0.014288990758359432
restriction O 0 3.259341974626295e-05
analysis O 0 5.131481884745881e-06
showed O 0 3.5402877983869985e-05
two O 0 3.0474495815724367e-06
other O 0 2.1354248929128516e-06
carriers O 0 9.841744031291455e-06
in O 0 1.3881067388865631e-05
the O 0 9.469856013311073e-05
family O 0 0.00011747050302801654
. O 0 0.00010427396045997739

The O 0 0.001506392378360033
C O 0 0.03546656668186188
- O 0 0.007093878462910652
T O 0 0.003201489569619298
mutation O 0 7.336016551562352e-06
is O 0 2.881632781281951e-06
located O 0 1.1675775567709934e-05
within O 0 2.0772706648131134e-06
a O 0 2.077979843306821e-06
recently O 0 6.1117170844227076e-06
proposed O 0 3.93790196540067e-06
putative O 0 2.7611500627244823e-05
alternative O 0 3.7679826618841616e-06
translation O 0 3.220584767404944e-05
initiation O 0 0.00021161841868888587
codon O 0 9.54239148995839e-05
( O 0 4.418308162712492e-05
TIC O 0 0.009893644601106644
- O 0 0.00012088456423953176
1 O 0 6.298264634096995e-05
) O 0 2.5472854758845642e-06
, O 0 1.3777464573649922e-06
supporting O 0 7.3433729994576424e-06
that O 0 1.6551110093132593e-05
TIC O 0 0.030673900619149208
- O 0 0.00017297352314926684
1 O 0 3.549699249560945e-05
is O 0 3.1332604066847125e-06
the O 0 1.5068542779772542e-05
real O 0 0.0001565715647302568
TIC O 0 0.01329844817519188
rather O 0 2.238017441413831e-05
than O 0 2.8667476726695895e-05
TIC O 0 0.050274819135665894
- O 0 0.0004533289175014943
2 O 0 0.0001630922924960032
. O 0 2.321380452485755e-05
. O 0 5.9820398746524006e-05

Human B-Disease 0 3.1312018109019846e-05
complement I-Disease 0 4.48316968686413e-05
factor I-Disease 0 0.0006543834460899234
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 0.0018573349807411432
with O 1 0.9999779462814331
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 1.0

This O 0 1.0321276022295933e-05
study O 0 3.981487225246383e-06
reports O 0 3.0893529583408963e-06
on O 0 1.4106841263128445e-05
six O 0 1.3430677427095361e-05
cases O 0 1.6855959984241053e-05
of O 0 0.0011183631140738726
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 0.00035598917747847736
the I-Disease 0 0.00011448207078501582
human I-Disease 0 8.838545909384266e-06
complement I-Disease 0 7.574452411063248e-06
regulatory I-Disease 0 1.6360565496142954e-05
protein I-Disease 0 2.7782209144788794e-05
Factor I-Disease 0 0.00018864989397116005
H I-Disease 1 0.998602569103241
( O 0 0.00010514904715819284
FH O 0 0.006054108962416649
) O 0 2.2372441890183836e-06
in O 0 8.792105177235499e-07
the O 0 1.4939770380806294e-06
context O 0 1.6491884480274166e-06
of O 0 2.708492502279114e-05
an O 0 9.805872105062008e-05
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999992847442627

Five O 0 0.00012961539323441684
of O 0 6.972347910050303e-05
the O 0 5.257164593786001e-05
cases O 0 6.506828867713921e-06
were O 0 1.3456794476951472e-05
observed O 0 7.893710062489845e-06
in O 0 2.779661599561223e-06
children O 0 1.91671847460384e-06
presenting O 0 2.689266148081515e-05
with O 0 0.0001265152241103351
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9958226680755615
. O 0 0.0013459321344271302

Two O 0 5.0056194595526904e-05
of O 0 0.00017199429566971958
the O 0 0.0002175861009163782
children O 0 4.258057742845267e-05
exhibited O 0 0.0006258534849621356
a O 0 0.00039594905683770776
homozygous O 0 0.00794465932995081
deficiency O 1 1.0
characterized O 0 0.0009368775645270944
by O 0 3.4165375836892053e-05
the O 0 7.273764640558511e-05
absence O 0 0.0001707729243207723
of O 0 0.00014334362640511245
the O 0 0.00019076094031333923
150 O 0 0.00014075470971874893
- O 0 0.00016956216131802648
kD O 0 0.0008362228982150555
form O 0 4.884509507974144e-06
of O 0 0.00011064873251598328
Factor O 0 0.000402779842261225
H O 1 0.9566386938095093
and O 0 1.5197098036878742e-05
the O 0 3.140086482744664e-05
presence O 0 3.46855194948148e-05
, O 0 4.644113687390927e-06
upon O 0 4.781561074196361e-05
immunoblotting O 0 0.0012578268069773912
, O 0 5.239996880845865e-06
of O 0 2.3103246348910034e-05
the O 0 7.855271542211995e-05
42 O 0 0.00020490627503022552
- O 0 0.0002562293957453221
kD O 0 0.00278199790045619
Factor O 0 0.00012049442011630163
H O 0 0.008794350549578667
- O 0 8.423071994911879e-05
like O 0 3.1846086585574085e-06
protein O 0 4.209760845697019e-06
1 O 0 6.30728027317673e-05
( O 0 2.477945963619277e-05
FHL O 0 0.009907769970595837
- O 0 0.00010750075307441875
1 O 0 4.139898737776093e-05
) O 0 2.486095354470308e-06
and O 0 1.7300296804023674e-06
other O 0 5.30004990650923e-06
FH O 0 0.007409379817545414
- O 0 0.00013845223293174058
related O 0 3.173275035806e-05
protein O 0 6.388467591023073e-05
( O 0 7.526148692704737e-05
FHR O 1 0.989124059677124
) O 0 6.692923489026725e-05
bands O 0 0.0006821439019404352
. O 0 0.00018526019994169474

Southern O 0 0.0006276422063820064
blot O 0 0.0005134477978572249
and O 0 1.1403003554733004e-05
PCR O 0 2.4907609258661978e-05
analysis O 0 1.137107801696402e-06
of O 0 3.6077639379072934e-05
DNA O 0 7.883366924943402e-05
of O 0 0.00010245506564388052
one O 0 1.8101209207088687e-05
patient O 0 2.118411794072017e-05
with O 0 1.8241331417812034e-05
homozygous O 0 0.0020120744593441486
deficiency O 1 0.9999996423721313
ruled O 0 0.0014326799428090453
out O 0 2.2454079953604378e-05
the O 0 1.777173747541383e-05
presence O 0 1.1002096471202094e-05
of O 0 2.914796641562134e-05
a O 0 1.559060183353722e-05
large O 0 1.66688969329698e-05
deletion O 0 3.35164659190923e-05
of O 0 0.00011260597239015624
the O 0 0.0003210684226360172
FH O 0 0.017770227044820786
gene O 0 9.038726602739189e-06
as O 0 7.739792636130005e-06
the O 0 3.26269437209703e-05
underlying O 0 0.0019720017444342375
defect O 0 0.007538535166531801
for O 0 0.00023948676243890077
the O 1 0.8589314222335815
deficiency O 1 1.0
. O 0 0.0034094734583050013

The O 0 0.00013089169806335121
other O 0 3.069149215662037e-06
four O 0 4.700004410551628e-06
children O 0 2.1198052309046034e-06
presented O 0 2.6556255761533976e-05
with O 0 2.1790192477055825e-05
heterozygous O 0 0.0008333537261933088
deficiency O 1 1.0
and O 0 0.0003045064222533256
exhibited O 0 0.07465284317731857
a O 0 0.0004947312409058213
normal O 0 0.00029873294988647103
immunoblotting O 0 0.0015004632296040654
pattern O 0 6.973996642045677e-05
of O 0 0.00010112435120390728
proteins O 0 2.1651632778230123e-05
of O 0 0.00024960353039205074
the O 0 0.0012777206720784307
FH O 1 0.9934564232826233
family O 0 0.00025662643020041287
. O 0 0.00011218669533263892

Factor B-Disease 1 0.9553984999656677
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
is O 0 2.5765210011741146e-05
the O 0 1.678052831266541e-05
only O 0 1.952787715708837e-05
complement B-Disease 1 0.99964439868927
deficiency I-Disease 1 1.0
associated O 0 0.006521427072584629
with O 0 0.0018300269730389118
HUS B-Disease 1 1.0
. O 0 0.007854809984564781

These O 0 2.3503122065449134e-05
observations O 0 3.2207015465246513e-05
suggest O 0 1.750950286805164e-05
a O 0 1.1012341929017566e-05
role O 0 3.81003410439007e-05
for O 0 4.6760782424826175e-05
FH O 1 0.968854546546936
and O 0 0.00014975470548961312
/ O 0 0.0006474991096183658
or O 0 0.00017527597083244473
FH O 0 0.06304998695850372
receptors O 0 8.019331289688125e-05
in O 0 3.386732714716345e-05
the O 0 0.0001829585962696001
pathogenesis O 1 0.9999707937240601
of O 0 0.3660387098789215
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.010256875306367874
. O 0 0.0005613567191176116

Further O 0 8.124196028802544e-05
evidence O 0 2.9082941182423383e-05
for O 0 2.443196081003407e-06
a O 0 1.0980074875988066e-05
major O 0 0.00013137009227648377
ancient O 0 0.0018824465805664659
mutation O 0 0.0008542833384126425
underlying O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9995636343955994
linkage O 1 0.997989296913147
disequilibrium O 0 0.23667290806770325
studies O 0 4.688563058152795e-05
in O 0 3.346760058775544e-05
the O 0 3.90254172089044e-05
Japanese O 0 0.00024189169926103204
population O 0 7.6067663030698895e-06
. O 0 3.0292296287370846e-05

The O 1 0.9963266253471375
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9977194666862488
DM B-Disease 1 1.0
) O 0 0.00026198741397820413
mutation O 0 1.0265539458487183e-05
is O 0 8.413061550527345e-06
an O 0 1.8864137018681504e-05
unstable O 0 0.005015136208385229
( O 0 0.0002477484231349081
CTG O 1 0.6796886324882507
) O 0 3.308654049760662e-05
n O 0 8.201570744859055e-05
repeat O 0 0.00024892427609302104
, O 0 6.199406925588846e-06
present O 0 1.2577619600051548e-05
at O 0 7.188611198216677e-05
a O 0 6.7979808591189794e-06
copy O 0 1.1317653843434528e-05
number O 0 2.9031700705672847e-06
of O 0 8.166139741661027e-05
5 O 0 0.00022348070342559367
- O 0 0.00021400196419563144
37 O 0 4.056013494846411e-05
repeats O 0 6.610154377995059e-05
on O 0 5.0477934564696625e-05
normal O 0 1.4703506167279556e-05
chromosomes O 0 5.645919372909702e-06
but O 0 9.905197657644749e-07
amplified O 0 1.2141077604610473e-05
to O 0 4.107253062102245e-06
50 O 0 2.0305280486354604e-05
- O 0 4.4800453906646e-05
3000 O 0 5.368295751395635e-05
copies O 0 1.9406628780416213e-05
on O 0 0.0004983335384167731
DM B-Disease 1 0.9999970197677612
chromosomes O 0 0.0008249972597695887
. O 0 0.0002524881565477699

Previous O 0 0.00026395608438178897
findings O 0 5.7429417211096734e-05
in O 0 3.065643977606669e-05
Caucasian O 0 0.00018252126756124198
populations O 0 6.624642992392182e-06
of O 0 6.853877857793123e-05
a O 0 0.0007226840825751424
DM B-Disease 1 1.0
founder O 1 0.9951704144477844
chromosome O 0 0.0002928209723904729
raise O 0 1.9100554709439166e-05
a O 0 5.4892066145839635e-06
question O 0 6.344254416035255e-06
about O 0 1.541578967589885e-06
the O 0 5.911399966862518e-06
molecular O 0 1.652054925216362e-05
events O 0 2.5029452444869094e-05
involved O 0 1.937323213496711e-05
in O 0 2.6833895390154794e-05
the O 0 7.998343789950013e-05
expansion O 0 0.0007148064905777574
mutation O 0 6.044555993867107e-05
. O 0 0.00012425107706803828

To O 0 3.930568345822394e-05
investigate O 0 4.774379704031162e-05
whether O 0 7.922859367681667e-06
a O 0 2.6541974875726737e-05
founder O 0 0.0005220959428697824
chromosome O 0 5.071590931038372e-05
for O 0 1.497733683208935e-05
the O 0 0.0004746092308778316
DM B-Disease 1 1.0
mutation O 0 4.6102544729365036e-05
exists O 0 2.529412267904263e-05
in O 0 6.389660029526567e-06
the O 0 1.0991599083354231e-05
Japanese O 0 7.281189755303785e-05
population O 0 2.7375381250749342e-06
, O 0 2.234721478089341e-06
we O 0 4.14611986343516e-06
genotyped O 0 0.00029448140412569046
families O 0 1.7594167047718656e-06
using O 0 2.728238996496657e-06
polymorphic O 0 5.843084727530368e-05
markers O 0 0.0007914301240816712
near O 0 0.0024945875629782677
the O 0 0.0004297353734727949
( O 0 0.00019185798009857535
CTG O 0 0.031677670776844025
) O 0 2.620688064780552e-05
n O 0 6.420139834517613e-05
repeat O 0 0.0002970349742099643
region O 0 0.0003901972668245435
and O 0 4.8071000492200255e-05
constructed O 0 0.007027722895145416
haplotypes O 0 0.0034300878178328276
. O 0 0.00033596676075831056

Six O 0 8.111006172839552e-05
different O 0 2.5503334200038807e-06
haplotypes O 0 0.00014595661195926368
were O 0 3.3060176065191627e-05
found O 0 1.6499390767421573e-05
and O 0 5.81215244892519e-05
DM B-Disease 1 0.9999998807907104
alleles O 0 8.575293031753972e-05
were O 0 0.00011889766028616577
always O 0 6.361827399814501e-05
haplotype O 0 0.00043104946962557733
A O 0 0.0025067648384720087
. O 0 0.0004272538935765624

To O 0 5.969839185127057e-05
find O 0 1.1271155926806387e-05
an O 0 1.059577812156931e-06
origin O 0 3.361808012414258e-06
of O 0 8.963154687080532e-05
the O 0 0.0003753076307475567
( O 0 0.00026258660363964736
CTG O 0 0.11915064603090286
) O 0 3.0341214369400404e-05
n O 0 7.215003279270604e-05
repeat O 0 0.00023393431911244988
mutation O 0 5.647868874802953e-06
and O 0 3.88166290576919e-06
to O 0 1.0933950761682354e-05
investigate O 0 5.293607318890281e-05
the O 0 4.8921938287094235e-05
mechanism O 0 7.141615060390905e-05
of O 0 3.900413139490411e-05
the O 0 5.5173026339616627e-05
expansion O 0 0.00015814129437785596
mutation O 0 1.8331436422158731e-06
in O 0 3.3198955406987807e-06
the O 0 8.008533768588677e-06
Japanese O 0 4.053221709909849e-05
population O 0 6.410159016922989e-07
we O 0 3.1558852242596913e-07
have O 0 1.523802097835869e-07
studied O 0 9.864568710327148e-06
90 O 0 2.5791565349209122e-05
Japanese O 0 0.0006915336125530303
DM B-Disease 1 0.9999701976776123
families O 0 1.553245965624228e-05
comprising O 0 3.128599564661272e-05
190 O 0 5.1029106543865055e-05
affected O 0 3.384162482689135e-05
and O 0 1.4826499864284415e-05
130 O 0 0.00014126001042313874
unaffected O 0 0.0004651489725802094
members O 0 5.8545858337311074e-05
. O 0 0.00011330415145494044

The O 0 0.0002524518349673599
results O 0 2.5272036509704776e-05
suggest O 0 1.732004420773592e-05
that O 0 1.4144353599476744e-06
a O 0 5.767292350356001e-06
few O 0 1.3123615644872189e-05
common O 0 1.1428041943872813e-05
ancestral O 0 0.00043882604222744703
mutations O 0 3.837935219053179e-05
in O 0 4.1770173993427306e-05
both O 0 3.757691592909396e-05
Caucasian O 0 0.0007302843732759356
and O 0 1.871679887699429e-05
Japanese O 0 0.00015645186067558825
populations O 0 1.4826960068603512e-06
have O 0 2.615026346575178e-07
originated O 0 4.223070845910115e-06
by O 0 5.431128329291823e-07
expansion O 0 3.5540826502256095e-05
of O 0 3.982097769039683e-05
an O 0 9.833226613409352e-06
ancestral O 0 0.0007917522452771664
n O 0 0.0001990830642171204
= O 0 0.00010206308797933161
5 O 0 4.201177944196388e-05
repeat O 0 7.07008657627739e-05
to O 0 1.0886516975006089e-05
n O 0 3.25926739606075e-05
= O 0 6.395013770088553e-05
19 O 0 0.00018443058070261031
- O 0 0.00010691498027881607
37 O 0 4.134442497161217e-05
copies O 0 5.836012132931501e-05
. O 0 8.311005512950942e-05

These O 0 1.3139545444573741e-05
data O 0 7.11638404027326e-06
support O 0 5.167622020962881e-06
multistep O 0 8.918563980842009e-05
models O 0 3.477490827208385e-05
of O 0 0.0004031849093735218
triplet O 0 0.0028971745632588863
repeat O 0 0.0008809083374217153
expansion O 0 0.0001788926456356421
that O 0 1.2474522463890025e-06
have O 0 2.371979093140908e-07
been O 0 5.288399620440032e-07
proposed O 0 8.821215260468307e-07
for O 0 2.191356315961457e-06
both O 0 6.258916255319491e-05
DM B-Disease 1 1.0
and O 0 0.0007118554785847664
Friedreichs B-Disease 1 0.9999711513519287
ataxia I-Disease 1 0.9997262358665466
. O 0 0.0006136376759968698
. O 0 0.00036666399682872

The O 0 3.8671907532261685e-05
molecular O 0 2.4624971047160216e-05
basis O 0 0.00010339670552639291
of O 1 0.9997865557670593
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0013931738212704659
the O 0 0.0002228578960057348
western O 0 0.00015294892364181578
Cape O 0 0.00039203095366247
, O 0 7.659331458853558e-06
South O 0 0.000139016323373653
Africa O 0 0.0001293644745601341
. O 0 5.303480429574847e-05

Deficiency B-Disease 1 1.0
of I-Disease 0 0.00628165528178215
the I-Disease 0 0.0012368288589641452
sixth I-Disease 0 0.0010112705640494823
component I-Disease 0 8.529816113878042e-05
of I-Disease 0 6.085422864998691e-05
human I-Disease 0 4.658346006181091e-05
complement I-Disease 0 0.00020394202147144824
( O 0 0.0002509110781829804
C6 O 1 0.9998441934585571
) O 0 1.3694357221538667e-05
has O 0 2.6991706363332924e-06
been O 0 3.181648935424164e-06
reported O 0 2.8699328140646685e-06
in O 0 1.6838115470818593e-06
a O 0 1.6932189055296476e-06
number O 0 1.4492351283479366e-06
of O 0 1.2056307241437025e-05
families O 0 2.1914879653195385e-06
from O 0 8.763085133978166e-06
the O 0 5.357423651730642e-05
western O 0 0.00011781445209635422
Cape O 0 0.0006097807199694216
, O 0 1.0515614121686667e-05
South O 0 0.00012384014553390443
Africa O 0 0.00011571083450689912
. O 0 5.43244241271168e-05

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.0005636148853227496
endemic O 0 0.000354591611539945
in O 0 3.3443477150285617e-05
the O 0 6.42051309114322e-05
Cape O 0 0.0003144622314721346
and O 0 7.278840143953857e-07
almost O 0 7.363166218965489e-07
all O 0 2.2093510665399663e-07
pedigrees O 0 2.3676251657889225e-05
of O 0 0.00010293334344169125
total O 1 0.9972842931747437
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.14878109097480774
C6Q0 O 1 0.9999982118606567
) O 0 2.0577725081238896e-05
have O 0 1.4689187537442194e-06
been O 0 5.577354386332445e-06
ascertained O 0 8.05710515123792e-05
because O 0 4.757510851050029e-06
of O 0 0.00017944580758921802
recurrent O 1 0.9999998807907104
disease O 1 1.0
. O 0 0.004462624434381723

We O 0 4.241716305841692e-05
have O 0 1.9219937712477986e-06
sequenced O 0 9.890699402603786e-06
the O 0 4.287922365620034e-06
expressed O 0 5.602591954811942e-06
exons O 0 0.0001305434270761907
of O 0 0.00020170261268503964
the O 0 0.001311569008976221
C6 O 1 0.9996939897537231
gene O 0 3.1269712053472176e-05
from O 0 8.651704774820246e-06
selected O 0 6.2538301790482365e-06
cases O 0 3.3405262911401223e-06
and O 0 1.3215360468166182e-06
have O 0 7.32906187295157e-07
found O 0 2.0752552245539846e-06
three O 0 4.861421530222287e-06
molecular O 0 0.0002164697361877188
defects O 0 0.35804447531700134
leading O 0 0.00043611376895569265
to O 0 7.410223770420998e-05
total O 0 0.0028611731249839067
deficiency O 1 1.0
879delG O 1 0.9905401468276978
, O 0 4.329921648604795e-05
which O 0 6.869079697935376e-06
is O 0 5.3968678912497126e-06
the O 0 3.466686393949203e-05
common O 0 4.99426168971695e-05
defect O 0 0.002394224051386118
in O 0 0.00010973080497933552
the O 0 0.0002442724071443081
Cape O 0 0.0013000996550545096
and O 0 1.561566023156047e-05
hitherto O 0 0.0006141220801509917
unreported O 0 0.00029498751973733306
, O 0 1.2286052879062481e-05
and O 0 1.3136150300852023e-05
1195delC O 0 0.0013766564661636949
and O 0 4.543710747384466e-05
1936delG O 0 0.0009447212796658278
, O 0 5.390160822571488e-06
which O 0 1.1765953331632772e-06
have O 0 3.9664001860728604e-07
been O 0 2.453838988003554e-06
previously O 0 1.0372647921030875e-05
reported O 0 9.39270103117451e-06
in O 0 1.3824419511365704e-05
African O 0 0.00012544657511170954
- O 0 0.00027590684476308525
Americans O 0 4.2930736526614055e-05
. O 0 5.603968747891486e-05

We O 0 3.364950680406764e-05
also O 0 4.195017027086578e-06
show O 0 4.633682237908943e-06
that O 0 5.247765670901572e-07
the O 0 1.0463394573889673e-05
879delG O 0 0.0006588512915186584
and O 0 4.330358933657408e-05
1195delC O 0 0.00850736815482378
defects O 0 0.018593840301036835
are O 0 3.3799290122260572e-06
associated O 0 1.328202233707998e-05
with O 0 2.7517469789017923e-05
characteristic O 1 0.9999868869781494
C6 O 1 1.0
/ O 1 0.9999994039535522
C7 O 1 1.0
region O 0 0.0031666411086916924
DNA O 0 0.0007836602162569761
marker O 0 0.0011143781011924148
haplotypes O 0 0.0005633772234432399
, O 0 8.80625520949252e-06
although O 0 3.410195404285332e-06
small O 0 3.737206043297192e-06
variations O 0 1.7823691450757906e-05
were O 0 5.398389475885779e-05
observed O 0 0.00012063134636264294
. O 0 0.00012210100248921663

The O 0 0.002947382628917694
1936delG O 0 0.09062068164348602
defect O 0 0.19304916262626648
was O 0 0.0013372066896408796
observed O 0 7.762296445434913e-05
only O 0 1.0801033567986451e-05
once O 0 9.013433009386063e-05
in O 0 1.4680260392196942e-05
the O 0 4.169964449829422e-05
Cape O 0 0.00033746843109838665
, O 0 1.5153908634601976e-06
but O 0 1.9054718336519727e-07
its O 0 1.075567979569314e-06
associated O 0 4.1659218368295114e-06
haplotype O 0 6.869026401545852e-05
could O 0 2.795346335915383e-05
be O 0 1.5091090972418897e-05
deduced O 0 0.000240600886172615
. O 0 7.418269524350762e-05

The O 0 0.00013755859981756657
data O 0 2.5093024305533618e-05
from O 0 1.9989945940324105e-05
the O 0 3.523584746289998e-05
haplotypes O 0 0.00015761260874569416
indicate O 0 1.8564489437267184e-05
that O 0 7.565641908513498e-07
these O 0 9.006803338706959e-07
three O 0 1.2571528714033775e-05
molecular O 0 0.0002520980197004974
defects O 0 0.016993990167975426
account O 0 7.981672388268635e-05
for O 0 6.372525240294635e-05
the O 0 0.0008432382601313293
defects O 1 0.7834994792938232
in O 0 6.995724106673151e-05
all O 0 1.1982648175035138e-05
the O 0 5.166580740478821e-05
38 O 0 0.00016058256733231246
unrelated O 0 0.00041496517951600254
C6Q0 O 1 0.8969265818595886
individuals O 0 7.118650955817429e-06
we O 0 6.574469352926826e-06
have O 0 2.1384939827839844e-06
studied O 0 5.2948951633879915e-05
from O 0 3.53016730514355e-05
the O 0 0.00017868331633508205
Cape O 0 0.0032616974785923958
. O 0 0.00011250616080360487

We O 0 2.9901670131948777e-05
have O 0 1.5715236258984078e-06
also O 0 1.3996749430589261e-06
observed O 0 7.431230642396258e-06
the O 0 3.912043393938802e-05
879delG O 0 0.0014237650902941823
defect O 0 0.0008055261569097638
in O 0 7.545507105533034e-05
two O 0 0.00010388797818450257
Dutch O 1 0.9996976852416992
C6 B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
deficient I-Disease 1 0.9999994039535522
kindreds O 0 0.0034957409370690584
, O 0 1.3722045878239442e-05
but O 0 3.114818582616863e-06
the O 0 4.877752508036792e-05
879delG O 0 0.003599723568186164
defect O 0 0.0031947556417435408
in O 0 0.0001279958669329062
the O 0 0.0002404165279585868
Cape O 0 0.0010972844902426004
probably O 0 3.513106639729813e-05
did O 0 4.979977347829845e-06
not O 0 6.194332513587142e-07
come O 0 2.055754066532245e-06
from O 0 5.152597623236943e-06
The O 0 3.8839552871650085e-05
Netherlands O 0 0.0002692813577596098
. O 0 3.246902269893326e-05
. O 0 6.401628343155608e-05

Complement B-Disease 1 0.9999996423721313
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.000468495738459751
seven O 0 0.00012721348321065307
further O 0 0.00015399113181047142
molecular O 0 0.0015344131970778108
defects O 1 0.9349400997161865
and O 0 5.2791187044931576e-05
their O 0 3.9793227188056335e-05
associated O 0 0.0002862625988200307
marker O 0 0.003083951538428664
haplotypes O 0 0.0037200788501650095
. O 0 0.000428843020927161

Seven O 0 5.6465072702849284e-05
further O 0 1.2157586752437055e-05
molecular O 0 4.435384107637219e-05
bases O 0 0.00021107133943587542
of O 1 0.9999579191207886
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.00048153725219890475
described O 0 0.0014109695330262184
. O 0 0.0002929516485892236

All O 0 6.8847798502247315e-06
these O 0 1.8844701799025643e-06
new O 0 1.0223246135865338e-05
molecular O 0 0.00030850566690787673
defects O 0 0.02984820120036602
involve O 0 0.0002069018955808133
single O 0 9.598582983016968e-05
- O 0 0.0002752153668552637
nucleotide O 0 1.9045657609240152e-05
events O 0 2.5502711650915444e-05
, O 0 7.749415999569464e-06
deletions O 0 5.049078754382208e-05
and O 0 1.2183400940557476e-05
substitutions O 0 2.656099240994081e-05
, O 0 3.776030098379124e-06
some O 0 1.6002329630282475e-06
of O 0 4.1874423914123327e-05
which O 0 1.7994809240917675e-05
alter O 0 0.00010341256711399183
splice O 0 0.00017904624110087752
sites O 0 5.519870683201589e-05
, O 0 6.56993142911233e-06
and O 0 8.44041642267257e-06
others O 0 2.715863593039103e-05
codons O 0 0.0003780362894758582
. O 0 0.0002815274056047201

They O 0 1.2983729902771302e-05
are O 0 8.861840115059749e-07
distributed O 0 2.6268867259204853e-06
along O 0 3.517169534461573e-05
the O 0 0.0002222630864707753
C7 O 1 0.9957204461097717
gene O 0 4.248043478582986e-05
, O 0 3.5392845347814728e-06
but O 0 6.539561923091242e-07
predominantly O 0 1.6535287841179525e-06
towards O 0 2.3049551600706764e-05
the O 0 3.463706161710434e-05
3 O 0 0.00014688355440739542
end O 0 0.0011696889996528625
. O 0 0.0002463869168423116

All O 0 3.24438551615458e-05
were O 0 2.696384945011232e-05
found O 0 1.0282353287038859e-05
in O 0 1.9099970813840628e-05
compound O 0 0.00023564169532619417
heterozygous O 0 1.8015620298683643e-05
individuals O 0 9.628323823562823e-06
. O 0 0.0002279959007864818

The O 0 0.21634279191493988
C6 O 1 1.0
/ O 1 0.9997703433036804
C7 O 1 0.9999939203262329
marker O 0 0.0031551476567983627
haplotypes O 0 0.000675467133987695
associated O 0 8.303780487040058e-05
with O 0 5.678648085449822e-05
most O 0 0.0031664245761930943
C7 B-Disease 1 1.0
defects I-Disease 1 0.999998927116394
are O 0 6.304177804850042e-05
tabulated O 0 0.0009317264775745571
. O 0 3.51646522176452e-05
. O 0 8.434888150077313e-05

A O 0 0.002846143674105406
genome O 0 0.0004895518068224192
- O 0 0.00011261434701737016
wide O 0 1.1516574886627495e-05
search O 0 2.012405957430019e-06
for O 0 3.3156557037727907e-06
chromosomal O 0 0.0004808870144188404
loci O 0 0.0006711501628160477
linked O 0 0.3695276379585266
to O 0 0.0007280239369720221
mental O 1 1.0
health O 0 0.044649314135313034
wellness O 0 0.0018273968016728759
in O 0 5.077179230283946e-05
relatives O 0 4.908698974759318e-05
at O 0 8.644967601867393e-05
high O 0 0.00013519862841349095
risk O 0 4.4928849092684686e-05
for O 0 0.00013806477363687009
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.999832272529602
the O 0 0.04878118634223938
Old O 0 0.0074664014391601086
Order O 0 0.00019808218348771334
Amish O 0 0.0007135701598599553
. O 0 6.458345160353929e-05

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 1.0
BPAD B-Disease 1 1.0
; O 1 0.9999407529830933
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.0001458440674468875
is O 0 1.0287708391842898e-05
characterized O 0 1.349537524220068e-05
by O 0 2.1299861145962495e-06
episodes O 0 7.685488526476547e-05
of O 0 0.0008394333999603987
mania B-Disease 1 0.9999978542327881
and O 0 0.0003918783040717244
/ O 0 0.010306422598659992
or O 0 0.0006952466792427003
hypomania B-Disease 1 0.9999576807022095
interspersed O 0 0.002091030590236187
with O 0 2.5636827558628283e-05
periods O 0 0.0009100604220293462
of O 0 0.0060687605291605
depression B-Disease 1 1.0
. O 0 0.002718657022342086

Compelling O 0 0.0006235615583136678
evidence O 0 0.00015240938228089362
supports O 0 1.0628492418618407e-05
a O 0 3.779517328439397e-06
significant O 0 7.955567525641527e-06
genetic O 0 2.0944768039043993e-05
component O 0 6.624555680900812e-05
in O 0 2.3057949874782935e-05
the O 0 4.7724224714329466e-05
susceptibility O 0 0.00020017600036226213
to O 0 0.00016484680236317217
develop O 0 0.007173091173171997
BPAD B-Disease 1 1.0
. O 0 0.0011791156139224768

To O 0 5.824114487040788e-05
date O 0 0.00016883006901480258
, O 0 7.550609097961569e-06
however O 0 5.19258355780039e-06
, O 0 4.581428129313281e-06
linkage O 0 5.678344678017311e-05
studies O 0 4.120391622564057e-06
have O 0 1.8274514559379895e-06
attempted O 0 3.927024590666406e-05
only O 0 1.921579496411141e-06
to O 0 4.406135758472374e-06
identify O 0 3.365733937243931e-05
chromosomal O 0 0.0006111503462307155
loci O 0 0.00043010353692807257
that O 0 2.824430885084439e-05
cause O 0 0.0001613495114725083
or O 0 2.3438702555722557e-05
increase O 0 1.6768066416261718e-05
the O 0 6.89335138304159e-05
risk O 0 8.97614736459218e-05
of O 0 0.00038040278013795614
developing O 0 0.0033067348413169384
BPAD B-Disease 1 1.0
. O 0 0.0010655670193955302

To O 0 6.360639235936105e-05
determine O 0 2.5651355826994404e-05
whether O 0 6.124880201241467e-06
there O 0 4.597341558110202e-06
could O 0 4.711411747848615e-06
be O 0 3.8003070130798733e-06
protective O 0 2.7846610464621335e-05
alleles O 0 3.469174316705903e-06
that O 0 4.235319920553593e-06
prevent O 0 0.00011203382018720731
or O 0 1.7228054275619797e-05
reduce O 0 4.170696411165409e-05
the O 0 5.788588896393776e-05
risk O 0 5.177589991944842e-05
of O 0 0.0003215772449038923
developing O 0 0.0019304315792396665
BPAD B-Disease 1 1.0
, O 0 1.9806224372587167e-05
similar O 0 1.1454471859906334e-06
to O 0 4.677825018006843e-06
what O 0 1.3754229257756379e-06
is O 0 4.3512392267075484e-07
observed O 0 8.613322961537051e-07
in O 0 1.9176507066731574e-06
other O 0 8.687788067618385e-06
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 0.0006731712492182851
we O 0 5.890538523090072e-05
used O 0 0.00014666884089820087
mental O 1 0.9999995231628418
health O 0 0.3573162257671356
wellness O 0 0.013156840577721596
( O 0 6.271689926506951e-05
absence O 0 0.00023059750674292445
of O 0 0.0002843034453690052
any O 0 0.0002246548538096249
psychiatric B-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
) O 0 0.0007970834267325699
as O 0 0.0001760028098942712
the O 0 8.762624929659069e-05
phenotype O 0 1.8549711967352778e-05
in O 0 2.1750829546363093e-05
our O 0 4.0224098484031856e-05
genome O 0 0.00017564337758813053
- O 0 0.0002462462580297142
wide O 0 0.00011879306111950427
linkage O 0 0.00040438934229314327
scan O 0 6.935649435035884e-05
of O 0 0.00011003898544004187
several O 0 5.685063297278248e-05
large O 0 0.00025162569363601506
multigeneration O 0 0.0059997327625751495
Old O 0 0.0007846853695809841
Order O 0 5.243696068646386e-05
Amish O 0 0.00024253882293123752
pedigrees O 0 0.00015079988224897534
exhibiting O 0 0.00025248745805583894
an O 0 2.9056436687824316e-05
extremely O 0 0.00024321451201103628
high O 0 0.0010647457093000412
incidence O 0 0.00653234776109457
of O 0 0.12547169625759125
BPAD B-Disease 1 1.0
. O 0 0.002008135663345456

We O 0 7.19714371371083e-05
have O 0 2.7180406050320016e-06
found O 0 2.8191027467983076e-06
strong O 0 1.9134345166094135e-06
evidence O 0 8.305901246785652e-06
for O 0 2.746583504631417e-06
a O 0 1.1757834727177396e-05
locus O 0 3.746120273717679e-05
on O 0 7.749782525934279e-05
chromosome O 0 0.00032933629699982703
4p O 0 0.02820599265396595
at O 0 0.0011316518066450953
D4S2949 O 0 0.0013428726233541965
( O 0 2.9243525204947218e-05
maximum O 0 0.00012724380940198898
GENEHUNTER O 1 0.7138407230377197
- O 0 0.0006561307818628848
PLUS O 0 0.0002566785260569304
nonparametric O 0 9.747929289005697e-05
linkage O 0 0.00010324930190108716
score O 0 1.8440305211697705e-05
= O 0 2.8264626962481998e-05
4 O 0 2.4395438231294975e-05
. O 0 5.059399427409517e-06
05 O 0 0.0004785606579389423
, O 0 1.8465751054463908e-05
P O 0 0.00039055346860550344
= O 0 4.2674149881349877e-05
5 O 0 2.035366924246773e-05
. O 0 2.8149388526799157e-06
22 O 0 2.444534948153887e-05
x O 0 2.942255378002301e-05
10 O 0 3.079703310504556e-05
( O 0 1.0287247278029099e-05
- O 0 6.989016401348636e-05
4 O 0 3.7022942706244066e-05
) O 0 3.991877292719437e-06
; O 0 3.0865317057759967e-06
SIBPAL O 0 0.010301749221980572
Pempirical O 0 0.0013397472212091088
value O 0 4.448846812010743e-05
< O 0 0.00011711617116816342
3 O 0 3.324049248476513e-05
x O 0 2.5514558728900738e-05
10 O 0 2.563030102464836e-05
( O 0 8.832985258777626e-06
- O 0 6.0574355302378535e-05
5 O 0 3.070658567594364e-05
) O 0 4.592057393892901e-06
) O 0 2.769939555946621e-06
and O 0 4.91309629069292e-06
suggestive O 0 0.00010614113125484437
evidence O 0 1.90267019206658e-05
for O 0 6.6838888415077236e-06
a O 0 2.305698217242025e-05
locus O 0 0.00012948000221513212
on O 0 0.00033667407114990056
chromosome O 0 0.0006466696504503489
4q O 0 0.0023730064276605844
at O 0 0.0006454535759985447
D4S397 O 0 0.001144115230999887
( O 0 3.224653482902795e-05
maximum O 0 0.00015003999578766525
GENEHUNTER O 1 0.7716490626335144
- O 0 0.000450250314315781
PLUS O 0 0.0002693905553314835
nonparametric O 0 8.794954919721931e-05
linkage O 0 8.451925532426685e-05
score O 0 1.879921182990074e-05
= O 0 2.0655899788835086e-05
3 O 0 1.5546462236670777e-05
. O 0 3.894760084222071e-06
29 O 0 7.070518040563911e-05
, O 0 1.0015412044594996e-05
P O 0 0.0003080785972997546
= O 0 3.123609349131584e-05
2 O 0 2.8289006877457723e-05
. O 0 1.9270814846095163e-06
57 O 0 1.2552026419143658e-05
x O 0 1.5983652701834217e-05
10 O 0 2.4286013285745867e-05
( O 0 9.774231330084149e-06
- O 0 6.292868056334555e-05
3 O 0 3.349333564983681e-05
) O 0 5.512903499038657e-06
; O 0 5.547627097257646e-06
SIBPAL O 0 0.009823295287787914
Pempirical O 0 0.0017951371846720576
value O 0 3.355017543071881e-05
< O 0 9.255977056454867e-05
1 O 0 4.528147110249847e-05
x O 0 2.2099267880548723e-05
10 O 0 2.6748510208562948e-05
( O 0 9.10556991584599e-06
- O 0 4.856179657508619e-05
3 O 0 2.244827919639647e-05
) O 0 1.5732196061435388e-06
) O 0 4.303401226479764e-07
that O 0 1.3542134524868743e-07
are O 0 4.021553081656748e-07
linked O 0 5.9539146604947746e-05
to O 0 6.138005119282752e-05
mental O 1 0.9999995231628418
health O 1 0.8539515733718872
wellness O 0 0.3143579065799713
. O 0 0.0005147326155565679

These O 0 4.0772032662061974e-05
findings O 0 3.0204892027541064e-05
are O 0 2.092201611958444e-06
consistent O 0 1.118215368478559e-05
with O 0 1.586714120094257e-06
the O 0 2.392245914961677e-05
hypothesis O 0 6.301790108409477e-06
that O 0 2.826474201356177e-07
certain O 0 1.4933559668861562e-06
alleles O 0 7.593307600473054e-06
could O 0 2.107363980030641e-05
prevent O 0 5.388010686147027e-05
or O 0 7.25728159522987e-06
modify O 0 1.4325722986541223e-05
the O 0 2.281043452967424e-05
clinical O 0 0.00013118544302415103
manifestations O 0 0.022478343918919563
of O 1 0.9954907298088074
BPAD B-Disease 1 1.0
and O 0 9.798553219297901e-05
perhaps O 0 4.3090865801787004e-05
other O 0 5.0537764764158055e-06
related O 0 0.0029443521052598953
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.9999359846115112

Segregation O 1 0.9999896287918091
distortion O 1 0.9999986886978149
in O 1 0.9999886751174927
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.8116934299468994

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999754428863525
DM B-Disease 1 1.0
) O 0 0.00010957229824271053
is O 0 7.183137313404586e-06
an O 0 7.605801783938659e-06
autosomal B-Disease 0 0.13311074674129486
dominant I-Disease 1 0.999988317489624
disease I-Disease 1 1.0
which O 0 0.0001074452229659073
, O 0 1.694091952231247e-05
in O 0 1.5637508113286458e-05
the O 0 8.422647078987211e-05
typical O 0 0.0001294222311116755
pedigree O 0 0.0001595815410837531
, O 0 2.7134847186971456e-06
shows O 0 5.52782285012654e-06
a O 0 8.156321200658567e-06
three O 0 1.178237289423123e-05
generation O 0 0.000305164692690596
anticipation O 0 0.000733097258489579
cascade O 0 0.006371459923684597
. O 0 0.00016759216669015586

This O 0 4.684663963416824e-06
results O 0 6.831672635598807e-06
in O 0 0.00012136851000832394
infertility B-Disease 1 1.0
and O 1 0.9999990463256836
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 2.6081943360622972e-05
with O 0 1.9209821857657516e-06
the O 0 5.854060873389244e-05
disappearance O 0 0.0005840266821905971
of O 0 0.0012575039872899652
DM B-Disease 1 1.0
in O 0 0.0002914915094152093
that O 0 3.513954288791865e-05
pedigree O 0 0.000556065293494612
. O 0 0.00012643972877413034

The O 0 0.00017654168186709285
concept O 0 0.00011010499292751774
of O 0 0.0006494628614746034
segregation O 1 0.9805230498313904
distortion O 0 0.03671405091881752
, O 0 4.46463527623564e-05
where O 0 1.7864258552435786e-05
there O 0 3.885196292685578e-06
is O 0 1.546629846416181e-06
preferential O 0 1.279422031075228e-05
transmission O 0 5.6448057875968516e-05
of O 0 3.3113592508016154e-05
the O 0 3.266368366894312e-05
larger O 0 1.3066481187706813e-05
allele O 0 1.4413811868507764e-06
at O 0 5.5742912081768736e-05
the O 0 0.00015161406190600246
DM B-Disease 1 0.9999960660934448
locus O 0 0.00025162112433463335
, O 0 9.3855651357444e-06
has O 0 2.0865265923930565e-06
been O 0 4.044486558996141e-06
put O 0 5.021568995289272e-06
forward O 0 9.455145118408836e-06
to O 0 6.551824299094733e-06
explain O 0 4.936922778142616e-05
partially O 0 0.00016698696708772331
the O 0 3.834558083326556e-05
maintenance O 0 0.0003944569907616824
of O 0 0.0011965243611484766
DM B-Disease 1 1.0
in O 0 0.00027822161791846156
the O 0 0.0001431884302292019
population O 0 2.563320958870463e-05
. O 0 5.577014235313982e-05

In O 0 0.000143943281727843
a O 0 4.067634290549904e-05
survey O 0 3.2649793865857646e-05
of O 0 0.00038408004911616445
DM B-Disease 1 0.9999997615814209
in O 0 0.0003685659321490675
Northern O 0 0.0001898435439215973
Ireland O 0 8.876936772139743e-05
, O 0 1.0460123121447396e-05
59 O 0 8.262391202151775e-05
pedigrees O 0 0.0003295926144346595
were O 0 0.00015236101171467453
ascertained O 0 0.001664424198679626
. O 0 0.00023918166698422283

Sibships O 0 0.01935998536646366
where O 0 0.0001127477953559719
the O 0 2.0061697796336375e-05
status O 0 1.6639418390695937e-05
of O 0 2.7880781999556348e-05
all O 0 4.22566927227308e-06
the O 0 1.3910725101595744e-05
members O 0 2.8230360840098e-06
had O 0 1.2592719031090382e-05
been O 0 4.962961156707024e-06
identified O 0 3.7931304177618586e-06
were O 0 3.141841943943291e-06
examined O 0 9.215451427735388e-06
to O 0 2.6119632821064442e-06
determine O 0 1.0560354894550983e-05
the O 0 2.907123780460097e-05
transmission O 0 9.079562732949853e-05
of O 0 0.00011124096636194736
the O 0 0.0006287090945988894
DM B-Disease 1 0.9999998807907104
expansion O 0 0.00125571817625314
from O 0 6.493775435956195e-05
affected O 0 1.9920753402402624e-05
parents O 0 1.4660007536804187e-06
to O 0 4.030993750347989e-06
their O 0 1.8071887097903527e-05
offspring O 0 0.00017667505017016083
. O 0 6.806285819038749e-05

Where O 0 0.00026840579812414944
the O 0 0.00017891959578264505
transmitting O 0 0.003177451901137829
parent O 0 3.897379065165296e-05
was O 0 0.000369116518413648
male O 0 0.00011406710837036371
, O 0 1.7212161765201017e-05
58 O 0 0.00024244819360319525
. O 0 0.0001652194478083402

3 O 0 0.00031993412994779646
% O 0 3.0211404009605758e-05
of O 0 0.00025815825210884213
the O 0 0.00048196961870417
offspring O 0 0.00015147621161304414
were O 0 3.2041767553891987e-05
affected O 0 1.8244532839162275e-05
, O 0 5.00546548209968e-06
and O 0 3.6897690733894706e-06
in O 0 1.2780975339410361e-05
the O 0 2.938343823188916e-05
case O 0 1.7905791537486948e-05
of O 0 5.0384103815304115e-05
a O 0 6.369938637362793e-05
female O 0 0.00017883126565720886
transmitting O 0 0.0024342788383364677
parent O 0 3.533639755914919e-05
, O 0 2.1917301637586206e-05
68 O 0 0.00021876538812648505
. O 0 0.0001942865055752918

7 O 0 0.000645000021904707
% O 0 6.193018634803593e-05
were O 0 0.00021062804444227368
affected O 0 0.0002847830764949322
. O 0 0.00025890686083585024

Studies O 0 0.00016857171431183815
on O 0 0.00034937509917654097
meiotic O 0 0.006690791342407465
drive O 0 0.0007944960379973054
in O 0 0.00021420264965854585
DM B-Disease 1 0.9999992847442627
have O 0 5.6727103583398275e-06
shown O 0 1.5076218005560804e-05
increased O 0 1.5376030205516145e-05
transmission O 0 4.081716178916395e-05
of O 0 1.5587598682031967e-05
the O 0 1.9244669601903297e-05
larger O 0 3.828426088148262e-06
allele O 0 7.661316203666502e-07
at O 0 2.7014189981855452e-05
the O 0 4.551321399048902e-05
DM B-Disease 1 0.9996953010559082
locus O 0 0.00011777457984862849
in O 0 5.4838936193846166e-05
non O 0 0.0005459782551042736
- O 0 0.002955108415335417
DM O 1 0.9999991655349731
heterozygotes O 0 0.0027980515733361244
for O 0 0.0001785432978067547
CTGn O 0 0.06999135762453079
. O 0 0.0003184516099281609

This O 0 1.6333002349711023e-05
study O 0 3.83896667699446e-06
provides O 0 1.3796319535686052e-06
further O 0 3.086732021984062e-06
evidence O 0 1.7073462004191242e-05
that O 0 4.7346447900054045e-06
the O 0 0.0001744054170558229
DM B-Disease 1 0.9999994039535522
expansion O 0 0.001120717846788466
tends O 0 7.508786075050011e-05
to O 0 1.1433024155849125e-05
be O 0 1.2948562471137848e-05
transmitted O 0 4.9751575716072693e-05
preferentially O 0 2.9334580176509917e-05
. O 0 4.2041596316266805e-05

Diagnosis O 1 0.9995372295379639
of O 1 0.9999815225601196
hemochromatosis B-Disease 1 1.0
. O 1 0.9966679215431213

If O 0 0.001352227758616209
untreated O 1 1.0
, O 0 0.006336440797895193
hemochromatosis B-Disease 1 1.0
can O 0 0.07535707950592041
cause O 1 0.999995231628418
serious O 1 0.9999995231628418
illness O 1 1.0
and O 0 0.0001471181894885376
early B-Disease 0 0.0013539295177906752
death I-Disease 0 0.0011455133790150285
, O 0 8.586147487221751e-06
but O 0 1.5769703622936504e-06
the O 0 4.967164568370208e-05
disease O 0 0.03593149408698082
is O 0 1.162827084044693e-05
still O 0 2.420555210846942e-05
substantially O 0 0.00012029409117531031
under O 0 0.00038884469540789723
- O 0 0.006723836529999971
diagnosed O 1 0.9996427297592163
. O 0 0.0006056434940546751

The O 0 0.000589456525631249
cornerstone O 0 0.02642996609210968
of O 0 0.00025337396073155105
screening O 0 7.49891041778028e-05
and O 0 1.2891516234958544e-05
case O 0 1.964952753041871e-05
detection O 0 4.266040195943788e-05
is O 0 3.1731581202620873e-06
the O 0 6.132139333203668e-06
measurement O 0 2.3079155653249472e-05
of O 0 0.00012279853399377316
serum O 0 0.0011176036205142736
transferrin O 0 0.0019694294314831495
saturation O 0 0.00019381764286663383
and O 0 1.1535535122675356e-05
the O 0 7.929221465019509e-05
serum O 0 0.001179913175292313
ferritin O 0 0.003104661824181676
level O 0 0.001005144789814949
. O 0 0.00014971445489209145

Once O 0 0.0012839180417358875
the O 0 0.00014296580047812313
diagnosis O 0 0.0008527067839168012
is O 0 4.5217522711027414e-05
suspected O 0 0.00030642386991530657
, O 0 1.791764771041926e-05
physicians O 0 1.6108733689179644e-05
must O 0 1.1368778359610587e-05
use O 0 2.6028274078271352e-05
serum O 0 0.001437102910131216
ferritin O 0 0.010072184726595879
levels O 0 0.0012761177495121956
and O 0 0.00025929222465492785
hepatic O 1 0.9999970197677612
iron O 1 1.0
stores O 0 0.0007440799963660538
on O 0 0.001766449655406177
liver O 1 0.9832647442817688
biopsy O 0 0.0011078170500695705
specimens O 0 8.671139949001372e-05
to O 0 1.6988322386168875e-05
assess O 0 5.307604078552686e-05
patients O 0 9.384330041939393e-06
for O 0 6.438927357521607e-06
the O 0 8.759600314078853e-05
presence O 0 0.00013079549535177648
of O 0 0.0055982861667871475
iron B-Disease 1 1.0
overload I-Disease 1 0.9999991655349731
. O 0 0.0012925459304824471

Liver O 1 0.999994158744812
biopsy O 0 0.02135796844959259
is O 0 8.029447053559124e-05
also O 0 7.813905540388077e-06
used O 0 5.625876838166732e-06
to O 0 5.909145784244174e-06
establish O 0 2.9196598916314542e-05
the O 0 1.9998336938442662e-05
presence O 0 1.8008850020123646e-05
or O 0 9.916039743984584e-06
absence O 0 0.00023939450329635292
of O 0 0.0010817090515047312
cirrhosis B-Disease 1 1.0
, O 0 0.0001512582675786689
which O 0 1.5901825463515706e-05
can O 0 5.91157504459261e-06
affect O 0 4.052788790431805e-05
prognosis O 0 0.006971446331590414
and O 0 7.347297650994733e-05
management O 0 0.000995496055111289
. O 0 0.00042503891745582223

A O 0 0.0011632040841504931
DNA O 0 0.00034413591492921114
- O 0 5.9238416724838316e-05
based O 0 6.949015869395225e-07
test O 0 8.692691721989831e-07
for O 0 2.8213671612320468e-06
the O 0 9.130738180829212e-05
HFE O 0 0.023849358782172203
gene O 0 1.557749419589527e-05
is O 0 4.099129455426009e-06
commercially O 0 8.977338438853621e-06
available O 0 4.2137955347243405e-07
, O 0 2.9299897619239346e-07
but O 0 7.756847253403976e-08
its O 0 4.1400329564567073e-07
place O 0 4.637749498215271e-06
in O 0 3.904745881300187e-06
the O 0 3.303893026895821e-05
diagnosis O 0 0.0009670601575635374
of O 0 0.005718681961297989
hemochromatosis B-Disease 1 1.0
is O 0 0.0007348420331254601
still O 0 9.321924153482541e-05
being O 0 2.3645114197279327e-05
evaluated O 0 6.795961235184222e-05
. O 0 5.478169987327419e-05

Currently O 0 0.0001900349889183417
, O 0 9.882091035251506e-06
the O 0 9.164567018160596e-06
most O 0 2.1881755856156815e-06
useful O 0 3.504656206132495e-06
role O 0 6.435243903979426e-06
for O 0 1.8871463680625311e-06
this O 0 6.45306329261075e-07
test O 0 1.1001444590874598e-06
is O 0 9.80416757556668e-07
in O 0 1.9176727619196754e-06
the O 0 9.982913979911245e-06
detection O 0 0.00017852695600595325
of O 0 0.0007444013026542962
hemochromatosis B-Disease 1 1.0
in O 0 0.0003738605009857565
the O 0 0.00012243444507475942
family O 0 1.2501469427661505e-05
members O 0 2.9425589218590176e-06
of O 0 5.002030957257375e-05
patients O 0 2.937657518486958e-05
with O 0 7.494380042771809e-06
a O 0 7.429093966493383e-05
proven O 0 0.0008478447562083602
case O 0 2.9307235308806412e-05
of O 0 0.00012282618263270706
the O 0 0.0008266482036560774
disease O 1 0.9999978542327881
. O 0 0.0006954070413485169

It O 0 8.126530701701995e-06
is O 0 2.7798789687949466e-06
crucial O 0 5.166433038539253e-05
to O 0 0.00011713091225828975
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999995231628418
because O 0 0.020829420536756516
phlebotomy O 1 0.999996542930603
therapy O 0 0.04093528538942337
can O 0 2.2932426873012446e-05
avert O 1 0.9993731379508972
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 0.0004401612386573106
can O 0 2.818387838487979e-05
even O 0 1.73678454302717e-05
lead O 0 3.825846943072975e-05
to O 0 1.8188489775639027e-05
normal O 0 8.755157614359632e-05
life O 0 0.00010700687562348321
expectancy O 0 0.000362613529432565
. O 0 2.4834014766383916e-05
. O 0 5.6618857342982665e-05

Prevalence O 0 0.002973813097923994
of O 0 0.000588000169955194
the O 0 0.0009172327117994428
I1307K O 0 0.00627764081582427
APC B-Disease 0 0.0012651411816477776
gene O 0 1.2489265827753115e-05
variant O 0 1.4322704373626038e-05
in O 0 5.098229848954361e-06
Israeli O 0 9.008520464703906e-06
Jews O 0 3.859295611619018e-05
of O 0 2.3489319573855028e-05
differing O 0 3.978109361923998e-06
ethnic O 0 1.0412708434159867e-05
origin O 0 6.055342055333313e-06
and O 0 7.92414357420057e-06
risk O 0 0.00011276952864136547
for O 0 0.0036488566547632217
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9984806180000305

BACKGROUND O 0 0.011347486637532711
& O 0 0.006181012839078903
AIMS O 0 0.0026958927046507597
Israeli O 0 0.00011416505003580824
Jews O 0 0.0004484632518142462
of O 0 0.00030559825245290995
European O 0 0.00012032036465825513
birth O 0 0.0008047021692618728
, O 0 2.885370486183092e-05
i O 0 5.6162516557378694e-05
. O 0 6.385085271176649e-06
e O 0 1.4396158803720027e-05
. O 0 3.719665755852475e-06
, O 0 4.689009074354544e-06
Ashkenazim O 0 0.0002914406359195709
, O 0 2.0805559870495927e-06
have O 0 5.997504217702954e-07
the O 0 3.515764183248393e-05
highest O 1 0.9999405145645142
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9985161423683167
of O 0 0.0014311695704236627
any O 0 4.036581231048331e-05
Israeli O 0 7.396428554784507e-05
ethnic O 0 9.678609785623848e-05
group O 0 6.727945583406836e-05
. O 0 0.0001376480795443058

The O 0 0.0010550598381087184
I1307K O 0 0.006378509569913149
APC B-Disease 0 0.002261465648189187
gene O 0 2.718141331570223e-05
variant O 0 7.328677747864276e-05
was O 0 0.00029418477788567543
found O 0 2.008229603234213e-05
in O 0 6.005405884934589e-05
6 O 0 0.000662344740703702
. O 0 0.0001644905423745513

1 O 0 0.00034705534926615655
% O 0 1.878940747701563e-05
of O 0 9.244156535714865e-05
American O 0 7.087569974828511e-05
Jews O 0 0.0003255198826082051
, O 0 1.0794135050673503e-05
28 O 0 4.353804251877591e-05
% O 0 4.35196716352948e-06
of O 0 5.1825882110279053e-05
their O 0 0.0002411350724287331
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999027252197266
, O 0 0.00010553016181802377
but O 0 4.604054538503988e-06
not O 0 1.7832078356150305e-06
in O 0 1.2699412764050066e-05
non O 0 0.00018065165204461664
- O 0 0.0003123920760117471
Jews O 0 0.0005956653039902449
. O 0 0.00017331395065411925

We O 0 0.00010384311462985352
assessed O 0 0.00013919963384978473
the O 0 0.00011212316167075187
I1307K O 0 0.0014609595527872443
prevalence O 0 0.0003020217118319124
in O 0 1.2516452443378512e-05
Israeli O 0 2.154080902982969e-05
Jews O 0 8.82865788298659e-05
of O 0 2.7285506803309545e-05
differing O 0 3.195332510586013e-06
ethnic O 0 8.750533197598998e-06
origin O 0 6.454789854615228e-06
and O 0 7.578071745228954e-06
risk O 0 0.0001791671384125948
for O 0 0.017765922471880913
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9975288510322571

METHODS O 0 0.0006266696727834642
DNA O 0 0.00016731528739910573
samples O 0 1.9583472749218345e-05
from O 0 2.9748080123681575e-05
500 O 0 7.185321010183543e-05
unrelated O 0 7.253752846736461e-05
Jews O 0 0.00028252118499949574
of O 0 0.00030576431890949607
European O 0 0.0001615168439457193
or O 0 8.163320308085531e-05
non O 0 0.0003019687137566507
- O 0 0.0001266131002921611
European O 0 8.674061064084526e-06
origin O 0 4.008865744253853e-06
, O 0 2.258060021631536e-06
with O 0 1.0956694040942239e-06
or O 0 8.235514542320743e-06
without O 0 1.0243770702800248e-05
a O 0 3.174207449774258e-05
personal O 0 0.00012664738460443914
and O 0 8.519346738466993e-05
/ O 0 0.0007103788666427135
or O 0 4.878440813627094e-05
family O 0 6.15597891737707e-05
history O 0 0.0005166912451386452
of O 0 0.0015463707968592644
neoplasia B-Disease 1 0.9982642531394958
, O 0 7.833324343664572e-05
were O 0 2.7106785637442954e-05
examined O 0 6.841126014478505e-05
for O 0 9.102921467274427e-06
the O 0 0.00010952131560770795
I1307K O 0 0.0008225681376643479
variant O 0 3.356019078637473e-05
by O 0 3.7745610370620852e-06
the O 0 2.256041443615686e-05
allele O 0 9.49813511397224e-06
- O 0 4.430653643794358e-05
specific O 0 3.6367171105666785e-06
oligonucleotide O 0 0.0004326384805608541
( O 0 0.000233323298743926
ASO O 1 0.8732147216796875
) O 0 3.4049517125822604e-05
method O 0 2.9110577088431455e-05
. O 0 6.125094660092145e-05

RESULTS O 0 0.0003205075045116246
In O 0 4.0238672227133065e-05
persons O 0 1.1206686394871213e-05
at O 0 6.423459126381204e-05
average O 0 1.3409152415988501e-05
risk O 0 5.9492038417374715e-05
for O 0 0.00041954347398132086
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0015240140492096543
I1307K O 0 0.0032111823093146086
was O 0 0.0003479010774753988
found O 0 9.688128557172604e-06
in O 0 3.6538556742016226e-05
5 O 0 0.00018878142873290926
. O 0 0.00011062298290198669

0 O 0 6.662249506916851e-05
% O 0 1.3741714610659983e-05
of O 0 0.00010800464224303141
120 O 0 0.00014632687089033425
European O 0 4.381527105579153e-05
and O 0 3.521956023178063e-05
1 O 0 0.00048572890227660537
. O 0 0.00014798753545619547

6 O 0 0.000617656740359962
% O 0 3.534765346557833e-05
of O 0 0.0002723830402828753
188 O 0 0.0003788104804698378
non O 0 0.00035768290399573743
- O 0 0.00014991928765084594
European O 0 7.823568012099713e-06
Jews O 0 0.0001385012292303145
( O 0 2.3355900339083746e-05
P O 0 0.0006339493556879461
= O 0 3.993857171735726e-05
0 O 0 1.049858929036418e-05
. O 0 1.2099730156478472e-05
08 O 0 0.00047169046592898667
) O 0 2.7296931875753216e-05
. O 0 5.686668009730056e-05

It O 0 3.971304977312684e-05
occurred O 0 0.0003864693862851709
in O 0 6.029104406479746e-05
15 O 0 0.0002669933601282537
. O 0 0.00012078155123163015

4 O 0 0.00029163018916733563
% O 0 1.8980745153385215e-05
of O 0 0.00010675910743884742
52 O 0 0.0001906536635942757
Ashkenazi O 0 0.0001374046696582809
Israelis O 0 8.312924182973802e-05
with O 0 4.282148074707948e-05
familial O 1 0.9987890124320984
cancer B-Disease 1 1.0
( O 0 0.0013767712516710162
P O 0 0.01685725338757038
= O 0 0.0001809140230761841
0 O 0 2.688799395400565e-05
. O 0 1.0382188520452473e-05
02 O 0 0.0007933491724543273
) O 0 5.371912720875116e-06
and O 0 3.582869794627186e-06
was O 0 0.0001087574491975829
not O 0 2.9637490115419496e-06
detected O 0 3.468756767688319e-05
in O 0 8.487460036121774e-06
51 O 0 6.13375668763183e-05
non O 0 8.884982526069507e-05
- O 0 3.2799965993035585e-05
European O 0 1.4614403198720538e-06
Jews O 0 5.549765410250984e-05
at O 0 0.00014054443454369903
increased O 0 0.000166753088706173
cancer B-Disease 1 0.9987102746963501
risk O 0 0.0008215145790018141
. O 0 0.00033785958657972515

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999998807907104
occurred O 1 0.9998359680175781
personally O 0 0.006645986344665289
or O 0 4.183499186183326e-05
in O 0 2.0246014173608273e-05
the O 0 2.18326040339889e-05
families O 0 1.6615177855783259e-06
of O 0 2.233186569355894e-05
13 O 0 0.00011410584556870162
of O 0 0.0001827751548262313
20 O 0 0.0003209110873285681
Ashkenazi O 0 0.00036863551940768957
I1307K O 0 0.0011722058989107609
carriers O 0 2.4069073333521374e-05
, O 0 4.569846623780904e-06
8 O 0 2.732957000262104e-05
of O 0 4.945036562276073e-05
whom O 0 9.100158786168322e-05
also O 0 1.3113619388605002e-05
had O 0 4.898607949144207e-05
a O 0 2.0087254597456194e-05
personal O 0 9.70006367424503e-05
or O 0 2.535318890295457e-05
family O 0 1.80071328941267e-05
history O 0 0.00033176850411109626
of O 0 0.0018566064536571503
noncolonic O 1 0.9999842643737793
neoplasia B-Disease 1 0.9999966621398926
. O 0 0.002832858357578516

CONCLUSIONS O 0 0.0012922418536618352
The O 0 0.0005692165577784181
I1307K O 0 0.0068247015587985516
APC O 0 0.0025374852120876312
variant O 0 7.35331850592047e-05
may O 0 2.4759805455687456e-05
represent O 0 9.437550943403039e-06
a O 0 2.3366750610875897e-05
susceptibility O 0 0.0002110167988575995
gene O 0 5.054088978795335e-05
for O 0 0.0001577419025124982
colorectal B-Disease 1 1.0
, I-Disease 0 0.00024844767176546156
or I-Disease 0 4.236493623466231e-05
other I-Disease 0 3.251171438023448e-05
, I-Disease 0 7.72784260334447e-05
cancers I-Disease 0 0.01160167995840311
in O 0 0.00019690790213644505
Ashkenazi O 0 0.0007087180856615305
Jews O 0 0.0016472152201458812
, O 0 5.770874849986285e-05
and O 0 2.7629384931060486e-05
partially O 0 0.0003711433382704854
explains O 0 1.8793243725667708e-05
the O 0 1.0814990673679858e-05
higher O 0 3.274726987001486e-05
incidence O 0 0.0017453101463615894
of O 1 0.9993715882301331
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0013593153562396765
European O 0 0.0001204000145662576
Israelis O 0 0.0003379729751031846
. O 0 0.0002126990439137444

Systematic O 0 6.337353261187673e-05
analysis O 0 8.872107173374388e-06
of O 0 0.0003388485638424754
coproporphyrinogen O 1 0.9823395609855652
oxidase O 0 0.0008721036720089614
gene O 0 0.0005234081181697547
defects O 1 0.5698968172073364
in O 0 0.0006510060047730803
hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.999994158744812
and O 0 0.00032627489417791367
mutation O 0 9.976654837373644e-05
update O 0 0.00046181996003724635
. O 0 0.00024289450084324926

Hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 1.0
( O 0 0.02100224792957306
HC B-Disease 1 1.0
) O 0 0.00026913921465165913
is O 0 2.631363895488903e-05
an O 0 4.293646998121403e-05
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999948740005493
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 1 0.9999946355819702
caused O 1 0.999998927116394
by O 0 0.00017842758097685874
deficient B-Disease 0 0.006970845628529787
activity I-Disease 0 2.462182419549208e-05
of I-Disease 0 0.00031709615723229945
coproporphyrinogen I-Disease 1 0.9945769309997559
III I-Disease 1 1.0
oxidase I-Disease 0 0.0007384295458905399
( O 0 0.00012644020898733288
CPO O 0 0.0075883036479353905
) O 0 4.738131246995181e-05
. O 0 5.9694120864151046e-05

Clinical O 0 0.001936280052177608
manifestations O 1 0.9337493181228638
of O 1 0.9965599179267883
the O 1 0.9999138116836548
disease O 1 1.0
are O 0 6.582537480426254e-06
characterized O 0 7.734425889793783e-05
by O 0 1.246388546860544e-05
acute O 1 0.9999821186065674
attacks O 0 0.0006902776658535004
of O 1 0.9999959468841553
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9873398542404175
precipitated O 1 0.9999933242797852
by O 0 0.00011321602505631745
drugs O 0 0.00022101921786088496
, O 0 3.2104777346830815e-05
fasting O 0 0.00024203128123190254
, O 0 4.053214070154354e-05
cyclical O 0 0.023073457181453705
hormonal O 0 0.006531766150146723
changes O 0 4.9087506340583786e-05
, O 0 8.454779890598729e-05
or O 0 0.015734335407614708
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.003875317517668009

Skin O 1 0.9999995231628418
photosensitivity O 1 0.9999992847442627
may O 0 0.0032320066820830107
also O 0 4.606018410413526e-05
be O 0 1.4975537851569243e-05
present O 0 6.968079833313823e-05
. O 0 9.562449849909171e-05

The O 0 0.00020826877153012902
seven O 0 8.482186967739835e-05
exons O 0 0.0003253362374380231
, O 0 1.1177526175742969e-05
the O 0 8.917177183320746e-05
exon O 0 0.0008389472495764494
/ O 0 0.00025541448849253356
intron O 0 0.0006830517668277025
boundaries O 0 5.537013748835307e-06
and O 0 2.667742592166178e-06
part O 0 1.4778588592889719e-05
of O 0 0.00010989312431775033
3 O 0 0.00016458828758914024
noncoding O 0 0.0003506959474179894
sequence O 0 1.545478153275326e-05
of O 0 5.896315997233614e-05
the O 0 0.0001261834113392979
CPO O 0 0.0023872433230280876
gene O 0 4.7551156967529096e-06
were O 0 3.445836227911059e-06
systematically O 0 1.69722279679263e-05
analyzed O 0 6.191678949107882e-06
by O 0 1.9247304408054333e-06
an O 0 5.438345397124067e-06
exon O 0 0.0003393875085748732
- O 0 8.534177322871983e-05
by O 0 7.744687536614947e-06
- O 0 0.00029690927476622164
exon O 0 0.00027871568454429507
denaturing O 0 0.0012963198823854327
gradient O 0 0.0012851872015744448
gel O 0 0.003589058294892311
electrophoresis O 0 0.001980147324502468
( O 0 0.00032639841083437204
DGGE O 1 0.9676304459571838
) O 0 1.54465433297446e-05
strategy O 0 1.1668862498481758e-05
followed O 0 4.0360173443332314e-06
by O 0 4.2097227037629636e-07
direct O 0 9.175481636702898e-07
sequencing O 0 6.833092811575625e-06
in O 0 6.2581557358498685e-06
seven O 0 3.432192897889763e-05
unrelated O 0 0.00011329982226016
heterozygous O 0 7.60603288654238e-05
HC B-Disease 1 0.9999963045120239
patients O 0 0.0003088164667133242
from O 0 0.00022564924438484013
France O 0 0.0003860557044390589
, O 0 5.489283284987323e-05
Holland O 0 0.0002825508126989007
, O 0 7.701306458329782e-06
and O 0 5.4702936722605955e-06
Czech O 0 0.000910947856027633
Republic O 0 0.0016071023419499397
. O 0 0.0002261424669995904

Seven O 0 0.0003123390779364854
novel O 0 0.00010905881208600476
mutations O 0 1.184137727250345e-05
and O 0 2.936607415904291e-06
two O 0 2.3300203793041874e-06
new O 0 8.621428605692927e-06
polymorphisms O 0 0.00011093587818322703
were O 0 0.0001105024857679382
detected O 0 0.0009340989054180682
. O 0 0.00016291820793412626

Among O 0 7.74357613408938e-05
these O 0 5.237154255155474e-06
mutations O 0 1.0468485015735496e-05
two O 0 7.567203738290118e-06
are O 0 4.6716013457626104e-06
missense O 0 0.0003185715468134731
( O 0 8.831681043375283e-05
G197W O 0 0.0030926985200494528
, O 0 6.0188216593815014e-05
W427R O 0 0.0010154418414458632
) O 0 1.1008141882484779e-05
, O 0 3.7842639812879497e-06
two O 0 2.991612291225465e-06
are O 0 1.8510922927816864e-06
nonsense O 0 0.0002167159109376371
( O 0 6.74734910717234e-05
Q306X O 0 0.0020715519785881042
, O 0 4.279290806152858e-05
Q385X O 0 0.0006449960637837648
) O 0 1.1323753824399319e-05
, O 0 3.080388751186547e-06
two O 0 1.3120021549184457e-06
are O 0 5.777850446975208e-07
small O 0 8.464357051707339e-06
deletions O 0 0.0001288189087063074
( O 0 9.097365546040237e-05
662de14bp O 0 0.0019023908535018563
; O 0 2.2210844690562226e-05
1168del3bp O 0 0.0017350040143355727
removing O 0 0.00020159303676337004
a O 0 3.746406582649797e-05
glycine O 0 6.805611337767914e-05
at O 0 0.00022508537222165614
position O 0 5.752622018917464e-05
390 O 0 0.00011113918299088255
) O 0 6.48021978122415e-06
, O 0 2.5617466690164292e-06
and O 0 1.0155836207559332e-06
one O 0 1.072057557394146e-06
is O 0 9.401065312886203e-07
a O 0 3.081281874983688e-06
splicing O 0 2.4052576918620616e-05
mutation O 0 1.0833096894202754e-05
( O 0 3.9575206756126136e-05
IVS1 O 0 0.30788299441337585
- O 0 0.000947007501963526
15c O 0 0.001266046310774982
- O 0 0.0001708734198473394
- O 0 9.918980504153296e-05
> O 0 6.56804331811145e-05
g O 0 4.4158947275718674e-05
) O 0 4.771606199938105e-06
which O 0 2.843672064045677e-06
creates O 0 1.7985097656492144e-05
a O 0 9.46032287174603e-06
new O 0 6.661844963673502e-06
acceptor O 0 4.943637122778455e-06
splice O 0 0.0005720087792724371
site O 0 0.0010898421751335263
. O 0 0.00022111766156740487

The O 0 0.00038664203020744026
pathological O 0 0.002549653174355626
significance O 0 0.0007066341349855065
of O 0 0.0006212444859556854
the O 0 0.00036966908373869956
point O 0 0.0007767095812596381
mutations O 0 0.00012021943985018879
G197W O 0 0.0010241594864055514
, O 0 3.6763194657396525e-05
W427R O 0 0.0006692975293844938
, O 0 1.1768604963435791e-05
and O 0 3.443588866502978e-06
the O 0 6.256230699364096e-05
in O 0 0.00013400371244642884
- O 0 0.0005679124733433127
frame O 0 0.00026884322869591415
deletion O 0 0.0001414238940924406
390delGly O 0 0.0011579787824302912
were O 0 2.173546454287134e-05
assessed O 0 3.500211823848076e-05
by O 0 2.1354796899686335e-06
their O 0 2.5701003778522136e-06
respective O 0 2.1930096409050748e-05
expression O 0 2.664120984263718e-05
in O 0 1.4404438843484968e-05
a O 0 1.0046750503533985e-05
prokaryotic O 0 2.0861147277173586e-05
system O 0 3.8920825318200514e-05
using O 0 6.277186457737116e-06
site O 0 0.00033256938331760466
- O 0 0.0001322409516433254
directed O 0 2.1302836103131995e-05
mutagenesis O 0 0.0006754999631084502
. O 0 0.00012730837624985725

These O 0 4.694647577707656e-05
mutations O 0 4.9546564696356654e-05
resulted O 0 0.00018695395556278527
in O 0 5.7952278439188376e-05
the O 0 7.608716987306252e-05
absence O 0 0.00010261483112117276
or O 0 6.487473001470789e-06
a O 0 1.0347423085477203e-05
dramatic O 0 0.00021708071290049702
decrease O 0 0.00042532733641564846
of O 0 0.002137682167813182
CPO O 1 0.9091764092445374
activity O 0 0.000557336607016623
. O 0 0.00019759700808208436

The O 0 0.0002500551054254174
two O 0 2.184649565606378e-05
polymorphisms O 0 0.00010220644617220387
were O 0 3.765087603824213e-05
localized O 0 0.00018333546177018434
in O 0 4.7889669076539576e-05
noncoding O 0 0.0005100609851069748
part O 0 4.242921932018362e-05
of O 0 5.116803367855027e-05
the O 0 2.992015470226761e-05
gene O 0 4.2360225052107126e-06
1 O 0 2.9772658308502287e-05
) O 0 2.895472334785154e-06
a O 0 2.2814634576207027e-05
C O 0 0.0008479781681671739
/ O 0 0.000223477283725515
G O 0 0.00039078842382878065
polymorphism O 0 1.773773692548275e-05
in O 0 2.434217640256975e-05
the O 0 5.8422043366590515e-05
promotor O 0 0.006082556676119566
region O 0 0.00041768886148929596
, O 0 2.8133606974733993e-05
142 O 0 0.00012008173507638276
bp O 0 0.0002335781609872356
upstream O 0 9.668121492723003e-05
from O 0 3.7897134461672977e-06
the O 0 6.320442935248138e-06
transcriptional O 0 2.7423373467172496e-05
initiation O 0 0.00011699171591317281
site O 0 0.00022454069403465837
( O 0 1.3639642020280007e-05
- O 0 0.00012017955305054784
142C O 0 0.0007354722474701703
/ O 0 0.00028671653126366436
G O 0 0.000582029577344656
) O 0 8.261811672127806e-06
, O 0 4.2275155465176795e-06
and O 0 4.948726200382225e-06
2 O 0 6.174368172651157e-05
) O 0 4.3398363231972326e-06
a O 0 1.3890202353650238e-05
6 O 0 0.00015320611419156194
bp O 0 8.090797200566158e-05
deletion O 0 2.644296364451293e-05
polymorphism O 0 6.236111858015647e-06
in O 0 9.944336852640845e-06
the O 0 1.600027462700382e-05
3 O 0 2.242335358459968e-05
noncoding O 0 0.00013335386756807566
part O 0 1.4420644220081158e-05
of O 0 8.411682938458398e-05
the O 0 0.0002308474067831412
CPO O 0 0.005426421295851469
gene O 0 2.2307152903522365e-05
, O 0 1.0094569915963802e-05
574 O 0 0.0005028608720749617
bp O 0 0.0002890872419811785
downstream O 0 9.111873077927157e-05
of O 0 2.5549403289915062e-05
the O 0 3.4209719160571694e-05
last O 0 2.141766162822023e-05
base O 0 1.565795173519291e-05
of O 0 2.6804125809576362e-05
the O 0 5.9978738136123866e-05
normal O 0 4.521786831901409e-05
termination O 0 0.00010602580005070195
codon O 0 7.514000026276335e-05
( O 0 1.7061871403711848e-05
+ O 0 0.0002475541259627789
574 O 0 0.0020462749525904655
delATTCTT O 0 0.006819748319685459
) O 0 9.685497207101434e-05
. O 0 0.00011637253919616342

Five O 0 0.0008495984948240221
intragenic O 0 0.016498679295182228
dimorphisms O 0 0.006871866062283516
are O 0 8.077088750724215e-06
now O 0 1.7661781384958886e-05
well O 0 8.356647413165774e-06
characterized O 0 3.0785991839366034e-05
and O 0 7.840539183234796e-06
the O 0 5.0278416892979294e-05
high O 0 0.00017152164946310222
degree O 0 9.52698101173155e-05
of O 0 0.00040828343480825424
allelic O 0 0.001906994846649468
heterogeneity O 0 0.0018714453326538205
in O 0 0.0006383610307238996
HC B-Disease 1 0.9999990463256836
is O 0 0.00011932860070373863
demonstrated O 0 0.00012578627502080053
with O 0 3.1505553579336265e-06
seven O 0 8.140188583638519e-06
new O 0 1.1451784303062595e-06
different O 0 1.9848475574235636e-07
mutations O 0 2.1167586510273395e-06
making O 0 3.1489450975641375e-06
a O 0 2.596123977127718e-06
total O 0 8.061167136474978e-06
of O 0 0.00013642759586218745
nineteen O 0 0.007114156614989042
CPO O 1 0.9911435842514038
gene B-Disease 0 0.0006885443581268191
defects I-Disease 0 0.06528796255588531
reported O 0 0.00017416248738300055
so O 0 2.1037554688518867e-05
far O 0 1.7324373402516358e-05
. O 0 1.5677882402087562e-05
. O 0 5.022613549954258e-05

Coincidence O 0 0.0004831510304939002
of O 0 0.00017983824363909662
two O 0 2.0969931938452646e-05
novel O 0 0.00019393558613955975
arylsulfatase O 0 0.0018703413661569357
A O 0 0.0002685217768885195
alleles O 0 8.424430234299507e-06
and O 0 1.217991484736558e-05
mutation O 0 1.7449961887905374e-05
459 O 0 0.0007597114890813828
+ O 0 0.0018058151472359896
1G O 0 0.012814697809517384
> O 0 0.00016635192150715739
A O 0 9.088157094083726e-05
within O 0 6.326141374302097e-06
a O 0 8.623452231404372e-06
family O 0 2.253564161946997e-05
with O 0 6.636264879489318e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 6.53590977890417e-05
molecular O 0 2.265849798277486e-05
basis O 0 1.093443097488489e-05
of O 0 0.00011108810576843098
phenotypic O 0 0.0012333672493696213
heterogeneity O 0 0.01021455880254507
. O 0 0.0013466571690514684

In O 0 0.0001530355802970007
a O 0 4.337534119258635e-05
family O 0 9.613028851163108e-06
with O 0 2.980343879244174e-06
three O 0 2.9394394005066715e-05
siblings O 0 0.00011652754619717598
, O 0 2.763999646049342e-06
one O 0 1.3971198313811328e-06
developed O 0 2.676091025932692e-05
classical O 0 0.0006682578823529184
late O 1 0.9811534881591797
infantile O 1 0.9999998807907104
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 0.23257437348365784
MLD B-Disease 1 1.0
) O 0 0.0002552139339968562
, O 0 4.552228710963391e-05
fatal O 0 0.002357941586524248
at O 0 0.001278588781133294
age O 0 0.0006797897513024509
5 O 0 0.00015613592404406518
years O 0 0.00011079021351179108
, O 0 8.101482308120467e-06
with O 0 1.5149534192460123e-05
deficient O 0 0.02858540788292885
arylsulfatase O 0 0.023670824244618416
A O 0 0.0042455666698515415
( O 0 0.00021815698710270226
ARSA O 0 0.3946836292743683
) O 0 6.039142590452684e-06
activity O 0 1.5757332221255638e-06
and O 0 1.2980012797925156e-06
increased O 0 2.9254402761580423e-05
galactosylsulfatide O 0 0.006245900876820087
( O 0 0.0002102560392813757
GS O 1 0.9999556541442871
) O 0 0.00012444362801034003
excretion O 0 0.0009822339052334428
. O 0 0.00017677125288173556

The O 0 0.00012870252248831093
two O 0 8.93170181370806e-06
other O 0 7.695991371292621e-06
siblings O 0 0.00017383463273290545
, O 0 2.0150302589172497e-05
apparently O 0 7.293831004062667e-05
healthy O 0 4.9405636673327535e-05
at O 0 0.00010555439803283662
12 O 0 3.618452319642529e-05
( O 0 7.425485364365159e-06
1 O 0 0.00010687643953133374
/ O 0 8.044407150009647e-05
2 O 0 7.039166666800156e-05
) O 0 4.3328432184353005e-06
and O 0 2.378737235630979e-06
15 O 0 3.6119155993219465e-05
years O 0 6.247669807635248e-05
, O 0 1.0360704436607193e-05
respectively O 0 3.658172136056237e-05
, O 0 6.1965461100044195e-06
and O 0 5.413481630966999e-06
their O 0 8.99615952221211e-06
father O 0 0.0003557299787644297
, O 0 2.5969462512875907e-05
apparently O 0 7.914286834420636e-05
healthy O 0 3.532072878442705e-05
as O 0 6.010942342982162e-06
well O 0 3.823704446404008e-06
, O 0 6.508293608931126e-06
presented O 0 0.00038941818638704717
ARSA O 1 0.999862790107727
and O 0 0.0002348154375795275
GS O 1 0.9973076581954956
values O 0 6.763565579603892e-06
within O 0 5.24969982507173e-06
the O 0 1.5084960978128947e-05
range O 0 4.7748442739248276e-05
of O 0 0.0013910551788285375
MLD B-Disease 1 1.0
patients O 0 0.002401395933702588
. O 0 0.0005021041142754257

Mutation O 0 6.619832129217684e-05
screening O 0 2.2225720385904424e-05
and O 0 3.335070459797862e-06
sequence O 0 3.0520857308147242e-06
analysis O 0 2.631066308822483e-06
disclosed O 0 6.088499867473729e-05
the O 0 1.8602522686705925e-05
involvement O 0 6.562358612427488e-05
of O 0 0.00012589161633513868
three O 0 4.08547384722624e-05
different O 0 1.1692980478983372e-05
ARSA O 0 0.45188799500465393
mutations O 0 1.5742562027298845e-05
being O 0 5.218960268393857e-06
the O 0 3.7757345126010478e-06
molecular O 0 4.558060481940629e-06
basis O 0 5.1279107537993696e-06
of O 0 0.0001607343729119748
intrafamilial O 0 0.006489529740065336
phenotypic O 0 0.001625697361305356
heterogeneity O 0 0.0062034232541918755
. O 0 0.0012735375203192234

The O 0 0.0010772972600534558
late O 0 0.013108243234455585
infantile O 1 0.9972911477088928
patient O 0 0.0009294429328292608
inherited O 1 0.9997931122779846
from O 0 0.001016151625663042
his O 0 0.0011915569193661213
mother O 0 0.00029004356474615633
the O 0 5.9251528000459075e-05
frequent O 0 2.0740459149237722e-05
0 O 0 4.042667933390476e-05
- O 0 0.00012133240670664236
type O 0 3.457247657934204e-05
mutation O 0 1.0967087291646749e-05
459 O 0 0.00030457318644039333
+ O 0 0.0009161662310361862
1G O 0 0.007271935697644949
> O 0 0.00017696333816275
A O 0 0.00028016342548653483
, O 0 1.2634026461455505e-05
and O 0 5.460890406538965e-06
from O 0 2.4184162612073123e-05
his O 0 9.79178148554638e-05
father O 0 0.0002345518587389961
a O 0 2.318592851224821e-05
novel O 0 5.9971309383399785e-05
, O 0 5.8601031014404725e-06
single O 0 9.71281133388402e-06
basepair O 0 0.0008599249995313585
microdeletion O 0 0.0011909168679267168
of O 0 0.00018684683891478926
guanine O 0 0.00014081703557167202
at O 0 0.0001791246177162975
nucleotide O 0 2.7663078071782365e-05
7 O 0 4.816373620997183e-05
in O 0 2.3510339815402403e-05
exon O 0 0.00018282189557794482
1 O 0 0.00017274112906306982
( O 0 5.844890620210208e-05
7delG O 0 0.002922800835222006
) O 0 8.75158584676683e-05
. O 0 0.00015142785559874028

The O 0 0.0002943618455901742
two O 0 7.25539939594455e-05
clinically O 0 0.006132146343588829
unaffected O 0 0.0009688506252132356
siblings O 0 0.0001371171383652836
carried O 0 1.3002799278183375e-05
the O 0 2.9685566914849915e-05
maternal O 0 0.00016772309027146548
mutation O 0 1.8160879335482605e-05
459 O 0 0.0007209362229332328
+ O 0 0.001467598369345069
1G O 0 0.01214197464287281
> O 0 0.000244602415477857
A O 0 0.0003753519558813423
and O 0 1.3046709682384972e-05
, O 0 5.598009465757059e-06
on O 0 2.4406283046118915e-05
their O 0 6.090537681302521e-06
paternal O 0 6.4212414145004e-05
allele O 0 7.033798283373471e-06
, O 0 4.931201146973763e-06
a O 0 7.633706445631105e-06
novel O 0 1.8729764633462764e-05
cytosine O 0 8.74245961313136e-06
to O 0 4.922724656353239e-06
thymidine O 0 6.367302557919174e-05
transition O 0 0.0003303170669823885
at O 0 0.0003469451912678778
nucleotide O 0 0.00011725585500244051
2435 O 0 0.004483642056584358
in O 0 4.454790541785769e-05
exon O 0 0.0002071774797514081
8 O 0 5.4657721193507314e-05
, O 0 3.8126640902191866e-06
resulting O 0 6.450998625950888e-06
in O 0 9.407026482222136e-06
substitution O 0 1.384531697112834e-05
of O 0 0.00019361944578122348
alanine O 0 0.00017575695528648794
464 O 0 0.0009611643035896122
by O 0 8.75373007147573e-05
valine O 0 0.0019097605254501104
( O 0 0.00013220262189861387
A464V O 0 0.002995167626067996
) O 0 8.633351535536349e-05
. O 0 9.805263835005462e-05

The O 0 0.0006235174951143563
fathers O 0 0.00026820373022928834
genotype O 0 0.00010272674262523651
thus O 0 9.65639264904894e-05
was O 0 0.0009243565145879984
7delG O 0 0.009222998283803463
/ O 0 0.0035475834738463163
A464V O 0 0.008671950548887253
. O 0 0.00047948549035936594

Mutation O 0 0.000202459457796067
A464V O 0 0.0012194622540846467
was O 0 0.00013856409350410104
not O 0 1.99550595425535e-06
found O 0 1.927323864947539e-06
in O 0 1.1147028089908417e-05
18 O 0 0.000383498496375978
unrelated O 0 0.004912053234875202
MLD B-Disease 1 1.0
patients O 0 0.0002966568572446704
and O 0 4.197157613816671e-05
50 O 0 0.00023821146169211715
controls O 0 0.0003079937305301428
. O 0 0.00020321275223977864

A464V O 0 0.004587738309055567
, O 0 2.1017283870605752e-05
although O 0 8.761037861404475e-06
clearly O 0 6.750207103323191e-05
modifying O 0 0.0005988656193949282
ARSA O 1 0.999976396560669
and O 0 0.0008925159927457571
GS O 1 1.0
levels O 0 0.001392796402797103
, O 0 3.399695924599655e-05
apparently O 0 5.906254591536708e-05
bears O 0 0.0001086261254386045
little O 0 8.022736437851563e-06
significance O 0 2.6876870833802968e-05
for O 0 6.1145851759647485e-06
clinical O 0 0.00021073129028081894
manifestation O 1 0.9789983630180359
of O 1 0.9999008178710938
MLD B-Disease 1 1.0
, O 0 0.000819378299638629
mimicking O 0 0.0018721510423347354
the O 0 0.00019610671733971685
frequent O 0 0.00030229074764065444
ARSA O 1 0.9996294975280762
pseudodeficiency O 0 0.01772340200841427
allele O 0 0.0001890029525384307
. O 0 0.00020934466738253832

Our O 0 0.000124590631457977
results O 0 6.762069460819475e-06
demonstrate O 0 1.6430862160632387e-05
that O 0 4.6459646796392917e-07
in O 0 1.6815135950309923e-06
certain O 0 1.8204292473456007e-06
genetic O 0 0.00015105734928511083
conditions O 0 0.0514039508998394
MLD B-Disease 1 1.0
- O 0 0.13492877781391144
like O 0 0.00029631119105033576
ARSA O 1 0.9996768236160278
and O 0 0.00027811762993223965
GS O 1 0.9989288449287415
values O 0 5.76143838770804e-06
need O 0 1.930311100295512e-06
not O 0 3.481360124624189e-07
be O 0 5.824311415381089e-07
paralleled O 0 2.934051190095488e-05
by O 0 2.661247663127142e-06
clinical O 0 0.0007745258626528084
disease O 1 0.9999951124191284
, O 0 5.0341361202299595e-05
a O 0 2.6758460080600344e-05
finding O 0 3.888725404976867e-05
with O 0 8.215502930397633e-06
serious O 0 0.0010767135536298156
diagnostic O 0 0.001343240961432457
and O 0 0.00038049306022003293
prognostic O 1 0.9997606873512268
implications O 0 0.09417108446359634
. O 0 0.0008940876577980816

Moreover O 0 0.000743926502764225
, O 0 2.6872308808378875e-05
further O 0 5.42057168786414e-05
ARSA O 0 0.022254133597016335
alleles O 0 1.5289757357095368e-05
functionally O 0 0.00010541368828853592
similar O 0 3.1923414098855574e-06
to O 0 2.2596586859435774e-05
A464V O 0 0.000692624191287905
might O 0 1.170025370811345e-05
exist O 0 4.637245183403138e-06
which O 0 6.897424214002967e-07
, O 0 5.309695438882045e-07
together O 0 1.1259178336331388e-06
with O 0 1.201107693304948e-06
0 O 0 4.062555672135204e-05
- O 0 0.00012516241986304522
type O 0 3.1567651603836566e-05
mutations O 0 1.7655718693276867e-05
, O 0 2.0500356185948476e-05
may O 0 0.00013215080252848566
cause O 0 0.0009355408838018775
pathological O 1 0.9999613761901855
ARSA O 1 1.0
and O 0 0.002241026144474745
GS O 1 1.0
levels O 0 0.000485096185002476
, O 0 2.309706360392738e-06
but O 0 1.781102412223845e-07
not O 0 9.31309926954782e-08
clinical O 0 5.176278136787005e-06
outbreak O 0 0.0001768550428096205
of O 0 0.0002935997617896646
the O 0 0.002130326582118869
disease O 1 0.9999943971633911
. O 0 9.757823863765225e-05
. O 0 0.0001128312578657642

Human O 1 0.9998589754104614
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999970197677612
to O 1 0.7838827967643738
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 0.004215876571834087
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9942871928215027
1 I-Disease 1 0.9962558746337891
. O 0 0.0007546659326180816

Heterozygous O 0 0.0030723363161087036
germ O 1 0.9996429681777954
- O 0 0.001229417510330677
line O 0 0.00017523588030599058
mutations O 0 3.7668796721845865e-06
in O 0 3.7737368074886035e-06
the O 0 1.4918293345544953e-05
DNA O 0 9.028280328493565e-05
mismatch O 0 0.0024931523948907852
repair O 0 0.0008931340416893363
genes O 0 1.584242818353232e-05
lead O 0 4.2782543459907174e-05
to O 0 6.929805385880172e-05
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9998941421508789

The O 0 0.0019397063879296184
disease O 1 0.999997615814209
susceptibility O 0 0.0011979314731433988
of O 0 0.0013252130011096597
individuals O 0 7.633018685737625e-05
who O 0 0.00019878374587278813
constitutionally O 0 0.0005256579606793821
lack O 0 0.00022101712238509208
both O 0 4.3240452214377e-05
wild O 0 0.0001509423163952306
- O 0 9.756502549862489e-05
type O 0 1.7083755665225908e-05
alleles O 0 4.944688498653704e-06
is O 0 7.299017397599528e-06
unknown O 0 0.00011809271381935105
. O 0 4.999966768082231e-05

We O 0 2.13431594602298e-05
have O 0 8.676019547237956e-07
identified O 0 2.672063601494301e-06
three O 0 2.4002215468499344e-06
offspring O 0 8.432596587226726e-06
in O 0 4.308453753765207e-06
a O 0 6.244595715543255e-05
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999964237213135
who O 0 0.003011140273883939
developed O 1 0.9994264841079712
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 0.9999997615814209
at O 0 0.006212042178958654
a O 0 5.9326270275050774e-05
very O 0 8.622349923825823e-06
early O 0 4.5737506297882646e-05
age O 0 0.000130898566567339
, O 0 8.101520506897941e-06
and O 0 3.765249175557983e-06
at O 0 9.12701289053075e-05
least O 0 4.214070941088721e-06
two O 0 1.6883042235349421e-06
of O 0 2.2174253899720497e-05
them O 0 9.262836101697758e-06
displayed O 0 0.00032369125983677804
signs O 0 0.0005065113073214889
of O 0 0.0006219583447091281
neurofibromatosis B-Disease 1 0.9999662637710571
type I-Disease 0 0.0018894539680331945
1 I-Disease 0 0.008195089176297188
( O 0 0.0004785095516126603
NF1 B-Disease 1 0.9965805411338806
) O 0 0.00012816782691515982
. O 0 0.00010201519762631506

DNA O 0 6.608724652323872e-05
sequence O 0 8.17025556898443e-06
analysis O 0 2.2538192752108444e-06
and O 0 5.320367108652135e-06
allele O 0 6.460295480792411e-06
- O 0 3.7056994187878445e-05
specific O 0 2.475670953572262e-06
amplification O 0 4.468750557862222e-05
in O 0 1.6080846762633882e-05
two O 0 9.177877473121043e-06
siblings O 0 5.716125087928958e-05
revealed O 0 8.697739394847304e-05
a O 0 2.2508063921122812e-05
homozygous O 0 0.0001790998358046636
MLH1 O 0 0.06426864862442017
mutation O 0 4.995257768314332e-05
( O 0 5.012129986425862e-05
C676T O 0 0.0020950392354279757
- O 0 0.0008389528375118971
- O 0 0.0004117738571949303
> O 0 0.00025741380522958934
Arg226Stop O 0 0.005965413060039282
) O 0 6.8100263888482e-05
. O 0 0.00010475503222551197

Thus O 0 0.00023292590049095452
, O 0 1.3803182810079306e-05
a O 0 2.6091423933394253e-05
homozygous O 0 0.0007178231608122587
germ O 1 0.9999992847442627
- O 0 0.009812012314796448
line O 0 0.0021397857926785946
MLH1 O 1 0.9679827094078064
mutation O 0 2.806412521749735e-05
and O 0 2.769538878055755e-05
consequent O 1 0.9991915822029114
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.001218923251144588
in O 0 0.0002642232575453818
a O 0 0.00014010154700372368
mutator O 0 0.009115587919950485
phenotype O 0 6.609732372453436e-05
characterized O 0 0.00011676915164571255
by O 0 5.7941335398936644e-05
leukemia B-Disease 1 1.0
and O 0 0.05344216525554657
/ O 1 0.9999995231628418
or O 1 0.9999332427978516
lymphoma B-Disease 1 1.0
associated O 1 0.9877311587333679
with O 0 0.001053709420375526
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9728929400444031
1 I-Disease 0 0.2884331941604614
. O 0 0.0001530103327240795
. O 0 9.096107532968745e-05

Missense O 0 0.0033398480154573917
mutations O 0 0.00011386237747501582
in O 0 5.171938755665906e-05
the O 0 5.1520572014851496e-05
most O 0 7.54157053961535e-06
ancient O 0 0.0002582621527835727
residues O 0 9.523810149403289e-05
of O 0 0.00018033088417723775
the O 0 0.0005689361714757979
PAX6 O 1 0.998102605342865
paired O 0 0.00017365570238325745
domain O 0 0.00010090221621794626
underlie O 0 0.0005174798425287008
a O 0 3.391997597645968e-05
spectrum O 0 0.000643908279016614
of O 1 0.9990469813346863
human O 1 1.0
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9999797344207764

Mutations O 0 0.00011455435742391273
of O 0 0.00016608026635367423
the O 0 0.00014436032506637275
human O 0 0.0001591082545928657
PAX6 O 1 0.9996309280395508
gene O 0 0.0009339235257357359
underlie O 1 0.999997615814209
aniridia B-Disease 1 1.0
( O 1 0.9999536275863647
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999420642852783
of I-Disease 1 0.9999721050262451
the I-Disease 1 0.9980903267860413
iris I-Disease 0 0.036642540246248245
) O 0 3.733007542905398e-05
, O 0 6.9252128014341e-06
a O 0 2.3783697542967275e-05
rare O 0 0.000527907453943044
dominant O 1 0.9202132821083069
malformation B-Disease 1 1.0
of I-Disease 1 0.9999721050262451
the I-Disease 1 0.9999743700027466
eye I-Disease 1 0.9999773502349854
. O 0 0.001369592733681202

The O 0 0.0003217185731045902
spectrum O 0 0.000574414327275008
of O 0 0.001328286132775247
PAX6 O 1 0.9999638795852661
mutations O 0 0.0005702732596546412
in O 0 0.0006994937430135906
aniridia B-Disease 1 0.9999998807907104
patients O 0 0.0002907612069975585
is O 0 2.177828901039902e-05
highly O 0 5.309583502821624e-05
biased O 0 2.0907273210468702e-05
, O 0 1.6699880234227749e-06
with O 0 9.007438848129823e-07
92 O 0 7.077142072375864e-05
% O 0 6.755687536497135e-06
of O 0 7.033545261947438e-05
all O 0 3.094496059929952e-05
reported O 0 7.974088657647371e-05
mutations O 0 3.951419057557359e-05
leading O 0 0.00016271065396722406
to O 0 3.3824140700744465e-05
premature O 0 0.00020559395488817245
truncation O 0 0.00014464084233622998
of O 0 0.00022134187747724354
the O 0 0.0002872985787689686
protein O 0 8.962966239778325e-05
( O 0 2.6659352442948148e-05
nonsense O 0 0.00017234889674000442
, O 0 7.32243643142283e-06
splicing O 0 3.601233402150683e-05
, O 0 6.217655027285218e-06
insertions O 0 4.741335578728467e-05
and O 0 6.542427399836015e-06
deletions O 0 4.8530320782447234e-05
) O 0 6.972742085054051e-06
and O 0 6.1569494391733315e-06
just O 0 1.8398008251097053e-05
2 O 0 4.0588536649011075e-05
% O 0 6.104296062403591e-06
leading O 0 2.762943768175319e-05
to O 0 5.814548785565421e-06
substitution O 0 6.9811117100471165e-06
of O 0 9.005956962937489e-05
one O 0 2.3593307560076937e-05
amino O 0 1.3599767044070177e-05
acid O 0 1.4262715012591798e-05
by O 0 5.141779183759354e-06
another O 0 2.343829874007497e-05
( O 0 2.621570456540212e-05
missense O 0 0.0004901742795482278
) O 0 0.00010167431901209056
. O 0 0.00016686027811374515

The O 0 0.00025146189727820456
extraordinary O 0 0.00012645008973777294
conservation O 0 2.1072091840323992e-05
of O 0 4.128520959056914e-05
the O 0 0.0001329398510279134
PAX6 O 0 0.014210464432835579
protein O 0 4.8846974095795304e-05
at O 0 8.296877786051482e-05
the O 0 4.9672878958517686e-05
amino O 0 3.8736790884286165e-05
acid O 0 9.646765101933852e-05
level O 0 0.000564909481909126
amongst O 0 0.0009775962680578232
vertebrates O 0 0.0007841166225261986
predicts O 0 0.00010682734136935323
that O 0 4.431140951055568e-06
pathological O 0 0.0012650801800191402
missense O 0 0.0009134605643339455
mutations O 0 6.688520807074383e-05
should O 0 2.18947789107915e-05
in O 0 2.407745341770351e-05
fact O 0 2.3558008251711726e-05
be O 0 4.7406806515937205e-06
common O 0 3.2679706691851607e-06
even O 0 4.522296421782812e-06
though O 0 1.2713159094346338e-06
they O 0 4.802347461918544e-07
are O 0 3.379438169304194e-07
hardly O 0 2.6574800358503126e-05
ever O 0 2.9344935683184303e-05
seen O 0 8.044054266065359e-05
in O 0 9.44379426073283e-05
aniridia B-Disease 1 0.9999974966049194
patients O 0 0.0005603458848781884
. O 0 0.0003214827738702297

This O 0 3.411683428566903e-05
indicates O 0 5.519323531189002e-05
that O 0 2.204877318945364e-06
there O 0 7.11980555934133e-06
is O 0 5.287236945150653e-06
a O 0 2.6571962735033594e-05
heavy O 0 0.001061533926986158
ascertainment O 0 0.010618176311254501
bias O 0 0.0001441476633772254
in O 0 1.2706464076472912e-05
the O 0 1.028056885843398e-05
selection O 0 8.270286343758926e-06
of O 0 6.630129064433277e-05
patients O 0 4.457523027667776e-05
for O 0 6.629092240473256e-05
PAX6 O 1 0.8284520506858826
mutation O 0 1.792161310731899e-05
analysis O 0 3.0196797524695285e-06
and O 0 3.975461822847137e-06
that O 0 2.429494543321198e-06
the O 0 7.409361569443718e-05
missing O 0 0.0009738843073137105
PAX6 O 1 0.7912349700927734
missense O 0 0.0015751339960843325
mutations O 0 0.00020828463311772794
frequently O 0 0.00010529012797633186
may O 0 0.0003416904073674232
underlie O 0 0.008026176132261753
phenotypes O 0 0.0004276200197637081
distinct O 0 0.00011798150808317587
from O 0 0.0005183388711884618
textbook O 0 0.01952475681900978
aniridia B-Disease 1 0.9999990463256836
. O 0 0.001568679348565638

Here O 0 0.0002603425527922809
we O 0 6.501996722363401e-06
present O 0 1.4128341717878357e-05
four O 0 1.9291192074888386e-05
novel O 0 0.00032336494768969715
PAX6 O 0 0.0335901640355587
missense O 0 0.0008823910029605031
mutations O 0 8.428794535575435e-05
, O 0 1.2603772120201029e-05
two O 0 4.139048542128876e-06
in O 0 1.7363805454806425e-05
association O 0 1.907172190840356e-05
with O 0 1.4487412954622414e-05
atypical O 0 0.0042885420843958855
phenotypes O 0 0.0028322332073003054
ectopia B-Disease 1 0.9982666969299316
pupillae I-Disease 0 0.2678525149822235
( O 0 6.174768350319937e-05
displaced B-Disease 0 0.00027213565772399306
pupils I-Disease 0 0.00038331642281264067
) O 0 0.00020082772243767977
and O 0 0.0014608135679736733
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999996423721313
( O 0 0.015774505212903023
searching B-Disease 0 0.005384222604334354
gaze I-Disease 0 0.006411729380488396
) O 0 2.2918347895029e-05
, O 0 4.59089233117993e-06
and O 0 2.520224597901688e-06
two O 0 2.7795661026175367e-06
in O 0 1.7776890672394074e-05
association O 0 1.1237230864935555e-05
with O 0 4.20289734393009e-06
more O 0 1.844491453084629e-05
recognizable O 0 0.007473567500710487
aniridia B-Disease 1 0.9999995231628418
phenotypes O 0 0.0037049532402306795
. O 0 0.0006251870072446764

Strikingly O 0 0.0016721704741939902
, O 0 1.3520495485863648e-05
all O 0 2.6400618935440434e-06
four O 0 5.9850303841813e-06
mutations O 0 6.741631750628585e-06
are O 0 1.8405185073788743e-06
located O 0 6.423544982681051e-05
within O 0 2.1146133803995326e-05
the O 0 0.00014152601943351328
PAX6 O 0 0.03051312454044819
paired O 0 0.00011027080472558737
domain O 0 3.9522670704172924e-05
and O 0 1.4096566701482516e-05
affect O 0 2.968239459733013e-05
amino O 0 2.001570101128891e-05
acids O 0 6.29702071819338e-06
which O 0 1.4047686818230432e-06
are O 0 3.9435698795387e-07
highly O 0 1.3822573237121105e-05
conserved O 0 2.6511317628319375e-05
in O 0 7.327396360778948e-06
all O 0 4.586289378494257e-06
known O 0 3.623926022555679e-05
paired O 0 3.9876762457424775e-05
domain O 0 9.529553062748164e-05
proteins O 0 5.0633560022106394e-05
. O 0 0.0001161773907369934

Our O 0 8.591433288529515e-05
results O 0 9.443510862183757e-06
support O 0 7.112489129212918e-06
the O 0 3.0578652513213456e-05
hypothesis O 0 1.3423174095805734e-05
that O 0 4.4469385329648503e-07
the O 0 3.924105840269476e-06
under O 0 1.6620359019725583e-05
- O 0 1.6369960576412268e-05
representation O 0 1.4101282204137533e-06
of O 0 5.717444946640171e-05
missense O 0 0.0006127910455688834
mutations O 0 0.00012674512981902808
is O 0 4.39794130215887e-05
caused O 0 0.0005328704719431698
by O 0 5.018347656005062e-05
ascertainment O 0 0.02217404544353485
bias O 0 0.0003442688030190766
and O 0 2.1633017240674235e-05
suggest O 0 1.5005301975179464e-05
that O 0 7.768675800434721e-07
a O 0 3.1481345104111824e-06
substantial O 0 3.430131619097665e-05
burden O 0 0.0003756161604542285
of O 0 0.0010933008743450046
PAX6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.6002888679504395
related I-Disease 0 0.001296666800044477
disease I-Disease 1 0.9997342228889465
remains O 0 0.001012994209304452
to O 0 2.057176061498467e-05
be O 0 2.1095756892464124e-05
uncovered O 0 0.0010142383398488164
. O 0 2.675396899576299e-05
. O 0 6.685873813694343e-05

The O 0 0.0002451281761750579
chromosomal O 0 0.00021741213276982307
order O 0 2.2153537429403514e-05
of O 0 0.0002061276463791728
genes O 0 8.871522004483268e-05
controlling O 0 0.00028355850372463465
the O 0 0.000194839303730987
major O 0 0.00219894596375525
histocompatibility O 1 0.9999990463256836
complex O 0 0.04998274892568588
, O 0 4.357288344181143e-05
properdin O 0 0.0011257333680987358
factor O 0 6.31672955933027e-05
B O 0 0.0007703893934376538
, O 0 1.4582616131519899e-05
and O 0 2.3180535208666697e-05
deficiency B-Disease 1 0.9999594688415527
of I-Disease 0 0.0006682971143163741
the I-Disease 0 0.00026155763771384954
second I-Disease 0 0.0001073803796316497
component I-Disease 0 7.419876055791974e-05
of I-Disease 0 0.00011395730689400807
complement I-Disease 0 0.0003687303978949785
. O 0 0.00014818960335105658

The O 0 9.492151002632454e-05
relationship O 0 1.8913671738118865e-05
of O 0 2.9719358280999586e-05
the O 0 1.956215601239819e-05
genes O 0 3.5744774322665762e-06
coding O 0 3.360823029652238e-05
for O 0 1.8259224816574715e-05
HLA O 0 0.0031258377712219954
to O 0 1.0383376320532989e-05
those O 0 2.265348030050518e-06
coding O 0 3.071408355026506e-05
for O 0 1.132968463934958e-05
properdin O 0 0.0017793974839150906
Factor O 0 0.00010180946992477402
B O 0 0.0008367167320102453
allotypes O 0 0.0015364621067419648
and O 0 1.1126096069347113e-05
for O 0 3.557395757525228e-05
deficiency B-Disease 1 0.9999765157699585
of I-Disease 0 0.0011167449411004782
the I-Disease 0 0.00024476804537698627
second I-Disease 0 5.560042700381018e-05
component I-Disease 0 5.1216655265307054e-05
of I-Disease 0 0.00011025503044947982
complement I-Disease 0 0.0003998442261945456
( O 0 0.0003103763738181442
C2 O 0 0.041117191314697266
) O 0 1.4567298421752639e-05
was O 0 6.95486378390342e-05
studied O 0 2.024997229455039e-05
in O 0 2.1551327336055692e-06
families O 0 9.557110161040328e-07
of O 0 2.57552346738521e-05
patients O 0 9.847843466559425e-05
with O 0 0.0007570530869998038
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9999998807907104

Patients O 0 0.0002200528106186539
were O 0 4.0255370549857616e-05
selected O 0 1.4826076039753389e-05
because O 0 1.051867570822651e-06
they O 0 1.924864676539073e-07
were O 0 1.463878675167507e-06
heterozygous O 0 5.763475883213687e-07
or O 0 3.136046643703594e-06
homozygous O 0 0.00010999711957992986
for O 0 0.0038729968946427107
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9943793416023254

12 O 0 0.0002756925532594323
families O 0 6.278515229496406e-06
with O 0 4.937723588227527e-06
15 O 0 0.00010739318531705067
matings O 0 0.0007165170391090214
informative O 0 0.00038354305434040725
for O 0 0.0019284687004983425
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.013617760501801968
found O 0 0.0007438105531036854
. O 0 0.0003905634512193501

Of O 0 0.0024443515576422215
57 O 0 0.0012429676717147231
informative O 0 0.0006083243642933667
meioses O 0 0.0033199794124811888
, O 0 6.265775027713971e-06
two O 0 1.2941053455506335e-06
crossovers O 0 2.925683247667621e-06
were O 0 4.5168394535721745e-06
noted O 0 1.0935879799944814e-05
between O 0 0.00015656229516025633
the O 0 0.03848522901535034
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.00018198082398157567
and O 0 3.341555566294119e-05
the O 0 0.00020860660879407078
HLA O 0 0.31289780139923096
- O 0 0.0007196433725766838
B O 0 0.0003145288210362196
gene O 0 2.6288566914445255e-06
, O 0 5.25474149526417e-07
with O 0 2.1477718803453172e-07
a O 0 3.461187134234933e-06
recombinant O 0 1.5581996194669046e-05
fraction O 0 1.6053218132583424e-05
of O 0 0.00011993136286037043
0 O 0 0.00014830651343800128
. O 0 0.0001228243054356426

035 O 0 0.19307726621627808
. O 0 0.0019881962798535824

A O 0 0.003597184782847762
lod O 0 0.005304613616317511
score O 0 6.073711847420782e-05
of O 0 9.510778909316286e-05
13 O 0 6.785975710954517e-05
was O 0 3.897379065165296e-05
calculated O 0 2.6950478968501557e-06
for O 0 4.421314315550262e-06
linkage O 0 0.0013925007078796625
between O 1 0.999994158744812
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.19363562762737274
HLA O 1 0.9999980926513672
- O 0 0.003474010154604912
B O 0 0.0006382758147083223
at O 0 4.259130218997598e-05
a O 0 2.4002420104807243e-06
maximum O 0 2.840053866748349e-06
likelihood O 0 3.120399014733266e-06
value O 0 1.3695982943318086e-06
of O 0 6.665480213996489e-06
the O 0 7.729826393187977e-06
recombinant O 0 5.9459571275510825e-06
fraction O 0 1.0456860763952136e-05
of O 0 6.64946564938873e-05
0 O 0 9.550084359943867e-05
. O 0 0.00010783566540339962

04 O 0 0.054612789303064346
. O 0 0.0014944359427317977

18 O 0 0.0005546765169128776
families O 0 1.4816860129940324e-05
with O 0 1.0404221939097624e-05
21 O 0 0.00023332753335125744
informative O 0 4.906729009235278e-05
matings O 0 0.00010724989988375455
for O 0 5.8784394241229165e-06
both O 0 1.529824839963112e-05
properdin O 0 0.0026426175609230995
Factor O 0 0.0002460216637700796
B O 0 0.001456394442357123
allotype O 0 0.002135594142600894
and O 0 6.503703480120748e-05
HLA O 0 0.03060145117342472
- O 0 0.0008206747006624937
B O 0 0.0005935007357038558
were O 0 4.890654236078262e-05
found O 0 3.590308187995106e-05
. O 0 0.00011086714221164584

Of O 0 0.0017717562150210142
72 O 0 0.001386184012517333
informative O 0 0.0003176765167154372
meioses O 0 0.003292179899290204
, O 0 2.1221989300101995e-05
three O 0 1.6746238543419167e-05
recombinants O 0 0.0011720502516254783
were O 0 3.2200321584241465e-05
found O 0 9.43713621381903e-06
, O 0 2.4858038614183897e-06
giving O 0 1.6108497220557183e-06
a O 0 4.39068253399455e-06
recombinant O 0 1.977153806365095e-05
fraction O 0 2.4366563593503088e-05
of O 0 0.0001547453721286729
0 O 0 0.00020536941883619875
. O 0 0.00013266885071061552

042 O 0 0.0907941609621048
. O 0 0.0009880135767161846

A O 0 0.0013317643897607923
lod O 0 0.00265165651217103
score O 0 2.501721064618323e-05
of O 0 7.837522571207955e-05
16 O 0 0.00024236543686129153
between O 0 0.0008248085505329072
HLA O 1 0.9726775884628296
- O 0 0.0013269013725221157
B O 0 0.0005260289181023836
and O 0 7.254236152220983e-06
Factor O 0 5.472374687087722e-05
B O 0 0.00052367162425071
allotypes O 0 0.0006300305831246078
was O 0 6.95529452059418e-05
calculated O 0 5.020525350118987e-06
at O 0 2.699088872759603e-05
a O 0 2.4181520075217122e-06
maximum O 0 5.374146894610021e-06
likelihood O 0 4.314596935728332e-06
value O 0 2.8178503725939663e-06
of O 0 9.69075335888192e-06
the O 0 7.961464689287823e-06
recombinant O 0 4.998424174118554e-06
fraction O 0 5.291686193231726e-06
of O 0 4.873126090387814e-05
0 O 0 9.133003186434507e-05
. O 0 8.257640729425475e-05

04 O 0 0.05825509503483772
. O 0 0.0014858396025374532

A O 0 0.0009108489030040801
crossover O 0 0.00011131725477753207
was O 0 0.00011294708383502439
shown O 0 8.702797458681744e-06
to O 0 2.0809011402889155e-06
have O 0 8.12122380011715e-07
occurred O 0 3.9372313040075824e-05
between O 0 8.645947673358023e-06
genes O 0 1.0653390063453116e-06
for O 0 1.4904833278706064e-06
Factor O 0 2.4103599571390077e-05
B O 0 0.00042399531230330467
and O 0 2.390323243162129e-05
HLA O 0 0.0137918870896101
- O 0 0.0005750925047323108
D O 0 0.0006493648397736251
, O 0 3.3763853934942745e-06
in O 0 3.3466837976448005e-06
which O 0 7.85409974923823e-06
HLA O 0 0.01035598199814558
- O 0 0.0006390586495399475
D O 0 0.0012625579256564379
segregared O 0 0.0011139196576550603
with O 0 2.256960215163417e-05
HLA O 0 0.04771149903535843
- O 0 0.0005955980159342289
A O 0 0.000512201979290694
and O 0 4.517554407357238e-05
B O 0 0.00193809624761343
. O 0 0.00014328800898510963

These O 0 1.4808017112954985e-05
studies O 0 4.597455699695274e-06
suggest O 0 2.544250492064748e-06
that O 0 1.3916421437443205e-07
the O 0 1.009957827591279e-06
genes O 0 3.518080120556988e-07
for O 0 7.769105536681309e-07
Factor O 0 8.554205123800784e-05
B O 0 0.017804697155952454
and O 0 0.0014651957899332047
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.748584564775229e-05
located O 0 0.00030783345573581755
outside O 0 2.6042402168968692e-05
those O 0 4.2378569560241885e-06
for O 0 2.4001548808882944e-05
HLA O 0 0.06519246101379395
, O 0 7.966546036186628e-06
that O 0 4.2686374968070595e-07
the O 0 2.965453859360423e-06
order O 0 3.0615192372351885e-06
of O 0 5.414661063696258e-05
genese O 0 0.0036846986040472984
is O 0 6.992295675445348e-05
HLA O 0 0.006755424663424492
- O 0 0.00020482909167185426
A O 0 0.00018572641420178115
, O 0 7.841114893381018e-06
- O 0 4.463129516807385e-05
B O 0 0.00020634906832128763
, O 0 8.832412277115509e-06
- O 0 7.142929825931787e-05
D O 0 0.00025244534481316805
, O 0 2.3900797714304645e-06
Factor O 0 2.5048459065146744e-05
B O 0 0.0014072164194658399
allotype O 1 0.9105996489524841
, O 0 0.001460329513065517
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 4.094573887414299e-05
that O 0 7.855476837903552e-07
the O 0 4.131145033170469e-06
genes O 0 2.6321279165131273e-06
coding O 0 0.00015370654000435024
for O 0 0.0006030318909324706
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.00044211753993295133
Factor O 0 0.00033986865309998393
B O 0 0.0007815597346052527
allotypes O 0 0.0003929148952011019
are O 0 4.3805928839901753e-07
approximately O 0 1.2025395335513167e-05
3 O 0 4.1336577851325274e-05
- O 0 5.841056918143295e-05
- O 0 3.808087421930395e-05
5 O 0 1.6764470274210908e-05
centimorgans O 0 0.0002263663918711245
from O 0 1.0721306352934334e-05
the O 0 8.467496081721038e-05
HLA O 0 0.00931217335164547
- O 0 0.00023061575484462082
A O 0 0.00034792543738149107
and O 0 4.2495634261285886e-05
HLA O 0 0.03112027607858181
- O 0 0.0010141384555026889
B O 0 0.000897784426342696
loci O 0 4.630717376130633e-05
, O 0 2.847148152795853e-06
and O 0 1.1378302815501229e-06
that O 0 7.377251449725009e-07
the O 0 1.0431333066662773e-05
apparent O 0 8.894765778677538e-05
lack O 0 6.617559847654775e-05
of O 0 0.00017822490190155804
recombinants O 0 0.0010274926899001002
between O 0 5.388051795307547e-05
the O 0 2.0317678718129173e-05
Factor O 0 1.4787301552132703e-05
B O 0 0.0006107535446062684
gene O 0 6.425051833502948e-05
and O 0 0.00032624471350573003
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0002568592317402363
suggests O 0 3.0679777410114184e-05
that O 0 8.923545919969911e-07
these O 0 4.0778306242827966e-07
two O 0 1.433545321560814e-06
genes O 0 5.123471964907367e-06
lie O 0 0.00011935886868741363
in O 0 1.2423125554050785e-05
close O 0 4.819235982722603e-05
proximity O 0 5.2371098718140274e-05
to O 0 1.6942729416768998e-05
one O 0 1.9083583538304083e-05
another O 0 5.1221046305727214e-05
. O 0 0.00010683295113267377

Distribution O 0 0.00011255079880356789
of O 0 0.001037060865201056
emerin O 1 0.7029338479042053
and O 0 0.00026125830481760204
lamins O 0 0.01005974505096674
in O 0 7.53706626710482e-05
the O 0 0.00013429536193143576
heart O 0 0.0015892938245087862
and O 0 1.1333250768075231e-05
implications O 0 0.00010083219240186736
for O 0 9.733373008202761e-05
Emery B-Disease 1 0.999098539352417
- I-Disease 1 0.9999978542327881
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.4575079083442688

Emerin O 0 0.01559519488364458
is O 0 4.504407843342051e-05
a O 0 2.7979063816019334e-05
nuclear O 0 0.0003403227310627699
membrane O 0 3.187943730154075e-05
protein O 0 4.476187314139679e-06
which O 0 2.7129362933919765e-06
is O 0 2.747804501268547e-06
missing O 0 3.733683843165636e-05
or O 0 1.0834232853085268e-05
defective O 0 0.0006356759695336223
in O 0 0.00029687327332794666
Emery B-Disease 1 0.9895011782646179
- I-Disease 1 0.9999878406524658
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9991336464881897
EDMD B-Disease 1 1.0
) O 0 0.0011063219280913472
. O 0 0.000342737534083426

It O 0 4.5871518523199484e-05
is O 0 7.127903700165916e-06
one O 0 2.79738901554083e-06
member O 0 5.468812105391407e-06
of O 0 4.150330642005429e-05
a O 0 4.769055885844864e-05
family O 0 5.544126906897873e-05
of O 0 0.0005820899968966842
lamina O 1 0.9920334219932556
- O 0 0.000660120218526572
associated O 0 6.5725571403163485e-06
proteins O 0 1.454857169846946e-06
which O 0 2.302038183188415e-06
includes O 0 1.5152149899222422e-05
LAP1 O 1 0.9888971447944641
, O 0 7.084988465066999e-05
LAP2 O 0 0.04247292876243591
and O 0 4.431989145814441e-05
lamin O 0 0.0009208389674313366
B O 0 0.0010181628167629242
receptor O 0 0.00020276375289540738
( O 0 0.0001631022460060194
LBR O 1 0.9962736368179321
) O 0 9.7284369985573e-05
. O 0 0.00011197957064723596

A O 0 0.0009313261834904552
panel O 0 6.771211337763816e-05
of O 0 0.00010731272050179541
16 O 0 0.00024429289624094963
monoclonal O 0 5.143015005160123e-05
antibodies O 0 3.9946873584995046e-05
( O 0 4.1118768422165886e-05
mAbs O 0 0.0006402134895324707
) O 0 2.1360926893976284e-06
has O 0 1.0870122650885605e-06
been O 0 1.194751234834257e-06
mapped O 0 3.2431546514999354e-06
to O 0 2.0697723357443465e-06
six O 0 3.1316233162215212e-06
specific O 0 5.6577812301839e-07
sites O 0 8.42359531816328e-06
throughout O 0 8.12495818536263e-06
the O 0 3.2125604775501415e-05
emerin O 0 0.0017495503416284919
molecule O 0 2.2271486159297638e-05
using O 0 1.9474076907499693e-05
phage O 0 0.0005215689307078719
- O 0 0.00010502879013074562
displayed O 0 0.00010127894347533584
peptide O 0 5.536059688893147e-05
libraries O 0 1.511618302174611e-05
and O 0 1.7974542743104394e-06
has O 0 1.1566902458071127e-06
been O 0 1.4445282658925862e-06
used O 0 2.582547267593327e-06
to O 0 1.1423378964536823e-05
localize O 0 0.0019241146510466933
emerin O 0 0.004265596158802509
in O 0 0.00010228102473774925
human O 0 0.00011917393567273393
and O 0 0.00014595648099202663
rabbit O 0 0.003319059731438756
heart O 1 0.9727732539176941
. O 0 0.00044119294034317136

Several O 0 0.00027793023036792874
mAbs O 0 0.0015661162324249744
against O 0 7.684755837544799e-05
different O 0 1.1154386811540462e-05
emerin O 0 0.005970229860395193
epitopes O 0 0.000669732631649822
did O 0 4.497875124798156e-05
not O 0 5.638021320919506e-06
recognize O 0 8.383918611798435e-05
intercalated O 0 0.006056003738194704
discs O 0 0.005987469106912613
in O 0 0.00016554270405322313
the O 0 0.00043675120105035603
heart O 0 0.009353180415928364
, O 0 1.4680765161756426e-05
though O 0 2.718631776588154e-06
they O 0 9.851011100181495e-07
recognized O 0 4.1299699660157785e-05
cardiomyocyte O 0 0.0038339782040566206
nuclei O 0 0.0004996585776098073
strongly O 0 2.9463322789524682e-05
, O 0 6.41277165414067e-06
both O 0 8.45030717755435e-06
at O 0 0.00036755818291567266
the O 0 0.00029871362494304776
rim O 0 0.001694345148280263
and O 0 1.4595249012927525e-05
in O 0 6.752794433850795e-05
intranuclear O 0 0.0023407847620546818
spots O 0 0.00019657306256704032
or O 0 2.470702020218596e-05
channels O 0 0.00014752020069863647
. O 0 0.00014024644042365253

A O 0 0.011711026541888714
polyclonal O 0 0.01168361771851778
rabbit O 0 0.001491590985096991
antiserum O 0 0.0008853256003931165
against O 0 0.00015671718574594706
emerin O 0 0.002845714334398508
did O 0 2.2193673430592753e-05
recognize O 0 2.3041640815790743e-05
both O 0 1.603846794751007e-05
nuclear O 0 0.001781092956662178
membrane O 0 0.0001292749511776492
and O 0 2.264672366436571e-05
intercalated O 0 0.0014597093686461449
discs O 0 0.001517872093245387
but O 0 4.888787316303933e-06
, O 0 2.1102364371472504e-06
after O 0 1.1891826943610795e-05
affinity O 0 1.5108299521671142e-05
purification O 0 0.00042264079093001783
against O 0 0.00019205383432563394
a O 0 0.00020846027473453432
pure O 0 0.0025447553489357233
- O 0 0.001757801859639585
emerin O 0 0.004107234999537468
band O 0 0.0003395980456843972
on O 0 7.757027196930721e-05
a O 0 2.68985349975992e-05
western O 0 0.00012561916082631797
blot O 0 0.000651007576379925
, O 0 2.115754978149198e-05
it O 0 7.706765245529823e-06
stained O 0 0.0009143148199655116
only O 0 9.947922080755234e-06
the O 0 7.219538383651525e-05
nuclear O 0 0.0015699248760938644
membrane O 0 0.00021623374777846038
. O 0 8.141685248119757e-05

These O 0 1.3916802345192991e-05
results O 0 5.89028604736086e-06
would O 0 2.0492184376053046e-06
not O 0 5.705729790861369e-07
be O 0 5.717762974200014e-07
expected O 0 5.966343451291323e-06
if O 0 3.1158883757598232e-06
immunostaining O 0 0.000828809745144099
at O 0 0.0002882989647332579
intercalated O 0 0.003173365956172347
discs O 0 0.0020245518535375595
were O 0 5.182578388485126e-05
due O 0 0.00012062133464496583
to O 0 1.1246000212850049e-05
a O 0 6.101583494455554e-06
product O 0 4.362542313174345e-06
of O 0 4.501753574004397e-05
the O 0 0.00016140045772772282
emerin O 0 0.004874739795923233
gene O 0 3.160150663461536e-05
and O 0 8.40045959193958e-06
, O 0 6.192482032929547e-06
therefore O 0 1.1647737665043678e-05
, O 0 2.533007318561431e-06
cast O 0 8.648965376778506e-06
some O 0 3.2582115636614617e-06
doubt O 0 3.121869667666033e-05
upon O 0 1.6229347238549963e-05
the O 0 1.1530750271049328e-05
hypothesis O 0 1.7483474948676303e-05
that O 0 1.2674937352130655e-05
cardiac B-Disease 1 0.9999983310699463
defects I-Disease 1 0.9999996423721313
in O 1 0.5157693028450012
EDMD B-Disease 1 1.0
are O 0 2.724016121646855e-05
caused O 0 0.00017841804947238415
by O 0 8.351245014637243e-06
absence O 0 0.00014357056352309883
of O 0 0.000660938210785389
emerin O 1 0.5268408060073853
from O 0 0.0009231520816683769
intercalated O 0 0.2644580006599426
discs O 1 0.774774968624115
. O 0 0.0005424133851192892

Although O 0 0.0005181973101571202
emerin O 0 0.00831780768930912
was O 0 0.0005210012313909829
abundant O 0 5.348464765120298e-05
in O 0 1.3314348507265095e-05
the O 0 3.775327422772534e-05
membranes O 0 9.07713983906433e-05
of O 0 0.0002357046032557264
cardiomyocyte O 0 0.04105556756258011
nuclei O 0 0.0009835211094468832
, O 0 2.4663044314365834e-05
it O 0 4.790208549820818e-06
was O 0 0.00014106510207057
absent O 0 5.9312122175469995e-05
from O 0 1.5766045180498622e-05
many O 0 1.3715713066630997e-05
non O 0 0.000490634236484766
- O 0 0.00173317885491997
myocyte O 0 0.011176355183124542
cells O 0 5.8314952184446156e-05
in O 0 3.259068762417883e-05
the O 0 0.0002376538614043966
heart O 0 0.03151490539312363
. O 0 0.0003102449991274625

This O 0 2.0096642401767895e-05
distribution O 0 2.3156298993853852e-05
of O 0 0.0002911742776632309
emerin O 0 0.009185479022562504
was O 0 0.00032687795464880764
similar O 0 2.3296981908060843e-06
to O 0 6.913981451361906e-06
that O 0 3.667408009278006e-06
of O 0 0.00016141924425028265
lamin O 0 0.002210240811109543
A O 0 0.0004764495533891022
, O 0 6.0297043091850355e-06
a O 0 4.01097258873051e-06
candidate O 0 4.696751602750737e-06
gene O 0 1.6074523045972455e-06
for O 0 2.5625236048654187e-06
an O 0 5.176026206754614e-06
autosomal O 0 0.00015287965652532876
form O 0 0.00028125106473453343
of O 1 0.9999901056289673
EDMD B-Disease 1 1.0
. O 0 0.01120231207460165

In O 0 0.00026470687589608133
contrast O 0 0.00027265274547971785
, O 0 0.00017708705854602158
lamin O 0 0.010535028763115406
B1 O 1 0.9997480511665344
was O 0 0.001000837655737996
absent O 0 0.0004799924499820918
from O 0 0.00010211739572696388
cardiomyocyte O 0 0.008180342614650726
nuclei O 0 0.0007714381208643317
, O 0 2.26227621169528e-05
showing O 0 0.00012687766866292804
that O 0 5.446499926620163e-05
lamin O 0 0.008902081288397312
B1 O 1 0.965671181678772
is O 0 8.436119969701394e-06
not O 0 5.667620825988706e-07
essential O 0 6.105477950768545e-06
for O 0 4.545766842056764e-06
localization O 0 0.0002303858782397583
of O 0 0.00014907197328284383
emerin O 0 0.0031403345055878162
to O 0 7.124595867935568e-05
the O 0 0.0003426217008382082
nuclear O 0 0.006602506618946791
lamina O 0 0.027280697599053383
. O 0 0.0002873966295737773

Lamin O 1 0.8103744983673096
B1 O 1 0.9998650550842285
is O 0 6.397709512384608e-05
also O 0 1.0101358384417836e-05
almost O 0 2.8437225410016254e-05
completely O 0 0.00024652108550071716
absent O 0 0.0002815611951518804
from O 0 0.0002713151916395873
skeletal O 1 0.9999798536300659
muscle O 1 0.995442271232605
nuclei O 1 0.9967876672744751
. O 0 0.004770302679389715

In O 0 0.0020108961034566164
EDMD B-Disease 1 1.0
, O 0 1.4774585906707216e-05
the O 0 7.918885785329621e-06
additional O 0 3.676133928820491e-06
absence O 0 0.00018103187903761864
of O 0 0.0010451244888827205
lamin O 0 0.23774057626724243
B1 O 1 0.9999984502792358
from O 0 0.0016409076051786542
heart O 1 0.9999986886978149
and O 0 0.0020678716246038675
skeletal O 1 1.0
muscle O 1 0.9998326301574707
nuclei O 1 0.9751253128051758
which O 0 0.00014406615810003132
already O 0 0.00014403405657503754
lack O 0 0.00040977756725624204
emerin O 0 0.004440260585397482
may O 0 4.1870749555528164e-05
offer O 0 2.6699035515775904e-06
an O 0 2.341717390663689e-06
alternative O 0 6.112742994446307e-06
explanation O 0 1.4422761523746885e-05
of O 0 7.21430842531845e-05
why O 0 9.090479579754174e-05
these O 0 9.292662980442401e-06
tissues O 0 7.164357521105558e-05
are O 0 2.275355427627801e-06
particularly O 0 2.1432026187540032e-05
affected O 0 6.467122148023918e-05
. O 0 2.7958365535596386e-05
. O 0 7.347830251092091e-05

Genetic O 0 0.0002223995834356174
mapping O 0 0.0002347464906051755
of O 0 0.0018324763514101505
the O 0 0.02000068873167038
copper B-Disease 1 0.9999992847442627
toxicosis I-Disease 1 0.9982799291610718
locus O 0 0.0009325600694864988
in O 0 0.000384896295145154
Bedlington O 0 0.011675279587507248
terriers O 0 0.0021280492655932903
to O 0 6.4795785874594e-05
dog O 0 0.00026046414859592915
chromosome O 0 9.244739339919761e-05
10 O 0 3.654493411886506e-05
, O 0 3.483273758320138e-06
in O 0 5.8130408433498815e-06
a O 0 1.2159813195466995e-05
region O 0 0.00011930173786822706
syntenic O 0 0.001119829947128892
to O 0 1.9448370949248783e-05
human O 0 4.554491169983521e-05
chromosome O 0 0.00024906385806389153
region O 0 0.0010669062612578273
2p13 O 0 0.007674153428524733
- O 0 0.0032075531780719757
p16 O 0 0.0013077720068395138
. O 0 0.0001725233596516773

Abnormal O 1 0.9999992847442627
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999719858169556
is O 0 7.625830039614812e-05
recognized O 0 2.44997936533764e-05
as O 0 2.0982995920348912e-05
an O 0 3.8904276152607054e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9999864101409912
man O 1 0.9919245839118958
, O 0 0.00020639610011130571
mouse O 0 0.0004660215345211327
, O 0 9.162452624877915e-05
rat O 0 0.0024588231462985277
and O 0 7.41798648959957e-05
dog O 0 0.0009139655740000308
. O 0 0.00020160032727289945

The O 0 0.0005279144970700145
major O 0 0.003123948350548744
cause O 0 0.013742358423769474
of O 1 0.9981435537338257
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999974966049194
in O 0 0.001379418303258717
man O 0 0.00033353656181134284
is O 0 3.917831236321945e-06
a O 0 1.0337964340578765e-05
dysfunctional O 0 0.0005812561721540987
ATP7B O 1 0.9892409443855286
gene O 0 5.529174086404964e-05
, O 0 2.409275111858733e-05
causing O 0 0.001215198659338057
Wilson B-Disease 1 0.9969647526741028
disease I-Disease 1 0.9999998807907104
( O 0 0.0005492644850164652
WD B-Disease 1 0.9999537467956543
) O 0 0.00015739182708784938
. O 0 0.00015381447155959904

Mutations O 0 0.00022209531744010746
in O 0 8.927617454901338e-05
the O 0 0.0002348467824049294
ATP7B O 0 0.3614891767501831
genes O 0 1.1691151485138107e-05
have O 0 1.248261469299905e-06
also O 0 1.856441826930677e-06
been O 0 7.661808012926485e-06
demonstrated O 0 0.00010838452726602554
in O 0 0.00010547320562181994
mouse O 0 0.00026055608759634197
and O 0 8.830375736579299e-05
rat O 0 0.004267654847353697
. O 0 0.0001304451288888231

The O 0 0.0011093566427007318
ATP7B O 1 0.9965416789054871
gene O 0 3.926545105059631e-05
has O 0 5.1018523663515225e-06
been O 0 4.768312464875635e-06
excluded O 0 8.670248462294694e-06
in O 0 2.722816816458362e-06
the O 0 9.938837138179224e-06
much O 0 2.4257453333120793e-05
rarer O 0 0.0009122068295255303
human O 0 0.0012213046429678798
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 0 0.02106671966612339
- I-Disease 0 0.0030468860641121864
Indian I-Disease 0 9.330701141152531e-05
childhood I-Disease 0 0.05779733508825302
cirrhosis I-Disease 1 1.0
, O 0 9.458862768951803e-05
indicating O 0 0.0005147404735907912
genetic O 0 0.00041649708873592317
heterogeneity O 0 0.0034615444019436836
. O 0 0.0009050679509527981

By O 0 2.9392153010121547e-05
investigating O 0 4.482485746848397e-05
the O 0 4.832886406802572e-05
common O 0 0.00011324916704325005
autosomal O 1 0.9970760345458984
recessive O 1 0.9999995231628418
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 0.33909112215042114
CT B-Disease 1 0.9999531507492065
) O 0 0.0001862252247519791
in O 0 0.0002882044645957649
Bedlington O 0 0.023441223427653313
terriers O 0 0.002900413703173399
, O 0 9.171630154014565e-06
we O 0 1.587879637554579e-06
have O 0 3.753400505956961e-07
identified O 0 2.0490658698690822e-06
a O 0 1.2373715208013891e-06
new O 0 1.2426789908204228e-06
locus O 0 1.3039259101788048e-05
involved O 0 2.096367461490445e-05
in O 0 0.0003673472674563527
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9926066398620605

We O 0 4.283912858227268e-05
examined O 0 3.3786327549023554e-05
whether O 0 3.679283736346406e-06
the O 0 3.945432399632409e-05
WD B-Disease 0 0.1169438511133194
gene O 0 0.0001703611487755552
ATP7B O 1 0.5924018621444702
was O 0 0.0005877497023902833
also O 0 1.1474456186988391e-05
causative O 0 0.00014115849626250565
for O 0 3.154074875055812e-05
CT B-Disease 0 0.0034352915827184916
by O 0 8.104851985990535e-06
investigating O 0 3.869404099532403e-05
the O 0 6.395287346094847e-05
chromosomal O 0 0.001541870296932757
co O 0 0.0019411237444728613
- O 0 0.0008493844652548432
localization O 0 0.0008896340732462704
of O 0 0.001080846879631281
ATP7B O 1 0.999962568283081
and O 0 0.0001290420477744192
C04107 O 0 0.0008539740229025483
, O 0 4.596044163918123e-06
using O 0 2.310182253495441e-06
fluorescence O 0 2.8295102310949005e-05
in O 0 7.233762880787253e-05
situ O 0 0.002881779568269849
hybridization O 0 7.963517418829724e-05
( O 0 3.366928285686299e-05
FISH O 0 0.00029726215871050954
) O 0 9.837859579420183e-06
. O 0 3.050822124350816e-05

C04107 O 0 0.00703304260969162
is O 0 2.457066875649616e-05
an O 0 5.488143870024942e-06
anonymous O 0 2.9450344300130382e-05
microsatellite O 0 0.0006173094734549522
marker O 0 0.0004819707537535578
closely O 0 0.00015361804980784655
linked O 0 0.0006570550613105297
to O 0 0.00033860121038742363
CT B-Disease 1 0.9971938133239746
. O 0 0.0005537235410884023

However O 0 0.0003860750002786517
, O 0 0.00014402181841433048
BAC O 0 0.3376549184322357
clones O 0 0.002833922626450658
containing O 0 0.0007784619810990989
ATP7B O 1 0.990696907043457
and O 0 5.682992559741251e-05
C04107 O 0 0.0005063503631390631
mapped O 0 4.0106504457071424e-05
to O 0 1.3094062524032779e-05
the O 0 7.930552237667143e-05
canine O 0 0.0009715788764879107
chromosome O 0 0.00044961218372918665
regions O 0 0.00030901285936124623
CFA22q11 O 0 0.025118127465248108
and O 0 0.00012445265019778162
CFA10q26 O 0 0.010720370337367058
, O 0 2.1014016965636984e-05
respectively O 0 2.5264083888032474e-05
, O 0 4.8019178393587936e-06
demonstrating O 0 7.937171903904527e-05
that O 0 1.4369300515681971e-05
WD B-Disease 0 0.00658371252939105
cannot O 0 1.3786802810500376e-05
be O 0 3.713052365128533e-06
homologous O 0 5.085877637611702e-05
to O 0 0.00010583247058093548
CT B-Disease 0 0.16847272217273712
. O 0 0.0003941746545024216

The O 0 0.0017678012372925878
copper O 0 0.14821527898311615
transport O 0 0.0005851405439898372
genes O 0 0.00030239802435971797
CTR1 O 1 0.9994404911994934
and O 0 0.00015179271576926112
CTR2 O 1 0.9963148236274719
were O 0 6.126870721345767e-05
also O 0 4.618928414856782e-06
excluded O 0 1.1706526493071578e-05
as O 0 3.993815425928915e-06
candidate O 0 3.4461547784303548e-06
genes O 0 2.0421384760993533e-06
for O 0 7.099478352756705e-06
CT B-Disease 0 0.005015554837882519
since O 0 5.68613140785601e-05
they O 0 6.245904273782799e-07
both O 0 8.517156402376713e-07
mapped O 0 1.6818226868053898e-05
to O 0 1.755099765432533e-05
canine O 0 0.0007704002782702446
chromosome O 0 0.001046566292643547
region O 0 0.002912479918450117
CFA11q22 O 1 0.9837745428085327
. O 0 0.0006653363234363496

2 O 0 0.00299912435002625
- O 0 0.0017625658074393868
22 O 0 0.0009688034770078957
. O 0 0.00022527389228343964

5 O 0 0.003157309489324689
. O 0 0.0006936791469343007

A O 0 0.0006376444362103939
transcribed O 0 0.00012587997480295599
sequence O 0 1.8906062905443832e-05
identified O 0 1.583587254572194e-05
from O 0 1.3676462913281284e-05
the O 0 8.814501052256674e-05
C04107 O 0 0.0014373987214639783
- O 0 0.00034953703288920224
containing O 0 0.00021547553478740156
BAC O 0 0.01323604304343462
was O 0 0.00013312874943949282
found O 0 2.1231535356491804e-06
to O 0 2.336014404136222e-06
be O 0 1.5580868648612523e-06
homologous O 0 3.988136995758396e-06
to O 0 3.1047293305164203e-06
a O 0 3.899193870893214e-06
gene O 0 2.1284672584442887e-06
expressed O 0 2.8559593374666292e-06
from O 0 1.8049135178443976e-05
human O 0 4.406929656397551e-05
chromosome O 0 0.0004715782997664064
2p13 O 0 0.004154211841523647
- O 0 0.0007091116276569664
p16 O 0 0.00020913916523568332
, O 0 7.067748811095953e-06
a O 0 1.3807685718347784e-05
region O 0 0.00012000319111393765
devoid O 0 0.0003207370755262673
of O 0 5.3699655836680904e-05
any O 0 2.2676720618619584e-05
positional O 0 0.0004602157569024712
candidate O 0 0.00011882104445248842
genes O 0 6.42508894088678e-05
. O 0 8.520377741660923e-05

Molecular O 0 8.20739078335464e-05
analysis O 0 6.34757088846527e-06
of O 0 0.00012148314999649301
the O 0 0.0003506334323901683
APC B-Disease 0 0.0010136101627722383
gene O 0 6.4742584982013796e-06
in O 0 7.051583907013992e-06
205 O 0 1.747452188283205e-05
families O 0 1.4459189969784347e-06
: O 0 2.978031488964916e-06
extended O 0 3.944815034628846e-05
genotype O 0 0.00018688480486162007
- O 0 0.0003708483709488064
phenotype O 0 3.4406708437018096e-05
correlations O 0 0.00016322826559189707
in O 0 0.00012327039439696819
FAP B-Disease 0 0.007213512435555458
and O 0 8.443137630820274e-06
evidence O 0 1.1498631465656217e-05
for O 0 3.1512315672443947e-06
the O 0 1.52214943227591e-05
role O 0 3.4907781810034066e-05
of O 0 0.00018710785661824048
APC B-Disease 0 0.0011687263613566756
amino O 0 1.44383129736525e-05
acid O 0 1.5541614629910327e-05
changes O 0 2.106108149746433e-05
in O 0 0.0036992530804127455
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 0.022312123328447342

BACKGROUND O 0 0.0060895592905581
/ O 0 0.0010035367449745536
AIMS O 0 0.0006141631165519357
The O 0 5.416458589024842e-05
development O 0 0.00014793493028264493
of O 1 0.982111930847168
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0004238697874825448
a O 0 5.329290797817521e-05
variable O 0 5.296714789437829e-06
range O 0 2.7491138098412193e-05
of O 0 0.000188222446013242
extracolonic O 0 0.011669382452964783
manifestations O 0 0.0045138150453567505
in O 0 0.0008327920804731548
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9997846484184265
FAP B-Disease 1 0.9999831914901733
) O 0 4.363942571217194e-05
is O 0 2.6526552119321423e-06
the O 0 4.534872914518928e-06
result O 0 2.7302846774546197e-06
of O 0 2.743692311923951e-05
the O 0 3.929841113858856e-05
dominant O 0 0.00026054438785649836
inheritance O 0 0.00019007065566256642
of O 0 0.0024973738472908735
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.00339607335627079
APC B-Disease 0 0.012299795635044575
) O 0 4.0124901715898886e-05
gene O 0 2.992346344399266e-05
mutations O 0 7.453518628608435e-05
. O 0 0.00019922640058211982

In O 0 0.00012476503616198897
this O 0 5.021161996410228e-06
study O 0 4.601078671839787e-06
, O 0 1.1070993650719174e-06
direct O 0 1.4453468111241818e-06
mutation O 0 9.374171554554778e-07
analysis O 0 1.0523933724471135e-06
of O 0 3.937404108000919e-05
the O 0 0.00018086229101754725
APC B-Disease 0 0.0014380080392584205
gene O 0 1.0555580956861377e-05
was O 0 5.84212648391258e-05
performed O 0 1.780162529030349e-05
to O 0 3.975083018303849e-06
determine O 0 1.4336862477648538e-05
genotype O 0 8.612564124632627e-05
- O 0 0.0001090975129045546
phenotype O 0 7.196796559583163e-06
correlations O 0 3.2482123060617596e-05
for O 0 1.7287056834902614e-05
nine O 0 0.00032458617351949215
extracolonic O 0 0.007589542306959629
manifestations O 0 0.00164012610912323
and O 0 3.298062802059576e-05
to O 0 2.366776425333228e-05
investigate O 0 7.115220068953931e-05
the O 0 9.956383291864768e-05
incidence O 0 0.0004155472561251372
of O 0 0.00040337597602047026
APC B-Disease 0 0.0016619103262200952
mutations O 0 1.5375779184978455e-05
in O 0 6.234593456611037e-05
non O 0 0.010140645317733288
- O 1 0.9999891519546509
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.014850137755274773

METHODS O 0 0.0017844991525635123
The O 0 0.0007214901852421463
APC B-Disease 0 0.002042241860181093
gene O 0 2.208506703027524e-05
was O 0 8.865871495800093e-05
analysed O 0 5.852229878655635e-05
in O 0 1.350103866570862e-05
190 O 0 4.169984458712861e-05
unrelated O 0 0.00018114151316694915
FAP B-Disease 0 0.0038745037745684385
and O 0 1.8783781342790462e-05
15 O 0 0.0002236868313048035
non O 0 0.0693378746509552
- O 1 0.9999970197677612
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.010364184156060219
using O 0 0.000289673829684034
denaturing O 0 0.014964163303375244
gradient O 0 0.002994142472743988
gel O 0 0.0027712646406143904
electrophoresis O 0 0.00029990580515004694
, O 0 1.0895593732129782e-05
the O 0 1.733475255605299e-05
protein O 0 5.477894774230663e-06
truncation O 0 7.450739940395579e-05
test O 0 5.197805421630619e-06
, O 0 1.8337258325118455e-06
and O 0 1.137679532803304e-06
direct O 0 4.63554306406877e-06
sequencing O 0 8.676913421368226e-05
. O 0 6.77428615745157e-05

RESULTS O 0 0.003807875094935298
Chain O 0 0.0008903132402338088
terminating O 0 0.00036905266460962594
signals O 0 0.0001252304791705683
were O 0 1.5129566236282699e-05
only O 0 2.778977886919165e-06
identified O 0 5.32201102032559e-06
in O 0 9.557133125781547e-06
patients O 0 8.905963113647886e-06
belonging O 0 2.07721514016157e-05
to O 0 1.4759601072000805e-05
the O 0 0.00011538106627995148
FAP B-Disease 0 0.008215892128646374
group O 0 7.87649696576409e-06
( O 0 9.865311767498497e-06
105 O 0 0.00011821372027043253
patients O 0 8.062739652814344e-05
) O 0 5.207482536206953e-05
. O 0 0.00011151794751640409

Amino O 0 0.00040957177407108247
acid O 0 9.346802107756957e-05
changes O 0 8.616629202151671e-06
were O 0 1.981196692213416e-05
identified O 0 9.817858881433494e-06
in O 0 1.230561247211881e-05
four O 0 9.633918125473429e-06
patients O 0 1.3337921700440347e-05
, O 0 2.9284076390467817e-06
three O 0 1.9892811451427406e-06
of O 0 6.642920197919011e-05
whom O 0 0.00013146857963874936
belonged O 0 0.000511090736836195
to O 0 1.4814147107244935e-05
the O 0 6.061525709810667e-05
non O 0 0.0003248034918215126
- O 0 0.0005368857528083026
FAP O 0 0.006006937474012375
group O 0 2.5689148969831876e-05
of O 1 0.9445785880088806
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999992847442627
. O 0 0.003237048862501979

Genotype O 0 0.003747729118913412
- O 0 0.0009431042126379907
phenotype O 0 4.176635047770105e-05
correlations O 0 0.00010877018212340772
identified O 0 2.6922605684376322e-05
significant O 0 3.6809742596233264e-05
differences O 0 0.00010729920904850587
in O 0 4.442779754754156e-05
the O 0 4.466671452973969e-05
nature O 0 3.3153057302115485e-05
of O 0 6.690032023470849e-05
certain O 0 7.320575241465122e-05
extracolonic O 1 0.919863224029541
manifestations O 0 0.02743612788617611
in O 0 0.0016531147994101048
FAP B-Disease 1 0.9963453412055969
patients O 0 0.00012435135431587696
belonging O 0 6.556641164934263e-05
to O 0 1.657366556173656e-05
three O 0 3.757974263862707e-05
mutation O 0 5.073520514997654e-05
subgroups O 0 0.0005693003768101335
. O 0 0.00034696931834332645

CONCLUSIONS O 0 0.0008239735616371036
Extended O 0 0.0006769612082280219
genotype O 0 0.0005755004822276533
- O 0 0.00043208495480939746
phenotype O 0 2.0965933799743652e-05
correlations O 0 4.6090324758552015e-05
made O 0 2.2309452106128447e-05
in O 0 1.0080726497108117e-05
this O 0 1.7669616454440984e-06
study O 0 3.7729919313278515e-06
may O 0 8.084486580628436e-06
have O 0 7.966492603372899e-07
the O 0 4.692019501817413e-06
potential O 0 9.08924175746506e-06
to O 0 1.8617129171616398e-06
determine O 0 2.8670112897088984e-06
the O 0 5.220489128987538e-06
most O 0 1.1188298003617092e-06
appropriate O 0 2.8289059628150426e-06
surveillance O 0 3.6134591937297955e-05
and O 0 1.2613030776265077e-05
prophylactic O 0 0.0010714479722082615
treatment O 0 0.0004231731581967324
regimens O 0 0.00048928550677374
for O 0 1.535662704554852e-05
those O 0 1.3551643860409968e-05
patients O 0 1.4609785466745961e-05
with O 0 5.461160981212743e-06
mutations O 0 2.6011499357991852e-05
associated O 0 4.908937626169063e-05
with O 0 2.760257302725222e-05
life O 0 0.0011960359988734126
threatening O 0 0.0016489445697516203
conditions O 0 0.002604768145829439
. O 0 0.0005585036124102771

This O 0 1.9415847418713383e-05
study O 0 6.912794106028741e-06
also O 0 1.7610785789656802e-06
provided O 0 3.876960818161024e-06
evidence O 0 2.141845652658958e-05
for O 0 7.231014933495317e-06
the O 0 6.270362791838124e-05
pathological O 0 0.0017217834247276187
nature O 0 0.0001939629582921043
of O 0 0.0006919973529875278
amino O 0 0.0002127392217516899
acid O 0 0.0001294139656238258
changes O 0 2.5333902158308774e-05
in O 0 8.73979224707e-05
APC O 0 0.0006481708260253072
associated O 0 7.0768746809335425e-06
with O 0 2.3123334358388092e-06
both O 0 1.8437580365571193e-05
FAP B-Disease 0 0.25695672631263733
and O 0 6.624024535994977e-05
non O 1 0.7954348921775818
- O 1 0.9999995231628418
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9972296357154846
. O 0 0.000302695669233799
. O 0 0.0001624921860639006

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999995231628418
cancer B-Disease 1 1.0
risk O 1 0.9509879946708679
of O 1 0.9930821657180786
the O 1 0.9533208012580872
APC O 0 0.18252971768379211
I1307K O 0 0.004377055447548628
polymorphism O 0 0.00021481193834915757
. O 0 0.0001958850771188736

Germ O 1 0.9999983310699463
- O 0 0.005200264975428581
line O 0 0.00040766544407233596
and O 0 1.593266824784223e-05
somatic O 0 6.402647704817355e-05
truncating O 0 0.0004340771120041609
mutations O 0 1.1099960829596967e-05
of O 0 0.00011971279309364036
the O 0 0.00038272273377515376
APC B-Disease 0 0.0013621351681649685
gene O 0 5.4004208323021885e-06
are O 0 4.972096121491631e-07
thought O 0 2.7249391223449493e-06
to O 0 4.5505121306632645e-06
initiate O 0 0.00043391447979956865
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999990463256836
formation O 1 0.9899783134460449
in O 1 0.5847225189208984
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 1.0
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.250017911195755
respectively O 0 0.002808797173202038
. O 0 0.00037302548298612237

Recently O 0 0.0008028517477214336
, O 0 3.391231439309195e-05
an O 0 3.957871740567498e-05
isoleucine O 0 0.005750947166234255
- O 0 0.0013151372550055385
- O 0 0.000691899738740176
> O 0 0.00021326402202248573
lysine O 0 0.00011892056500073522
polymorphism O 0 2.499858419469092e-05
at O 0 0.0003295809729024768
codon O 0 0.00013944008969701827
1307 O 0 0.004552875179797411
( O 0 3.930553430109285e-05
I1307K O 0 0.00044112486648373306
) O 0 4.191937932773726e-06
of O 0 3.446671325946227e-05
the O 0 0.0001429251569788903
APC B-Disease 0 0.0010404790518805385
gene O 0 7.574798928544624e-06
has O 0 1.4372262739925645e-06
been O 0 2.3733487068966497e-06
identified O 0 2.7008134111383697e-06
in O 0 5.461661203298718e-06
6 O 0 5.5028838687576354e-05
% O 0 1.2820858501072507e-05
- O 0 8.518322283634916e-05
7 O 0 4.763401375385001e-05
% O 0 3.8758444134145975e-06
of O 0 3.6488836485659704e-05
the O 0 7.819748861948028e-05
Ashkenazi O 0 0.000154790366650559
Jewish O 0 7.002719939919189e-05
population O 0 1.8791755792335607e-05
. O 0 4.87067736685276e-05

To O 0 0.0001057074114214629
assess O 0 0.00016554286412429065
the O 0 8.203071774914861e-05
risk O 0 4.008983523817733e-05
of O 0 4.4525771954795346e-05
this O 0 1.042510848492384e-05
common O 0 5.9875077567994595e-05
APC B-Disease 0 0.002140773693099618
allelic O 0 0.0006802019197493792
variant O 0 0.0014378683408722281
in O 0 0.0029944339767098427
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.000231652389629744
we O 0 1.1605659892666154e-05
have O 0 9.418151307727385e-07
analyzed O 0 8.536472705600318e-06
a O 0 7.005227416811977e-06
large O 0 2.3341981432167813e-05
cohort O 0 0.00010774254042189568
of O 0 0.00010319358989363536
unselected O 0 0.0053976355120539665
Ashkenazi O 0 0.0003687613061629236
Jewish O 0 0.00014225838822312653
subjects O 0 0.0006214493769221008
with O 0 0.00025127443950623274
adenomatous B-Disease 1 0.9999964237213135
polyps I-Disease 1 0.9986155033111572
and O 0 0.00016612191393505782
. O 0 0.0002235139545518905
or O 1 0.9936887621879578
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.0005010372260585427
for O 0 4.58312060800381e-05
the O 0 0.0006485307822003961
APC O 0 0.005402086302638054
I1307K O 0 0.0020409885328263044
polymorphism O 0 0.00012341153342276812
. O 0 0.0001281700242543593

The O 0 0.0018488633213564754
APC O 0 0.007096028421074152
I1307K O 0 0.0011325975647196174
allele O 0 9.114571184909437e-06
was O 0 8.54724130476825e-05
identified O 0 9.548478374199476e-06
in O 0 1.3996261259308085e-05
48 O 0 3.1119005143409595e-05
( O 0 6.204090823302977e-06
10 O 0 1.1437408829806373e-05
. O 0 1.7168940757983364e-06
1 O 0 1.9251900084782392e-05
% O 0 4.545974661596119e-06
) O 0 3.255024921600125e-06
of O 0 0.00010719940473791212
476 O 0 0.002865726128220558
patients O 0 0.0006446417537517846
. O 0 0.0004374140116851777

Compared O 0 0.00024171006225515157
with O 0 8.177668860298581e-06
the O 0 4.0763789002085105e-05
frequency O 0 1.601283838681411e-05
in O 0 5.6622684496687725e-06
two O 0 8.049705684243236e-07
separate O 0 1.1514797506606556e-06
population O 0 9.875448085949756e-07
control O 0 1.1240360436204355e-05
groups O 0 1.312367544414883e-06
, O 0 6.153263257147046e-06
the O 0 8.239212911576033e-05
APC O 0 0.0026334139984101057
I1307K O 0 0.0008709585526958108
allele O 0 6.170268989080796e-06
is O 0 1.59837213686842e-06
associated O 0 9.048075639839226e-07
with O 0 3.814930096268654e-07
an O 0 1.4636107152909972e-06
estimated O 0 2.9488621294149198e-05
relative O 0 7.309407374123111e-05
risk O 0 7.605364953633398e-05
of O 0 0.00033548843930475414
1 O 0 0.002127504674717784
. O 0 0.00026748102391138673

5 O 0 0.0015470291255041957
- O 0 0.0010781617602333426
1 O 0 0.0005225744098424911
. O 0 0.0001376283762510866

7 O 0 0.001483860076405108
for O 0 0.0006648279377259314
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999995231628418
( O 0 0.0007259874837473035
both O 0 0.0002215000131400302
P O 0 0.008744313381612301
= O 0 0.00026418393827043474
. O 0 2.405168197583407e-05
01 O 0 0.0011698416201397777
) O 0 3.406647374504246e-05
. O 0 9.748755837790668e-05

Furthermore O 0 0.0002731260028667748
, O 0 1.4433301657845732e-05
compared O 0 2.627056346682366e-05
with O 0 2.6589477784000337e-05
noncarriers O 0 0.03535895422101021
, O 0 0.00014036228822078556
APC O 0 0.0024281011428683996
I1307K O 0 0.0008416248019784689
carriers O 0 9.333795787824783e-06
had O 0 6.928026778041385e-06
increased O 0 5.543153292819625e-06
numbers O 0 7.25728159522987e-06
of O 0 0.0003258046053815633
adenomas B-Disease 1 0.9999955892562866
and O 0 0.005222691688686609
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.0007651515770703554
patient O 0 0.00041486069676466286
( O 0 6.83302860124968e-05
P O 0 0.0020754337310791016
= O 0 0.00014269042003434151
. O 0 1.654956395213958e-05
03 O 0 0.000871960713993758
) O 0 1.0363767614762764e-05
, O 0 2.8556594315887196e-06
as O 0 5.602324563369621e-06
well O 0 3.725342139659915e-06
as O 0 6.769683295715367e-06
a O 0 1.9356613847776316e-05
younger O 0 0.00012479847646318376
age O 0 0.00021413443027995527
at O 0 0.0012641871580854058
diagnosis O 0 0.008338888175785542
. O 0 0.0007305642357096076

We O 0 6.450725777540356e-05
conclude O 0 0.00013967335689812899
that O 0 4.722964149550535e-06
the O 0 9.130755643127486e-05
APC O 0 0.0018245633691549301
I1307K O 0 0.0007226441521197557
variant O 0 7.289644418051466e-05
leads O 0 5.5699933000141755e-05
to O 0 6.341318658087403e-05
increased O 0 0.000987860606983304
adenoma B-Disease 1 1.0
formation O 0 0.021160461008548737
and O 0 0.00010015412408392876
directly O 0 4.03311823902186e-05
contributes O 0 2.0661258531617932e-05
to O 0 8.365920621145051e-06
3 O 0 2.9445343898260035e-05
% O 0 5.3459402806765866e-06
- O 0 3.100856702076271e-05
4 O 0 1.0242949429084547e-05
% O 0 8.240772331191693e-07
of O 0 6.620361091336235e-06
all O 0 6.227458470675629e-06
Ashkenazi O 0 0.0004771456588059664
Jewish O 1 0.9822673201560974
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7641288042068481

The O 0 0.0002204698685090989
estimated O 0 0.00011271759285591543
relative O 0 0.00010870373080251738
risk O 0 5.453287667478435e-05
for O 0 2.4261060389108025e-05
carriers O 0 6.671963637927547e-05
may O 0 3.614017623476684e-05
justify O 0 4.2073683289345354e-05
specific O 0 1.1010009757228545e-06
clinical O 0 1.7554462829139084e-05
screening O 0 1.202678231493337e-05
for O 0 6.868051514175022e-06
the O 0 4.5941567805130035e-05
360 O 0 8.217509457608685e-05
, O 0 4.545532647171058e-06
000 O 0 3.8220507121877745e-05
Americans O 0 6.437625415856019e-06
expected O 0 9.474723810853902e-06
to O 0 1.4369218661158811e-05
harbor O 0 0.0010433527640998363
this O 0 2.2079975678934716e-06
allele O 0 1.995425918721594e-06
, O 0 1.0881011576202582e-06
and O 0 1.0884697303481516e-06
genetic O 0 1.0164693776459899e-05
testing O 0 7.602705409226473e-06
in O 0 1.4819714124314487e-05
the O 0 3.215055039618164e-05
setting O 0 5.538250843528658e-05
of O 0 0.000133959882077761
long O 0 0.00041140697430819273
- O 0 0.00020956795196980238
term O 0 5.537976176128723e-05
- O 0 2.4424887669738382e-05
outcome O 0 4.340539817349054e-06
studies O 0 1.683196614976623e-06
may O 0 3.779776989176753e-06
impact O 0 1.2507157407526392e-05
significantly O 0 8.410287409787998e-05
on O 0 0.004120292142033577
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9972115159034729
in O 0 0.00011046444706153125
this O 0 1.2918935681227595e-05
population O 0 5.529288500838447e-06
. O 0 3.404266681172885e-05

Localization O 0 0.004763258621096611
of O 0 0.001142394612543285
human O 0 0.0005138508859090507
BRCA1 O 0 0.0008111104252748191
and O 0 1.88403319043573e-05
its O 0 1.964617331395857e-05
loss O 0 0.00018759393424261361
in O 0 7.74426298448816e-05
high O 0 0.0005545412423089147
- O 0 0.00020410116121638566
grade O 0 0.0004998017684556544
, O 0 1.3036858945270069e-05
non B-Disease 0 0.00037108073593117297
- I-Disease 0 0.0121452072635293
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.006186748389154673

Although O 0 1.9830453311442398e-05
the O 0 1.2913909813505597e-05
link O 0 8.48848358145915e-05
between O 0 0.00010634984209900722
the O 0 0.0003501824103295803
BRCA1 O 0 0.03175582364201546
tumour B-Disease 1 1.0
- O 0 0.006667475216090679
suppressor O 0 0.0007080240757204592
gene O 0 1.4684461348224431e-05
and O 0 1.6694209989509545e-05
hereditary B-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.001176096498966217
established O 0 0.000230453530093655
, O 0 4.14563737649587e-06
the O 0 9.003179002320394e-06
role O 0 3.0381750548258424e-05
, O 0 2.6140512545680394e-06
if O 0 5.388055228650046e-07
any O 0 1.0795160960697103e-06
, O 0 2.187720838264795e-06
of O 0 4.7215096856234595e-05
BRCA1 O 0 0.0005490025505423546
in O 0 0.00012982926273252815
non B-Disease 0 0.0016741418512538075
- I-Disease 0 0.0048209247179329395
familial I-Disease 0 0.4557259678840637
cancers I-Disease 1 0.999983549118042
is O 0 0.00021904485765844584
unclear O 0 0.00031794013921171427
. O 0 0.00010196211223956198

BRCA1 O 0 0.0025287154130637646
mutations O 0 6.18085905443877e-05
are O 0 3.748256858671084e-06
rare O 0 6.430580833693966e-05
in O 0 0.00010619195381877944
sporadic B-Disease 0 0.0043709250167012215
cancers I-Disease 1 0.9990360736846924
, O 0 4.1560851968824863e-05
but O 0 9.388536454935092e-06
loss O 0 0.00023396400501951575
of O 0 0.0006124927313067019
BRCA1 O 0 0.002063559368252754
resulting O 0 0.0002126272884197533
from O 0 0.00011904763960046694
reduced O 0 9.444136230740696e-05
expression O 0 4.1075189074035734e-05
or O 0 3.261879101046361e-05
incorrect O 0 0.00011366145918145776
subcellular O 0 0.0008137763361446559
localization O 0 0.0007002124912105501
is O 0 1.195552795252297e-05
postulated O 0 7.666457531740889e-05
to O 0 2.6899301701632794e-06
be O 0 1.1075280781369656e-06
important O 0 4.857278781855712e-06
in O 0 7.78253706812393e-06
non B-Disease 0 0.00020281689648982137
- I-Disease 0 0.0007358963484875858
familial I-Disease 1 0.991772472858429
breast I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9999089241027832

Epigenetic O 0 0.020900584757328033
loss O 0 0.23665539920330048
, O 0 0.0001719696883810684
however O 0 3.674163963296451e-05
, O 0 5.1622082537505776e-06
has O 0 6.268550123422756e-07
not O 0 1.2386992409574304e-07
received O 0 1.2961802440258907e-06
general O 0 1.0648378520272672e-05
acceptance O 0 8.307906682603061e-05
due O 0 0.0002800683432724327
to O 0 3.7442132452270016e-05
controversy O 0 0.00021512449893634766
regarding O 0 3.7152676668483764e-05
the O 0 8.044760033953935e-05
subcellular O 0 0.0004449477419257164
localization O 0 0.00039575627306476235
of O 0 0.00030606010113842785
BRCA1 O 0 0.0007922725635580719
proteins O 0 1.4170886970532592e-05
, O 0 2.473240328981774e-06
reports O 0 2.499798938515596e-06
of O 0 1.4999936865933705e-05
which O 0 3.453204953984823e-06
have O 0 1.2136885061408975e-06
ranged O 0 0.00011388061830075458
from O 0 1.8144140994991176e-05
exclusively O 0 2.5755038222996518e-05
nuclear O 0 0.00024007796309888363
, O 0 2.33537730309763e-06
to O 0 2.766845227597514e-06
conditionally O 0 4.4485455873655155e-05
nuclear O 0 0.00010863617353606969
, O 0 1.8806191519615822e-06
to O 0 5.881910510652233e-06
the O 0 0.0001765177585184574
ER O 1 0.9965477585792542
/ O 0 0.0010913194855675101
golgi O 0 0.0045632254332304
, O 0 2.009357740462292e-05
to O 0 2.8734642910421826e-05
cytoplasmic O 0 0.00022446346702054143
invaginations O 0 0.0038585274014621973
into O 0 0.00012904044706374407
the O 0 0.00025305862072855234
nucleus O 0 0.0013238497776910663
. O 0 0.0002236840664409101

In O 0 0.00013862489140592515
an O 0 8.512442946084775e-06
attempt O 0 6.722442776663229e-05
to O 0 1.8729513612925075e-05
resolve O 0 0.00011434459884185344
this O 0 4.026779151899973e-06
issue O 0 1.3483809198078234e-05
, O 0 1.4420246543522808e-06
we O 0 1.0391847808932653e-06
have O 0 6.192501587065635e-07
comprehensively O 0 0.000287271715933457
characterized O 0 7.403034396702424e-05
19 O 0 0.0005517816171050072
anti O 0 0.0025090849958360195
- O 0 0.0035673973616212606
BRCA1 O 0 0.0013157724170014262
antibodies O 0 8.968250767793506e-05
. O 0 0.00010714910604292527

These O 0 0.00010389660019427538
reagents O 0 0.00040404486935585737
detect O 0 0.0006554214050993323
a O 0 0.00010804873454617336
220 O 0 0.000239706743741408
- O 0 0.0003211412695236504
kD O 0 0.001768243033438921
protein O 0 8.408088433498051e-06
localized O 0 1.1087858183600474e-05
in O 0 5.944806162005989e-06
discrete O 0 2.8019278033752926e-05
nuclear O 0 0.00045472278725355864
foci O 0 0.0006226035766303539
in O 0 2.9383523724391125e-05
all O 0 2.9768512831651606e-05
epithelial O 0 0.0063871643505990505
cell O 0 0.000903536390978843
lines O 0 9.612955182092264e-05
, O 0 3.5441685213299934e-06
including O 0 1.5198398841675953e-06
those O 0 5.965592663415009e-06
derived O 0 7.043814548524097e-05
from O 0 0.0006515762070193887
breast B-Disease 1 0.9985901713371277
malignancies I-Disease 1 0.9989450573921204
. O 0 0.001373671111650765

Immunohistochemical O 0 0.029893916100263596
staining O 0 0.004155867267400026
of O 0 0.007716451771557331
human O 0 0.007359587587416172
breast O 0 0.18749259412288666
specimens O 0 0.0002781905641313642
also O 0 3.797034514718689e-05
revealed O 0 0.0006215935572981834
BRCA1 O 0 0.001196472905576229
nuclear O 0 0.0018921528244391084
foci O 0 0.004741836804896593
in O 0 0.0004378230660222471
benign O 1 0.9999982118606567
breast O 1 0.9999998807907104
, O 0 0.009496740996837616
invasive B-Disease 1 0.9999998807907104
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.002664796309545636
low B-Disease 1 0.9999041557312012
- I-Disease 1 0.9998555183410645
grade I-Disease 1 0.9999992847442627
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.00315503659658134

Conversely O 0 0.0019634950440376997
, O 0 0.00010746323823696002
BRCA1 O 0 0.0007606641156598926
expression O 0 8.424197585554793e-05
was O 0 0.0004211129853501916
reduced O 0 9.207981202052906e-05
or O 0 3.4711265470832586e-05
undetectable O 0 0.0007219193503260612
in O 0 1.0142005521629471e-05
the O 0 7.124016519810539e-06
majority O 0 2.45992873715295e-06
of O 0 6.205640966072679e-05
high O 0 0.001697125961072743
- O 0 0.0018279273062944412
grade O 0 0.05166862532496452
, O 0 0.00044576157233677804
ductal B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 0 0.0001222673454321921
suggesting O 0 6.832878716522828e-05
that O 0 3.70554585060745e-06
absence O 0 0.0001315864792559296
of O 0 0.0003052464744541794
BRCA1 O 0 0.000714985013473779
may O 0 4.2644944187486544e-05
contribute O 0 1.6282258002320305e-05
to O 0 1.280188462260412e-05
the O 0 9.519234299659729e-05
pathogenesis O 0 0.005160119850188494
of O 0 6.581115303561091e-05
a O 0 8.302179594465997e-06
significant O 0 1.0911126992141362e-05
percentage O 0 3.389841367607005e-05
of O 0 0.00017639763245824724
sporadic B-Disease 1 0.9609991908073425
breast I-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9999927282333374
. O 0 0.0003040167794097215
. O 0 0.0002640879829414189

